PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	STEPHENS, DS; HAJJEH, RA; BAUGHMAN, WS; HARVEY, RC; WENGER, JD; FARLEY, MM				STEPHENS, DS; HAJJEH, RA; BAUGHMAN, WS; HARVEY, RC; WENGER, JD; FARLEY, MM			SPORADIC MENINGOCOCCAL DISEASE IN ADULTS - RESULTS OF A 5-YEAR POPULATION-BASED STUDY	ANNALS OF INTERNAL MEDICINE			English	Note							IMMUNODEFICIENCY; MENINGITIS; INFECTION	Objective: To define the incidence, demographics, clinical features, and risk factors for sporadic meningococcal disease in adults (greater than or equal to 18 years) residing in metropolitan Atlanta. Design: Prospective, population-based surveillance, with retrospective review of clinical and laboratory records. Setting: Eight-county metropolitan Atlanta area. Patients: All adult patients in whom Neisseria meningitidis was isolated from normally sterile sites (blood, cerebrospinal fluid) during the period 1 December 1988 to 30 November 1993. Measurements: Incidence, relative risk, clinical and laboratory parameters, and serogroup of meningococcal isolates. Results: For the 5-year period, 44 (33%) of 132 cases of meningococcal disease in Atlanta occurred in adults (annual incidence, 0.50/100 000 adults per year). Twenty-three (52%) of the 44 adults presented without rash or meningitis, the two most obvious signs of meningococcal disease. Pneumonia, sinusitis, or purulent tracheobronchitis, but without rash, were the likely sources of meningococcal bacteremia in 15 (34%) of the 44 adults. Twelve of the 15 patients with meningococcal respiratory infection were older than 50 years of age or were immunocompromised (or both), and three fourths of the 15 patients had disease caused by serogroups B, Y, and W-135. Overall, two thirds of adults older than 24 years of age with meningococcal disease had one or more immunocompromising conditions (for example, low complement 50 level [CH50], corticosteroid use, congestive heart failure, multiple myeloma, human immunodeficiency virus infection). Meningococcemia or meningococcal meningitis, often caused by serogroup C, were the presentations in 14 of 15 adults 18 to 24 years old; only 2 had an identified underlying condition. Conclusions: In this 5-year population-based study, one third of all cases of sporadic meningococcal disease occurred in adults. Over half of the adults presented without rash or meningitis. Pneumonia, sinusitis, and tracheobronchitis are important sources of bacteremic meningococcal disease, especially in immunocompromised patients and elderly persons.	CTR DIS CONTROL & PREVENT, ATLANTA, GA USA	Centers for Disease Control & Prevention - USA	STEPHENS, DS (corresponding author), EMORY UNIV, SCH MED, VET AFFAIRS MED CTR, ATLANTA, GA 30322 USA.		Stephens, David S/A-8788-2012					APICELLA MA, 1995, PRINCIPLES PRACTICE, P1896; BANKS JS, 1948, LANCET, P635; BENOIT FL, 1963, AM J MED, V35, P103, DOI 10.1016/0002-9343(63)90167-0; COHEN MS, 1979, ANN INTERN MED, V91, P7, DOI 10.7326/0003-4819-91-1-7; ELLISON RT, 1983, NEW ENGL J MED, V308, P913, DOI 10.1056/NEJM198304213081601; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; IRWIN RS, 1975, ANN INTERN MED, V82, P493, DOI 10.7326/0003-4819-82-4-493; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; JURADO RL, 1993, CLIN INFECT DIS, V17, P224, DOI 10.1093/clinids/17.2.224; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; NITTA AT, 1993, AIDS, V7, P87, DOI 10.1097/00002030-199301000-00013; PINNER RW, 1992, J INFECT DIS, V166, P359, DOI 10.1093/infdis/166.2.359; SALTZMAN RL, 1987, REV INFECT DIS, V9, P1127; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; WITT D, 1982, AM REV RESPIR DIS, V125, P255; WOLF RE, 1968, AM J MED, V44, P243, DOI 10.1016/0002-9343(68)90156-3; WOODS CR, 1994, J INFECT DIS, V170, P453, DOI 10.1093/infdis/170.2.453; 1995, MMWR-MORBID MORTAL W, V44, P121	20	83	86	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1995	123	12					937	940		10.7326/0003-4819-123-12-199512150-00007	http://dx.doi.org/10.7326/0003-4819-123-12-199512150-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK120	7486489				2022-12-24	WOS:A1995TK12000007
J	GJERTSEN, MK; BAKKA, A; BREIVIK, J; SAETERDAL, I; SOLHEIM, BG; SOREIDE, O; THORSBY, E; GAUDERNACK, G				GJERTSEN, MK; BAKKA, A; BREIVIK, J; SAETERDAL, I; SOLHEIM, BG; SOREIDE, O; THORSBY, E; GAUDERNACK, G			VACCINATION WITH MUTANT RAS PEPTIDES AND INDUCTION OF T-CELL RESPONSIVENESS IN PANCREATIC-CARCINOMA PATIENTS CARRYING THE CORRESPONDING RAS MUTATION	LANCET			English	Note							REJECTION	Mutations in codon 12 of K-RAS are frequently found in pancreatic adenocarcinomas. T-cell responses specific for individual RAS mutations can be elicited in vitro by stimulation of peripheral blood mononuclear cells with synthetic peptides. Mutant ras peptides are therefore a candidate vaccine for specific immunotherapy in pancreatic carcinoma patients. When vaccinated with a synthetic ras peptide representing the K-RAS mutation in their tumours, a transient ras-specific T-cell response was induced in two of five patients treated. The vaccination protocol involved multiple in fusions of large amounts of peptide-pulsed antigen-presenting-cells obtained by leucapheresis. These results indicate that specific T-cell responses against mutations uniquely harboured in tumour cells can be induced in cancer patients by vaccination.	NATL HOSP,INST TRANSPLANTAT IMMUNOL,OSLO,NORWAY; NATL HOSP,DEPT SURG B,OSLO,NORWAY; RED CROSS & NATL HOSP BLOOD CTR,OSLO,NORWAY	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway			Klemp, Marianne/AAQ-5652-2021	Klemp, Marianne/0000-0002-9530-8344				BECKER JC, 1993, INT IMMUNOL, V5, P1501, DOI 10.1093/intimm/5.12.1501; FOSSUM B, 1994, INT J CANCER, V56, P40, DOI 10.1002/ijc.2910560108; FOSSUM B, 1995, CANCER IMMUNOL IMMUN, V40, P165; GEDDEDAHL T, 1992, INT IMMUNOL, V4, P1331, DOI 10.1093/intimm/4.11.1331; GEDDEDAHL T, 1993, EUR J IMMUNOL, V23, P754, DOI 10.1002/eji.1830230328; JUNG S, 1991, J EXP MED, V73, P273; KAHN SM, 1991, ONCOGENE, V6, P1079; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VAESSEN LMB, 1992, CLIN EXP IMMUNOL, V88, P213	10	164	173	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1399	1400		10.1016/S0140-6736(95)92408-6	http://dx.doi.org/10.1016/S0140-6736(95)92408-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475823	Bronze			2022-12-24	WOS:A1995TG20700011
J	SMITH, JD; ROSE, ML; POMERANCE, A; BURKE, M; YACOUB, MH				SMITH, JD; ROSE, ML; POMERANCE, A; BURKE, M; YACOUB, MH			REDUCTION OF CELLULAR REJECTION AND INCREASE IN LONGER-TERM SURVIVAL AFTER HEART-TRANSPLANTATION AFTER HLA-DR MATCHING	LANCET			English	Article							CARDIAC ALLOGRAFT RECIPIENTS; RISK-FACTORS; ANTIGENS; HISTOCOMPATIBILITY	HLA matching in cardiac transplants is perceived as being logistically difficult. We studied 1135 consecutive primary cardiac allografts between 1980 and 1994 to assess the effect of HLA mismatching on long-term graft survival acid cellular rejection episodes within 3 months of transplantation. We found a significant association between HLA-DR mismatching and the number of episodes of rejection (no mismatch 0.80 [SE 0.13], one mismatch 1.22 [0.06], two mismatches 1.42 [0.06], p<0.05). We found a similar correlation between the total number of biopsy specimens showing evidence of cellular rejection and HLA-DR mismatch. The time between operation and the first rejection episode shortened with increasing HLA-DR mismatch (no mismatch 85.5 [37.3] days, one mismatch 43.1 [8.1], two mismatches 24.1 [2.9], p<0.05). Furthermore, the proportion of patients with no evidence of rejection correlated with HLA-DR incompatibility. A significant association between improved graft survival and HLA-DR mismatching was found over 1, 5, and 10 years after transplantation (no mismatch 1 year 92%, 5 years 83%, 10 years 76%, one mismatch 1 year 81%, 5 years 73%, 10 years 59%, and two mismatches 78% 1 year, 5 years 70%, and 10 years 52%, p=0.02). Increased efforts to prospectively HLA match patients has resulted in 25% of patients transplanted between January and May 1995 (n=13/52) receiving grafts matched for HLA-DR. HLA matching reduces the frequency and severity of acute cardiac allograft rejection and improves graft survival for up to 10 years. Our preliminary results suggest that it is possible to use HLA matching prospectively for our selection of recipients.	HAREFIELD HOSP,IMPERIAL COLL SCI & TECHNOL,NATL HEART & LUNG INST,DEPT CARDIOTHORAC SURG,HAREFIELD UB9 6JH,MIDDX,ENGLAND; HAREFIELD HOSP,ROYAL BROMPTON & NATL HEART HOSP,CTR HEART SCI,HAREFIELD UB9 6JH,MIDDX,ENGLAND	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital								Billingham M E, 1990, J Heart Transplant, V9, P587; BRAND DL, 1970, HISTOCOMPATIBILITY T, P357; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; COCHRANE A, 1992, TRANSPLANT P, V24, P169; DISESA VJ, 1990, ANN THORAC SURG, V49, P220, DOI 10.1016/0003-4975(90)90141-R; FESTENSTEIN H, 1989, IMMUNOBIOLOGY HLA II, P526; FRIST WH, 1987, ANN THORAC SURG, V44, P242, DOI 10.1016/S0003-4975(10)62062-0; KERMAN RH, 1994, TRANSPLANTATION, V57, P884, DOI 10.1097/00007890-199403270-00020; KHAGHANI A, 1989, TRANSPLANT P, V21, P799; LAUFER G, 1989, J THORAC CARDIOV SUR, V98, P1113; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OPELZ G, 1994, NEW ENGL J MED, V330, P816, DOI 10.1056/NEJM199403243301203; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PFEFFER PF, 1988, TRANSPLANT P, V20, P367; POLLACK MS, 1990, CLIN TRANSPLANT, V4, P269; RAFFOUX C, 1987, TRANSPLANT P, V19, P3559; ROSE M, 1988, HUM IMMUNOL, V23, P179, DOI 10.1016/0198-8859(88)90056-0; ROSE ML, 1986, TRANSPLANTATION, V41, P776, DOI 10.1097/00007890-198606000-00021; SHEIL AGR, 1993, TRANSPLANT P, V25, P1383; SHELDON S, 1994, TRANSPLANTATION, V6, P719; VALERI M, 1990, TRANSPLANT P, V4, P1906; VANROOD JJ, 1976, NATURE, V262, P795, DOI 10.1038/262795a0; YACOUB M, 1987, TRANSPLANT P, V1, P2487; ZERBE TR, 1991, TRANSPLANTATION, V52, P485, DOI 10.1097/00007890-199109000-00019	24	64	68	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 18	1995	346	8986					1318	1322		10.1016/S0140-6736(95)92341-1	http://dx.doi.org/10.1016/S0140-6736(95)92341-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE916	7475769				2022-12-24	WOS:A1995TE91600007
J	SMYTH, RL; ASHBY, D; OHEA, U; BURROWS, E; LEWIS, P; VANVELZEN, D; DODGE, JA				SMYTH, RL; ASHBY, D; OHEA, U; BURROWS, E; LEWIS, P; VANVELZEN, D; DODGE, JA			FIBROSING COLONOPATHY IN CYSTIC-FIBROSIS - RESULTS OF A CASE-CONTROL STUDY	LANCET			English	Article								Fibrosing colonopathy was first described in cystic fibrosis (CF) children in 1994. We have done a nested case-control study to identify possible associations with this condition. A case ascertainment within the UK CF population to identify any cases that occurred between January, 1984, and April, 1994, found 14 cases, all under 14 years and confirmed by independent histopathological review. All had presented since April, 1993; 12 were boys and six had received some or all of their care in Liverpool. Each case was matched, by date of birth, with four controls from the UK CF Registry. Information was obtained about cases and controls from their case records and by a structured interview with the families. In the 12 months before surgery, there was an association between the occurrence of fibrosing colonopathy and use of high-strength pancreatic enzyme preparations. This association was dose related. Odds ratio per extra 1000 high-strength capsules was 1.45 (95% CI 1.14-1.84), For use of protease, the odds ratio per million extra units per kg was 1.55 (1.19-2.03). For usage of individual high-strength products at any time during the 12 months before surgery some differences were observed; for Creon 25000 the odds ratio was 0.38 (0.10-1.42), for Nutrizym 22 43.4 (2.51-751), and for Pancrease HL 8.4 (1.95-36.1). These last two confidence intervals are extremely wide and compatible with these two products having the same odds ratios. Laxative use was independently predictive (odds ratio 2.42 [1.20-4.94]). We conclude that there is a dose-related association between high-strength pancreatic enzyme preparations and fibrosing colonopathy.	UNIV LIVERPOOL,DEPT STAT & COMPUTAT MATH,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND; UNIV WALES COLL CARDIFF,COLL MED,DEPT MED COMP & STAT,CARDIFF,S GLAM,WALES; ROYAL CHILDRENS HOSP,DEPT FETAL & INFANT PATHOL,LIVERPOOL,MERSEYSIDE,ENGLAND; QUEENS UNIV BELFAST,DEPT CHILD HLTH,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	University of Liverpool; Cardiff University; Queens University Belfast	SMYTH, RL (corresponding author), ROYAL LIVERPOOL CHILDRENS HOSP ALDER HEY,RESP UNIT,LIVERPOOL L12 2AP,MERSEYSIDE,ENGLAND.							BRESLOW N, INT AGENCY RES CANCE, V32; CAMPBELL CA, 1994, LANCET, V343, P109; Dodge J A, 1993, Paediatr Perinat Epidemiol, V7, P157, DOI 10.1111/j.1365-3016.1993.tb00390.x; KNABE N, 1994, LANCET, V343, P1230, DOI 10.1016/S0140-6736(94)92443-0; MACSWEENEY EJ, 1995, LANCET, V345, P752; MAHONY MJ, 1994, LANCET, V343, P599; OADES PJ, 1994, LANCET, V343, P109, DOI 10.1016/S0140-6736(94)90836-2; OHARE MMT, 1995, J PEDIATR GASTR NUTR, V21, P59, DOI 10.1097/00005176-199507000-00010; PETTEI MJ, 1994, J PEDIATR-US, V125, P587, DOI 10.1016/S0022-3476(94)70014-1; ROSENSTEIN BJ, 1983, J PEDIATR GASTR NUTR, V2, P299, DOI 10.1097/00005176-198305000-00014; SMYTH RL, 1994, LANCET, V343, P85, DOI 10.1016/S0140-6736(94)90817-6; WALLER PC, 1992, BRIT MED J, V304, P1470, DOI 10.1136/bmj.304.6840.1470; 1993, GUIDELINES CO SPONSO; ABPI DATA SHEET COMP	14	108	112	1	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1247	1251		10.1016/S0140-6736(95)91860-4	http://dx.doi.org/10.1016/S0140-6736(95)91860-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475715				2022-12-24	WOS:A1995TE14500008
J	BANNERMAN, DM; GOOD, MA; BUTCHER, SP; RAMSAY, M; MORRIS, RGM				BANNERMAN, DM; GOOD, MA; BUTCHER, SP; RAMSAY, M; MORRIS, RGM			DISTINCT COMPONENTS OF SPATIAL-LEARNING REVEALED BY PRIOR TRAINING AND NMDA RECEPTOR BLOCKADE	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-FORMATION; SELECTIVE IMPAIRMENT; MEMORY; CORTEX; RATS; AP5; ANTAGONIST; ACID; TRANSMISSION	SYNAPTIC plasticity dependent on N-methyl-D-aspartate (NMDA) receptors is thought to underlie certain types of learning and memory(1 3). In support of this, both hippocampal long-term potentiation and spatial learning in a watermaze are impaired by blocking NMDA receptors with a selective antagonist D(-)-2-amino-5-phosphonovaleric acid (AP5)(4) or by a mutation in one of the receptor subunits(5). Here we report, however, that the AP5-induced learning deficit can be almost completely prevented if rats are pretrained in a different watermaze before administration of the drug. This is not because of stimulus generalization, and occurs despite learning of the second task remaining hippocampus dependent. An APS-induced learning deficit is, however, still seen if the animals are pretrained using a non-spatial task. Thus, despite its procedural simplicity, the watermaze may involve multiple cognitive processes with distinct pharmacological properties; although required for some component of spatial learning, NMDA receptors may not be required for encoding the spatial representation of a specific environment.	UNIV EDINBURGH,SCH MED,CTR NEUROSCI,EDINBURGH EH8 9LE,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,SCH MED,DEPT PHARMACOL,EDINBURGH EH8 9LE,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,FUJISAWA INST NEUROSCI,EDINBURGH EH8 9JZ,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh; University of Edinburgh			Morris, Richard G M/C-9982-2013	Bannerman, David/0000-0002-3024-7595				ALFORD S, 1994, NMDA RECEPTOR, P277; BARNES CA, 1994, J NEUROSCI, V14, P5793; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BUTCHER SP, 1991, EXP BRAIN RES, V83, P521; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DAVIS S, 1992, J NEUROSCI, V12, P21; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; HEALE V, 1990, PHARMACOL BIOCHEM BE, V36, P145, DOI 10.1016/0091-3057(90)90140-D; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Johnson-Laird, 1983, MENTAL MODELS; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MORRIS RGM, 1988, EXCITATORY AMINO ACI, P297; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; SILLITO AM, 1990, NEUROSCIENCE, V34, P273, DOI 10.1016/0306-4522(90)90137-S; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SUTHERLAND NS, 1970, MECHANISMS ANIMAL DI; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	27	476	485	1	42	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					182	186		10.1038/378182a0	http://dx.doi.org/10.1038/378182a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477320				2022-12-24	WOS:A1995TD75900053
J	PARGE, HE; FOREST, KT; HICKEY, MJ; CHRISTENSEN, DA; GETZOFF, ED; TAINER, JA				PARGE, HE; FOREST, KT; HICKEY, MJ; CHRISTENSEN, DA; GETZOFF, ED; TAINER, JA			STRUCTURE OF THE FIBER-FORMING PROTEIN PILIN AT 2.6-ANGSTROM RESOLUTION	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE; POLAR PILI; DISSOCIATION; EXPRESSION; ANTIBODIES; FIMBRIAE; MUTANT; ACTIN; PAO	The crystallographic structure of Neisseria gonorrhoeae pilin, which assembles into the multifunctional pilus adhesion and virulence factor, reveals an alpha-beta roll fold with a striking 85 Angstrom alpha-helical spine and an O-linked disaccharide. Hey residues stabilize interactions that allow sequence hypervariability, responsible for pilin's celebrated antigenic variation, within disulphide region beta-strands and connections. Pilin surface shape, hydrophobicity and sequence variation constrain pilus assembly to the packing of flat subunit faces against alpha(1) helices. Helical fibre assembly is postulated to form a core of coiled alpha(1) helices banded by beta-sheet, leaving carbohydrate and hypervariable sequence regions exposed to solvent.	SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute			Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429				BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; BRADLEY DE, 1974, VIROLOGY, V58, P149, DOI 10.1016/0042-6822(74)90150-0; BRUNGER AT, 1992, X PLOR SYSTEM XRAY C; BUCHANAN TM, 1976, INFECT IMMUN, V13, P1483, DOI 10.1128/IAI.13.5.1483-1489.1976; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DALRYMPLE B, 1987, J MOL EVOL, V25, P261, DOI 10.1007/BF02100020; DUPUY B, 1994, J BACTERIOL, V176, P1323, DOI 10.1128/jb.176.5.1323-1331.1994; ELLEMAN TC, 1987, MOL MICROBIOL, V1, P377, DOI 10.1111/j.1365-2958.1987.tb01945.x; FOLKHARD W, 1981, J MOL BIOL, V149, P79, DOI 10.1016/0022-2836(81)90261-8; FUREY W, 1990, P AM CRYSTALLOGRAPHI, P73; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; HAMADEH RM, 1994, 9TH INT PATH NEISS C, P132; JONSSON AB, 1994, MOL MICROBIOL, V13, P403, DOI 10.1111/j.1365-2958.1994.tb00435.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTICK JS, 1987, J BACTERIOL, V169, P33, DOI 10.1128/jb.169.1.33-41.1987; Mattick JS, 1993, GENETICS MOL BIOL AN, P517; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455; PARGE HE, 1990, J BIOL CHEM, V265, P2278; PASLOSKE BL, 1989, J BACTERIOL, V171, P2142, DOI 10.1128/jb.171.4.2142-2147.1989; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROTHBARD JB, 1985, P NATL ACAD SCI USA, V82, P915, DOI 10.1073/pnas.82.3.915; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; SCHOOLNIK GK, 1990, NEW GENERATION VACCI, P565; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SEGAL E, 1985, CELL, V40, P293, DOI 10.1016/0092-8674(85)90143-6; Seifert H, 1984, MICROBIOL REV, V52, P327; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; STEWART DJ, 1982, RES VET SCI, V32, P140, DOI 10.1016/S0034-5288(18)32404-4; STROM MS, 1994, METHOD ENZYMOL, V235, P527; Swanson J., 1989, MOBILE DNA, P743; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; VIRJI M, 1989, J GEN MICROBIOL, V135, P3239; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; WATTS TH, 1983, BIOCHEMISTRY-US, V22, P3640, DOI 10.1021/bi00284a016; WATTS TH, 1982, CAN J BIOCHEM CELL B, V60, P867, DOI 10.1139/o82-110; WATTS TH, 1982, J BACTERIOL, V151, P1508, DOI 10.1128/JB.151.3.1508-1513.1982; WOODS DE, 1980, INFECT IMMUN, V29, P1146	50	391	404	2	22	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					32	38		10.1038/378032a0	http://dx.doi.org/10.1038/378032a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477282				2022-12-24	WOS:A1995TC46900040
J	AUSTIN, MA; BRESLOW, JL; HENNEKENS, CH; BURING, JE; WILLETT, WC; KRAUSS, RM				AUSTIN, MA; BRESLOW, JL; HENNEKENS, CH; BURING, JE; WILLETT, WC; KRAUSS, RM			LOW-DENSITY LIPOPROTEIN SUBCLASS PATTERNS AND RISK OF MYOCARDIAL-INFARCTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,DONNER LAB,1 CYCLOTRON RD 1-213,BERKELEY,CA 94720; ROCKEFELLER UNIV,BIOCHEM GENET & METAB LAB,NEW YORK,NY 10021; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PREVENT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT CLIN EPIDEMIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rockefeller University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health			Breslow, Jan L/B-7544-2008		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033577, P01HL018574, R29HL038760] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL-33577, HL-38760, HL-18574] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSTIN MA, 1986, LANCET, V2, P592; AUSTIN MA, IN PRESS AM J HUM GE; BRESLOW NE, 1980, PUBLICATION INT A 32, V1; BRUNZELL JD, 1983, J LIPID RES, V24, P147; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; BYARD P J, 1984, Genetic Epidemiology, V1, P43, DOI 10.1002/gepi.1370010107; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CROUSE JR, 1985, J LIPID RES, V26, P566; EISENBERG S, 1984, J CLIN INVEST, V74, P470, DOI 10.1172/JCI111444; ERNST N, 1980, CIRCULATION, V62, P41; FISHER WR, 1983, METABOLISM, V32, P283, DOI 10.1016/0026-0495(83)90194-4; FISHER WR, 1972, BIOCHEMISTRY-US, V11, P519, DOI 10.1021/bi00754a006; Fleiss JL, 1981, STAT METHODS RATES P; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRUNDY SM, 1986, NEW ENGL J MED, V314, P745, DOI 10.1056/NEJM198603203141204; HASKELL WL, 1980, CIRCULATION, V62, P53; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HEISS G, 1980, CIRCULATION, V62, P116; HEISS G, 1983, NIH831266 PUBL, P7; HENNEKENS CH, 1987, CIRCULATION, V76, P501; HUANG LS, 1986, P NATL ACAD SCI USA, V83, P644, DOI 10.1073/pnas.83.3.644; HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503; ISELIUS L, 1985, ACTA MED SCAND, V217, P161; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KISSEBAH AH, 1984, ARTERIOSCLEROSIS, V4, P614, DOI 10.1161/01.ATV.4.6.614; KLEINBAUM DJ, 1978, APPLIED REGRESSION A; KRAUSS RM, 1983, CLIN RES, V31, pA503; KRAUSS RM, 1987, AM HEART J, V113, P578, DOI 10.1016/0002-8703(87)90636-3; KRAUSS RM, 1980, CLIN CHIM ACTA, V104, P275, DOI 10.1016/0009-8981(80)90385-X; KRAUSS RM, 1982, J LIPID RES, V23, P97; KRAUSS RM, 1987, LANCET, V2, P62; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LAW A, 1986, LANCET, V1, P1301; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; LIPPEL K, 1981, ARTERIOSCLEROSIS, V1, P406, DOI 10.1161/01.ATV.1.6.406; MCNAMARA JR, 1987, ARTERIOSCLEROSIS, V7, P483, DOI 10.1161/01.ATV.7.5.483; MICHELI H, 1979, ATHEROSCLEROSIS, V32, P264; MILLER GJ, 1975, LANCET, V1, P16; Morgenstern H, 1982, EPIDEMIOLOGIC RES PR, P403; PEARSON TA, 1979, AM J EPIDEMIOL, V109, P285, DOI 10.1093/oxfordjournals.aje.a112682; PRIESTLEY L, 1985, NUCLEIC ACIDS RES, V13, P6789, DOI 10.1093/nar/13.18.6789; ROHLFING JJ, 1986, WESTERN J MED, V145, P210; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; SCHAEFER EJ, 1987, CIRCULATION, V76, P531; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHEN MMS, 1981, J LIPID RES, V22, P236; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; The Lipid Research Clinics Coronary Primary Prevention Trial results, 1984, JAMA, V251, P351; THIRD JLHC, 1984, METABOLISM, V33, P136, DOI 10.1016/0026-0495(84)90126-4; VERGANI C, 1981, CLIN CHIM ACTA, V114, P45, DOI 10.1016/0009-8981(81)90226-6; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed; 1985, SAS USERS GUIDE; 1980, NIH801527 PUBL, V1, P28; 1975, DHEW NIH75628 PUBL, V1, P51	57	1391	1423	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	1988	260	13					1917	1921						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2703	3418853				2022-12-24	WOS:A1988Q270300027
J	ZUGER, A; SCHUSTER, M; SIMBERKOFF, MS; RAHAL, JJ; HOLZMAN, RS				ZUGER, A; SCHUSTER, M; SIMBERKOFF, MS; RAHAL, JJ; HOLZMAN, RS			MAINTENANCE AMPHOTERICIN-B FOR CRYPTOCOCCAL MENINGITIS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)	ANNALS OF INTERNAL MEDICINE			English	Note									NYU, SCH MED, DEPT MED, 550 1ST AVE, NEW YORK, NY 10016 USA; BELLEVUE HOSP CTR, MED CTR, NEW YORK, NY 10016 USA; MANHATTAN VET ADM MED CTR, NEW YORK, NY USA; GOLDWATER MEM HOSP, NEW YORK, NY USA	New York University; Bellevue Hospital Center								DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602; KOVACS JA, 1985, ANN INTERN MED, V103, P533, DOI 10.7326/0003-4819-103-4-533; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234	3	50	50	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	1988	109	7					592	593		10.7326/0003-4819-109-7-592	http://dx.doi.org/10.7326/0003-4819-109-7-592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4157	3421567				2022-12-24	WOS:A1988Q415700013
J	WOLFFE, AP; BROWN, DD				WOLFFE, AP; BROWN, DD			DEVELOPMENTAL REGULATION OF 2 5S RIBOSOMAL-RNA GENES	SCIENCE			English	Article									CARNEGIE INST WASHINGTON, DEPT EMBRYOL, BALTIMORE, MD 21210 USA	Carnegie Institution for Science					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022395] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22395] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; ANDREWS MT, 1987, CELL, V51, P445, DOI 10.1016/0092-8674(87)90640-4; BIEKER JJ, 1985, CELL, V40, P119, DOI 10.1016/0092-8674(85)90315-0; BIRKENMEIER EH, 1978, CELL, V15, P1077, DOI 10.1016/0092-8674(78)90291-X; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; BOGENHAGEN DF, 1982, CELL, V28, P413, DOI 10.1016/0092-8674(82)90359-2; BOGENHAGEN DF, 1980, CELL, V19, P27, DOI 10.1016/0092-8674(80)90385-2; BOGENHAGEN DF, 1987, RNA POLYM REGULATION, P219; BOULANGER PA, 1987, J BIOL CHEM, V262, P15098; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; BROWN DD, 1977, P NATL ACAD SCI USA, V74, P2064, DOI 10.1073/pnas.74.5.2064; BROWN DD, 1985, CELL, V42, P759, DOI 10.1016/0092-8674(85)90272-7; BROWN DD, 1984, CELL, V37, P359, DOI 10.1016/0092-8674(84)90366-0; BROWN DD, 1964, J MOL BIOL, V8, P688, DOI 10.1016/S0022-2836(64)80117-0; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CAPLAN A, 1987, J MOL BIOL, V193, P57, DOI 10.1016/0022-2836(87)90626-7; CIZEWSKI V, 1983, NUCLEIC ACIDS RES, V11, P7043, DOI 10.1093/nar/11.20.7043; COZZARELLI NR, 1983, CELL, V34, P829, DOI 10.1016/0092-8674(83)90540-8; CUSICK ME, 1983, BIOCHEMISTRY-US, V22, P3873, DOI 10.1021/bi00285a024; DARBY MK, 1988, P NATL ACAD SCI USA, V85, P5516, DOI 10.1073/pnas.85.15.5516; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; FAIRALL L, 1986, J MOL BIOL, V192, P577, DOI 10.1016/0022-2836(86)90278-0; FEDOROFF NV, 1978, CELL, V13, P701, DOI 10.1016/0092-8674(78)90220-9; FELSENFELD G, 1986, CELL, V44, P375, DOI 10.1016/0092-8674(86)90456-3; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; FISHER EA, 1986, BIOCHEMISTRY-US, V25, P8010, DOI 10.1021/bi00372a033; FORD PJ, 1973, NATURE-NEW BIOL, V241, P7, DOI 10.1038/newbio241007a0; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; GARGIULO G, 1984, CELL, V38, P511, DOI 10.1016/0092-8674(84)90506-3; GILBERT DM, 1986, P NATL ACAD SCI USA, V83, P2924, DOI 10.1073/pnas.83.9.2924; GLIKIN GC, 1984, CELL, V37, P33, DOI 10.1016/0092-8674(84)90298-8; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GOTTESFELD J, 1982, CELL, V28, P781, DOI 10.1016/0092-8674(82)90057-5; GRAHAM CF, 1966, DEV BIOL, V14, P439, DOI 10.1016/0012-1606(66)90024-8; GUINTA DR, 1986, MOL CELL BIOL, V6, P2536, DOI 10.1128/MCB.6.7.2536; GUINTA DR, 1986, P NATL ACAD SCI USA, V83, P5150, DOI 10.1073/pnas.83.14.5150; GURDON JB, 1982, NATURE, V299, P652, DOI 10.1038/299652a0; HANAS JS, 1983, J BIOL CHEM, V258, P4120; HANAS JS, 1983, P NATL ACAD SCI-BIOL, V80, P2142, DOI 10.1073/pnas.80.8.2142; HANNON R, 1984, J MOL BIOL, V180, P131, DOI 10.1016/0022-2836(84)90434-0; HANNON R, 1986, EMBO J, V5, P3313, DOI 10.1002/j.1460-2075.1986.tb04645.x; HARPER ME, 1983, NUCLEIC ACIDS RES, V11, P2313, DOI 10.1093/nar/11.8.2313; HENTSCHEL CC, 1978, DEV BIOL, V65, P496, DOI 10.1016/0012-1606(78)90044-1; HIRSCHHORN RR, 1984, P NATL ACAD SCI-BIOL, V81, P6004, DOI 10.1073/pnas.81.19.6004; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6921, DOI 10.1021/bi00345a026; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KORN LJ, 1981, NATURE, V289, P461, DOI 10.1038/289461a0; LAMARCA MJ, 1975, DEV BIOL, V47, P384, DOI 10.1016/0012-1606(75)90292-4; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; MAIRY M, 1971, DEV BIOL, V24, P143, DOI 10.1016/0012-1606(71)90092-3; MATTAJ IW, 1985, NATURE, V316, P163, DOI 10.1038/316163a0; MCCONKEY GA, 1988, GENE DEV, V2, P205, DOI 10.1101/gad.2.2.205; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MILLSTEIN L, 1987, J BIOL CHEM, V262, P17100; NASMYTH K, 1987, EMBO J, V6, P243, DOI 10.1002/j.1460-2075.1987.tb04745.x; OTTONELLO S, 1987, EMBO J, V6, P1921, DOI 10.1002/j.1460-2075.1987.tb02452.x; PARDUE ML, 1973, CHROMOSOMA, V42, P191, DOI 10.1007/BF00320940; PARKER CS, 1977, P NATL ACAD SCI USA, V74, P44, DOI 10.1073/pnas.74.1.44; PECK LJ, 1987, MOL CELL BIOL, V7, P3503, DOI 10.1128/MCB.7.10.3503; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PETERSON RC, 1980, CELL, V20, P131, DOI 10.1016/0092-8674(80)90241-X; PICARD B, 1980, EUR J BIOCHEM, V109, P359, DOI 10.1111/j.1432-1033.1980.tb04802.x; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; RHODES D, 1986, CELL, V46, P123, DOI 10.1016/0092-8674(86)90866-4; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; RINKE J, 1982, CELL, V29, P149, DOI 10.1016/0092-8674(82)90099-X; SAKONJU S, 1981, CELL, V23, P665, DOI 10.1016/0092-8674(81)90429-3; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; SAKONJU S, 1980, CELL, V19, P13, DOI 10.1016/0092-8674(80)90384-0; SAKONJU S, 1982, THESIS J HOPKINS U B; SCHLISSEL MS, 1984, CELL, V37, P903, DOI 10.1016/0092-8674(84)90425-2; SCHUMPERLI D, 1986, CELL, V45, P471, DOI 10.1016/0092-8674(86)90277-1; SEGALL J, 1980, J BIOL CHEM, V255, P1986; SETZER DR, 1985, J BIOL CHEM, V260, P2483; SHASTRY BS, 1982, J BIOL CHEM, V257, P2979; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; Taylor J.H., 1987, Results and Problems in Cell Differentiation, V14, P173; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS C, 1969, ARCH INT PHYS BIOCH, V77, P402; THOMAS JO, 1983, EUR J BIOCHEM, V134, P109, DOI 10.1111/j.1432-1033.1983.tb07538.x; URSPRUNG H, 1968, STABILITY DIFFERENTI; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684; WAKEFIELD L, 1983, EMBO J, V2, P1613, DOI 10.1002/j.1460-2075.1983.tb01632.x; WANDELT C, 1983, NUCLEIC ACIDS RES, V11, P3795, DOI 10.1093/nar/11.11.3795; WEGNEZ M, 1972, FEBS LETT, V25, P13, DOI 10.1016/0014-5793(72)80443-5; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; WILLIAMSON P, 1978, BIOCHEMISTRY-US, V17, P5695, DOI 10.1021/bi00619a015; WOLFFE AP, 1987, CELL, V49, P301, DOI 10.1016/0092-8674(87)90279-0; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; WOLFFE AP, 1988, EMBO J, V7, P1071, DOI 10.1002/j.1460-2075.1988.tb02915.x; WOLFFE AP, 1987, CELL, V51, P732, DOI 10.1016/0092-8674(87)90096-1; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; WORMINGTON WM, 1982, COLD SPRING HARB SYM, V47, P879; WORMINGTON WM, 1981, CELL, V24, P809, DOI 10.1016/0092-8674(81)90106-9; WORMINGTON WM, 1983, DEV BIOL, V99, P248, DOI 10.1016/0012-1606(83)90273-7	109	199	200	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	1988	241	4873					1626	1632		10.1126/science.3420414	http://dx.doi.org/10.1126/science.3420414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1372	3420414				2022-12-24	WOS:A1988Q137200028
J	DUMOULIN, GC; STOTTMEIER, KD; PELLETIER, PA; TSANG, AY; HEDLEYWHYTE, J				DUMOULIN, GC; STOTTMEIER, KD; PELLETIER, PA; TSANG, AY; HEDLEYWHYTE, J			CONCENTRATION OF MYCOBACTERIUM-AVIUM BY HOSPITAL HOT WATER-SYSTEMS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note									BETH ISRAEL HOSP, CHARLES A DANA RES FDN, BOSTON, MA 02215 USA; BOSTON UNIV, BOSTON CITY HOSP, SCH MED, BOSTON, MA 02118 USA; NATL JEWISH CTR IMMUNOL & RESP MED, DENVER, CO USA	Harvard University; Beth Israel Deaconess Medical Center; Boston Medical Center; Boston University; National Jewish Health	DUMOULIN, GC (corresponding author), HARVARD UNIV, BETH ISRAEL HOSP,SCH MED,DEPT ANAESTHESIA,DA-717, 330 BROOKLINE, BOSTON, MA 02215 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI052574] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-52574] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNOW PM, 1985, J INFECT DIS, V152, P145, DOI 10.1093/infdis/152.1.145; BEST M, 1983, LANCET, V2, P307; COSTRINI AM, 1981, AM REV RESPIR DIS, V123, P104; DEGIROLAMI PC, 1987, 87TH ANN M AM SOC MI; du Moulin G. C., 1986, ASM NEWS, V52, P525; DUMOULIN GC, 1978, APPL ENVIRON MICROB, V36, P771, DOI 10.1128/AEM.36.5.771-773.1978; DUMOULIN GC, 1985, J CLIN MICROBIOL, V22, P9, DOI 10.1128/JCM.22.1.9-12.1985; DUMOULIN GC, 1986, 26TH INT C ANT AG CH; HANRAHAN JP, 1987, AM J EPIDEMIOL, V125, P639, DOI 10.1093/oxfordjournals.aje.a114577; HORSBURGH CR, 1986, ANTIMICROB AGENTS CH, V30, P955, DOI 10.1128/AAC.30.6.955; MASUR H, 1987, J INFECT DIS, V155, P127, DOI 10.1093/infdis/155.1.127; MCSWIGGAN D A, 1974, Tubercle, V55, P291, DOI 10.1016/0041-3879(74)90038-5; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; PELLETIER PA, 1988, MICROBIOL SCI, V5, P147; STINE TM, 1987, JAMA-J AM MED ASSOC, V258, P809, DOI 10.1001/jama.258.6.809; TSANG AY, 1983, INT J SYST BACTERIOL, V33, P285, DOI 10.1099/00207713-33-2-285; ZAKOWSKI P, 1982, JAMA-J AM MED ASSOC, V248, P2980, DOI 10.1001/jama.248.22.2980	17	198	200	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	1988	260	11					1599	1601		10.1001/jama.260.11.1599	http://dx.doi.org/10.1001/jama.260.11.1599			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9650	3411741				2022-12-24	WOS:A1988P965000031
J	HOLM, C; KIRCHGESSNER, TG; SVENSON, KL; FREDRIKSON, G; NILSSON, S; MILLER, CG; SHIVELY, JE; HEINZMANN, C; SPARKES, RS; MOHANDAS, T; LUSIS, AJ; BELFRAGE, P; SCHOTZ, MC				HOLM, C; KIRCHGESSNER, TG; SVENSON, KL; FREDRIKSON, G; NILSSON, S; MILLER, CG; SHIVELY, JE; HEINZMANN, C; SPARKES, RS; MOHANDAS, T; LUSIS, AJ; BELFRAGE, P; SCHOTZ, MC			HORMONE-SENSITIVE LIPASE - SEQUENCE, EXPRESSION, AND CHROMOSOMAL LOCALIZATION TO 19 CENT-Q13.3	SCIENCE			English	Article									UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT MICROBIOL,LOS ANGELES,CA 90024; CITY HOPE NATL MED CTR,BECKMAN RES INT,DIV IMMUNOL,DUARTE,CA 91010; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,TORRANCE,CA 90509; VET ADM WADSWORTH MED CTR,LOS ANGELES,CA 90073	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	HOLM, C (corresponding author), UNIV LUND,DEPT MED & PHYSIOL CHEM 4,POB 94,S-22100 LUND,SWEDEN.		nilsson, staffan/D-1298-2012					ALBRINK MJ, 1974, DUNCANS DIS METABOLI, P417; Belfrage P., 1984, P365; BENAVRAM CM, 1986, P NATL ACAD SCI USA, V83, P4185, DOI 10.1073/pnas.83.12.4185; BODMER MW, 1987, BIOCHIM BIOPHYS ACTA, V909, P237, DOI 10.1016/0167-4781(87)90083-2; BROOK JD, 1984, HUM GENET, V68, P282, DOI 10.1007/BF00292584; CANNON B, 1985, NEW PERSPECTIVES ADI, P223; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; COOK KG, 1983, BIOCHIM BIOPHYS ACTA, V752, P46, DOI 10.1016/0005-2760(83)90231-X; DECARO J, 1981, BIOCHIM BIOPHYS ACTA, V671, P129, DOI 10.1016/0005-2795(81)90126-4; DOCHERTY AJP, 1985, NUCLEIC ACIDS RES, V13, P1891, DOI 10.1093/nar/13.6.1891; ENZI G, 1977, J CLIN INVEST, V60, P1221, DOI 10.1172/JCI108881; FREDRIKSON G, 1987, J IMMUNOL METHODS, V97, P65, DOI 10.1016/0022-1759(87)90106-2; GARTON AJ, 1988, FEBS LETT, V229, P68, DOI 10.1016/0014-5793(88)80799-3; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; HOLM C, 1986, J BIOL CHEM, V261, P5659; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KOMAROMY MC, 1987, P NATL ACAD SCI USA, V84, P1526, DOI 10.1073/pnas.84.6.1526; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krebs E G, 1981, Curr Top Cell Regul, V18, P401; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUSIS AJ, 1986, P NATL ACAD SCI USA, V83, P3929, DOI 10.1073/pnas.83.11.3929; MCLEAN J, 1986, P NATL ACAD SCI USA, V83, P2335, DOI 10.1073/pnas.83.8.2335; NILSSON S, IN PRESS BIOMED CHRO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIVELY JE, 1987, ANAL BIOCHEM, V163, P517, DOI 10.1016/0003-2697(87)90257-0; SPARKES RS, 1986, HUM GENET, V74, P133, DOI 10.1007/BF00282076; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; STRALFORS P, 1987, ENZYMES B, V18, P147; YANGFENG TL, 1985, SCIENCE, V228, P728, DOI 10.1126/science.3873110	33	297	321	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 16	1988	241	4872					1503	1506		10.1126/science.3420405	http://dx.doi.org/10.1126/science.3420405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0479	3420405				2022-12-24	WOS:A1988Q047900041
J	MELBY, JC				MELBY, JC			THERAPY OF CUSHING DISEASE - A CONSENSUS FOR PITUITARY MICROSURGERY	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											MELBY, JC (corresponding author), BOSTON UNIV HOSP, MED CTR, BOSTON, MA 02218 USA.							AVGERINOS PC, 1987, J CLIN ENDOCR METAB, V65, P906, DOI 10.1210/jcem-65-5-906; CORRIGAN DF, 1977, NEW ENGL J MED, V296, P861, DOI 10.1056/NEJM197704142961508; Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137; EISENHARDT L, 1938, YALE J BIOL MED, V11, P507; Hardy J, 1969, Clin Neurosurg, V16, P185; KJELLBERG RN, 1984, SECRETORY TUMORS PIT, P295; LAWS ER, 1982, J NEUROSURG, V56, P739; MAMPALAM TJ, 1988, ANN INTERN MED, V109, P487, DOI 10.7326/0003-4819-109-6-487; SALASSA RM, 1978, MAYO CLIN PROC, V53, P24; SCHRELL U, 1987, J CLIN ENDOCR METAB, V64, P1150, DOI 10.1210/jcem-64-6-1150; STYNE DM, 1984, NEW ENGL J MED, V310, P889, DOI 10.1056/NEJM198404053101405; TYRRELL JB, 1978, NEW ENGL J MED, V298, P753, DOI 10.1056/NEJM197804062981401; YOUNG WF, 1988, MAYO CLIN PROC, V63, P256, DOI 10.1016/S0025-6196(12)65099-X	13	57	57	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	1988	109	6					445	446		10.7326/0003-4819-109-6-445	http://dx.doi.org/10.7326/0003-4819-109-6-445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2568	3415103				2022-12-24	WOS:A1988Q256800001
J	RUSSELL, M				RUSSELL, M			OZONE POLLUTION - THE HARD CHOICES	SCIENCE			English	Editorial Material									OAK RIDGE NATL LAB,KNOXVILLE,TN 37996	United States Department of Energy (DOE); Oak Ridge National Laboratory	RUSSELL, M (corresponding author), UNIV TENNESSEE,KNOXVILLE,TN 37996, USA.							RUSSELL M, 1988, ORNLTM10908 REP; RUSSELL M, 1988, ORNLTM10909 REP	2	18	18	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 9	1988	241	4871					1275	1276		10.1126/science.3413490	http://dx.doi.org/10.1126/science.3413490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9812	3413490				2022-12-24	WOS:A1988P981200002
J	PALCA, J				PALCA, J			LOMA-LINDA HALTS CONTROVERSIAL TRIAL	NATURE			English	Editorial Material																		1987, NATURE, V330, P592	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	1988	335	6185					7	7						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9022	3412462				2022-12-24	WOS:A1988P902200016
J	MANTZOURANIS, EC; ROSEN, FS; COLTEN, HR				MANTZOURANIS, EC; ROSEN, FS; COLTEN, HR			RETICULOENDOTHELIAL CLEARANCE IN CYSTIC-FIBROSIS AND OTHER INFLAMMATORY LUNG-DISEASES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CTR BLOOD RES,BOSTON,MA; HARVARD UNIV,SCH MED,BOSTON,MA 02115; WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110; ST LOUIS CHILDRENS HOSP,ST LOUIS,MO 63178	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	MANTZOURANIS, EC (corresponding author), CHILDRENS HOSP MED CTR,DIV PULM MED & CELL BIOL,300 LONGWOOD AVE,BOSTON,MA 02115, USA.							ANTES U, 1987, Complement, V4, P127; ATKINSON JP, 1974, J CLIN INVEST, V54, P339, DOI 10.1172/JCI107769; ATKINSON JP, 1974, J CLIN INVEST, V53, P1742, DOI 10.1172/JCI107726; ATKINSON JP, 1973, J CLIN INVEST, V52, P1509, DOI 10.1172/JCI107325; AUERBACH HS, 1985, LANCET, V2, P686; CHURCH JA, 1981, CHEST, V80, P405, DOI 10.1378/chest.80.4.405; COOK CD, 1961, J PEDIATR-US, V59, P710, DOI 10.1016/S0022-3476(61)80007-3; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; FRANK MM, 1979, NEW ENGL J MED, V300, P518, DOI 10.1056/NEJM197903083001002; FRIEDMAN D, 1985, J CLIN INVEST, V75, P162, DOI 10.1172/JCI111669; GIBSON LE, 1959, PEDIATRICS, V23, P545; HAMBURGER MI, 1982, ARTHRITIS RHEUM, V25, P48, DOI 10.1002/art.1780250108; HOSEA SW, 1981, NEW ENGL J MED, V304, P245, DOI 10.1056/NEJM198101293040501; KELTON JG, 1985, BLOOD, V66, P490; LAWLEY TJ, 1981, NEW ENGL J MED, V304, P185, DOI 10.1056/NEJM198101223040401; MATTHEWS WJ, 1980, NEW ENGL J MED, V302, P245, DOI 10.1056/NEJM198001313020501; MCFARLANE H, 1975, BRIT MED J, V1, P423, DOI 10.1136/bmj.1.5955.423; MOSS RB, 1981, J PEDIATR-US, V99, P215, DOI 10.1016/S0022-3476(81)80453-2; NYDEGGER UE, 1974, J CLIN INVEST, V54, P297, DOI 10.1172/JCI107765; Polgar G, 1971, PULMONARY FUNCTION T, P170; RITCHIE RF, 1973, AM J CLIN PATHOL, V59, P151; Snedecor G. W., 1980, STATISTICAL METHODS, P166; SORENSEN RU, 1981, PEDIATR RES, V15, P14, DOI 10.1203/00006450-198101000-00004; SOTER NA, 1979, J PEDIATR-US, V95, P197; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THEOFILOPOULOS AN, 1976, J CLIN INVEST, V57, P169, DOI 10.1172/JCI108257; VANDERWOUDE FJ, 1984, CLIN EXP IMMUNOL, V55, P473; WISNIESKI JJ, 1985, AM REV RESPIR DIS, V132, P770	28	15	17	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	1988	319	6					338	343		10.1056/NEJM198808113190604	http://dx.doi.org/10.1056/NEJM198808113190604			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6095	3393195				2022-12-24	WOS:A1988P609500004
J	LOONEY, DJ; FISHER, AG; PUTNEY, SD; RUSCHE, JR; REDFIELD, RR; BURKE, DS; GALLO, RC; WONGSTAAL, F				LOONEY, DJ; FISHER, AG; PUTNEY, SD; RUSCHE, JR; REDFIELD, RR; BURKE, DS; GALLO, RC; WONGSTAAL, F			TYPE-RESTRICTED NEUTRALIZATION OF MOLECULAR CLONES OF HUMAN IMMUNODEFICIENCY VIRUS	SCIENCE			English	Article									NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892; REPLIGEN CORP,CAMBRIDGE,MA 02139	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	LOONEY, DJ (corresponding author), WALTER REED ARMY INST RES,DEPT VIRAL DIS,WASHINGTON,DC 20307, USA.			/0000-0002-5704-8094				CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; CROWL R, 1985, CELL, V41, P979, DOI 10.1016/S0092-8674(85)80078-7; FISCHER AG, IN PRESS NATURE; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; HAHN BH, 1984, NATURE, V312, P166, DOI 10.1038/312166a0; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HO DD, 1985, NEW ENGL J MED, V312, P649, DOI 10.1056/NEJM198503073121015; HU SL, 1987, NATURE, V328, P721, DOI 10.1038/328721a0; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; MATTHEWS TJ, 1986, P NATL ACAD SCI USA, V83, P9709, DOI 10.1073/pnas.83.24.9709; MEYERS G, 1987, HUMAN RETROVINUSES A, V2, P38; NARA PL, 1987, J VIROL, V61, P3173, DOI 10.1128/JVI.61.10.3173-3180.1987; PUTNEY SD, 1986, SCIENCE, V234, P1392, DOI 10.1126/science.2431482; RASHEED S, 1986, VIROLOGY, V150, P1, DOI 10.1016/0042-6822(86)90260-6; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; ROBERTGUROFF M, 1985, NATURE, V316, P72, DOI 10.1038/316072a0; ROBEY WG, 1986, P NATL ACAD SCI USA, V83, P7023, DOI 10.1073/pnas.83.18.7023; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; SAAG M, IN PRESS NATURE; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; STEIMER KS, IN PRESS VACCINES 88; WEISS RA, 1986, NATURE, V324, P572, DOI 10.1038/324572a0; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0	27	125	140	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 15	1988	241	4863					357	359		10.1126/science.3388046	http://dx.doi.org/10.1126/science.3388046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P2272	3388046				2022-12-24	WOS:A1988P227200040
J	MALHOTRA, V; ORCI, L; GLICK, BS; BLOCK, MR; ROTHMAN, JE				MALHOTRA, V; ORCI, L; GLICK, BS; BLOCK, MR; ROTHMAN, JE			ROLE OF AN N-ETHYLMALEIMIDE-SENSITIVE TRANSPORT COMPONENT IN PROMOTING FUSION OF TRANSPORT VESICLES WITH CISTERNAE OF THE GOLGI STACK	CELL			English	Article									STANFORD UNIV,DEPT BIOCHEM,STANFORD,CA 94305; UNIV GENEVA,SCH MED,INST HISTOL & EMBRYOL,DEPT MORPHOL,CH-1211 GENEVA 4,SWITZERLAND	Stanford University; University of Geneva			Malhotra, Vivek/O-9811-2014; Block, Marc R/M-2740-2013; Tuluc, Petronel/C-2527-2011	Malhotra, Vivek/0000-0001-6198-7943; Block, Marc R/0000-0003-2214-9706; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027044, R01DK027044] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27044-08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTS BM, 1984, COLD SPRING HARB SYM, V49, P1; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P414; BLOCK MR, 1988, IN PRESS P NATL ACAD; BRAELL WA, 1984, CELL, V39, P511, DOI 10.1016/0092-8674(84)90458-6; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; KORNBERG A, 1987, J CELL SCI S, V7, P1; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; ROTHMAN JE, 1987, J BIOL CHEM, V262, P12502; WATTENBERG BW, 1986, J BIOL CHEM, V261, P2208; WATTENBERG BW, 1986, J BIOL CHEM, V261, P2202; WHITE J, 1983, Q REV BIOPHYS, V16, P151, DOI 10.1017/S0033583500005072	17	333	337	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 15	1988	54	2					221	227		10.1016/0092-8674(88)90554-5	http://dx.doi.org/10.1016/0092-8674(88)90554-5			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P4103	3390865				2022-12-24	WOS:A1988P410300012
J	Klag, MJ; Whelton, PK; Randall, BL; Neaton, JD; Brancati, FL; Ford, CE; Shulman, NB; Stamler, J				Klag, MJ; Whelton, PK; Randall, BL; Neaton, JD; Brancati, FL; Ford, CE; Shulman, NB; Stamler, J			Blood pressure and end-stage renal disease in men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR INTERVENTION TRIAL; CORONARY HEART-DISEASE; DIABETES-MELLITUS; RISK-FACTORS; PROGRESSION; INSUFFICIENCY; HYPERTENSION; FAILURE; DEATH; RACE	Background, End-stage renal disease in the United States creates a large burden for both individuals and society as a whole, Efforts to prevent the condition require an understanding of modifiable risk factors. Methods. We assessed the development of end-stage renal disease through 1990 in 332,544 men, 35 to 57 years of age, who were screened between 1973 and 1975 for entry into the Multiple Risk Factor Intervention Trial (MRFIT). We used data from the national registry for treated end-stage renal disease of the Health Care Financing Administration and from records on death from renal disease from the National Death Index and the Social Security Administration. Results. During an average of 16 years of follow-up, 814 subjects either died of end-stage renal disease or were treated for that condition (15.6 cases per 100,000 person-years of observation), A strong, graded relation between both systolic and diastolic blood pressure and end-stage renal disease was identified, independent of associations between the disease and age, race, income, use of medication for diabetes mellitus, history of my-ocardial infarction, serum cholesterol concentration, and cigarette smoking. As compared with men with an optimal level of blood pressure (systolic pressure <120 mm Hg and diastolic pressure <80 mm Hg), the relative risk of end-stage renal disease for those with stage 4 hypertension (systolic pressure greater than or equal to 210 mm Hg or diastolic pressure greater than or equal to 120 mm Hg) was 22.1 (P<0.001). These relations were not due to end-stage renal disease that occurred soon after screening and, in the 12,866 screened men who entered the MRFIT study, were not changed by taking into account the base-line serum creatinine concentration and urinary protein excretion, The estimated risk of end-stage renal disease associated with elevations of systolic pressure was greater than that linked with elevations of diastolic pressure when both variables were considered together, Conclusions. Elevations of blood pressure are a strong independent risk factor for end-stage renal disease; interventions to prevent the disease need to emphasize the prevention and control of both high-normal and high blood pressure. (C) 1996, Massachusetts Medical Society.	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT HLTH POLICY & MANAGEMENT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, BALTIMORE, MD USA; UNIV MINNESOTA, SCH PUBL HLTH, DIV BIOSTAT, MINNEAPOLIS, MN 55455 USA; UNIV TEXAS, HLTH SCI CTR, HOUSTON, TX USA; EMORY UNIV, DEPT MED, ATLANTA, GA 30322 USA; NORTHWESTERN UNIV, SCH MED, DEPT PREVENT MED, CHICAGO, IL USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; Emory University; Northwestern University					NHLBI NIH HHS [R01 HL28715] Funding Source: Medline; NIDDK NIH HHS [R01 DK41837] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041837] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGSTROM J, 1986, CLIN NEPHROL, V25, P1; BRAZY PC, 1990, KIDNEY INT, V37, P1113, DOI 10.1038/ki.1990.93; COX DR, 1972, J R STAT SOC B, V34, P187; DISCHINGER P, 1986, CONTROL CLIN TRIALS, V7, pS137; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KINCAIDSMITH P, 1958, Q J MED, V27, P117; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MAMDANI BH, 1974, NEW ENGL J MED, V291, P1343, DOI 10.1056/NEJM197412192912509; MROCZEK WJ, 1969, CIRCULATION, V40, P893, DOI 10.1161/01.CIR.40.6.893; NEATON JD, 1987, CONTROL CLIN TRIALS, V8, pS41; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; PARVING HH, 1983, LANCET, V1, P1175; PERERA G A, 1955, J Chronic Dis, V1, P33, DOI 10.1016/0021-9681(55)90019-9; PERNEGER TV, 1995, AM J EPIDEMIOL, V141, P10, DOI 10.1093/oxfordjournals.aje.a117338; PERNEGER TV, 1993, JAMA-J AM MED ASSOC, V269, P488, DOI 10.1001/jama.269.4.488; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; PETTINGER WA, 1989, HYPERTENSION, V13, P766, DOI 10.1161/01.HYP.13.6.766; RAVID M, 1992, ARCH INTERN MED, V152, P1225, DOI 10.1001/archinte.152.6.1225; ROSANSKY SJ, 1990, ARCH INTERN MED, V150, P2073, DOI 10.1001/archinte.150.10.2073; ROSTAND SG, 1989, NEW ENGL J MED, V320, P684, DOI 10.1056/NEJM198903163201102; SHERWIN R, 1981, PREV MED, V10, P402, DOI 10.1016/0091-7435(81)90058-X; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Statistical design considerations in the multiple risk factor intervention trial (MRFIT), 1977, J CHRON DIS, V30, P261; TIERNEY WM, 1989, AM J KIDNEY DIS, V13, P485, DOI 10.1016/S0272-6386(89)80006-X; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; WHELTON PK, 1989, HYPERTENSION S1, V13, P19, DOI DOI 10.1161/HYPERTENSIONAHA.113.02250; WHITTLE JC, 1991, ARCH INTERN MED, V151, P1359, DOI 10.1001/archinte.151.7.1359; ZUCCHELLI P, 1992, KIDNEY INT, V42, P452, DOI 10.1038/ki.1992.309; 1994, NIH943176 PUBL; 1994, REPORT TASK FORCE RE; 1993, ARCH INTERN MED, V153, P598; 1987, HCFA03274 HLTH CAR F; 1974, DHEW NIH75628 NAT HE; 1980, DHHS PHS801260 DEP H	41	1231	1278	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1996	334	1					13	18		10.1056/NEJM199601043340103	http://dx.doi.org/10.1056/NEJM199601043340103			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM482	7494564	Bronze			2022-12-24	WOS:A1996TM48200003
J	MANABE, YC; VINETZ, JM; MOORE, RD; MERZ, C; CHARACHE, P; BARTLETT, JG				MANABE, YC; VINETZ, JM; MOORE, RD; MERZ, C; CHARACHE, P; BARTLETT, JG			CLOSTRIDIUM DIFICILE COLITIS - AN EFFICIENT CLINICAL APPROACH TO DIAGNOSIS	ANNALS OF INTERNAL MEDICINE			English	Article						CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; DIARRHEA; TOXINS; FECES	DIFFICILE-ASSOCIATED DIARRHEA; RISK-FACTORS; HOSPITALIZED-PATIENTS; TOXIN; INFECTION; COHORT	Objective: To define clinical and laboratory variables that suggest the presence of Clostridium difficile colitis and to establish the number of stool specimens needed to reasonably exclude the diagnosis of C. difficile colitis. Design: Prospective study of consecutive inpatients whose stool specimens were sent to be evaluated for the presence of C. difficile toxin. Setting: University teaching hospital. Patients: 268 hospital inpatients in medical, surgical, and gynecology units. Measurements: Structured history and physical examination; detection of C. difficile toxin by cytotoxin tissue-culture assay with anti-C. difficile antiserum neutralization and by enzyme-linked immunoassay (EIA) for C. difficile toxins A and B; and detection of fecal leukocytes by microscopic examination and by latex agglutination lactoferrin assay. Results: 43 of 268 consecutive inpatients were positive for C. difficile toxin by EIA or tissue-culture assay. Although toxin was detected by EIA alone in 39 of the 43 patients, it was detected in an additional 4 patients (10%) by tissue-culture assay alone. Univariate and multivariate logistic regression analysis showed that the following clinical and laboratory features were associated with C. difficile toxin positivity: the onset of diarrhea 6 or more days after the administration of antibiotics (odds ratio, 1.38 [95% CI, 1.10 to 3.79]); hospital stay longer than 15 days (odds ratio, 1.33 [CI, 1.09 to 3.95]); the presence of fecal leukocytes determined by microscopy (odds ratio, 2.39 [CI, 1.05 to 5.42]) or lactoferrin assay (odds ratio, 3.74 [CI, 1.80 to 7.76]); the presence of semiformed (as opposed to watery) stools (odds ratio, 2.33 [CI, 1.10 to 4.90]); and cephalosporin use (odds ratio, 2.36 [CI, 1.10 to 5.09]). Toxin-positive patients were no more likely than controls to have had fever, abdominal pain or cramps, leukocytosis, green-colored diarrhea, or blood in the stool or to have received clindamycin or penicillin derivatives. Of the 43 patients with C. difficile toxin, 34 (79%) had positive results for the toxin on the first stool specimen, 5 (cumulative, 91%) had positive results on the second specimen, and 4 had positive results on the third specimen. Overall, the negative predictive value of the first stool specimen was 97%. All patients who had two or more clinical or laboratory predictors were diagnosed with C. difficile disease when either the first or the second stool specimen was positive for toxin. Conclusions: Clinicians at the bedside can use readily available clinical and laboratory information to decide which patients are likely to have C. difficile disease and when it is appropriate and useful to order specific diagnostic tests for C. difficile toxin. Such data are also useful in determining the number of stool samples that reasonably excludes the diagnosis of C. difficile colitis.	JOHNS HOPKINS UNIV, SCH MED, DIV INFECT DIS, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DIV INTERNAL MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV HOSP, CLIN MICROBIOL LAB, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University				Vinetz, Joseph/0000-0001-8344-2004				ANAND A, 1994, AM J GASTROENTEROL, V89, P519; BARTLETT JG, 1990, REV INFECT DIS, V12, pS243, DOI 10.1093/clinids/12.Supplement_2.S243; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; BORRIELLO SP, 1992, EUR J CLIN MICROBIOL, V11, P360, DOI 10.1007/BF01962079; BOWMAN RA, 1986, FEMS MICROBIOL LETT, V34, P31, DOI 10.1016/0378-1097(86)90265-X; BROWN E, 1990, INFECT CONT HOSP EP, V11, P283; FEKETY R, 1993, JAMA-J AM MED ASSOC, V269, P71, DOI 10.1001/jama.269.1.71; GERDING DN, 1989, ANN INTERN MED, V110, P255, DOI 10.7326/0003-4819-110-4-255; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; GUERRANT RL, 1992, J CLIN MICROBIOL, V30, P1238, DOI 10.1128/JCM.30.5.1238-1242.1992; MCFARLAND LV, 1991, INFECT IMMUN, V59, P2456, DOI 10.1128/IAI.59.7.2456-2462.1991; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; MERZ CS, 1994, J CLIN MICROBIOL, V32, P1142, DOI 10.1128/JCM.32.5.1142-1147.1994; MOGG GAG, 1979, BRIT J SURG, V66, P738, DOI 10.1002/bjs.1800661017; TEDESCO FJ, 1974, ANN INTERN MED, V81, P429, DOI 10.7326/0003-4819-81-4-429; THIBAULT A, 1991, INFECT CONT HOSP EP, V12, P345, DOI 10.2307/30145209; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; YONG WH, 1994, J CLIN MICROBIOL, V32, P1360, DOI 10.1128/JCM.32.5.1360-1361.1994	18	133	137	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1995	123	11					835	+		10.7326/0003-4819-123-11-199512010-00004	http://dx.doi.org/10.7326/0003-4819-123-11-199512010-00004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG209	7486465				2022-12-24	WOS:A1995TG20900004
J	LUECKE, H; CHANG, BT; MAILLIARD, WS; SCHLAEPFER, DD; HAIGLER, HT				LUECKE, H; CHANG, BT; MAILLIARD, WS; SCHLAEPFER, DD; HAIGLER, HT			CRYSTAL-STRUCTURE OF THE ANNEXIN-XII HEXAMER AND IMPLICATIONS FOR BILAYER INSERTION	NATURE			English	Article							SELF-ASSOCIATION; CALCIUM; SYNEXIN; IDENTIFICATION; RESOLUTION; MEMBRANES; CHANNELS	ANNEXINS are a family of calcium- and phospholipid-binding proteins(1,2) implicated in a number of biological processes including membrane fusion(3) and ion channel formation(4-7). The crystal structure of the annexin XII hexamer, refined at 2.8 Angstrom resolution, forms a concave disk with 3-2 symmetry, about 100 Angstrom in diameter and 70 Angstrom thick with a central hydrophilic pore. Six intermolecular Ca2+ ions are involved in hexamer formation. An additional 18 Ca2+ ions are located on the perimeter of the disk, accessible only from the side of the hexameric disk. On the basis of the hexamer structure we propose here a new mode of protein-phospholipid bilayer interaction that is distinct from the hydrophobic insertion of typical membrane proteins. This speculative model postulates the Ca2+-dependent insertion of the hydrophilic annexin XII hexamer into phospholipid bilayers with local reorientation of the bilayer phospholipids.	UNIV CALIF IRVINE,DEPT PHYSIOL & BIOPHYS,IRVINE,CA 92717	University of California System; University of California Irvine	LUECKE, H (corresponding author), STANFORD SYNCHROTRON RADIAT LAB,MS 69,STANFORD,CA 94305, USA.		Luecke, Hartmut/F-4712-2012; Haigler, Harry/C-3788-2011	Luecke, Hartmut/0000-0002-4938-0775; 				AHN NG, 1988, J BIOL CHEM, V262, P18657; BERENDES R, 1993, SCIENCE, V262, P427, DOI 10.1126/science.7692599; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BURGER A, 1994, J MOL BIOL, V237, P479, DOI 10.1006/jmbi.1994.1249; CONCHA NO, 1992, FEBS LETT, V314, P159, DOI 10.1016/0014-5793(92)80964-I; CREUTZ CE, 1979, J BIOL CHEM, V254, P553; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; DEMANGE P, 1994, TRENDS BIOCHEM SCI, V19, P272, DOI 10.1016/0968-0004(94)90002-7; Hille B., 1992, IONIC CHANNELS EXCIT; HOLLAND DR, 1990, J BIOL CHEM, V265, P17649; HUBER R, 1992, J MOL BIOL, V223, P683, DOI 10.1016/0022-2836(92)90984-R; HUBER R, 1990, EMBO J, V99, P3867; JOST M, 1994, BIOCHEM J, V298, P553, DOI 10.1042/bj2980553; LECKBAND DE, 1992, SCIENCE, V255, P1419, DOI 10.1126/science.1542789; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Moss S. E, 1992, ANNEXINS; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; NEUMANN JM, 1994, EUR J BIOCHEM, V225, P819, DOI 10.1111/j.1432-1033.1994.0819b.x; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; ROJAS E, 1990, J BIOL CHEM, V265, P21207; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SCHLAEPFER DD, 1992, J BIOL CHEM, V267, P9529; SMART OS, 1994, BIOCHEM SOC T, V22, pS146, DOI 10.1042/bst022146s; SWAIRJO MA, 1994, REV BIOPHYS BIOMOLEC, V23, P193; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; VOGES D, 1994, J MOL BIOL, V238, P199, DOI 10.1006/jmbi.1994.1281; WEAVER JC, 1993, ANN NY ACAD SCI, V720, P141; WENG XW, 1993, PROTEIN SCI, V2, P448; ZAKS WJ, 1991, BIOCHEMISTRY-US, V30, P9607, DOI 10.1021/bi00104a007	30	125	128	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					512	515		10.1038/378512a0	http://dx.doi.org/10.1038/378512a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477411				2022-12-24	WOS:A1995TH05400077
J	XIA, ZG; DICKENS, M; RAINGEAUD, J; DAVIS, RJ; GREENBERG, ME				XIA, ZG; DICKENS, M; RAINGEAUD, J; DAVIS, RJ; GREENBERG, ME			OPPOSING EFFECTS OF ERK AND JNK-P38 MAP KINASES ON APOPTOSIS	SCIENCE			English	Article							NERVE GROWTH-FACTOR; PROGRAMMED CELL-DEATH; MICROTUBULE-ASSOCIATED PROTEIN-2; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; SYMPATHETIC NEURONS; SIGNAL-TRANSDUCTION; FACTOR DEPRIVATION; FACTOR WITHDRAWAL; PROTO-ONCOGENE	Apoptosis plays an important role during neuronal development, and defects in apoptosis may underlie various neurodegenerative disorders, To characterize molecular mechanisms that regulate neuronal apoptosis, the contributions to cell death of mitogen-activated protein (MAP) kinase family members, including ERK (extracellular signal-regulated kinase), JNK (c-JUN NH2-terminal protein kinase), and p38, were examined after withdrawal of nerve growth factor (NGF) from rat PC-12 pheochromocytoma cells. NGF withdrawal led to sustained activation of the JNK and p38 enzymes and inhibition of ERKs, The effects of dominant-interfering or constitutively activated forms of various components of the JNK-p38 and ERK signaling pathways demonstrated that activation of JNK and p38 and concurrent inhibition of ERK are critical for induction of apoptosis in these cells. Therefore, the dynamic balance between growth factor-activated ERK and stress-activated JNK-p38 pathways may be important in determining whether a cell survives or undergoes apoptosis.	CHILDRENS HOSP,DEPT NEUROL,DIV NEUROSCI,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; UNIV MASSACHUSETTS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,PROGRAM MOLEC MED,WORCESTER,MA 01605; UNIV MASSACHUSETTS,SCH MED,HOWARD HUGHES MED INST,WORCESTER,MA 01605	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester			Dickens, Martin/B-2001-2012		NCI NIH HHS [CA43855, CA65861] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043855, R01CA065861] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN NG, 1993, MOL CELL BIOCHEM, V127, P201; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOONSTRA J, 1983, J CELL BIOL, V97, P92, DOI 10.1083/jcb.97.1.92; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BUCKMASTER EA, 1994, EUR J NEUROSCI, V6, P1316, DOI 10.1111/j.1460-9568.1994.tb00322.x; CAMPBELL JS, 1995, RECENT PROG HORM RES, V50, P131; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FERRARI G, 1993, J NEUROSCI, V13, P1879; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KOIKE T, 1992, PROG NEUROPSYCHOPHAR, V16, P65; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAINGEAUD J, UNPUB; RAPP UR, 1994, ONCOGENE, V9, P3493; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SIUSS HK, 1994, MOL CELL BIOL, V14, P8376; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; TENG KK, 1993, J NEUROSCI, V13, P3124; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOGARI A, 1983, BIOCHEM BIOPH RES CO, V114, P1189, DOI 10.1016/0006-291X(83)90688-5; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; XIA ZY, UNPUB; YAN MH, 1994, NATURE, V372, P798; YOUNG SW, 1994, FEBS LETT, V338, P212, DOI 10.1016/0014-5793(94)80367-6	81	4907	5109	7	390	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1326	1331		10.1126/science.270.5240.1326	http://dx.doi.org/10.1126/science.270.5240.1326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481820				2022-12-24	WOS:A1995TF89900029
J	ROTHMAN, KJ; MOORE, LL; SINGER, MR; NGUYEN, USDT; MANNINO, S; MILUNSKY, A				ROTHMAN, KJ; MOORE, LL; SINGER, MR; NGUYEN, USDT; MANNINO, S; MILUNSKY, A			TERATOGENICITY OF HIGH VITAMIN-A INTAKE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERVITAMINOSIS-A; SUPPLEMENTATION; CONGENERS; DEFECTS	Background. Studies in animals indicate that natural forms of vitamin A are teratogenic. Synthetic retinoids chemically similar to vitamin A cause birth defects in humans; as in animals, the defects appear to affect tissues derived from the cranial neural crest. Methods. Between October 1984 and June 1987, we identified 22,748 pregnant women when they underwent screening either by measurement of maternal serum alpha-fetoprotein or by amniocentesis. Nurse interviewers obtained information on the women's diet, medications, and illnesses during the first trimester of pregnancy, as well as information on their family and medical history and exposure to environmental agents. We obtained information on the outcomes of pregnancy from the obstetricians who delivered the babies or from the women themselves. Of the 22,748 women, 339 had babies with birth defects; 121 of these babies had defects occurring in sites that originated in the cranial neural crest. Results. For defects associated with cranial-neural-crest tissue, the ratio of the prevalence among the babies born to women who consumed more than 15,000 IU of preformed vitamin A per day from food and supplements to the prevalence among the babies whose mothers consumed 5000 IU or less per day was 3.5 (95 percent confidence interval, 1.7 to 7.3). For vitamin A from supplements alone, the ratio of the prevalence among the babies born to women who consumed more than 10,000 IU per day to that among the babies whose mothers consumed 5000 IU or less per day was 4.8 (95 percent confidence interval, 2.2 to 10.5). Using a smoothed regression curve, we found an apparent threshold near 10,000 IU per day of supplemental vitamin A. The increased frequency of defects was concentrated among the babies born to women who had consumed high levels of vitamin A before the seventh week of gestation. Conclusions. High dietary intake of preformed vitamin A appears to be teratogenic. Among the babies born to women who took more than 10,000 IU of preformed vitamin A per day in the form of supplements, we estimate that about 1 infant in 57 had a malformation attributable to the supplement.	BOSTON UNIV,SCH MED,CTR HUMAN GENET,BOSTON,MA 02118; UNIV G DANNUNZIO,INST HUMAN PATHOL & SOCIAL MED,CHAIR HYG,CHIETI,ITALY	Boston University; G d'Annunzio University of Chieti-Pescara	ROTHMAN, KJ (corresponding author), BOSTON UNIV,SCH MED,EVANS DEPT MED,PREVENT MED & EPIDEMIOL SECT,B-612,88 E NEWTON ST,BOSTON,MA 02118, USA.			Nguyen, Uyen-Sa/0000-0003-2715-9073; Singer, Martha/0000-0003-4048-7987; Milunsky, Aubrey/0000-0003-2114-4823; Rothman, Kenneth/0000-0003-2398-1705; Moore, Lynn/0000-0002-1028-919X	NINDS NIH HHS [NS 19561] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019561] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1987, Teratology, V35, P269; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; COHLAN SQ, 1954, PEDIATRICS, V13, P556; DENCKER L, 1991, J CRAN GENET DEV BIO, V11, P303; ECKHOFF C, 1990, ARCH TOXICOL, V64, P502, DOI 10.1007/BF01977634; EVANS K, 1991, BRIT J OPHTHALMOL, V75, P691, DOI 10.1136/bjo.75.11.691; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183; KIRBY ML, 1987, PEDIATR RES, V21, P219, DOI 10.1203/00006450-198703000-00001; KIZER KW, 1990, WESTERN J MED, V152, P78; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARTINEZFRIAS ML, 1990, EUR J EPIDEMIOL, V6, P118, DOI 10.1007/BF00145783; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; PINNOCK CB, 1992, MED J AUSTRALIA, V157, P804; ROSA FW, 1986, TERATOLOGY, V33, P355, DOI 10.1002/tera.1420330315; ROSA FW, 1983, LANCET, V2, P513; Rothman K, 1986, MODERN EPIDEMIOLOGY; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; WERLER MM, 1990, TERATOLOGY, V42, P497, DOI 10.1002/tera.1420420506; 1985, 0025M CTR DIS CONTR; 1987, MMWR-MORBID MORTAL W, V36, P80; 1989, RECOMMENDED DIETARY, P84	25	461	476	0	22	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	1995	333	21					1369	1373		10.1056/NEJM199511233332101	http://dx.doi.org/10.1056/NEJM199511233332101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF521	7477116				2022-12-24	WOS:A1995TF52100001
J	MOLLOY, JE; BURNS, JE; KENDRICKJONES, J; TREGEAR, RT; WHITE, DCS				MOLLOY, JE; BURNS, JE; KENDRICKJONES, J; TREGEAR, RT; WHITE, DCS			MOVEMENT AND FORCE PRODUCED BY A SINGLE MYOSIN HEAD	NATURE			English	Article							SLIDING MOVEMENT; ACTIN-FILAMENTS; SUBFRAGMENT-1	MUSCLE contraction is driven by the cyclical interaction of myosin with actin, coupled to the breakdown of ATP. Studies of the interaction of filamentous myosin(1) and of a double-headed proteolytic fragment, heavy meromyosin (HMM)(2,3), with actin have demonstrated discrete mechanical events, arising from stochastic interaction of single myosin molecules with actin. Here we show, using an optical-tweezers transducer(2,4), that a single myosin subfragment-1 (S1), which is a single myosin head, can act as an independent generator of force and movement. Our analysis accounts for the broad distribution of displacement amplitudes observed, and indicates that the underlying: movement (working stroke) produced by a single acto-S1 interaction is similar to 4 nm, considerably shorter than previous estimates(1-3,5) but consistent with structural data(6). We measure the average force generated by S1 or HMM to be at least 1.7 pN under isometric conditions.	MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND	MRC Laboratory Molecular Biology	MOLLOY, JE (corresponding author), UNIV YORK, DEPT BIOL, YORK YO1 5DW, N YORKSHIRE, ENGLAND.			Molloy, Justin/0000-0002-8307-2450; Burns, Julie/0000-0003-1238-8826				ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Einstein A., 1956, THEORY BROWNIAN MOVE; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; ISHIJIMA A, 1994, BIOCHEM BIOPH RES CO, V199, P1057, DOI 10.1006/bbrc.1994.1336; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; MIYATA H, 1994, J BIOCHEM, V115, P644, DOI 10.1093/oxfordjournals.jbchem.a124389; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0	14	494	515	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	1995	378	6553					209	212		10.1038/378209a0	http://dx.doi.org/10.1038/378209a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477328				2022-12-24	WOS:A1995TD75900061
J	BRODINE, SK; MASCOLA, JR; WEISS, PJ; ITO, SI; PORTER, KR; ARTENSTEIN, AW; GARLAND, FC; MCCUTCHAN, FE; BURKE, DS				BRODINE, SK; MASCOLA, JR; WEISS, PJ; ITO, SI; PORTER, KR; ARTENSTEIN, AW; GARLAND, FC; MCCUTCHAN, FE; BURKE, DS			DETECTION OF DIVERSE HIV-1 GENETIC SUBTYPES IN THE USA	LANCET			English	Note								Of the nine genetic subtypes of HIV-1 that exist world wide, subtype B predominates in North America and Europe. Thus, most knowledge about HIV-1 and most vaccine development efforts are based on subtype B viruses. We document here the detection of HIV-1 subtypes A, D, and E in five US servicemen who acquired these non-subtype-B infections during overseas deployments. The dispersal of diverse HIV-1 subtypes into regions of the world with previously restricted genetic diversity may have important implications for the epidemiology of the epidemic and for the design and implementation of vaccine trials.	USN,MED RES INST,DEPT INFECT DIS,BETHESDA,MD; WALTER REED ARMY INST RES,DIV RETROVIROL,ROCKVILLE,MD; USN,MED CTR,DEPT INTERNAL MED,DIV INFECT DIS,SAN DIEGO,CA 92152; HENRY M JACKSON FDN,ROCKVILLE,MD	Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Navy; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	BRODINE, SK (corresponding author), USN,HLTH RES CTR,DIV CLIN EPIDEMIOL,DEPT HLTH SCI & EPIDEMIOL,SAN DIEGO,CA 92186, USA.		Mascola, John/AAI-7193-2021	/0000-0002-5704-8094				ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; GAO F, 1993, AIDS RES HUM RETROV, V10, P625; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; MASTRO TD, 1994, LANCET, V343, P204, DOI 10.1016/S0140-6736(94)90990-3; MYERS G, 1994, HUMAN RETROVIRUSES A; SALMINEN M, 1993, VIROLOGY, V195, P185, DOI 10.1006/viro.1993.1359	10	125	125	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 4	1995	346	8984					1198	1199		10.1016/S0140-6736(95)92901-0	http://dx.doi.org/10.1016/S0140-6736(95)92901-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC976	7475661				2022-12-24	WOS:A1995TC97600011
J	KINGHAM, JGC				KINGHAM, JGC			PEPPERMINT OIL AND COLON SPASM	LANCET			English	Editorial Material							IRRITABLE BOWEL SYNDROME				KINGHAM, JGC (corresponding author), SINGLETON HOSP,SWANSEA SA2 8QA,W GLAM,WALES.							DEW MJ, 1984, BRIT J CLIN PRACT, V38, P394; DUTHIE HL, 1981, BRIT J SURG, V68, P820; FINK AM, 1995, CLIN RADIOL, V50, P160, DOI 10.1016/S0009-9260(05)83047-8; GOEI R, 1995, CLIN RADIOL, V50, P553, DOI 10.1016/S0009-9260(05)83191-5; HAWTHORN M, 1988, Alimentary Pharmacology and Therapeutics, V2, P101; HILLS JM, 1991, GASTROENTEROLOGY, V101, P55, DOI 10.1016/0016-5085(91)90459-X; JARVIS LJ, 1992, CLIN RADIOL, V46, pA435; KLEIN KB, 1988, GASTROENTEROLOGY, V95, P232, DOI 10.1016/0016-5085(88)90319-8; LEICESTER RJ, 1982, LANCET, V2, P989; NASH P, 1986, BRIT J CLIN PRACT, V40, P292; REES WDW, 1979, BMJ-BRIT MED J, V2, P835, DOI 10.1136/bmj.2.6194.835; ROGERS J, 1988, LANCET, V2, P98; SKUCAS J, 1994, AM J ROENTGENOL, V162, P1323, DOI 10.2214/ajr.162.6.8191992; SPARKS MJW, 1995, BRIT J RADIOL, V68, P841, DOI 10.1259/0007-1285-68-812-841; THOENI RF, 1988, RADIOLOGY, V167, P7, DOI 10.1148/radiology.167.1.3347749; 1988, LANCET, V1, P1144	16	14	15	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					986	986		10.1016/S0140-6736(95)91684-9	http://dx.doi.org/10.1016/S0140-6736(95)91684-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475590				2022-12-24	WOS:A1995RZ59900006
J	VENN, A; WATSON, L; LUMLEY, J; GILES, G; KING, C; HEALY, D				VENN, A; WATSON, L; LUMLEY, J; GILES, G; KING, C; HEALY, D			BREAST AND OVARIAN-CANCER INCIDENCE AFTER INFERTILITY AND IN-VITRO FERTILIZATION	LANCET			English	Article							WOMEN; RISK	Concern has been expressed that exposure to fertility drugs might be associated with a risk of ovarian cancer. We have examined the incidence of breast and ovarian cancer in a cohort of 10 358 women referred for in-vitro fertilisation (IVF) treatment in Victoria, Australia, between 1978 and 1992. The ''exposed'' group (n=5564) had had ovarian stimulation to induce multiple folliculogenesis and the ''unexposed'' group (n=4794) had been referred for IVF but were untreated or had had ''natural cycle'' treatment without ovarian stimulation. Duration of follow-up ranged from 1 to 15 years. Cases of cancer were determined by record linkage with data from population-based cancer registries. 34 cases of invasive breast cancer and 6 of invasive ovarian cancer were observed. A comparison with the expected numbers, derived by applying age-standardised general population rates to the cohort gave standardised incidence ratios (SIR) for breast cancer of 0.89 (95% CI 0.55-1.46) in the exposed group and 0.98 (0.62-1.56) in the unexposed group, and for ovarian cancer SIRs were 1.70 (0.55-5.27) and 1.62 (0.52-5.02), respectively. Rates of all cancers were not significantly different from general population rates. The relative risk (RR) of cancer, adjusted for age and infertility type, was, in the treated group compared with the untreated group, 1.11 (95% CI 0.56-2.20) for breast cancer and 1.45 (0.28-7.55) for ovarian cancer. The risk of body of uterus cancer was increased in the exposed and unexposed groups combined (SIR 2.84 [1.18-6.81]). Women with unexplained infertility, independent of IVF exposure, had significantly increased risks of ovarian cancer (RR=19.19 [2.23-165.0]) and body of uterus cancer (RR=6.34 [1.06-38.0]) compared with women with known causes of infertility. This relatively short-term follow-up suggests that ovarian stimulation with IVF is not associated with an increased risk of breast cancer. Although there was no significantly increased risk of ovarian cancer after ovarian stimulation with IVF the small number of cases limits the conclusions that can be drawn. Longer-term follow-up of large cohorts of women who have been in IVF programmes will be necessary.	NATL PERINATAL EPIDEMIOL UNIT,OXFORD,ENGLAND; ANTICANC COUNCIL VICTORIA,CTR EPIDEMIOL,CARLTON,VIC,AUSTRALIA; MAROONDAH BREASTSCREEN,E RINGWOOD,VIC,AUSTRALIA; MONASH UNIV,MONASH MED CTR,DEPT OBSTET & GYNAECOL,CLAYTON,VIC 3168,AUSTRALIA	University of Oxford; Monash University	VENN, A (corresponding author), LA TROBE UNIV,CTR STUDY MOTHERS & CHILDRENS HLTH,463 CARDIGAN ST,CARLTON,VIC 3053,AUSTRALIA.		Venn, Alison J/J-2803-2013					BRINTON LA, 1989, AM J EPIDEMIOL, V129, P712, DOI 10.1093/oxfordjournals.aje.a115186; COWAN LD, 1981, AM J EPIDEMIOL, V114, P209, DOI 10.1093/oxfordjournals.aje.a113184; Creasy G W, 1992, Obstet Gynecol Surv, V47, P654, DOI 10.1097/00006254-199209000-00026; DEWAARD F, 1982, CANCER EPIDEMIOL, P901; Fischel S., 1989, BRIT MED J, V299, P309; GAMMON MD, 1990, AM J EPIDEMIOL, V132, P708, DOI 10.1093/oxfordjournals.aje.a115712; GILES GG, 1992, CANCER VICTORIA 1982; HEALY DL, 1994, LANCET, V343, P1539, DOI 10.1016/S0140-6736(94)92941-6; MACLACHLAN V, 1989, NEW ENGL J MED, V320, P1233, DOI 10.1056/NEJM198905113201902; PRESTON D. L., 1993, EPICURE USERS GUIDE; RON E, 1987, AM J EPIDEMIOL, V125, P780, DOI 10.1093/oxfordjournals.aje.a114595; ROSSING MA, 1994, NEW ENGL J MED, V331, P771, DOI 10.1056/NEJM199409223311204; TROUNSON AO, 1981, SCIENCE, V212, P616; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; 1995, LONG TERM EFFECTS WO	15	255	261	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					995	1000		10.1016/S0140-6736(95)91687-3	http://dx.doi.org/10.1016/S0140-6736(95)91687-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475593				2022-12-24	WOS:A1995RZ59900009
J	BURKE, DS; BRUNDAGE, JF; REDFIELD, RR; DAMATO, JJ; SCHABLE, CA; PUTMAN, P; VISINTINE, R; KIM, HI				BURKE, DS; BRUNDAGE, JF; REDFIELD, RR; DAMATO, JJ; SCHABLE, CA; PUTMAN, P; VISINTINE, R; KIM, HI			MEASUREMENT OF THE FALSE POSITIVE RATE IN A SCREENING-PROGRAM FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									WALTER REED ARMY INST RES,DIV PREVENT MED,WASHINGTON,DC 20307; CTR DIS CONTROL,AIDS PROGRAM,ATLANTA,GA 30333; BIOTECH RES LABS,ROCKVILLE,MD; US MIL ENTRANCE PROC COMMAND,N CHICAGO,IL; DAMON LABS,NEWBERRY PK,CA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA	BURKE, DS (corresponding author), WALTER REED ARMY INST RES,DIV COMMUNICABLE DIS & IMMUNOL,WASHINGTON,DC 20307, USA.		Brundage, John/Q-9244-2019	/0000-0002-5704-8094				BARIN F, 1985, SCIENCE, V228, P1094, DOI 10.1126/science.2986291; BURKE DS, 1987, NEW ENGL J MED, V317, P131, DOI 10.1056/NEJM198707163170302; BURKE DS, 1987, ANN INTERN MED, V106, P671, DOI 10.7326/0003-4819-106-5-671; CLEARY PD, 1987, JAMA-J AM MED ASSOC, V258, P1757, DOI 10.1001/jama.258.13.1757; GOEDERT JJ, 1986, ANN INTERN MED, V105, P609, DOI 10.7326/0003-4819-105-4-609; HERBOLD JR, 1986, MIL MED, V151, P623; MEYER KB, 1987, NEW ENGL J MED, V317, P238, DOI 10.1056/NEJM198707233170410; NEWMARK P, 1987, NATURE, V327, P355, DOI 10.1038/327355a0; NIGHTINGALE SL, 1987, JAMA-J AM MED ASSOC, V257, P3030; THORN RM, 1987, J CLIN MICROBIOL, V25, P1207, DOI 10.1128/JCM.25.7.1207-1212.1987; 1986, IMMUNOLOGY SERIES CT, V15; 1987, MAR CONS C HIV TEST; 1987, MMWR, V36, P509	13	163	165	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	1988	319	15					961	964		10.1056/NEJM198810133191501	http://dx.doi.org/10.1056/NEJM198810133191501			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4155	3419477				2022-12-24	WOS:A1988Q415500001
J	GILL, G; PTASHNE, M				GILL, G; PTASHNE, M			NEGATIVE EFFECT OF THE TRANSCRIPTIONAL ACTIVATOR GAL4	NATURE			English	Article											GILL, G (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.							BRAM RJ, 1985, P NATL ACAD SCI USA, V82, P43, DOI 10.1073/pnas.82.1.43; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON SA, 1986, P NATL ACAD SCI USA, V83, P6553, DOI 10.1073/pnas.83.17.6553; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; NOGI Y, 1984, MOL GEN GENET, V195, P29, DOI 10.1007/BF00332719; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; SADOWSKI I, UNPUB NATURE; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; SILVERMAN SJ, 1982, MOL CELL BIOL, V2, P1212, DOI 10.1128/MCB.2.10.1212; STRUHL K, 1985, NUCLEIC ACIDS RES, V13, P8587, DOI 10.1093/nar/13.23.8587; STRUHL K, 1984, P NATL ACAD SCI-BIOL, V81, P7865, DOI 10.1073/pnas.81.24.7865; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; YOCUM RR, 1984, MOL CELL BIOL, V4, P1985, DOI 10.1128/MCB.4.10.1985	30	583	654	2	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 25	1988	334	6184					721	724		10.1038/334721a0	http://dx.doi.org/10.1038/334721a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7985	3412449				2022-12-24	WOS:A1988P798500066
J	KRAMER, RA; ZAKHER, J; KIM, G				KRAMER, RA; ZAKHER, J; KIM, G			ROLE OF THE GLUTATHIONE REDOX CYCLE IN ACQUIRED AND DENOVO MULTIDRUG RESISTANCE	SCIENCE			English	Article											KRAMER, RA (corresponding author), HARVARD UNIV,SCH MED,JOINT CTR RADIAT THERAPY,BOSTON,MA 02115, USA.							BABSON JR, 1981, BIOCHEM PHARMACOL, V30, P2299, DOI 10.1016/0006-2952(81)90102-7; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BATIST G, 1986, J BIOL CHEM, V261, P5544; BECHHANSEN NT, 1976, J CELL PHYSIOL, V88, P23, DOI 10.1002/jcp.1040880104; BELL DR, 1985, J CLIN ONCOL, V3, P311, DOI 10.1200/JCO.1985.3.3.311; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; CORNWELL MM, 1986, J BIOL CHEM, V261, P7921; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, BIOCH PHARM, V36, P2879; COWAN KH, 1986, P NATL ACAD SCI USA, V83, P9328, DOI 10.1073/pnas.83.24.9328; DEXTER DL, 1979, CANCER RES, V39, P1020; DURSE L, 1988, P AM ASS CANCER RES, V29, P319; FAIRCHILD CR, 1987, CANCER RES, V47, P5141; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Fine R. L., 1986, CANC CHEMOTERAPY, P117; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FRISCHER H, 1977, J LAB CLIN MED, V89, P1080; GERLACH JH, 1987, J CLIN ONCOL, V5, P1452, DOI 10.1200/JCO.1987.5.9.1452; GOODMAN GE, 1987, CANCER RES, V47, P2295; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; HABIG WH, 1974, J BIOL CHEM, V249, P7130; INABA M, 1979, CANCER RES, V39, P2200; JOHNSON RK, 1976, CANCER TREAT REP, V60, P99; KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Kramer R. K., UNPUB; NILES RM, 1987, CANCER INVEST, V5, P545, DOI 10.3109/07357908709020314; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powis G., 1987, METABOLISM ACTION AN, P211; PROHASKA JR, 1977, BIOCHEM BIOPH RES CO, V76, P437, DOI 10.1016/0006-291X(77)90744-6; RIEHM H, 1971, CANCER RES, V31, P409; RUSH GF, 1986, TOXICOL APPL PHARM, V85, P324, DOI 10.1016/0041-008X(86)90339-X; SCHRAUFSTATTER IU, 1985, J CLIN INVEST, V76, P1131, DOI 10.1172/JCI112068; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; SHREVE MR, 1979, BIOCHEM J, V177, P761, DOI 10.1042/bj1770761; SINHA BK, 1987, BIOCHEMISTRY-US, V26, P3776, DOI 10.1021/bi00387a006; SUGIMOTO Y, 1987, MOL CELL BIOL, V7, P4549, DOI 10.1128/MCB.7.12.4549; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TSURUO T, 1982, CANCER RES, V42, P4730; TWENTYMAN PR, 1984, BRIT J CANCER, V50, P625, DOI 10.1038/bjc.1984.229; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; WEISENTHAL LM, 1985, CANCER TREAT REP, V69, P615; YEH GC, 1987, CANCER RES, V47, P5994	43	336	336	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1988	241	4866					694	697		10.1126/science.3399900	http://dx.doi.org/10.1126/science.3399900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5539	3399900				2022-12-24	WOS:A1988P553900033
J	SMITH, WCS; CROMBIE, IK; TAVENDALE, RT; GULLAND, SK; TUNSTALLPEDOE, HD				SMITH, WCS; CROMBIE, IK; TAVENDALE, RT; GULLAND, SK; TUNSTALLPEDOE, HD			URINARY ELECTROLYTE EXCRETION, ALCOHOL-CONSUMPTION, AND BLOOD-PRESSURE IN THE SCOTTISH HEART HEALTH STUDY	BRITISH MEDICAL JOURNAL			English	Article											SMITH, WCS (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,CARDIOVASC EPIDEMIOL UNIT,DUNDEE DD1 9SY,SCOTLAND.							BEEVERS DG, 1980, BMJ-BRIT MED J, V281, P641, DOI 10.1136/bmj.281.6241.641; BOON NA, 1985, BMJ-BRIT MED J, V290, P949, DOI 10.1136/bmj.290.6473.949; BULPITT CJ, 1986, J CHRON DIS, V39, P211, DOI 10.1016/0021-9681(86)90026-3; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; GROBBEE DE, 1986, BRIT MED J, V293, P27, DOI 10.1136/bmj.293.6538.27; JOOSSENS JV, 1983, PREV MED, V12, P53, DOI 10.1016/0091-7435(83)90171-8; LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806; Rose G, 1982, CARDIOVASCULAR SURVE; SALONEN JT, 1983, J EPIDEMIOL COMMUN H, V37, P32, DOI 10.1136/jech.37.1.32; SMITH W C S, 1987, Health Bulletin (Edinburgh), V45, P211; STAESSEN J, 1981, J EPIDEMIOL COMMUN H, V35, P256, DOI 10.1136/jech.35.4.256; WATT GCM, 1982, J EPIDEMIOL COMMUN H, V36, P197, DOI 10.1136/jech.36.3.197	12	115	115	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 30	1988	297	6644					329	330		10.1136/bmj.297.6644.329	http://dx.doi.org/10.1136/bmj.297.6644.329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4527	3416163	Bronze, Green Published			2022-12-24	WOS:A1988P452700019
J	GIBBINS, RL; SAUNDERS, J				GIBBINS, RL; SAUNDERS, J			HOW TO DEVELOP DIABETIC CARE IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article									NEVILL HALL HOSP,ABERGAVENNY NP7 7EG,GWENT,WALES									ALBERTI KGM, 1983, OXFORD TXB MED, V1, P5; HOWIE JGR, 1979, RES GENERAL PRACTICE; Sonksen PH, 1985, DIABETES REFERENCE B; WATKINS PJ, 1983, ABC DIABETES	4	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 16	1988	297	6642					187	189		10.1136/bmj.297.6642.187	http://dx.doi.org/10.1136/bmj.297.6642.187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P2951	3408960	Green Published, Bronze			2022-12-24	WOS:A1988P295100026
J	HANSON, PJV; JEFFRIES, DJ; BATTEN, JC; COLLINS, JV				HANSON, PJV; JEFFRIES, DJ; BATTEN, JC; COLLINS, JV			INFECTION CONTROL REVISITED - DILEMMA FACING TODAYS BRONCHOSCOPISTS	BRITISH MEDICAL JOURNAL			English	Article									BROMPTON HOSP,FULHAM RD,LONDON SW3 6HP,ENGLAND; ST MARYS HOSP,LONDON W2 1PG,ENGLAND; ST STEPHENS HOSP,LONDON SW10 9TH,ENGLAND	Royal Brompton Hospital; Imperial College London								AYLIFFE GAJ, 1986, J HOSP INFECT, V7, P295; BABB JR, 1984, J STERILE SERV MANAG, P8; Bageant R A, 1981, Respir Care, V26, P1255; BIRNIE GG, 1983, GUT, V24, P171, DOI 10.1136/gut.24.2.171; BOND WW, 1983, J CLIN MICROBIOL, V18, P535, DOI 10.1128/JCM.18.3.535-538.1983; CHAYT KJ, 1986, JAMA-J AM MED ASSOC, V256, P2356, DOI 10.1001/jama.256.17.2356; DAWSON DJ, 1982, AM REV RESPIR DIS, V126, P1095; GOLDSTEIN B, 1985, J HOSP INFECT, V6, P194; GRANT P, 1985, PHLS COMMUNICABLE DI, V42, P4; HANSON PJV, 1987, THORAX, V42, P81, DOI 10.1136/thx.42.2.81; HUSSAIN SA, 1978, CHEST, V74, P4; KOBAYASHI H, 1984, J CLIN MICROBIOL, V20, P214, DOI 10.1128/JCM.20.2.214-216.1984; LEERS WD, 1980, CAN MED ASSOC J, V123, P275; MARTIN LS, 1985, J INFECT DIS, V152, P400, DOI 10.1093/infdis/152.2.400; MCCRAY E, 1986, NEW ENGL J MED, V314, P1127, DOI 10.1056/NEJM198604243141729; NELSON KE, 1983, AM REV RESPIR DIS, V127, P97, DOI 10.1164/arrd.1983.127.1.97; PAPPAS SA, 1983, AM REV RESPIR DIS, V127, P391; QUINNAN GV, 1986, TRANSFUSION, V26, P481, DOI 10.1046/j.1537-2995.1986.26587020131.x; Resnick L, 1987, Am J Med, V82, P553, DOI 10.1016/0002-9343(87)90461-X; RESNICK L, 1986, JAMA-J AM MED ASSOC, V255, P1887, DOI 10.1001/jama.255.14.1887; SALAHUDDIN SZ, 1986, BLOOD, V68, P281; SIEGMANIGRA Y, 1985, J HOSP INFECT, V6, P218; SPIRE B, 1984, LANCET, V2, P899; WASHINGTON J, 1985, HOSPITAL INFECTI MAY, P60; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; ZIZA JM, 1985, NEW ENGL J MED, V313, P183; 1986, MMWR, V35, P76; 1987, MMWR, V36, P285; 1986, SAFETY INFORMATI MAY; 1985, MMWR, V34, P681; IN PRESS GUT; 1987, MMWR, V36, P25	32	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 16	1988	297	6642					185	187		10.1136/bmj.297.6642.185	http://dx.doi.org/10.1136/bmj.297.6642.185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P2951	3408959	Bronze, Green Published			2022-12-24	WOS:A1988P295100025
J	AKHURST, RJ; FEE, F; BALMAIN, A				AKHURST, RJ; FEE, F; BALMAIN, A			LOCALIZED PRODUCTION OF TGF-BETA MESSENGER-RNA IN TUMOR PROMOTER-STIMULATED MOUSE EPIDERMIS	NATURE			English	Article									ST MARYS HOSP,SCH MED,DEPT BIOCHEM,LONDON,ENGLAND	Imperial College London	AKHURST, RJ (corresponding author), BEATSON INST CANC RES,SWITCHBACK RD,GLASGOW G61 1BD,SCOTLAND.			AKHURST, ROSEMARY/0000-0002-4474-9668				BAIRD WM, 1971, CANCER RES, V31, P1434; BALMAIN A, 1976, J INVEST DERMATOL, V67, P246, DOI 10.1111/1523-1747.ep12513451; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1982, NUCLEIC ACIDS RES, V10, P4259, DOI 10.1093/nar/10.14.4259; BALMAIN A, 1976, Z KREBSFORSCH KLIN O, V86, P251, DOI 10.1007/BF00286944; BALMAIN A, 1978, CARCINOGENESIS, V2, P153; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; HAWLEYNELSON P, 1982, EXP CELL RES, V137, P155, DOI 10.1016/0014-4827(82)90017-9; HECKER E, 1982, CARCINOGENESIS COMPR, V7; IVERSEN OH, 1969, HOMEOSTATIC REGULATO, P29; JETTEN AM, 1986, EXP CELL RES, V167, P539, DOI 10.1016/0014-4827(86)90193-X; KRIEG L, 1974, CANCER RES, V34, P3135; LASKIN JD, 1981, CELL, V25, P441, DOI 10.1016/0092-8674(81)90062-3; LECHNER JF, 1983, CANCER RES, V43, P5915; Marks F, 1978, CARCINOGENESIS, V2, P97; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; PARKINSON EK, 1982, CARCINOGENESIS, V3, P525, DOI 10.1093/carcin/3.5.525; PARKINSON EK, 1985, BRIT J CANCER, V52, P479, DOI 10.1038/bjc.1985.219; Pinkus H, 1971, SKIN, P1; RAICK AN, 1973, CANCER RES, V33, P269; REINERS JJ, 1983, CELL, V32, P247, DOI 10.1016/0092-8674(83)90515-9; SHIPLEY GD, 1986, CANCER RES, V46, P2068; SPORN MB, 1983, SCIENCE, V219, P1329, DOI 10.1126/science.6572416; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; WEISS P, 1957, J GEN PHYSIOL, V41, P1, DOI 10.1085/jgp.41.1.1; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; YUSPA SH, 1982, CANCER RES, V42, P2344; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0	29	262	268	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 28	1988	331	6154					363	365		10.1038/331363a0	http://dx.doi.org/10.1038/331363a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	L8032	3422343				2022-12-24	WOS:A1988L803200071
J	GIBBS, CS; COUTRE, SE; TSIANG, M; LI, WX; JAIN, AK; DUNN, KE; LAW, VS; MAO, CT; MATSUMURA, SY; MEJZA, SJ; PABORSKY, LR; LEUNG, LLK				GIBBS, CS; COUTRE, SE; TSIANG, M; LI, WX; JAIN, AK; DUNN, KE; LAW, VS; MAO, CT; MATSUMURA, SY; MEJZA, SJ; PABORSKY, LR; LEUNG, LLK			CONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING	NATURE			English	Article							BLOOD-COAGULATION; STRUCTURAL BASIS; HUMAN-FIBRINOGEN; ACTIVATION; COFACTOR; PRIMATES; DOMAINS; INVIVO; CHAIN	AT sites of vascular injury, thrombin interacts with multiple procoagulant substrates(1-6) to mediate both fibrin clotting and platelet aggregation. But upon binding to thrombomodulin on the vascular endothelium, thrombin instead activates protein C, thereby functioning as an anticoagulant and attenuating clot formation(7). Upon infusion in vivo, both the procoagulant and anticoagulant effects of thrombin were observed(8,9). Preliminary studies indicating that thrombin's protein C activating and fibrinogen clotting activities could be dissociated by mutagenesis(10) suggested to us that a thrombin variant that lacked procoagulant activity while retaining anticoagulant function might be an attractive antithrombotic agent. Using protein engineering, we introduced a single substitution, E229A, that substantially shifted thrombin's specificity in favour of the anticoagulant substrate, protein C. In monkeys, this modified thrombin functioned as an endogenous protein C activator demonstrating dose-dependent, reversible anticoagulation without any indication of procoagulant activity. Notably, template bleeding times were not prolonged, suggesting a reduced potential for bleeding complications.	GILEAD SCI,FOSTER CITY,CA 94404	Gilead Sciences				Coutre, Steven/0000-0001-8420-5748				BANFIELD DK, 1992, P NATL ACAD SCI USA, V89, P2779, DOI 10.1073/pnas.89.7.2779; BOROWSKI M, 1985, J BIOL CHEM, V260, P9258; COMP PC, 1982, J CLIN INVEST, V70, P127, DOI 10.1172/JCI110584; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; FENTON JW, 1977, J BIOL CHEM, V252, P3587; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GRAYCAR TP, 1987, J CELL BIOCHEM     S, V11, P234; GRUBER A, 1991, CIRCULATION, V84, P2454, DOI 10.1161/01.CIR.84.6.2454; GRUBER A, 1992, BLOOD, V79, P2340; HANSON SR, 1993, J CLIN INVEST, V92, P2003, DOI 10.1172/JCI116795; HIGGINS DL, 1983, J BIOL CHEM, V258, P9276; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; LORAND L, 1992, THROMBIN STRUCTURE F, P257; Mann K.G.R., 1987, HEMOSTASIS THROMBOSI, P148; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; NI F, 1989, BIOCHEMISTRY-US, V28, P3106, DOI 10.1021/bi00433a054; ORTHNER CL, 1993, THROMB HAEMOSTASIS, V69, P441; OWEN WG, 1981, J BIOL CHEM, V256, P5532; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; TSIANG M, 1995, J BIOL CHEM, V270, P19370, DOI 10.1074/jbc.270.33.19370; TSIANG M, 1992, J BIOL CHEM, V267, P6164; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WU Q, 1991, P NATL ACAD SCI USA, V88, P6675; YE J, 1994, J BIOL CHEM, V269, P17965; 1985, GUIDE CARE USE LABOR, V8523	27	126	133	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					413	416		10.1038/378413a0	http://dx.doi.org/10.1038/378413a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477382				2022-12-24	WOS:A1995TF89300066
J	JIANG, H; LUO, JQ; URANO, T; FRANKEL, P; LU, ZM; FOSTER, DA; FEIG, LA				JIANG, H; LUO, JQ; URANO, T; FRANKEL, P; LU, ZM; FOSTER, DA; FEIG, LA			INVOLVEMENT OF RAL GTPASE IN V-SRC-INDUCED PHOSPHOLIPASE-D ACTIVATION	NATURE			English	Article							BINDING PROTEIN; KINASE; FAMILY	AN early response to the tyrosine kinase activity of v-Src is an increase in phospholipase D (PLD) activity(1), which leads to the generation of biologically active lipid second messengers, including phosphatidic acid, lysophosphatidic acid and diacylglycerol(2). We have recently demonstrated that v-Src-induced PLD activity is mediated by Ras(3), although Ras involvement was indirect, requiring a cytosolic factor for PLD activation(3). Ras interacts with(4-6) and activates Ral-GDS(13), the exchange factor responsible for the activation of Ral GTPases. Here we report that this newly identified Ras/Ral signalling pathway mediates PLD activation by v-Src. PLD activity could be precipitated from v-Src-transformed cell lysates with immobilized RalA protein and with an anti-Ral antibody. A mutation to the region of RalA analogous to the 'effector domain' of Ras did not reduce the ability of RalA to complex with PLD, although deletion of a Ral-specific amino-terminal region did. Overexpression of RalA potentiated PLD activation by v-Src, and expression of dominant negative RalA mutants inhibited both v-Src- and v-Ras-induced PLD activity. Thus RalA is involved in the tyrosine kinase activation of PLD through its unique N terminus, and that PLD is a downstream target of a Ras/Ral GTPase cascade.	CUNY HUNTER COLL,INST BIOMOLEC STRUCT & FUNCT,NEW YORK,NY 10021; CUNY HUNTER COLL,DEPT SCI BIOL,NEW YORK,NY 10021; TUFTS UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02111	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); Tufts University			Urano, Tomohiko/AFS-9574-2022					BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAMERO A, 1994, ONCOGENE, V9, P1387; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; EMKEY R, 1991, J BIOL CHEM, V266, P9703; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FOSTER DA, 1993, CELL SIGNAL, V5, P389, DOI 10.1016/0898-6568(93)90078-Z; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; JIANG H, 1995, J BIOL CHEM, V270, P6006, DOI 10.1074/jbc.270.11.6006; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; LAMBETH JD, 1995, J BIOL CHEM, V270, P2431, DOI 10.1074/jbc.270.6.2431; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; QURESHI SA, 1992, J BIOL CHEM, V267, P17635; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SIDDIQI AR, 1995, J BIOL CHEM, V270, P8466, DOI 10.1074/jbc.270.15.8466; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; SONG JG, 1993, BIOCHEM J, V294, P711, DOI 10.1042/bj2940711; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; URANO T, IN PRESS EMBO J; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	25	252	254	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					409	412		10.1038/378409a0	http://dx.doi.org/10.1038/378409a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477381				2022-12-24	WOS:A1995TF89300065
J	BARKER, DJP; OSMOND, C; RODIN, I; FALL, CHD; WINTER, PD				BARKER, DJP; OSMOND, C; RODIN, I; FALL, CHD; WINTER, PD			LOW-WEIGHT GAIN IN INFANCY AND SUICIDE IN ADULT LIFE	BRITISH MEDICAL JOURNAL			English	Article									UNIV SOUTHAMPTON,ROYAL S HANTS HOSP,DEPT PSYCHIAT,SOUTHAMPTON SO14 0YG,HANTS,ENGLAND	University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital	BARKER, DJP (corresponding author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,MRC,ENVIRONM EPIDEMIOL UNIT,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND.			Osmond, Clive/0000-0002-9054-4655				BARKER DJP, 1995, LANCET, V345, P1087, DOI 10.1016/S0140-6736(95)90821-8; BARRACLOUGH BM, 1974, BR J PSYCH, V74, P443; CHECKLEY S, 1992, HDB AFFECTIVE DISORD; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; VANKNORRING AL, 1982, ACTA PSYCHIAT SCAND, V65, P283	5	92	96	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1203	1203		10.1136/bmj.311.7014.1203	http://dx.doi.org/10.1136/bmj.311.7014.1203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TD768	7488897	Green Published			2022-12-24	WOS:A1995TD76800021
J	HART, AC; SIMS, S; KAPLAN, JM				HART, AC; SIMS, S; KAPLAN, JM			SYNAPTIC CODE FOR SENSORY MODALITIES REVEALED BY C-ELEGANS GLR-1 GLUTAMATE-RECEPTOR	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EXPRESSION	How does the nervous system encode environmental stimuli as sensory experiences? Both the type (visual, olfactory, gustatory, mechanical or auditory) and the quality of a stimulus (spatial position, intensity or frequency) are represented as a neural code. Here we undertake a genetic analysis of sensory modality coding in Caenorhabditis elegans. The ASH sensory neurons respond to two distinct sensory stimuli (nose touch and osmotic stimuli). A mutation in the glr-1 (glutamate receptor) gene eliminates the response to nose touch but not to osmotic repellents. The predicted GLR-1 protein is roughly 40% identical to mammalian AMPA-class glutamate receptor (GluR) subunits. Analysis of glr-1 expression and genetic mosaics indicates that GLR-1 receptors act in synaptic targets of the ASH neurons. We propose that discrimination between the ASH sensory modalities arises from differential release of ASH neurotransmitters in response to different stimuli.	MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HODGKIN J, 1983, GENETICS, V103, P43; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHIM MD, 1994, J NEUROSCI, V14, P4244; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	18	309	320	0	18	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					82	85		10.1038/378082a0	http://dx.doi.org/10.1038/378082a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477294				2022-12-24	WOS:A1995TC46900055
J	HENKEMEYER, M; ROSSI, DJ; HOLMYARD, DP; PURI, MC; MBAMALU, G; HARPAL, K; SHIH, TS; JACKS, T; PAWSON, T				HENKEMEYER, M; ROSSI, DJ; HOLMYARD, DP; PURI, MC; MBAMALU, G; HARPAL, K; SHIH, TS; JACKS, T; PAWSON, T			VASCULAR SYSTEM DEFECTS AND NEURONAL APOPTOSIS IN MICE LACKING RAS GTPASE-ACTIVATING PROTEIN	NATURE			English	Article							TYROSINE PHOSPHORYLATION; MOLECULAR-CLONING; GAP; BINDING; RECEPTORS; KINASES; DOMAIN; CELLS; P21	The gene encoding p120-rasGAP, a negative regulator of pas, has been disrupted in mice. This Gap mutation affects the ability of endothelial cells to organize into a highly vascularized network and results in extensive neuronal cell death. Mutations in the Gap and Nf1 genes have a synergistic effect, such that embryos homozygous for mutations in both genes show an exacerbated Gap phenotype. Thus rasGAP and neurofibromin act together to regulate pas activity during embryonic development.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5S 1A8,CANADA; MIT,CTR CANC RES,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	University of Toronto; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	HENKEMEYER, M (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,PROGRAMME MOLEC BIOL & CANC,600 UNIV AVE,TORONTO,ON M5G 1X5,CANADA.		Puri, Mira/C-4412-2014; Pawson, Tony J/E-4578-2013	Henkemeyer, Mark/0000-0002-7525-1061				ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; CONLON RA, 1995, DEVELOPMENT, V121, P1533; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FERNANDEZSARABI.MJ, 1993, NATURE, V366, P274; FERRARI G, 1994, EMBO J, V13, P5922, DOI 10.1002/j.1460-2075.1994.tb06937.x; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FOX PL, 1994, ONCOGENE, V9, P3519; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GOU D, 1995, J BIOL CHEM, V270, P6729; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JIMENEZ B, 1995, ONCOGENE, V10, P811; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KIM HA, 1995, ONCOGENE, V11, P325; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879, DOI 10.1128/MCB.14.10.6879; MARSHALL CJ, 1991, TRENDS GENET, V7; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; REY I, 1994, ONCOGENE, V9, P685; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Risau W., 1991, DEV VASCULAR SYSTEM, P58; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SEETHARAM L, 1995, ONCOGENE, V10, P135; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SOSNOWSKI RG, 1993, J CELL BIOL, V121, P113, DOI 10.1083/jcb.121.1.113; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAITENBERGER J, 1994, J BIOL CHEM, V269, P26988; WANG HG, 1995, J CELL BIOL, V129, P1103, DOI 10.1083/jcb.129.4.1103; WURST W, 1993, GENE TARGETING PRACT, P31; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9	50	288	291	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					695	701		10.1038/377695a0	http://dx.doi.org/10.1038/377695a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477259				2022-12-24	WOS:A1995TB46900045
J	ICHIKI, T; LABOSKY, PA; SHIOTA, C; OKUYAMA, S; IMAGAWA, Y; FOGO, A; NIIMURA, F; ICHIKAWA, I; HOGAN, BLM; INAGAMI, T				ICHIKI, T; LABOSKY, PA; SHIOTA, C; OKUYAMA, S; IMAGAWA, Y; FOGO, A; NIIMURA, F; ICHIKAWA, I; HOGAN, BLM; INAGAMI, T			EFFECTS ON BLOOD-PRESSURE AND EXPLORATORY-BEHAVIOR OF MICE LACKING ANGIOTENSIN-II TYPE-2 RECEPTOR	NATURE			English	Article							RAT-BRAIN; EXPRESSION; SUBTYPES; CLONING; ANTAGONISTS; MECHANISMS; AT1	THERE are two major angiotensin II receptor isoforms, AT(1) and AT(2). AT(1) mediates the well-known presser and mitogenic effects of angiotensin II (refs 1-5), but the signalling mechanism and physiological role of AT(2) (refs 6-11) has not been established. Its abundant expression in fetal tissues(12) and certain brain nuclei(13) suggest possible roles in growth, development and neuronal functions. Here we report the unexpected finding that the targeted disruption of the mouse AT(2) gene resulted in a significant increase in blood pressure and increased sensitivity to the presser action of angiotensin II. Thus AT(2) mediates a depressor effect and antagonizes the AT(1)-mediated presser action of angiotensin II. In addition, disruption of the AT(2) gene attenuated exploratory behaviour and lowered body temperature. Our results show that angiotensin II activates AT(1) and AT(2), which have mutually counteracting haemodynamic effects, and that AT(2) regulates central nervous system functions, including behaviour.	VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT CELL BIOL,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232; TAISHO PHARMACEUT CO LTD,MED RES LABS,LAB 1,OMIYA,SAITAMA 330,JAPAN	Vanderbilt University; Vanderbilt University; Vanderbilt University; Howard Hughes Medical Institute; Vanderbilt University; Taisho Pharmaceutical Holdings Co Ltd				Labosky, Patricia/0000-0001-5880-2194				ASHTON H, 1987, BRAIN SYSTEMS DISORD, P1; BOTTARI SP, 1993, FRONT NEUROENDOCRIN, V14, P123, DOI 10.1006/frne.1993.1005; BUISSON B, 1995, J BIOL CHEM, V270, P1670, DOI 10.1074/jbc.270.4.1670; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; ICHIHARA K, 1993, J PHARMACOL EXP THER, V264, P122; ICHIKI T, 1995, CIRC RES, V76, P693, DOI 10.1161/01.RES.76.5.693; Irwin S., 1964, DRUG EVALUATION, P36; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KEISER JA, 1992, J PHARMACOL EXP THER, V262, P1154; KOIKE G, 1994, BIOCHEM BIOPH RES CO, V203, P1842, DOI 10.1006/bbrc.1994.2402; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LO M, 1995, J CLIN INVEST, V95, P1394, DOI 10.1172/JCI117792; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NAVERI L, 1994, REGUL PEPTIDES, V52, P21, DOI 10.1016/0167-0115(94)90017-5; PEACH MJ, 1981, BIOCHEM PHARMACOL, V30, P2745, DOI 10.1016/0006-2952(81)90410-X; PHILLIPS MI, 1993, REGUL PEPTIDES, V43, P1; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SCHEUER DA, 1993, AM J PHYSIOL, V264, pR917, DOI 10.1152/ajpregu.1993.264.5.R917; SMITHIES O, 1994, P NATL ACAD SCI USA, V91, P3612, DOI 10.1073/pnas.91.9.3612; SOLISRAMIRES R, 1993, GUIDE TECHNIQUES MOU, P855; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; SUMNERS C, 1991, P NATL ACAD SCI USA, V88, P7567, DOI 10.1073/pnas.88.17.7567; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TOFOVIC SP, 1991, HYPERTENSION, V18, P774, DOI 10.1161/01.HYP.18.6.774; TSUTSUMI K, 1991, AM J PHYSIOL, V261, pR209, DOI 10.1152/ajpregu.1991.261.1.R209; YOSHIDA M, 1994, AM J PHYSIOL, V266, pR802, DOI 10.1152/ajpregu.1994.266.3.R802	29	765	776	0	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					748	750		10.1038/377748a0	http://dx.doi.org/10.1038/377748a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477267				2022-12-24	WOS:A1995TB46900061
J	ERNEST, JT				ERNEST, JT			INTRAOCULAR DEVICE FOR CYTOMEGALOVIRUS-INFECTION	LANCET			English	Editorial Material							SUSTAINED-RELEASE GANCICLOVIR; VIRUS RETINITIS				ERNEST, JT (corresponding author), UNIV CHICAGO,DEPT OPHTHALMOL & VISUAL SCI,CHICAGO,IL 60637, USA.							ANAND R, 1993, ARCH OPHTHALMOL-CHIC, V111, P223, DOI 10.1001/archopht.1993.01090020077027; JABS DA, 1987, OPHTHALMOLOGY, V94, P824; JACOBSON MA, 1989, ANTIMICROB AGENTS CH, V33, P736, DOI 10.1128/AAC.33.5.736; MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023; PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P472; ROWE WP, 1956, P SOC EXP BIOL MED, V92, P418, DOI 10.3181/00379727-92-22497; SANBORN GE, 1992, ARCH OPHTHALMOL-CHIC, V110, P188, DOI 10.1001/archopht.1992.01080140044023; SMITH TJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P255, DOI 10.1001/archopht.1992.01080140111037; 1994, ARCH OPHTHALMOL-CHIC, V112, P19; 1995, INVEST OPHTH VIS SCI, V36, pS180	10	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					983	984		10.1016/S0140-6736(95)91681-4	http://dx.doi.org/10.1016/S0140-6736(95)91681-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475587				2022-12-24	WOS:A1995RZ59900003
J	ALVAREZBUYLLA, A; NOTTEBOHM, F				ALVAREZBUYLLA, A; NOTTEBOHM, F			MIGRATION OF YOUNG NEURONS IN ADULT AVIAN BRAIN	NATURE			English	Article											ALVAREZBUYLLA, A (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.			Alvarez-Buylla, Arturo/0000-0003-4426-8925				ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; ALVAREZBUYLLA A, IN PRESS J NEUROSCI; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BURD GD, 1985, J COMP NEUROL, V240, P143, DOI 10.1002/cne.902400204; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; JACOBSON M, 1978, DEV NEUROBIOLOGY, P66; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1987, HDB PHYSL NERVOUS 2, V5; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; RAKIC P, 1981, TRENDS NEUROSCI, V4, P184, DOI 10.1016/0166-2236(81)90060-6; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1986, CELL CONTACT ADHESIO; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; 1970, ANAT REC, V166, P257	16	286	292	1	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					353	354		10.1038/335353a0	http://dx.doi.org/10.1038/335353a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419503				2022-12-24	WOS:A1988Q137300059
J	[Anonymous]				[Anonymous]			GENOME MONITORING	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					284	284						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419490				2022-12-24	WOS:A1988Q137300003
J	FISHER, JM; SOSSIN, W; NEWCOMB, R; SCHELLER, RH				FISHER, JM; SOSSIN, W; NEWCOMB, R; SCHELLER, RH			MULTIPLE NEUROPEPTIDES DERIVED FROM A COMMON PRECURSOR ARE DIFFERENTIALLY PACKAGED AND TRANSPORTED	CELL			English	Article											FISHER, JM (corresponding author), STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA.							BENDAYAN M, 1984, J ELECTRON MICR TECH, V1, P243, DOI 10.1002/jemt.1060010304; BENDAYAN M, 1983, J HISTOCHEM CYTOCHEM, V31, P101, DOI 10.1177/31.1.6187796; ERICKSON BW, 1975, PROTEINS, P257; FARQUHAR MG, 1981, J CELL BIOL, V91, pS77, DOI 10.1083/jcb.91.3.77s; FUMAGALLI G, 1985, J CELL BIOL, V100, P2019, DOI 10.1083/jcb.100.6.2019; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HELLER E, 1980, P NATL ACAD SCI-BIOL, V77, P2328, DOI 10.1073/pnas.77.4.2328; JAMIESON JD, 1967, J CELL BIOL, V34, P597, DOI 10.1083/jcb.34.2.597; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KAGAN A, 1979, OXYTOCIN METHODS HOR, P328; KAUER JA, 1987, J NEUROSCI, V7, P3623; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KREINER T, 1984, J NEUROSCI, V4, P2581; KREINER T, 1986, J CELL BIOL, V102, P769, DOI 10.1083/jcb.102.3.769; KUPFERMANN I, 1967, NATURE, V216, P814, DOI 10.1038/216814a0; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MAYERI E, 1985, J NEUROSCI, V5, P2060; NAMBU JR, 1986, J NEUROSCI, V6, P2026; NEWCOMB R, 1987, J NEUROSCI, V7, P854; NEWCOMB R, 1988, IN PRESS J BIOL CHEM; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; ROTHMAN BS, 1983, P NATL ACAD SCI-BIOL, V80, P5753, DOI 10.1073/pnas.80.18.5753; ROTHMAN BS, 1983, GEN COMP ENDOCR, V52, P134, DOI 10.1016/0016-6480(83)90166-1; SCHELLER RH, 1983, CELL, V32, P7, DOI 10.1016/0092-8674(83)90492-0; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; TOOZE J, 1987, J CELL BIOL, V105, P155, DOI 10.1083/jcb.105.1.155; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; TRIFARO JM, 1982, SECRETORY GRANULE, P3; WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551	34	172	172	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 9	1988	54	6					813	822		10.1016/S0092-8674(88)91131-2	http://dx.doi.org/10.1016/S0092-8674(88)91131-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	Q1020	3409320				2022-12-24	WOS:A1988Q102000011
J	ZIRING, PR; KASTNER, T; FRIEDMAN, DL; POND, WS; BARNETT, ML; SONNENBERG, EM; STRASSBURGER, K				ZIRING, PR; KASTNER, T; FRIEDMAN, DL; POND, WS; BARNETT, ML; SONNENBERG, EM; STRASSBURGER, K			PROVISION OF HEALTH-CARE FOR PERSONS WITH DEVELOPMENTAL-DISABILITIES LIVING IN THE COMMUNITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									MORRISTOWN MEM HOSP,CTR DEV DISABIL,BOX 60,100 MADISON AVE,MORRISTOWN,NJ 07960; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032; MORRISTOWN MEM HOSP,DEPT PEDIAT,MORRISTOWN,NJ 07960; MORRISTOWN MEM HOSP,DEPT DENT,MORRISTOWN,NJ 07960; COLUMBIA UNIV,COLL DENT,NEW YORK,NY 10027	Atlantic Health System; Columbia University; Atlantic Health System; Atlantic Health System; Columbia University								ALLARD MA, 1980, CURRENT FUTURE DEV I; BIRENBAUM A, 1976, RESETTLING RETARDED; BRADLEY VJ, 1981, CHANGING GOVT POLICI, P193; BRESLAU N, 1982, MED CARE, V20, P347, DOI 10.1097/00005650-198204000-00001; BRESLAU N, 1981, MED CARE, V19, P741, DOI 10.1097/00005650-198107000-00005; COHEN HJ, 1980, URBAN COMMUNITY CARE; CONLEY RW, 1973, EC MENTAL RETARDATIO; COPELAND WC, 1981, CHANGING GOVT POLICI, P159; DESALVA RM, 1979, MENT RETARD, V14, P25; DESALVA RM, 1979, MENT RETARD NEWS, V28, P4; FLANAGAN P, 1980, SEP C ENS VIAB COMPR; FROOM J, 1976, NIH76877 DHEW PUBL, P77; FUJIMOTO A, 1978, AM J PUBLIC HEALTH, V68, P406, DOI 10.2105/AJPH.68.4.406; GARRARD SD, 1982, AM J PUBLIC HEALTH, V72, P1226, DOI 10.2105/AJPH.72.11.1226; Garrard SD, 1983, HDB MENTAL RETARDATI; GOTOWKA TD, 1982, AM J PUBLIC HEALTH, V72, P1246, DOI 10.2105/AJPH.72.11.1246; HAMILTON BB, 1978, R26 NW U REH I CHIC; HOGAN MF, 1980, NORMALIZATION SOCIAL; HULL JT, 1980, AM J MENT DEF, V85, P253; INTAGLIATA J, 1980, MENT RETARD, V18, P305; LAKIN KC, 1983, AM J MENT DEFIC, V88, P253; LANDESMANDWYER S, 1981, LIVING COMMUNITY; MERKER EL, 1984, AM FAM PHYSICIAN, V29, P228; MINIHAN PM, 1986, AM J PUBLIC HEALTH, V76, P1201; NELSON RP, 1978, NEW ENGL J MED, V299, P1039, DOI 10.1056/NEJM197811092991904; NELSON SM, 1980, SEP C ENS VIAB COMPR; SCHALOCK RL, 1978, AM J MENT DEF, V83, P240; SCHEERENBERGER RC, 1970, MENT RETARD, V8, P10; SCHOR EL, 1981, PEDIATRICS, V67, P536; SCURLETIS TD, 1976, INTERVENTION STRATEG, P305; SUTTER P, 1980, MENT RETARD, V18, P189; SUTTER P, 1980, AM J MENT DEF, V85, P262; WIECK C, 1980, 9 U MINN DEV DIS PRO; WILSNACK W, 1980, LIVING ENV MENTALLY; Wolfensberger Wolf, 1972, PRINCIPLE NORMALIZAT; WRIGHT SW, 1962, AM J DIS CHILD, V104, P142, DOI 10.1001/archpedi.1962.02080030144006; ZIRING PR, 1987, MENT RETARD, V25, P207; 1980, WILLOWBROOK I COMMUN; 1983, RESTRUCTURING MEDICA; 1977, DHEW OHD7721016 PUBL; 1979, DEINSTITUTIONALIZATI; 1978, 5 YEAR COMPREHENSIVE	42	43	43	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	1988	260	10					1439	1444		10.1001/jama.260.10.1439	http://dx.doi.org/10.1001/jama.260.10.1439			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P9020	3404602				2022-12-24	WOS:A1988P902000027
J	JACOB, R; MERRITT, JE; HALLAM, TJ; RINK, TJ				JACOB, R; MERRITT, JE; HALLAM, TJ; RINK, TJ			REPETITIVE SPIKES IN CYTOPLASMIC CALCIUM EVOKED BY HISTAMINE IN HUMAN-ENDOTHELIAL CELLS	NATURE			English	Article											JACOB, R (corresponding author), SK & F RES LTD,FRYTHE,WELWYN AL6 9AR,HERTS,ENGLAND.							AMBLER SK, 1988, J BIOL CHEM, V263, P1952; BAENZIGER NL, 1980, BIOCHEM BIOPH RES CO, V92, P1435, DOI 10.1016/0006-291X(80)90447-7; BIDEN TJ, 1986, J BIOL CHEM, V261, P1931; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; CRONE C, 1987, News in Physiological Sciences, V2, P16; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTH PH, 1983, MICROVASC RES, V25, P322, DOI 10.1016/0026-2862(83)90022-5; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; HANSS M, 1987, J LAB CLIN MED, V109, P97; HARDEN TK, 1988, BIOCHEM J, V252, P583, DOI 10.1042/bj2520583; Hille B, 1984, IONIC CHANNELS EXCIT; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; KILLACKEY JJF, 1986, AM J PATHOL, V122, P50; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LO WWY, 1987, BIOCHEM BIOPH RES CO, V148, P47, DOI 10.1016/0006-291X(87)91074-6; MCINTYRE TM, 1985, J CLIN INVEST, V76, P271, DOI 10.1172/JCI111957; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; MIYAZAKI S, 1988, J CELL BIOL, V106, P345, DOI 10.1083/jcb.106.2.345; MORRIS AJ, 1987, BIOCHEM J, V248, P489, DOI 10.1042/bj2480489; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; Noble D, 1979, INITIATION HEARTBEAT; ORELLANA S, 1987, J BIOL CHEM, V262, P1638; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RESINK TJ, 1987, BIOCHEM BIOPH RES CO, V144, P438, DOI 10.1016/S0006-291X(87)80529-6; ROTROSEN D, 1986, J CELL BIOL, V103, P2379, DOI 10.1083/jcb.103.6.2379; SCHACHTER M, 1973, HISTAMINE ANTIHISTAM, V1; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SHEARS SB, 1987, BIOCHEM J, V246, P139, DOI 10.1042/bj2460139; SPAT A, 1986, NATURE, V319, P514, DOI 10.1038/319514a0; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR CW, 1988, BIOCHEM BIOPH RES CO, V150, P626, DOI 10.1016/0006-291X(88)90438-X; TSIEN RY, 1986, TRENDS BIOCHEM SCI, V11, P450, DOI 10.1016/0968-0004(86)90245-8; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8	37	397	399	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 1	1988	335	6185					40	45		10.1038/335040a0	http://dx.doi.org/10.1038/335040a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9022	3412458				2022-12-24	WOS:A1988P902200044
J	SANDER, K; LEHMANN, R				SANDER, K; LEHMANN, R			DROSOPHILA NURSE CELLS PRODUCE A POSTERIOR SIGNAL REQUIRED FOR EMBRYONIC SEGMENTATION AND POLARITY	NATURE			English	Article									MAX PLANCK INST ENTWICKLUNGSBIOL 3,D-7400 TUBINGEN,FED REP GER; MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	Max Planck Society; MRC Laboratory Molecular Biology	SANDER, K (corresponding author), BIOL INST ZOOL 1,ALBERSTR 21,D-7600 FREIBURG,FED REP GER.							BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BOHRMANN J, 1987, ROUX ARCH DEV BIOL, V196, P279, DOI 10.1007/BF00395950; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; BULL AL, 1966, J EXP ZOOL, V161, P221, DOI 10.1002/jez.1401610207; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; FROHNHOFER HG, 1986, J EMBRYOL EXP MORPH, V97, P169; GUTZEIT HO, 1982, J EMBRYOL EXP MORPH, V67, P101; King R. C., 1970, OVARIAN DEV DROSOPHI; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LOHSSCHARDIN M, 1979, DEV BIOL, V73, P239, DOI 10.1016/0012-1606(79)90065-4; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; MOHLER J, 1986, GENETICS, V112, P803; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1977, ROUX ARCH DEV BIOL, V183, P249, DOI 10.1007/BF00867325; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; SCHUEPBACH T, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P302	19	42	43	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 1	1988	335	6185					68	70		10.1038/335068a0	http://dx.doi.org/10.1038/335068a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9022	3412461				2022-12-24	WOS:A1988P902200055
J	MCMICHAEL, AJ; BAGHURST, PA; WIGG, NR; VIMPANI, GV; ROBERTSON, EF; ROBERTS, RJ				MCMICHAEL, AJ; BAGHURST, PA; WIGG, NR; VIMPANI, GV; ROBERTSON, EF; ROBERTS, RJ			PORT-PIRIE COHORT STUDY - ENVIRONMENTAL EXPOSURE TO LEAD AND CHILDRENS ABILITIES AT THE AGE OF 4 YEARS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CSIRO,DIV HUMAN NUTR,ADELAIDE,SA 5000,AUSTRALIA; FLINDERS UNIV S AUSTRALIA,MED CTR,CHILD ADOLESCENT & FAMILY HLTH SERV,BEDFORD PK,SA 5042,AUSTRALIA; FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT PAEDIAT,BEDFORD PK,SA 5042,AUSTRALIA; ADELAIDE CHILDRENS HOSP,DEPT CHEM PATHOL,N ADELAIDE,SA 5006,AUSTRALIA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Flinders University South Australia; Flinders University South Australia	MCMICHAEL, AJ (corresponding author), UNIV ADELAIDE,DEPT COMMUNITY MED,N TERRACE,ADELAIDE,SA 5000,AUSTRALIA.							BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; BRADLEY RH, 1977, J EDUC PSYCHOL, V69, P697, DOI 10.1037/0022-0663.69.6.697; BRAND C, 1987, NATURE, V328, P110, DOI 10.1038/328110a0; CALDER IC, 1986, MED J AUSTRALIA, V144, P509, DOI 10.5694/j.1326-5377.1986.tb112272.x; DIETRICH KN, 1987, PEDIATRICS, V80, P721; FULTON M, 1987, LANCET, V1, P1221; HERNBERG S, 1970, LANCET, V1, P63; KAUFMAN AS, 1977, CLIN EVALUATION YOUN, P81; LANSDOWN R, 1986, INT ARCH OCC ENV HEA, V57, P225, DOI 10.1007/BF00405790; Lansdown R., 1986, LEAD DEBATE, P235; MCCARTHY D, 1972, MANUAL MCCARTHY SCAL, P1; MCMICHAEL AJ, 1985, MED J AUSTRALIA, V143, P499, DOI 10.5694/j.1326-5377.1985.tb119911.x; MCMICHAEL AJ, 1986, J EPIDEMIOL COMMUN H, V40, P18, DOI 10.1136/jech.40.1.18; NEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689, DOI 10.1056/NEJM197903293001301; OTTO D, 1985, ENVIRON RES, V38, P168, DOI 10.1016/0013-9351(85)90082-9; OTTO D, 1982, NEUROBEH TOXICOL TER, V4, P733; SMITH M, 1985, J AM ACAD CHILD PSY, V24, P24, DOI 10.1016/S0002-7138(09)60406-4; SMITH RE, 1983, SOIL SCI SOC AM J, V47, P1; Wechsler D, 1981, ADULT INTELLIGENCE S; WIGG NR, IN PRESS J EPIDEMIOL; WINNEKE G, 1983, INT ARCH OCC ENV HEA, V51, P231, DOI 10.1007/BF00377755; YULE W, 1986, LEAD DEBATE ENV TOXI, P193; 1983, 2636 STAND ASS AUSTR; 1985, 2787 STAND ASS AUSTR	24	365	371	0	7	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	1988	319	8					468	475		10.1056/NEJM198808253190803	http://dx.doi.org/10.1056/NEJM198808253190803			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P8210	3405253				2022-12-24	WOS:A1988P821000003
J	ORLOWSKI, JP; KANOTI, GA; MEHLMAN, MJ				ORLOWSKI, JP; KANOTI, GA; MEHLMAN, MJ			THE ETHICS OF USING NEWLY DEAD PATIENTS FOR TEACHING AND PRACTICING INTUBATION TECHNIQUES	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CASE WESTERN RESERVE UNIV,SCH LAW,CLEVELAND,OH 44106	Case Western Reserve University	ORLOWSKI, JP (corresponding author), CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106, USA.							ABRAMSON NS, 1981, JAMA-J AM MED ASSOC, V246, P2828; COHEN DL, 1987, J MED EDUC, V62, P789; Crawford T, 1987, Physician Exec, V13, P25; DICKSON D, 1988, SCIENCE, V239, P1370, DOI 10.1126/science.3347837; JONSEN AR, 1978, PEDIATRICS, V62, P131; NEWTON MJ, 1986, J MED ETHICS, V12, P207, DOI 10.1136/jme.12.4.207; SHELP EE, 1984, CASES BIOETHICS HAST, P64; 1986, HASTINGS CTR REP, V16, P28	8	57	57	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	1988	319	7					439	441		10.1056/NEJM198808183190710	http://dx.doi.org/10.1056/NEJM198808183190710			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P6842	3398895				2022-12-24	WOS:A1988P684200010
J	SCHNEIDER, A; HEMPHILL, A; WYLER, T; SEEBECK, T				SCHNEIDER, A; HEMPHILL, A; WYLER, T; SEEBECK, T			LARGE MICROTUBULE-ASSOCIATED PROTEIN OF T-BRUCEI HAS TANDEMLY REPEATED, NEAR-IDENTICAL SEQUENCES	SCIENCE			English	Article									UNIV BERN,INST ALLGEMEINE MIKROBIOL,CH-3012 BERN,SWITZERLAND; UNIV BERN,INST ZOOL,CH-3012 BERN,SWITZERLAND	University of Bern; University of Bern				Hemphill, Andrew/0000-0002-0622-2128				ANGELOPOULOS E, 1970, J PROTOZOOL, V17, P39, DOI 10.1111/j.1550-7408.1970.tb05157.x; BRAMBLETT GT, 1987, P NATL ACAD SCI USA, V84, P3259, DOI 10.1073/pnas.84.10.3259; COWMAN AF, 1985, CELL, V40, P775, DOI 10.1016/0092-8674(85)90337-X; DOLAN MT, 1986, J CELL SCI, V80, P123; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; GOLDSTEIN LSB, 1986, J CELL BIOL, V102, P2076, DOI 10.1083/jcb.102.6.2076; HEMPHILL A, UNPUB; HERZOG W, 1987, EUR J BIOCHEM, V92, P1; HUBER G, 1985, J CELL BIOL, V100, P496, DOI 10.1083/jcb.100.2.496; IMBODEN M, 1986, J MOL BIOL, V188, P393, DOI 10.1016/0022-2836(86)90163-4; IMBODEN MA, 1987, NUCLEIC ACIDS RES, V15, P7357, DOI 10.1093/nar/15.18.7357; JENSEN CG, 1986, ANN NY ACAD SCI, V466, P417, DOI 10.1111/j.1749-6632.1986.tb38411.x; KIMMEL BE, 1985, GENE, V35, P237, DOI 10.1016/0378-1119(85)90002-2; KUENG V, UNPUB; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; MAIER G, 1987, BIOL CHEM H-S, V368, P440; MOWATT MR, 1987, MOL CELL BIOL, V7, P2828; MUSKAVITCH MAT, 1982, CELL, V29, P1041, DOI 10.1016/0092-8674(82)90467-6; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; PETERSON DS, 1986, NATURE, V322, P566, DOI 10.1038/322566a0; PILLUS L, 1986, P NATL ACAD SCI USA, V83, P2468, DOI 10.1073/pnas.83.8.2468; RODITI I, 1987, NATURE, V325, P272, DOI 10.1038/325272a0; RUSSELL DG, 1984, MOL CELL BIOL, V4, P779, DOI 10.1128/MCB.4.4.779; SATHER S, 1985, P NATL ACAD SCI USA, V82, P5695, DOI 10.1073/pnas.82.17.5695; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; SCHNEIDER A, UNPUB; SEEBECK T, 1983, P NATL ACAD SCI-BIOL, V80, P4634, DOI 10.1073/pnas.80.15.4634; SEEBECK T, 1988, P NATL ACAD SCI USA, V85, P1101, DOI 10.1073/pnas.85.4.1101; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; STIEGER J, 1984, J BIOL CHEM, V259, P4596; THOMASHOW LS, 1983, CELL, V32, P35, DOI 10.1016/0092-8674(83)90494-4; Vallee R B, 1984, Cell Muscle Motil, V5, P289; WICHE G, 1985, TRENDS BIOCHEM SCI, V10, P67, DOI 10.1016/0968-0004(85)90235-X; WU J, 1987, GENE, V61, P51, DOI 10.1016/0378-1119(87)90364-7	36	82	83	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 22	1988	241	4864					459	462		10.1126/science.3393912	http://dx.doi.org/10.1126/science.3393912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3354	3393912				2022-12-24	WOS:A1988P335400037
J	WEBSTER, NJG; GREEN, S; JIN, JR; CHAMBON, P				WEBSTER, NJG; GREEN, S; JIN, JR; CHAMBON, P			THE HORMONE-BINDING DOMAINS OF THE ESTROGEN AND GLUCOCORTICOID RECEPTORS CONTAIN AN INDUCIBLE TRANSCRIPTION ACTIVATION FUNCTION	CELL			English	Article											WEBSTER, NJG (corresponding author), FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,F-67085 STRASBOURG,FRANCE.		Webster, Nick/AAI-8410-2021					BECKER PB, 1986, NATURE, V324, P686, DOI 10.1038/324686a0; BOURGEOIS S, 1984, EMBO J, V3, P751, DOI 10.1002/j.1460-2075.1984.tb01879.x; BREATHNACH R, 1983, NUCLEIC ACIDS RES, V11, P7119, DOI 10.1093/nar/11.20.7119; BUSSO N, 1987, EXP CELL RES, V173, P425, DOI 10.1016/0014-4827(87)90282-5; CARSON MA, 1987, MOL ENDOCRINOL, V1, P791, DOI 10.1210/mend-1-11-791; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DENIS M, 1988, IN PRESS NATURE; GEIER A, 1987, J STEROID BIOCHEM, V28, P471, DOI 10.1016/0022-4731(87)90504-8; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GROYER A, 1987, NATURE, V328, P624, DOI 10.1038/328624a0; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MANIATIS T, 1982, MOL CLONING LABORATO; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SANCHEZ ER, 1987, MOL ENDOCRINOL, V1, P908, DOI 10.1210/mend-1-12-908; SASSONECORSI P, 1985, COLD SPRING HARB SYM, V50, P747, DOI 10.1101/SQB.1985.050.01.092; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; WAKELING AE, 1987, IN PRESS ADV CANCER; WASYLYK C, 1986, EMBO J, V5, P553, DOI 10.1002/j.1460-2075.1986.tb04246.x; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x	39	551	573	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 15	1988	54	2					199	207		10.1016/0092-8674(88)90552-1	http://dx.doi.org/10.1016/0092-8674(88)90552-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P4103	3390864				2022-12-24	WOS:A1988P410300010
J	SCURR, JH; COLERIDGESMITH, PD; HASTY, JH				SCURR, JH; COLERIDGESMITH, PD; HASTY, JH			DEEP VENOUS THROMBOSIS - A CONTINUING PROBLEM	BRITISH MEDICAL JOURNAL			English	Article									UNIV COLL & MIDDLESEX HOSP MED SCH,DEPT SURG STUDIES,LONDON,ENGLAND	University of London; University College London								BARNES RW, 1972, SURGERY, V72, P971; NEGUS D, 1968, BRIT J SURG, V55, P835, DOI 10.1002/bjs.1800551108; NIH Consensus Development, 1986, JAMA, V256, P744; SIGEL B, 1972, ARCH SURG-CHICAGO, V104, P174	4	118	118	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					28	28		10.1136/bmj.297.6640.28	http://dx.doi.org/10.1136/bmj.297.6640.28			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408903	Green Published, Bronze			2022-12-24	WOS:A1988P100000022
J	BREGMAN, BS; KUNKELBAGDEN, E; SCHNELL, L; DAI, HN; GAO, D; SCHWAB, ME				BREGMAN, BS; KUNKELBAGDEN, E; SCHNELL, L; DAI, HN; GAO, D; SCHWAB, ME			RECOVERY FROM SPINAL-CORD INJURY MEDIATED BY ANTIBODIES TO NEURITE GROWTH-INHIBITORS	NATURE			English	Article							LOCOMOTOR FUNCTION; ADULT-RATS; NEWBORN; REGENERATION; PLASTICITY; DAMAGE; AXONS; CATS; LESIONS	THERE is little axonal growth after central nervous system (CNS) injury in adult mammals. The administration of antibodies (IN-1) to neutralize the myelin-associated neurite growth inhibitory proteins leads to long-distance regrowth of a proportion of CNS axons after injury(1-5). Our aim was: to determine if spinal cord lesion in adult rats, followed by treatment with antibodies to neurite growth inhibitors, can lead to regeneration and anatomical plasticity of other spinally projecting pathways; to determine if the anatomical projections persist at long survival intervals; and to determine whether this fibre growth is associated with recovery of function. We report here that brain stem-spinal as well as corticospinal axons undergo regeneration and anatomical plasticity after application of IN-1 antibodies. There is a recovery of specific reflex and locomotor functions after spinal cord injury in these adult rats. Removal of the sensorimotor cortex in IN-1-treated rats 2-3 months later abolished the recovered contact-placing responses, suggesting that the recovery was dependent upon the regrowth of these pathways.	UNIV ZURICH,BRAIN RES INST,CH-8029 ZURICH,SWITZERLAND	University of Zurich	BREGMAN, BS (corresponding author), GEORGETOWN UNIV,MED CTR,DEPT CELL BIOL,DIV NEUROBIOL,3900 RESERVOIR RD NW,WASHINGTON,DC 20007, USA.		Schwab, Martin E/B-6818-2016					ALSTERMARK B, 1987, NEUROSCI RES, V5, P66; AMASSIAN VE, 1978, J PHYSIOL-PARIS, V74, P165; BARBEAU H, 1991, BRAIN RES, V546, P250, DOI 10.1016/0006-8993(91)91489-N; BREGMAN BS, 1983, DEV BRAIN RES, V9, P137, DOI 10.1016/0165-3806(83)90047-0; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; BREGMAN BS, 1986, J COMP NEUROL, V244, P86, DOI 10.1002/cne.902440107; BREGMAN BS, 1983, DEV BRAIN RES, V9, P119, DOI 10.1016/0165-3806(83)90046-9; BREGMAN BS, 1982, SCIENCE, V217, P553, DOI 10.1126/science.7089581; BREGMAN BS, 1987, DEV BRAIN RES, V34, P245, DOI 10.1016/0165-3806(87)90213-6; BREGMAN BS, 1987, DEV BRAIN RES, V34, P265, DOI 10.1016/0165-3806(87)90214-8; CADELLI D, 1991, EUR J NEUROSCI, V3, P825, DOI 10.1111/j.1460-9568.1991.tb00093.x; DIETZ V, 1994, LANCET, V344, P1260, DOI 10.1016/S0140-6736(94)90751-X; EIDELBERG E, 1977, EXP NEUROL, V56, P312, DOI 10.1016/0014-4886(77)90350-8; GOLDBERGER ME, 1990, EXP NEUROL, V107, P113, DOI 10.1016/0014-4886(90)90149-M; KUNKELBAGDEN E, 1990, EXP BRAIN RES, V81, P25; KUNKELBAGDEN E, 1992, EXP NEUROL, V116, P40, DOI 10.1016/0014-4886(92)90174-O; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; VILENSKY JA, 1992, J MOTOR BEHAV, V24, P288, DOI 10.1080/00222895.1992.9941624; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x	25	600	644	1	22	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					498	501		10.1038/378498a0	http://dx.doi.org/10.1038/378498a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477407				2022-12-24	WOS:A1995TH05400073
J	THOMPSON, JN				THOMPSON, JN			PREVENTING ADHESIONS	LANCET			English	Editorial Material											THOMPSON, JN (corresponding author), HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT SURG, LONDON, ENGLAND.							BECKER JM, 1995, SODIUM HYALURONATE B; DIZEREGA GS, 1994, FERTIL STERIL, V61, P219; SEKIBA K, 1992, OBSTET GYNECOL, V79, P518; THOMPSON JN, 1995, BRIT J SURG, V82, P3, DOI 10.1002/bjs.1800820103; VIPOND MN, 1990, LANCET, V335, P1120, DOI 10.1016/0140-6736(90)91125-T; WHAWELL SA, 1995, EUR J SURG, V161, P315; WISEMAN DM, 1994, POLYM SITE SPECIFIC, P369	7	4	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	1995	346	8987					1382	1382		10.1016/S0140-6736(95)92403-5	http://dx.doi.org/10.1016/S0140-6736(95)92403-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475818				2022-12-24	WOS:A1995TG20700006
J	PORTEGIES, P				PORTEGIES, P			HIV-1, THE BRAIN, AND COMBINATION THERAPY	LANCET			English	Editorial Material							AIDS DEMENTIA COMPLEX; ZIDOVUDINE TREATMENT; CEREBROSPINAL-FLUID				PORTEGIES, P (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,1105 AZ AMSTERDAM,NETHERLANDS.							BREW BJ, 1992, AIDS, V6, P461, DOI 10.1097/00002030-199205000-00004; BUTLER KM, 1991, NEW ENGL J MED, V324, P137, DOI 10.1056/NEJM199101173240301; CHOO V, 1995, LANCET, V346, P895, DOI 10.1016/S0140-6736(95)92725-5; DEGANS J, 1988, AIDS, V2, P37, DOI 10.1097/00002030-198802000-00006; DISTEFANO M, 1993, LANCET, V342, P865, DOI 10.1016/0140-6736(93)92724-8; GRAY F, 1994, AIDS, V8, P489, DOI 10.1097/00002030-199404000-00011; MAEHLEN J, 1995, AIDS, V9, P1165, DOI 10.1097/00002030-199510000-00008; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; PORTEGIES P, 1989, BRIT MED J, V299, P819, DOI 10.1136/bmj.299.6703.819; PORTEGIES P, 1994, J ACQ IMMUN DEF SYND, V7, pS38; PORTEGIES P, 1993, AIDS, V7, P669, DOI 10.1097/00002030-199305000-00010; PORTEGIES P, 1994, LANCET, V344, P759, DOI 10.1016/S0140-6736(94)92252-7; Price R W, 1995, AIDS, V9 Suppl A, pS221; SIDTIS JJ, 1993, ANN NEUROL, V33, P343, DOI 10.1002/ana.410330403; VAGO L, 1993, J ACQ IMMUN DEF SYND, V6, P42; WILDEMANN B, 1993, NEUROLOGY, V43, P2659, DOI 10.1212/WNL.43.12.2659	16	30	30	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1244	1245		10.1016/S0140-6736(95)91857-4	http://dx.doi.org/10.1016/S0140-6736(95)91857-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475712	Bronze			2022-12-24	WOS:A1995TE14500005
J	ZUREIK, M; DUCIMETIERE, P; WARNET, JM; ORSSAUD, G				ZUREIK, M; DUCIMETIERE, P; WARNET, JM; ORSSAUD, G			FATTY-ACID PROPORTIONS IN CHOLESTEROL ESTERS AND RISK OF PREMATURE DEATH FROM CANCER IN MIDDLE-AGED FRENCH MEN	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ESTERIFYING SERUM-CHOLESTEROL; LUNG-CANCER; DIETARY-CHOLESTEROL; ASSOCIATION; MORTALITY; CONSUMPTION; PREVENTION; LIPIDS; PLASMA	Objective-To assess the association of proportions of fatty acids in cholesterol esters with the risk of premature death ti om cancer in middle aged men. Design-Prospective cohort study. Setting-Paris, France. Subjects-3277 working men aged 36-52 in 1981-5. Main outcome measures-Cancer mortality during an average of 9.3 years of follow up. Results-59 men died of cancer during follow up. The age adjusted relative risks for men in the highest thirds of the distribution of the proportions of linoleic, palmitoleic, and oleic acid in cholesterol esters as compared with those in the corresponding lowest thirds were 0.16 (95% confidence interval 0.05 to 0.51), 3.39 (1.63 to 7.05), and 4.22 (1.95 to 9.12), respectively. Adjustment for and stratification by smoking, alcohol consumption, serum cholesterol concentration, and body mass index did not alter the results. At the time of examination subjects with cancer had a lower intake of polyunsaturated fats, assessed by 24 hour recall, than those without cancer (13.2 v 17.4 g/day, P< 0.01). Conclusions-Monounsaturated and polyunsaturated fatty acids of cholesterol esters are strong biological markers that predict premature death from cancer in French men. Consistently, intake of polyunsaturated fats did not seem to increase the risk of death from cancer. The association of biological markers of dietary fat intake with incidence of and mortality from cancer should be investigated prospectively in other populations.	CTR MEDICOSOCIAL, DIRECT ACT SOCIALE ENFANCE & SANTE LAB, F-75013 PARIS, FRANCE		ZUREIK, M (corresponding author), HOP BROUSSAIS, INSERM, U258, F-75014 PARIS, FRANCE.		Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217				AITCHISON J, 1986, MONOGRAPHS STATISTIC; AUSTOKER J, 1994, BRIT MED J, V308, P1610, DOI 10.1136/bmj.308.6944.1610; BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331; BYERS TE, 1987, AM J EPIDEMIOL, V125, P351, DOI 10.1093/oxfordjournals.aje.a114542; CAMBIEN F, 1988, AM J EPIDEMIOL, V127, P75, DOI 10.1093/oxfordjournals.aje.a114793; CAMBIEN F, 1980, AM J EPIDEMIOL, V112, P388, DOI 10.1093/oxfordjournals.aje.a113004; CAROLL KK, 1986, PROG CLIN BIOL RES, V206, P237; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1994, LANCET, V344, P1719, DOI 10.1016/S0140-6736(94)92883-5; DEBACKER G, 1989, ATHEROSCLEROSIS, V78, P237, DOI 10.1016/0021-9150(89)90229-3; Ducimetiere P., 1992, Nutrition Metabolism and Cardiovascular Diseases, V2, P195; ETIENNE G, 1963, ANN BIOL CLIN, V21, P851; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREUDENHEIM JL, 1989, EPIDEMIOL REV, V11, P229, DOI 10.1093/oxfordjournals.epirev.a036039; GOODMAN MT, 1988, AM J EPIDEMIOL, V128, P1241, DOI 10.1093/oxfordjournals.aje.a115078; ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; ISO H, 1994, J CLIN EPIDEMIOL, V47, P961, DOI 10.1016/0895-4356(94)90110-4; Karmali R A, 1986, Prog Clin Biol Res, V222, P687; KNEKT P, 1991, NUTR CANCER, V16, P267, DOI 10.1080/01635589109514165; KOLONEL LN, 1988, AM J EPIDEMIOL, V127, P999, DOI 10.1093/oxfordjournals.aje.a114903; KRITCHEVSKY SB, 1992, AM J EPIDEMIOL, V135, P509, DOI 10.1093/oxfordjournals.aje.a116318; LAW MR, 1991, CANCER CAUSE CONTROL, V2, P253, DOI 10.1007/BF00052142; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; MCGEE D, 1985, INT J EPIDEMIOL, V14, P97, DOI 10.1093/ije/14.1.97; MOILANEN T, 1985, AM J CLIN NUTR, V42, P708, DOI 10.1093/ajcn/42.4.708; NIKKARI T, 1983, AM J CLIN NUTR, V37, P848, DOI 10.1093/ajcn/37.5.848; PRENTICE RL, 1990, CANCER CAUSE CONTROL, V1, P81, DOI 10.1007/BF00053187; RENAUD S, 1979, TABLE COMPOSITION AL, P63; RICHARD JL, 1981, NOUV PRESSE MED, V10, P1111; ROSSENEU M, 1994, ATHEROSCLEROSIS, V108, P127, DOI 10.1016/0021-9150(94)90107-4; SANTOS MT, 1984, ATHEROSCLEROSIS, V50, P53, DOI 10.1016/0021-9150(84)90007-8; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364; SCHUIT AJ, 1993, AM J EPIDEMIOL, V137, P966, DOI 10.1093/oxfordjournals.aje.a116769; SHEKELLE RB, 1981, LANCET, V2, P1185; SHEPHERD J, 1987, BRIT MED J, V295, P1245, DOI 10.1136/bmj.295.6608.1245; TUCKEY RC, 1979, ANAL BIOCHEM, V94, P402, DOI 10.1016/0003-2697(79)90381-6; TUYNS AJ, 1988, NUTR CANCER, V11, P189, DOI 10.1080/01635588809513986; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; URSIN G, 1993, AM J EPIDEMIOL, V137, P916, DOI 10.1093/oxfordjournals.aje.a116753; WARNET JM, 1985, BRIT MED J, V290, P1859, DOI 10.1136/bmj.290.6485.1859; WILLETT W, 1989, NATURE, V338, P389, DOI 10.1038/338389a0	41	28	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	1995	311	7015					1251	1254		10.1136/bmj.311.7015.1251	http://dx.doi.org/10.1136/bmj.311.7015.1251			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE859	7496232	Green Published			2022-12-24	WOS:A1995TE85900017
J	WANG, JT; SYED, A; HSIEH, ML; GRALLA, JD				WANG, JT; SYED, A; HSIEH, ML; GRALLA, JD			CONVERTING ESCHERICHIA-COLI RNA-POLYMERASE INTO AN ENHANCER-RESPONSIVE ENZYME - ROLE OF AN NH2-TERMINAL LEUCINE PATCH IN SIGMA(54)	SCIENCE			English	Article							TRANSCRIPTIONAL ENHANCERS; BINDING PROTEINS; PROMOTER; ACTIVATOR; NTRC; INITIATION; SIGMA-54; GLNA	The protein sigma(54) associates with Escherichia coli core RNA polymerase to form a holoenzyme that binds promoters but is inactive in the absence of enhancer activation, Here, mutants of sigma(54) enabled polymerases to transcribe without enhancer protein and adenosine triphosphate. The mutations are in leucines within the NH2-terminal glutamine-rich domain of sigma(54). Multiple leucine substitutions mimicked the effect of enhancer protein, which suggests that the enhancer protein functions to disrupt a leucine patch. The results indicate that sigma(54) acts both as an inhibitor of polymerase activity and as a receptor that interacts with enhancer protein to overcome this inhibition, and that these two activities jointly confer enhancer responsiveness.	UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NIGMS NIH HHS [GM35754] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035754] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; GRALLA JD, 1991, CELL, V66, P415, DOI 10.1016/0092-8674(81)90001-5; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HSIEH ML, 1994, J MOL BIOL, V239, P15, DOI 10.1006/jmbi.1994.1347; HSIEH ML, 1994, J BIOL CHEM, V269, P373; KUSTU S, 1991, TRENDS BIOCHEM SCI, V16, P397, DOI 10.1016/0968-0004(91)90163-P; MOORE JB, 1993, J BACTERIOL, V175, P2692, DOI 10.1128/JB.175.9.2692-2701.1993; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; NORTH AK, 1993, J BACTERIOL, V175, P4267, DOI 10.1128/JB.175.14.4267-4273.1993; POPHAM D, 1991, J BIOL CHEM, V266, P19510; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; RAY L, 1990, J BACTERIOL, V172, P818, DOI 10.1128/jb.172.2.818-823.1990; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; SYED A, UNPUB; TINTUT Y, 1994, P NATL ACAD SCI USA, V91, P2120, DOI 10.1073/pnas.91.6.2120; TINTUT Y, 1995, GENE DEV, V9, P2305, DOI 10.1101/gad.9.18.2305; TINTUT Y, 1995, J BIOL CHEM, V270, P24392, DOI 10.1074/jbc.270.41.24392; WANG TW, UNPUB; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WEISS DS, 1991, CELL, V67, P155, DOI 10.1016/0092-8674(91)90579-N; WONG CN, 1994, J MOL BIOL, V236, P81, DOI 10.1006/jmbi.1994.1120	25	82	82	0	7	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					992	994		10.1126/science.270.5238.992	http://dx.doi.org/10.1126/science.270.5238.992			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481805				2022-12-24	WOS:A1995TD87800050
J	OBRIEN, J; LONG, H				OBRIEN, J; LONG, H			URINARY-INCONTINENCE - LONG-TERM EFFECTIVENESS OF NURSING INTERVENTION IN PRIMARY-CARE	BRITISH MEDICAL JOURNAL			English	Article											OBRIEN, J (corresponding author), SOMERSET HLTH COMMISS,DEPT PUBL HLTH MED,TAUNTON TA1 7PQ,SOMERSET,ENGLAND.							HAHN I, 1993, BRIT J UROL, V72, P421, DOI 10.1111/j.1464-410X.1993.tb16170.x; LARGOJANSSEN TLM, 1992, FAM PRACT, V9, P284; MOURITSEN L, 1991, BRIT J UROL, V68, P32, DOI 10.1111/j.1464-410X.1991.tb15252.x; OBRIEN J, 1991, BRIT MED J, V303, P1308, DOI 10.1136/bmj.303.6813.1308; 1991, AGENDA ACTION CONTIN	5	20	20	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1208	1208		10.1136/bmj.311.7014.1208	http://dx.doi.org/10.1136/bmj.311.7014.1208			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488903	Green Published			2022-12-24	WOS:A1995TD76800027
J	GORDON, SM; TIPPLE, M; BLAND, LA; JARVIS, WR				GORDON, SM; TIPPLE, M; BLAND, LA; JARVIS, WR			PYROGENIC REACTIONS ASSOCIATED WITH THE REUSE OF DISPOSABLE HOLLOW-FIBER HEMODIALYZERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											GORDON, SM (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,HOSP INFECT PROGRAM,BLDG 1,ROOM 5044,ATLANTA,GA 30333, USA.							ALTER MJ, 1988, JAMA-J AM MED ASSOC, V260, P2073, DOI 10.1001/jama.260.14.2073; ALTER MJ, 1983, DIALYSIS TRANSPLANT, V12, P860; BERNICK JJ, 1980, CLIN NEPHROL, V14, P13; Bland L, 1985, Trans Am Soc Artif Intern Organs, V31, P556; BOLAN G, 1985, J INFECT DIS, V152, P1013, DOI 10.1093/infdis/152.5.1013; DAUGIRDAS JT, 1988, KIDNEY INT S24, V33, pS37; DUMOULIN GC, 1987, APPL ENVIRON MICROB, V53, P1322, DOI 10.1128/AEM.53.6.1322-1326.1987; Favero MS., 1985, HOSPITAL INFECTIONS, P267; FAVERO MS, 1981, NEPHRON, V27, P307; GAZENFIELDGAZIT E, 1969, ISRAEL J MED SCI, V5, P1032; GREISMAN SE, 1969, P SOC EXP BIOL MED, V131, P1154, DOI 10.3181/00379727-131-34059; HINDMAN SH, 1975, HLTH LAB SCI, V12, P321; KANT KS, 1981, KIDNEY INT, V19, P728, DOI 10.1038/ki.1981.73; KANTOR RJ, 1983, AM J MED, V74, P449, DOI 10.1016/0002-9343(83)90978-6; KOLMOS HJ, 1984, J HOSP INFECT, V5, P70, DOI 10.1016/0195-6701(84)90103-8; LEVIN NW, 1986, GUIDE REPROCESSING H, P75; MOLLER S, 1978, ACTA MED SCAND, V203, P345; PETERSEN NJ, 1981, T AM SOC ART INT ORG, V27, P155; PETERSEN NJ, 1987, DIALYSIS TRANSPLANT, V7, P57; POLLAK VE, 1988, KIDNEY INT S24, V33, pS49; POLLAK VE, 1986, AM J NEPHROL, V6, P101; ROBINSON PJ, 1971, BRIT MED J, V1, P528, DOI 10.1136/bmj.1.5748.528; SOLANO JT, 1975, LANCET, V2, P732; VILLARROEL F, 1985, ARTIF ORGANS, V9, P231, DOI 10.1111/j.1525-1594.1985.tb04384.x; WALLENSTEIN S, 1980, AM J EPIDEMIOL, V111, P367, DOI 10.1093/oxfordjournals.aje.a112908; WESTPHAL O, 1975, INT ARCH ALLER A IMM, V49, P1, DOI 10.1159/000231374; WINEMAN RJ, 1986, GUIDE REPROCESSING H, P173; 1986, REUSE HEMODIALYZERS; 1982, AM NATIONAL STANDARD; 1960, STANDARD METHODS EXA; 1986, MMWR, V35, P417	31	47	47	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	1988	260	14					2077	2081		10.1001/jama.260.14.2077	http://dx.doi.org/10.1001/jama.260.14.2077			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q3421	3418872				2022-12-24	WOS:A1988Q342100021
J	BLENDON, RJ; DONELAN, K				BLENDON, RJ; DONELAN, K			DISCRIMINATION AGAINST PEOPLE WITH AIDS - THE PUBLICS PERSPECTIVE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											BLENDON, RJ (corresponding author), HARVARD UNIV,SCH PUBL HLTH,HARVARD AIDS INST,BOSTON,MA 02115, USA.		Donelan, Karen/R-6162-2019					[Anonymous], 1988, CONFRONTING AIDS UPD; BRANDT AM, 1988, AM J PUBLIC HEALTH, V78, P367, DOI 10.2105/AJPH.78.4.367; CORBETT M, 1982, POLITICAL TOLERANCE, P65; CURRAN WJ, 1986, PHS860032 PUBL; FACKELMANN KA, 1988, MED HLTH PERSPE 0613, P1; GALLUP G, 1986, GALLUP POLL PUBLIC O; GROSS SJ, 1975, PUBLIC OPIN QUART, V39, P358, DOI 10.1086/268234; HASTINGS EH, 1988, INDEX INT PUBLIC OPI, P192; KUTNER B, 1952, J ABNORM SOC PSYCH, V47, P649, DOI 10.1037/h0053883; MUELLER J, 1988, PUBLIC OPIN QUART, V52, P1, DOI 10.1086/269079; MUSTO DF, 1986, MILBANK Q, V64, P97, DOI 10.2307/3350043; Parmet W E, 1987, Law Med Health Care, V15, P61; QUINLEY H, 1988, PUBLIC OP        MAY, P53; 1985, WASHINGTON POST  SEP; 1988, HLTH CARE ISSUES; 1988, PEOPLE PRESS POLITIC; 1987, WASHINGTON POST 0311; 1987, AIDS SURVEY; 1987, GALLUP POLL     0713; 1988, GALLUP POLL     0720; 1988, ADV DATA VITAL HLTH, V151; 1987, US NEWS WORLD R 0401; 1987, ADV DATA VITAL HLTH, V150; 1987, ADV DATA VITAL HLTH, V147; 1988, ANTIGAY VIOLENCE VIC; 1988, ADV DATA VITAL HLTH, V153; 1985, NY TIMES        0626, P45; 1987, MMWR S6, V36, P1; 1986, GALLUP NEWSWEEK 1124; 1988, GALLUP REPORT    JAN; 1987, GALLUP POLL     1122; 1988, GALLUP REPORT    JUN; 1987, GALLUP POLL     1126; 1987, ADV DATA VITAL HLTH, V146; 1985, HARRIS SURVEY	35	119	119	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	1988	319	15					1022	1026		10.1056/NEJM198810133191522	http://dx.doi.org/10.1056/NEJM198810133191522			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4155	3419476				2022-12-24	WOS:A1988Q415500033
J	HUGHES, AL; NEI, M				HUGHES, AL; NEI, M			PATTERN OF NUCLEOTIDE SUBSTITUTION AT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I LOCI REVEALS OVERDOMINANT SELECTION	NATURE			English	Article									UNIV TEXAS, HLTH SCI CTR, CTR DEMOG & POPULAT GENET, HOUSTON, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston								ARNOLD B, 1984, NUCLEIC ACIDS RES, V12, P9473, DOI 10.1093/nar/12.24.9473; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Clark B., 1976, Symposia Br Soc Parasit, V14, P87; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; COWAN EP, 1987, IMMUNOGENETICS, V25, P241, DOI 10.1007/BF00404694; DECASTRO JAL, 1982, P NATL ACAD SCI-BIOL, V79, P3813; Doherty P C, 1975, Nature, V256, P50; DURAN LW, 1987, J IMMUNOL, V139, P2818; ENSSLE KH, 1987, HUM IMMUNOL, V18, P135, DOI 10.1016/0198-8859(87)90011-5; FIGUEROA F, 1986, CURR TOP MICROBIOL, V127, P100; FIGUEROA F, 1988, H 2 GENES PRODUCTS F, P61; GILL TJ, 1983, TRANSPLANTATION, V35, P1; GUSSOW D, 1987, IMMUNOGENETICS, V25, P313, DOI 10.1007/BF00404424; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 1988, GENETICS, V119, P205; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HOLMES N, 1985, EMBO J, V4, P2849, DOI 10.1002/j.1460-2075.1985.tb04013.x; KLEIN J, 1986, CRC CR REV IMMUNOL, V6, P295; Klein J, 1978, Adv Immunol, V26, P55, DOI 10.1016/S0065-2776(08)60229-1; Klein J., 1986, NATURAL HIST MAJOR H; KLITZ W, 1986, AM J HUM GENET, V39, P340; KOLLER BH, 1985, J IMMUNOL, V134, P2727; KOTTMANN AH, 1986, IMMUNOGENETICS, V23, P396, DOI 10.1007/BF00372673; KVIST S, 1983, EMBO J, V2, P245, DOI 10.1002/j.1460-2075.1983.tb01413.x; MARUYAMA T, 1981, GENETICS, V98, P441; MCCONNELL TJ, 1988, NATURE, V332, P651, DOI 10.1038/332651a0; Mellor A L, 1986, Oxf Surv Eukaryot Genes, V3, P95; MELLOR AL, 1983, NATURE, V306, P792, DOI 10.1038/306792a0; MOORE KW, 1982, SCIENCE, V215, P679, DOI 10.1126/science.7058332; MORITA T, 1985, IMMUNOGENETICS, V21, P367, DOI 10.1007/BF00430802; Nei M., 1980, Vito Volterra symposium on mathematical models in biology. Proceedings of a conference held at the Centro Linceo Interdisciplinare, Accademia Nazionale dei Lincei, Rome, December 17-21, 1979., P17; NEI M, 1984, EVOL BIOL, V17, P73; NEI M, 1985, MOL BIOL EVOL, V2, P66; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 1987, MOL EVOLUTIONARY GEN; NGUYEN C, 1985, IMMUNOGENETICS, V21, P479, DOI 10.1007/BF00430931; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251; SCHEPART BS, 1986, J IMMUNOL, V136, P3489; SHER BT, 1985, P NATL ACAD SCI USA, V82, P1175, DOI 10.1073/pnas.82.4.1175; SNELL GD, 1968, FOLIA BIOL-PRAGUE, V14, P335; SODOYER R, 1984, EMBO J, V3, P879, DOI 10.1002/j.1460-2075.1984.tb01900.x; STRACHAN T, 1984, EMBO J, V3, P887, DOI 10.1002/j.1460-2075.1984.tb01901.x; SZOTS H, 1986, P NATL ACAD SCI USA, V83, P1428, DOI 10.1073/pnas.83.5.1428; TEWARSON S, 1983, TISSUE ANTIGENS, V22, P204, DOI 10.1111/j.1399-0039.1983.tb01193.x; WATTS S, 1987, J IMMUNOL, V139, P3878; WAYS JP, 1985, J BIOL CHEM, V260, P1924; WEISS E, 1983, EMBO J, V2, P453, DOI 10.1002/j.1460-2075.1983.tb01444.x; ZEMMOUR J, 1988, IMMUNOGENETICS, V27, P281, DOI 10.1007/BF00376123	52	1604	1629	3	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	1988	335	6186					167	170		10.1038/335167a0	http://dx.doi.org/10.1038/335167a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9647	3412472				2022-12-24	WOS:A1988P964700056
J	RALPH, MR; MENAKER, M				RALPH, MR; MENAKER, M			A MUTATION OF THE CIRCADIAN SYSTEM IN GOLDEN-HAMSTERS	SCIENCE			English	Article									UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403	University of Oregon			Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH009483, T32MH017148] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 13162] Funding Source: Medline; NIMH NIH HHS [MH 09483, MH 17148] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; BRUCE VG, 1976, MOL BASIS CIRCADIAN, P339; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; DECOURSEY PJ, 1964, J CELL COMPAR PHYSL, V63, P189, DOI 10.1002/jcp.1030630208; Feldman J.F., 1982, PHOTOCHEM PHOTOBIOL, V7, P319; FELDMAN JF, 1983, BIOSCIENCE, V33, P426, DOI 10.2307/1309070; FELDMAN JF, 1982, ANNU REV PLANT PHYS, V33, P583, DOI 10.1146/annurev.pp.33.060182.003055; HALL J C, 1987, Journal of Biological Rhythms, V2, P153, DOI 10.1177/074873048700200301; KONOPKA RJ, 1979, FED PROC, V38, P2602; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1960, COLD SPRING HARBOR S, V25, P15; PITTENDRIGH CS, 1974, NEUROSCIENCES 3RD ST; von Holst E., 1939, ERGEBNISSE PHYSL, V42, P228, DOI [10.1007/BF02322567, DOI 10.1007/BF02322567]; WEVER R, 1972, J THEOR BIOL, V36, P119, DOI 10.1016/0022-5193(72)90181-6	14	520	536	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 2	1988	241	4870					1225	1227		10.1126/science.3413487	http://dx.doi.org/10.1126/science.3413487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9021	3413487				2022-12-24	WOS:A1988P902100041
J	DAVIS, JM; VENESSMEEHAN, K; NOTTER, RH; BHUTANI, VK; KENDIG, JW; SHAPIRO, DL				DAVIS, JM; VENESSMEEHAN, K; NOTTER, RH; BHUTANI, VK; KENDIG, JW; SHAPIRO, DL			CHANGES IN PULMONARY MECHANICS AFTER THE ADMINISTRATION OF SURFACTANT TO INFANTS WITH RESPIRATORY-DISTRESS SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV ROCHESTER,SCH MED & DENT,DEPT PEDIAT NEONATOL,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,SPECIALIZED CTR RES PULM DIS NEWBORNS,ROCHESTER,NY 14642	University of Rochester; University of Rochester					NHLBI NIH HHS [HL-36543] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL036543] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERMEL MS, 1984, LUNG, V162, P99, DOI 10.1007/BF02715636; BHAT R, 1987, PEDIATR RES, V21, pA443; BHUTANI VK, 1988, PEDIATR PULM, V4, P150, DOI 10.1002/ppul.1950040306; BHUTANI VK, 1988, PEDIATRICS, V81, P419; EGAN EA, 1983, J APPL PHYSIOL, V55, P875, DOI 10.1152/jappl.1983.55.3.875; ENHORNING G, 1985, PEDIATRICS, V76, P145; FARRELL PM, 1982, LUNG DEV BIOL CLIN P; FUJIWARA T, 1984, PULMONARY SURFACTANT, P479; GITLIN JD, 1987, PEDIATRICS, V79, P31; HALLMAN M, 1985, J PEDIATR-US, V106, P963, DOI 10.1016/S0022-3476(85)80253-5; HOLM BA, 1985, CHEM PHYS LIPIDS, V38, P287, DOI 10.1016/0009-3084(85)90022-2; JOBE A, 1981, J CLIN INVEST, V67, P370, DOI 10.1172/JCI110044; KWONG MS, 1985, PEDIATRICS, V76, P585; MERRITT TA, 1986, NEW ENGL J MED, V315, P785, DOI 10.1056/NEJM198609253151301; METCALFE IL, 1982, J APPL PHYSIOL, V53, P838, DOI 10.1152/jappl.1982.53.4.838; MILIC-EMILI J, 1977, International Anesthesiology Clinics, V15, P39, DOI 10.1097/00004311-197715020-00002; NOTTER RH, 1984, J APPL PHYSIOL, V57, P1613, DOI 10.1152/jappl.1984.57.6.1613; NOTTER RH, 1987, CLIN PERINATOL, V14, P433, DOI 10.1016/S0095-5108(18)30746-2; NOTTER RH, 1983, CHEM PHYS LIPIDS, V33, P67, DOI 10.1016/0009-3084(83)90009-9; NOTTER RH, 1985, PEDIATR RES, V19, P569, DOI 10.1203/00006450-198506000-00014; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; ROBERTSON B, 1980, LUNG, V158, P57, DOI 10.1007/BF02713705; Robertson B, 1984, PULMONARY SURFACTANT; SHAPIRO DL, 1985, PEDIATRICS, V76, P593; WHITSETT JA, 1986, PEDIATR RES, V20, P460, DOI 10.1203/00006450-198605000-00016	25	122	122	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	1988	319	8					476	479		10.1056/NEJM198808253190804	http://dx.doi.org/10.1056/NEJM198808253190804			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P8210	3405254				2022-12-24	WOS:A1988P821000004
J	OLDRIDGE, NB; GUYATT, GH; FISCHER, ME; RIMM, AA				OLDRIDGE, NB; GUYATT, GH; FISCHER, ME; RIMM, AA			CARDIAC REHABILITATION AFTER MYOCARDIAL-INFARCTION - COMBINED EXPERIENCE OF RANDOMIZED CLINICAL-TRIALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV WISCONSIN,SCH MED MCC,DEPT MED,MILWAUKEE,WI 53201; MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA; MCMASTER UNIV,MED CTR,DEPT MED,HAMILTON L8S 4L8,ONTARIO,CANADA; MCMASTER UNIV,MED CTR,DEPT CLIN EPIDEMIOL & BIOSTAT,HAMILTON L8S 4L8,ONTARIO,CANADA; MED COLL WISCONSIN,DEPT MED,DIV BIOSTAT & CLIN EPIDEMIOL,MILWAUKEE,WI 53226	University of Wisconsin System; University of Wisconsin Milwaukee; McMaster University; McMaster University; McMaster University; Medical College of Wisconsin								[Anonymous], 1982, JAMA, V248, P1465; CARSON P, 1982, J R COLL PHYSICIANS, V16, P141; DEBUSK RF, 1986, NEW ENGL J MED, V314, P161, DOI 10.1056/NEJM198601163140307; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; GILPIN EA, 1983, AM J CARDIOL, V52, P240, DOI 10.1016/0002-9149(83)90115-7; GOMEZMARIN O, 1987, NEW ENGL J MED, V316, P1353, DOI 10.1056/NEJM198705283162201; GUYATT G, 1986, QUAL LIFE CARDIOVASC, V2, P304; GUYATT G, 1986, QUAL LIFE CARDIOVASC, V2, P317; HEDBACK B, 1987, EUR HEART J, V8, P234, DOI 10.1093/oxfordjournals.eurheartj.a062265; HELMERS C, 1976, ACTA MED SCAND, V200, P469; KALLIO V, 1979, LANCET, V2, P1081; KANNEL WB, 1979, AM J CARDIOL, V44, P53, DOI 10.1016/0002-9149(79)90250-9; KENTALA E, 1972, Annals of Clinical Research, V4, P1; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARRA S, 1985, EUR HEART J, V6, P656, DOI 10.1093/oxfordjournals.eurheartj.a061917; MAY GS, 1982, PROG CARDIOVASC DIS, V24, P331, DOI 10.1016/0033-0620(82)90010-X; MAYOU R, 1981, LANCET, V2, P1399; NAUGHTON J, 1984, CLIN SPORT MED, V3, P545; OLDRIDGE N, 1986, J CARDIOPULM REHABIL, V6, P153; OLDRIDGE NB, 1983, AM J CARDIOL, V51, P70, DOI 10.1016/S0002-9149(83)80013-7; PALATSI I, 1976, ACTA MED SCAND, V559, P1; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; POHJOLA S, 1980, BRIT HEART J, V43, P176, DOI 10.1136/hrt.43.2.176; RECHNITZER PA, 1983, AM J CARDIOL, V51, P65, DOI 10.1016/S0002-9149(83)80012-5; ROMAN O, 1983, CARDIOLOGY, V70, P223, DOI 10.1159/000173598; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; SHAW LW, 1981, AM J CARDIOL, V48, P39, DOI 10.1016/0002-9149(81)90570-1; Shephard RJ., 1983, J CARDIOPULM REHABIL, V3, P294; STERN MJ, 1982, ARCH INTERN MED, V142, P1093, DOI 10.1001/archinte.142.6.1093; STERN MJ, 1981, ARCH INTERN MED, V141, P1463, DOI 10.1001/archinte.141.11.1463; ULVENSTAM G, 1985, EUR HEART J, V6, P294, DOI 10.1093/oxfordjournals.eurheartj.a061856; VERMEULEN A, 1983, AM HEART J, V105, P798, DOI 10.1016/0002-8703(83)90243-0; WEINBLATT E, 1968, AM J PUBLIC HEALTH N, V58, P1329, DOI 10.2105/AJPH.58.8.1329; WEINBLATT E, 1982, JAMA-J AM MED ASSOC, V247, P1576, DOI 10.1001/jama.247.11.1576; WILHELMSEN L, 1975, PREV MED, V4, P491, DOI 10.1016/0091-7435(75)90035-3; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1983, EURO REP STUD, V84, P1; 1964, WHO TECH REP SER, V270; 1983, N ENGL J MED, V309, P331	40	760	791	1	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	1988	260	7					945	950		10.1001/jama.260.7.945	http://dx.doi.org/10.1001/jama.260.7.945			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6566	3398199				2022-12-24	WOS:A1988P656600023
J	BLATTNER, W; GALLO, RC; TEMIN, HM				BLATTNER, W; GALLO, RC; TEMIN, HM			HIV CAUSES AIDS	SCIENCE			English	Editorial Material									NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892; UNIV WISCONSIN,MCARDLE LAB CANC RES,MADISON,WI 53706	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison	BLATTNER, W (corresponding author), NCI,FAMILY STUDIES SECT,BETHESDA,MD 20892, USA.							CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; GALLO RC, 1987, NATURE, V326, P435; GOEDERT JJ, 1988, AIDS ETIOLOGY DIAGNO; NOVICK BE, 1987, AIDS, V1, P3; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PETERMAN TA, 1988, JAMA-J AM MED ASSOC, V259, P55, DOI 10.1001/jama.259.1.55; PIOT P, 1988, SCIENCE, V239, P573, DOI 10.1126/science.3277271; SALAHUDDIN SZ, 1985, P NATL ACAD SCI USA, V82, P5530, DOI 10.1073/pnas.82.16.5530; WARD JW, 1988, NEW ENGL J MED, V318, P473, DOI 10.1056/NEJM198802253180803	9	87	88	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1988	241	4865					515	515		10.1126/science.3399881	http://dx.doi.org/10.1126/science.3399881			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4350	3399881				2022-12-24	WOS:A1988P435000004
J	GREATOREX, RA; DIXON, AK; FLOWER, CDR; PULVERTAFT, RW				GREATOREX, RA; DIXON, AK; FLOWER, CDR; PULVERTAFT, RW			LIMITATIONS OF COMPUTED-TOMOGRAPHY IN LEAKING ABDOMINAL AORTIC-ANEURYSMS	BRITISH MEDICAL JOURNAL			English	Article									ADDENBROOKES HOSP,DEPT RADIOL,CAMBRIDGE CB2 2QQ,ENGLAND	Addenbrooke's Hospital; University of Cambridge	GREATOREX, RA (corresponding author), ADDENBROOKES HOSP,DEPT SURG,CAMBRIDGE CB2 2QQ,ENGLAND.							AXELBAUM SP, 1976, AM J ROENTGENOL, V127, P75, DOI 10.2214/ajr.127.1.75; BREWSTER DC, 1975, NEW ENGL J MED, V292, P822, DOI 10.1056/NEJM197504172921602; COHEN JM, 1985, RADIOLOGY, V155, P705, DOI 10.1148/radiology.155.3.4001373; DIXON AK, 1981, BRIT J SURG, V68, P47, DOI 10.1002/bjs.1800680116; GARLIS H, 1980, SURGERY, V87, P300; GOMES MN, 1978, COMPUT TOMOGR, V2, P99, DOI 10.1016/0363-8235(78)90007-8; JOHNSON G, 1980, ARCH SURG-CHICAGO, V115, P51; KADIR S, 1980, ARCH SURG-CHICAGO, V115, P631; LEOPOLD GR, 1972, SURGERY, V72, P939; LINEAWEAVER WC, 1982, ARCH SURG-CHICAGO, V117, P1095; NUSBAUM JW, 1971, ARCH SURG-CHICAGO, V102, P385; PERRETT LV, 1978, AUST NZ J SURG, V48, P275, DOI 10.1111/j.1445-2197.1978.tb05228.x; ROBICSEK F, 1981, SURGERY, V89, P275; SENAPATI A, 1986, J CARDIOVASC SURG, V27, P719; YOUNG AE, 1980, BRIT MED J, V280, P765, DOI 10.1136/bmj.280.6216.765	15	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1988	297	6643					284	285		10.1136/bmj.297.6643.284	http://dx.doi.org/10.1136/bmj.297.6643.284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4266	3416149	Bronze, Green Published			2022-12-24	WOS:A1988P426600027
J	BARRETT, TG; BUNDEY, SE; MACLEOD, AF				BARRETT, TG; BUNDEY, SE; MACLEOD, AF			NEURODEGENERATION AND DIABETES - UK NATIONWIDE STUDY OF WOLFRAM (DIDMOAD) SYNDROME	LANCET			English	Article							OPTIC ATROPHY; MELLITUS; INSIPIDUS	Wolfram syndrome is the association of diabetes mellitus and optic atrophy, and is sometimes called DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness). Incomplete characterisation of this autosomal recessive syndrome has relied on case-reports, and there is confusion with mitochondrial genome disorders. We therefore undertook a UK nationwide cross-sectional case-finding study to describe the natural history, complications, prevalence, and inheritance of the syndrome. We identified 45 patients with Wolfram syndrome-a prevalence of one per 770000. Non-autoimmune, insulin-deficient diabetes mellitus presented at a median age of 6 years, followed by optic atrophy (11 years). Cranial diabetes insipidus occurred in 33 patients (73%) with sensorineural deafness (28, 62%) in the second decade; renal;tract abnormalities (26, 58%) presented in the third decade followed by neurological complications (cerebellar ataxia, myoclonus [28, 62%]) in the fourth decade. Other abnormalities included gastrointestinal dysmotility in 11 (24%), and primary gonadal atrophy in seven of ten males investigated. Median age at death (commonly central respiratory failure with brain-stem atrophy) was 30 years (range 25-49). The natural history of Wolfram syndrome suggests that most patients will eventually develop most complications of this progressive, neurodegenerative disorder. Family studies indicate autosomal recessive inheritance with a carrier frequency of one in 354, an absence of a maternal history of diabetes or deafness, and an absence of the mitochondrial tRNA Leu (3243) mutation. Juvenile-onset diabetes mellitus and optic atrophy are the best available diagnostic criteria for Wolfram syndrome, the differential diagnosis of which includes other causes of neurodegeneration.	UNIV BIRMINGHAM, DEPT PAEDIAT & CHILD HLTH, CLIN GENET UNIT, BIRMINGHAM, W MIDLANDS, ENGLAND; ROYAL SHREWSBURY HOSP NHS TRUST, SHREWSBURY, SALOP, ENGLAND	University of Birmingham			Barrett, Timothy/F-1682-2010	Barrett, Timothy/0000-0002-6873-0750				BARRETT TG, 1995, J INHERIT METAB DIS, V18, P218, DOI 10.1007/BF00711771; BLASI C, 1986, DIABETES CARE, V9, P521, DOI 10.2337/diacare.9.5.521; BORNAPIGNATTI C, 1989, J PEDIATR, V114, P405; BU XD, 1993, LANCET, V342, P598, DOI 10.1016/0140-6736(93)91416-J; BUNDEY S, 1992, J INHERIT METAB DIS, V15, P315, DOI 10.1007/BF02435965; CARSON MJ, 1977, AM J DIS CHILD, V131, P1382, DOI 10.1001/archpedi.1977.02120250064010; CREMERS C W R J, 1977, Acta Paediatrica Scandinavica Supplement, P1; DIDMOAD, 1986, LANCET, V1, P1075; EMERY AEH, 1986, METHODOLOGY MED GENE; FRASER FC, 1977, J MED GENET, V14, P190, DOI 10.1136/jmg.14.3.190; GARCIALUNA PP, 1988, ACTA PAEDIATR SCAND, V77, P413, DOI 10.1111/j.1651-2227.1988.tb10669.x; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GUNN T, 1976, J PEDIATR-US, V89, P565, DOI 10.1016/S0022-3476(76)80387-3; HAGOPIAN WA, 1993, DIABETES, V42, P631, DOI 10.2337/diabetes.42.4.631; HAMPTON SM, 1988, CLIN ENDOCRINOL, V29, P9, DOI 10.1111/j.1365-2265.1988.tb00244.x; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; MCCARTY DJ, 1993, INT J EPIDEMIOL, V22, P559, DOI 10.1093/ije/22.3.559; MONSON JP, 1983, LANCET, V1, P1286; PAGE MM, 1976, Q J MED, V45, P505; PEDEN NR, 1986, Q J MED, V58, P167; PILZ D, 1994, J MED GENET, V31, P328, DOI 10.1136/jmg.31.4.328; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; ROSE FC, 1966, Q J MED, V35, P385; ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679; Wolfram D.J., 1938, MAYO CLIN PROC, V13, P715	28	402	423	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	1995	346	8988					1458	1463		10.1016/S0140-6736(95)92473-6	http://dx.doi.org/10.1016/S0140-6736(95)92473-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490992				2022-12-24	WOS:A1995TH15600010
J	LAFONT, A; GUEROT, C; LEMARCHAND, P				LAFONT, A; GUEROT, C; LEMARCHAND, P			WHICH GENE FOR WHICH RESTENOSIS	LANCET			English	Editorial Material									INSERM,U25,PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	LAFONT, A (corresponding author), FAC NECKER ENFANTS MALAD,PARIS,FRANCE.		lemarchand, patricia/C-3247-2011	lemarchand, patricia/0000-0002-5330-2008				CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; GUZMAN RJ, 1994, P NATL ACAD SCI USA, V91, P10732, DOI 10.1073/pnas.91.22.10732; ISNER JM, 1994, LANCET, V344, P1653, DOI 10.1016/S0140-6736(94)90454-5; KAKUTA T, 1994, CIRCULATION, V89, P2809, DOI 10.1161/01.CIR.89.6.2809; LAFONT A, 1995, CIRC RES, V76, P996, DOI 10.1161/01.RES.76.6.996; MINTZ GS, 1994, CIRCULATION, V90, P1; NUNES GL, 1995, ARTERIOSCL THROM VAS, V15, P156, DOI 10.1161/01.ATV.15.1.156; OBRIEN ER, 1993, CIRC RES, V73, P223, DOI 10.1161/01.RES.73.2.223; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; POST MJ, 1994, CIRCULATION, V89, P2816, DOI 10.1161/01.CIR.89.6.2816; STRAUSS BH, 1994, CIRC RES, V75, P650, DOI 10.1161/01.RES.75.4.650; TANAKA H, 1995, ANN NY ACAD SCI, V748, P526; VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137; WALLER BF, 1991, CIRCULATION S2, V83, P128	14	19	24	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 2	1995	346	8988					1442	1443		10.1016/S0140-6736(95)92467-1	http://dx.doi.org/10.1016/S0140-6736(95)92467-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490986				2022-12-24	WOS:A1995TH15600004
J	HENDERSON, AS; EASTEAL, S; JORM, AF; MACKINNON, AJ; KORTEN, AE; CHRISTENSEN, H; CROFT, L; JACOMB, PA				HENDERSON, AS; EASTEAL, S; JORM, AF; MACKINNON, AJ; KORTEN, AE; CHRISTENSEN, H; CROFT, L; JACOMB, PA			APOLIPOPROTEIN-E ALLELE EPSILON-4, DEMENTIA, AND COGNITIVE DECLINE IN A POPULATION-SAMPLE	LANCET			English	Article							ALZHEIMERS-DISEASE; TYPE-4 ALLELE	From clinically based series it has been proposed that, in homozygotes for the apolipoprotein E epsilon 4 (apoE epsilon 4) allele, Alzheimer's disease is almost inevitable by the age of 80. A population sample of persons aged 70 years and over was interviewed in 1990-91 to ascertain the presence of dementia or cognitive impairment. The sample was re-interviewed in 1994, when the apoE genotype was also determined. Prevalence data for the 638 persons who completed the second examination revealed a linear association between having an apoE epsilon 4 allele and both dementia and cognitive impairment (for heterozygotes, odds ratio for dementia 1.89, 95% confidence interval 1.04-3.44 and for homozygotes OR 3.58, 95% CI 1.82-11.82; both adjusted for age). However, even in subjects homozygous for epsilon 4 the estimated prevalence of dementia by age 90 was only about 50%. Persons with one or two epsilon 4 alleles were more likely to have a family history of dementia than those with none. This study confirms in a population sample that the epsilon 4 allele is a risk factor for dementia, but refutes the suggestion that homozygosity for the epsilon 4 allele is sufficient for the development of Alzheimer's disease: persons with either one or two epsilon 4 alleles may reach late old age without cognitive impairment.	AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,HUMAN GENET GRP,CANBERRA,ACT 2601,AUSTRALIA; MENTAL HLTH RES INST,BIOSTAT & PSYCHOMETR UNIT,PARKVILLE,VIC,AUSTRALIA	Australian National University; John Curtin School of Medical Research; Florey Institute of Neuroscience & Mental Health	HENDERSON, AS (corresponding author), AUSTRALIAN NATL UNIV,NATL HLTH & MED RES COUNCIL,SOCIAL PSYCHIAT RES UNIT,GPO BOX 4,CANBERRA,ACT 0200,AUSTRALIA.		Christensen, Helen/F-5053-2012; Jorm, Anthony F/B-5555-2009	Christensen, Helen/0000-0003-0435-2065; Jorm, Anthony F/0000-0002-1424-4116; Mackinnon, Andrew/0000-0003-0831-9801; Easteal, Simon/0000-0002-0462-502X				[Anonymous], 1993, ICD 10 CLASSIFICATIO; BENJAMIN R, 1994, LANCET, V343, P1564; BROUSSEAU T, 1994, NEUROLOGY, V44, P342, DOI 10.1212/WNL.44.2.342; CHRISTENSEN H, 1994, AGE AGEING, V23, P204, DOI 10.1093/ageing/23.3.204; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; FESKENS EJM, 1994, BRIT MED J, V309, P1202, DOI 10.1136/bmj.309.6963.1202; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HENDERSON AS, 1994, PSYCHOL MED, V24, P473, DOI 10.1017/S0033291700027446; HENDRIE HC, 1995, ANN NEUROL, V37, P118, DOI 10.1002/ana.410370123; HIXSON JE, 1990, J LIPID RES, V31, P545; Jorm AF, 1992, MEMORY FUNCTIONING D, P267, DOI DOI 10.1016/S0166-4115(08)60939-5; JORM AF, 1993, PROBLEM DEMENTIA AUS; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; KUUSISTO J, 1995, BRIT MED J, V309, P636; MACKINNON A, 1993, ACTA PSYCHIAT SCAND, V87, P146, DOI 10.1111/j.1600-0447.1993.tb03346.x; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; Nelson H.E., 1982, NATIONAL ADULT READI; PEACOCK ML, 1994, NEUROLOGY, V44, P339, DOI 10.1212/WNL.44.2.339; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; RICHARDS B, 1992, HUM MOL GENET, V2, P159; RIGGS JE, 1994, ARCH NEUROL-CHICAGO, V51, P750, DOI 10.1001/archneur.1994.00540200024011; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; ROYCHOUDHURY AK, 1958, HUMAN POLYMORPHIC GE; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCOTT J, 1993, LANCET, V342, P696, DOI 10.1016/0140-6736(93)91704-P; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; 1992, ACTA PSYCHIAT SCAND, V85, P105; 1987, DIAGNOSTIC STATISTIC	30	250	254	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1387	1390		10.1016/S0140-6736(95)92405-1	http://dx.doi.org/10.1016/S0140-6736(95)92405-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475820				2022-12-24	WOS:A1995TG20700008
J	ECONOMIDES, AN; RAVETCH, JV; YANCOPOULOS, GD; STAHL, N				ECONOMIDES, AN; RAVETCH, JV; YANCOPOULOS, GD; STAHL, N			DESIGNER CYTOKINES - TARGETING ACTIONS TO CELLS OF CHOICE	SCIENCE			English	Article							LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; CNTF RECEPTOR; SIGNAL TRANSDUCER; ALPHA COMPONENT; ONCOSTATIN-M; EXPRESSION; GP-130; GP130	Some growth factors are therapeutically useful partly because restricted expression of their receptors limits their action to particular cell types. However, no unique stimulatory factor is known for many clinically relevant cell types, such as CD34(+) hematopoietic stem cells. Here, soluble alpha receptor (R alpha) components for interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) were targeted in an active form to cells expressing surface markers such as CD34 or CD45, thereby rendering those cells responsive to IL-6 or CNTF. The targeting of R alpha components may provide the means to create ''designer'' cytokines that activate a desired cell type expressing a specific cell surface marker.	REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591; SLOAN KETTERING INST,BIOCHEM GENET LAB,NEW YORK,NY 10021	Regeneron; Memorial Sloan Kettering Cancer Center			Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Economides, Aris/0000-0002-6508-8942				ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CORNISH J, 1993, ENDOCRINOLOGY, V132, P1359, DOI 10.1210/en.132.3.1359; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; ECONOMIDES A, UNPUB; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; HAAKFRENDSCHO M, 1994, J IMMUNOL, V152, P1347; HILTON DJ, 1991, J CELL BIOCHEM, V46, P21, DOI 10.1002/jcb.240460105; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; METCALF D, 1989, P NATL ACAD SCI USA, V86, P5948, DOI 10.1073/pnas.86.15.5948; METCALF D, 1994, STEM CELLS, V1, P259; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; PANAYOTATOS N, 1994, BIOCHEMISTRY-US, V33, P5813, DOI 10.1021/bi00185a020; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; ROWE JM, 1992, J CLIN PHARMACOL, V32, P486, DOI 10.1177/009127009203200602; STAHL N, 1993, J BIOL CHEM, V268, P7628; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; ZAULI G, 1994, BLOOD, V83, P167	26	22	35	0	0	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1351	1353		10.1126/science.270.5240.1351	http://dx.doi.org/10.1126/science.270.5240.1351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481821				2022-12-24	WOS:A1995TF89900036
J	PANGANIBAN, G; SEBRING, A; NAGY, L; CARROLL, S				PANGANIBAN, G; SEBRING, A; NAGY, L; CARROLL, S			THE DEVELOPMENT OF CRUSTACEAN LIMBS AND THE EVOLUTION OF ARTHROPODS	SCIENCE			English	Article							DISTAL-LESS; DEVELOPING FOREBRAIN; RESTRICTED EXPRESSION; DROSOPHILA EMBRYO; HOMEOBOX GENES; HOMEODOMAIN	Arthropods exhibit great diversity in the position, number, morphology, and function of their limbs. The evolutionary relations among limb types and among the arthropod groups that bear them (insects, crustaceans, myriapods, and chelicerates) are controversial. Here, the use of molecular probes, including an antibody to proteins encoded by arthropod and vertebrate Distal-less (Dll and Dlx) genes, provided evidence that common genetic mechanisms underlie the development of all arthropod limbs and their branches and that all arthropods derive from a common ancestor. However, differences between crustacean and insect body plans were found to correlate with differences in the deployment of particular homeotic genes and in the ways that these genes regulate limb development.	UNIV WISCONSIN,MOLEC BIOL LAB,MADISON,WI 53706; UNIV WISCONSIN,HOWARD HUGHES MED INST,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison			Boekhoff-Falk, Grace E/B-2240-2008	Boekhoff-Falk, Grace E/0000-0002-9877-8309				AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Anderson D. T., 1973, EMBRYOLOGY PHYLOGENY; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BEAUCHEMIN M, 1992, DEV BIOL, V154, P55, DOI 10.1016/0012-1606(92)90047-K; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; BOUDREAUX HB, 1987, ANTHR PHYLOGENY SPEC; BUDD G, COMMUNICATION; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; COHEN B, 1993, DEVELOPMENT, V117, P597; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; DIRKSEN ML, 1993, MECH DEVELOP, V41, P121, DOI 10.1016/0925-4773(93)90042-V; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; EMERSON MJ, 1990, SCIENCE, V250, P667, DOI 10.1126/science.250.4981.667; FRENCH V, 1994, CURR BIOL, V4, P34, DOI 10.1016/S0960-9822(00)00006-3; HELD LI, 1995, BIOESSAYS, V17, P721, DOI 10.1002/bies.950170809; HESSLER R R, 1975, Fossils and Strata, V4, P437; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P236, DOI 10.1139/z92-037; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANTON SM, 1964, MANDIBULAR MECHANISM, V247; PANGANIBAN G, UNPUB; PANGANIBAN G, 1994, CURR BIOL, V4, P67; PAPALOPULU N, 1993, DEVELOPMENT, V117, P961; PATEL NH, COMMUNICATION; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; ROBINSON GW, 1991, NEW BIOL, V3, P1183; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schrehardt A, 1987, ARTEMIA RES ITS APPL, V1, P5; SIMCOX AA, 1989, DEVELOPMENT, V107, P715; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Snodgrass RE, 1935, PRINCIPLES INSECT MO; SNODGRASS RE, 1938, SMITHSONIAN MISCELLA, V97; SNODGRASS RE, 1958, SMITHSONIAN MISCELLA, V138; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Williams JA, 1995, DNA CLONING, P15; ZRZAVY J, 1994, J EVOLUTION BIOL, V7, P743, DOI 10.1046/j.1420-9101.1994.7060743.x	42	290	300	2	45	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1363	1366		10.1126/science.270.5240.1363	http://dx.doi.org/10.1126/science.270.5240.1363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481825				2022-12-24	WOS:A1995TF89900040
J	TADDESE, A; NAH, SY; MCCLESKEY, EW				TADDESE, A; NAH, SY; MCCLESKEY, EW			SELECTIVE OPIOID INHIBITION OF SMALL NOCICEPTIVE NEURONS	SCIENCE			English	Article							CONDUCTION-VELOCITY; GANGLION-CELLS; NERVE ACTIVITY; CAT; PAIN; SUBSTANCE; RECEPTORS; MORPHINE; CURRENTS; RELEASE	Opioid analgesia, the selective suppression of pain without effects on other sensations, also distinguishes between different types of pain: severe, persistent pain is potently inhibited by opioids, but they fail to conceal the sensation of a pinprick. The cellular basis for this specificity was analyzed by means of patch-clamp experiments performed on fluorescently labeled nociceptive neurons (nociceptors) that innervate rat tooth pulp. Activation of the mu opioid receptor inhibited calcium channels on almost all small nociceptors but had minimal effect on large nociceptors. Somatostatin had the opposite specificity, preferentially inhibiting calcium channels on the large cells. Because persistent pain is mediated by slow-conducting, small nociceptors, opioids are thus likely to inhibit neurotransmitter release only at those primary synapses specialized for persistent pain.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Oregon Health & Science University								AHLQUIST ML, 1984, PAIN, V19, P353, DOI 10.1016/0304-3959(84)90081-2; AHLQUIST ML, 1985, ADV PAIN RES THER, V9, P352; AKINS PT, 1993, NEUROSCIENCE, V56, P759, DOI 10.1016/0306-4522(93)90372-M; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541, DOI 10.1113/jphysiol.1967.sp008227; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; COOPER BY, 1986, PAIN, V24, P93, DOI 10.1016/0304-3959(86)90030-8; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONG WK, 1985, BRAIN RES, V334, P389, DOI 10.1016/0006-8993(85)90239-2; EDWALL L, 1977, PAIN, V3, P121, DOI 10.1016/0304-3959(77)90075-6; FORS UGH, 1988, PAIN, V33, P253, DOI 10.1016/0304-3959(88)90097-8; GO VLW, 1987, J PHYSIOL-LONDON, V391, P141, DOI 10.1113/jphysiol.1987.sp016731; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; JUMA I, 1978, BRAIN RES, V171, P573; JYVASJARVI E, 1987, J PHYSIOL-LONDON, V391, P193, DOI 10.1113/jphysiol.1987.sp016733; LEE KH, 1986, J COMP NEUROL, V243, P335, DOI 10.1002/cne.902430305; Lewis T, 1937, CLIN SCI, V3, P67; MARFURT CF, 1984, J COMP NEUROL, V223, P353; MOISES HC, 1994, J NEUROSCI, V14, P5903; NARHI M, 1994, ARCH ORAL BIOL, V39, pS23, DOI 10.1016/0003-9969(94)90184-8; RANG HP, 1994, TXB PAIN, pCH1; SANDKUHLER J, 1990, NEUROSCIENCE, V34, P565, DOI 10.1016/0306-4522(90)90165-Z; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SEWARD E, 1991, P ROY SOC B-BIOL SCI, V244, P129, DOI 10.1098/rspb.1991.0061; SHEFNER SA, 1981, BRAIN RES, V221, P109, DOI 10.1016/0006-8993(81)91066-0; STEPHENSON JL, 1995, EXP NEUROL, V131, P11, DOI 10.1016/0014-4886(95)90003-9; TOREBJORK H, 1972, EXP BRAIN RES, V16, P321; WALL PD, 1994, PAIN, pCH1; WILDING TJ, 1995, J NEUROSCI, V15, P4124; WILLIAMS J, 1981, NEUROSCI LETT, V21, P211, DOI 10.1016/0304-3940(81)90384-0	34	130	133	0	6	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1366	1369		10.1126/science.270.5240.1366	http://dx.doi.org/10.1126/science.270.5240.1366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481826				2022-12-24	WOS:A1995TF89900041
J	HUANG, MX; GU, GQ; FERGUSON, EL; CHALFIE, M				HUANG, MX; GU, GQ; FERGUSON, EL; CHALFIE, M			A STOMATIN-LIKE PROTEIN NECESSARY FOR MECHANOSENSATION IN C-ELEGANS	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL MICROTUBULES; SYNTHETIC PEPTIDES; REGULATORY DOMAIN; MEMBRANE-PROTEIN; GENE; EXPRESSION; PRODUCT; TUBULIN	The mec-2 gene is required for the function of a set of six touch receptor neurons in the nematode Caenorhabditis elegans; mec-2 mutants, which are touch-insensitive, have touch cells that appear morphologically normal(1,2). Gene interaction studies suggest that mec-2 positively regulates the activity of the putative mechanosensory transduction channel (ref. 3 and the present paper), comprised in part of proteins encoded by the two degenerin genes mec-4 and mec-10 (refs 3-5). The central region of the mec-2 protein (MEC-2) is very similar to stomatin, an integral membrane protein (band 7.2b) in human red blood cells that is thought to regulate cation conductance(6). MEC-2-LacZ fusions are distributed along the touch receptor axons. This axonal distribution, which is mediated by the mec-2-specific amino terminus, is disrupted by mutations in mec-12, an alpha-tubulin gene needed for touch cell function. Our results indicate that MEC-2 links the mechanosensory channel and the microtubule cytoskeleton of the touch receptor neurons. Such linkage provides the basis for a mechanism of mechanosensation whereby microtubule displacement leads to channel opening.	COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	Columbia University				Ferguson, Edwin/0000-0003-4125-4253				BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1979, J CELL BIOL, V82, P278, DOI 10.1083/jcb.82.1.278; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MANOIL C, 1990, J BACTERIOL, V172, P1035, DOI 10.1128/jb.172.2.1035-1042.1990; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1993, DEVELOPMENT, V119, P773; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; RIVAS CI, 1988, P NATL ACAD SCI USA, V85, P6092, DOI 10.1073/pnas.85.16.6092; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; SALZER U, 1993, BIOCHIM BIOPHYS ACTA, V1151, P149, DOI 10.1016/0005-2736(93)90098-K; Sambrook J., 1989, MOL CLONING LAB MANU; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAVAGE C, 1994, J CELL SCI, V107, P2165; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STEWART GW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P15, DOI 10.1016/0925-4439(93)90116-I; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823	33	193	209	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					292	295		10.1038/378292a0	http://dx.doi.org/10.1038/378292a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477350				2022-12-24	WOS:A1995TE85800052
J	DOLAN, RJ; FLETCHER, P; FRITH, CD; FRISTON, KJ; FRACKOWIAK, RSJ; GRASBY, PM				DOLAN, RJ; FLETCHER, P; FRITH, CD; FRISTON, KJ; FRACKOWIAK, RSJ; GRASBY, PM			DOPAMINERGIC MODULATION OF IMPAIRED COGNITIVE ACTIVATION IN THE ANTERIOR CINGULATE CORTEX IN SCHIZOPHRENIA	NATURE			English	Article							MONKEY PREFRONTAL CORTEX; DELAYED-RESPONSE TASK; CEREBRAL BLOOD-FLOW; RECEPTOR-BINDING; APOMORPHINE; TOMOGRAPHY; RELEASE; GABA	DOPAMINERGIC dysregulation remains an empirical cornerstone for theories concerning the causation of schizophrenia. Evidence for a dopamine system dysfunction in schizophrenia includes the psychosis-inducing effects of dopaminergic agonists(1,2) and the antipsychotic potency of dopaminergic antagonists(3'4). Here we use positron emission tomography (PET) to examine the regulatory role of dopamine on cortical function in normal subjects and unmedicated schizophrenic patients. Using a factorial experimental design, we compared the effect of dopaminergic manipulation with apomorphine on a neural response to a cognitive task. In the schizophrenic patients, relative to controls, an impaired cognitive activation of the anterior cingulate cortex was significantly modulated by a manipulation of dopaminergic neurotransmission. Thus, after apomorphine, the schizophrenic subjects displayed a significantly enhanced cognitive activation of the anterior cingulate cortex relative to the controls. These data provide in vivo evidence that an impaired cognitive-task-induced activation of the anterior cingulate cortex in schizophrenic patients can be significantly modulated by a dopaminergic manipulation.	ROYAL FREE HOSP, SCH MED, LONDON NW3, ENGLAND; UCL, DEPT PSYCHOL, LONDON WC1E 6BT, ENGLAND; HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Imperial College London	DOLAN, RJ (corresponding author), INST NEUROL, WELLCOME DEPT COGNIT NEUROL, QUEEN SQ, LONDON WC1N 3BG, ENGLAND.		Friston, Karl/D-9230-2011; Frith, Chris D/A-2171-2009; Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; Fletcher, Paul/F-5380-2011	Friston, Karl/0000-0001-7984-8909; Frith, Chris D/0000-0002-8665-0690; Frackowiak, Richard/0000-0002-3151-822X; Dolan, Ray/0000-0001-9356-761X; Fletcher, Paul/0000-0001-8257-1517	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943; BENES FM, 1992, J NEUROSCI, V12, P924; BENES FM, 1986, ARCH GEN PSYCHIAT, V43, P31; Bleuler E., 1950, DEMENTIA PRAECOX; CLEGHORN JM, 1991, PSYCHIAT RES-NEUROIM, V40, P135, DOI 10.1016/0925-4927(91)90005-B; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; DAVIDSON M, 1987, AM J PSYCHIAT, V144, P934; Fallon JH, 1987, CEREB CORTEX, V6, P41; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FRISTON KJ, IN PRESS HUM BRAIN M; FRISTON KJ, 1995, HUM BRAIN MAPP, V2, P198; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRASBY PM, 1993, PSYCHOL MED, V23, P605, DOI 10.1017/S0033291700025381; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; LIEBERMAN JA, 1984, AM J PSYCHIAT, V141, P633; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RETAUX S, 1991, NEUROSCIENCE, V42, P61, DOI 10.1016/0306-4522(91)90150-M; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1385, DOI 10.1152/jn.1990.63.6.1385; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; TAMMINGA CA, 1992, ARCH GEN PSYCHIAT, V49, P522; WEINBERGER DR, 1988, TRENDS NEUROSCI, V11, P367, DOI 10.1016/0166-2236(88)90060-4; [No title captured]	30	321	326	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					180	182		10.1038/378180a0	http://dx.doi.org/10.1038/378180a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TD759	7477319	Green Submitted			2022-12-24	WOS:A1995TD75900052
J	GROSHEIDE, PM; WLADIMIROFF, JW; HEIJTINK, RA; MAZEL, JA; CHRISTIAENS, GCML; NUIJTEN, ASM; SCHALM, SW; DUERLOOVOLLAARD, A; ZWIJNENBERG, J; VANDERLAAR, T; BANFFER, JRJ; BAKKERBENDIK, M; BORRIAN, MJ; RIBBERTSMEENK, H; DEGAST, GG; GERARDS, LJ; VANDIJK, H; FETTER, WPF; BAERTS, W				GROSHEIDE, PM; WLADIMIROFF, JW; HEIJTINK, RA; MAZEL, JA; CHRISTIAENS, GCML; NUIJTEN, ASM; SCHALM, SW; DUERLOOVOLLAARD, A; ZWIJNENBERG, J; VANDERLAAR, T; BANFFER, JRJ; BAKKERBENDIK, M; BORRIAN, MJ; RIBBERTSMEENK, H; DEGAST, GG; GERARDS, LJ; VANDIJK, H; FETTER, WPF; BAERTS, W			PROPOSAL FOR ROUTINE ANTENATAL SCREENING AT 14 WEEKS FOR HEPATITIS-B SURFACE-ANTIGEN	BRITISH MEDICAL JOURNAL			English	Article							VIRUS CARRIER STATE; PERINATAL TRANSMISSION; ACTIVE IMMUNIZATION; CONTROLLED TRIAL; PREVENTION; INFECTION; EFFICACY; VACCINE; MOTHERS; INFANTS	Objective-To develop a low cost, high compliance screening programme for identification of carriers of hepatitis B surface antigen in the obstetric population of the Netherlands. Design-A seven year open, descriptive study of screening for hepatitis B surface antigen as part of routine prenatal laboratory testing at 14 weeks of gestation. Compliance with programme evaluated by checking delivery records (hospitals) or registration of births in the 30 participating municipalities (rural area). Setting-Three large city hospitals (two tertiary referral centres) and one rural area with a large number of home deliveries. Subjects-99 706 pregnant women applying for prenatal care for the first time. Main outcome measures-Proportion of pregnant women routinely screened; prevalence of hepatitis B surface antigen in large cities and rural area. Results-Uptake of screening reached 97% in the hospitals after inclusion of 10% screened at delivery; the estimated uptake in the rural area was >95%. Prevalence of hepatitis B surface antigen was 1.6% in the large cities and 0.3% in the rural area. For screening at delivery the prevalence was 2.5 times higher (4%, P < 0.01) than for screening at week 14 of gestation. Conclusion-Incorporation of universal testing for hepatitis B surface antigen into routine prenatal laboratory testing is practical; high compliance is achieved when screening is supplemented with rapid screening at delivery for those who escaped routine prenatal care.	UNIV HOSP DIJKZIGT,DEPT INTERNAL MED 2,3015 GD ROTTERDAM,NETHERLANDS; UNIV HOSP DIJKZIGT,DEPT OBSTET,3015 GD ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT VIROL,3000 DR ROTTERDAM,NETHERLANDS; ACAD HOSP,DEPT OBSTET & GYNAECOL,UTRECHT,NETHERLANDS; STATE SCH TRAINING MIDWIVES,ROTTERDAM,NETHERLANDS; RUWAARD VAN PUTTEN HOSP,DEPT PAEDIAT,SPIJKERVISSE,NETHERLANDS; REG PUBL HLTH LAB,ROTTERDAM,NETHERLANDS; ACAD HOSP ROTTERDAM DIJKZIGT,DEPT INTERNAL MED,3000 DR ROTTERDAM,NETHERLANDS; REG LAB PATHOL & MICROBIOL,ENSCHEDE,NETHERLANDS; BLOOD TRANSFUS LAB,UTRECHT,NETHERLANDS; WILHELMINA CHILDRENS HOSP,UTRECHT,NETHERLANDS; SOPHIA HOSP,DEPT PAEDIAT,ZWOLLA,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Wilhelmina Kinderziekenhuis								AREVALO JA, 1988, JAMA-J AM MED ASSOC, V259, P365, DOI 10.1001/jama.259.3.365; BEASLEY RP, 1983, HEPATOLOGY, V3, P135; DELCANHO R, 1994, J HEPATOL, V20, P483, DOI 10.1016/S0168-8278(05)80494-5; FRANCIS DP, 1985, PEDIATRICS, V76, P851; GREENSPOON JS, 1989, J REPROD MED, V34, P655; GROSHEIDE PM, 1993, AM J DIS CHILD, V147, P1316, DOI 10.1001/archpedi.1993.02160360058019; IP HMH, 1989, LANCET, V1, P406; JONAS MM, 1987, ANN INTERN MED, V107, P335, DOI 10.7326/0003-4819-107-2-335; MAUPAS P, 1981, LANCET, V1, P289; MAYNARD JE, 1983, INT J EPIDEMIOL, V61, P731; MAZEL JA, 1984, BRIT MED J, V288, P513, DOI 10.1136/bmj.288.6416.513; SCHALM SW, 1989, PEDIATRICS, V83, P1041; SILVERMAN NS, 1991, JAMA-J AM MED ASSOC, V20, P2852; TADA H, 1982, PEDIATRICS, V70, P613; WAINWRIGHT RB, 1986, INT J EPIDEMIOL, V15, P567, DOI 10.1093/ije/15.4.567; 1984, MMWR-MORBID MORTAL W, V33, P285; 1983, B WORLD HEALTH ORGAN, V61, P731	17	14	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1197	1199		10.1136/bmj.311.7014.1197	http://dx.doi.org/10.1136/bmj.311.7014.1197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488895	Green Published			2022-12-24	WOS:A1995TD76800019
J	KIM, E; NIETHAMMER, M; ROTHSCHILD, A; JAN, YN; SHENG, M				KIM, E; NIETHAMMER, M; ROTHSCHILD, A; JAN, YN; SHENG, M			CLUSTERING OF SHAKER-TYPE K+ CHANNELS BY INTERACTION WITH A FAMILY OF MEMBRANE-ASSOCIATED GUANYLATE KINASES	NATURE			English	Article							TUMOR-SUPPRESSOR PROTEIN; SEPTATE JUNCTIONS; POTASSIUM CHANNEL; NMDA RECEPTOR; NEURONS; DIVERSITY; HOMOLOG; BRAIN; GENE	ANCHORING Of ion channels at specific subcellular sites is critical for neuronal signalling, but the mechanisms underlying channel localization and clustering are largely unknown (reviewed in ref. 1). Voltage-gated K+ channels are concentrated in various neuronal domains, including presynaptic terminals, nodes of Ranvier and dendrites, where they regulate local membrane excitability. Here we present functional and biochemical evidence that cell-surface clustering of Shaker-subfamily K+ channels is mediated by the PSD-95 family of membrane-associated putative guanylate kinases, as a result of direct binding of the carboxy-terminal cytoplasmic tails of the K+ channel subunits to two PDZ (also known as GLGF or DHR) domains in the PSD-95 protein(2). The ability of PDZ domains to function as independent modules for protein-protein interaction, and their presence in other junction-associated molecules (such as ZO-1 (ref. 3) and syntrophin(4)), suggest that PDZ-domain-containing polypeptides may be widely involved in the organization of proteins at sites of membrane specialization.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROBIOL,BOSTON,MA 02114; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Bartel PL, 1993, USING 2 HYBRID SYSTE, P153; CHANDY KG, 1995, HDB RECEPTORS CHANNE, P1; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISHII T, 1993, J BIOL CHEM, V268, P2836; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	29	880	911	0	32	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					85	88		10.1038/378085a0	http://dx.doi.org/10.1038/378085a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477295				2022-12-24	WOS:A1995TC46900056
J	BLOCH, S; KISSANE, DW				BLOCH, S; KISSANE, DW			PSYCHOSOCIAL CARE AND BREAST-CANCER	LANCET			English	Editorial Material							TRIAL		MONASH UNIV,DEPT PSYCHOL MED,CLAYTON,VIC 3168,AUSTRALIA	Monash University	BLOCH, S (corresponding author), UNIV MELBOURNE,DEPT PSYCHIAT,MELBOURNE,VIC,AUSTRALIA.			Kissane, David/0000-0002-5930-4573				ANDERSEN BL, 1992, J CONSULT CLIN PSYCH, V60, P552, DOI 10.1037/0022-006X.60.4.552; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; FAWZY FI, 1993, ARCH GEN PSYCHIAT, V50, P681; GREER S, 1990, LANCET, V335, P49, DOI 10.1016/0140-6736(90)90173-3; GREER S, 1992, BRIT MED J, V304, P675, DOI 10.1136/bmj.304.6828.675; Moorey S., 1989, PSYCHOL THERAPY PATI; MULDER CL, 1992, PSYCHO-ONCOLOGY, V1, P155; PRESBERG BA, 1993, PSYCHO-ONCOLOGY, V2, P215; SPIEGEL D, 1989, LANCET, V1, P888; TRIJSBURG RW, 1992, PSYCHOSOM MED, V54, P489, DOI 10.1097/00006842-199207000-00011; 1995, CLIN PRACTICE GUIDEL; 1994, MED J AUST S, V161	12	17	18	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1114	1115		10.1016/S0140-6736(95)91794-2	http://dx.doi.org/10.1016/S0140-6736(95)91794-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TB549	7475597				2022-12-24	WOS:A1995TB54900004
J	CANDINAS, D; GUNSON, BK; NIGHTINGALE, P; HUBSCHER, S; MCMASTER, P; NEUBERGER, JM				CANDINAS, D; GUNSON, BK; NIGHTINGALE, P; HUBSCHER, S; MCMASTER, P; NEUBERGER, JM			SEX MISMATCH AS A RISK FACTOR FOR CHRONIC REJECTION OF LIVER ALLOGRAFTS	LANCET			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; VANISHING-BILEDUCT SYNDROME; DUCT SYNDROME; TRANSPLANTATION; GRAFT; IMMUNOSUPPRESSION; INFECTION	Chronic irreversible rejection is a major cause of graft loss and retransplantation after orthotopic liver allotransplantation. To identify risk factors we retrospectively analysed 423 adult consecutive primary liver allograft recipients. The endpoint of the study was graft failure due to chronic rejection leading either to retransplantation or death. Chronic rejection developed in 22 (5.2%) patients. Pretransplant diagnosis of primary biliary cirrhosis or autoimmune hepatitis, recipient age less than 30 years, 1 or more episodes of acute cellular rejection, and transplantation of an organ from cytomegalovirus (CMV). IgG positive donor to an IgG negative recipient were identified as risk factors for chronic rejection. Transplantation of a liver from a male donor into a female recipient was also associated with an increased probability of chronic rejection. By logistic regression analysis, the probability of chronic rejection was predicted by: sex and cytomegalovirus match of donor and recipient, the presence of acute rejection, recipient age, transplantation for autoimmune hepatitis or primary biliary cirrhosis, and recipients receiving no azathioprine during the third month after transplantation. Sensitisation to antigens expressed by bile-duct epithelium as in primary biliary cirrhosis or exposure to donor bile-duct minor histocompatibility antigens, such as the male sex related H-Y antigen, may provide an explanation, More selective allocation of donor organs may allow a reduction in the incidence of ductopaenic rejection and graft loss.	QUEEN ELIZABETH HOSP,LIVER & HEPATOBILIARY UNIT,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND; UNIV BIRMINGHAM,DEPT MED,WOLFSON COMP LABS,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND; UNIV BIRMINGHAM,SCH MED,DEPT PATHOL,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND	University of Birmingham; University of Birmingham; University of Birmingham			Neuberger, James/ABG-3010-2020	Gunson, Bridget/0000-0001-6149-9915				ADAMS DH, 1990, J HEPATOL, V10, P113, DOI 10.1016/0168-8278(90)90081-2; BACKMAN L, 1993, TRANSPLANTATION, V55, P1078; BASADONNA GP, 1995, TRANSPLANTATION, V55, P993; BISMUTH A, 1991, REV FR TRANSFUS HEM, V34, P449, DOI 10.1016/S1140-4639(05)80139-X; BLATTS KP, 1988, TRANSPLANTATION, V45, P376; DEMETRIS AJ, 1988, HEPATOLOGY, V8, P939, DOI 10.1002/hep.1840080439; DEVLIN JJ, 1993, TRANSPLANTATION, V56, P1381, DOI 10.1097/00007890-199312000-00020; DONALDSON P, 1993, HEPATOLOGY, V17, P1008, DOI 10.1002/hep.1840170611; DONALDSON PT, 1987, LANCET, V1, P945; DOUSSET B, 1993, TRANSPLANTATION, V55, P529, DOI 10.1097/00007890-199303000-00014; GNANT MFX, 1991, TRANSPLANT P, V23, P1434; GOULMY E, 1991, BONE MARROW TRANSPL, V7, P49; GRIEM P, 1991, CELL, V65, P633, DOI 10.1016/0092-8674(91)90095-G; GUBERNATIS G, 1988, TRANSPLANT INT, V1, P155, DOI 10.1111/j.1432-2277.1988.tb01805.x; HUBSCHER S, 1993, IMMUNOLOGY LIVER TRA, P216; LESOURD BM, 1994, IMMUNOL LETT, V40, P235, DOI 10.1016/0165-2478(94)00062-X; MANEZ R, 1993, TRANSPLANTATION, V55, P1067, DOI 10.1097/00007890-199305000-00024; MCMASTER P, 1994, TRANSPL INT S1, V7, P32; OGRADY JG, 1988, LANCET, V2, P302; PADBURY RTA, 1993, TRANSPLANTATION, V55, P789, DOI 10.1097/00007890-199304000-00020; PAYA CV, 1992, HEPATOLOGY, V16, P66, DOI 10.1002/hep.1840160113; SIMPSON E, 1991, IMMUNOL LETT, V29, P9, DOI 10.1016/0165-2478(91)90192-D; SOIN AS, 1995, TRANSPLANT P, V27, P1129; VANHOEK B, 1991, TRANSPLANT P, V23, P1403; VOOGT PJ, 1990, LANCET, V335, P131, DOI 10.1016/0140-6736(90)90003-N; WIESNER RH, 1991, HEPATOLOGY, V14, P721, DOI 10.1002/hep.1840140424	26	111	111	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1117	1121		10.1016/S0140-6736(95)91797-7	http://dx.doi.org/10.1016/S0140-6736(95)91797-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475600				2022-12-24	WOS:A1995TB54900007
J	LEVY, D				LEVY, D			HAVE EXPERT PANEL GUIDELINES KEPT PACE WITH NEW CONCEPTS IN HYPERTENSION	LANCET			English	Editorial Material							RISK				LEVY, D (corresponding author), NHLBI, BLDG 10, BETHESDA, MD 20892 USA.							ALDERMAN MH, 1993, ANN INTERN MED, V119, P329, DOI 10.7326/0003-4819-119-4-199308150-00013; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1991, JAMA, V265, P3255; BLACK HR, 1994, HYPERTENSION, V23, P275; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; JACKSON R, BRIT MED J, V307, P107; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; OPARIL S, 1993, NEW ENGL J MED, V328, P959, DOI 10.1056/NEJM199304013281311; SAGIE A, 1993, NEW ENGL J MED, V329, P1912, DOI 10.1056/NEJM199312233292602; TOBIAN L, 1994, AM J HYPERTENS, V7, P859, DOI 10.1093/ajh/7.10.859; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; ZANCHETTI A, 1993, J HYPERTENS, V11, P905	16	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	1995	346	8983					1112	1113		10.1016/S0140-6736(95)91792-6	http://dx.doi.org/10.1016/S0140-6736(95)91792-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475595				2022-12-24	WOS:A1995TB54900002
J	ABRAHAMOV, A; ELSTEIN, D; GROSSTSUR, V; FARBER, B; GLASER, Y; HADASHALPERN, I; RONEN, S; TAFAKJDI, M; HOROWITZ, M; ZIMRAN, A				ABRAHAMOV, A; ELSTEIN, D; GROSSTSUR, V; FARBER, B; GLASER, Y; HADASHALPERN, I; RONEN, S; TAFAKJDI, M; HOROWITZ, M; ZIMRAN, A			GAUCHERS-DISEASE VARIANT CHARACTERIZED BY PROGRESSIVE CALCIFICATION OF HEART-VALVES AND UNIQUE GENOTYPE	LANCET			English	Article							INVOLVEMENT; GLUCOCEREBROSIDASE; DEFICIENCY; MUTATIONS	Gaucher's disease is the most prevalent sphingolipid storage disease, characterised by substantial genetic and phenotypic variability. Cardiac manifestations are rare. We report 12 Arab Gaucher's disease patients, 2-20 years of age, who presented with oculomotor apraxia but only slight classic signs of the disease. All but the youngest had calcifications of the aortic or mitral valves or both. All these patients were homozygous for the rare point mutation D409H (1342C). Valvular calcifications increased with age and showed progression during 2 years of follow-up. Two of the oldest patients underwent aortic valve replacement, and one sibling had died suddenly at age 16, before this study. Corneal opacities were another common feature. The potentially fatal course of this Gaucher's disease variant, and the availability of a reliable PCR-based method for heterozygote detection, mean that population screening and genetic counselling in the geographic area at risk are important. Affected individuals should be closely monitored by echocardiography to gauge the need for valve replacement. The potential of enzyme replacement to prevent these cardiac complications cannot be ascertained at present, because of the high cost of therapy.	SHAARE ZEDEK MED CTR,GAUCHER CLIN,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DEPT PEDIAT,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DEPT PEDIAT CARDIOL,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DEPT PEDIAT NEUROL,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DEPT OPHTHALMOL,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DEPT MED,IL-91031 JERUSALEM,ISRAEL; TEL AVIV UNIV,FAC LIFE SCI,DEPT CELLULAR BIOL & IMMUNOL,RAMAT AVIV,ISRAEL; JENIN HLTH DIST OFF,JENIN,JORDAN	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University								BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BENBASSA.J, 1968, AM J MED, V44, P647, DOI 10.1016/0002-9343(68)90067-3; Beutler E., 1995, METABOLIC MOL BASES, P2641; BRADY RO, 1994, 4TH INT GAUCH DIS C; CASTA A, 1984, AM J CARDIOL, V54, P1390, DOI 10.1016/S0002-9149(84)80115-0; CHABAS A, 1995, J MED GENET, V32, P740, DOI 10.1136/jmg.32.9.740; EDWARDS WD, 1983, AM J CARDIOL, V52, P654, DOI 10.1016/0002-9149(83)90052-8; GROSSTSUR V, 1989, PEDIATR NEUROL, V5, P128, DOI 10.1016/0887-8994(89)90042-8; HOROWITZ M, 1993, AM J HUM GENET, V53, P921; Lee R. E., 1982, GaAs IC Symposium. IEEE Gallium Arsenide Integrated Circuit Symposium. Technical Digest 1982, P177; PATTERSON MC, 1993, NEUROLOGY, V43, P1993, DOI 10.1212/WNL.43.10.1993; ROBERTS WC, 1967, CIRCULATION, V35, P783, DOI 10.1161/01.CIR.35.4.783; SARACLAR M, 1991, PEDITA CARDIOLOGY, V13, P56; SMITH RRL, 1978, AM J MED, V65, P352, DOI 10.1016/0002-9343(78)90832-X; TAMARI I, 1983, ARCH INTERN MED, V143, P2010, DOI 10.1001/archinte.143.10.2010; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUTSUMI A, 1982, GANKA RHINSHOIHO, V76, P1730; UYAMA E, 1992, ACTA NEUROL SCAND, V86, P407, DOI 10.1111/j.1600-0404.1992.tb05109.x; WILSON ER, 1985, ARCH PATHOL LAB MED, V109, P82	19	154	160	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					1000	1003		10.1016/S0140-6736(95)91688-1	http://dx.doi.org/10.1016/S0140-6736(95)91688-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475546				2022-12-24	WOS:A1995RZ59900010
J	TELI, MR; DAY, CP; BURT, AD; BENNETT, MK; JAMES, OFW				TELI, MR; DAY, CP; BURT, AD; BENNETT, MK; JAMES, OFW			DETERMINANTS OF PROGRESSION TO CIRRHOSIS OR FIBROSIS IN PURE ALCOHOLIC FATTY LIVER	LANCET			English	Article							LIPID-PEROXIDATION; DISEASE; INJURY	''Pure'' alcoholic fatty liver has been widely assumed to be ''benign'' with very low risk of progression to cirrhosis. Studies thus far have included either patients with coexisting recognised precursor lesions of cirrhosis or have been restricted to short-term histological follow-up. We have followed 88 patients, first seen between 1978 and 1985, with a histological diagnosis of pure alcoholic fatty liver and no evidence of fibrosis or alcoholic hepatitis, for a median of 10.5 years, to determine any factors predictive of disease progression. Of the 88, at follow-up nine had developed cirrhosis and a further seven fibrosis. Eight of nine patients with cirrhosis had continuing alcohol consumption of more than 40 units per week at follow-up; in the other patients, consumption was unknown. Independent histological predictors of progression on index biopsy were: presence of mixed macro/microvesicular fat, and presence of giant mitochondria. We can no longer regard alcoholic fatty liver as benign. in the presence of continuing high alcohol consumption the above histological features identified those at high risk (47-61%) of disease progression. Therefore, patients with these features should be counselled intensively regarding their alcohol consumption.	MED SCH NEWCASTLE UPON TYNE, DEPT MED, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND; MED SCH NEWCASTLE UPON TYNE, DEPT PATHOL, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND	Newcastle University - UK; Newcastle University - UK			Burt, Alastair D/D-3634-2013; Day, Christopher/Z-3305-2019	Burt, Alastair D/0000-0002-3011-7774; 				CEDERBAUM AI, 1989, FREE RADICAL BIO MED, V7, P537, DOI 10.1016/0891-5849(89)90029-4; CHEDID A, 1986, GASTROENTEROLOGY, V90, P1858, DOI 10.1016/0016-5085(86)90253-2; CHRISTOFFERSEN P, 1972, ACTA PATH MICRO IM A, VA 80, P557; EDMONDSON HA, 1967, MEDICINE, V46, P119, DOI 10.1097/00005792-196703000-00006; FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1; ITOH S, 1987, AM J GASTROENTEROL, V82, P650; LEEVY CM, 1962, MEDICINE, V41, P249, DOI 10.1097/00005792-196209000-00003; LEEVY CM, 1968, MED CLIN N AM, V52, P1445, DOI 10.1016/S0025-7125(16)32838-3; LETTERON P, 1993, GUT, V34, P409, DOI 10.1136/gut.34.3.409; LIEBER CS, 1976, FED PROC, V35, P1232; LIEBER CS, 1965, J CLIN INVEST, V44, P1009, DOI 10.1172/JCI105200; MORGAN MY, 1977, BRIT MED J, V1, P939, DOI 10.1136/bmj.1.6066.939; MORGAN MY, 1991, OXFORD TXB CLIN HEPA, P816; PAROLA M, 1993, BIOCHEM BIOPH RES CO, V194, P1044, DOI 10.1006/bbrc.1993.1927; PORTA EA, 1965, AM J PATHOL, V46, P657; SHERLOCK S, 1995, LANCET, V345, P227; SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2; TELI MR, IN PRESS HEPATOLOGY; WORNER TM, 1985, JAMA-J AM MED ASSOC, V254, P627, DOI 10.1001/jama.254.5.627; ZAKIM D, 1990, HEPATOLOGY TXB LIVER, P848	20	344	351	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	1995	346	8981					987	990		10.1016/S0140-6736(95)91685-7	http://dx.doi.org/10.1016/S0140-6736(95)91685-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475591				2022-12-24	WOS:A1995RZ59900007
J	RON, A; ROGERS, DE				RON, A; ROGERS, DE			NEW-YORK CITYS HEALTH-CARE CRISIS - AIDS, THE POOR, AND LIMITED RESOURCES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT MED,NEW YORK,NY 10021	Cornell University; NewYork-Presbyterian Hospital	RON, A (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PUBL HLTH,1300 YORK AVE,ROOM A-631,NEW YORK,NY 10021, USA.							1988, AIDS WEEKLY SUR 0606; 1988, NEW YORK CITY STRATE	2	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	1988	260	10					1453	1453						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P9020	3404605				2022-12-24	WOS:A1988P902000031
J	MALIM, MH; HAUBER, J; FENRICK, R; CULLEN, BR				MALIM, MH; HAUBER, J; FENRICK, R; CULLEN, BR			IMMUNODEFICIENCY VIRUS REV TRANS-ACTIVATOR MODULATES THE EXPRESSION OF THE VIRAL REGULATORY GENES	NATURE			English	Article									DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University				Malim, Michael/0000-0002-7699-2064				ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; CULLEN BR, 1988, J VIROL, V62, P2498, DOI 10.1128/JVI.62.7.2498-2501.1988; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; GALLO R, 1988, NATURE, V333, P504, DOI 10.1038/333504a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HAUBER J, 1987, UCLA S MOL CELL BIOL, V67, P191; HIRSCH V, 1987, CELL, V49, P307, DOI 10.1016/0092-8674(87)90283-2; KNIGHT DM, 1987, SCIENCE, V236, P837, DOI 10.1126/science.3033827; LEVY JA, 1986, SCIENCE, V232, P998, DOI 10.1126/science.3010461; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; ROSEN CA, 1986, NATURE, V319, P555, DOI 10.1038/319555a0; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; TERWILLIGER E, 1988, J VIROL, V62, P655, DOI 10.1128/JVI.62.2.655-658.1988; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WRIGHT CM, 1986, SCIENCE, V234, P988, DOI 10.1126/science.3490693	27	355	368	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 8	1988	335	6186					181	183		10.1038/335181a0	http://dx.doi.org/10.1038/335181a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9647	3412474				2022-12-24	WOS:A1988P964700061
J	SAIKI, RK; CHANG, CA; LEVENSON, CH; WARREN, TC; BOEHM, CD; KAZAZIAN, HH; ERLICH, HA				SAIKI, RK; CHANG, CA; LEVENSON, CH; WARREN, TC; BOEHM, CD; KAZAZIAN, HH; ERLICH, HA			DIAGNOSIS OF SICKLE-CELL ANEMIA AND BETA-THALASSEMIA WITH ENZYMATICALLY AMPLIFIED DNA AND NONRADIOACTIVE ALLELE-SPECIFIC OLIGONUCLEOTIDE PROBES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CETUS CORP,DEPT CHEM,EMERYVILLE,CA 94608; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University	SAIKI, RK (corresponding author), CETUS CORP,DEPT HUMAN GENET,1400 53RD ST,EMERYVILLE,CA 94608, USA.							AMSELEM S, 1988, AM J HUM GENET, V43, P95; CHEHAB FF, 1987, BLOOD, V69, P1141; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; CONNOLLY BA, 1985, NUCLEIC ACIDS RES, V13, P4485, DOI 10.1093/nar/13.12.4485; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1986, BLOOD, V68, P964; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MAROTTA CA, 1977, J BIOL CHEM, V252, P5019; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1983, J CLIN INVEST, V71, P775, DOI 10.1172/JCI110826; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; ROSATELLI C, 1985, LANCET, V1, P241; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHELDON EL, 1986, P NATL ACAD SCI USA, V83, P9085, DOI 10.1073/pnas.83.23.9085; Weatherall DJ, 1981, THALASSEMIA SYNDROME; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	24	277	304	0	17	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 1	1988	319	9					537	541		10.1056/NEJM198809013190903	http://dx.doi.org/10.1056/NEJM198809013190903			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P8454	3405266				2022-12-24	WOS:A1988P845400003
J	LANDEGREN, U; KAISER, R; SANDERS, J; HOOD, L				LANDEGREN, U; KAISER, R; SANDERS, J; HOOD, L			A LIGASE-MEDIATED GENE DETECTION TECHNIQUE	SCIENCE			English	Article											LANDEGREN, U (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Landegren, Ulf D/A-8197-2019					BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; CASKEY CT, 1987, SCIENCE, V236, P1223, DOI 10.1126/science.3296189; CONNELL C, 1987, BIOTECHNIQUES, V5, P342; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; COOPER DN, 1987, LANCET, V1, P273; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; HORVATH SJ, 1987, METHOD ENZYMOL, V154, P314; HUNKAPILLER T, COMMUNICATION; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; McKusick V. A., 1986, MENDELIAN INHERITANC; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; SAIKI RK, 1985, BIO-TECHNOL, V3, P1008, DOI 10.1038/nbt1185-1008; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SMITH LM, 1985, NUCLEIC ACIDS RES, V13, P2399, DOI 10.1093/nar/13.7.2399; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SOINI E, 1983, CLIN CHEM, V29, P65; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; TIWARI JL, 1985, HLA DISEASE ASS; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; WHITELEY NM, 1986, Patent No. 1854942; WINSLOW RM, 1983, METABOLIC BASIS INHE, P1666; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575	25	623	1385	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 26	1988	241	4869					1077	1080		10.1126/science.3413476	http://dx.doi.org/10.1126/science.3413476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7986	3413476				2022-12-24	WOS:A1988P798600028
J	RIGAMONTI, D; HADLEY, MN; DRAYER, BP; JOHNSON, PC; HOENIGRIGAMONTI, K; KNIGHT, JT; SPETZLER, RF				RIGAMONTI, D; HADLEY, MN; DRAYER, BP; JOHNSON, PC; HOENIGRIGAMONTI, K; KNIGHT, JT; SPETZLER, RF			CEREBRAL CAVERNOUS MALFORMATIONS - INCIDENCE AND FAMILIAL OCCURRENCE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BARROW NEUROL INST,DIV NEUROL SURG,350 W THOMAS RD,PHOENIX,AZ 85013; BARROW NEUROL INST,DIV NEURORADIOL,PHOENIX,AZ 85013; BARROW NEUROL INST,DIV NEUROPATHOL,PHOENIX,AZ 85013	Barrow Neurological Institute; Barrow Neurological Institute; Barrow Neurological Institute								Berry R G, 1966, Res Publ Assoc Res Nerv Ment Dis, V41, P40; BICKNELL JM, 1978, ARCH NEUROL-CHICAGO, V35, P746, DOI 10.1001/archneur.1978.00500350050010; BRUHLMANN Y, 1985, NEUROCHIRURGIE, V31, P271; CLARK JV, 1970, J NEUROL NEUROSUR PS, V33, P871, DOI 10.1136/jnnp.33.6.871; COMBELLES G, 1983, NEUROCHIRURGIE, V29, P263; DARWIN RH, 1986, RADIOLOGY, V160, P375, DOI 10.1148/radiology.160.2.3726116; GIOMBINI S, 1978, ACTA NEUROCHIR, V40, P61, DOI 10.1007/BF01773116; GOMORI JM, 1986, RADIOLOGY, V158, P707, DOI 10.1148/radiology.158.3.3945744; HAYMAN LA, 1982, AM J MED GENET, V11, P147, DOI 10.1002/ajmg.1320110205; KIDD HA, 1947, LANCET, V1, P747; Kufs H, 1928, Z GESAMTE NEUROL PSY, V113, P651, DOI 10.1007/BF02884519; McCormick W., 1984, INTRACRANIAL ARTERIO, P44, DOI 10.1016/S1042-3680(18)30174-8; MCCORMICK WF, 1966, J NEUROSURG, V24, P807, DOI 10.3171/jns.1966.24.4.0807; Michael JC, 1936, ARCH NEURO PSYCHIATR, V36, P514, DOI 10.1001/archneurpsyc.1936.02260090067003; RIGAMONTI D, 1987, J NEUROSURG, V67, P518, DOI 10.3171/jns.1987.67.4.0518; RUSSELL DS, 1977, PATHOLOGY TUMOURS NE, P116; SARWAR M, 1978, ARCH NEUROL-CHICAGO, V35, P323, DOI 10.1001/archneur.1978.00500290069012; SAVOIARDO M, 1983, AM J NEURORADIOL, V4, P945; Stehbens WE, 1972, PATHOLOGY CEREBRAL B; TAGLE P, 1986, J NEUROSURG, V64, P720, DOI 10.3171/jns.1986.64.5.0720; VAQUERO J, 1983, NEUROSURGERY, V12, P208, DOI 10.1227/00006123-198302000-00013; Zulch KJ, 1965, BRAIN TUMORS THEIR B	22	496	509	0	7	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	1988	319	6					343	347		10.1056/NEJM198808113190605	http://dx.doi.org/10.1056/NEJM198808113190605			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6095	3393196				2022-12-24	WOS:A1988P609500005
J	CLARKE, M; CLAYTON, DG; MASON, ES; MACVICAR, J				CLARKE, M; CLAYTON, DG; MASON, ES; MACVICAR, J			ASIAN MOTHERS RISK-FACTORS FOR PERINATAL DEATH - THE SAME OR DIFFERENT - A 10 YEAR REVIEW OF LEICESTERSHIRE PERINATAL DEATHS	BMJ-BRITISH MEDICAL JOURNAL			English	Article									LEICESTER ROYAL INFIRM, DEPT OBSTET & GYNAECOL, LEICESTER LE2 7LX, ENGLAND	University of Leicester	CLARKE, M (corresponding author), LEICESTER ROYAL INFIRM, DEPT COMMUNITY HLTH, LEICESTER LE2 7LX, ENGLAND.							Breslow N.E., 1980, STAT METHODS CANC RE, P192; CLARKE M, 1983, BRIT MED J, V286, P621, DOI 10.1136/bmj.286.6365.621; CLARKE M, 1981, AM J EPIDEMIOL, V113, P636, DOI 10.1093/oxfordjournals.aje.a113142; ELBOURNE D, 1985, RECENT ADV COMMUNITY, V3, P221; HEINEMANN W, 1975, BRIT BIRTHS 1970; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; MCILWAINE GM, 1979, BMJ-BRIT MED J, V2, P1103, DOI 10.1136/bmj.2.6198.1103; PHAROAH POD, 1982, LANCET, V1, P491; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; WIGGLESWORTH JS, 1980, LANCET, V2, P684; YOUNG ID, 1987, BMJ-BRIT MED J, V295, P89, DOI 10.1136/bmj.295.6590.89; 1986, 29 DEP HLTH SOC SEC; 1980, PERINATAL NEONATAL M, P1; 1963, PERINATAL MORTALITY	14	23	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	1988	297	6645					384	387		10.1136/bmj.297.6645.384	http://dx.doi.org/10.1136/bmj.297.6645.384			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408977	Green Published, Bronze			2022-12-24	WOS:A1988P545000018
J	DUESBERG, P				DUESBERG, P			HIV IS NOT THE CAUSE OF AIDS	SCIENCE			English	Editorial Material											DUESBERG, P (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC BIOL,BERKELEY,CA 94720, USA.							ALBERT J, 1987, J MED VIROL, V23, P67, DOI 10.1002/jmv.1890230108; BAUM R, 1987, CHEM ENG NEWS   1123, P14; CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0; COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335; COLEBUNDERS R, 1987, LANCET, V1, P492; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; DUESBERG PH, 1987, CANCER RES, V47, P1199; FALK LA, 1987, NEW ENGL J MED, V316, P1547; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FRIEDLAND GH, 1987, NEW ENGL J MED, V317, P1125, DOI 10.1056/NEJM198710293171806; GALLO D, 1987, J CLIN MICROBIOL, V25, P1291, DOI 10.1128/JCM.25.7.1291-1294.1987; GALLO R C, 1987, Scientific American, V256, P47; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; KESSLER HA, 1987, JAMA-J AM MED ASSOC, V258, P1196; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PALLANGYO KJ, 1987, LANCET, V2, P972; RANKI A, 1987, LANCET, V2, P589; RICHMAN DD, 1987, J INFECT DIS, V156, P823, DOI 10.1093/infdis/156.5.823; SELIK RM, 1987, AIDS, V1, P175; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; SONNABEND J, 1988, NEW YORK NATIVE 0509, P19; SPRENT J, 1977, B T CELLS IMMUNE REC, P59; VONBRIESEN H, 1987, J MED VIROL, V23, P51, DOI 10.1002/jmv.1890230107; 1988, AIDS WEEKLY SUR 0418; 1987, J AM MED ASS, V258, P1143	25	64	66	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1988	241	4865					514	514		10.1126/science.3399880	http://dx.doi.org/10.1126/science.3399880			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4350	3399880				2022-12-24	WOS:A1988P435000002
J	MCNAUGHTON, SJ				MCNAUGHTON, SJ			MINERAL-NUTRITION AND SPATIAL CONCENTRATIONS OF AFRICAN UNGULATES	NATURE			English	Article											MCNAUGHTON, SJ (corresponding author), SYRACUSE UNIV,BIOL RES LABS,SYRACUSE,NY 13244, USA.							Albl P., 1977, Madoqua (Ser 1), V10, P79; [Anonymous], 1982, PRINCIPLES PLANT NUT; Barber S. A., 1984, SOIL NUTRIENT BIOAVA; BELL RHV, 1971, SCI AM, V224, P86; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Delany M.J., 1979, ECOLOGY AFRICAN MAMM; DENTON D, 1984, HUNGER SALT; ELTRINGHAM SK, 1980, ECOLOGY CONSERVATION; ESTES RD, 1967, J MAMMAL, V48, P189, DOI 10.2307/1378022; Georgiadis N. J., 1987, THESIS SYRACUSE U; HACKER JB, 1987, NUTRITION HERBIVORES; HARGROVE WL, 1985, PLANT SOIL, V88, P93, DOI 10.1007/BF02140668; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JARRETT W. H. F., 1964, EAST AFRICAN WILDLIFE J, V2, P158; Jones R.L., 1985, MINERAL LICKS GEOPHA; Leuthold W., 1977, AFRICAN UNGULATES; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1983, ECOL MONOGR, V53, P291, DOI 10.2307/1942533; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; MECH LD, 1977, SCIENCE, V198, P320, DOI 10.1126/science.198.4314.320; MUNTER RC, 1984, COMMUN SOIL SCI PLAN, V15, P1285, DOI 10.1080/00103628409367559; RISENHOOVER KL, 1986, OECOLOGIA, V71, P121, DOI 10.1007/BF00377330; Robbins C.T., 1983, WILDLIFE FEEDING NUT; ROGERS LL, 1980, J WILDLIFE MANAGE, V44, P253; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; SINGH BR, 1987, SOIL SCI, V143, P241, DOI 10.1097/00010694-198704000-00002; THOMPSON LT, 1983, HDB INDUCTIVELY COUP; VESEY-FITZGERALD DESMOND F., 1960, JOUR MAMMAL, V41, P161, DOI 10.2307/1376351; WEIR JS, 1972, OIKOS, V23, P1, DOI 10.2307/3543921; WENTWORTH TR, 1987, SOIL SCI, V144, P190, DOI 10.1097/00010694-198709000-00005; WILSON DE, 1977, WILDL MONOGR, V4; ZUMPT IF, 1978, S AFR J WILDL RES, V8, P131; [No title captured]; [No title captured]; 1984, NUTRIENT REQUIREMENT; [No title captured]; SERENGETI ECOLOGICAL	39	218	225	2	49	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 28	1988	334	6180					343	345		10.1038/334343a0	http://dx.doi.org/10.1038/334343a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4349	3393225				2022-12-24	WOS:A1988P434900058
J	SAMUELSSON, C				SAMUELSSON, C			RETROSPECTIVE DETERMINATION OF RADON IN HOUSES	NATURE			English	Article											SAMUELSSON, C (corresponding author), UNIV LUND HOSP,DEPT RADIAT PHYS,S-22185 LUND,SWEDEN.							FLEISCHER RL, 1987, HEALTH PHYS, V52, P219; FORBERG S, 1987, SSI P32786 ROYAL I T; HOTZL H, 1978, NUCL INSTRUM METHODS, V150, P177, DOI 10.1016/0029-554X(78)90363-4; LIVELY RS, 1987, HEALTH PHYS, V52, P411, DOI 10.1097/00004032-198704000-00001; LUNDIN FE, 1971, JOINT MONOGRAPH US D, V1; Miles J. C., 1984, Radiation Protection Dosimetry, V7, P169; TUREKIAN KK, 1977, ANNU REV EARTH PL SC, V5, P227, DOI 10.1146/annurev.ea.05.050177.001303	7	90	90	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 28	1988	334	6180					338	340		10.1038/334338a0	http://dx.doi.org/10.1038/334338a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4349	3393224				2022-12-24	WOS:A1988P434900056
J	MAXWELL, DJ; CRAWFORD, DC; CURRY, PVM; TYNAN, MJ; ALLAN, LD				MAXWELL, DJ; CRAWFORD, DC; CURRY, PVM; TYNAN, MJ; ALLAN, LD			OBSTETRIC IMPORTANCE, DIAGNOSIS, AND MANAGEMENT OF FETAL TACHYCARDIAS	BRITISH MEDICAL JOURNAL			English	Article									GUYS HOSP,DEPT PERINATAL CARDIOL,15TH FLOOR,GUYS TOWER,LONDON SE1 9RT,ENGLAND; GUYS HOSP,DEPT PAEDIAT CARDIOL,LONDON SE1 9RT,ENGLAND; GUYS HOSP,DEPT ADULT CARDIOL,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust								ALLAN LD, 1984, BRIT HEART J, V52, P542; ALLAN LD, 1983, BRIT HEART J, V50, P240; COLLEY N, 1986, EUR J OBSTET GYN R B, V23, P261, DOI 10.1016/0028-2243(86)90158-9; DUMESIC AD, 1982, N ENGL J MED, V37, P1128; HEDVALL G, 1973, ACTA PAEDIATR SCAND, V62, P550, DOI 10.1111/j.1651-2227.1973.tb08156.x; KLEINMAN CS, 1985, J CLIN ULTRASOUND, V13, P265, DOI 10.1002/jcu.1870130406; KLEINMAN CS, 1983, AM J CARDIOL, V51, P237, DOI 10.1016/S0002-9149(83)80042-3; SCHREINER RL, 1978, J PERINAT MED, V6, P274, DOI 10.1515/jpme.1978.6.6.274; Shenker L, 1979, Obstet Gynecol Surv, V34, P561, DOI 10.1097/00006254-197908000-00001; SIBER DL, 1969, AM J DIS CHILD, V117, P722; SILVERMAN NH, 1985, J CLIN ULTRASOUND, V13, P255, DOI 10.1002/jcu.1870130405; SPINNATO JA, 1984, OBSTET GYNECOL, V64, P730; WLADIMIROFF JW, 1985, BRIT J HOSP MED, V34, P134	13	90	91	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1988	297	6641					107	110		10.1136/bmj.297.6641.107	http://dx.doi.org/10.1136/bmj.297.6641.107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1954	3408929	Green Published, Bronze			2022-12-24	WOS:A1988P195400018
J	DEGRAAF, RM; VISSCHER, J; SCHWARTZ, AW				DEGRAAF, RM; VISSCHER, J; SCHWARTZ, AW			A PLAUSIBLY PREBIOTIC SYNTHESIS OF PHOSPHONIC-ACIDS	NATURE			English	Article							AQUEOUS FORMALDEHYDE; ELEMENT	THE insolubility of calcium phosphate in water is a significant stumbling block in the chemistry required for the origin of life(1). The discovery of alkyl phosphonic acids in the Murchison meteorite(2) suggests the possibility of delivery of these water-soluble, phosphorus-containing molecules by meteorites or comets to the early Earth. This could have provided a supply of organic phosphorus for the earliest stages of chemical evolution; although probably not components of early genetic systems, phosphonic acids may have been precursors to the first nucleic acids(3). Here we report the synthesis of several phosphonic acids, including the most abundant found in the Murchison meteorite, by ultraviolet irradiation of orthophosphorous acid in the presence of formaldehyde, primary alcohols, or acetone, We argue that similar reactions might explain the presence of phosphonic acids in Murchison, and could also have occurred on the prebiotic Earth.	CATHOLIC UNIV NIJMEGEN,FAC SCI,EVOLUT BIOL RES GRP,6525 ED NIJMEGEN,NETHERLANDS	Radboud University Nijmegen			de Graaf, Rob/E-7665-2012	de Graaf, Rob/0000-0001-9143-8961				BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; Calvert J. G., 1966, PHOTOCHEMISTRY, V8, P99; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COOPER GW, 1992, GEOCHIM COSMOCHIM AC, V56, P4109, DOI 10.1016/0016-7037(92)90023-C; ENGEL R, 1977, CHEM REV, V77, P349, DOI 10.1021/cr60307a003; FEGLEY B, 1980, ICARUS, V41, P439, DOI 10.1016/0019-1035(80)90228-6; FREEDMAN LD, 1957, CHEM REV, V57, P479, DOI 10.1021/cr50015a003; GULICK A, 1955, AM SCI, V43, P479; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; MATSUURA N, 1971, B CHEM SOC JPN, V44, P1027, DOI 10.1246/bcsj.44.1027; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; PARK HR, 1988, J PHOTOCH PHOTOBIO A, V43, P155, DOI 10.1016/1010-6030(88)80015-7; SCHWARTZ AW, 1993, J MOL EVOL, V36, P101, DOI 10.1007/BF00166245; SCHWARTZ AW, 1973, INORG NUCL CHEM LETT, V9, P39, DOI 10.1016/0020-1650(73)80083-2; SCHWARTZ AW, 1993, TETRAHEDRON LETT, V34, P2201, DOI 10.1016/S0040-4039(00)60382-9; SEIFERT KG, 1973, ANGEW CHEM INT EDIT, V12, P763, DOI 10.1002/anie.197307631; VANDERLINDE HJ, 1971, PHOTOCHEM PHOTOBIOL, V13, P147; Walker J. F., 1964, FORMALDEHYDE	18	63	64	1	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					474	477		10.1038/378474a0	http://dx.doi.org/10.1038/378474a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477402				2022-12-24	WOS:A1995TH05400065
J	NIGHTINGALE, SL				NIGHTINGALE, SL			PROPOSAL FOR EMERGENCY USE RESEARCH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,FDA PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.							1995, FED REGISTER, V60, P49086	1	6	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	1995	274	20					1578	1578		10.1001/jama.274.20.1578	http://dx.doi.org/10.1001/jama.274.20.1578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE738	7474231				2022-12-24	WOS:A1995TE73800004
J	OPTENBERG, SA; THOMPSON, IM; FRIEDRICHS, P; WOJCIK, B; STEIN, CR; KRAMER, B				OPTENBERG, SA; THOMPSON, IM; FRIEDRICHS, P; WOJCIK, B; STEIN, CR; KRAMER, B			RACE, TREATMENT, AND LONG-TERM SURVIVAL FROM PROSTATE-CANCER IN AN EQUAL-ACCESS MEDICAL-CARE DELIVERY SYSTEM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL-DIFFERENCES; UNITED-STATES; BLACK; ADENOCARCINOMA; MORTALITY; STAGE; POPULATIONS; CARCINOMA; DIAGNOSIS; PATTERNS	Objective.-To evaluate long-term survival of black and white prostate cancer patients in an equal-access medical care system to help distinguish biological from medical and social explanations of mortality differences. Design and Setting.-Retrospective study of US Department of Defense tumor registry patients with prostate cancer. Ethnicity, age, diagnosis, staging, risk factors, treatment, and survival end points were extracted. Patients.-Prostate cancer patients (N=1606; 7.5% black, 92.5% white) who were active-duty personnel, dependents, or retirees eligible for care in the military medical system. Main Outcome Measuress-Racial differences in tumor stage and grade, risk factors, recurrence, and treatment wait time (time between initial diagnosis and initial treatment); influence of stage, grade, treatment, wait time, age, and race on survival. Results.-No differences were found in behavioral risk factors or tumor grade or size, but blacks entered active treatment (P<.001) and exhibited a higher relative risk of cancer (P=.01) in younger age groups, presented with higher stage (P<.001), and demonstrated increased progression in distant metastatic disease (P=.01). No significant differences were detected in overall wait time. When adjusted for stage, no difference was found in type of treatment. Overall, stage, grade, and age were found to affect survival (P=.04 to P<.001), but race did not, When analyzed by stage, blacks demonstrated a clear trend of longer survival for distant metastatic disease (P=.04 to P=.06). This trend was confirmed using Kaplan-Meier estimates (P=.04, likelihood ratio), Conclusions.-This analysis suggests that in an equal-access medical care system there are no stage-specific differences in treatment between black and white prostate cancer patients, Survival among blacks is similar to that among whites and may surpass it for high-stage disease.	USA,MED DEPT CTR & SCH,CTR HLTHCARE EDUC & STUDIES,SAN ANTONIO,TX; BROOKE ARMY MED CTR,UROL SERV,SAN ANTONIO,TX; NCI,DIV CANC PREVENT & CONTROL,BETHESDA,MD	San Antonio Military Medical Center; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								APRIKIAN AG, 1994, CANCER, V74, P1768, DOI 10.1002/1097-0142(19940915)74:6<1768::AID-CNCR2820740620>3.0.CO;2-9; AUSTIN JP, 1990, AM J CLIN ONCOL-CANC, V13, P465, DOI 10.1097/00000421-199012000-00002; AUSTIN JP, 1993, AM J CLIN ONCOL-CANC, V16, P140, DOI 10.1097/00000421-199304000-00012; AZIZ H, 1988, AM J CLIN ONCOL-CANC, V11, P166, DOI 10.1097/00000421-198804000-00015; BALLWEG JA, 1989, PUBLIC HEALTH REP, V104, P498; BANG KM, 1988, CANCER, V61, P1255, DOI 10.1002/1097-0142(19880315)61:6<1255::AID-CNCR2820610634>3.0.CO;2-7; BEAHRS OH, 1992, MANUAL STAGING CANCE; BLAIR A, 1978, J NATL CANCER I, V61, P1379; BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; BRAWN PN, 1994, CANCER, V74, P1607, DOI 10.1002/1097-0142(19940901)74:5<1607::AID-CNCR2820740518>3.0.CO;2-F; DAYAL HH, 1982, J CHRON DIS, V35, P553, DOI 10.1016/0021-9681(82)90074-1; DEMARKWAHNEFRIED W, 1993, UROLOGY, V42, P269, DOI 10.1016/0090-4295(93)90615-H; DEMERS RY, 1994, ARCH INTERN MED, V154, P1211, DOI 10.1001/archinte.154.11.1211; ELEY JW, 1994, JAMA-J AM MED ASSOC, V242, P947; FLEISS JL, 1981, STATISTICAL METHODS, V23, P26; HARLAN L, 1995, J CLIN ONCOL, V13, P93, DOI 10.1200/JCO.1995.13.1.93; HUSSAIN F, 1992, INT J RADIAT ONCOL, V24, P451, DOI 10.1016/0360-3016(92)91059-V; JEPSON C, 1991, AM J PUBLIC HEALTH, V81, P501, DOI 10.2105/AJPH.81.4.501; LAWTON CA, 1994, RADIOLOGY, V92, P37; LEE JY, 1990, SOUTHERN MED J, V83, P185, DOI 10.1097/00007611-199002000-00012; LEVINE RL, 1979, J UROLOGY, V121, P761, DOI 10.1016/S0022-5347(17)56981-5; LIFF JM, 1991, CANCER, V67, P1454, DOI 10.1002/1097-0142(19910301)67:5<1454::AID-CNCR2820670533>3.0.CO;2-K; MEBANE C, 1990, J NATL MED ASSOC, V82, P782; METTLIN C, 1987, CANCER, V60, P474, DOI 10.1002/1097-0142(19870801)60:3+<474::AID-CNCR2820601508>3.0.CO;2-5; METTLIN CJ, 1994, CANCER, V74, P1640, DOI 10.1002/1097-0142(19940901)74:5<1640::AID-CNCR2820740525>3.0.CO;2-3; MYERS RE, 1994, UROLOGY, V43, P480, DOI 10.1016/0090-4295(94)90235-6; NATARAJAN N, 1989, J SURG ONCOL, V40, P232, DOI 10.1002/jso.2930400406; PAMIES RJ, 1992, PRIMARY CARE, V19, P443; POLEDNAK AP, 1990, CANCER-AM CANCER SOC, V66, P1654, DOI 10.1002/1097-0142(19901001)66:7<1654::AID-CNCR2820660734>3.0.CO;2-I; POLEDNAK AP, 1992, CANCER, V70, P2152, DOI 10.1002/1097-0142(19921015)70:8<2152::AID-CNCR2820700824>3.0.CO;2-#; RIES LAG, 1994, SEER CANCER STATISTI; ROACH M, 1992, INT J RADIAT ONCOL, V24, P441, DOI 10.1016/0360-3016(92)91058-U; RUFFER J E, 1991, International Journal of Radiation Oncology, Biology, Physics, V21, P212, DOI 10.1016/0360-3016(91)90609-8; TANARI N, 1993, CANCER, V71, P1289; TARGONSKI PV, 1991, J NATL MED ASSOC, V83, P1094; WHITMORE WF, 1984, UROL CLIN N AM, V11, P205; 1994, PHS951101 US DHEW PU, V2; 1992, SAS P229 SAS I INC R, P433; 1993, DEFENSE ENROLLMENT E; 1989, SAS STATOR USERS GUI; 1974, US DHEW HRA751101 PH, V2; 1994, DEFENSE MED INFORMAT; 1985, PHS851101 US DHEW PU, V2	43	198	201	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	1995	274	20					1599	1605		10.1001/jama.274.20.1599	http://dx.doi.org/10.1001/jama.274.20.1599			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE738	7474244				2022-12-24	WOS:A1995TE73800024
J	HELLER, RF; STEELE, PL; FISHER, JD; ALEXANDER, HM; DOBSON, AJ				HELLER, RF; STEELE, PL; FISHER, JD; ALEXANDER, HM; DOBSON, AJ			SUCCESS OF CARDIOPULMONARY-RESUSCITATION AFTER HEART-ATTACK IN-HOSPITAL AND OUTSIDE HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-ARREST; SURVIVAL	Objectives-To determine factors associated with cardiopulmonary resuscitation being attempted after cardiac arrest from myocardial infarction, in or outside hospital, and estimate short term and long term survival rates. Design-Descriptive cross sectional and cohort study. Setting-Community based register of all suspected heart attacks and sudden cardiac deaths in Lower Hunter region of New South Wales, Australia. Subject-4924 men and women aged 25-69. Main outcome measures-Rates of attempted cardiopulmonary resuscitation and survival after successful resuscitation. Results-Cardiopulmonary resuscitation was attempted in 41% of cases of cardiac arrest after myocardial infarction outside hospital and 63% of cases in hospital, Survival rates at 28 days were 12% and 39% respectively, Among the survivors, although 41% had another myocardial infarction (or coronary death), 81% of both groups were still alive two years later. Younger and better educated people were more likely to receive cardiopulmonary resuscitation in either setting, and being married predicted cardiopulmonary resuscitation being attempted outside hospital. Younger age predicted better survival rates after attempted resuscitation in hospital. Conclusions-The reasons for better education to predict cardiopulmonary resuscitation being attempted need explanation. The higher survival rate after cardiopulmonary resuscitation in hospital compared with outside hospital and the good long term prognosis for survivors in both settings suggest that attempts to improve success of cardiopulmonary resuscitation outside hospital may be worth while.	UNIV NEWCASTLE,FAC MED & HLTH SCI,CTR CLIN EPIDEMIOL & BIOSTAT,NEWCASTLE,NSW 2308,AUSTRALIA	University of Newcastle			Dobson, Annette J/B-5273-2008	Heller, Richard/0000-0003-3161-5967				BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BEURET P, 1993, RESUSCITATION, V25, P171, DOI 10.1016/0300-9572(93)90093-6; DOBSON AJ, 1988, ACTA MED SCAND S, V728, P84; EBELL MH, 1992, J FAM PRACTICE, V34, P551; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; HALLSTROM A, 1993, AM J PUBLIC HEALTH, V83, P245, DOI 10.2105/AJPH.83.2.245; JOSLYN SA, 1993, AM J EMERG MED, V11, P200, DOI 10.1016/0735-6757(93)90124-T; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1433, DOI 10.1001/jama.270.12.1433; SOLOMON NA, 1993, ARCH INTERN MED, V153, P1218, DOI 10.1001/archinte.153.10.1218; TRESCH DD, 1993, AM J MED, V95, P123, DOI 10.1016/0002-9343(93)90252-K; TUNSTALLPEDOE H, 1992, BRIT MED J, V304, P1347, DOI 10.1136/bmj.304.6838.1347; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583	12	18	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1332	1336		10.1136/bmj.311.7016.1332	http://dx.doi.org/10.1136/bmj.311.7016.1332			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496282	Green Published			2022-12-24	WOS:A1995TF90100019
J	DEACON, NJ; TSYKIN, A; SOLOMON, A; SMITH, K; LUDFORDMENTING, M; HOOKER, DJ; MCPHEE, DA; GREENWAY, AL; ELLETT, A; CHATFIELD, C; LAWSON, VA; CROWE, S; MAERZ, A; SONZA, S; LEARMONT, J; SULLIVAN, JS; CUNNINGHAM, A; DWYER, D; DOWTON, D; MILLS, J				DEACON, NJ; TSYKIN, A; SOLOMON, A; SMITH, K; LUDFORDMENTING, M; HOOKER, DJ; MCPHEE, DA; GREENWAY, AL; ELLETT, A; CHATFIELD, C; LAWSON, VA; CROWE, S; MAERZ, A; SONZA, S; LEARMONT, J; SULLIVAN, JS; CUNNINGHAM, A; DWYER, D; DOWTON, D; MILLS, J			GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEF GENE; FOLLOW-UP; AIDS; INFECTION; PROGRESSION; DISEASE; CELLS; MEN; DNA	A blood donor infected with human immunodeficiency virus-type 1 (HIV-1) and a cohort of six blood or blood product recipients infected from this donor remain free of HIV-1-related disease with stable and normal CD4 lymphocyte counts 10 to 14 years after infection. HIV-1 sequences from either virus isolates or patient peripheral blood mononuclear cells had similar deletions in the nef gene and in the region of overlap of nef and the U3 region of the long terminal repeat (LTR). Full-length sequencing of one isolate genome and amplification of selected HIV-1 genome regions from other cohort members revealed no other abnormalities of obvious functional significance. These data show that survival after HIV infection can be determined by the HIV genome and support the importance of nef or the U3 region of the LTR in determining the pathogenicity of HIV-1.	MACFARLANE BURNET CTR MED RES,NATL CTR HIV VIROL RES,AIDS CELLULAR BIOL UNIT,FAIRFIELD,VIC 3078,AUSTRALIA; MACFARLANE BURNET CTR MED RES,NATL CTR HIV VIROL RES,AIDS PATHOGENESIS UNIT,FAIRFIELD,VIC 3078,AUSTRALIA; NEW S WALES RED CROSS,BLOOD TRANSFUS SERV,SYDNEY 2000,NSW,AUSTRALIA; WESTMEAD HOSP,DEPT VIROL,WESTMEAD,NSW 2145,AUSTRALIA; WESTMEAD HOSP,NATL CTR HIV VIROL RES,INST CLIN PATHOL & MED RES,WESTMEAD,NSW 2145,AUSTRALIA	Australian Red Cross Blood Service; University of Sydney; University of Sydney	DEACON, NJ (corresponding author), MACFARLANE BURNET CTR MED RES,NATL CTR HIV VIROL RES,AIDS MOLEC BIOL UNIT,YARRA BEND RD,FAIRFIELD,VIC 3078,AUSTRALIA.		Lawson, Victoria/AAJ-7392-2021; McPhee, Dale A/D-1825-2011	Tsykin, Anna/0000-0001-5965-6803; Cunningham, Anthony/0000-0002-6744-5667; Greenway, Alison/0000-0001-8908-2708; Lawson, Victoria/0000-0002-7362-7176				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ARCHER G, 1988, 4TH INT C AIDS STOCK; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; FERRE F, 1993, AIDS, V7, pS21, DOI 10.1097/00002030-199311002-00006; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; GOODALL J, 1994, THESIS U MELBOURNE; GOU LH, 1982, NUCLEIC ACIDS RES, V10, P2065; GREENOUGH TC, 1994, AIDS RES HUM RETROV, V10, P395, DOI 10.1089/aid.1994.10.395; GREENWAY AL, UNPUB; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; HUANG YX, 1995, J VIROL, V69, P93, DOI 10.1128/JVI.69.1.93-100.1995; KAPLAN JE, 1992, J ACQ IMMUN DEF SYND, V5, P565; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1994, J VIROL, V68, P2031, DOI 10.1128/JVI.68.3.2031-2037.1994; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEAMONT J, 1995, AIDS RES HUM RETROV, V11, P1; LEAMONT J, 1992, LANCET, V340, P863; LEARMONT J, 1994, 10TH INT C AIDS YOK; LEARMONT J, UNPUB; LEE TH, 1991, AIDS, V5, P683, DOI 10.1097/00002030-199106000-00007; MCPHEE DJ, UNPUB; MEYERS G, 1994, HUMAN RETROVIRUSES A; NEATE EV, 1987, AUST NZ J MED, V17, P461, DOI 10.1111/j.1445-5994.1987.tb00096.x; NOWAK M, 1993, AIDS, V7, pS3, DOI 10.1097/00002030-199301001-00002; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; RUTHERFORD GW, 1990, BRIT MED J, V301, P1183, DOI 10.1136/bmj.301.6762.1183; SANGER F, 1977, P NATL ACAD SCI USA, V84, P5463; SCHRAGER LK, 1994, AIDS, V8, P895; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; SEMPLE MG, 1993, J VIROL METHODS, V41, P176; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SMITH J, 1992, J GEN VIROL, V73, P1825, DOI 10.1099/0022-1317-73-7-1825; SOLOMON AI, UNPUB; TYSKIN A, UNPUB; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; 1992, MMWR-MORBID MORTAL W, V41, P961	40	1006	1021	0	16	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					988	991		10.1126/science.270.5238.988	http://dx.doi.org/10.1126/science.270.5238.988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481804				2022-12-24	WOS:A1995TD87800049
J	COBB, SR; BUHL, EH; HALASY, K; PAULSEN, O; SOMOGYI, P				COBB, SR; BUHL, EH; HALASY, K; PAULSEN, O; SOMOGYI, P			SYNCHRONIZATION OF NEURONAL-ACTIVITY IN HIPPOCAMPUS BY INDIVIDUAL GABAERGIC INTERNEURONS	NATURE			English	Article							MEMBRANE-POTENTIAL OSCILLATIONS; INHIBITORY INTERNEURONS; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; THETA-RHYTHM; CELLS; CA1	SYNCHRONIZATION Of neuronal activity is fundamental in the operation of cortical networks(1). With respect to an ongoing synchronized oscillation, the precise timing of action potentials is an attractive candidate mechanism for information coding(2-5) Networks of inhibitory interneurons have been proposed to have a role in entraining cortical, synchronized 40-Hz activity(6,7). Here we demonstrate that individual GABAergic interneurons(8) can effectively phase spontaneous firing and subthreshold oscillations in hippocampal pyramidal cells at theta frequencies (4-7 Hz). The efficiency of this entrainment is due to interaction of GABA(A)-receptor-mediated hyperpolarizing synaptic events with intrinsic oscillatory mechanisms tuned to this frequency range in pyramidal cells. Moreover, this GABAergic mechanism is sufficient to synchronize the firing of pyramidal cells. Thus, owing to the divergence of each GABAergic interneuron(9,10), more than a thousand pyramidal cells may share a common temporal reference established by an individual interneuron.	ATTILA JOZSEF UNIV, DEPT ZOOL & CELL BIOL, H-6722 SZEGED, HUNGARY	Szeged University	COBB, SR (corresponding author), UNIV OXFORD, DEPT PHARMACOL, MRC, ANAT NEUROPHARMACOL UNIT, MANSFIELD RD, OXFORD OX1 3TH, ENGLAND.		Paulsen, Ole/ABB-4843-2020	Paulsen, Ole/0000-0002-2258-5455	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; GINSBORG BL, 1973, BIOCHIM BIOPHYS ACTA, V300, P289, DOI 10.1016/0304-4157(73)90007-5; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; LI XG, 1992, EXP BRAIN RES, V90, P519; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; NIEDERMEYER Ernst, 1982, ELECTROEN CLIN NEURO; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; SIK A, IN PRESS J NEUROSCI; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SOMOGYI P, 1989, P RET RES F, V2, P35; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, J NEUROSCI, V15, P30; YLINEN A, 1995, HIPPOCAMPUS, V5, P79	28	1146	1159	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					75	78		10.1038/378075a0	http://dx.doi.org/10.1038/378075a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477292				2022-12-24	WOS:A1995TC46900053
J	DEWEERD, P; GATTASS, R; DESIMONE, R; UNGERLEIDER, LG				DEWEERD, P; GATTASS, R; DESIMONE, R; UNGERLEIDER, LG			RESPONSES OF CELLS IN MONKEY VISUAL-CORTEX DURING PERCEPTUAL FILLING-IN OF AN ARTIFICIAL SCOTOMA	NATURE			English	Article							RECEPTIVE-FIELDS; MACAQUE MONKEY; STRIATE CORTEX; CONNECTIONS	WHEN we view a scene through one eye, we typically do not see the scotomas created by the optic disc and the blood vessels overlying the retinal surface. Similarly, when a texture field containing a hole is steadily viewed in peripheral vision (artificial scotoma), the hole appears to fill in with the surrounding texture in a matter of seconds, demonstrating that the visual system fills in information across regions where no information is available(1-5). Here we show that, in monkeys viewing a similar texture field with a hole, the responses of extrastriate visual neurons with receptive fields covering the hole increase gradually to a level comparable to that elicited by the same texture without a hole. The time course of these dynamic changes in activity parallels the time course of perceived filling-in of the hole by human observers, suggesting that this process mediates perceptual filling-in.	NIMH,PSYCHOL & PSYCHOPATHOL LAB,BETHESDA,MD 20892; NIMH,NEUROPSYCHOL LAB,BETHESDA,MD 20892; UNIV FED RIO DE JANEIRO,BIOPHYS INST CARLOS CHAGAS,DEPT NEUROBIOL,BR-21941 RIO JANEIRO,BRAZIL	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Universidade Federal do Rio de Janeiro			Desimone, Robert/G-1121-2018	Desimone, Robert/0000-0002-5938-4227				BENDER MB, 1946, ARCH NEURO PSYCHIATR, V55, P627, DOI 10.1001/archneurpsyc.1946.02300170075008; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOMATSU H, 1994, VISUAL NEUROSCI, V11, P1103, DOI 10.1017/S0952523800006921; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MILLER EK, 1993, J NEUROSCI, V13, P1460; NELSON JI, 1985, EXP BRAIN RES, V61, P54; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; OHZAWA I, 1985, J NEUROPHYSIOL, V42, P833; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1993, VISION RES, V33, P717, DOI 10.1016/0042-6989(93)90191-X; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; YOSHIOKA T, 1992, J NEUROSCI, V12, P2785; Zipser K., 1994, Society for Neuroscience Abstracts, V20, P1477	22	176	176	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					731	734						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477262				2022-12-24	WOS:A1995TB46900056
J	VANDOREN, K; HIRSH, D				VANDOREN, K; HIRSH, D			TRANS-SPLICED LEADER RNA EXISTS AS SMALL NUCLEAR RIBONUCLEOPROTEIN-PARTICLES IN CAENORHABDITIS-ELEGANS	NATURE			English	Article											VANDOREN, K (corresponding author), SYNERGEN INC,1885 33RD ST,BOULDER,CO 80301, USA.							BEKTESH S, 1988, GENE DEV, V2, P1277, DOI 10.1101/gad.2.10.1277; BEKTESH SL, 1988, NUCLEIC ACIDS RES, V16, P5692, DOI 10.1093/nar/16.12.5692; BILLINGS PB, 1984, J BIOL CHEM, V259, P2850; BRINGMANN P, 1986, EMBO J, V5, P3509, DOI 10.1002/j.1460-2075.1986.tb04676.x; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; BRUZIK JP, 1988, NATURE, V335, P559, DOI 10.1038/335559a0; CAMPBELL DA, 1984, NATURE, V311, P350, DOI 10.1038/311350a0; EPSTEIN P, 1980, J BIOL CHEM, V255, P8901; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; GREEN MR, 1983, CELL, V32, P681, DOI 10.1016/0092-8674(83)90054-5; HAMM J, 1987, EMBO J, V6, P3479, DOI 10.1002/j.1460-2075.1987.tb02672.x; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; KINLAW CS, 1983, J BIOL CHEM, V258, P7181; KOOTER JM, 1984, EMBO J, V3, P2387, DOI 10.1002/j.1460-2075.1984.tb02144.x; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LUHRMANN R, 1982, NUCLEIC ACIDS RES, V10, P7103, DOI 10.1093/nar/10.22.7103; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; MILHAUSEN M, 1984, CELL, V38, P721, DOI 10.1016/0092-8674(84)90267-8; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; NELSON DW, 1985, GENE, V38, P245, DOI 10.1016/0378-1119(85)90224-0; PETTERSSON I, 1984, J BIOL CHEM, V259, P5907; REDDY R, 1974, J BIOL CHEM, V249, P6486; RIEDEL N, 1987, SCIENCE, V235, P328, DOI 10.1126/science.2948278; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; THOMAS JD, 1988, CELL, V54, P533, DOI 10.1016/0092-8674(88)90075-X; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	28	87	87	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 6	1988	335	6190					556	559						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q3412	3419533				2022-12-24	WOS:A1988Q341200058
J	KEATES, RAB; HALLETT, FR				KEATES, RAB; HALLETT, FR			DYNAMIC INSTABILITY OF SHEARED MICROTUBULES OBSERVED BY QUASI-ELASTIC LIGHT-SCATTERING	SCIENCE			English	Article									UNIV GUELPH,DEPT PHYS,BIOPHYS INTERDEPT GRP,GUELPH N1G 2W1,ONTARIO,CANADA	University of Guelph	KEATES, RAB (corresponding author), UNIV GUELPH,DEPT CHEM & BIOCHEM,BIOPHYS INTERDEPT GRP,GUELPH N1G 2W1,ONTARIO,CANADA.							CAPLOW M, 1986, J BIOL CHEM, V261, P6233; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CHEN YD, 1985, P NATL ACAD SCI USA, V82, P1131, DOI 10.1073/pnas.82.4.1131; HALLETT FR, 1985, BIOPOLYMERS, V24, P947, DOI 10.1002/bip.360240604; HALLETT FR, 1985, BIOPOLYMERS, V24, P2403, DOI 10.1002/bip.360241216; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; KEATES RAB, 1984, CAN J BIOCHEM CELL B, V62, P803, DOI 10.1139/o84-102; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KRISTOFFERSON D, 1986, J CELL BIOL, V102, P1007, DOI 10.1083/jcb.102.3.1007; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MORRISON ID, 1985, LANGMUIR, V1, P496, DOI 10.1021/la00064a016; ROTHWELL SW, 1987, J CELL BIOL, V105, P863, DOI 10.1083/jcb.105.2.863; SAMMAK PJ, 1987, J CELL BIOL, V104, P395, DOI 10.1083/jcb.104.3.395; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; WALKER R A, 1987, Journal of Cell Biology, V105, p29A	16	21	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 23	1988	241	4873					1642	1645		10.1126/science.3420415	http://dx.doi.org/10.1126/science.3420415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1372	3420415				2022-12-24	WOS:A1988Q137200031
J	BALABAN, E; TEILLET, MA; LEDOUARIN, N				BALABAN, E; TEILLET, MA; LEDOUARIN, N			APPLICATION OF THE QUAIL-CHICK CHIMERA SYSTEM TO THE STUDY OF BRAIN-DEVELOPMENT AND BEHAVIOR	SCIENCE			English	Article									COLL FRANCE,INST EMBRYOL CELLULAIRE & MOLEC,F-94736 NOGENT SUR MARNE,FRANCE; ROCKEFELLER UNIV,FIELD RES CTR,MILLBROOK,NY 12545	UDICE-French Research Universities; PSL Research University Paris; College de France; Rockefeller University	BALABAN, E (corresponding author), CNRS,INST EMBRYOL CELLULAIRE & MOLEC,49BIS AVE BELLE GABRIELLE,F-94736 NOGENT SUR MARNE,FRANCE.		Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433	NIMH NIH HHS [5T32 MH15125-10] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015125] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andrew R. J., 1969, P97; BALABAN E, UNPUB; BROWN JL, 1971, BEHAVIOUR, V39, P91, DOI 10.1163/156853971X00203; CARIOU M-L, 1969, Bulletin Biologique de la France et de la Belgique, V103, P323; CARIOU ML, 1971, THESIS U RENNES; COULY GF, 1985, DEV BIOL, V110, P422, DOI 10.1016/0012-1606(85)90101-0; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; GUYOMARCH JC, 1965, B SOC SCI BRETAGNE, V60, P81; Hamilton JB, 1938, ENDOCRINOLOGY, V23, P53, DOI 10.1210/endo-23-1-53; KINUTANI M, 1985, DEV BIOL, V111, P243, DOI 10.1016/0012-1606(85)90449-X; KINUTANI M, 1986, CELL, V45, P307, DOI 10.1016/0092-8674(86)90395-8; Konishi M., 1963, Z TIERPSYCHOL, V20, P349, DOI DOI 10.1111/J.1439-0310.1963.TB01156.X; Le Douarin N., 1984, CHIMERAS DEV BIOL; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1986, TRENDS NEUROSCI, V9, P175, DOI 10.1016/0166-2236(86)90055-X; MARLER P.M. KREITH, 1962, ANIMAL BEHAVIOUR, V10, P48, DOI 10.1016/0003-3472(62)90130-6; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; Phillips R.E., 1975, P243; RAKIC P, 1977, J COMP NEUROL, V176, P23, DOI 10.1002/cne.901760103; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1984, J COMP NEUROL, V223, P1; SCHEICH H, 1983, ADV VERTEBRATE NEURO, P731; Seller T.J., 1983, P93; SELLER TJ, 1981, TRENDS NEUROSCI, V4, P301, DOI 10.1016/0166-2236(81)90094-1; SELLER TJ, 1983, BEHAV BRAIN RES, V9, P305, DOI 10.1016/0166-4328(83)90135-3; SIEGEL P. B., 1965, BEHAVIOUR, V24, P229, DOI 10.1163/156853965X00039	27	106	107	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 9	1988	241	4871					1339	1342		10.1126/science.3413496	http://dx.doi.org/10.1126/science.3413496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9812	3413496				2022-12-24	WOS:A1988P981200027
J	HILL, D; WHITE, V; JOLLEY, D; MAPPERSON, K				HILL, D; WHITE, V; JOLLEY, D; MAPPERSON, K			SELF EXAMINATION OF THE BREAST - IS IT BENEFICIAL - META-ANALYSIS OF STUDIES INVESTIGATING BREAST SELF EXAMINATION AND EXTENT OF DISEASE IN PATIENTS WITH BREAST-CANCER	BRITISH MEDICAL JOURNAL			English	Article											HILL, D (corresponding author), ANTICANC COUNCIL VICTORIA,CTR BEHAV RES CANC,CARLTON,VIC 3053,AUSTRALIA.			White, Victoria/0000-0001-6619-8484				BRADLEY GW, 1978, J PERS SOC PSYCHOL, V36, P56, DOI 10.1037/0022-3514.36.1.56; BREMOND A, 1982, SEMAINE HOSPITAUX PA, V58, P1317; Bullough B, 1980, Nurse Pract, V5, P31; DOWLE CS, 1987, BRIT J SURG, V74, P217, DOI 10.1002/bjs.1800740323; FELDMAN JG, 1981, CANCER, V47, P2740, DOI 10.1002/1097-0142(19810601)47:11<2740::AID-CNCR2820471133>3.0.CO;2-4; Fleiss JL, 1981, STAT METHODS RATES P; FOSTER RS, 1984, CANCER, V53, P999, DOI 10.1002/1097-0142(19840215)53:4<999::AID-CNCR2820530429>3.0.CO;2-N; FOSTER RS, 1978, NEW ENGL J MED, V299, P265, DOI 10.1056/NEJM197808102990601; GOULDMARTIN K, 1982, PREV MED, V11, P429, DOI 10.1016/0091-7435(82)90046-9; GREENWALD P, 1978, NEW ENGL J MED, V299, P271, DOI 10.1056/NEJM197808102990602; HARRIS JR, 1985, CANCER PRINCIPLES PR, V2, P1119; HISLOP TG, 1984, CAN MED ASSOC J, V131, P1349; HOLLEB AI, 1981, ISRAEL J MED SCI, V17, P839; HOWE HL, 1983, CANCER DETECT PREV, V6, P473; HUGULEY CM, 1981, CANCER, V47, P989, DOI 10.1002/1097-0142(19810301)47:5<989::AID-CNCR2820470530>3.0.CO;2-V; LOUIS TA, 1985, ANNU REV PUBL HEALTH, V6, P1; MOORE FD, 1978, NEW ENGL J MED, V299, P304, DOI 10.1056/NEJM197808102990610; OMALLEY MS, 1987, JAMA-J AM MED ASSOC, V257, P2197; OWEN WL, 1985, SOUTHERN MED J, V78, P1170, DOI 10.1097/00007611-198510000-00007; PAYNE CD, 1985, GLIM SYSTEM MANUAL R; PHILIP J, 1984, BRIT J CANCER, V50, P7, DOI 10.1038/bjc.1984.133; PHILIP J, 1986, CANCER, V58, P973, DOI 10.1002/1097-0142(19860815)58:4<973::AID-CNCR2820580429>3.0.CO;2-5; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SCHWARTZ M, 1978, CANCER, V41, P1550; SEMIGLAZOV VF, 1987, B WORLD HEALTH ORGAN, V65, P391; SENIE RT, 1981, AM J PUBLIC HEALTH, V71, P583, DOI 10.2105/AJPH.71.6.583; SMITH EM, 1980, PREV MED, V9, P409, DOI 10.1016/0091-7435(80)90235-2; SMITH EM, 1985, CANCER, V55, P432, DOI 10.1002/1097-0142(19850115)55:2<432::AID-CNCR2820550223>3.0.CO;2-9; STRAX P, 1979, CANCER B, V31, P142; TAMBURINI M, 1981, TUMORI J, V67, P219; TURNER J, 1984, LANCET, V2, P337; WEISS NS, 1983, AM J EPIDEMIOL, V118, P457	32	97	98	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1988	297	6643					271	275		10.1136/bmj.297.6643.271	http://dx.doi.org/10.1136/bmj.297.6643.271			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4266	3416148	Green Published			2022-12-24	WOS:A1988P426600023
J	HAQ, IU; JACKSON, PR; YEO, WW; RAMSAY, LE				HAQ, IU; JACKSON, PR; YEO, WW; RAMSAY, LE			SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE	LANCET			English	Article							SERUM-CHOLESTEROL; MORTALITY; MANAGEMENT; FRAMINGHAM; REDUCTION; TRIALS	When used for the secondary prevention of coronary heart disease, treatment with an inhibitor of hydroxymethylglutaryl-coenzyme-A reductase results in worthwhile benefit that clearly exceeds any risk in patients whose risk of coronary death is 1.5% or more per year. This evidence can be extrapolated logically to primary prevention of coronary disease provided that treatment is targeted at those with similar or higher risk. We present a table that refines previously proposed methods of risk prediction. The table identifies subjects who have the specified degree of coronary risk; shows the serum cholesterol concentration that confers that degree of risk in the individual; and identifies subjects who will not have this degree of risk, irrespective of their cholesterol concentration. It is simple enough for use in ordinary practice. The table highlights the predominant effect of age on coronary risk; a person who is free of vascular disease and younger than 52 years is unlikely to have the specified degree of risk. Even in older people (60-70 years) several risk factors are generally required to attain this degree of risk. Some people are candidates for lipid-lowering drug treatment with serum cholesterol as low as 5.5 mmol/L, whereas others with cholesterol as high as 9.0 mmol/L are not. Although cholesterol lowering is a powerful method for preventing coronary events in people at high risk, cholesterol measurement by itself is not a good way to identify those with high coronary risk. The method can be adapted readily to target a different level of coronary-risk as new evidence on the benefit and risk of treatment becomes available.	ROYAL HALLAMSHIRE HOSP, DEPT MED & PHARMACOL, CLIN PHARMACOL & THERAPEUT SECT, SHEFFIELD S10 2JF, S YORKSHIRE, ENGLAND	University of Sheffield				Yeo, Wilfred/0000-0001-9554-5203				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; [Anonymous], 1988, BRIT MED J, V296, P316; ASSMANN G, 1986, PROCAM TRIAL; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; EVANS P, 1994, BRIT MED J, V309, P509, DOI 10.1136/bmj.309.6953.509; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; HOLME I, 1990, CIRCULATION, V82, P1916, DOI 10.1161/01.CIR.82.6.1916; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; MANN JI, 1988, BRIT MED J, V296, P1702, DOI 10.1136/bmj.296.6638.1702; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; National Cholesterol Education Program, 1994, CIRCULATION, V89, P1333, DOI [10.1161/01.CIR.89.3.1333, DOI 10.1161/01.CIR.89.3.1333]; OLIVER M, 1995, BMJ-BRIT MED J, V310, P1280, DOI 10.1136/bmj.310.6990.1280; PEDERSEN TR, 1994, LANCET, V344, P1383; PYORALA K, 1994, EUR HEART J, V15, P1300; RAMSAY LE, 1991, BMJ-BRIT MED J, V303, P953, DOI 10.1136/bmj.303.6808.953; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SEVER P, 1993, BMJ-BRIT MED J, V306, P983, DOI 10.1136/bmj.306.6883.983; SHAPER AG, 1986, BRIT MED J, V293, P474, DOI 10.1136/bmj.293.6545.474; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367; THOMPSON SG, 1990, J CLIN EPIDEMIOL, V43, P783, DOI 10.1016/0895-4356(90)90238-K; TUNSTALLPEDOE H, 1991, BRIT MED J, V303, P744, DOI 10.1136/bmj.303.6805.744; TURNER RC, 1993, J HYPERTENS, V11, P309; WHINCUP PH, 1994, TXB HYPERTENSION, P38; 1989, WORLD HLTH STATISTIC	30	126	127	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	1995	346	8988					1467	1471		10.1016/S0140-6736(95)92477-9	http://dx.doi.org/10.1016/S0140-6736(95)92477-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490996				2022-12-24	WOS:A1995TH15600014
J	ONATE, SA; TSAI, SY; TSAI, MJ; OMALLEY, BW				ONATE, SA; TSAI, SY; TSAI, MJ; OMALLEY, BW			SEQUENCE AND CHARACTERIZATION OF A COACTIVATOR FOR THE STEROID-HORMONE RECEPTOR SUPERFAMILY	SCIENCE			English	Article							HUMAN PROGESTERONE-RECEPTOR; THYROID-HORMONE; RETINOIC ACID; RETINOBLASTOMA PROTEIN; RESPONSE ELEMENTS; ESTROGEN-RECEPTOR; ACTIVATION; TRANSCRIPTION; TRANSACTIVATION; ANTIHORMONE	A yeast two-hybrid system was used to identify a protein that interacts with and enhances the human progesterone receptor (hPR) transcriptional activity without altering the basal activity of the promoter. Because the protein stimulated transactivation of all the steroid receptors tested, it has been termed steroid receptor coactivator-1 (SRC-1). Coexpression of SRC-1 reversed the ability of the estrogen receptor to squelch activation by hPR. Also, the amino terminal truncated form of SRC-1 acted as a dominant-negative repressor. Together, these results indicate that SRC-1 encodes a coactivator that is required for full transcriptional activity of the steroid receptor superfamily.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA	Baylor College of Medicine					NICHD NIH HHS [HD08188] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BANIAHMAD A, 1993, P NATL ACAD SCI USA, V90, P8832, DOI 10.1073/pnas.90.19.8832; BANIAHMAD C, 1995, MOL ENDOCRINOL, V9, P34, DOI 10.1210/me.9.1.34; BEEKMAN JM, 1993, MOL ENDOCRINOL, V7, P1266, DOI 10.1210/me.7.10.1266; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conneely OM, 1989, GENE REGULATION STER, V4, P220; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ELASHRY D, 1989, MOL ENDOCRINOL, V3, P1545, DOI 10.1210/mend-3-10-1545; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; KLEINHITPASS L, 1990, CELL, V60, P247, DOI 10.1016/0092-8674(90)90740-6; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; LENG XH, 1994, J BIOL CHEM, V269, P31436; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; ONATE SA, UNPUB; PEREIRA F, 1991, BIOCHEM BIOPH RES CO, V175, P831, DOI 10.1016/0006-291X(91)91640-X; SMITH CL, 1993, P NATL ACAD SCI USA, V90, P6120, DOI 10.1073/pnas.90.13.6120; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4	30	1943	1992	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	1995	270	5240					1354	1357						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481822				2022-12-24	WOS:A1995TF89900037
J	GOOD, MF				GOOD, MF			WHAT CAN A WORM TEACH US ABOUT AUTOIMMUNITY	LANCET			English	Editorial Material							T-CELLS; TOLERANCE; EPITOPES				GOOD, MF (corresponding author), QUEENSLAND INST MED RES,BRISBANE,QLD 4006,AUSTRALIA.							BRAUN G, 1991, J EXP MED, V174, P169, DOI 10.1084/jem.174.1.169; BRONZE MS, 1988, J EXP MED, V167, P1849, DOI 10.1084/jem.167.6.1849; GALLIN MY, 1995, J EXP MED, V182, P41, DOI 10.1084/jem.182.1.41; GROSS WL, 1993, CLIN EXP IMMUNOL, V91, P1; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; POMBO D, 1988, J IMMUNOL, V140, P3594; PRUKSAKORN S, 1994, INT IMMUNOL, V6, P1235, DOI 10.1093/intimm/6.8.1235; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; TAYLORROBINSON AW, 1994, EUR J IMMUNOL, V24, P980, DOI 10.1002/eji.1830240430	12	4	4	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 18	1995	346	8986					1311	1312		10.1016/S0140-6736(95)92337-3	http://dx.doi.org/10.1016/S0140-6736(95)92337-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE916	7475765				2022-12-24	WOS:A1995TE91600003
J	BOONE, KE; WATTERS, DAK				BOONE, KE; WATTERS, DAK			THE INCIDENCE OF MALARIA AFTER SPLENECTOMY IN PAPUA-NEW-GUINEA	BRITISH MEDICAL JOURNAL			English	Article							MANAGEMENT	In the tropics, as in the developed world, the spleen is the commonest intra-abdominal organ to be injured. Splenic enlargement due to chronic malaria predisposes to splenic injury, particularly in low velocity blunt trauma due to domestic violence or assault, both of which are common in Papua New Guinea. In developed countries the risk of sepsis after splenectomy has resulted in a more conservative approach to splenic trauma. In the tropics death from malaria after splenectomy has been reported, but no formal study has been undertaken. We studied the sequelae of splenic trauma and splenectomy in patients living in an area of Papua New Guinea where malaria is endemic.	DIV SURG,BOROKO,PAPUA N GUINEA				Watters, David Allan/AAI-1022-2020	Watters, David Allan/0000-0002-5742-8417				CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; DEODHAR HA, 1993, BRIT MED J, V307, P1408, DOI 10.1136/bmj.307.6916.1408; HAMILTON DR, 1982, AUST NZ J SURG, V52, P310, DOI 10.1111/j.1445-2197.1982.tb05407.x; LOOAREESUWAN S, 1993, CLIN INFECT DIS, V16, P361, DOI 10.1093/clind/16.3.361; WILSON RH, 1992, INJURY, V23, P5, DOI 10.1016/0020-1383(92)90116-A	5	46	47	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	1995	311	7015					1273	1273		10.1136/bmj.311.7015.1273	http://dx.doi.org/10.1136/bmj.311.7015.1273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE859	7496237	Green Published			2022-12-24	WOS:A1995TE85900023
J	KIECOLTGLASER, JK; MARUCHA, PT; MALARKEY, WB; MERCADO, AM; GLASER, R				KIECOLTGLASER, JK; MARUCHA, PT; MALARKEY, WB; MERCADO, AM; GLASER, R			SLOWING OF WOUND-HEALING BY PSYCHOLOGICAL STRESS	LANCET			English	Article							EXPRESSION; HEALTH	There is evidence that psychological stress adversely affects the immune system. We have investigated the effects of such stress, caused by caring for a relative with Alzheimer's disease, on wound healing. We studied 13 women caring for demented relatives (mean age 62 . 3 [SE 2 . 3] years) and 13 controls matched for age (60 . 4 [2 . 8] years) and family income. All subjects underwent a 3 . 5 mm punch biopsy wound. Healing was assessed by photography of the wound and the response to hydrogen peroxide (healing was defined as no foaming). Wound healing took significantly longer in caregivers than in controls (48 . 7 [2 . 9] vs 39 . 3 [3 . 0] days, p<0 . 05). Peripheral-blood leucocytes from caregivers produced significantly less interleukin-1 beta mRNA in response to lipopolysaccharide stimulation than did controls' cells. Stress-related defects in wound repair could have important clinical implications, for instance for recovery from surgery.	OHIO STATE UNIV,COLL DENT,DEPT PSYCHIAT,PERIODONTOL SECT,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,DEPT MED,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,DEPT MED MICROBIOL & IMMUNOL,COLUMBUS,OH 43210	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University			Mercado, Ana/ABB-5559-2021; Kiecolt-Glaser, Janice K/A-3236-2009; Glaser, Ronald/E-3124-2011	Kiecolt-Glaser, Janice K/0000-0003-4900-9578; 	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH042096, R01MH050538] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR0034] Funding Source: Medline; NIMH NIH HHS [R37 MH42096, R01 MH50538] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; BARBUL A, 1990, CLIN PLAST SURG, V17, P433; BURNS EA, 1990, GERIATRIC MED, P312; Cohen S., 1988, SOCIAL PSYCHOL HLTH; ESTERLING BA, 1994, HEALTH PSYCHOL, V13, P291, DOI 10.1037/0278-6133.13.4.291; GIASER R, 1994, HDB HUMAN STRESS IMM; GROVE GL, 1982, ARCH DERMATOL RES, V272, P381, DOI 10.1007/BF00509069; GRUBER RP, 1975, PLAST RECONSTR SURG, V55, P472, DOI 10.1097/00006534-197555040-00013; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; LIGHT E, 1994, STRESS EFFECTS FAMIL; LOWRY SF, 1993, ARCH SURG-CHICAGO, V28, P1235; MARUCHA PT, 1990, J IMMUNOL, V145, P2932; MCCANN JJ, 1991, THESIS RUSH U COLLEG; NEMETH AJ, 1991, ARCH DERMATOL, V127, P1679, DOI 10.1001/archderm.127.11.1679; SHERIDAN JF, 1991, J NEUROIMMUNOL, V31, P245, DOI 10.1016/0165-5728(91)90046-A; STRIETER RM, 1990, J LEUKOCYTE BIOL, V47, P366, DOI 10.1002/jlb.47.4.366; THOMPSON R, 1990, PHYS WORLD, V3, P18, DOI 10.1088/2058-7058/3/12/16	18	655	666	0	58	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 4	1995	346	8984					1194	1196		10.1016/S0140-6736(95)92899-5	http://dx.doi.org/10.1016/S0140-6736(95)92899-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TC976	7475659	Bronze			2022-12-24	WOS:A1995TC97600009
J	POMBO, CM; KEHRL, JH; SANCHEZ, I; KATZ, P; AVRUCH, J; ZON, LI; WOODGETT, JR; FORCE, T; KYRIAKIS, JM				POMBO, CM; KEHRL, JH; SANCHEZ, I; KATZ, P; AVRUCH, J; ZON, LI; WOODGETT, JR; FORCE, T; KYRIAKIS, JM			ACTIVATION OF THE SAPK PATHWAY BY THE HUMAN STE20 HOMOLOG GERMINAL CENTER KINASE	NATURE			English	Article								EUKARYOTIC cells respond to different extracellular stimuli by recruiting homologous signalling pathways that use members of the MEKK, MEK and ERK families of protein kinases. The MEKK-->MEK-->ERK core pathways of Saccharomyces cerevisiae may themselves be regulated by members of the STE20 family of protein kinases(1,2). Here we report specific activation of the mammalian stress-activated protein kinase (SAPK) pathway by germinal centre kinase (GCK; ref. 3), a human STE20 homologue(3,4). SAPKs, members of the ERK family, are activated in situ by inflammatory stimuli, including tumour-necrosis factor (TNF) and interleukin-1, and phosphorylate and probably stimulate the transactivation function of c-Jun(5-7). Although GCK is found in many tissues, its expression in lymphoid follicles is restricted to the cells of the germinal centre, where it may participate in B-cell differentiation(3). Activation of the SAPK pathway by GCK illustrates further the striking, conservation of eukaryotic signalling mechanisms and defines the first physiological function of a mammalian Ste20.	MASSACHUSETTS GEN HOSP E, DIABET RES LAB, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP E, CARDIOL UNIT, BOSTON, MA 02129 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02129 USA; NIAID, IMMUNOREGULAT LAB, BETHESDA, MD 20892 USA; GEORGETOWN UNIV, MED CTR, DEPT MED, WASHINGTON, DC 20007 USA; CHILDRENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; CHILDRENS HOSP, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA; PRINCESS MARGARET HOSP, ONTARIO CANC INST, TORONTO, ON M4X 1K9, CANADA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Georgetown University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre			Kehrl, John/AAE-6292-2019; Woodgett, Jim/F-1087-2010; Pombo, Celia M/L-4479-2014	Woodgett, Jim/0000-0003-3731-5797; Force, Thomas/0000-0002-0450-8659; Pombo, Celia M/0000-0003-2541-9468; Kehrl, John/0000-0002-6526-159X				AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CHOI KY, 1994, CELL, V78, P499; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FRIESEN H, 1994, GENE DEV, V8, P2162, DOI 10.1101/gad.8.18.2162; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; YAN MH, 1994, NATURE, V372, P798	23	207	215	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	1995	377	6551					750	754		10.1038/377750a0	http://dx.doi.org/10.1038/377750a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477268				2022-12-24	WOS:A1995TB46900062
J	JACKSON, TR; BLAIR, LAC; MARSHALL, J; GOEDERT, M; HANLEY, MR				JACKSON, TR; BLAIR, LAC; MARSHALL, J; GOEDERT, M; HANLEY, MR			THE MAS ONCOGENE ENCODES AN ANGIOTENSIN RECEPTOR	NATURE			English	Article									MRC,MOLEC NEUROBIOL UNIT,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND; MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology								BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BURT DR, 1980, NEUROTRANSMITTER B 1, V9, P152; CONNELL JMC, 1986, TRENDS PHARMACOL SCI, V7, P412, DOI 10.1016/0165-6147(86)90404-9; CORPS AN, 1985, BIOCHEM J, V231, P781, DOI 10.1042/bj2310781; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; FERRARIO CM, 1983, HYPERTENSION, V5, pV73, DOI 10.1161/01.HYP.5.6_Pt_3.V73; GILLO B, 1987, J PHYSIOL-LONDON, V392, P349, DOI 10.1113/jphysiol.1987.sp016784; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANLEY MR, 1987, NATURE, V329, P766, DOI 10.1038/329766a0; HANLEY MR, 1985, NATURE, V315, P14, DOI 10.1038/315014a0; HANLEY MR, 1988, NEURON, V1, P175, DOI 10.1016/0896-6273(88)90137-7; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NATHANS J, 1987, A REV NEUROSCI, V10, P161; RABIN M, 1988, ONCOGENE RES, V1, P169; REGOLI D, 1979, CAN J PHYSIOL PHARM, V57, P129, DOI 10.1139/y79-020; WHITE MM, 1985, P NATL ACAD SCI USA, V82, P4852, DOI 10.1073/pnas.82.14.4852; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P5339, DOI 10.1073/pnas.85.14.5339; ZACHARY I, 1987, DEV BIOL, V124, P295, DOI 10.1016/0012-1606(87)90483-0	29	373	376	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 29	1988	335	6189					437	440		10.1038/335437a0	http://dx.doi.org/10.1038/335437a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q2364	3419518				2022-12-24	WOS:A1988Q236400050
J	NG, SKC; HAUSER, WA; BRUST, JCM; SUSSER, M				NG, SKC; HAUSER, WA; BRUST, JCM; SUSSER, M			ALCOHOL-CONSUMPTION AND WITHDRAWAL IN NEW-ONSET SEIZURES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									COLUMBIA UNIV, SCH PUBL HLTH, DIV EPIDEMIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV, FAC MED, DEPT NEUROL, NEW YORK, NY 10032 USA; HARLEM HOSP CTR, DEPT NEUROL, NEW YORK, NY 10037 USA	Columbia University; Columbia University	NG, SKC (corresponding author), COLUMBIA UNIV, GH SERGIEVSKY CTR, FAC MED, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Hauser, W Allen/AAB-5277-2020		NICHD NIH HHS [K08 HD00702] Funding Source: Medline; NINDS NIH HHS [R01 NS 17236-04A] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000702] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1981, Epilepsia, V22, P489; ARMOR DJ, 1976, R1739NIAAA PUBL; BERNADT MW, 1982, LANCET, V1, P325; BERRY RG, 1952, EPILEPSIA, V1, P21; Conover W. J., 1980, PRACTICAL NONPARAMET; DAM AM, 1985, EPILEPSIA, V26, P227, DOI 10.1111/j.1528-1157.1985.tb05410.x; DEVETAG F, 1983, ITAL J NEUROL SCI, V4, P275, DOI 10.1007/BF02043479; DUNBAR JA, 1982, BRIT MED J, V285, P1083, DOI 10.1136/bmj.285.6348.1083; EARNEST MP, 1976, EPILEPSIA, V17, P387, DOI 10.1111/j.1528-1157.1976.tb04450.x; ELLIS FW, 1970, J PHARMACOL EXP THER, V175, P88; ESSIG CF, 1968, ARCH NEUROL-CHICAGO, V18, P626, DOI 10.1001/archneur.1968.00470360048004; FALK JL, 1972, SCIENCE, V177, P811, DOI 10.1126/science.177.4051.811; FREUND G, 1969, ARCH NEUROL-CHICAGO, V21, P315, DOI 10.1001/archneur.1969.00480150105013; GERSON IM, 1979, CLIN ELECTROENCEPHAL, V10, P40, DOI 10.1177/155005947901000105; GILL GV, 1982, BRIT MED J, V285, P1770, DOI 10.1136/bmj.285.6357.1770; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; GIROIRE H, 1956, REV NEUROL PARIS, V94, P634; GOLDSTEI.DB, 1971, SCIENCE, V172, P288, DOI 10.1126/science.172.3980.288; GOLDSTEIN DB, 1972, J PHARMACOL EXP THER, V180, P203; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; HILLBOM ME, 1980, EPILEPSIA, V21, P459, DOI 10.1111/j.1528-1157.1980.tb04296.x; ISBELL H, 1955, Q J STUD ALCOHOL, V16, P1; Kalinowsky LB, 1942, ARCH NEURO PSYCHIATR, V48, P946, DOI 10.1001/archneurpsyc.1942.02290120098006; KLUPP M, 1980, FORTSCHR MED, V98, P1777; Lennox WG, 1941, Q J STUD ALCOHOL, V2, P1; MAISTO SA, 1979, J CONSULT CLIN PSYCH, V47, P106, DOI 10.1037/0022-006X.47.1.106; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MARINACCI A. A., 1963, BULL LOS ANGELES NEUROL SOC, V28, P241; MCQUARRIE DG, 1958, J PHARMACOL EXP THER, V124, P264; MELLO NK, 1970, J PHARMACOL EXP THER, V173, P101; MENDELSO.JH, 1966, PSYCHOSOM MED, V28, P1; MENDELSON JH, 1966, ANN NY ACAD SCI, V133, P828, DOI 10.1111/j.1749-6632.1966.tb50930.x; MENDELSON JH, 1964, QUART J STUD ALCOH S, V2, P1; Muller EH, 1910, MON PSYCHIATR NEUROL, V28, P1; OGATA M, 1968, PSYCHOSOM MED, V30, P463, DOI 10.1097/00006842-196809000-00001; ORFORD J, 1973, BEHAV RES THER, V11, P565, DOI 10.1016/0005-7967(73)90115-0; PIEPER WA, 1972, LIFE SCI, V11, P989, DOI 10.1016/0024-3205(72)90178-6; PIEPER WA, 1972, SCIENCE, V176, P71, DOI 10.1126/science.176.4030.71; RICHTER CD, 1956, NEUROPHARMACOLOGY, V3, P39; SHAPER AG, 1985, ANN CLIN BIOCHEM, V22, P50, DOI 10.1177/000456328502200104; SHAPER AG, 1987, BMJ-BRIT MED J, V294, P733, DOI 10.1136/bmj.294.6574.733; SOBELL LC, 1975, J NERV MENT DIS, V161, P32, DOI 10.1097/00005053-197507000-00004; SOBELL LC, 1978, J CONSULT CLIN PSYCH, V46, P901, DOI 10.1037/0022-006X.46.5.901; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; THOMPSON GEORGE N., 1963, BULL LOS ANGELES NEUROL SOC, V28, P217; TUKUE I, 1968, HIROSHIMAIGAKU, V21, P171; UGARTE G, 1972, Q J STUD ALCOHOL, V33, P698; VICTOR M., 1967, EPILEPSIA, V8, P1; WHITEHEAD TP, 1978, LANCET, V1, P978; WHITTFIELD JB, 1981, AUST NZ J MED, V11, P132, DOI 10.1111/j.1445-5994.1981.tb04219.x; YAMANE H, 1981, EUR NEUROL, V20, P17, DOI 10.1159/000115199; YANAI J, 1976, J STUD ALCOHOL, V37, P1564, DOI 10.15288/jsa.1976.37.1564; 1986, SUGI SUPPLEMENTAL LI	53	123	124	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	1988	319	11					666	673						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q0375	3412384				2022-12-24	WOS:A1988Q037500002
J	GREEN, A; BERAL, V; MOSER, K				GREEN, A; BERAL, V; MOSER, K			MORTALITY IN WOMEN IN RELATION TO THEIR CHILDBEARING HISTORY	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV LONDON LONDON SCH HYG & TROP MED, DEPT EPIDEMIOL, LONDON WC1E 7HT, ENGLAND; CITY UNIV LONDON, SOCIAL STAT RES UNIT, LONDON EC1V 0HB, ENGLAND	University of London; London School of Hygiene & Tropical Medicine; City University London			Green, Adele C/B-5324-2011; Green, Adele C/P-2736-2014	Green, Adele C/0000-0002-2753-4841				BEARD CM, 1984, AM J EPIDEMIOL, V120, P108, DOI 10.1093/oxfordjournals.aje.a113859; BENGTSSON C, 1973, ACTA MED SCAND, P75; BERAL V, 1983, CIBA F SYMP, V96, P182; BERAL V, 1985, J EPIDEMIOL COMMUN H, V39, P343, DOI 10.1136/jech.39.4.343; BRINTON LA, 1987, J NATL CANCER I, V79, P23; BYERS T, 1982, J NATL CANCER I, V69, P1059; CARTWRIGHT A, 1976, MANY CHILDREN, P96; Dorn Harold F., 1943, HUMAN BIOL, V15, P73; FITZGERALD M, 1961, Q J MED, V30, P57; FOX AJ, 1982, SERIES LS, V1; FRAGA A, 1974, J RHEUMATOL, V1, P293; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; HELIOVAARA M, 1981, J EPIDEMIOL COMMUN H, V35, P197, DOI 10.1136/jech.35.3.197; KVALE G, 1987, AM J EPIDEMIOL, V126, P831, DOI 10.1093/oxfordjournals.aje.a114720; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MILLER AB, 1980, J CHRON DIS, V33, P595, DOI 10.1016/0021-9681(80)90002-8; OLIVER MF, 1985, CLIN SCI, V14, P15; PLESKO I, 1985, INT J CANCER, V36, P529, DOI 10.1002/ijc.2910360502; POTTER JD, 1983, J NATL CANCER I, V71, P703; PYKE DA, 1956, LANCET, V1, P818; SCOTT JS, 1982, BRIT MED J, V284, P1657, DOI 10.1136/bmj.284.6330.1657; WEISS NS, 1981, J NATL CANCER I, V67, P57; WEST KM, 1978, EPIDEMIOLOGY DIABETE, P221; WINKELSTEIN W Jr, 1958, J Chronic Dis, V7, P273, DOI 10.1016/0021-9681(58)90085-7	24	109	109	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	1988	297	6645					391	395		10.1136/bmj.297.6645.391	http://dx.doi.org/10.1136/bmj.297.6645.391			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408979	Green Published, Bronze			2022-12-24	WOS:A1988P545000020
J	CANTWELL, BMJ; CARMICHAEL, J; GHANI, SE; HARRIS, AL				CANTWELL, BMJ; CARMICHAEL, J; GHANI, SE; HARRIS, AL			THROMBOSES AND THROMBOEMBOLI IN PATIENTS WITH LYMPHOMA DURING CYTO-TOXIC CHEMOTHERAPY	BRITISH MEDICAL JOURNAL			English	Article											CANTWELL, BMJ (corresponding author), UNIV NEW CASTLE UPON TYNE,NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,ENGLAND.		Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409				LEVINE MN, 1988, NEW ENGL J MED, V318, P404, DOI 10.1056/NEJM198802183180703; NICOLSON GL, 1985, CANCER RES, V45, P331; RICKLES FR, 1983, BLOOD, V62, P14; SEIFTER EJ, 1985, CANCER TREAT REP, V69, P1011; WILSON JE, 1985, CECIL TXB MED, P426	5	21	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 16	1988	297	6642					179	180		10.1136/bmj.297.6642.179	http://dx.doi.org/10.1136/bmj.297.6642.179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P2951	3408956	Bronze, Green Published			2022-12-24	WOS:A1988P295100021
J	EVANS, G; JACKSON, RK				EVANS, G; JACKSON, RK			MICRODISCECTOMY FOR TREATING LUMBAR-DISK PROTRUSION	BRITISH MEDICAL JOURNAL			English	Editorial Material											EVANS, G (corresponding author), SOUTHAMPTON GEN HOSP,DEPT ORTHOPAED,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND.							ARMSTRONG JR, 1951, J BONE JOINT SURG BR, V33, P31, DOI 10.1302/0301-620X.33B1.31; BLOM S, 1967, J NEUROSURG, V26, P25, DOI 10.3171/jns.1967.26.1part1.0025; EBELING U, 1986, ACTA NEUROCHIR, V81, P45, DOI 10.1007/BF01456264; GOALD H J, 1980, Journal of Microsurgery, V2, P95; GOALD HJ, 1979, SURG GYNECOL OBSTET, V149, P247; GOALD JG, 1978, SPINE, V3, P183; MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P891, DOI 10.2106/00004623-197153050-00004; NYSTROM B, 1987, ACTA NEUROL SCAND, V76, P129, DOI 10.1111/j.1600-0404.1987.tb03556.x; Rogers L A, 1987, N C Med J, V48, P117; SACHDEV V P, 1986, Microsurgery, V7, P55, DOI 10.1002/micr.1920070202; THOMAS AMC, 1987, J BONE JOINT SURG BR, V69, P696, DOI 10.1302/0301-620X.69B5.3680326; WILLIAMS R W, 1978, Spine, V3, P175; WILLIAMS RW, 1986, SPINE, V11, P851, DOI 10.1097/00007632-198610000-00023; WILSON DH, 1981, NEUROSURGERY, V8, P422, DOI 10.1227/00006123-198104000-00003; WILSON DH, 1979, NEUROSURGERY, V4, P137, DOI 10.1227/00006123-197902000-00005	15	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					5	5		10.1136/bmj.297.6640.5	http://dx.doi.org/10.1136/bmj.297.6640.5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408910	Bronze, Green Published			2022-12-24	WOS:A1988P100000004
J	SUGARMAN, J; REISNER, EG; KURTZBERG, J				SUGARMAN, J; REISNER, EG; KURTZBERG, J			ETHICAL ASPECTS OF BANKING PLACENTAL BLOOD FOR TRANSPLANTATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECONSTITUTION; BODY	Transplantation of blood cells harvested from the umbilical cord immediately after birth has been effective in repopulating the bone marrow. These placental blood transplantations may be safer than conventional bone marrow transplantations and may suspend the need to harvest bone marrow, a process fraught with difficulties. Further understanding and advancement of this emerging technology require developing large banks of placental blood. In this article, we examine some of the ethical issues associated with placental blood banking, including (1) questions about ownership of the tissue, (2) the necessity and nature of obtaining informed consent from parents for harvesting placental blood and the information-gathering process associated with it, (3) obligations to notify parents and children of the results of medical testing for infectious diseases and genetic information, (4) matters of privacy and confidentiality related to such information, and (5) the need for fair and equitable harvesting of and access to placental blood.	DUKE UNIV,MED CTR,CTR HLTH POLICY RES & EDUC,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,PEDIAT BONE MARROW TRANSPLANT PROGRAM,DURHAM,NC 27710	Duke University; Duke University; Duke University	SUGARMAN, J (corresponding author), DUKE UNIV,MED CTR,CTR STUDY AGING & HUMAN DEV,DIV GEN INTERNAL MED,PROGRAM MED ETH,BOX 3040,DURHAM,NC 27710, USA.			Sugarman, Jeremy/0000-0001-7022-8332				ANDREWS LB, 1986, HASTINGS CENT REP, V16, P28, DOI 10.2307/3562693; [Anonymous], 1986, HIST THEORY INFORM C; AUERBACH AD, 1994, BLOOD CELLS, V20, P303; Campbell C S, 1993, Second Opin, V19, P69; DULA A, 1994, CAMB Q HEALTHC ETHIC, V3, P347, DOI 10.1017/S0963180100005168; GALE RP, 1995, NEW ENGL J MED, V332, P392, DOI 10.1056/NEJM199502093320612; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; KURTZBERG J, 1994, BLOOD CELLS, V20, P275; MCCULLOUGH J, 1994, BLOOD CELLS, V20, P609; McCullough J, 1989, BONE MARROW TRANSPL, P641; MURRAY TH, 1987, HASTINGS CENT REP, V17, P30, DOI 10.2307/3562041; ROBERTSON JA, 1991, FERTIL STERIL, V55, P681; ROBERTSON JA, 1989, HASTINGS CENT REP, V19, P7, DOI 10.2307/3561979; RUBINSTEIN P, 1993, BLOOD, V81, P1679; RUBINSTEIN P, 1994, BLOOD CELLS, V20, P587; WAGNER JE, 1994, BLOOD CELLS, V20, P227	16	61	62	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	1995	274	22					1783	1785		10.1001/jama.274.22.1783	http://dx.doi.org/10.1001/jama.274.22.1783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TJ225	7500510				2022-12-24	WOS:A1995TJ22500029
J	COLLURA, RV; STEWART, CB				COLLURA, RV; STEWART, CB			INSERTIONS AND DUPLICATIONS OF MTDNA IN THE NUCLEAR GENOMES OF OLD-WORLD MONKEYS AND HOMINOIDS	NATURE			English	Article							MITOCHONDRIAL-DNA; EVOLUTION; SEQUENCES; AMPLIFICATION; PRIMATES	USING oligonucleotide primers designed to match conserved regions of mammalian mitochondrial DNA (mtDNA)(1), we have amplified and sequenced two divergent cytochrome b nuclear pseudogenes from orangutan cellular DNA. Evolutionary analysis suggests that a nuclear transfer occurred about 30 million years ago on the lineage leading to the catarrhines (Old World monkeys and hominoids), and involved a long (at least 3 kilobases), probably damaged, piece of mtDNA. After this transfer, the pseudogene duplicated, giving rise to the two copies that are probably present in all hominoids, including humans. More recent transfers involving the entire cytochrome b gene have also occurred in the Old World monkeys. Such nuclear copies of mtDNA can confound phylogenetic and population genetic studies(2-4), and be an insidious source of DNA contamination of 'ancient'(3,5) and forensic DNA. Indeed, contamination with these anciently transferred human pseudogenes(5) is almost certainly the source of the cytochrome b sequences recently reported from 'dinosaur bone DNA'(6).	SUNY ALBANY,DEPT BIOL SCI,ALBANY,NY 12222	State University of New York (SUNY) System; State University of New York (SUNY) Albany								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ausubel F, 1989, MOL REPROD DEV, V1, P146; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; COHEN J, 1995, SCIENCE, V268, P22, DOI 10.1126/science.7701333; FELSENSTEIN J, 1994, PHYLIP PHYLOGENY INF; FUKUDA M, 1985, J MOL BIOL, V186, P257, DOI 10.1016/0022-2836(85)90102-0; GINGERICH PD, 1986, MOL BIOL EVOL, V3, P205; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; HEDGES SB, 1995, SCIENCE, V268, P1191, DOI 10.1126/science.7761839; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HU GX, 1994, GENE, V147, P197, DOI 10.1016/0378-1119(94)90065-5; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LI WH, IN PRESS MOL PHYLOGE; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MADDISON WP, 1994, ANAL PHYLOGENY CHARA; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Quinn TW, 1992, MOL ECOL, V1, P105, DOI 10.1111/j.1365-294X.1992.tb00162.x; SAITOU N, 1994, MOL BIOL EVOL, V11, P504; SHAY JW, 1992, MUTAT RES, V275, P227, DOI 10.1016/0921-8734(92)90026-L; SMITH MF, 1992, MOL BIOL EVOL, V9, P204; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; WOODWARD SR, 1995, SCIENCE, V268, P1194, DOI 10.1126/science.268.5214.1194; WOODWARD SR, 1994, SCIENCE, V266, P1229; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; ZISCHLER H, 1995, SCIENCE, V268, P1192, DOI 10.1126/science.7605504; ZULLO S, 1991, J MOL BIOL, V221, P1223	29	168	176	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					485	489		10.1038/378485a0	http://dx.doi.org/10.1038/378485a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477403				2022-12-24	WOS:A1995TH05400069
J	CHENG, AM; ROWLEY, B; PAO, W; HAYDAY, A; BOLEN, JB; PAWSON, T				CHENG, AM; ROWLEY, B; PAO, W; HAYDAY, A; BOLEN, JB; PAWSON, T			SYK TYROSINE KINASE REQUIRED FOR MOUSE VIABILITY AND B-CELL DEVELOPMENT	NATURE			English	Article							BONE-MARROW; PROTEIN; CHAIN; REARRANGEMENT; SELECTION; RECEPTOR; GENES	The Syk cytoplasmic protein-tyrosine kinase has two amino-terminal SH2 domains and a carboxy-terminal catalytic domain(1). Syk, and its close relative ZAP-70 (ref. 2), are apparently pivotal in coupling antigen- and Fc-receptors to downstream signalling events(3,4). Syk associates with activated Fc receptors(5), the T cell receptor complex(6) and the B-cell antigen-receptor complex (BCR) in immature and mature B lymphocytes(7). On receptor activation, the tandem SH2 domains of Syk bind dual phosphotyrosine sites in the conserved ITAM motifs of receptor signalling chains, such as the immunoglobulin alpha and beta-chains of the BCR, leading to Syk activation(3,4,8). Here we have investigated Syk function in vivo by generating a mouse strain with a targeted mutation in the syk gene. Homozygous syk mutants suffered severe haemorrhaging as embryos and died perinatally, indicating that Syk has a critical role in maintaining vascular integrity or in wound healing during embryogenesis. Analysis of syk(-/-) lymphoid cells showed that the syk mutation impaired the differentiation of B-lineage cells, apparently by disrupting signalling from the pre-BCR complex and thereby preventing the clonal expansion, and further maturation, of pre-B cells.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5S 1A8,CANADA; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,PROGRAMME MOLEC BIOL & CANC,TORONTO,ON M5G 1X5,CANADA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT ONCOL,PRINCETON,NJ 08453; YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06520	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Bristol-Myers Squibb; Yale University			Pawson, Tony J/E-4578-2013					ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; CARLSSON L, 1992, EUR J IMMUNOL, V22, P71, DOI 10.1002/eji.1830220112; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHUKWUOCHA RU, 1994, J IMMUNOGENET, V40, P76; CLARK EA, 1994, J BIOL CHEM, V269, P28859; DECKER DJ, 1991, J IMMUNOL, V146, P350; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; DURDEN DL, 1994, BLOOD, V84, P2102; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Joyner AL, 1993, GENE TARGETING PRACT; KARASUYAMA H, 1992, J EXP MED, V172, P969; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; REZAUL K, 1995, FIBROSIS HEMOSTAS, V72, P937; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	31	543	573	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					303	306		10.1038/378303a0	http://dx.doi.org/10.1038/378303a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477353				2022-12-24	WOS:A1995TE85800055
J	PIEPER, R; LUO, GL; CANE, DE; KHOSLA, C				PIEPER, R; LUO, GL; CANE, DE; KHOSLA, C			CELL-FREE SYNTHESIS OF POLYKETIDES BY RECOMBINANT ERYTHROMYCIN POLYKETIDE SYNTHASES	NATURE			English	Article							MACROLIDE BIOSYNTHESIS; CHAIN-ELONGATION; SACCHAROPOLYSPORA-ERYTHRAEA; STREPTOMYCES-ERYTHREUS; COENZYME-A; ACID; IDENTIFICATION; ORGANIZATION; INTERMEDIATE	Modular polyketide synthases (PKSs) are complex multi-enzyme proteins that catalyse the bacterial biosynthesis of many pharmaceutically useful polyketides. The PKSs are organized into a series of modules, each containing the active catalytic sites required for one step in the synthesis process(1,4). Here we report a method for cell-free enzymatic synthesis of 6-deoxyerythronolide B (6-dEB), the parent molecule of the antibiotic erythromycin A, using recombinant 6-deoxyerythronolide B synthase (DEBS), a modular PKS with at least 28 distinct active sites. We have also synthesized in vitro a triketide lactone by using a truncated mutant of DEBS. The availability of such cell-free synthetic routes will allow direct investigation of the structural and mechanistic basis for the unusual combination of high substrate specificity(5-10) and tolerance to genetic reprogramming(2,11-15) found in this enzyme family.	STANFORD UNIV,DEPT CHEM ENGN,STANFORD,CA 94305; BROWN UNIV,DEPT CHEM,PROVIDENCE,RI 02912	Stanford University; Brown University				Khosla, Chaitan/0000-0001-6529-495X				BROWN MJB, 1995, J CHEM SOC CHEM COMM, P1517, DOI 10.1039/c39950001517; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; CANE DE, 1995, J ANTIBIOT, V48, P647, DOI 10.7164/antibiotics.48.647; CANE DE, 1987, J AM CHEM SOC, V109, P1255, DOI 10.1021/ja00238a051; CANE DE, 1991, TETRAHEDRON LETT, V32, P5457, DOI 10.1016/0040-4039(91)80057-D; CANE DE, 1993, J AM CHEM SOC, V115, P522, DOI 10.1021/ja00055a023; CANE DE, 1995, J AM CHEM SOC, V117, P6633, DOI 10.1021/ja00129a044; CORCORAN JW, 1981, ANTIBIOTICS, V4, P146; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; CORTES J, 1995, SCIENCE, V288, P1487; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; DIMROTH P, 1970, EUR J BIOCHEM, V13, P98, DOI 10.1111/j.1432-1033.1970.tb00904.x; DONADIO S, 1993, P NATL ACAD SCI USA, V90, P7119, DOI 10.1073/pnas.90.15.7119; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; DULTON CJ, 1994, TETRAHEDRON LETT, V35, P327; HUNAITI AA, 1984, ANTIMICROB AGENTS CH, V25, P173, DOI 10.1128/AAC.25.2.173; KAO CM, 1994, SCIENCE, V265, P509, DOI 10.1126/science.8036492; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; KAO CM, 1994, J AM CHEM SOC, V116, P11612, DOI 10.1021/ja00104a069; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; LANZ T, 1991, J BIOL CHEM, V266, P9971; LEADLAY PF, 1993, BIOCHEM SOC T, V21, P218, DOI 10.1042/bst0210218; MACNEIL DJ, 1992, GENE, V115, P119, DOI 10.1016/0378-1119(92)90549-5; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; OFFENZELLER M, 1993, J BIOL CHEM, V268, P26127; OHagan D., 1991, POLYKETIDE METABOLIT; PIEPER R, IN PRESS J AM CHEM S; PLATE CA, 1970, J BIOL CHEM, V245, P2868; ROBERTS G, 1984, BIOCHEM SOC T, V12, P642, DOI 10.1042/bst0120642; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; SHEN B, 1993, SCIENCE, V262, P1535, DOI 10.1126/science.8248801; WALDT SJ, 1989, BIOCHEMISTRY-US, V28, P4523; WAWSZKIEWICZ EJ, 1964, BIOCHEM Z, V340, P213; WIESMANN KEH, 1995, CHEM BIOL, V2, P583, DOI 10.1016/1074-5521(95)90122-1; YUE S, 1987, J AM CHEM SOC, V109, P1253, DOI 10.1021/ja00238a050	35	95	105	2	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					263	266		10.1038/378263a0	http://dx.doi.org/10.1038/378263a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477343				2022-12-24	WOS:A1995TE85800043
J	REID, RC; ALONSO, JM				REID, RC; ALONSO, JM			SPECIFICITY OF MONOSYNAPTIC CONNECTIONS FROM THALAMUS TO VISUAL-CORTEX	NATURE			English	Article							SIMPLE RECEPTIVE-FIELDS; CAT STRIATE CORTEX; SPATIAL STRUCTURE; INPUTS; CELLS	In cortical area 17 of the cat, simple receptive fields are arranged in elongated subregions that respond best to bright (on) or dark (off) oriented contours, whereas the receptive fields of their thalamic inputs have a concentric on and off organization(1). This dramatic transformation suggests that there are specific rules governing the connections made between thalamic and cortical neurons(1-3) (see ref. 4). Here we report a study of these rules in which we recorded from thalamic (lateral geniculate nucleus; LGN) and cortical neurons simultaneously and related their receptive fields to their connectivity, as measured by cross-correlation analysis(5,6). The probability of finding a monosynaptic connection was high when a geniculate receptive field was superimposed anywhere over an elongated simple-cell subregion of the same signature (on or off). However, 'inappropriate' connections from geniculate cells of the opposite receptive field signature were extremely rare. Together, these findings imply that the outline of the elongated, simple receptive field, and thus of cortical orientation selectivity, is laid down at the level of the first synapse from the thalamic afferents.			REID, RC (corresponding author), ROCKEFELLER UNIV, NEUROBIOL LAB, NEW YORK, NY 10021 USA.							Alonso Jose-Manuel, 1993, Society for Neuroscience Abstracts, V19, P425; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; FERSTER D, 1987, J NEUROSCI, V7, P1780; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; REID RC, 1994, SOC NEUR ABSTR, V20, P425; RODLECK RW, 1965, VISION RES, V5, P583; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Sutter E.E., 1987, ADV METHODS PHYSIOLO, V1, P303; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Usrey W. Martin, 1995, Society for Neuroscience Abstracts, V21, P21	15	541	546	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1995	378	6554					281	284						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477347				2022-12-24	WOS:A1995TE85800049
J	DIEPOLDER, HM; ZACHOVAL, R; HOFFMANN, RM; WIERENGA, EA; SANTANTONIO, T; JUNG, MC; EICHENLAUB, D; PAPE, GR				DIEPOLDER, HM; ZACHOVAL, R; HOFFMANN, RM; WIERENGA, EA; SANTANTONIO, T; JUNG, MC; EICHENLAUB, D; PAPE, GR			POSSIBLE MECHANISM INVOLVING T-LYMPHOCYTE RESPONSE TO NONSTRUCTURAL PROTEIN-3 IN VIRAL CLEARANCE IN ACUTE HEPATITIS-C VIRUS-INFECTION	LANCET			English	Note								In acute hepatitis C virus (HCV) infection only 20-50% of patients spontaneously clear the virus. To characterise the immune reaction during that phase we studied the response of peripheral blood mononuclear cells (PBMC) to the recombinant HCV proteins core, non-structural protein 3 (NS3), NS4, and NS5 in 14 patients with acute hepatitis C. All eight patients with self-limited disease compared with two of six with evolving chronic infection showed an NS3- specific PBMC response (p=0.015). Of 65 patients with established chronic hepatitis C, five showed a PBMC response to NS3. NS3-specific CD4 T-cell clones from patients with self-limited infection predominantly produced interferon-gamma and may thus support cytotoxic effector mechanisms important for viral clearance.	UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,D-81377 MUNICH,GERMANY; UNIV AMSTERDAM,CELL BIOL & HISTOL LAB,1105 AZ AMSTERDAM,NETHERLANDS; UNIV BARI,MALATTIE INFETT CLIN,BARI,ITALY; HOSP SCHWABING,DEPT INTERNAL MED 4,MUNICH,GERMANY	University of Munich; University of Amsterdam; Universita degli Studi di Bari Aldo Moro	DIEPOLDER, HM (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,INST IMMUNOL,D-81377 MUNICH,GERMANY.		Yang, Chen/G-1379-2010					ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; BOTARELLI P, 1993, GASTROENTEROLOGY, V104, P580, DOI 10.1016/0016-5085(93)90430-K; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; FARCI P, 1991, SCIENCE, V258, P135; FERRARI C, 1994, HEPATOLOGY, V19, P286; HOFFMANN RM, 1995, HEPATOLOGY, V21, P632, DOI 10.1002/hep.1840210305; JUNG MC, 1995, J VIROL, V69, P3358, DOI 10.1128/JVI.69.6.3358-3368.1995; KOZIEL MJ, 1993, J VIROL, V67, P7522, DOI 10.1128/JVI.67.12.7522-7532.1993; LAI ME, 1994, LANCET, V343, P388, DOI 10.1016/S0140-6736(94)91224-6; MINUTELLO MA, 1993, J EXP MED, V178, P17, DOI 10.1084/jem.178.1.17	10	624	654	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					1006	1007		10.1016/S0140-6736(95)91691-1	http://dx.doi.org/10.1016/S0140-6736(95)91691-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475549				2022-12-24	WOS:A1995RZ59900013
J	PURUGGANAN, MD; KUMAR, CV; TURRO, NJ; BARTON, JK				PURUGGANAN, MD; KUMAR, CV; TURRO, NJ; BARTON, JK			ACCELERATED ELECTRON-TRANSFER BETWEEN METAL-COMPLEXES MEDIATED BY DNA	SCIENCE			English	Article									COLUMBIA UNIV,DEPT CHEM,NEW YORK,NY 10027	Columbia University				Kumar, Challa/0000-0002-8399-1334				Adam G., 1968, STRUCTURAL CHEM MOL, P198; BARTON JK, 1986, J AM CHEM SOC, V108, P6391, DOI 10.1021/ja00280a047; BARTON JK, 1986, J AM CHEM SOC, V108, P2081, DOI 10.1021/ja00268a057; BARTON JK, 1986, SCIENCE, V233, P727, DOI 10.1126/science.3016894; BARTON JK, 1984, J AM CHEM SOC, V106, P2172, DOI 10.1021/ja00319a043; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BRUNSCHWIG B, 1978, J AM CHEM SOC, V100, P7568, DOI 10.1021/ja00492a023; CHEN SF, 1981, J AM CHEM SOC, V103, P369; CLEMENTI E, 1982, INT J QUANTUM CHEM Q, V9, P213; CLOSS GL, 1986, J PHYS CHEM-US, V90, P3673, DOI 10.1021/j100407a039; DEVAULT D, 1980, Q REV BIOPHYS, V13, P387, DOI 10.1017/S003358350000175X; FROMHERZ P, 1986, J AM CHEM SOC, V108, P5361, DOI 10.1021/ja00277a060; FUJITA I, 1973, INORG CHEM, V12, P2758, DOI 10.1021/ic50130a004; GUARR T, 1983, J AM CHEM SOC, V105, P616, DOI 10.1021/ja00341a049; HEITELE H, 1985, J AM CHEM SOC, V107, P8286, DOI 10.1021/ja00312a093; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; INOKUTI M, 1965, J CHEM PHYS, V43, P1978, DOI 10.1063/1.1697063; ISIED SS, 1984, PROG INORG CHEM, V32, P443, DOI 10.1002/9780470166338.ch5; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JORAN A, 1986, NATURE, V327, P508; JORAN AD, 1984, J AM CHEM SOC, V106, P6090, DOI 10.1021/ja00332a062; KUMAR CV, 1985, J AM CHEM SOC, V107, P5518, DOI 10.1021/ja00305a032; LIANG N, 1986, J AM CHEM SOC, V108, P4665, DOI 10.1021/ja00275a076; MACGREGOR RB, 1987, BIOCHEMISTRY-US, V26, P4008, DOI 10.1021/bi00387a040; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; MARCUS RA, 1968, J PHYS CHEM-US, V72, P891, DOI 10.1021/j100849a019; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; MCGOURTY JL, 1983, J AM CHEM SOC, V105, P4472; MCLENDON G, 1985, J AM CHEM SOC, V107, P7811, DOI 10.1021/ja00312a002; OTTO P, 1983, J CHEM PHYS, V78, P454; PAGLIA E, 1957, GAZZ CHIM ITAL, V87, P1125; REDI M, 1980, J CHEM PHYS, V72, P6651, DOI 10.1063/1.439124; REHMANN J, 1988, THESIS COLUMBIA U NE; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; SIMOLO KP, 1984, J AM CHEM SOC, V106, P5012, DOI 10.1021/ja00329a067; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tonks L, 1936, PHYS REV, V50, P955, DOI 10.1103/PhysRev.50.955; Turro N. J., 1978, MODERN MOL PHOTOCHEM, P246	39	149	176	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 23	1988	241	4873					1645	1649		10.1126/science.3420416	http://dx.doi.org/10.1126/science.3420416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1372	3420416				2022-12-24	WOS:A1988Q137200032
J	LEDERBERG, J				LEDERBERG, J			MEDICAL SCIENCE, INFECTIOUS-DISEASE, AND THE UNITY OF HUMANKIND	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											LEDERBERG, J (corresponding author), ROCKEFELLER UNIV,OFF PRESIDENT,1230 YORK AVE,NEW YORK,NY 10021, USA.							BURNET FM, 1972, NATURAL HIST INFECTI; DULBECCO R, 1987, DESIGN LIFE, P125; KILBOURNE ED, 1987, INFLUENZA; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LEDERBERG J, 1952, PHYSIOL REV, V32, P403, DOI 10.1152/physrev.1952.32.4.403; LEDERBERG J, 1975, AMA PRISM, V3, P33; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; SMITH T, 1934, PARASITISM DISEASE	8	43	46	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	1988	260	5					684	685		10.1001/jama.260.5.684	http://dx.doi.org/10.1001/jama.260.5.684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4773	3392795				2022-12-24	WOS:A1988P477300033
J	PINSKY, PF; HURWITZ, ES; SCHONBERGER, LB; GUNN, WJ				PINSKY, PF; HURWITZ, ES; SCHONBERGER, LB; GUNN, WJ			REYES-SYNDROME AND ASPIRIN - EVIDENCE FOR A DOSE-RESPONSE EFFECT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											PINSKY, PF (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,DIV VIRAL DIS,BLDG 6,ROOM 119,ATLANTA,GA 30333, USA.							BROOKMEYER R, 1986, AM J EPIDEMIOL, V124, P693, DOI 10.1093/oxfordjournals.aje.a114443; HALPIN TJ, 1982, JAMA-J AM MED ASSOC, V248, P687, DOI 10.1001/jama.248.6.687; HURWITZ ES, 1985, NEW ENGL J MED, V313, P849, DOI 10.1056/NEJM198510033131403; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; STARKO KM, 1980, PEDIATRICS, V66, P859; TRAUNER DA, 1988, NEUROLOGY, V38, P239, DOI 10.1212/WNL.38.2.239; VAUGHAN VC, 1979, NELSON TXB PEDIATRIC; WALDMAN RJ, 1982, JAMA-J AM MED ASSOC, V247, P3089, DOI 10.1001/jama.247.22.3089; YOU KS, 1983, SCIENCE, V221, P163, DOI 10.1126/science.6857275	10	54	54	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	1988	260	5					657	661		10.1001/jama.260.5.657	http://dx.doi.org/10.1001/jama.260.5.657			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4773	3392791				2022-12-24	WOS:A1988P477300027
J	VANDESANDE, JH; RAMSING, NB; GERMANN, MW; ELHORST, W; KALISCH, BW; VONKITZING, E; PON, RT; CLEGG, RC; JOVIN, TM				VANDESANDE, JH; RAMSING, NB; GERMANN, MW; ELHORST, W; KALISCH, BW; VONKITZING, E; PON, RT; CLEGG, RC; JOVIN, TM			PARALLEL STRANDED DNA	SCIENCE			English	Article									MAX PLANCK INST BIOPHYS CHEM,DEPT MOLEC BIOL,D-3400 GOTTINGEN,FED REP GER	Max Planck Society	VANDESANDE, JH (corresponding author), UNIV CALGARY,DEPT MED BIOCHEM,CALGARY T2N 4N1,ALBERTA,CANADA.		German, Markus W/L-1531-2013	Ramsing, Niels Birger/0000-0002-1011-2343; Germann, Markus/0000-0002-1674-8166				ARNOTT S, 1972, BIOCHEM BIOPH RES CO, V47, P1504, DOI 10.1016/0006-291X(72)90243-4; ARNOTT S, 1970, PROGR BIOPHYS MOL BI, V21, P267; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Chaconas G, 1980, Methods Enzymol, V65, P75; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; DICKERSON RE, 1988, UNUSUAL DNA STRUCTUR, P287; ELHORST W, UNPUB; ERIE D, 1987, BIOCHEMISTRY-US, V26, P7150, DOI 10.1021/bi00396a042; GERMANN MW, 1987, ANAL BIOCHEM, V165, P399, DOI 10.1016/0003-2697(87)90288-0; GERMANN MW, UNPUB; HAKOSHIMA T, 1981, P NATL ACAD SCI-BIOL, V78, P7309, DOI 10.1073/pnas.78.12.7309; HARSHMAN KD, 1985, NUCLEIC ACIDS RES, V13, P4825, DOI 10.1093/nar/13.13.4825; INMAN RB, 1964, J MOL BIOL, V8, P452, DOI 10.1016/S0022-2836(64)80003-6; INMAN RB, 1964, J MOL BIOL, V9, P624, DOI 10.1016/S0022-2836(64)80171-6; ISHIKAWA F, 1972, J MOL BIOL, V70, P475, DOI 10.1016/0022-2836(72)90554-2; JORGENSON KF, 1988, J BIOMOL STRUCT DYN, V5, P1005, DOI 10.1080/07391102.1988.10506446; JOVIN TM, 1987, ANNU REV PHYS CHEM, V38, P521, DOI 10.1146/annurev.physchem.38.1.521; Kim S H, 1976, Prog Nucleic Acid Res Mol Biol, V17, P181, DOI 10.1016/S0079-6603(08)60070-7; KLUG A, 1974, J MOL BIOL, V89, P511, DOI 10.1016/0022-2836(74)90480-X; KOOLE LH, 1987, J AM CHEM SOC, V109, P3916, DOI 10.1021/ja00247a015; LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439; LEE JS, 1979, NUCLEIC ACIDS RES, V6, P3073, DOI 10.1093/nar/6.9.3073; LEE JS, 1984, NUCLEIC ACIDS RES, V12, P6603, DOI 10.1093/nar/12.16.6603; LEFLER CF, 1969, J BIOL CHEM, V244, P594; MARRIOTT G, UNPUB; MATTEUCCI MD, 1980, TETRAHEDRON LETT, V21, P719, DOI 10.1016/S0040-4039(00)71455-9; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; MIRZABEKOV AD, 1974, MOL BIOL REP, V1, P379, DOI 10.1007/BF00385669; MORVAN F, 1987, NUCLEIC ACIDS RES, V15, P7027, DOI 10.1093/nar/15.17.7027; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; OGILVIE KK, 1973, CAN J CHEM, V51, P3799, DOI 10.1139/v73-569; PATTABIRAMAN N, 1986, BIOPOLYMERS, V25, P1603, DOI 10.1002/bip.360250903; PJURA PE, 1987, J MOL BIOL, V197, P257, DOI 10.1016/0022-2836(87)90123-9; PRASEUTH D, 1987, J MOL BIOL, V196, P939, DOI 10.1016/0022-2836(87)90416-5; PULLEYBLANK DE, 1985, CELL, V42, P271, DOI 10.1016/S0092-8674(85)80122-7; RAMSING NB, IN PRESS NUCLEIC ACI; RAMSING NB, UNPUB; RICH A, 1961, J MOL BIOL, V3, P71, DOI 10.1016/S0022-2836(61)80009-0; RILEY M, 1966, J MOL BIOL, V20, P359, DOI 10.1016/0022-2836(66)90069-6; SAENGER W, 1984, PRINCIPLES NUCLEIC A; SARMA MH, 1986, FEBS LETT, V205, P223, DOI 10.1016/0014-5793(86)80902-4; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; SMITH M, 1962, J AM CHEM SOC, V84, P430, DOI 10.1021/ja00862a023; STOKKE T, 1985, J HISTOCHEM CYTOCHEM, V33, P333, DOI 10.1177/33.4.2579998; THUONG NT, 1987, P NATL ACAD SCI USA, V84, P5129, DOI 10.1073/pnas.84.15.5129; VONKITZING E, 1987, EUR BIOPHYS J BIOPHY, V15, P13, DOI 10.1007/BF00255031; WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311; WESTHOF E, 1980, P NATL ACAD SCI-BIOL, V77, P1852, DOI 10.1073/pnas.77.4.1852	51	220	236	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1988	241	4865					551	557		10.1126/science.3399890	http://dx.doi.org/10.1126/science.3399890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4350	3399890				2022-12-24	WOS:A1988P435000028
J	GLOTH, FM; GUNDBERG, CM; HOLLIS, BW; HADDAD, JG; TOBIN, JD				GLOTH, FM; GUNDBERG, CM; HOLLIS, BW; HADDAD, JG; TOBIN, JD			VITAMIN-D DEFICIENCY IN HOMEBOUND ELDERLY PERSONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; POPULATION; SERUM; OSTEOCALCIN; CALCIUM	Objective.-To assess the vitamin D status in homebound, community-dwelling elderly persons; sunlight-deprived elderly nursing home residents; and healthy, ambulatory elderly persons. Design.-A cohort analytic study. Participants.-Of 244 subjects at least 65 years old, 116 subjects (85 women and 31 men) had been confined indoors for at least 6 months, either in private dwellings in the community (the Hopkins Elder Housecall Program) or in a teaching nursing home (The Johns Hopkins Geriatrics Center). The 128 control subjects, a healthy ambulatory group, came from the Baltimore Longitudinal Study on Aging. All subjects were free of diseases or medications that might interfere with their vitamin D status. Main Outcome measures.-Serum levels of 25-hydroxyvitamin D (25-OHD) and 1,25-dihydroxyvitamin D (1,25-[OH]D-2) were measured in all subjects. In a subgroup of 80 subjects, serum levels of intact parathyroid hormone (PTH), ionized calcium, and osteocalcin and intake of vitamin D (through 3-day food records) were assessed. A randomly selected cohort of sunlight-deprived subjects also had serum levels of vitamin D binding protein measured. Results.-In sunlight-deprived subjects overall, the mean 25-OHD level was 30 nmol/L (12 ng/mL) (range, <10 to 77 nmol/L [<4 to 31 ng/mL]) and the mean 1,25(OH)(2)D level was 52 pmol/L (20 pg/mL) (range, 18 to 122 pmol/L [7 to 47 pg/mL]). In the sunlight-deprived subjects, 54% of community dwellers and 38% of nursing home residents had serum levels of 25-OHD below 25 nmol/L (10 ng/mL) (normal range, 25 to 137 nmol/L [10 to 55 ng/mL]). A significant inverse relationship existed between 25-OHD (ie, Log [25-OHD]) and PTH when they were analyzed together (r=-0.42; R(2)=0.18; P<.001) and for each cohort separately. All other parameters measured, except ionized calcium, differed significantly from the Baltimore Longitudinal Study Group means. The mean (SD) daily intakes of vitamin D (121 [132] IU) and calcium (583 [322] mg) were below the recommended dietary allowance only in the community-dwelling homebound population. The mean vitamin D binding protein level in the sunlight-deprived subgroup was in the normal range. Conclusions.-Despite a relatively high degree of vitamin supplementation in the United States, homebound elderly persons are likely to suffer from vitamin D deficiency.	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV GERIATR MED & GERONTOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS BAYVIEW MED CTR, BALTIMORE, MD USA; YALE UNIV, SCH MED, DEPT ORTHOPED, NEW HAVEN, CT USA; MED UNIV S CAROLINA, CHILDRENS HOSP, DEPT PEDIAT, CHARLESTON, SC 29425 USA; UNIV PENN, DIV ENDOCRINOL, PHILADELPHIA, PA 19104 USA; NIA, GERONTOL RES CTR, BALTIMORE, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Yale University; Medical University of South Carolina; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	GLOTH, FM (corresponding author), UNION MEM HOSP, DEPT MED, DIV GERIATR, 201 E UNIV PKWY, BALTIMORE, MD 21218 USA.				NCRR NIH HHS [MO1 RR02719] Funding Source: Medline; NIAMS NIH HHS [AR 38460] Funding Source: Medline; NIA NIH HHS [5 T32 AG00120-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000120] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; Chalmers J, 1967, J Bone Joint Surg Br, V49, P403; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; GLOTH FM, 1991, J AM GERIATR SOC, V39, P137, DOI 10.1111/j.1532-5415.1991.tb01615.x; GLOTH FM, 1995, J AM GERIATR SOC, V43, P822, DOI 10.1111/j.1532-5415.1995.tb07059.x; GLOTH FM, 1995, AM J PHYS MED REHAB, V74, P45, DOI 10.1097/00002060-199501000-00008; GLOTH FM, 1991, ARCH INTERN MED, V151, P1662, DOI 10.1001/archinte.151.8.1662; GLOTH FM, 1995, J AM GERIATR SOC, V43, P1269, DOI 10.1111/j.1532-5415.1995.tb07404.x; GLOTH FM, 1993, J BONE MINER RES, V8, pS216; GLOTH FM, 1990, J BONE MINER RES S2, V5, pS268; GLOTH FM, IN PRESS J AM DIET A; GUILLEMANT S, 1989, J STEROID BIOCHEM, V33, P1155, DOI 10.1016/0022-4731(89)90424-X; GUNDBERG CM, 1984, METHOD ENZYMOL, V107, P516; HOLLIS BW, 1986, CLIN CHEM, V32, P2060; HOLLIS BW, 1993, CLIN CHEM, V39, P529; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; OMDAHL JL, 1982, AM J CLIN NUTR, V36, P1225, DOI 10.1093/ajcn/36.6.1225; OOMS ME, 1995, J BONE MINER RES, V10, P1177; PARFITT AM, 1982, AM J CLIN NUTR, V36, P1014, DOI 10.1093/ajcn/36.5.1014; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; SKARIA J, 1975, ACTA NEUROL SCAND, V51, P37; VILLAREAL DT, 1991, J CLIN ENDOCR METAB, V72, P628, DOI 10.1210/jcem-72-3-628; WEBB AR, 1990, AM J CLIN NUTR, V51, P1075, DOI 10.1093/ajcn/51.6.1075; YASUMURA S, 1987, J CLIN ENDOCR METAB, V64, P681, DOI 10.1210/jcem-64-4-681; [No title captured]; 1989, NATIONAL ACADEMY SCI	26	359	375	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1683	1686		10.1001/jama.274.21.1683	http://dx.doi.org/10.1001/jama.274.21.1683			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH151	7474272				2022-12-24	WOS:A1995TH15100024
J	SNOW, TP; WITT, AN				SNOW, TP; WITT, AN			THE INTERSTELLAR CARBON BUDGET AND THE ROLE OF CARBON IN DUST AND LARGE MOLECULES	SCIENCE			English	Article							AROMATIC HYDROCARBON MOLECULES; HYDROGENATED AMORPHOUS-CARBON; B-TYPE STARS; CHEMICAL EVOLUTION; GALACTIC DISK; SOLAR NEIGHBORHOOD; ORION NEBULA; ELEMENTAL ABUNDANCES; EXTINCTION CURVE; ZETA-OPHIUCHI	Published data on stellar composition show that carbon in the sun is substantially more abundant than in other stars. A carbon abundance of 225 carbon atoms per 10(6) hydrogen atoms is representative of galactic stars, whereas Published values for the sun range from 350 to 470 carbon atoms per 10(6) hydrogen atoms. Other elements are also present in enhanced quantities in the solar system, consistent with suggestions that a supernova event was closely associated with the formation of the solar system. The overabundance of carbon in the solar system has many important implications, including new constraints on nucleosynthesis models for supernovae and substantial modification of the so-called ''cosmic'' composition normally adopted in discussions of galactic and interstellar abundances. A reduction in the galactic carbon budget, as suggested by the stellar composition data, strongly constrains the quantity of carbon that is available for the formation of interstellar dust, and some dust models now appear implausible because they require more carbon than is available.	UNIV TOLEDO,RITTER OBSERV,TOLEDO,OH 43606	University System of Ohio; University of Toledo	SNOW, TP (corresponding author), UNIV COLORADO,CTR ASTROPHYS & SPACE ASTRON,BOULDER,CO 80309, USA.		Witt, Adolf N./AAX-6976-2021					AANNESTAD PA, 1995, ASTROPHYS J, V443, P653, DOI 10.1086/175557; ADAMSON AJ, 1990, MON NOT R ASTRON SOC, V243, P400; ADELMAN SJ, 1993, PUBL ASTRON SOC PAC, V105, P327, DOI 10.1086/133158; ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; AMARI S, 1995, ASTROPHYS J, V447, pL147, DOI 10.1086/309573; ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BALDWIN JA, 1991, ASTROPHYS J, V374, P580, DOI 10.1086/170146; BOESGAARD AM, 1989, ASTROPHYS J, V336, P798, DOI 10.1086/167050; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; BUCHMANN L, 1993, PHYS REV LETT, V70, P726, DOI 10.1103/PhysRevLett.70.726; BUSOLETTI E, 1987, APJ, V321, pL87; CAMERON AGW, 1995, ASTROPHYS J, V447, pL53, DOI 10.1086/309554; CAMERON AGW, 1973, SPACE SCI REV, V15, P121, DOI 10.1007/BF00172440; CARDELLI JA, 1993, ASTROPHYS J, V402, pL17, DOI 10.1086/186689; CARDELLI JA, 1991, ASTROPHYS J, V377, pL57, DOI 10.1086/186116; CARDELLI JA, IN PRESS ASTROPHYS J; CARIGI L, 1994, ASTROPHYS J, V424, P181, DOI 10.1086/173881; CARLBERG RG, 1985, ASTROPHYS J, V294, P674, DOI 10.1086/163337; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CUNHA K, 1994, ASTROPHYS J, V426, P170, DOI 10.1086/174053; DESERT FX, 1990, ASTRON ASTROPHYS, V237, P215; Draine B, 1989, INTERSTELLAR DUST, P313; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; DULEY WW, 1990, ASTROPHYS J, V351, pL49, DOI 10.1086/185677; DULEY WW, 1987, MON NOT R ASTRON SOC, V229, P203, DOI 10.1093/mnras/229.2.203; DULEY WW, 1985, MON NOT R ASTRON SOC, V215, P259, DOI 10.1093/mnras/215.2.259; DULEY WW, 1989, MON NOT R ASTRON SOC, V236, P709, DOI 10.1093/mnras/236.4.709; DULEY WW, 1995, DIFFUSE INTERSTELLAR, V359; EDVARDSSON B, 1993, ASTRON ASTROPHYS, V275, P101; FANG Z, 1993, PHYS REV A, V48, P1114, DOI 10.1103/PhysRevA.48.1114; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; FURTON DG, 1993, ASTROPHYS J, V415, pL51, DOI 10.1086/187030; GIES DR, 1992, ASTROPHYS J, V387, P673, DOI 10.1086/171116; GREVESSE N, 1991, ASTRON ASTROPHYS, V242, P488; GREVESSE N, 1992, INFRARED SOLAR PHYSI, P539; Grevesse N., 1993, ORIGIN EVOLUTION ELE, P15; HOBBS LM, 1982, ASTROPHYS J, V252, pL21, DOI 10.1086/183711; HOLWEGER H, 1974, SOL PHYS, V39, P19, DOI 10.1007/BF00154968; HONG SS, 1980, ASTRON ASTROPHYS, V88, P194; JENKINS EB, 1979, ASTROPHYS J, V231, P55, DOI 10.1086/157163; JENKINS EB, 1983, ASTROPHYS J, V270, P88, DOI 10.1086/161100; JOBLIN C, 1992, ASTROPHYS J, V393, pL79, DOI 10.1086/186456; JONES AP, 1990, MON NOT R ASTRON SOC, V247, P305; KILIAN J, 1994, ASTRON ASTROPHYS, V284, P437; KILIAN J, 1992, ASTRON ASTROPHYS, V262, P171; KILIANMONTENBRU.J, 1994, ASTRON ASTROPHYS, V291, P757; LAMBERT DL, 1978, MON NOT R ASTRON SOC, V182, P249, DOI 10.1093/mnras/182.2.249; LEGER A, 1995, ASTRON ASTROPHYS, V293, pL53; LENNON DJ, 1985, ASTROPHYS J, V294, P200, DOI 10.1086/163287; LUCK RE, 1994, ASTROPHYS J SUPPL S, V91, P309, DOI 10.1086/191940; MALINIE G, 1993, ASTROPHYS J, V413, P633, DOI 10.1086/173032; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; MATHIS JS, 1989, ASTROPHYS J, V341, P808, DOI 10.1086/167538; MATTEUCCI F, 1983, ASTRON ASTROPHYS, V123, P121; MEYER DM, 1994, ASTROPHYS J, V437, pL59, DOI 10.1086/187682; MORTON DC, 1975, ASTROPHYS J, V197, P85, DOI 10.1086/153490; OLIVE KA, 1982, ASTROPHYS J, V257, P276, DOI 10.1086/159986; OTT U, 1993, NATURE, V364, P25, DOI 10.1038/364025a0; PAGEL BEJ, 1989, EVOLUTIONARY PHENOMENA IN GALAXIES, P201; PAGEL BEJ, 1975, MON NOT R ASTRON SOC, V172, P13, DOI 10.1093/mnras/172.1.13; PAPOULAR R, 1993, ASTRON ASTROPHYS, V270, pL5; PEIMBERT M, 1993, ASTROPHYS J, V414, P626, DOI 10.1086/173108; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; PUGET JL, 1989, ANNU REV ASTRON ASTR, V27, P161; REEVES H, 1978, PROTOSTARS PLANETS, P399; ROLLESTON WRJ, 1994, ASTRON ASTROPHYS, V284, P72; ROY JR, 1995, ASTRON ASTROPHYS, V294, P432; RUBIN RH, 1991, ASTROPHYS J, V374, P564, DOI 10.1086/170145; RUBIN RH, 1993, ASTROPHYS J, V413, P242, DOI 10.1086/172992; SALAMA F, 1992, ASTROPHYS J, V395, P301, DOI 10.1086/171652; SALAMA F, 1992, NATURE, V358, P42, DOI 10.1038/358042a0; SANCISI R, 1974, GALACTIC RADIO ASTRO, P115; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SCHUSTER WJ, 1989, ASTRON ASTROPHYS, V222, P69; SEARLE L, 1972, ASTROPHYS J, V173, P25, DOI 10.1086/151398; Snow T., UNPUB; SNOW TP, 1976, ASTROPHYS J, V204, P759, DOI 10.1086/154223; SNOW TP, IN PRESS ASTROPHYS J; SOFIA UJ, 1994, ASTROPHYS J, V430, P650, DOI 10.1086/174438; SORRELL WH, 1990, MON NOT R ASTRON SOC, V243, P570; Tielens A. G. G. M., 1995, DIFFUSE INTERSTELLAR; Tielens A.G.G.M., 1987, INTERSTELLAR PROCESS, P397; TINSLEY BM, 1980, FUNDAM COSMIC PHYS, V5, P587; TOMKIN J, 1995, ASTRON J, V109, P2204, DOI 10.1086/117446; TWAROG BA, 1980, ASTROPHYS J, V242, P242, DOI 10.1086/158460; TWAROG BA, 1982, ASTROPHYS J, V261, P636, DOI 10.1086/160375; WELTY DE, 1986, PUBL ASTRON SOC PAC, V98, P857, DOI 10.1086/131834; WHITTET DCB, 1989, MON NOT R ASTRON SOC, V241, P707, DOI 10.1093/mnras/241.4.707; WHITTET DCB, 1984, MON NOT R ASTRON SOC, V210, P479, DOI 10.1093/mnras/210.2.479; Williams, 1993, DUST CHEM ASTRONOMY, P9; ZHAO Z, 1993, PHYS REV LETT, V70, P2066, DOI 10.1103/PhysRevLett.70.2066; [No title captured]	94	164	164	0	13	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1455	1460		10.1126/science.270.5241.1455	http://dx.doi.org/10.1126/science.270.5241.1455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491489				2022-12-24	WOS:A1995TH37500028
J	MEIER, UC; KLENERMAN, P; GRIFFIN, P; JAMES, W; KOPPE, B; LARDER, B; MCMICHAEL, A; PHILLIPS, R				MEIER, UC; KLENERMAN, P; GRIFFIN, P; JAMES, W; KOPPE, B; LARDER, B; MCMICHAEL, A; PHILLIPS, R			CYTOTOXIC T-LYMPHOCYTE LYSIS INHIBITED BY VIABLE HIV MUTANTS	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENETIC-VARIATION; RECOGNITION; RETROVIRUS; CELLS	Immune evasion by the human immunodeficiency virus (HIV) is unexplained but may involve the mutation of viral antigens. When cytotoxic T lymphocytes engaged CD4-positive cells that were acutely infected with HIV bearing natural variant epitopes in reverse transcriptase, substantial inhibition of specific antiviral lysis was observed. Mutant viruses capable of these transactive effects could facilitate the persistence of a broad range of HIV variants in the face of an active and specific immune response.	JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,OXFORD OX1 3RE,ENGLAND; WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND	University of Oxford; University of Oxford; University of Oxford; GlaxoSmithKline; Wellcome Research Laboratories			james, william/H-4289-2013; Meier, Ute Christiane/N-6891-2018; Larder, Brendan/AAB-3106-2020	james, william/0000-0002-2506-1198; Meier, Ute Christiane/0000-0002-8838-5464; klenerman, paul/0000-0003-4307-9161	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BEVAN MJ, 1975, J EXP MED, V142, P1349, DOI 10.1084/jem.142.6.1349; BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; COFFIN JM, 1995, NATURE, V375, P534, DOI 10.1038/375534a0; COLLIN M, 1994, J GEN VIROL, V75, P1597, DOI 10.1099/0022-1317-75-7-1597; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; EBERLE J, 1992, J VIROL METHODS, V40, P347, DOI 10.1016/0166-0934(92)90092-R; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KLENERMAN P, 1995, EUR J IMMUNOL, V25, P1927, DOI 10.1002/eji.1830250720; KLENERMAN P, UNPUB; KLENERMAN P, 1994, NATURE, V269, P403; KOUP RA, 1995, J EXP MED, V180, P779; LARDER BA, 1989, P NATL ACAD SCI USA, V86, P4803, DOI 10.1073/pnas.86.13.4803; LARDER BA, 1993, NATURE, V365, P451, DOI 10.1038/365451a0; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; MCADAM S, 1995, J IMMUNOL, V155, P2729; MDRENAS J, 1995, SCIENCE, V267, P515; MEIER UE, UNPUB; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; PAUL WE, 1995, CELL, V82, P177, DOI 10.1016/0092-8674(95)90304-6; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; REID S, UNPUB; SHIMOTOHNO K, 1982, J VIROL, V41, P163, DOI 10.1128/JVI.41.1.163-171.1982; SIMON JHM, 1993, J EXP MED, V177, P949, DOI 10.1084/jem.177.4.949; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; ZHANG LQ, 1991, AIDS, V5, P675, DOI 10.1097/00002030-199106000-00006	33	93	94	0	0	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1360	1362		10.1126/science.270.5240.1360	http://dx.doi.org/10.1126/science.270.5240.1360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481824				2022-12-24	WOS:A1995TF89900039
J	MCCULLOCH, P; CHOY, A; MARTIN, L				MCCULLOCH, P; CHOY, A; MARTIN, L			ASSOCIATION BETWEEN TUMOR ANGIOGENESIS AND TUMOR-CELL SHEDDING INTO EFFLUENT VENOUS-BLOOD DURING BREAST-CANCER SURGERY	LANCET			English	Note							CARCINOMA; INDICATOR	Tumour angiogenesis is a powerful prognostic indicator in breast cancer. Shedding of tumour cells into the bloodstream is essential for haematogenous metastasis. The relation between cell shedding and angiogenesis in human cancer is not known. We studied vascular density and cell shedding in 16 women undergoing breast cancer surgery. Circulating cells were found in one patient before, in six during, acid none after operation. Vascular density was related to detection of circulating tumour cells during surgery (correlation coefficient for first intraoperative sampling=0.56, p=0.024, 95% CI 0.08 to 0.83). Tumour cell shedding during surgery is related to vascular density; the relevance of this relation to the prognostic significance of vascular density in breast cancer merits further study.			MCCULLOCH, P (corresponding author), ROYAL LIVERPOOL UNIV HOSP,DEPT SURG,LIVERPOOL L7 8XP,MERSEYSIDE,ENGLAND.			McCulloch, Peter/0000-0002-3210-8273				FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; LIOTTA LA, 1976, CANCER RES, V36, P889; MCCULLOCH P, 1994, LANCET, V344, P402; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	6	90	91	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 18	1995	346	8986					1334	1335		10.1016/S0140-6736(95)92345-4	http://dx.doi.org/10.1016/S0140-6736(95)92345-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE916	7475773				2022-12-24	WOS:A1995TE91600011
J	VAUGHAN, J; DONALDSON, C; BITTENCOURT, J; PERRIN, MH; LEWIS, K; SUTTON, S; CHAN, R; TURNBULL, AV; LOVEJOY, D; RIVIER, C; RIVIER, J; SAWCHENKO, PE; VALE, W				VAUGHAN, J; DONALDSON, C; BITTENCOURT, J; PERRIN, MH; LEWIS, K; SUTTON, S; CHAN, R; TURNBULL, AV; LOVEJOY, D; RIVIER, C; RIVIER, J; SAWCHENKO, PE; VALE, W			UROCORTIN, A MAMMALIAN NEUROPEPTIDE RELATED TO FISH UROTENSIN-I AND TO CORTICOTROPIN-RELEASING FACTOR	NATURE			English	Article							EDINGER-WESTPHAL NUCLEUS; RAT; EXPRESSION; CLONING; CRF; SEQUENCE; RECEPTOR; SYSTEM; GENE	Corticotropin-releasing factor (CRF), a peptide first isolated from mammalian brain(1), is critical in the regulation of the pituitary-adrenal axis, and in complementary stress-related endocrine, autonomic and behavioural responses(2). Fish urotensin I and amphibian sauvagine were considered to be homologues(3) of CRF until peptides even more closely related to CRF were identified in these same vertebrate classes(4,5). We have characterized another mammalian member of the CRF family and have localized its urotensin-like immunoreactivity to, and cloned related complementary DNAs from, a discrete rat midbrain region. The deduced protein encodes a peptide that we name urocortin, which is related to urotensin (63% sequence identity) and CRF (45% sequence identity). Synthetic urocortin evokes secretion of adrenocorticotropic hormone (ACTH) both in vitro and in vivo and binds and activates transfected type-1 CRF receptors(6,9), the subtype expressed by pituitary corticotropes. The coincidence of urotensin-like immunoreactivity with type-2 CRF receptors(10-13) in brain, and our observation that urocortin is more potent than CRF at binding and activating type-2 CRF receptors, as well as at inducing c-Fos (an index of cellular activation) in regions enriched in type-2 CRF receptors, indicate that this new peptide could be an endogenous ligand for type-2 CRF receptors.	SALK INST BIOL STUDIES,CLAYTON FDN LABS PEPTIDE BIOL,LA JOLLA,CA 92037; SALK INST BIOL STUDIES,NEURONAL STRUCT & FUNCT LAB,LA JOLLA,CA 92037	Salk Institute; Salk Institute			Bittencourt, Jackson Cioni/AAF-6896-2021; Bittencourt, Jackson/B-4696-2011; Bittencourt, Jackson/I-9187-2014	Bittencourt, Jackson Cioni/0000-0002-8908-6474; Bittencourt, Jackson/0000-0002-8908-6474; Bittencourt, Jackson/0000-0002-8908-6474	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-26741] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAN RKW, 1993, J NEUROSCI, V13, P5125; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; CHUNG RY, 1987, NEUROSCI LETT, V83, P13, DOI 10.1016/0304-3940(87)90208-4; IMAKI J, 1991, BRAIN RES, V547, P28; ISHIDA I, 1986, P NATL ACAD SCI USA, V83, P803; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Lederis K., 1985, Recent Progress in Hormone Research, V41, P553; Lederis K., 1994, P67; LOEWY AD, 1978, BRAIN RES, V141, P153, DOI 10.1016/0006-8993(78)90624-8; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P3351; McDougal D. H., 2014, COMPR PHYSIOL, DOI [10.1002/cphy.c140014, DOI 10.1002/CPHY.C140014]; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; OKAWARA Y, 1988, P NATL ACAD SCI USA, V85, P8439, DOI 10.1073/pnas.85.22.8439; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; PERRIN MH, 1993, ENDOCRINOLOGY, V133, P3058, DOI 10.1210/en.133.6.3058; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; SAPER CB, 1979, J COMP NEUROL, V183, P689, DOI 10.1002/cne.901830402; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; STENZELPOORE MP, 1992, MOL ENDOCRINOL, V6, P1716, DOI 10.1210/me.6.10.1716; SUTTON SW, 1995, ENDOCRINOLOGY, V136, P1097, DOI 10.1210/en.136.3.1097; THOMPSON RC, 1987, MOL ENDOCRINOL, V1, P363, DOI 10.1210/mend-1-5-363; VALE W, 1983, METHOD ENZYMOL, V103, P565; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VALE W, 1983, RECENT PROG HORM RES, V39, P245; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Webster William R., 1995, P797	30	1334	1368	0	40	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					287	292		10.1038/378287a0	http://dx.doi.org/10.1038/378287a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477349				2022-12-24	WOS:A1995TE85800051
J	NYGARD, O; VOLLSET, SE; REFSUM, H; STENSVOLD, I; TVERDAL, A; NORDREHAUG, JE; UELAND, PM; KVALE, G				NYGARD, O; VOLLSET, SE; REFSUM, H; STENSVOLD, I; TVERDAL, A; NORDREHAUG, JE; UELAND, PM; KVALE, G			TOTAL PLASMA HOMOCYSTEINE AND CARDIOVASCULAR RISK PROFILE - THE HORDALAND HOMOCYSTEINE STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CORONARY-ARTERY DISEASE; VASCULAR-DISEASE; METHIONINE METABOLISM; LIPOPROTEIN LEVELS; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; UNITED-STATES; HEART-DISEASE; FOLATE LEVELS	Objective.-To estimate the relations between established cardiovascular risk factors and total homocysteine (tHcy) in plasma. Design.-Health examination survey by the Norwegian Health Screening Service in 1992 and 1993. Setting.-General community, Hordaland County of Western Norway. Participants.-A total of 7591 men and 8585 women, 40 to 67 years of age, with no history of hypertension, diabetes, coronary heart disease, or cerebrovascular disease were included. Main Outcome Measure.-Plasma tHcy level. Results.-The level of plasma tHcy was higher in men than in women and increased with age. In subjects 40 to 42 years old, geometric means were 10.8 mu mol/L for 5918 men and 9.1 mu mol/L for 6348 women. At age 65 to 67 years, the corresponding tHcy values were 12.3 mu mol/L (1386 men) and 11.0 mu mol/L (1932 women). Plasma tHcy level increased markedly with the daily number of cigarettes smoked in all age groups. Its relation to smoking was particularly strong in women. The combined effect of age, sex, and smoking was striking. Heavy-smoking men aged 65 to 67 years had a mean tHcy level 4.8 mu mol/L higher than never-smoking women aged 40 to 42 years. Plasma tHcy level also was positively related to total cholesterol level, blood pressure, and heart rate and inversely related to physical activity. The relations were not substantially changed by multivariate adjustment, including intake of vitamin supplements, fruits, and vegetables. Conclusions.-Elevated plasma tHcy level was associated with major components of the cardiovascular risk profile, ie, male sex, old age, smoking, high blood pressure, elevated cholesterol level, and lack of exercise. These findings should influence future studies on the etiology and pathogenesis of cardiovascular disease.	UNIV BERGEN, DEPT BIOL CLIN, DIV PHARMACOL, BERGEN, NORWAY; UNIV BERGEN, CTR INT HLTH, BERGEN, NORWAY; HAUKELAND UNIV HOSP, DEPT HEART DIS, BERGEN, NORWAY; NATL HLTH SCREENING SERV, OSLO, NORWAY	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital			Ueland, Per M/C-7340-2013; Refsum, Helga/A-4073-2010	Tverdal, Aage/0000-0002-2909-5678; Ueland, Per Magne/0000-0002-1903-0571				ANDERSSON A, 1992, EUR J CLIN CHEM CLIN, V30, P377; ANDERSSON A, 1992, EUR J CLIN INVEST, V22, P79, DOI 10.1111/j.1365-2362.1992.tb01940.x; ANKER G, 1995, INT J CANCER, V60, P365; ARAKI A, 1993, ATHEROSCLEROSIS, V103, P149, DOI 10.1016/0021-9150(93)90258-V; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; ARAKI A, 1989, ATHEROSCLEROSIS, V79, P139, DOI 10.1016/0021-9150(89)90118-4; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; BERG K, 1992, CLIN GENET, V41, P315; BERGMARK C, 1993, EUR J VASCULAR SURG, V7, P391, DOI 10.1016/S0950-821X(05)80255-5; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bjartveit K, 1979, Acta Med Scand Suppl, V634, P1; BOERS GH, 1983, J CLIN INVEST, V72, P1971, DOI 10.1172/JCI111161; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM L, 1992, SCAND J CLIN LAB INV, V52, P283, DOI 10.3109/00365519209088360; BRATTSTROM L, 1994, J INTERN MED, V236, P633, DOI 10.1111/j.1365-2796.1994.tb00856.x; BRATTSTROM LE, 1985, METABOLISM, V34, P1073, DOI 10.1016/0026-0495(85)90082-4; CHEN ATL, 1989, ENVIRON MOL MUTAGEN, V13, P319, DOI 10.1002/em.2850130407; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; D'Avanzo B, 1993, Ann Epidemiol, V3, P645; DASTUR DK, 1972, BMJ-BRIT MED J, V3, P260, DOI 10.1136/bmj.3.5821.260; DECESARIS R, 1992, CARDIOLOGY, V81, P233, DOI 10.1159/000175809; DIXON WJ, 1992, BMDP STATISTICAL SOF, V1; FISKERSTRAND T, 1993, CLIN CHEM, V39, P263; GOLDBERG L, 1985, MED CLIN N AM, V69, P41; JACOBSEN DW, 1994, CLIN CHEM, V40, P873; JOOSTEN E, 1993, AM J CLIN NUTR, V58, P468, DOI 10.1093/ajcn/58.4.468; KANG SS, 1986, J CLIN INVEST, V77, P1482, DOI 10.1172/JCI112461; KANG SS, 1986, METABOLISM, V35, P889, DOI 10.1016/0026-0495(86)90049-1; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; LINNELL JC, 1968, BRIT MED J, V2, P215, DOI 10.1136/bmj.2.5599.215; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; MALINOW MR, 1993, CIRCULATION, V87, P1107, DOI 10.1161/01.CIR.87.4.1107; MALINOW MR, 1994, J INTERN MED, V236, P603, DOI 10.1111/j.1365-2796.1994.tb00854.x; MALINOW MR, 1994, CLIN CHEM, V40, P857; MANSOOR MA, 1995, ARTERIOSCL THROM VAS, V15, P232, DOI 10.1161/01.ATV.15.2.232; MCCULLY KS, 1975, ATHEROSCLEROSIS, V22, P215, DOI 10.1016/0021-9150(75)90004-0; MCPHILLIPS JB, 1994, J AM DIET ASSOC, V94, P287, DOI 10.1016/0002-8223(94)90370-0; MOLGAARD J, 1992, J INTERN MED, V231, P273; MORRIS JN, 1980, LANCET, V2, P1207; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; REFSUM H, 1989, CLIN CHEM, V35, P1921; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; UBBINK JB, 1993, AM J CLIN NUTR, V57, P47, DOI 10.1093/ajcn/57.1.47; UELAND PM, 1995, CLIN CHEM, V41, P340; UELAND PM, 1993, CLIN CHEM, V39, P1764; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; VANDERMOOREN MJ, 1994, EUR J CLIN INVEST, V24, P733; VERMAAK WJH, 1990, AM J CLIN NUTR, V51, P1058, DOI 10.1093/ajcn/51.6.1058; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; WEINTRAUB MS, 1989, CIRCULATION, V79, P1007, DOI 10.1161/01.CIR.79.5.1007; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350; WILLIAMS RR, 1990, CORONARY ARTERY DIS, V1, P681, DOI 10.1097/00019501-199011000-00008; WONG PWK, 1988, AM J MED, V84, P1093, DOI 10.1016/0002-9343(88)90328-2; WU LL, 1994, CLIN CHEM, V40, P552; 1991, S PLUS USERS MANUAL, V1	62	896	932	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	1995	274	19					1526	1533		10.1001/jama.274.19.1526	http://dx.doi.org/10.1001/jama.274.19.1526			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD571	7474221				2022-12-24	WOS:A1995TD57100029
J	CORBETTA, M; SHULMAN, GL; MIEZIN, FM; PETERSEN, SE				CORBETTA, M; SHULMAN, GL; MIEZIN, FM; PETERSEN, SE			SUPERIOR PARIETAL CORTEX ACTIVATION DURING SPATIAL ATTENTION SHIFTS AND VISUAL FEATURE CONJUNCTION	SCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; BRAIN; RESPONSES; SEARCH; PET	Positron emission tomography was used to measure changes in the regional cerebral blood flow of normal people while they searched visual displays for targets defined by color, by motion, or by a conjunction of color and motion. A region in the superior parietal cortex was activated only during the conjunction task, at a location that had previously been shown to be engaged by successive shifts of spatial attention. Correspondingly, the time needed to detect a conjunction target increased with the number of items in the display, which is consistent with the use of a mechanism that successively analyzes each item in the visual field.	WASHINGTON UNIV,SCH MED,MCDONNELL CTR STUDY HIGHER BRAIN FUNCT,ST LOUIS,MO 63110	Washington University (WUSTL)	CORBETTA, M (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL & NEUROL SURG,ST LOUIS,MO 63110, USA.		Corbetta, Maurizio/AAZ-5219-2020; Petersen, Steve/ABF-1368-2020	CORBETTA, MAURIZIO/0000-0001-8295-3304	NATIONAL EYE INSTITUTE [R01EY008775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS006833, P50NS006833] Funding Source: NIH RePORTER; NEI NIH HHS [EY08775] Funding Source: Medline; NINDS NIH HHS [NS06833, NS2533] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUCKNER RL, 1995, J NEUROSCI, V15, P12; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CORBETTA M, 1991, J NEUROSCI, V8, P2383; De Renzi E., 1982, DISORDERS SPACE EXPL; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; HEINZE HJ, 1995, NATURE, V372, P543; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; HUNTON DE, UNPUB; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; POSNER MI, 1984, J NEUROSCI, V4, P1863; Talairach J., 1988, COPLANAR STEREOTAXIC; TOWNSEND JT, 1972, BRIT J MATH STAT PSY, V25, P168, DOI 10.1111/j.2044-8317.1972.tb00490.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; YAMAMOTO M, 1982, IEEE T NUCL SCI, V29, P529, DOI 10.1109/TNS.1982.4335901	20	565	576	0	29	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					802	805		10.1126/science.270.5237.802	http://dx.doi.org/10.1126/science.270.5237.802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TC712	7481770				2022-12-24	WOS:A1995TC71200042
J	CHRISTY, NP				CHRISTY, NP			CORTICOSTEROID-THERAPY AND UNINTENTIONAL CAMOUFLAGE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											CHRISTY, NP (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032, USA.							CHRISTY NP, 1962, J CLIN ENDOCR METAB, V22, P155, DOI 10.1210/jcem-22-2-155; CHRISTY NP, 1960, CLIN ENDOCRINOL, V1, P53; CHRISTY NP, 1988, CURRENT THERAPY ENDO, P104; CHRISTY NP, 1988, CURRENT THERAPY ENDO, P112; CHRISTY NP, 1971, HUMAN ADRENAL CORTEX, P395; COPE CL, 1972, ADRENAL STEROIDS DIS, P519; DRUCKER WD, 1965, AM J MED, V38, P522, DOI 10.1016/0002-9343(65)90130-0; GAMBERTOGLIO JG, 1980, J PHARMACOKINET BIOP, V8, P1, DOI 10.1007/BF01059447; JACOBS TP, 1988, JAMA-J AM MED ASSOC, V260, P2082, DOI 10.1001/jama.260.14.2082; JENKINS JS, 1967, BRIT MED J, V2, P205, DOI 10.1136/bmj.2.5546.205; Kepler EJ, 1941, ARCH INTERN MED, V68, P1010, DOI 10.1001/archinte.1941.00200110162009; KNOWLTON AI, 1971, HUMAN ADRENAL CORTEX, P329; MULLER AF, 1958, INT S ALDOSTERONE, P111; Peterson RR, 1971, HUMAN ADRENAL CORTEX; PICKUP ME, 1979, CLIN PHARMACOKINET, V4, P111, DOI 10.2165/00003088-197904020-00004; POWELL LW, 1972, GUT, V13, P690, DOI 10.1136/gut.13.9.690; SALASSA RM, 1953, JAMA-J AM MED ASSOC, V152, P1509, DOI 10.1001/jama.1953.03690160009004; SHEEHAN HL, 1949, Q J MED, V42, P319; TYRRELL JB, 1987, ENDOCRINOL METAB, P788; WYNN V, 1955, BR MED J, V4912, P505	20	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	1988	260	14					2107	2109						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q3421	3418878				2022-12-24	WOS:A1988Q342100032
J	LI, HH; GYLLENSTEN, UB; CUI, XF; SAIKI, RK; ERLICH, HA; ARNHEIM, N				LI, HH; GYLLENSTEN, UB; CUI, XF; SAIKI, RK; ERLICH, HA; ARNHEIM, N			AMPLIFICATION AND ANALYSIS OF DNA-SEQUENCES IN SINGLE HUMAN-SPERM AND DIPLOID-CELLS	NATURE			English	Article									UNIV SO CALIF,DEPT BIOL SCI,MOLEC BIOL SECT,LOS ANGELES,CA 90089; CETUS CORP,DEPT HUMAN GENET,EMERYVILLE,CA 94608	University of Southern California				Arnheim, Norman/0000-0003-1247-1347				BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GILL P, 1985, BIOTECHNOLOGY, V3, P1008; HOBBS HH, 1987, NUCLEIC ACIDS RES, V15, P379, DOI 10.1093/nar/15.1.379; LINDGREN V, 1985, P NATL ACAD SCI USA, V82, P8567, DOI 10.1073/pnas.82.24.8567; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PUWARAVUTIPANIC.T, 1975, EXP CELL RES, V90, P153, DOI 10.1016/0014-4827(75)90368-7; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561	16	543	600	0	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 29	1988	335	6189					414	417		10.1038/335414a0	http://dx.doi.org/10.1038/335414a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q2364	3419517				2022-12-24	WOS:A1988Q236400040
J	LONGNECKER, MP; BERLIN, JA; ORZA, MJ; CHALMERS, TC				LONGNECKER, MP; BERLIN, JA; ORZA, MJ; CHALMERS, TC			A META-ANALYSIS OF ALCOHOL-CONSUMPTION IN RELATION TO RISK OF BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									HARVARD UNIV,SCH PUBL HLTH,TECHNOL ASSESSMENT GRP L7A,677 HUNTINGTON AVE,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health				Longnecker, Matthew/0000-0001-6073-5322	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS005523] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA035291] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM003116] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS05523] Funding Source: Medline; NCI NIH HHS [R01-CA-35291] Funding Source: Medline; NLM NIH HHS [R01 LM-03116] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BEGG CB, 1983, LANCET, V1, P293; BEGG CB, IN PRESS J R STAT SO; BYERS T, 1982, LANCET, V1, P799; CHALMERS TC, 1987, STAT MED, V6, P733, DOI 10.1002/sim.4780060704; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; CHALMERS TC, 1965, GASTROENTEROLOGY, V49, P22; COLDITZ GA, 1985, AM HEART J, V109, P886, DOI 10.1016/0002-8703(85)90654-4; CULLEN K, 1982, INT J EPIDEMIOL, V11, P67, DOI 10.1093/ije/11.1.67; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DRAPER NR, 1981, APPLIED REGRESSION A, P105; FRIEDMAN LA, 1986, AM J EPIDEMIOL, V124, P481, DOI 10.1093/oxfordjournals.aje.a114418; GOLDMAN L, 1979, ANN INTERN MED, V90, P92, DOI 10.7326/0003-4819-90-1-92; GORDON T, 1983, AM HEART J, V105, P667, DOI 10.1016/0002-8703(83)90492-1; HARRIS RE, 1988, JAMA-J AM MED ASSOC, V259, P2867, DOI 10.1001/jama.259.19.2867; HARVEY EB, 1987, J NATL CANCER I, V78, P657; HIATT RA, 1984, AM J EPIDEMIOL, V120, P676, DOI 10.1093/oxfordjournals.aje.a113934; HIATT RA, 1988, CANCER RES, V48, P2284; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; KATSOUYANNI K, 1986, INT J CANCER, V38, P815, DOI 10.1002/ijc.2910380606; KLATSKY AL, 1981, ANN INTERN MED, V95, P139, DOI 10.7326/0003-4819-95-2-139; KLATSKY AL, 1981, CIRCULATION, V64, P32; KLATSKY AL, 1987, AM J EPIDEMIOL, V126, P770; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P163; LAVECCHIA C, 1985, J NATL CANCER I, V75, P61; LE MG, 1984, AM J EPIDEMIOL, V120, P350, DOI 10.1093/oxfordjournals.aje.a113899; LICHTENSTEIN MJ, 1987, J CHRON DIS, V40, P893, DOI 10.1016/0021-9681(87)90190-1; LONGNECKER MP, 1988, AM J PUBLIC HEALTH, V78, P153, DOI 10.2105/AJPH.78.2.153; MILLER DR, 1987, AM J EPIDEMIOL, V126, P736; MONSON RR, 1975, CANCER, V36, P1077, DOI 10.1002/1097-0142(197509)36:3<1077::AID-CNCR2820360335>3.0.CO;2-E; OCONNELL DL, 1987, J NATL CANCER I, V78, P229; PAGANINIHILL A, 1983, LANCET, V2, P626; ROGERS AE, IN PRESS LAB INVEST; ROHAN TE, 1988, INT J CANCER, V41, P695, DOI 10.1002/ijc.2910410510; ROSENBERG L, 1982, LANCET, V1, P267; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; SCHATZKIN A, 1987, NEW ENGL J MED, V316, P1169, DOI 10.1056/NEJM198705073161901; SILVERBERG E, 1986, CA-CANCER J CLIN, V36, P9; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; TALAMINI R, 1984, BRIT J CANCER, V49, P723, DOI 10.1038/bjc.1984.114; WEBSTER LA, 1983, LANCET, V2, P724; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525; 1985, NATIONAL HLTH INTERV	43	271	271	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	1988	260	5					652	656						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4773	3392790				2022-12-24	WOS:A1988P477300026
J	SYKES, PA; KERR, R				SYKES, PA; KERR, R			TREATMENT OF INGROWING TOENAILS BY SURGEONS AND CHIROPODISTS	BRITISH MEDICAL JOURNAL			English	Article									TRAFFORD HOSP,DEPT SURG,MANCHESTER,ENGLAND; TRAFFORD HOSP,DEPT CHIROPODY,MANCHESTER,ENGLAND									MILLER SS, 1985, BRIT MED J, V291, P91, DOI 10.1136/bmj.291.6488.91-a; MURRAY WR, 1975, BRIT J SURG, V62, P409, DOI 10.1002/bjs.1800620522; SYKES P A, 1986, Journal of the Royal College of Surgeons of Edinburgh, V31, P300; WALLACE A, 1986, PULSE           0712, P25	4	18	18	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 30	1988	297	6644					335	336		10.1136/bmj.297.6644.335	http://dx.doi.org/10.1136/bmj.297.6644.335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4527	3416165	Bronze, Green Published			2022-12-24	WOS:A1988P452700024
J	WING, KD				WING, KD			RH-5849, A NONSTEROIDAL ECDYSONE AGONIST - EFFECTS ON A DROSOPHILA CELL-LINE	SCIENCE			English	Article											WING, KD (corresponding author), ROHM & HAAS CO, RES LABS, SPRING HOUSE, PA 19477 USA.		Wing, Keith D./HGA-8091-2022					BERGAMASCO R., 1980, PROGR ECDYSONE RES, P299; BROOKS GT, 1987, J PESTIC SCI, V12, P113; CHERBAS L, 1986, INSECT BIOCHEM, V16, P241, DOI 10.1016/0020-1790(86)90102-2; CHERBAS L, 1980, ROUX ARCH DEV BIOL, V189, P1, DOI 10.1007/BF00848562; CHERBAS L, 1984, BIOSYNTHESIS METABOL, P305; CHERBAS L, 1980, INVERTEBRATE SYSTEMS, P217; CHERBAS P, 1977, SCIENCE, V197, P275, DOI 10.1126/science.877552; CHERBAS P, 1988, P NATL ACAD SCI USA, V85, P2096, DOI 10.1073/pnas.85.7.2096; Cook JW, 1933, NATURE, V131, P56, DOI 10.1038/131056b0; COURGEON AM, 1972, EXP CELL RES, V74, P327, DOI 10.1016/0014-4827(72)90384-9; DUAX WL, 1985, ENVIRON HEALTH PERSP, V61, P111, DOI 10.2307/3430065; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GALBRAITH MN, 1981, AUST J CHEM, V34, P2607, DOI 10.1071/CH9812607; JORDAN VC, 1985, ENVIRON HEALTH PERSP, V61, P97, DOI 10.2307/3430064; Koolman J., 1985, P343; KUBO I, 1983, J INSECT PHYSIOL, V29, P307, DOI 10.1016/0022-1910(83)90031-8; LANDON TM, 1988, J BIOL CHEM, V263, P4693; MAROY P, 1978, P NATL ACAD SCI USA, V75, P6035, DOI 10.1073/pnas.75.12.6035; RAYNAUD JP, 1986, ROLE RECEPTORS BIOL, P63; Retnakaran A., 1985, P529; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; ROBBINS WE, 1968, SCIENCE, V161, P1158, DOI 10.1126/science.161.3846.1158; ROBBINS WE, 1970, STEROIDS, V16, P105, DOI 10.1016/S0039-128X(70)80100-3; Roberts D.B., 1986, P1; SAGE BA, 1985, METHOD ENZYMOL, V111, P458; SAGE BA, 1982, J BIOL CHEM, V257, P6373; WING KD, 1988, SCIENCE, V241, P467, DOI 10.1126/science.3393913; YUND MA, 1979, MOL CELL ENDOCRINOL, V14, P19, DOI 10.1016/0303-7207(79)90055-8; YUND MA, 1985, COMPREHENSIVE INSECT, V7, P473; [No title captured]	31	361	388	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	1988	241	4864					467	469		10.1126/science.241.4864.470	http://dx.doi.org/10.1126/science.241.4864.470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3354	3393913				2022-12-24	WOS:A1988P335400040
J	SANTORO, C; MERMOD, N; ANDREWS, PC; TJIAN, R				SANTORO, C; MERMOD, N; ANDREWS, PC; TJIAN, R			A FAMILY OF HUMAN CCAAT-BOX-BINDING PROTEINS ACTIVE IN TRANSCRIPTION AND DNA-REPLICATION - CLONING AND EXPRESSION OF MULTIPLE CDNAS	NATURE			English	Article									UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720; PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus			santoro, claudio/G-6819-2012	Andrews, Philip/0000-0001-6843-5420				ANDREWS PC, 1987, ANAL BIOCHEM, V161, P524, DOI 10.1016/0003-2697(87)90484-2; BENOIST C, 1980, NUCLEIC ACIDS RES, V8, P127, DOI 10.1093/nar/8.1.127; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GROSS C, 1976, J BACTERIOL, V128, P382, DOI 10.1128/JB.128.1.382-389.1976; GUGGENHEIMER RA, 1984, P NATL ACAD SCI-BIOL, V81, P3069, DOI 10.1073/pnas.81.10.3069; HAUSER CA, 1985, CELL, V43, P19, DOI 10.1016/0092-8674(85)90008-X; HENNIGHAUSEN L, 1985, NATURE, V314, P289, DOI 10.1038/314289a0; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; LANDSCHULZ B, IN PRESS GENES DEV; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEEGWATER PAJ, 1985, EMBO J, V4, P1515, DOI 10.1002/j.1460-2075.1985.tb03811.x; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LIEBHABER SA, 1980, P NATL ACAD SCI-BIOL, V77, P7054, DOI 10.1073/pnas.77.12.7054; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCKNIGHT SL, 1984, CELL, V37, P253, DOI 10.1016/0092-8674(84)90321-0; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; OIKARINEN J, 1987, J BIOL CHEM, V262, P11064; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; PRUIJN GJM, 1986, NATURE, V322, P656, DOI 10.1038/322656a0; RAWLINS DR, 1984, CELL, V37, P309, DOI 10.1016/0092-8674(84)90327-1; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; REISMAN D, 1986, MOL CELL BIOL, V6, P3838, DOI 10.1128/MCB.6.11.3838; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; ROSENFELD PJ, 1987, MOL CELL BIOL, V7, P875, DOI 10.1128/MCB.7.2.875; Ruegg U T, 1977, Methods Enzymol, V47, P111; SALZMAN NP, 1986, PAPOVAVIRIDAE, V1, P27; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1986, NUCLEIC ACIDS RES, V14, P2863, DOI 10.1093/nar/14.7.2863; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; STENLUND A, 1987, SCIENCE, V236, P1666, DOI 10.1126/science.3037693; THEISEN M, 1986, EMBO J, V5, P719, DOI 10.1002/j.1460-2075.1986.tb04273.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VELDMAN GM, 1985, MOL CELL BIOL, V5, P649, DOI 10.1128/MCB.5.4.649	53	713	716	1	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 21	1988	334	6179					218	224		10.1038/334218a0	http://dx.doi.org/10.1038/334218a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3802	3398920				2022-12-24	WOS:A1988P380200043
J	JEON, YH; NEGISHI, T; SHIRAKAWA, M; YAMAZAKI, T; FUJITA, N; ISHIHAMA, A; KYOGOKU, Y				JEON, YH; NEGISHI, T; SHIRAKAWA, M; YAMAZAKI, T; FUJITA, N; ISHIHAMA, A; KYOGOKU, Y			SOLUTION STRUCTURE OF THE ACTIVATOR CONTACT DOMAIN OF THE RNA-POLYMERASE ALPHA-SUBUNIT	SCIENCE			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTION ACTIVATION; FUNCTIONAL MAP; PROTEINS; RECOGNITION; OCT-1	The structure of the carboxyl-terminal domain of the Escherichia coli RNA polymerase oc subunit (alpha CTD), which is regarded as the contact site for transcription activator proteins and for the promoter UP element, was determined by nuclear magnetic resonance spectroscopy, Its compact structure of four helices and two long arms enclosing its hydrophobic core shows a folding topology distinct from those of other DNA-binding proteins, The UP element binding site was found on the surface comprising helix 1, the amino-terminal end of helix 4, and the preceding loop, Mutation experiments indicated that the contact sites for transcription activator proteins are also on the same surface.	OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN; NATL INST GENET,DEPT MOLEC GENET,MISHIMA,SHIZUOKA 411,JAPAN; NARA INST SCI & TECHNOL,GRAD SCH BIOSCI,NARA 63001,JAPAN	Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nara Institute of Science & Technology			Jeon, Young Ho/F-4483-2011					ASSAMUNT N, 1993, CELL, V73, P193, DOI 10.1016/0092-8674(93)90171-L; Bax A., 1993, NMR PROTEINS, P33; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BRUNGER AT, 1992, VERSION 3 1; Burgess RR, 1976, RNA POLYMERASE, P69; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P946; DEKKER N, 1993, NATURE, V362, P852, DOI 10.1038/362852a0; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HELLMAN J, 1988, ANNU REV BIOCHEM, V57, P839; IGARASHI K, 1991, P NATL ACAD SCI USA, V88, P8958, DOI 10.1073/pnas.88.20.8958; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; ISHIHAMA A, 1988, TRENDS GENET, V4, P282, DOI 10.1016/0168-9525(88)90170-9; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kyogoku Y, 1995, METHOD ENZYMOL, V261, P524; MAJUMDAR A, 1993, J BIOMOL NMR, V3, P387; MATSUO Y, 1994, PROTEIN SCI, V3, P2055, DOI 10.1002/pro.5560031118; MURAKAMI K, UNPUB; NEGISHI T, 1995, J MOL BIOL, V248, P723, DOI 10.1006/jmbi.1995.0254; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TAO K, IN PRESS J BACTERIOL; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	29	153	156	1	5	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1495	1497		10.1126/science.270.5241.1495	http://dx.doi.org/10.1126/science.270.5241.1495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491496				2022-12-24	WOS:A1995TH37500039
J	DASGUPTA, B; BOWLES, J				DASGUPTA, B; BOWLES, J			SCINTIGRAPHIC LOCALIZATION OF STEROID INJECTION SITE IN PLANTAR FASCIITIS	LANCET			English	Note								Plantar fasciitis is a common cause of heel pain. We evaluated scintigraphic localisation of the inflammatory focus in 15 patients with this condition. Technetium-labelled bone scans precisely localised abnormal discrete areas of tracer uptake in 12 (80%) of patients in the medial and posterior aspect below the inferior surface of the calcaneum. Steroid injection at the inflammatory site abolished local tenderness and reduced pain in all 12. Our findings support an injection approach through the medial heel border posterior to the point of heel tenderness. Technetium scintigraphy may be a useful investigation to localise the steroid injection site in resistant cases of plantar fasciitis.			DASGUPTA, B (corresponding author), SOUTHEND HLTH CARE TRUST,WESTCLIFF ON SEA SS0 0RY,ESSEX,ENGLAND.		Bowles, Josephine/AAG-4903-2020	Bowles, Josephine/0000-0003-2867-7438				BEIKOWITZ JF, 1991, RADIOLOGY, V179, P665; INTENZO CM, 1991, CLIN NUCL MED, V16, P325, DOI 10.1097/00003072-199105000-00006; MAPP PI, 1993, OXFORD TXB RHEUMATOL; SCHEPSIS AA, 1991, CLIN ORTHOPAEDICS, V266, P185; SELMAN JR, 1994, FOOT ANKLE INT, V15, P376; Wall J R, 1993, Foot Ankle, V14, P465	6	29	29	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1400	1401		10.1016/S0140-6736(95)92409-4	http://dx.doi.org/10.1016/S0140-6736(95)92409-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475824				2022-12-24	WOS:A1995TG20700012
J	WINSTON, DJ				WINSTON, DJ			PREVENTION OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS	LANCET			English	Editorial Material							BONE-MARROW TRANSPLANTATION; IMMUNE GLOBULIN; GANCICLOVIR PROPHYLAXIS; VIRUS INFECTION; DOUBLE-BLIND; TRIAL				WINSTON, DJ (corresponding author), UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024, USA.							BOECKH M, 1994, 34TH INT C ANT AG CH, V7; BOWDEN RA, 1986, NEW ENGL J MED, V314, P1006, DOI 10.1056/NEJM198604173141602; GOODRICH JM, 1993, ANN INTERN MED, V118, P173, DOI 10.7326/0003-4819-118-3-199302010-00003; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; HIBBERD PL, 1995, ANN INTERN MED, V123, P18, DOI 10.7326/0003-4819-123-1-199507010-00002; MARTIN M, 1994, TRANSPLANTATION, V58, P225; PRENTICE HG, 1994, LANCET, V343, P749, DOI 10.1016/S0140-6736(94)91835-X; SINGH N, 1994, ANN INTERN MED, V120, P375, DOI 10.7326/0003-4819-120-5-199403010-00004; SNYDMAN DR, 1993, ANN INTERN MED, V119, P984, DOI 10.7326/0003-4819-119-10-199311150-00004; WINSTON DJ, 1993, ANN INTERN MED, V118, P179, DOI 10.7326/0003-4819-118-3-199302010-00004; WINSTON DJ, 1987, ANN INTERN MED, V106, P12, DOI 10.7326/0003-4819-106-1-12; WINSTON DJ, 1995, LANCET, V346, P69, DOI 10.1016/S0140-6736(95)92110-9; WINSTON DJ, IN PRESS TRANSPLANTA	13	21	21	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1380	1381		10.1016/S0140-6736(95)92401-9	http://dx.doi.org/10.1016/S0140-6736(95)92401-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475816	Bronze			2022-12-24	WOS:A1995TG20700004
J	BALDINI, N; SCOTLANDI, K; BARBANTIBRODANO, G; MANARA, MC; MAURICI, D; BACCI, G; BERTONI, F; PICCI, P; SOTTILI, S; CAMPANACCI, M; SERRA, M				BALDINI, N; SCOTLANDI, K; BARBANTIBRODANO, G; MANARA, MC; MAURICI, D; BACCI, G; BERTONI, F; PICCI, P; SOTTILI, S; CAMPANACCI, M; SERRA, M			EXPRESSION OF P-GLYCOPROTEIN IN HIGH-GRADE OSTEOSARCOMAS IN RELATION TO CLINICAL OUTCOME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIDRUG-RESISTANCE GENE; MONOCLONAL-ANTIBODIES; DRUG-RESISTANCE; OSTEO-SARCOMA; IMMUNOHISTOCHEMICAL DETECTION; MULTIPLE-MYELOMA; HUMAN CANCERS; CELL-LINES; CHEMOTHERAPY; VERAPAMIL	Background. Increased levels of P-glycoprotein occur in some osteosarcomas. In this study we determined the relation between P-glycoprotein status and outcome in patients with high-grade osteosarcoma. Methods. P-glycoprotein status was determined immunohistochemically in specimens of osteosarcoma of the extremities (stage II) from 92 patients who were treated with surgery and chemotherapy. The P-glycoprotein status was analyzed in relation to the length of event-free survival. Results. The presence of increased levels of P-glycoprotein in the osteosarcoma was significantly associated with a decreased probability of remaining event-free after diagnosis (P=0.002). In a multivariate analysis, P-glycoprotein status (P=0.001) and the extent of tumor necrosis after preoperative chemotherapy (P=0.04) were independent predictors of clinical outcome. The risk of adverse events was increased substantially (rate ratio, 3.37; 95 percent confidence interval, 1.60 to 7.10) among patients with increased levels of P-glycoprotein in tumor cells, as compared with patients who did not have increased levels of P-glycoprotein in tumor cells. Conclusions. In patients with high-grade osteosarcoma treated with surgery and chemotherapy, the presence of increased levels of P-glycoprotein in tumor cells is associated with a significantly increased risk of adverse events and is independent of the extent of necrosis after preoperative chemotherapy.			BALDINI, N (corresponding author), IST ORTOPED RIZZOLI,DIPARTIMENTO ONCOL,RIC ONCOL LAB,VIA BARBIANO 1-10,I-40136 BOLOGNA,ITALY.		Baldini, Nicola/J-4806-2016; Scotlandi, Katia/J-9009-2016; Serra, Massimo/J-4878-2016; Manara, Maria Cristina/K-3366-2018; Picci, Piero/J-5979-2016	Baldini, Nicola/0000-0003-2228-3833; Scotlandi, Katia/0000-0001-6114-9499; Serra, Massimo/0000-0003-0742-1177; Manara, Maria Cristina/0000-0001-5686-720X; Picci, Piero/0000-0002-8519-4101; Barbanti Brodano, Giovanni/0000-0002-7075-7020				BACCI G, 1993, CANCER, V72, P3227, DOI 10.1002/1097-0142(19931201)72:11<3227::AID-CNCR2820721116>3.0.CO;2-C; BALDINI N, IN PRESS EUR J CELL; Blaney S M, 1993, Cancer Treat Res, V62, P55; BOIOCCHI M, 1992, EUR J CANCER, V28A, P1099, DOI 10.1016/0959-8049(92)90465-E; BRADLEY G, 1994, CANCER METAST REV, V13, P223, DOI 10.1007/BF00689638; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; CAMPANACCI M, 1981, CANCER, V48, P1569, DOI 10.1002/1097-0142(19811001)48:7<1569::AID-CNCR2820480717>3.0.CO;2-X; CHAN HSL, 1990, J CLIN ONCOL, V8, P689, DOI 10.1200/JCO.1990.8.4.689; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; COX DR, 1972, J R STAT SOC B, V34, P187; DAHLIN DC, 1977, AM J SURG PATHOL, V1, P61, DOI 10.1097/00000478-197701010-00007; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; EILBER F, 1987, J CLIN ONCOL, V5, P21, DOI 10.1200/JCO.1987.5.1.21; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, V153, P106; FIENBERG SE, 1977, ANAL CROSS CLASSIFIE, P8; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; GERLACH JH, 1987, J CLIN ONCOL, V5, P1452, DOI 10.1200/JCO.1987.5.9.1452; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROGAN T, 1990, LAB INVEST, V63, P815; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; LINK MP, 1991, CLIN ORTHOP RELAT R, V270, P8; MILLER RG, 1981, SURVIVAL ANAL, P44; OMEARA A, 1992, ONCOLOGY, V49, P203; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; SALMON SE, 1991, BLOOD, V78, P44; SAMUELS BL, 1991, CANCER RES, V51, P521; SCHEPER RJ, 1988, INT J CANCER, V42, P389, DOI 10.1002/ijc.2910420314; SCHLAIFER D, 1991, BRIT J CANCER, V63, P164; SCHLAIFER D, 1990, BRIT J CANCER, V62, P177, DOI 10.1038/bjc.1990.256; SERRA M, 1993, ANTICANCER RES, V13, P323; SERRA M, IN PRESS EUR J CANCE; SIKIC BI, 1993, J CLIN ONCOL, V11, P1629, DOI 10.1200/JCO.1993.11.9.1629; SONNEVELD P, 1992, LANCET, V340, P255, DOI 10.1016/0140-6736(92)92353-H; SONNEVELD P, 1994, J CLIN ONCOL, V12, P1584, DOI 10.1200/JCO.1994.12.8.1584; STEIN U, 1993, EUR J CANCER, V29A, P1979, DOI 10.1016/0959-8049(93)90457-Q; TAWA A, 1990, CANCER, V66, P1980, DOI 10.1002/1097-0142(19901101)66:9<1980::AID-CNCR2820660922>3.0.CO;2-E; TOFFOLI G, 1992, ANN ONCOL, V3, P63, DOI 10.1093/oxfordjournals.annonc.a058073; TWENTYMAN PR, 1992, BIOCHEM PHARMACOL, V43, P109, DOI 10.1016/0006-2952(92)90668-9; VANDERVALK P, 1990, ANN ONCOL, V1, P56; VERGIER B, 1993, BRIT J CANCER, V68, P1221, DOI 10.1038/bjc.1993.508; WUNDER JS, 1993, J ORTHOPAED RES, V11, P396, DOI 10.1002/jor.1100110311; YUEN AR, 1994, J CLIN ONCOL, V12, P2453, DOI 10.1200/JCO.1994.12.11.2453; YUSA K, 1989, CANCER RES, V49, P5002; Zelterman D., 1992, MED USES STAT, P293	49	346	358	0	8	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	1995	333	21					1380	1385		10.1056/NEJM199511233332103	http://dx.doi.org/10.1056/NEJM199511233332103			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF521	7477118				2022-12-24	WOS:A1995TF52100003
J	LEE, KF; SIMON, H; CHEN, H; BATES, B; HUNG, MC; HAUSER, C				LEE, KF; SIMON, H; CHEN, H; BATES, B; HUNG, MC; HAUSER, C			REQUIREMENT FOR NEUREGULIN RECEPTOR ERBB2 IN NEURAL AND CARDIAC DEVELOPMENT	NATURE			English	Article							NERVOUS-SYSTEM; TRIGEMINAL MOTONEURONS; CHICK-EMBRYOS; CREST CELLS; EXPRESSION; MIGRATION; GANGLIA; DIFFERENTIATION; HINDBRAIN; PROTEIN	THE receptor erbB2/neu is a member of the epidermal growth factor receptor (EGFR or erbB) family that also includes erbB3 and erbB4(1). Amplification of the erbB2/neu gene is found in many cancer types and its overexpression is correlated with a poor prognosis for breast and ovarian cancer patients(2). Investigation of the biology of erbB2 led to the identification of a family of ligands termed neuregulins which included the neu-differentiation factors(3,4), the heregulins(5), a ligand with acctylcholine-receptor-inducing activity(6) and glial growth factor(7). Several lines of evidence suggest that heterodimerization of erbB2 with other erbB receptors is required for neuregulin signalling(1). Here we investigate the developmental role of erbB2 in mammalian development in mice carrying an erbB2 null allele. We find that mutant embryos die before E11, probably as a result of dysfunctions associated with a lack of cardiac trabeculae. Development of cranial neural-crest-derived sensory ganglia was markedly affected, DiI retrograde tracing revealed that the development of motor nerves was also compromised. Our results demonstrate the importance of erbB2 in neural and cardiac development.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030; WHITEHEAD INST,CAMBRIDGE,MA 02142	University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute	LEE, KF (corresponding author), SALK INST BIOL STUDIES,CLAYTON FDN LABS PEPTIDE BIOL,10010 N TORREY PINES RD,LA JOLLA,CA 92037, USA.		Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740				CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P1; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DENT JA, 1989, DEVELOPMENT, V105, P61; DONG Z, 1995, NEURON, V15, P589; EASTER SS, 1993, J NEUROSCI, V13, P285; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; LEDOUARIN NM, 1988, ANNU REV CELL BIOL, V4, P375, DOI 10.1146/annurev.cb.04.110188.002111; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEYER D, 1995, NATURE, V378, P394; MEYER D, 1994, P NATL ACAD SCI USA, V94, P1064; MOODY SA, 1983, J COMP NEUROL, V213, P344, DOI 10.1002/cne.902130309; MOODY SA, 1983, J COMP NEUROL, V213, P327, DOI 10.1002/cne.902130308; NICHOLS DH, 1981, J EMBRYOL EXP MORPH, V64, P105; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; PRESS MF, 1990, ONCOGENE, V5, P953; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WESTON JA, 1966, DEV BIOL, V14, P246, DOI 10.1016/0012-1606(66)90015-7; WHITE MRA, 1992, ONCOGENE, V7, P677	32	1001	1037	2	32	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					394	398		10.1038/378394a0	http://dx.doi.org/10.1038/378394a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477377				2022-12-24	WOS:A1995TF89300061
J	KLEIN, DF				KLEIN, DF			RESPIRATION DISORDERS IN PANIC ATTACKS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											KLEIN, DF (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	1995	274	19					1504	1504						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD571	7474207				2022-12-24	WOS:A1995TD57100011
J	MIXON, MB; LEE, E; COLEMAN, DE; BERGHUIS, AM; GILMAN, AG; SPRANG, SR				MIXON, MB; LEE, E; COLEMAN, DE; BERGHUIS, AM; GILMAN, AG; SPRANG, SR			TERTIARY AND QUATERNARY STRUCTURAL-CHANGES IN G(I-ALPHA-1) INDUCED BY GTP HYDROLYSIS	SCIENCE			English	Article							GAMMA-SUBUNIT COMPLEX; BETA-GAMMA; G-PROTEIN; ALPHA-SUBUNIT; SIGNAL-TRANSDUCTION; GUANINE-NUCLEOTIDES; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; BINDING; DISAGGREGATION	Crystallographic analysis of 2.2 angstrom resolution shows that guanosine triphosphate (GTP) hydrolysis triggers conformational changes in the heterotrimeric G-protein alpha subunit, G(i alpha 1). The switch II and switch III segments become disordered, and linker II connecting the Ras and alpha helical domains moves, thus altering the structures of potential effector and beta gamma binding regions. Contacts between the alpha-helical and Ras domains are weakened, possibly facilitating the release of guanosine diphosphate (GDP). The amino and carboxyl termini, which contain receptor and beta gamma binding determinants, are disordered in the complex with GTP, but are organized into a compact microdomain on GDP hydrolysis. The amino terminus also forms extensive quaternary contacts with neighboring alpha subunits in the lattice, suggesting that multimers of alpha subunits or heterotrimers may play a role in signal transduction.	UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Berghuis, Albert M/A-6495-2008	Berghuis, Albert/0000-0002-2663-025X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034497, R01GM034497] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 46371] Funding Source: Medline; NIGMS NIH HHS [GM34497] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BERGHUIS A, UNPUB; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHAKRABARTI P, 1993, J MOL BIOL, V234, P463, DOI 10.1006/jmbi.1993.1599; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CODINA J, 1994, J BIOL CHEM, V269, P29339; COLEMAN DC, UNPUB; COLEMAN DE, 1994, J MOL BIOL, V238, P630, DOI 10.1006/jmbi.1994.1320; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; COPLEY RR, 1994, J MOL BIOL, V242, P321; COULTER S, 1992, P NATL ACAD SCI USA, V89, P5842, DOI 10.1073/pnas.89.13.5842; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAF R, 1992, J BIOL CHEM, V267, P24307; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HINGORANI VN, 1988, J BIOL CHEM, V263, P6916; JAHANGEER S, 1993, P NATL ACAD SCI USA, V90, P8782, DOI 10.1073/pnas.90.19.8782; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES TA, 1990, UNPUB O VERSION 5 6; KLEUSS C, UNPUB; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE E, 1992, J BIOL CHEM, V267, P1212; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NAKAMURA S, 1990, P NATL ACAD SCI USA, V87, P6413, DOI 10.1073/pnas.87.16.6413; NAKAMURA SI, 1991, P NATL ACAD SCI USA, V88, P7150, DOI 10.1073/pnas.88.16.7150; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEER EJ, 1988, J BIOL CHEM, V263, P8996; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NICHOLLS A, 1992, GRASP GRAPHIC REPRES; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RODBELL M, 1992, CURR TOP CELL REGUL, V32, P1; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; VAILLANCOURT RR, 1990, P NATL ACAD SCI USA, V87, P3645, DOI 10.1073/pnas.87.10.3645; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	58	260	261	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	1995	270	5238					954	960		10.1126/science.270.5238.954	http://dx.doi.org/10.1126/science.270.5238.954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481799				2022-12-24	WOS:A1995TD87800038
J	TALBOT, WS; TREVARROW, B; HALPERN, ME; MELBY, AE; FARR, G; POSTLETHWAIT, JH; JOWETT, T; KIMMEL, CB; KIMELMAN, D				TALBOT, WS; TREVARROW, B; HALPERN, ME; MELBY, AE; FARR, G; POSTLETHWAIT, JH; JOWETT, T; KIMMEL, CB; KIMELMAN, D			A HEMEOBOX GENE ESSENTIAL FOR ZEBRAFISH NOTOCHORD DEVELOPMENT	NATURE			English	Article							HOMEO-BOX GENE; MOUSE T-GENE; FLOOR PLATE; MESODERM FORMATION; EMPTY SPIRACLES; XENOPUS-LAEVIS; NEURAL-TUBE; EMBRYO; EXPRESSION; INDUCTION	The notochord is a midline mesodermal structure with an essential patterning function in all vertebrate embryos. Zebrafish floating head (flh) mutants lack a notochord, but develop with prechordal plate and other mesodermal derivatives, indicating that flh functions specifically in notochord development. We show that floating head Is the zebrafish homologue of Xnot, a homeobox gene expressed In the amphibian organizer and notochord. We propose that flh regulates notochord precursor cell fate.	UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403; UNIV NEWCASTLE UPON TYNE,DEPT BIOCHEM & GENET,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND	University of Washington; University of Washington Seattle; University of Oregon; Newcastle University - UK					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTABA ARI, 1992, DEVELOPMENT, V116, P81; ALTABA ARI, 1992, DEVELOPMENT, V115, P67; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; DIRKSEN ML, 1992, GENE DEV, V6, P599, DOI 10.1101/gad.6.4.599; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; GONT LK, 1993, DEVELOPMENT, V119, P991; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1995, DEVELOPMENT, V121, P4257; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HELDE KA, 1993, DEV BIOL, V159, P418, DOI 10.1006/dbio.1993.1252; HENION PD, IN PRESS DEV GENET; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Ho R.K., 1992, Seminars in Developmental Biology, V3, P53; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KESSAIN S, 1993, ADV DEV BIOL, V2, P1; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; OPPENHEIMER JM, 1959, J EXP ZOOL, V140, P247, DOI 10.1002/jez.1401400205; PIKE SH, 1992, DEVELOPMENT, V144, P825; PLACZEK M, 1990, SCIENCE, V250, P985, DOI 10.1126/science.2237443; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SASAKI H, 1993, DEVELOPMENT, V118, P47; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; STEIN S, 1995, MECH DEVELOP, V49, P37, DOI 10.1016/0925-4773(94)00300-C; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; THISSE C, 1993, DEVELOPMENT, V119, P1203; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308	51	404	408	0	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					150	157		10.1038/378150a0	http://dx.doi.org/10.1038/378150a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477317				2022-12-24	WOS:A1995TD75900043
J	CHEN, YM; CHEN, CF; RILEY, DJ; ALLRED, DC; CHEN, PL; VONHOFF, D; OSBORNE, CK; LEE, WH				CHEN, YM; CHEN, CF; RILEY, DJ; ALLRED, DC; CHEN, PL; VONHOFF, D; OSBORNE, CK; LEE, WH			ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER	SCIENCE			English	Article							GLUCOCORTICOID RECEPTOR; NUCLEAR-LOCALIZATION; CELL-CYCLE; HORMONE; PROTEIN; PHOSPHORYLATION; EXPRESSION; CLONING; GENE	The BRCA1 gene product was identified as a 220-kilodalton nuclear phosphoprotein in normal cells, including breast ductal epithelial cells, and in 18 of 20 tumor cell lines derived from tissues other than breast and ovary. In 16 of 17 breast and ovarian cancer lines and 17 of 17 samples of cells obtained from malignant effusions, however, BRCA1 localized mainly in cytoplasm. Absence of BRCA1 or aberrant subcellular location was also observed to a variable extent in histological sections of many breast cancer biopsies. These findings suggest that BRCA1 abnormalities may be involved in the pathogenesis of many breast cancers, sporadic as well as familial.	UNIV TEXAS, HLTH SCI CTR, CTR MOLEC MED, INST BIOTECHNOL, SAN ANTONIO, TX 78245 USA; UNIV TEXAS, HLTH SCI CTR, DEPT PATHOL, SAN ANTONIO, TX 78284 USA; UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV MED ONCOL, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio				Chen, Chi-Fen/0000-0002-6391-821X	NCI NIH HHS [CA58318, P50CA58183] Funding Source: Medline; NEI NIH HHS [EY05758] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058183] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; BOYD J, 1995, NAT GENET, V9, P335, DOI 10.1038/ng0495-335; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chen Y, UNPUB; CHEN YM, 1994, MOL CELL BIOL, V14, P6764, DOI 10.1128/MCB.14.10.6764; CLAUS EB, 1991, AM J HUM GENET, V48, P232; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jensen E V, 1991, Curr Top Pathol, V83, P365; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; LAUDET V, 1991, NUCLEIC ACIDS RES, V19, P1105, DOI 10.1093/nar/19.5.1105; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; SCHNEIDER J, 1988, CELL, V54, P117, DOI 10.1016/0092-8674(88)90185-7; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; VOGELSTEIN B, 1994, CELL, V79, P1, DOI 10.1016/0092-8674(94)90393-X	29	286	304	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	1995	270	5237					789	791		10.1126/science.270.5237.789	http://dx.doi.org/10.1126/science.270.5237.789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481765				2022-12-24	WOS:A1995TC71200037
J	OKAMURA, H; TSUTSUI, H; KOMATSU, T; YUTSUDO, M; HAKURA, A; TANIMOTO, T; TORIGOE, K; OKURA, T; NUKADA, Y; HATTORI, K; AKITA, K; NAMBA, M; TANABE, F; KONISHI, K; FUKUDA, S; KURIMOTO, M				OKAMURA, H; TSUTSUI, H; KOMATSU, T; YUTSUDO, M; HAKURA, A; TANIMOTO, T; TORIGOE, K; OKURA, T; NUKADA, Y; HATTORI, K; AKITA, K; NAMBA, M; TANABE, F; KONISHI, K; FUKUDA, S; KURIMOTO, M			CLONING OF A NEW CYTOKINE THAT INDUCES IFN-GAMMA PRODUCTION BY T-CELLS	NATURE			English	Article								THE mechanism underlying the differentiation of CD4(+) T cells into functionally distinct subsets (Th1 and Th2) is incompletely understood(1-3), and hitherto unidentified cytokines may be required for the functional maturation of these cells(4). Here we report the cloning of a recently identified IFN-gamma-inducing factor (IGIF) that augments natural killer (NK) activity in spleen cells(5,6). The gene encodes a precursor protein of 192 amino acids and a mature protein of 157 amino acids, which have no obvious similarities to any peptide in the databases. Messenger RNAs for IGIF and interleukin-12 (IL-12) are readily detected in Kupffer cells and activated macrophages. Recombinant IGIF induces IFN-gamma more potently than does IL-12, apparently through a separate pathway. Administration of anti-IGIF antibodies prevents liver damage in mice inoculated with Propionibacterium acnes and challenged with lipopolysaccharide, which induces toxic shock. IGIF may he involved in the development of Th1 cells and also in mechanisms of tissue injury in inflammatory reactions.	HYOGO MED UNIV,DEPT IMMUNOL & MED ZOOL,NISHINOMIYA,HYOGO,JAPAN; OSAKA CITY UNIV,TONEYAMA INST TB,TOYONAKA,OSAKA,JAPAN; INST MICROBIAL DIS,SUITA,OSAKA,JAPAN; HAYASHIBARA CO INC,FUJISAKI INST,HAYASHIBARA BIOCHEM LABS,OKAYAMA,JAPAN	Hyogo College of Medicine; University of Hyogo; Osaka Metropolitan University; Hayashibara Biochemical Laboratories, Inc.	OKAMURA, H (corresponding author), HYOGO MED UNIV,DEPT BACTERIOL,1-1 MUKOGAWA CHO,NISHINOMIYA,HYOGO,JAPAN.			Tsutsui, Hiroko/0000-0001-7928-4875				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EYHORN S, 1988, J HEPATOL, V6, P23, DOI 10.1016/S0168-8278(88)80459-8; FERLUGA J, 1978, LANCET, P661; KARASUYAMA H, 1989, J EXP MED, V196, P13; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LOCKSLEY RM, 1993, P NATL ACAD SCI USA, V90, P5879, DOI 10.1073/pnas.90.13.5879; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NAKAMURA K, 1993, INFECT IMMUN, V61, P64, DOI 10.1128/IAI.61.1.64-70.1993; OKAMURA H, IN PRESS INFECT IMMU; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; TSUTSUI H, 1992, HEPATO-GASTROENTEROL, V39, P553; WYNN TA, 1994, J EXP MED, V179, P1551, DOI 10.1084/jem.179.5.1551; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	13	2253	2526	4	63	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					88	91		10.1038/378088a0	http://dx.doi.org/10.1038/378088a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477296				2022-12-24	WOS:A1995TC46900057
J	KEMPER, K; FORSYTH, B				KEMPER, K; FORSYTH, B			MEDICALLY UNNECESSARY HOSPITAL USE IN CHILDREN SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									YALE UNIV,SCH MED,DEPT PEDIAT,DIV GEN PEDIAT,NEW HAVEN,CT 06510	Yale University								BAUMSLAG N, 1987, LANCET, V2, P400; BERTHIER A, 1986, LANCET, V2, P598; BLANCHE S, 1986, J PEDIATR-US, V109, P965, DOI 10.1016/S0022-3476(86)80277-3; DOWDLE WR, 1987, SURGEON GENERALS WOR, P20; DUFF RS, 1972, PEDIATRICS, V49, P169; FELDBLUM PJ, 1988, AM J PUBLIC HEALTH, V78, P52, DOI 10.2105/AJPH.78.1.52; FISCHL MA, 1987, JAMA-J AM MED ASSOC, V257, P640, DOI 10.1001/jama.257.5.640; Fleiss JL, 1981, STAT METHODS RATES P; FRANCIS DP, 1987, JAMA-J AM MED ASSOC, V257, P1357, DOI 10.1001/jama.257.10.1357; FRIEDLAND GH, 1987, NEW ENGL J MED, V317, P1125, DOI 10.1056/NEJM198710293171806; FUJIKAWA LS, 1985, LANCET, V2, P529; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; GLASS RM, 1988, JAMA-J AM MED ASSOC, V259, P1369, DOI 10.1001/jama.259.9.1369; HO DD, 1985, NEW ENGL J MED, V313, P1606; HOFF R, 1988, NEW ENGL J MED, V318, P525, DOI 10.1056/NEJM198803033180901; KAPLAN JE, 1985, PEDIATR INFECT DIS J, V4, P468, DOI 10.1097/00006454-198509000-00004; KAPLAN LD, 1987, JAMA-J AM MED ASSOC, V257, P1367; KEMPER KJ, 1988, NEW ENGL J MED, V318, P1033, DOI 10.1056/NEJM198804213181605; KUSHNIK H, 1987, SURGEON GENERALS WOR, P48; LEPAGE P, 1987, LANCET, V2, P400; LIFSON AR, 1988, JAMA-J AM MED ASSOC, V259, P1353, DOI 10.1001/jama.259.9.1353; LOVEJOY FH, 1971, J PEDIATR-US, V79, P868, DOI 10.1016/S0022-3476(71)80408-0; MARZUK PM, 1988, JAMA-J AM MED ASSOC, V259, P1333, DOI 10.1001/jama.259.9.1333; MATTHEWS GW, 1987, JAMA-J AM MED ASSOC, V257, P344, DOI 10.1001/jama.257.3.344; MEYER KB, 1987, NEW ENGL J MED, V317, P238, DOI 10.1056/NEJM198707233170410; MOK JQ, 1987, LANCET, V1, P1164; OLESKE J, 1988, 56TH ANN M AM AC PED; OLESKE J, 1987, AAP NEWS         NOV, P2; OPPENHEIMER GM, 1986, HASTINGS CENT REP, V16, P18, DOI 10.2307/3562690; PAHWA S, 1986, JAMA-J AM MED ASSOC, V255, P2299, DOI 10.1001/jama.255.17.2299; QUINN TC, 1987, SURGEON GENERAL WORK, P7; ROGERS MF, 1987, PEDIATRICS, V79, P1008; RUBENSTEIN A, 1987, SURGEON GENERALS WOR, P29; RUBINSTEIN A, 1986, CURR PROBL PEDIATR, V16, P365; SCHECHTER MT, 1985, LANCET, V1, P379; SCOTT GB, 1985, JAMA-J AM MED ASSOC, V253, P363, DOI 10.1001/jama.253.3.363; SCOTT GB, 1984, NEW ENGL J MED, V310, P76, DOI 10.1056/NEJM198401123100202; SIU AL, 1988, JAMA-J AM MED ASSOC, V259, P1343, DOI 10.1001/jama.259.9.1343; TERVO T, 1986, LANCET, V1, P379; WAHN V, 1986, LANCET, V2, P694; WEINBERG DS, 1987, NEW ENGL J MED, V317, P1469, DOI 10.1056/NEJM198712033172309; 1987, MMWR, V36, P728; 1988, MMWR, V27, P1; 1986, MMWR, V35, P595; 1987, SURVEILLANCE REPORT; 1988, MMWR, V36, P833; 1987, FDA DRUG B, V17, P14; 1988, PEDIATR NEWS     JAN, P30; 1988, AJDC, V142, P267; 1988, AIDS WEEKLY SURVEILL	50	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	1988	260	13					1906	1909		10.1001/jama.260.13.1906	http://dx.doi.org/10.1001/jama.260.13.1906			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2703	3418852				2022-12-24	WOS:A1988Q270300025
J	HORIKOSHI, M; HAI, T; LIN, YS; GREEN, MR; ROEDER, RG				HORIKOSHI, M; HAI, T; LIN, YS; GREEN, MR; ROEDER, RG			TRANSCRIPTION FACTOR ATF INTERACTS WITH THE TATA FACTOR TO FACILITATE ESTABLISHMENT OF A PREINITIATION COMPLEX	CELL			English	Article									HARVARD UNIV, DEPT BIOCHEM & MOLEC BIOL, CAMBRIDGE, MA 02138 USA	Harvard University	HORIKOSHI, M (corresponding author), ROCKEFELLER UNIV, BIOCHEM & MOLEC BIOL LAB, NEW YORK, NY 10021 USA.		Hai, Tsonwin/H-4480-2011; Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315				ABMAYR SM, 1988, GENE DEV, V2, P542, DOI 10.1101/gad.2.5.542; BITTER GA, 1983, ANAL BIOCHEM, V128, P294, DOI 10.1016/0003-2697(83)90378-0; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROWN DD, 1984, CELL, V37, P359, DOI 10.1016/0092-8674(84)90366-0; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FIRE A, 1984, J BIOL CHEM, V259, P2509; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HAI T, 1988, CELL, V54, P1043, DOI 10.1016/0092-8674(88)90119-5; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HEINTZ N, 1984, P NATL ACAD SCI-BIOL, V81, P2713, DOI 10.1073/pnas.81.9.2713; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MIZUSHIMASUGANO J, 1986, P NATL ACAD SCI USA, V83, P8511, DOI 10.1073/pnas.83.22.8511; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NAKAJIMA N, 1988, IN PRESS MOL CELL BI; Ptashne M., 1986, A GENETIC SWITCH; REINBERG D, 1987, J BIOL CHEM, V262, P3310; REINBERG D, 1987, J BIOL CHEM, V262, P3322; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SERFLING E, 1985, TRENDS GENET, V1, P224, DOI 10.1016/0168-9525(85)90088-5; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; TOPOL J, 1985, CELL, V42, P527, DOI 10.1016/0092-8674(85)90110-2; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; WIEDERRECHT G, 1987, CELL, V48, P507, DOI 10.1016/0092-8674(87)90201-7; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	51	409	411	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 23	1988	54	7					1033	1042		10.1016/0092-8674(88)90118-3	http://dx.doi.org/10.1016/0092-8674(88)90118-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	Q3063	3416354				2022-12-24	WOS:A1988Q306300016
J	ROUAULT, TA; HENTZE, MW; CAUGHMAN, SW; HARFORD, JB; KLAUSNER, RD				ROUAULT, TA; HENTZE, MW; CAUGHMAN, SW; HARFORD, JB; KLAUSNER, RD			BINDING OF A CYTOSOLIC PROTEIN TO THE IRON-RESPONSIVE ELEMENT OF HUMAN FERRITIN MESSENGER-RNA	SCIENCE			English	Article											ROUAULT, TA (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892, USA.		Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876				AZIZ N, 1986, NUCLEIC ACIDS RES, V14, P915, DOI 10.1093/nar/14.2.915; BROWN AJP, 1983, P NATL ACAD SCI-BIOL, V80, P1265, DOI 10.1073/pnas.80.5.1265; CAREY J, 1983, BIOCHEMISTRY, V24, P4239; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; DIDSBURY JR, 1987, J BIOL CHEM, V261, P7901; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HENTZE MW, IN PRESS GENE; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; ROGERS J, 1987, P NATL ACAD SCI USA, V84, P2277, DOI 10.1073/pnas.84.8.2277; ROUAULT TA, 1987, P NATL ACAD SCI USA, V84, P6335, DOI 10.1073/pnas.84.18.6335; ROUAULT TA, UNPUB; STEVENS PW, 1987, MOL CELL BIOL, V7, P1751, DOI 10.1128/MCB.7.5.1751; ZAHRINGER J, 1976, P NATL ACAD SCI USA, V73, P857, DOI 10.1073/pnas.73.3.857; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	17	327	327	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 2	1988	241	4870					1207	1210		10.1126/science.3413484	http://dx.doi.org/10.1126/science.3413484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9021	3413484				2022-12-24	WOS:A1988P902100034
J	HUGHES, SM; LILLIEN, LE; RAFF, MC; ROHRER, H; SENDTNER, M				HUGHES, SM; LILLIEN, LE; RAFF, MC; ROHRER, H; SENDTNER, M			CILIARY NEUROTROPHIC FACTOR INDUCES TYPE-2 ASTROCYTE DIFFERENTIATION IN CULTURE	NATURE			English	Article									UNIV LONDON UNIV COLL,DEPT BIOL,MRC,DEV NEUROBIOL PROGRAM,LONDON WC1E 6BT,ENGLAND; MAX PLANCK INST PSYCHIAT,DEPT NEUROCHEM,D-8033 MARTINSRIED,FED REP GER	University of London; University College London; Max Planck Society			Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014; Hughes, Simon M/S-1073-2016	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Hughes, Simon M/0000-0001-8227-9225				BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; HARPER GP, 1983, NEUROSCIENCE, V8, P375, DOI 10.1016/0306-4522(83)90073-8; HELFAND SL, 1976, DEV BIOL, V50, P541, DOI 10.1016/0012-1606(76)90174-3; HUGHES SM, 1987, DEVELOPMENT, V101, P157; LAEMMLI UK, 1974, J MOL BIOL, V80, P577; LEMKE GE, 1984, J NEUROSCI, V4, P75; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LILLIEN LE, IN PRESS NEURON; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MILLER RH, IN PRESS A REV NEURO; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; NOBLE M, 1988, NATURE, V333, P559; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PRUSS RM, 1979, NATURE, V280, P688, DOI 10.1038/280688a0; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; ROHRER H, 1987, BIOL CHEM H-S, V368, P1290; RUDGE JS, 1987, DEV BRAIN RES, V32, P103, DOI 10.1016/0165-3806(87)90143-X; RUDGE JS, 1985, DEV BRAIN RES, V19, P161, DOI 10.1016/0165-3806(85)90188-9; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; WILLIAMS BP, 1985, DEV BIOL, V112, P126, DOI 10.1016/0012-1606(85)90126-5	31	286	296	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 1	1988	335	6185					70	73		10.1038/335070a0	http://dx.doi.org/10.1038/335070a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9022	3412463	Green Submitted			2022-12-24	WOS:A1988P902200056
J	GUSS, JM; MERRITT, EA; PHIZACKERLEY, RP; HEDMAN, B; MURATA, M; HODGSON, KO; FREEMAN, HC				GUSS, JM; MERRITT, EA; PHIZACKERLEY, RP; HEDMAN, B; MURATA, M; HODGSON, KO; FREEMAN, HC			PHASE DETERMINATION BY MULTIPLE-WAVELENGTH X-RAY-DIFFRACTION - CRYSTAL-STRUCTURE OF A BASIC BLUE COPPER PROTEIN FROM CUCUMBERS	SCIENCE			English	Article									STANFORD UNIV, STANFORD SYNCHROTRON RADIAT LAB, STANFORD, CA 94309 USA; STANFORD UNIV, DEPT CHEM, STANFORD, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University	GUSS, JM (corresponding author), UNIV SYDNEY, DEPT INORGAN CHEM, SYDNEY, NSW 2006, AUSTRALIA.		Guss, Jules M/B-1283-2009; Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079				ADAM A, 1985, MICROBIOLOGY FERMENT, V1, P1; ADMAN ET, 1981, ISRAEL J CHEM, V21, P8, DOI 10.1002/ijch.198100003; AIKAZYAN VT, 1981, BIOCHIM BIOPHYS ACTA, V667, P421, DOI 10.1016/0005-2795(81)90208-7; AIKAZYAN VT, 1979, FEBS LETT, V104, P127, DOI 10.1016/0014-5793(79)81098-4; AINSCOUGH EW, 1987, BIOCHEMISTRY-US, V26, P71, DOI 10.1021/bi00375a011; ALKAZYAN VT, 1975, FEBS LETT, V55, P272, DOI 10.1016/0014-5793(75)81009-X; BERGMAN C, 1977, BIOCHEM BIOPH RES CO, V77, P1052, DOI 10.1016/S0006-291X(77)80084-3; BLAIR DF, 1985, J AM CHEM SOC, V107, P5755, DOI 10.1021/ja00306a025; BLOW DM, 1959, ACTA CRYSTALLOGR, V12, P794, DOI 10.1107/S0365110X59002274; COLMAN PM, 1978, NATURE, V272, P319, DOI 10.1038/272319a0; COLMAN PM, 1977, J MOL BIOL, V112, P649, DOI 10.1016/S0022-2836(77)80168-X; DAHLIN S, 1987, RECL TRAV CHIM PAY B, V106, P419; DAHLIN S, 1984, BIOCHEM J, V218, P609, DOI 10.1042/bj2180609; EICHHORN K, COMMUNICATION; ENGESETH HR, 1984, FEBS LETT, V171, P257, DOI 10.1016/0014-5793(84)80499-8; ENGESETH HR, 1984, J BIOL CHEM, V259, P4822; FALK KE, 1972, BIOCHIM BIOPHYS ACTA, V285, P84, DOI 10.1016/0005-2795(72)90182-1; FARVER O, 1987, BIOCHEMISTRY-US, V26, P7317, DOI 10.1021/bi00397a018; FARVER O, 1988, OXIDASES RELATED RED, P270; FERRIS NS, 1978, J AM CHEM SOC, V100, P5939, DOI 10.1021/ja00486a055; GEWIRTH AA, 1987, INORG CHEM, V26, P1133, DOI 10.1021/ic00254a032; Gray H. B., 1983, COMMENTS INORG CHEM, V2, P203; GUSS JM, 1983, J MOL BIOL, V169, P521; HARADA S, 1986, J APPL CRYSTALLOGR, V19, P448, DOI 10.1107/S0021889886088970; Hendrickson W. A., 1985, T AM CRYSTALLOGR ASS, V21, P11; HENDRICKSON WA, 1971, ACTA CRYSTALL B-STRU, VB 27, P1472, DOI 10.1107/S0567740871004175; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P41; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HILL HAO, 1979, J INORG BIOCHEM, V11, P101; Honl H, 1933, ANN PHYS-BERLIN, V18, P625; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KAHN R, 1985, FEBS LETT, V179, P133, DOI 10.1016/0014-5793(85)80207-6; KARLE J, 1980, INT J QUANTUM CHEM, V18, P357; KING G, 1984, FEBS LETT, V166, P288, DOI 10.1016/0014-5793(84)80097-6; KORSZUN ZR, 1987, J MOL BIOL, V196, P413, DOI 10.1016/0022-2836(87)90701-7; LYE RC, 1980, P NATL ACAD SCI-BIOL, V77, P5884, DOI 10.1073/pnas.77.10.5884; MALMSTRO.BG, 1970, BIOCHIM BIOPHYS ACTA, V205, P48, DOI 10.1016/0005-2728(70)90060-5; MARKOSSIAN KA, 1974, BIOCHIM BIOPHYS ACTA, V359, P47, DOI 10.1016/0005-2795(74)90130-5; MAUK AG, 1980, J AM CHEM SOC, V102, P4360, DOI 10.1021/ja00533a012; MCMASTER WH, 1969, UCRL50174 PUBL; MCMILLIN D R, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1339, DOI 10.1073/pnas.71.4.1339; MCMILLIN DR, 1981, P NATL ACAD SCI USA, V78, P6567, DOI 10.1073/pnas.78.11.6567; MERRITT EA, UNPUB DESCRIPTION GE; MIMS WB, 1984, BIOPHYS J, V45, P755, DOI 10.1016/S0006-3495(84)84219-8; MORPURGO L, 1972, BIOCHIM BIOPHYS ACTA, V271, P292, DOI 10.1016/0005-2795(72)90203-6; MURATA M, 1982, P NATL ACAD SCI-BIOL, V79, P6434, DOI 10.1073/pnas.79.21.6434; NERSISSIAN AM, 1985, BIOCHIM BIOPHYS ACTA, V830, P195, DOI 10.1016/0167-4838(85)90028-7; NORRIS GE, 1986, J AM CHEM SOC, V108, P2784, DOI 10.1021/ja00270a064; NORRIS GE, 1983, J MOL BIOL, V165, P501, DOI 10.1016/S0022-2836(83)80216-2; PAHLER A, UNPUB; PEISACH J, 1982, BIOPHYS J, V38, P277, DOI 10.1016/S0006-3495(82)84559-1; PEISACH J, 1967, J BIOL CHEM, V242, P2847; PETRATOS K, 1987, FEBS LETT, V218, P209, DOI 10.1016/0014-5793(87)81048-7; PHILLIPS JC, 1980, ACTA CRYSTALLOGR A, V36, P856, DOI 10.1107/S0567739480001817; PHILLIPS JC, 1977, ACTA CRYSTALLOGR A, V33, P445, DOI 10.1107/S0567739477001168; PHIZACKERLEY RP, 1986, NUCL INSTRUM METH A, V246, P579, DOI 10.1016/0168-9002(86)90157-9; REINHAMMAR B, 1987, RECL TRAV CHIM PAY B, V106, P360; REINHAMMAR BR, 1972, BIOCHIM BIOPHYS ACTA, V275, P245, DOI 10.1016/0005-2728(72)90045-X; ROBERTS JE, 1980, J AM CHEM SOC, V102, P825, DOI 10.1021/ja00522a063; RYDEN L, 1979, BIOCHIMIE, V61, P781, DOI 10.1016/S0300-9084(79)80272-2; SAKURAI T, 1982, FEBS LETT, V147, P220, DOI 10.1016/0014-5793(82)81046-6; SAKURAI T, 1986, INORG CHIM A-BIOINOR, V123, pL21, DOI 10.1016/S0020-1693(00)85668-6; SIIMAN O, 1976, J AM CHEM SOC, V98, P744, DOI 10.1021/ja00419a017; SMITH JL, 1987, ACTA CRYSTALLOGR A, V43, pC10; SOLOMON EI, 1980, J AM CHEM SOC, V102, P168, DOI 10.1021/ja00521a029; TANIGUCHI VT, 1980, PURE APPL CHEM, V52, P2275, DOI 10.1351/pac198052102275; TEMPLETON LK, 1982, ACTA CRYSTALLOGR A, V38, P74, DOI 10.1107/S056773948200014X; TENNENT DL, 1979, J AM CHEM SOC, V101, P2307, DOI 10.1021/ja00503a010; VICKERY LE, 1971, THESIS U CALIFORNIA; WANG BC, 1985, METHOD ENZYMOL, V115, P106; WHERLAND S, 1975, J AM CHEM SOC, V97, P5260, DOI 10.1021/ja00851a040	71	194	196	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	1988	241	4867					806	811		10.1126/science.3406739	http://dx.doi.org/10.1126/science.3406739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P6162	3406739				2022-12-24	WOS:A1988P616200021
J	STAUDT, LM; CLERC, RG; SINGH, H; LEBOWITZ, JH; SHARP, PA; BALTIMORE, D				STAUDT, LM; CLERC, RG; SINGH, H; LEBOWITZ, JH; SHARP, PA; BALTIMORE, D			CLONING OF A LYMPHOID-SPECIFIC CDNA-ENCODING A PROTEIN-BINDING THE REGULATORY OCTAMER DNA MOTIF	SCIENCE			English	Article									WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)			Staudt, Louis/AAC-5324-2019		NCI NIH HHS [P30-CAL4051, P01-CA42063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CILIBERTO G, 1985, EMBO J, V4, P1537, DOI 10.1002/j.1460-2075.1985.tb03814.x; DAVIDSON I, 1986, NATURE, V323, P544, DOI 10.1038/323544a0; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; FOSTER J, 1985, NATURE, V315, P423, DOI 10.1038/315423a0; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GOPOL TV, 1985, SCIENCE, V229, P1102; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LEBOWITZ J, UNPUB; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; MANIATIS T, 1982, MOL CLONING LABORATO; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; MATTAJ IW, 1985, NATURE, V316, P163, DOI 10.1038/316163a0; MURPHY JT, 1982, CELL, V29, P265, DOI 10.1016/0092-8674(82)90111-8; ONDEK B, 1987, EMBO J, V6, P1017, DOI 10.1002/j.1460-2075.1987.tb04854.x; PARSLOW TG, 1987, SCIENCE, V235, P1498, DOI 10.1126/science.3029871; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PICARD D, 1985, EMBO J, V4, P2831, DOI 10.1002/j.1460-2075.1985.tb04011.x; QUEEN C, 1984, MOL CELL BIOL, V4, P1042, DOI 10.1128/MCB.4.6.1042; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHIRM S, 1987, GENE DEV, V1, P65, DOI 10.1101/gad.1.1.65; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SIVE HL, 1986, MOL CELL BIOL, V6, P3329, DOI 10.1128/MCB.6.10.3329; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; STAUDT L, UNPUB; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0	37	278	296	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1988	241	4865					577	580		10.1126/science.3399892	http://dx.doi.org/10.1126/science.3399892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4350	3399892				2022-12-24	WOS:A1988P435000034
J	MURPHY, DJ; SELLERS, S; MACKENZIE, IZ; YUDKIN, PL; JOHNSON, AM				MURPHY, DJ; SELLERS, S; MACKENZIE, IZ; YUDKIN, PL; JOHNSON, AM			CASE-CONTROL STUDY OF ANTENATAL AND INTRAPARTUM RISK-FACTORS FOR CEREBRAL-PALSY IN VERY PRETERM SINGLETON BABIES	LANCET			English	Article							GERMINAL MATRIX HEMORRHAGE; LOW-BIRTH-WEIGHT; MATERNAL TOXEMIA; INFANTS; DELIVERY; CHORIOAMNIONITIS; INFECTION; NEWBORN; EVENTS; LABOR	The increase in survival of very preterm babies during the 1980s was accompanied by a sharp increase in the rate of cerebral palsy in this group. The relation between antenatal and intrapartum factors and cerebral palsy in such babies has not been well defined. To identify adverse and protective antenatal and intrapartum factors we undertook a case-control study of 59 very preterm babies who developed cerebral palsy, identified from a population-based register, and 234 randomly selected controls. The frequency of cerebral palsy decreased with increasing gestational age and birthweight. Antenatal complications occurred in 215 (73%) of the women with preterm deliveries. Factors associated with an increased risk of cerebral palsy after adjustment for gestational age were chorioamnionitis (odds ratio 4.2 [95% CI 1.4-12.0]) rupture of membranes (2.3 [1.2-4.2]), and infection (2.3 [1.2-4.5]). Pre-eclampsia was associated with a reduced risk of cerebral palsy (0.4 [0.2-0.9]), as was delivery without labour (0.3 [0.2-0.7]). There was no increased risk of cerebral palsy with intrauterine growth retardation (1.0 [0.9-1.1]). The effect of rigorous management of adverse antenatal factors on the frequency of cerebral palsy in very preterm babies should be tested in randomised controlled trials.	RADCLIFFE INFIRM,NATL PERINATAL EPIDEMIOL UNIT,OXFORD OX2 6HE,ENGLAND; JOHN RADCLIFFE NHS TRUST,NUFFIELD DEPT OBSTET & GYNAECOL,OXFORD,ENGLAND	Radcliffe Infirmary; University of Oxford				Murphy, Deirdre/0000-0001-6074-6718				AMON E, 1987, AM J OBSTET GYNECOL, V156, P1143, DOI 10.1016/0002-9378(87)90128-1; BERNAL AL, 1989, BRIT J OBSTET GYNAEC, V96, P1133, DOI 10.1111/j.1471-0528.1989.tb03187.x; BLAIR E, 1990, AM J OBSTET GYNECOL, V162, P229, DOI 10.1016/0002-9378(90)90856-3; CHENG LC, 1992, BRIT J OBSTET GYNAEC, V99, P817, DOI 10.1111/j.1471-0528.1992.tb14413.x; GAFFNEY G, 1994, BRIT MED J, V308, P743, DOI 10.1136/bmj.308.6931.743; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; JOHNSON A, 1989, COMMUNITY MED, V11, P352; KITCHEN W, 1985, OBSTET GYNECOL, V66, P149; KUBAN KCK, 1992, J CHILD NEUROL, V7, P70, DOI 10.1177/088307389200700113; LEVITON A, 1988, OBSTET GYNECOL, V72, P571; LEVITON A, 1990, EARLY HUM DEV, V24, P1, DOI 10.1016/0378-3782(90)90002-Z; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P549; MACDONALD D, 1985, AM J OBSTET GYNECOL, V152, P524, DOI 10.1016/0002-9378(85)90619-2; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; NELSON KB, 1985, JAMA-J AM MED ASSOC, V254, P1473, DOI 10.1001/jama.254.11.1473; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; NELSON KB, 1995, PEDIATRICS, V95, P263; O'Shea M, 1992, Paediatr Perinat Epidemiol, V6, P352, DOI 10.1111/j.1365-3016.1992.tb00775.x; OSHEA TM, 1991, PEDIATRICS; PETTERSON B, 1993, BRIT MED J, V307, P1239, DOI 10.1136/bmj.307.6914.1239; PHAROAH POD, 1990, ARCH DIS CHILD, V65, P602, DOI 10.1136/adc.65.6.602; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P336, DOI 10.1016/0002-9378(89)90515-2; SINHA SK, 1990, ARCH DIS CHILD-FETAL, V65, P1017, DOI 10.1136/adc.65.10_Spec_No.1017; TORFS CP, 1990, J PEDIATR-US, V116, P615, DOI 10.1016/S0022-3476(05)81615-4; TROUNCE JQ, 1988, ARCH DIS CHILD, V63, P17, DOI 10.1136/adc.63.1.17; VOHR B, 1992, J PEDIATR-US, V121, P280, DOI 10.1016/S0022-3476(05)81204-1; WEINDLING AM, 1985, BRIT J OBSTET GYNAEC, V92, P1218, DOI 10.1111/j.1471-0528.1985.tb04865.x; YU VYH, 1984, BRIT J OBSTET GYNAEC, V91, P633, DOI 10.1111/j.1471-0528.1984.tb04822.x; 1995, LANCET, V345, P1455	30	331	337	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 2	1995	346	8988					1449	1454		10.1016/S0140-6736(95)92471-X	http://dx.doi.org/10.1016/S0140-6736(95)92471-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490990				2022-12-24	WOS:A1995TH15600008
J	ROSENBERG, PS				ROSENBERG, PS			SCOPE OF THE AIDS EPIDEMIC IN THE UNITED-STATES	SCIENCE			English	Article							INCUBATION PERIOD; HOMOSEXUAL MEN; HIV-INFECTION; SAN-FRANCISCO; COHORT; PREVALENCE; THERAPY; AGE	Two-dimensional deconvolution techniques are used here to reconstruct age-specific human immunodeficiency virus(HIV) infection rates in the United States from surveillance data on acquired immunodeficiency syndrome (AIDS). This approach suggests that 630,000 to 897,000 adults and adolescents in the United States were living with HIV infection as of January 1993, including 107,000 to 150,000 women. The estimated incidence of HIV infection declined markedly over time among white males, especially those older than 30 years. In contrast, HIV incidence appears to have remained relatively constant among women and minorities. As of January 1993, prevalence was highest among young adults in their late twenties and thirties and among minorities. An estimated 3 percent of black men and 1 percent of black women in their thirties were living with HIV infection as of that date. If infection rates remain at these levels, HIV must be considered as endemic in the United States.			ROSENBERG, PS (corresponding author), NCI,ROCKVILLE,MD 20852, USA.			Rosenberg, Philip/0000-0001-6349-9126				BECKER NG, 1993, BIOMETRIKA, V80, P165, DOI 10.1093/biomet/80.1.165; BIGGAR RJ, 1990, AIDS, V4, P1059, DOI 10.1097/00002030-199011000-00002; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; GAIL MH, 1990, J ACQ IMMUN DEF SYND, V3, P296; GRAHAM NMH, 1991, J ACQ IMMUN DEF SYND, V4, P267; GWINN M, 1991, JAMA-J AM MED ASSOC, V265, P1704, DOI 10.1001/jama.265.13.1704; HENDRIKS JCM, 1993, AIDS, V7, P231, DOI 10.1097/00002030-199302000-00012; KARON JM, COMMUNICATION; LANG W, 1993, J ACQ IMMUN DEF SYND, V6, P191; MARIOTTO AB, 1992, AM J EPIDEMIOL, V135, P428, DOI 10.1093/oxfordjournals.aje.a116303; MCQUILLAN GM, 1994, J ACQ IMMUN DEF SYND, V7, P1195; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; ROSENBERG PS, 1994, AIDS, V8, P803, DOI 10.1097/00002030-199406000-00013; ROSENBERG PS, 1991, J ACQ IMMUN DEF SYND, V4, P392; ROSENBERG PS, 1992, STAT MED, V11, P1633, DOI 10.1002/sim.4780111302; ROSENBERG PS, 1994, STAT MED, V13, P1975, DOI 10.1002/sim.4780131909; VERDECCHIA A, 1994, INT J EPIDEMIOL, V23, P1027, DOI 10.1093/ije/23.5.1027; 1994, LANCET, V343, P871; 1987, MORB MORTAL WKLY S1, V36; 1992, MORB MORTAL WKLY REP, V41; 1990, MMWR-MORBID MORTAL W, V39, P110; 1994, MMWR-MORBID MORTAL W, V43, P826	24	150	152	1	2	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1372	1375		10.1126/science.270.5240.1372	http://dx.doi.org/10.1126/science.270.5240.1372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481828				2022-12-24	WOS:A1995TF89900043
J	GASSMANN, M; CASAGRANDA, F; ORIOLI, D; SIMON, H; LAI, C; KLEIN, R; LEMKE, G				GASSMANN, M; CASAGRANDA, F; ORIOLI, D; SIMON, H; LAI, C; KLEIN, R; LEMKE, G			ABERRANT NEURAL AND CARDIAC DEVELOPMENT IN MICE LACKING THE ERBB4 NEUREGULIN RECEPTOR	NATURE			English	Article							GLIAL GROWTH-FACTOR; NERVOUS-SYSTEM; PROTEIN; FAMILY; HINDBRAIN; MEMBER; HER4/P180(ERBB4); IDENTIFICATION; PURIFICATION; DISRUPTION	VARIOUS in vitro studies have suggested that ErbB4 (HER4) is a receptor for the neuregulins, a family of closely related proteins implicated as regulators of neural and muscle development, and of the differentiation and oncogenic transformation of mammary epithelia(1-3). Here we demonstrate that ErbB4 is an essential in vivo regulator of both cardiac muscle differentiation and axon guidance in the central nervous system (CNS). Mice lacking ErbB4 die during mid-embryogenesis from the aborted development of myocardial trabeculae in the heart ventricle. They also display striking alterations in innervation of the hindbrain in the CNS that are consistent with the restricted expression of the ErbB4 gene in rhombomeres 3 and 5. Similarities in the cardiac phenotype of ErbB4 and neuregulin gene mutants suggest that ErbB4 functions as a neuregulin receptor in the heart; however, differences in the hindbrain phenotypes of these mutants are consistent with the action of a new ErbB4 ligand in the CNS.	EUROPEAN MOLEC BIOL LAB, DIFFERENTIAT PROGRAMME, D-69012 HEIDELBERG, GERMANY; Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA	European Molecular Biology Laboratory (EMBL); Scripps Research Institute	GASSMANN, M (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.		Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163; ORIOLI, DONATA/0000-0002-3830-3408; Gassmann, Martin/0000-0001-6201-3032				CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CHALLICE CE, 1974, TISSUE CELL, V6, P447, DOI 10.1016/0040-8166(74)90037-8; Chang H., 1994, Society for Neuroscience Abstracts, V20, P1694; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; COVELL DA, 1989, J COMP NEUROL, V286, P488, DOI 10.1002/cne.902860407; DENT JA, 1989, DEVELOPMENT, V105, P61; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GOODEARL ADJ, 1993, J BIOL CHEM, V268, P18095; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LEMKE GE, 1984, J NEUROSCI, V4, P75; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NIETO MA, 1991, DEVELOPMENT, P59; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SWLATEK PJ, 1993, GENE DEV, V7, P2071; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361	32	893	920	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	1995	378	6555					390	394		10.1038/378390a0	http://dx.doi.org/10.1038/378390a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477376				2022-12-24	WOS:A1995TF89300060
J	WHITFIELD, LS; SULSTON, JE; GOODFELLOW, PN				WHITFIELD, LS; SULSTON, JE; GOODFELLOW, PN			SEQUENCE VARIATION OF THE HUMAN Y-CHROMOSOME	NATURE			English	Article							DNA POLYMORPHISM	WE have generated over 100 kilobases of sequence from the nonrecombining portion of the Y chromosomes from five humans and one common chimpanzee. The human subjects were chosen to match the earliest branches of the human mitochondrial tree. The survey of 18.3 kilobases from each human detected only three sites at which substitutions were present, whereas the human and chimpanzee sequences showed 1.3% divergence. The coalescence time estimated from our Y chromosome sample is more recent than that of the mitochondrial genome. A recent coalescence time for the Y chromosome could have been caused by the selected sweep of an advantageous Y chromosome or extensive migration of human males.	SANGER CTR, HINXTON CB10 1RQ, CAMBS, ENGLAND	Wellcome Trust Sanger Institute	WHITFIELD, LS (corresponding author), UNIV CAMBRIDGE, DEPT GENET, CAMBRIDGE CB2 3EH, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1993, MEGA MOL EVOLUTIONAR; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; CLARK AG, 1987, GENETICS, V115, P569; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; ELLIS N, 1990, NATURE, V344, P663, DOI 10.1038/344663a0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; WHITFIELD LS, 1995, GENOMICS, V27, P306, DOI 10.1006/geno.1995.1047; YANG Z, 1995, SYST BIOL, V44, P384, DOI 10.2307/2413599; Yang Z., 1995, PAML PHYLOGENETIC AN; YANG ZB, 1994, J MOL EVOL, V39, P105; YANG ZH, 1995, J MOL EVOL, V40, P689, DOI 10.1007/BF00160518	16	210	212	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	1995	378	6555					379	380		10.1038/378379a0	http://dx.doi.org/10.1038/378379a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477372				2022-12-24	WOS:A1995TF89300056
J	EPSTEIN, PR; PENA, OC; RACEDO, JB				EPSTEIN, PR; PENA, OC; RACEDO, JB			CLIMATE AND DISEASE IN COLOMBIA	LANCET			English	Editorial Material									UNIV MAGDALENA,SANTA MARTA,COLOMBIA; UNIV JORGE TADEO LOZANO,BOGOTA,COLOMBIA	Universidad del Magdalena; Universidad de Bogota Jorge Tadeo Lozano	EPSTEIN, PR (corresponding author), HARVARD UNIV,CAMBRIDGE HOSP,SCH PUBL HLTH,NEW DIS GRP,CAMBRIDGE,MA, USA.							DOBSON A, 1993, LANCET, V342, P1096, DOI 10.1016/0140-6736(93)92069-6; EPSTEIN PR, 1993, LANCET, V341, P1404, DOI 10.1016/0140-6736(93)90962-G; Mancera P. Jose Ernesto, 1994, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V23, P103; Valiela I., 1984, MARINE ECOLOGICAL PR, DOI 10.1007/978-1-4757-4125-4; 1995, MMWR-MORBID MORTAL W, V44, P775; 1995, MMWR-MORBID MORTAL W, V44, P721	6	24	30	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1243	1244		10.1016/S0140-6736(95)91856-6	http://dx.doi.org/10.1016/S0140-6736(95)91856-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475711				2022-12-24	WOS:A1995TE14500004
J	LANGFORD, LA; PIATYSZEK, MA; XU, RS; SCHOLD, SC; SHAY, JW				LANGFORD, LA; PIATYSZEK, MA; XU, RS; SCHOLD, SC; SHAY, JW			TELOMERASE ACTIVITY IN HUMAN BRAIN-TUMORS	LANCET			English	Note								Malignant gliomas are invasive into surrounding brain and are refractory to therapy. Telomerase stabilises telomere length and may immortalise cells to allow unlimited proliferation. Our analysis of telomerase activity in 90 human gliomas showed that 19 of 19 oligodendrogliomas and 38 of 51 glioblastoma multiformes have detectable telomerase activity. The absence of telomerase activity in anaplastic astrocytomas (2/20 positive)and in one-quarter (13/51) of the glioblastomas suggests that these tumours follow different pathways of neoplastic progression. Thus we have found that a distinct subgroup of brain tumour consists of transformed yet pre-immortal cells.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT NEUROL,DALLAS,TX 75235; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL NEUROPATHOL,HOUSTON,TX	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center			Piatyszek, Mieczyslaw A./F-9365-2015; Shay, Jerry W/F-7878-2011	Piatyszek, Mieczyslaw A./0000-0003-0502-3239; 				COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; GREIDER CW, 1994, CURR OPIN GENET DEV, V4, P203, DOI 10.1016/S0959-437X(05)80046-2; HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; NURNBERG P, 1993, HUM GENET, V91, P190; Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880; Shay Jerry W., 1994, Molecular and Cellular Differentiation, V2, P1; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; WRIGHT WE, IN PRESS DEV GENET	10	215	224	1	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1267	1268		10.1016/S0140-6736(95)91865-5	http://dx.doi.org/10.1016/S0140-6736(95)91865-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475720				2022-12-24	WOS:A1995TE14500013
J	WAXMAN, J; SHEER, D				WAXMAN, J; SHEER, D			IS PROSTATE-CANCER WORTH DIAGNOSING	LANCET			English	Editorial Material							POPULATION		IMPERIAL CANC RES FUND, HYMAN CYTOGENET LAB, LONDON WC2A 3PX, ENGLAND	Cancer Research UK	WAXMAN, J (corresponding author), HAMMERSMITH HOSP, DEPT ONCOL, LONDON, ENGLAND.		Sheer, Denise/C-6705-2011	Sheer, Denise/0000-0001-9067-1796	Cancer Research UK [A3585] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BANDYK MG, 1994, GENE CHROMOSOME CANC, V9, P19, DOI 10.1002/gcc.2870090105; BOOKSTEIN R, 1994, J CELL BIOCHEM, P217; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; GADDIPATI JP, 1994, CANCER RES, V54, P2861; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; HANKS GE, 1987, INT J RADIAT ONCOL, V13, P499, DOI 10.1016/0360-3016(87)90063-0; JOHANSSON JE, 1989, LANCET, V1, P799; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; PEDERSEN KV, 1990, BRIT MED J, V300, P1041, DOI 10.1136/bmj.300.6731.1041; SMITH DS, 1995, UROLOGY, V45, P70, DOI 10.1016/S0090-4295(95)96812-1; TAKAHASHI S, 1994, CANCER RES, V54, P3574; UMBAS R, 1994, CANCER RES, V54, P3929; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; ZINCKE H, 1994, J CLIN ONCOL, V12, P2254, DOI 10.1200/JCO.1994.12.11.2254	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	1995	346	8984					1177	1178		10.1016/S0140-6736(95)92895-2	http://dx.doi.org/10.1016/S0140-6736(95)92895-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC976	7475655				2022-12-24	WOS:A1995TC97600005
J	WHATLEY, SD; ROBERTS, AG; ELDER, GH				WHATLEY, SD; ROBERTS, AG; ELDER, GH			DE-NOVO MUTATION AND SPORADIC PRESENTATION OF ACUTE INTERMITTENT PORPHYRIA	LANCET			English	Note							PORPHOBILINOGEN DEAMINASE GENE	Acute intermittent porphyria (AIP) is a low-penetrant autosomal dominant disorder characterised by life-threatening neurovisceral attacks, often precipitated by drugs. Prognosis is improved by presymptomatic diagnosis and counselling. We found that 29 of 103 (28%) unrelated patients presented as sporadic cases. One patient had a de-novo mutation. The same mutation has arisen de novo at least three times in 12% of British AIP families. About 3% (95% CI 1-8%) of all AIP index cases may have de-novo mutations. These findings emphasise the high frequency of sporadic presentation of AIP and indicate the limitations of presymptomatic diagnosis as an aid to management.	UNIV WALES HOSP,COLL MED,DEPT BIOCHEM MED,CARDIFF CF4 4XN,S GLAM,WALES	Cardiff University				Anderson, Karl/0000-0002-6499-8573	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BONKOVSKY HL, 1993, GASTROENTEROLOGY, V105, P590, DOI 10.1016/0016-5085(93)90739-Y; BROWNLIE PD, 1994, PROTEIN SCI, V3, P1644, DOI 10.1002/pro.5560031004; CHEN CH, 1994, J CLIN INVEST, V94, P1927, DOI 10.1172/JCI117543; Cooper D. N., 1993, HUMAN GENE MUTATION; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; KAUPPINEN R, 1995, HUM MOL GENET, V4, P215, DOI 10.1093/hmg/4.2.215; LLEWELLYN DH, 1987, LANCET, V2, P706; ONG PML, 1995, J MED GENET, V32, pA141; SCOBIE GA, 1990, HUM GENET, V85, P157	9	21	21	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					1007	1008		10.1016/S0140-6736(95)91692-X	http://dx.doi.org/10.1016/S0140-6736(95)91692-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475550				2022-12-24	WOS:A1995RZ59900014
J	MARION, RW				MARION, RW			WHEN TOM DIED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	1988	260	11					1619	1619						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9650	3411744				2022-12-24	WOS:A1988P965000037
J	STAMM, WE; HANDSFIELD, HH; ROMPALO, AM; ASHLEY, RL; ROBERTS, PL; COREY, L				STAMM, WE; HANDSFIELD, HH; ROMPALO, AM; ASHLEY, RL; ROBERTS, PL; COREY, L			THE ASSOCIATION BETWEEN GENITAL ULCER DISEASE AND ACQUISITION OF HIV INFECTION IN HOMOSEXUAL MEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle			Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NIAID NIH HHS [AI-17805, AI-20381, AI-12192] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI012192, R01AI020381, R01AI017805] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; ASHLEY RL, 1987, J VIROL METHODS, V18, P159, DOI 10.1016/0166-0934(87)90121-2; CAMERON DW, 1987, 3RD INT C ACQ IMM SY; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; Cox DR., 1970, ANAL BINARY DATA; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; GOODELL SE, 1983, NEW ENGL J MED, V308, P868, DOI 10.1056/NEJM198304143081503; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; HANDSFIELD HH, 1987, J CLIN MICROBIOL, V25, P879, DOI 10.1128/JCM.25.5.879-884.1987; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; HUFF JC, 1981, J AM ACAD DERMATOL, V5, P550, DOI 10.1016/S0190-9622(81)70115-4; KINGSLEY LA, 1987, LANCET, V1, P345; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; LUKEHART SA, 1980, J IMMUNOL, V124, P461; MELBYE M, 1984, BRIT MED J, V289, P573, DOI 10.1136/bmj.289.6445.573; POPOVIC M, 1984, SCIENCE, V224, P503; QUINN TC, 1988, NEW ENGL J MED, V318, P197, DOI 10.1056/NEJM198801283180401; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; QUINN TC, 1983, NEW ENGL J MED, V309, P576, DOI 10.1056/NEJM198309083091002; TSANG V, 1985, IMMUNOELECTROTRANSFE; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	22	391	397	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	1988	260	10					1429	1433		10.1001/jama.260.10.1429	http://dx.doi.org/10.1001/jama.260.10.1429			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P9020	3404600				2022-12-24	WOS:A1988P902000025
J	LESK, AM; CHOTHIA, C				LESK, AM; CHOTHIA, C			ELBOW MOTION IN THE IMMUNOGLOBULINS INVOLVES A MOLECULAR BALL-AND-SOCKET JOINT	NATURE			English	Article									EUROPEAN MOLEC BIOL LAB,D-6900 HEIDELBERG,FED REP GER; UNIV LONDON UNIV COLL,CHRISTOPHER INGOLD LAB,LONDON WC1H 0AJ,ENGLAND	European Molecular Biology Laboratory (EMBL); University of London; University College London	LESK, AM (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.			Lesk, Arthur/0000-0002-2596-0601				ABOLA EE, 1980, BIOCHEMISTRY-US, V19, P432, DOI 10.1021/bi00544a005; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BENNETT WS, 1984, CRC CR REV BIOCH MOL, V15, P291, DOI 10.3109/10409238409117796; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; CHIEN Y, 1984, NATURE, V312, P31, DOI 10.1038/312031a0; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; COLMAN PM, 1976, J MOL BIOL, V100, P257, DOI 10.1016/S0022-2836(76)80062-9; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; CYGLER M, 1987, J BIOL CHEM, V262, P643; DAVIES DR, 1983, ANNU REV IMMUNOL, V1, P87, DOI 10.1146/annurev.iy.01.040183.000511; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; LESK AM, 1984, J MOL BIOL, V174, P175, DOI 10.1016/0022-2836(84)90371-1; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; POLJAK RJ, 1974, P NATL ACAD SCI USA, V71, P3440, DOI 10.1073/pnas.71.9.3440; PRASED L, 1987, J BIOL CHEM, V263, P2571; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; SAITO H, 1984, NATURE, V312, P36, DOI 10.1038/312036a0; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SAUL FA, 1978, J BIOL CHEM, V253, P585; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; SUH S W, 1986, Proteins Structure Function and Genetics, V1, P74, DOI 10.1002/prot.340010112; VITALI J, 1987, J MOL BIOL, V198, P351, DOI 10.1016/0022-2836(87)90318-4; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	28	127	139	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 8	1988	335	6186					188	190		10.1038/335188a0	http://dx.doi.org/10.1038/335188a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9647	3412476				2022-12-24	WOS:A1988P964700064
J	HAINES, A; HARTOG, M				HAINES, A; HARTOG, M			DOCTORS AND THE TEST BAN - 25 YEARS ON	BRITISH MEDICAL JOURNAL			English	Article									UNIV BRISTOL,SOUTHMEAD HOSP,DEPT MED,BRISTOL BS10 5NB,AVON,ENGLAND	Southmead Hospital; University of Bristol	HAINES, A (corresponding author), UNIV COLL & MIDDLESEX SCH MED,WHITTINGTON HOSP,DEPT PRIMARY HLTH CARE,HIGHGATE WING,LONDON N19 5HT,ENGLAND.			Haines, Andy/0000-0002-8053-4605				ARONOW S, 1962, NEW ENGL J MED, V266, P1145, DOI 10.1056/NEJM196205312662206; COLLINS WR, 1961, SCIENCE, V134, P980, DOI 10.1126/science.134.3484.980; DARBY SC, 1988, BRIT MED J, V296, P332, DOI 10.1136/bmj.296.6618.332; DELAMOTHE T, 1988, BRIT MED J, V296, P1728, DOI 10.1136/bmj.296.6638.1728; DEWITT HE, 1985, B ATOM SCI, V41, P10, DOI 10.1080/00963402.1985.11456061; DUNHAM CL, 1958, BIOL MED PHYS, V6, P175; EISENBUD M, 1962, SCIENCE, V136, P370, DOI 10.1126/science.136.3514.370; ERVIN FR, 1962, NEW ENGL J MED, V266, P1127, DOI 10.1056/NEJM196205312662204; GOLDANSKII V, 1988, IPPNW REPORT, V6, P7; Goldblat J., 1983, ARMS CONTROL AGREEME; KIDDER R, 1987, MAINTAINING US STOCK; KURODA PK, 1962, SCIENCE, V137, P991, DOI 10.1126/science.137.3534.991; LEIDERMAN P. HERBERT, 1962, NEW ENGLAND JOUR MED, V266, P1149, DOI 10.1056/NEJM196205312662207; MIDDLETON J, 1987, BRIT MED J, V294, P1551, DOI 10.1136/bmj.294.6586.1551; NISHIWAKI Y, 1955, MED ASS PREVENTION W, V15, P2; PARKER T, 1961, J S C Med Assoc, V57, P28; ROSENTHAL HL, 1966, J DENT RES, V45, P343, DOI 10.1177/00220345660450022201; SEABORG G, 1981, KENNEDY KRUSHCHEV TE; SIDEL VW, 1962, NEW ENGL J MED, V266, P1137, DOI 10.1056/NEJM196205312662205; SIVARD RL, 1987, WORLD MILITARY SOCIA; SMITH R, 1988, BRIT MED J, V296, P185, DOI 10.1136/bmj.296.6616.185; STOTT R, 1988, EVEN BOMB DROPS; WARREN S, 1962, NEW ENGL J MED, V266, P1123, DOI 10.1056/NEJM196205312662201; YEABSLEY HJ, 1962, NZ MED J, V61, P247; 1977, 1977 UN SCI COMM EFF; 1983, MED EFFECTS NUCLEAR; 1988, NUCLEAR ATTACK ETHIC; 1957, B ATOMIC SCI, V13, P202; 1962, NATURE, V192, P400; 1988, CEASE FIRE 88 IPPNW; 1986, LONG TERM ENV MED EF; 1982, 1982 UN SCI COMM EFF	32	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					408	411		10.1136/bmj.297.6645.408	http://dx.doi.org/10.1136/bmj.297.6645.408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408986	Green Published, Bronze			2022-12-24	WOS:A1988P545000028
J	ROSE, SR; ROSS, JL; URIARTE, M; BARNES, KM; CASSORLA, FG; CUTLER, GB				ROSE, SR; ROSS, JL; URIARTE, M; BARNES, KM; CASSORLA, FG; CUTLER, GB			THE ADVANTAGE OF MEASURING STIMULATED AS COMPARED WITH SPONTANEOUS GROWTH-HORMONE LEVELS IN THE DIAGNOSIS OF GROWTH-HORMONE DEFICIENCY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HAHNEMANN UNIV, DEPT PEDIAT, PHILADELPHIA, PA 19102 USA	Drexel University	ROSE, SR (corresponding author), NICHHD, DEV ENDOCRINOL BRANCH, BLDG 10, RM 10-N-262, BETHESDA, MD 20892 USA.			Ross, Judith/0000-0002-8613-2498				ABBOUD CF, 1986, MAYO CLIN PROC, V61, P35, DOI 10.1016/S0025-6196(12)61397-4; ALBERTSSONWIKLA.K, 1983, ACTA ENDOCR-COP    S, V256, P72; BERCU BB, 1986, J CLIN ENDOCR METAB, V63, P709, DOI 10.1210/jcem-63-3-709; BIERICH JR, 1987, ACTA PAEDIATR SCAND, P48; CACCIARI E, 1985, J PEDIATR-US, V106, P891, DOI 10.1016/S0022-3476(85)80232-8; Cameron N., 1986, HUMAN GROWTH, V3, P3; COSTIN G, 1987, J PEDIATR-US, V110, P362, DOI 10.1016/S0022-3476(87)80495-X; DAUGHADAY WH, 1984, JAMA-J AM MED ASSOC, V251, P2251; DAUGHADAY WH, 1977, NEW ENGL J MED, V297, P1267, DOI 10.1056/NEJM197712082972308; DEAN HJ, 1986, CAN MED ASSOC J, V135, P297; FASS B, 1979, AM J DIS CHILD, V133, P931, DOI 10.1001/archpedi.1979.02130090059010; FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665; FRASIER SD, 1974, PEDIATRICS, V53, P929; GERTNER JM, 1984, J PEDIATR-US, V104, P172, DOI 10.1016/S0022-3476(84)80987-7; GOURMELEN M, 1979, PEDIATR RES, V13, P221, DOI 10.1203/00006450-197904000-00002; Greulich WW, 1959, RADIOGRAPHIC ATLAS S; HINDMARSH P, 1987, CLIN ENDOCRINOL, V27, P581, DOI 10.1111/j.1365-2265.1987.tb01188.x; HINDMARSH PC, 1987, INT S GROWTH DISORDE, P3; LANES R, 1986, J PEDIATR-US, V109, P781, DOI 10.1016/S0022-3476(86)80693-X; LIU L, 1987, J CLIN ENDOCR METAB, V64, P651, DOI 10.1210/jcem-64-4-651; MAHONEY CP, 1987, PEDIATR CLIN N AM, V34, P825; MAURAS N, 1987, J CLIN ENDOCR METAB, V64, P596, DOI 10.1210/jcem-64-3-596; MILLER JD, 1982, J CLIN ENDOCR METAB, V55, P989, DOI 10.1210/jcem-55-5-989; ODELL WD, 1967, J LAB CLIN MED, V70, P973; PENNY R, 1969, J CLIN ENDOCR METAB, V29, P1499, DOI 10.1210/jcem-29-11-1499; Raiti  S., 1986, HUMAN GROWTH HORMONE; REITER EO, 1988, J CLIN ENDOCR METAB, V66, P68, DOI 10.1210/jcem-66-1-68; RICHARDS GE, 1987, AM J DIS CHILD, V141, P553, DOI 10.1001/archpedi.1987.04460050095039; ROCHICCIOLI P, 1987, ACTA PAEDIATR SCAND, P72; ROMSHE CA, 1984, J PEDIATR-US, V104, P177, DOI 10.1016/S0022-3476(84)80988-9; ROSE SR, 1988, 8TH INT C END KYOT; ROSE SR, IN PRESS J PEDIATR E; ROSENFELD RG, 1986, J PEDIATR-US, V109, P428, DOI 10.1016/S0022-3476(86)80112-3; ROSS JL, 1987, J PEDIATR-US, V110, P369, DOI 10.1016/S0022-3476(87)80496-1; RUDMAN D, 1985, PEDIATR RES, V19, P975, DOI 10.1203/00006450-198510000-00001; SANAYAMA K, 1987, ENDOCRINOL JAPON, V34, P627; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SPILIOTIS BE, 1984, JAMA-J AM MED ASSOC, V251, P2223, DOI 10.1001/jama.251.17.2223; TAKAHASHI Y, 1968, J CLIN INVEST, V47, P2079, DOI 10.1172/JCI105893; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; VANVLIET G, 1983, NEW ENGL J MED, V309, P1016; YOULTON R, 1969, PEDIATRICS, V43, P989; ZADIK Z, 1985, PEDIATRICS, V76, P355; 1986, STATISTICAL ABSTRACT, P18; 1984, LANCET, V2, P1189	45	238	241	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	1988	319	4					201	207		10.1056/NEJM198807283190403	http://dx.doi.org/10.1056/NEJM198807283190403			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4105	3393172				2022-12-24	WOS:A1988P410500003
J	BROADWELL, RD				BROADWELL, RD			ABSENCE OF A BLOOD-BRAIN-BARRIER WITHIN TRANSPLANTED BRAIN-TISSUE	SCIENCE			English	Article									UNIV MARYLAND,SCH MED,DIV NEUROPATHOL,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore	BROADWELL, RD (corresponding author), UNIV MARYLAND,SCH MED,DIV NEUROL SURG,BALTIMORE,MD 21201, USA.							BALIN BJ, 1987, J NEUROCYTOL, V16, P721, DOI 10.1007/BF01611981; BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209; BROADWELL R, 1987, Society for Neuroscience Abstracts, V13, P1250; BROADWELL RD, 1988, P NATL ACAD SCI USA, V85, P632, DOI 10.1073/pnas.85.2.632; BROADWELL RD, 1981, P NATL ACAD SCI-BIOL, V78, P7820, DOI 10.1073/pnas.78.12.7820; BROADWELL RD, 1987, CIRCUMVENTRICULAR OR, V2, P61; BROADWELL RD, 1987, COMP NEUROL, V260, P42; DUSART I, 1987, Society for Neuroscience Abstracts, V13, P289; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; LEE M H, 1987, Society for Neuroscience Abstracts, V13, P289; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; ROSENSTEIN JM, 1987, SCIENCE, V235, P772, DOI 10.1126/science.2433767; SORENSON JC, 1987, SOC NEUR ABSTR, V13, P289; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1	14	22	22	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 22	1988	241	4864					473	473		10.1126/science.3393914	http://dx.doi.org/10.1126/science.3393914			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3354	3393914				2022-12-24	WOS:A1988P335400042
J	KLEIN, RS; PHELAN, JA; FREEMAN, K; SCHABLE, C; FRIEDLAND, GH; TRIEGER, N; STEIGBIGEL, NH				KLEIN, RS; PHELAN, JA; FREEMAN, K; SCHABLE, C; FRIEDLAND, GH; TRIEGER, N; STEIGBIGEL, NH			LOW OCCUPATIONAL RISK OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION AMONG DENTAL PROFESSIONALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									MONTEFIORE MED CTR,DEPT DENT,BRONX,NY 10467; MONTEFIORE MED CTR,DEPT BIOSTAT,BRONX,NY 10467; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT DENT,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT ORAL & MAXILLOFACIAL SURG,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT EPIDEMIOL & SOCIAL MED,BRONX,NY 10461; CTR DIS CONTROL,AIDS PROGRAM,ATLANTA,GA 30333	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Centers for Disease Control & Prevention - USA	KLEIN, RS (corresponding author), MONTEFIORE MED CTR,DEPT MED,DIV INFECT DIS,111 E 210TH ST,BRONX,NY 10467, USA.			Steigbigel, Neal/0000-0002-9378-5403				[Anonymous], 1982, MMWR-MORBID MORTAL W; AUERBACH DM, 1984, AM J MED, V76, P487, DOI 10.1016/0002-9343(84)90668-5; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BRODER S, 1984, NEW ENGL J MED, V311, P1292, DOI 10.1056/NEJM198411153112006; BRODERSEN M, 1974, LANCET, V1, P675; CURRAN JW, 1984, NEW ENGL J MED, V310, P69, DOI 10.1056/NEJM198401123100201; ECHAVEZ MI, 1987, J PUBLIC HEALTH DENT, V47, P182, DOI 10.1111/j.1752-7325.1987.tb02002.x; EVATT BL, 1984, ANN INTERN MED, V100, P499, DOI 10.7326/0003-4819-100-4-499; FELDMAN RE, 1975, JAMA-J AM MED ASSOC, V232, P1228, DOI 10.1001/jama.232.12.1228; FLYNN NM, 1987, WESTERN J MED, V146, P439; FRIEDLAND GH, 1985, ARCH INTERN MED, V145, P1413, DOI 10.1001/archinte.145.8.1413; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GERBERDING JL, 1987, J INFECT DIS, V156, P1, DOI 10.1093/infdis/156.1.1; GERBERDING JL, 1986, 26TH INT C ANT AG CH, P283; GERBERT B, 1987, J AM DENT ASSOC, V114, P311, DOI 10.14219/jada.archive.1987.0078; GOCKE DJ, 1969, LANCET, V2, P248; GRINT P, 1985, COMMUNICAB DIS REP, V42, P4; GROOPMAN JE, 1984, SCIENCE, V226, P447, DOI 10.1126/science.6093247; HARRIS C, 1983, NEW ENGL J MED, V308, P1181, DOI 10.1056/NEJM198305193082001; HEATHCOT.J, 1974, LANCET, V1, P71; HENDERSON DK, 1986, ANN INTERN MED, V104, P644, DOI 10.7326/0003-4819-104-5-644; HIRSCH MS, 1985, NEW ENGL J MED, V312, P1, DOI 10.1056/NEJM198501033120101; HO DD, 1985, NEW ENGL J MED, V313, P1606; JAFFE HW, 1983, ANN INTERN MED, V99, P145, DOI 10.7326/0003-4819-99-2-145; KUNIN CM, 1959, AM J MED SCI, V237, P293, DOI 10.1097/00000441-195903000-00003; LANDESMAN SH, 1983, ARCH INTERN MED, V143, P2307, DOI 10.1001/archinte.143.12.2307; LOURIA DB, 1967, ANN INTERN MED, V67, P1, DOI 10.7326/0003-4819-67-1-1; LUBICK HA, 1986, J AM DENT ASSOC, V113, P10, DOI 10.14219/jada.archive.1986.0139; MARMOR M, 1982, LANCET, V1, P1083; MCCRAY E, 1986, NEW ENGL J MED, V314, P1127, DOI 10.1056/NEJM198604243141729; MCDONALD MI, 1983, LANCET, V2, P882; MOSLEY JW, 1975, J AM DENT ASSOC, V90, P992, DOI 10.14219/jada.archive.1975.0239; MOSLEY JW, 1975, NEW ENGL J MED, V293, P729, DOI 10.1056/NEJM197510092931501; NEISSONVERNANT C, 1986, LANCET, V2, P814; OKSENHENDLER E, 1986, NEW ENGL J MED, V315, P582; OLESKE J, 1983, JAMA-J AM MED ASSOC, V249, P2345, DOI 10.1001/jama.249.17.2345; PRINCE AM, 1968, P NATL ACAD SCI USA, V60, P814, DOI 10.1073/pnas.60.3.814; RAVENHOLT RT, 1983, LANCET, V2, P885; REDEKER AG, 1975, NEW ENGL J MED, V293, P1055; RUBINSTEIN A, 1983, JAMA-J AM MED ASSOC, V249, P2350, DOI 10.1001/jama.249.17.2350; SCHIFF ER, 1986, J AM DENT ASSOC, V113, P390, DOI 10.14219/jada.archive.1986.0210; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; SHIMIZU Y, 1963, GASTROENTEROLOGY, V44, P740; SMITH JL, 1976, J INFECT DIS, V133, P705, DOI 10.1093/infdis/133.6.705; SNYDMAN DR, 1975, ANN INTERN MED, V83, P838, DOI 10.7326/0003-4819-83-6-838; STRICOF RL, 1986, NEW ENGL J MED, V314, P1115; SZMUNESS W, 1975, ANN INTERN MED, V83, P489, DOI 10.7326/0003-4819-83-4-489; THOMAS PA, 1984, JAMA-J AM MED ASSOC, V252, P639, DOI 10.1001/jama.252.5.639; TSANG VCW, 1983, METHOD ENZYMOL, V92, P377; VILLAREJOS VM, 1974, NEW ENGL J MED, V291, P1375, DOI 10.1056/NEJM197412262912602; Weil R B, 1977, N Y State Dent J, V43, P587; WEISS SH, 1985, JAMA-J AM MED ASSOC, V254, P2089, DOI 10.1001/jama.254.15.2089; ZAGURY D, 1984, SCIENCE, V226, P449, DOI 10.1126/science.6208607; 1984, LANCET, V2, P1376; 1986, MMWR, V35, P237; [No title captured]; 1986, MMWR, V35, P76; 1987, MMWR, V36, P285; 1985, MMWR, V34, P313; 1983, MMWR, V32, P613; 1984, MMWR, V33, P377; [No title captured]; 1985, MMWR, V34, P329	63	172	174	1	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	1988	318	2					86	90		10.1056/NEJM198801143180205	http://dx.doi.org/10.1056/NEJM198801143180205			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	L6001	3422106				2022-12-24	WOS:A1988L600100005
J	HSU, SL; MARKS, J; SHAW, JP; TAM, M; HIGGS, DR; SHEN, CC; SHEN, CKJ				HSU, SL; MARKS, J; SHAW, JP; TAM, M; HIGGS, DR; SHEN, CC; SHEN, CKJ			STRUCTURE AND EXPRESSION OF THE HUMAN THETA-1-GLOBIN GENE	NATURE			English	Article									UNIV CALIF DAVIS, DEPT GENET, DAVIS, CA 95616 USA; ACAD SINICA, INST MOL BIOL, TAIPEI 115, TAIWAN; UNIV OXFORD, JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND	University of California System; University of California Davis; Academia Sinica - Taiwan; University of Oxford			shen, Che-Kun James/L-1343-2015					CHARNAY P, 1983, SCIENCE, V220, P1281, DOI 10.1126/science.6574602; CHENG JF, 1986, J BIOL CHEM, V261, P839; DEAN A, 1981, SCIENCE, V212, P459, DOI 10.1126/science.6163216; DEAN A, 1983, P NATL ACAD SCI-BIOL, V80, P5515, DOI 10.1073/pnas.80.18.5515; FEI, IN PRESS BR J HAEMAT; FISCHELGHODSIAM N, IN PRESS NATURE; HESS J, 1985, J MOL BIOL, V184, P7, DOI 10.1016/0022-2836(85)90039-7; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KARLSSON S, 1985, ANNU REV BIOCHEM, V54, P1071; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEUNG S, 1987, NATURE, V329, P551, DOI 10.1038/329551a0; LIEBHABER SA, 1981, NATURE, V290, P26, DOI 10.1038/290026a0; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; MARKS J, 1986, COLD SPRING HARB SYM, V51, P499, DOI 10.1101/SQB.1986.051.01.061; MARKS J, 1986, NATURE, V321, P785, DOI 10.1038/321785a0; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NORTH G, 1987, NATURE, V326, P641, DOI 10.1038/326641a0; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; RUTHERFORD T, 1981, P NATL ACAD SCI-BIOL, V78, P348, DOI 10.1073/pnas.78.1.348; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; SAWADA I, 1986, J MOL BIOL, V192, P693, DOI 10.1016/0022-2836(86)90022-7; SHAW JP, 1987, NATURE, V326, P717, DOI 10.1038/326717a0; SHAW JP, IN PRESS HAEMOGLOBUL, V5; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4	26	51	52	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	1988	331	6151					94	96		10.1038/331094a0	http://dx.doi.org/10.1038/331094a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	L5505	3422341				2022-12-24	WOS:A1988L550500065
J	MULLER, AD; SONNENBERG, A				MULLER, AD; SONNENBERG, A			PREVENTION OF COLORECTAL-CANCER BY FLEXIBLE ENDOSCOPY AND POLYPECTOMY - A CASE-CONTROL STUDY OF 32702 VETERANS	ANNALS OF INTERNAL MEDICINE			English	Article						COLORECTAL NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; SIGMOIDOSCOPY; COLONOSCOPY; COLONIC POLYPS	RISK; POLYPS; CARCINOMA; ADENOMAS; RECTUM; COLON	Objective: To determine whether patients with colorectal cancer are less likely than unaffected controls to have had one or more endoscopic procedures (flexible sigmoidoscopy, colonoscopy, or polypectomy) before being diagnosed with cancer. Design: Case-control study. Setting: Hospitals of the Department of Veterans Affairs. Patients: 8722 and 7629 case-patients with colon and rectal cancer, respectively, and age-, sex-, race-matched controls who were discharged at the same time as the corresponding case-patients. Measurements: Number and type of endoscopic procedures of the large bowel done from 1981 until the development of colorectal cancer in each case-patient. The influence of endoscopic procedures on the development of colorectal cancer was tested by conditional multiple logistic regression analysis. Results: Compared with controls, patients with colorectal cancer were less likely to have had an endoscopic procedure of the large bowel before being diagnosed with cancer (odds ratio for colon cancer, 0.51 [95% CI, 0.44 to 0.58]; odds ratio for rectal cancer, 0.55 [CI, 0.47 to 0.64]). In patients who had flexible sigmoidoscopy, colonoscopy, and polypectomy, the odds ratios were even smaller. When analyzed by separate 1-year intervals, patients with cancer had significantly fewer procedures during periods of up to 6 years before the onset of their cancer. Similarly, fewer inpatient and outpatient procedures were done in patients than in controls. Conclusions: Endoscopic procedures of the large bowel reduce the risk for developing colon and rectal cancer by 50%, their protective influence lasting 6 years.	VET AFFAIRS MED CTR, GASTROENTEROL SECT, ALBUQUERQUE, NM 87108 USA; MED COLL WISCONSIN, DEPT FAMILY MED, MILWAUKEE, WI 53226 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin								AHLQUIST DA, 1993, NEW ENGL J MED, V329, P1351; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Breslow N, 1980, STAT METHODS CANC RE, P248; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GILBERTSEN VA, 1978, CANCER, V41, P1137, DOI 10.1002/1097-0142(197803)41:3<1137::AID-CNCR2820410350>3.0.CO;2-G; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; KEEFFE EB, 1993, GASTROINTEST ENDOSC, V39, P840, DOI 10.1016/S0016-5107(93)70284-9; KIRSCHNER CG, 1994, PHYSICIANS CURRENT P; LOTFI AM, 1986, MAYO CLIN PROC, V61, P337, DOI 10.1016/S0025-6196(12)61950-8; MACRAE FA, 1983, GUT, V24, P376, DOI 10.1136/gut.24.5.376; MADARA JL, 1983, AM J PATHOL, V110, P230; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; SANDLER RS, 1995, GASTROENTEROLOGY, V109, P302; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SIMONS BD, 1992, J NATL CANCER I, V84, P962, DOI 10.1093/jnci/84.12.962; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; TURNER D, 1993, CAN MED ASSOC J, V149, P595; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; 1989, DHHS PHS891260; 1992, SAS STAT SOFTWARE CH, P435	23	484	490	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1995	123	12					904	+		10.7326/0003-4819-123-12-199512150-00002	http://dx.doi.org/10.7326/0003-4819-123-12-199512150-00002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK120	7486484				2022-12-24	WOS:A1995TK12000002
J	DELEON, M; WANG, Y; JONES, L; PEREZREYES, E; WEI, XY; SOONG, TW; SNUTCH, TP; YUE, DT				DELEON, M; WANG, Y; JONES, L; PEREZREYES, E; WEI, XY; SOONG, TW; SNUTCH, TP; YUE, DT			ESSENTIAL CA2+-BINDING MOTIF FOR CA2+-SENSITIVE INACTIVATION OF L-TYPE CA2+ CHANNELS	SCIENCE			English	Article							CALCIUM-DEPENDENT INACTIVATION; FUNCTIONAL EXPRESSION; ALPHA-1 SUBUNIT; BETA-SUBUNIT; BINDING; NEURONS; CLONING; PHOSPHORYLATION; BRAIN; CELLS	Intracellular calcium (Ca2+) inhibits the opening of L-type (alpha(1C)) Ca2+ channels, providing physiological control of Ca2+ entry into a wide variety of cells. A structural determinant of this Ca2+-sensitive inactivation was revealed by chimeric Ca2+ channels derived from parental alpha(1C) and alpha(1E) channels, the latter of which is a neuronal channel lacking Ca2+ inactivation. A consensus Ca2+-binding motif (an EF hand), located on the alpha(1C) subunit, was required for Ca2+ inactivation. Donation of the alpha(1C) EF-hand region to the alpha(1E) channel conferred the Ca2+-inactivating phenotype. These results strongly suggest that Ca2+ binding to the alpha(1C) subunit initiates Ca2+ inactivation.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOMED ENGN,PROGRAM MOLEC & CELLULAR SYST PHYSIOL,BALTIMORE,MD 21205; LOYOLA UNIV,DEPT PHYSIOL,MAYWOOD,IL 60153; MED COLL GEORGIA,INST MOLEC MED & GENET,AUGUSTA,GA 30912; UNIV BRITISH COLUMBIA,BIOTECHNOL LAB,VANCOUVER,BC V6T 1Z3,CANADA	Johns Hopkins University; Loyola University Chicago; University System of Georgia; Augusta University; University of British Columbia			Snutch, Terrance P/L-3464-2019	Snutch, Terrance P/0000-0001-5182-1296; Soong, Tuck Wah/0000-0002-0876-0325				ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; BRODIN P, 1990, J BIOL CHEM, V265, P11125; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; HAACK JA, 1994, BIOPHYS J, V66, P1051, DOI 10.1016/S0006-3495(94)80886-0; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KRETSINGER RH, 1972, NATURE-NEW BIOL, V240, P85, DOI 10.1038/newbio240085a0; LINSE S, 1991, J BIOL CHEM, V266, P8050; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; NOBLE D, 1979, INITIATION HEARTBEAT, P1; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PLANT TD, 1988, J PHYSIOL-LONDON, V404, P731, DOI 10.1113/jphysiol.1988.sp017316; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Reuter H, 1973, Prog Biophys Mol Biol, V26, P1, DOI 10.1016/0079-6107(73)90016-3; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHERUBL H, 1993, AM J PHYSIOL, V264, pE354, DOI 10.1152/ajpendo.1993.264.3.E354; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; WANG Q, 1995, CELL, V80, P1; WEI XY, 1994, J BIOL CHEM, V269, P1635; WEI XY, 1991, J BIOL CHEM, V266, P21943; WELLING A, 1993, CIRC RES, V73, P974, DOI 10.1161/01.RES.73.5.974; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745	38	226	227	0	4	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1502	1506		10.1126/science.270.5241.1502	http://dx.doi.org/10.1126/science.270.5241.1502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491499				2022-12-24	WOS:A1995TH37500042
J	LYDALL, D; WEINERT, T				LYDALL, D; WEINERT, T			YEAST CHECKPOINT GENES IN DNA-DAMAGE PROCESSING - IMPLICATIONS FOR REPAIR AND ARREST	SCIENCE			English	Article							EXONUCLEASE ACTIVE-SITE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHORYLATION; REPLICATION; MITOSIS; POLYMERASES; P34CDC28; PROTEIN; MUTANTS	Yeast checkpoint control genes were found to affect processing of DNA damage as well as cell cycle arrest. An assay that measures DNA damage processing in vivo showed that the checkpoint genes RAD17, RAD24, and MEC3 activated an exonuclease that degrades DNA. The degradation is probably a direct consequence of checkpoint protein function, because RAD17 encodes a putative 3'-5' DNA exonuclease. Another checkpoint gene, RAD9, had a different role: It inhibited the degradation by RA17, RAD24, and MEC3. A model of how processing of DNA damage may be linked to both DNA repair and cell cycle arrest is proposed.			LYDALL, D (corresponding author), UNIV ARIZONA,DEPT MOLEC & CELLULAR BIOL,TUCSON,AZ 85721, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045276] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 45276-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1992, GENE, V112, P139, DOI 10.1016/0378-1119(92)90316-H; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; HOLLIDAY R, 1976, GENET RES, V27, P413, DOI 10.1017/S0016672300016621; KASTAN MB, 1991, CANCER RES, V51, P6304; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V689, P7491; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; LYDALL D, UNPUB; NASIM A, 1975, GENETICS, V79, P573; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; NOWAK R, 1995, SCIENCE, V268, P1700, DOI 10.1126/science.7792589; ONEL K, 1995, MOL CELL BIOL, V15, P5329; ONEL K, UNPUB; RILES L, 1993, GENETICS, V134, P81; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SORGER PK, 1992, NATURE, V355, P365, DOI 10.1038/355365a0; THELEN MP, 1994, J BIOL CHEM, V269, P747; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1993, GENETICS, V134, P63; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WITKIN EM, 1991, BIOCHIMIE, V73, P133, DOI 10.1016/0300-9084(91)90196-8	29	352	356	0	4	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1488	1491		10.1126/science.270.5241.1488	http://dx.doi.org/10.1126/science.270.5241.1488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491494				2022-12-24	WOS:A1995TH37500037
J	COLEMAN, MJ; MEYRAND, P; NUSBAUM, MP				COLEMAN, MJ; MEYRAND, P; NUSBAUM, MP			A SWITCH BETWEEN 2 MODES OF SYNAPTIC TRANSMISSION MEDIATED BY PRESYNAPTIC INHIBITION	NATURE			English	Article							SENSORY AFFERENTS; MODULATION; MECHANISM; TERMINALS; GANGLION; NEURONS; SYSTEM; CRAB	PRESYNAPTIC inhibition reduces chemical synaptic transmission in the central nervous system between pairs of neurons(1-4), but its role(s) in shaping the multisynaptic interactions underlying neural network activity are not well studied. We therefore used the crustacean stomatogastric nervous system to study how presynaptic inhibition of the identified projection neuron, modulatory commissural neuron 1 (MCN1), influences the MCN1 synaptic effects on the gastric mill neural network. Tonic MCN1 discharge excites gastric mill network neurons and activates the gastric mill rhythm(5,6). One network neuron, the lateral gastric (LG) neuron, presynaptically inhibits MCN1 and is electrically coupled to its terminals(5,6). We show here that this presynaptic inhibition selectively reduces or eliminates transmitter-mediated excitation from MCN1 without reducing its electrically mediated excitatory effects, thereby switching the network neurons excited by MCN1. By switching the type of synaptic output from MCN1 and, hence, the activated network neurons, this presynaptic inhibition is pivotal to motor pattern generation.	UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,BIRMINGHAM,AL 35294; UNIV ALABAMA,NEUROBIOL RES CTR,BIRMINGHAM,AL 35294; UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; UNIV BORDEAUX 1,NEUROBIOL & PHYSIOL COMPAREES LAB,F-33120 ARCACHON,FRANCE; CNRS,F-33120 ARCACHON,FRANCE	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)			Nusbaum, Michael/GWC-1917-2022	Nusbaum, Michael/0000-0001-5935-0046				ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; Bennett M V, 1992, Semin Cell Biol, V3, P29; CATTAERT D, 1992, J NEUROPHYSIOL, V67, P610, DOI 10.1152/jn.1992.67.3.610; Clarac F, 1992, Curr Opin Neurobiol, V2, P764, DOI 10.1016/0959-4388(92)90131-4; COLEMAN MJ, 1992, J COMP NEUROL, V325, P581, DOI 10.1002/cne.903250410; COLEMAN MJ, 1994, J NEUROSCI, V14, P6544; COLEMAN MJ, 1995, THESIS U ALABAMA BIR; DIXON DB, 1993, NEURON, V11, P267, DOI 10.1016/0896-6273(93)90183-R; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; Harris-Warrick Ronald M., 1992, P87; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HAYDON PG, 1991, J NEUROSCI, V11, P3851; KATZ PS, 1995, J NEUROSCI, V15, P6035; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; NORRIS BJ, 1994, J NEUROPHYSIOL, V72, P1451, DOI 10.1152/jn.1994.72.4.1451; Nusbaum Michael P., 1994, Current Opinion in Neurobiology, V4, P909, DOI 10.1016/0959-4388(94)90141-4; NUSBAUM MP, 1992, J NEUROSCI, V12, P2706; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Rudomin P, 1993, Curr Opin Neurobiol, V3, P997, DOI 10.1016/0959-4388(93)90173-V; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; SILLAR KT, 1994, J NEUROSCI, V14, P2636; SMALL SA, 1992, J NEUROSCI, V12, P1616; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; WATSON AHD, 1992, COMP BIOCHEM PHYS A, V103, P227, DOI 10.1016/0300-9629(92)90573-9; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; [No title captured]	30	125	125	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					502	505		10.1038/378502a0	http://dx.doi.org/10.1038/378502a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477408				2022-12-24	WOS:A1995TH05400074
J	MEYER, D; BIRCHMEIER, C				MEYER, D; BIRCHMEIER, C			MULTIPLE ESSENTIAL FUNCTIONS OF NEUREGULIN IN DEVELOPMENT	NATURE			English	Article							SEGMENT-SPECIFIC EXPRESSION; ZINC-FINGER GENE; NERVOUS-SYSTEM; MOUSE; HINDBRAIN; CELLS	NEUREGULIN (also called NDF, heregulin, GGF and ARIA) is a member of the EGF family which induces growth and differentiation of epithelial, glial and muscle cells in culture(1-4). The biological effects of the factor are mediated by tyrosine kinase receptors. Neuregulin can bind directly to erbB3 and erbB4 and receptor heterodimerization allows neuregulin-dependent activation of erbB2 (refs 1, 2, 5), A targeted mutation in mice reveals multiple essential roles of neuregulin in development, Here we show that neuregulin -/- embryos die during embryogenesis and display heart malformations. In addition, Schwann cell precursors and cranial ganglia fail to develop normally. The phenotype demonstrates that in vivo neuregulin acts locally and frequently in a paracrine manner. All cell types affected by the mutation express either erbB3 or erbB4, indicating that either of these tyrosine kinase receptors can be a component in recognition and transmission of essential neuregulin signals.						Meyer, Dirk/0000-0002-4020-4484				Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRONNERFRASER M, 1995, EXP CELL RES, V118, P405; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GOSSLER A, 1993, GENE TARGETING PRACT, P207; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; ICARDO JM, 1987, ACTA ANAT, V130, P264; JIN JJ, 1993, CELL GROWTH DIFFER, V4, P227; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEDOUARIN NM, 1986, TRENDS NEUROSCI, V9, P175, DOI 10.1016/0166-2236(86)90055-X; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO	30	984	1016	1	19	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					386	390		10.1038/378386a0	http://dx.doi.org/10.1038/378386a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477375				2022-12-24	WOS:A1995TF89300059
J	SILVERS, SM; HAMPSON, NB				SILVERS, SM; HAMPSON, NB			CARBON-MONOXIDE POISONING AMONG RECREATIONAL BOATERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Objective.-To describe the case characteristics of a series of patients poisoned with carbon monoxide (CO) while boating for recreation. Design.-Cases of patients referred for treatment of CO poisoning with hyperbaric oxygen were reviewed. Those cases that occurred during recreational boating were selected for analysis. Setting.-A private, urban, tertiary care center studied from July 1984 to June 1994. Patients.-Thirty-nine patients ranging in age from 6 months to 69 years who were poisoned in 27 separate incidents. Main Outcome Measures.-Characteristics of the poisoning incidents were assessed at initial patient presentation, immediately following treatment, and with follow-up telephone interviews. Results.-Of 512 patients treated for acute unintentional CO poisoning, 39 cases (8%) occurred in 27 incidents related to recreational boating activities. Individuals typically lost consciousness as a result of the poisoning. Most cases occurred aboard a boat that was older than 10 years, had an enclosable cabin, was longer than 22 feet, was powered by a gasoline engine, and was without a CO detector on board. Conclusions.-Carbon monoxide poisoning is a serious hazard associated with recreational boating. The installation of CO detectors aboard boat types typically associated with this syndrome st-could be strongly encouraged.	VIRGINIA MASON CLIN,DEPT MED,SEATTLE,WA 98111; VIRGINIA MASON MED CTR,DEPT HYPERBAR,SEATTLE,WA; UNIV ROCHESTER,SCH MED & DENT,ROCHESTER,NY 14627	Virginia Mason Medical Center; Virginia Mason Medical Center; University of Rochester			Silvers, Scott/AAM-1234-2021		NIEHS NIH HHS [ESO-0220] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		COBB N, 1991, JAMA-J AM MED ASSOC, V226, P659; GOMEZ GA, 1991, SURG CLIN N AM, V71, P419; GRACE TW, 1981, JAMA-J AM MED ASSOC, V246, P1698; HAMPSON NB, 1992, JAMA-J AM MED ASSOC, V267, P538, DOI 10.1001/jama.267.4.538; HAMPSON NB, 1994, JAMA-J AM MED ASSOC, V271, P52, DOI 10.1001/jama.271.1.52; KOREN G, 1991, REPROD TOXICOL, V5, P397, DOI 10.1016/0890-6238(91)90002-W; PIANTADOSI CA, 1990, UPDATE INTENSIVE CAR, V10, P460; RADFORD EP, 1982, PHS821250 PUBL; Tan E S, 1993, Ned Tijdschr Geneeskd, V137, P2266; 1994, BOATING 1994; 1994, BOATING STATISTICS 1; 1982, MMWR-MORBID MORTAL W, V31, P529	12	26	26	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	1995	274	20					1614	1616						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE738	7474247				2022-12-24	WOS:A1995TE73800027
J	MALIN, AS; GWANZURA, LKZ; KLEIN, S; ROBERTSON, VJ; MUSVAIRE, P; MASON, PR				MALIN, AS; GWANZURA, LKZ; KLEIN, S; ROBERTSON, VJ; MUSVAIRE, P; MASON, PR			PNEUMOCYSTIS-CARINII PNEUMONIA IN ZIMBABWE	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; CENTRAL-AFRICA; LUSAKA; ZAMBIA; AIDS	Pneumocystis carinii pneumonia (PCP) is said to be rare in Africa, with reported rates of 0-22% in human-immunodeficiency-virus (HIV) infected individuals with respiratory symptoms. Over one year in a central hospital in southern Africa, 64 HIV-infected patients with acute diffuse pneumonia unresponsive to penicillin and sputum smear-negative for acid-fast bacilli underwent fibreoptic bronchoscopy. Bronchoalveolar lavage fluid was assessed for bacteria, fungi, Pneumocystis carinii, and mycobacteria. 21 patients (33%) had PCP and 24 (39%) had tuberculosis; 6 of these had both infections. 5 patients had Kaposi's sarcoma (KS) associated with PCP, tuberculosis, or another infection, in 1 patient KS was the only finding, and in 21 no pathogen was identified. A logistic regression model was used to assess clinical, radiographic, and arterial blood gas predictors of PCP and tuberculosis, Fine reticulonodular shadowing on the chest radiograph (nodular component <1 mm) was the strongest independent predictor of PCP (odds ratio 8.5 [95% CI 6.1-10.9]). A respiratory rate of more than 40/min was the best clinical predictor of PCP (odds ratio 11.2 [95% CI 8.8-13.6]). Median CD4(+) T cell count for all cases of PCP was 134/mu L (range 5-355) and for tuberculosis without PCP 206/mu L (range 61-787). In resource-limited countries, a regionally appropriate management algorithm is required.	UNIV ZIMBABWE,DEPT CLIN PHARMACOL,HARARE,ZIMBABWE; UNIV ZIMBABWE,DEPT MED MICROBIOL,HARARE,ZIMBABWE; UNIV ZIMBABWE,DEPT PATHOL,HARARE,ZIMBABWE	University of Zimbabwe; University of Zimbabwe; University of Zimbabwe								ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; AFOLABI OA, 1993, 9 P INT C AIDS BERL; ALTMAN DG, 1991, PRACTICAL STAT MED R, P457; ATZORI C, 1993, T ROY SOC TROP MED H, V87, P55, DOI 10.1016/0035-9203(93)90418-P; BATUNGWANAYO J, 1994, AM J RESP CRIT CARE, V149, P1591, DOI 10.1164/ajrccm.149.6.8004318; CARME B, 1991, T ROY SOC TROP MED H, V85, P80, DOI 10.1016/0035-9203(91)90167-W; ELVIN KM, 1989, T ROY SOC TROP MED H, V83, P553, DOI 10.1016/0035-9203(89)90290-3; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; KAMANFU G, 1993, AM REV RESPIR DIS, V147, P658, DOI 10.1164/ajrccm/147.3.658; Lucas S., 1988, AIDS and associated cancers in Africa., P124; LUCAS SB, 1991, AIDS, V5, pS143; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; MACHIELS G, 1992, T ROY SOC TROP MED H, V86, P399, DOI 10.1016/0035-9203(92)90237-7; MCLEOD DT, 1989, T ROY SOC TROP MED H, V83, P694, DOI 10.1016/0035-9203(89)90400-8; MILLAR AB, 1990, THORAX, V45, P57, DOI 10.1136/thx.45.1.57; MILLER RF, 1992, LANCET, V339, P747, DOI 10.1016/0140-6736(92)90650-R; MILLER RF, 1989, THORAX, V44, P559, DOI 10.1136/thx.44.7.559; MUFSON MA, 1994, CURR OPIN INFECT DIS, V7, P178, DOI 10.1097/00001432-199404000-00006; PIOT P, 1992, AIDS AFRICA MANUAL P; SERWADDA D, 1989, AIDS, V3, P47; WAKEFIELD AE, 1990, T ROY SOC TROP MED H, V84, P800, DOI 10.1016/0035-9203(90)90087-U; WAKEFIELD AE, 1994, J CLIN MICROBIOL, V32, P2959, DOI 10.1128/JCM.32.12.2959-2961.1994; 1991, RRESPIRATORY CONDITI; 1986, WEEKLY EPIDEMIOL REC, V10, P72; 1994, ESSENTIAL DRUGS LIST, P95	25	89	91	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1258	1261		10.1016/S0140-6736(95)91862-0	http://dx.doi.org/10.1016/S0140-6736(95)91862-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475717				2022-12-24	WOS:A1995TE14500010
J	COHENCORY, S; FRASER, SE				COHENCORY, S; FRASER, SE			EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON OPTIC AXON BRANCHING AND REMODELING IN-VIVO	NATURE			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; RECEPTOR; TRKB; RAT; EXPRESSION; SURVIVAL; BDNF; NGF	NEUROTROPHINS are thought to be important for the survival and differentiation of vertebrate neurons(1). Roles have been suggested for target-derived neurotrophins, based both on their expression in target tissues at the time of neuron innervation(2,3), and on their effects on axonal sprouting(4-6). However, direct in vivo evidence of their involvement in axon arborization has remained elusive. We have used in vivo microscopy to follow individual optic axons over time, and have examined the role of the neurotrophin brain-derived neurotrophic factor (BDNF) in their development. Here we show that injection of BDNF into the optic tectum of live Xenopus laevis tadpoles increased the branching and complexity of optic axon terminal arbors. In contrast, injection of specific neutralizing antibodies to BDNF reduced axon arborization and complexity. The onset of these effects was rapid (within 2 hours) and persisted throughout the 24-hour observation period. Other neurotrophins had little or no significant effects. These results demonstrate the involvement of neurotrophins in the dynamic elaboration of axon terminals, and suggest a direct role for target-derived BDNF during synaptic patterning in the developing central nervous system.			COHENCORY, S (corresponding author), CALTECH, CTR BIOL IMAGING, DIV BIOL 139-74, PASADENA, CA 91125 USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223				BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1993, EXP NEUROL, V119, P165, DOI 10.1006/exnr.1993.1018; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DIAMOND J, 1992, J NEUROSCI, V12, P1454; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; EMFORS P, 1992, EUR J NEUROSCI, V4, P1140; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS WA, 1987, DEVELOPMENT, V101, P123; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KORSCHING S, 1988, DEV BIOL, V126, P40, DOI 10.1016/0012-1606(88)90236-9; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NAWA H, 1994, J NEUROSCI, V14, P3751; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F	30	506	514	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	1995	378	6553					192	196		10.1038/378192a0	http://dx.doi.org/10.1038/378192a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477323				2022-12-24	WOS:A1995TD75900056
J	GROSHEIDE, PM; KLOKMANHOUWELING, JM; CONYNVANSPAENDONCK, MAE; VERBRUGGE, HP; LATUPERISA, R; MAZEL, JA; LEMS, AA; YPMA, TD; GERARDS, LJ; AARTS, GJ; BOLSCHER, DJA; DUFFELS, GJJ; KOPPENAAL, A; ENGEL, B; VANDERVOORN, JG; KOSTER, EH; VANDERSTEUR, JB				GROSHEIDE, PM; KLOKMANHOUWELING, JM; CONYNVANSPAENDONCK, MAE; VERBRUGGE, HP; LATUPERISA, R; MAZEL, JA; LEMS, AA; YPMA, TD; GERARDS, LJ; AARTS, GJ; BOLSCHER, DJA; DUFFELS, GJJ; KOPPENAAL, A; ENGEL, B; VANDERVOORN, JG; KOSTER, EH; VANDERSTEUR, JB			PROGRAM FOR PREVENTING PERINATAL HEPATITIS-B INFECTION THROUGH SCREENING OF PREGNANT-WOMEN AND IMMUNIZATION OF INFANTS OF INFECTED MOTHERS IN THE NETHERLANDS, 1989-92	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PASSIVE-ACTIVE IMMUNIZATION; ANTIGEN-CARRIER MOTHERS; VACCINATION PROGRAM; SURFACE-ANTIGEN; IMMUNE GLOBULIN; VIRUS-INFECTION; TRANSMISSION	Objectives-To launch a programme for the prevention of perinatal infection with hepatitis B in the Netherlands. Design-Routine antenatal screening and intervention programme. Setting-Community antenatal programme, the Netherlands. Subjects-Infants of mothers who were carriers of hepatitis B detected by routine screening. Interventions-Infants of infected mothers received hepatitis B immunoglobulin at birth and four doses of hepatitis B vaccine in conjunction with routine immunisation at 3, 4, 5, and 11 months of age. Main outcome measures-Results of screening and immunisation from 1989-92. Results-The coverage of screening increased from 46% in 1989 to 84% in 1992. Hepatitis B surface antigen was detected in 2145 women (0.44%). The coverage of postnatal immunoprophylaxis in 1645 neonates born to mothers who were carriers of hepatitis B was 85% (1398); in 3% (42) there was a delay in administration of immunoglobulin of over 24 hours. In 1991, 96% (537), 95% (532), 94% (525), and 87% (489) of the infants received the first, second, third, and fourth dose of vaccine, respectively. There was considerable variation in the timing of vaccination; 17% (258) of the infants received their first dose more than two weeks late. Of the 59% (583) of infants who received the fourth dose more than two weeks beyond target age, 14% (141) also received their first dose too late. Conclusions-A prevention programme for perinatal hepatitis B in an area of low prevalence, when incorporated into existing health care, is feasible and achieves satisfactory coverage rates. Intensive follow up is needed to improve adherence to the immunisation schedule.	NATL INST PUBL HLTH & ENVIRONM PROTECT, DEPT INFECT DIS & EPIDEMIOL, 3720 BA BILTHOVEN, NETHERLANDS; MUNICIPAL PUBL HLTH SERV, HAARLEM, NETHERLANDS; NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS	Netherlands National Institute for Public Health & the Environment								BEASLEY RP, 1983, HEPATOLOGY, V3, P135; BEASLEY RP, 1983, LANCET, V2, P1099; CHEN D-S, 1987, Journal of the American Medical Association, V257, P2597, DOI 10.1001/jama.257.19.2597; GROSHEIDE PM, 1993, AM J DIS CHILD, V147, P1316, DOI 10.1001/archpedi.1993.02160360058019; GROSHEIDE PM, IN PRESS BMJ; HENNING KJ, 1992, AM J PUBLIC HEALTH, V82, P885, DOI 10.2105/AJPH.82.6.885; INSKIP HM, 1991, INT J EPIDEMIOL, V20, P764, DOI 10.1093/ije/20.3.764; JONAS MM, 1990, AM J GASTROENTEROL, V85, P277; MAZEL JA, 1984, BRIT MED J, V288, P513, DOI 10.1136/bmj.288.6416.513; NIU MT, 1992, AM J DIS CHILD, V146, P793, DOI 10.1001/archpedi.1992.02160190025012; SCHALM SW, 1989, PEDIATRICS, V83, P1041; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; STROFFOLINI T, 1989, VACCINE, V7, P152, DOI 10.1016/0264-410X(89)90056-X; VERBRUGGE HP, 1990, PEDIATRICS, V86, P1060; WEST DJ, 1993, VACCINE, V11, pS21, DOI 10.1016/0264-410X(93)90154-P	15	18	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	1995	311	7014					1200	1202		10.1136/bmj.311.7014.1200	http://dx.doi.org/10.1136/bmj.311.7014.1200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488896	Green Published			2022-12-24	WOS:A1995TD76800020
J	HOSSACK, KF; LEDDY, CL; JOHNSON, AM; SCHRIER, RW; GABOW, PA				HOSSACK, KF; LEDDY, CL; JOHNSON, AM; SCHRIER, RW; GABOW, PA			ECHOCARDIOGRAPHIC FINDINGS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV COLORADO,SCH MED,DEPT MED,DENVER,CO 80202	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	HOSSACK, KF (corresponding author), DENVER GEN HOSP,DIV CARDIOL,777 BANNOCK ST A009,DENVER,CO 80204, USA.			Johnson, Anne/0000-0003-1330-7100				ABBASI AS, 1980, CIRCULATION, V61, P143, DOI 10.1161/01.CIR.61.1.143; AKASAKA T, 1987, CIRCULATION, V76, P262, DOI 10.1161/01.CIR.76.2.262; BARLOW JB, 1963, AM HEART J, V66, P443, DOI 10.1016/0002-8703(63)90375-2; BIGELOW NH, 1953, AM J MED SCI, V225, P485, DOI 10.1097/00000441-195305000-00004; BUTKOWSKI RJ, 1985, KIDNEY INT, V28, P744, DOI 10.1038/ki.1985.193; CIOBANU M, 1982, AM J CARDIOL, V49, P339, DOI 10.1016/0002-9149(82)90510-0; DALGAARD OZ, 1957, ACTA MED SCAND, V328, P10; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; DUREN DR, 1988, J AM COLL CARDIOL, V11, P42; FEIGENBAUM H, 1981, ECHOCARDIOGR-J CARD, P551; GABOW PA, 1984, ANN INTERN MED, V101, P238, DOI 10.7326/0003-4819-101-2-238; GOOCH AS, 1972, AM J CARDIOL, V29, P611, DOI 10.1016/0002-9149(72)90161-0; GRANOT Y, 1988, CLIN RES, V36, pA135; GRANTHAM JJ, 1988, DISEASES KIDNEY, P583; HAMMER D, 1979, AM J MED, V67, P863, DOI 10.1016/0002-9343(79)90746-0; KISSANE JM, 1979, NEPHROLOGY, P887; KOLIBASH AJ, 1986, AM J CARDIOL, V58, P762, DOI 10.1016/0002-9149(86)90352-8; LEIER CV, 1984, ANN INTERN MED, V100, P683, DOI 10.7326/0003-4819-100-5-683; LEIER CV, 1980, ANN INTERN MED, V92, P171, DOI 10.7326/0003-4819-92-2-171; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; LOBSTEIN HP, 1973, NEW ENGL J MED, V289, P127, DOI 10.1056/NEJM197307192890304; MARDELLI TJ, 1981, CHEST, V79, P201, DOI 10.1378/chest.79.2.201; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; MONTOLIU J, 1980, LANCET, V1, P1133; MORGANROTH J, 1981, CHEST, V79, P23, DOI 10.1378/chest.79.1.23; NAGGAR CZ, 1986, AM J CARDIOL, V58, P1209, DOI 10.1016/0002-9149(86)90383-8; NUNEZ L, 1986, CHEST, V90, P299, DOI 10.1378/chest.90.2.299; OGAWA S, 1982, CIRCULATION, V65, P174, DOI 10.1161/01.CIR.65.1.174; PERLOFF JK, 1986, AM J CARDIOL, V57, P1124, DOI 10.1016/0002-9149(86)90686-7; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAVAGE DD, 1983, AM HEART J, V106, P571, DOI 10.1016/0002-8703(83)90704-4; SAVAGE DD, 1983, AM HEART J, V106, P577, DOI 10.1016/0002-8703(83)90705-6; SAVAGE DD, 1983, AM HEART J, V106, P582, DOI 10.1016/0002-8703(83)90706-8; SCHEFF RT, 1980, ANN INTERN MED, V92, P202, DOI 10.7326/0003-4819-92-2-202; THOMPSON JS, 1986, GENETICS MED, V4, P44; WANN LS, 1983, BRIT HEART J, V49, P334; WEISS AN, 1975, CIRCULATION, V52, P1091, DOI 10.1161/01.CIR.52.6.1091; WILSON PD, 1986, KIDNEY INT, V30, P371, DOI 10.1038/ki.1986.194	38	177	180	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	1988	319	14					907	912		10.1056/NEJM198810063191404	http://dx.doi.org/10.1056/NEJM198810063191404			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2854	3419455				2022-12-24	WOS:A1988Q285400004
J	GALVE, E; CANDELLRIERA, J; PIGRAU, C; PERMANYERMIRALDA, G; GARCIADELCASTILLO, H; SOLERSOLER, J				GALVE, E; CANDELLRIERA, J; PIGRAU, C; PERMANYERMIRALDA, G; GARCIADELCASTILLO, H; SOLERSOLER, J			PREVALENCE, MORPHOLOGIC TYPES, AND EVOLUTION OF CARDIAC VALVULAR DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HOSP GEN VALL HEBRON,DEPT MED,SERV MED INTERNA,E-08035 BARCELONA,SPAIN	Hospital Universitari Vall d'Hebron	GALVE, E (corresponding author), HOSP GEN VALL HEBRON,DEPT MED,SERV CARDIOL,PASEO VALL HEBRON S-N,E-08035 BARCELONA,SPAIN.							AKASAKA T, 1987, CIRCULATION, V76, P262, DOI 10.1161/01.CIR.76.2.262; ANSARI A, 1985, PROG CARDIOVASC DIS, V27, P421, DOI 10.1016/0033-0620(85)90003-9; BENOTTI JR, 1984, CHEST, V86, P140, DOI 10.1378/chest.86.1.140; BONFIGLIO TA, 1972, AM HEART J, V83, P153, DOI 10.1016/0002-8703(72)90133-0; BRIGDEN W, 1960, BRIT HEART J, V22, P1; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; CIOBANU M, 1982, AM J CARDIOL, V49, P339, DOI 10.1016/0002-9149(82)90510-0; DAJEE H, 1983, J THORAC CARDIOV SUR, V85, P718; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; DOHERTY NE, 1988, AM J CARDIOL, V61, P1144, DOI 10.1016/0002-9149(88)90150-6; ELKAYAM U, 1977, ANN RHEUM DIS, V36, P349, DOI 10.1136/ard.36.4.349; HATLE L, 1979, CIRCULATION, V60, P1096, DOI 10.1161/01.CIR.60.5.1096; HEJTMANCIK MR, 1964, AM HEART J, V68, P119, DOI 10.1016/0002-8703(64)90248-0; HUMPHREYS EM, 1948, ANN INTERN MED, V28, P12, DOI 10.7326/0003-4819-28-1-12; Klemperer P, 1941, ARCH PATHOL, V32, P569; KLINKHOFF AV, 1985, JAMA-J AM MED ASSOC, V253, P3273, DOI 10.1001/jama.253.22.3273; KONG THOMAS Q., 1962, CIRCULATION, V26, P7; KOSTUCKI W, 1986, AM J CARDIOL, V58, P309, DOI 10.1016/0002-9149(86)90068-8; LAUFER J, 1982, BRIT HEART J, V48, P294; Libman E, 1924, ARCH INTERN MED, V33, P701, DOI 10.1001/archinte.1924.00110300044002; MANISCALCO BS, 1975, CIRCULATION, V52, P211; PAGET SA, 1975, AM J MED, V59, P134, DOI 10.1016/0002-9343(75)90331-9; PONSLLADO G, 1986, AM J CARDIOL, V57, P806, DOI 10.1016/0002-9149(86)90618-1; PRITZKER MR, 1980, ANN INTERN MED, V93, P434, DOI 10.7326/0003-4819-93-3-434; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TORNOS MP, 1985, INT J CARDIOL, V7, P409, DOI 10.1016/0167-5273(85)90095-6; VAUGHTON KC, 1979, BRIT HEART J, V41, P730; ZOGHBI WA, 1986, CIRCULATION, V73, P452, DOI 10.1161/01.CIR.73.3.452	28	197	203	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	1988	319	13					817	823		10.1056/NEJM198809293191302	http://dx.doi.org/10.1056/NEJM198809293191302			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2011	3412413				2022-12-24	WOS:A1988Q201100002
J	RUMSEY, WL; VANDERKOOI, JM; WILSON, DF				RUMSEY, WL; VANDERKOOI, JM; WILSON, DF			IMAGING OF PHOSPHORESCENCE - A NOVEL METHOD FOR MEASURING OXYGEN DISTRIBUTION IN PERFUSED TISSUE	SCIENCE			English	Article											RUMSEY, WL (corresponding author), UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104, USA.			Wilson, David F/0000-0002-2626-5838	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036393, R01GM021524] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 21524, GM 36393] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMPRA JC, 1982, LIVER BIOL PATHOBIOL, P632; KEKONEN EM, 1987, J CELL PHYSIOL, V133, P119, DOI 10.1002/jcp.1041330115; MATSUMURA T, 1986, AM J PHYSIOL, V250, pG800, DOI 10.1152/ajpgi.1986.250.6.G800; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; VANDERKOOI JM, 1987, ADV EXP MED BIOL, V200, P189; Wilson D F, 1987, Adv Exp Med Biol, V215, P71; WILSON DF, 1988, J BIOL CHEM, V263, P2712; WILSON DF, 1988, ADV EXP MED BIOL, V220, P121	8	439	442	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 23	1988	241	4873					1649	1651		10.1126/science.3420417	http://dx.doi.org/10.1126/science.3420417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1372	3420417				2022-12-24	WOS:A1988Q137200033
J	CRAIG, PI; GILLESPIE, PE				CRAIG, PI; GILLESPIE, PE			THROUGH THE ENDOSCOPE BALLOON DILATATION OF BENIGN GASTRIC OUTLET OBSTRUCTION	BRITISH MEDICAL JOURNAL			English	Article											CRAIG, PI (corresponding author), WESTMEAD HOSP,DEPT MED,GASTROENTEROL UNIT,WESTMEAD,NSW 2145,AUSTRALIA.							BENJAMIN SB, 1984, GASTROINTEST ENDOSC, V30, P93, DOI 10.1016/S0016-5107(84)72329-7; HOGAN RB, 1986, GASTROINTEST ENDOSC, V32, P71, DOI 10.1016/S0016-5107(86)71758-6; JAFFIN BW, 1985, ANN SURG, V201, P176; KOZAREK RA, 1986, GASTROINTEST ENDOSC, V32, P15, DOI 10.1016/S0016-5107(86)71721-5; LINDOR KD, 1985, GASTROENTEROLOGY, V89, P545, DOI 10.1016/0016-5085(85)90449-4	5	21	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					396	396		10.1136/bmj.297.6645.396	http://dx.doi.org/10.1136/bmj.297.6645.396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408981	Green Published, Bronze			2022-12-24	WOS:A1988P545000022
J	JAGGER, J; HUNT, EH; BRANDELNAGGAR, J; PEARSON, RD				JAGGER, J; HUNT, EH; BRANDELNAGGAR, J; PEARSON, RD			RATES OF NEEDLE-STICK INJURY CAUSED BY VARIOUS DEVICES IN A UNIVERSITY HOSPITAL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV VIRGINIA, DEPT NEUROSURG, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, DEPT PATHOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, DEPT INTERNAL MED, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, DEPT EMPLOYEE HLTH, CHARLOTTESVILLE, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia								[Anonymous], 1984, LANCET, V2, P1376; BALDWIN AH, 1923, JAMA-J AM MED ASSOC, V80, P1375; BEVERLEY JKA, 1955, BMJ-BRIT MED J, V1, P577, DOI 10.1136/bmj.1.4913.577; CANNON NJ, 1972, J AMER MED ASSOC, V222, P1425, DOI 10.1001/jama.222.11.1425; CHACKO CW, 1966, B WORLD HEALTH ORGAN, V35, P809; CHAPPLER RR, 1977, ARCH DERMATOL, V113, P380, DOI 10.1001/archderm.113.3.380; COLLINS CH, 1987, J APPL BACTERIOL, V62, P385; EDMOND M, 1988, INFECT CONT HOSP EP, V9, P114, DOI 10.1086/645806; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Evans N, 1903, J AMER MED ASSOC, V40, P1772; GLASER JB, 1985, NEW ENGL J MED, V313, P266; GUGEL EA, 1986, NEW ENGL J MED, V315, P1487; HAMBRICK GW, 1962, ARCH DERMATOL, V85, P583, DOI 10.1001/archderm.1962.01590050013003; HAMORY BH, 1983, AM J INFECT CONTROL, V11, P174, DOI 10.1016/0196-6553(83)90077-9; HILL A, 1971, BRIT MED J, V2, P711, DOI 10.1136/bmj.2.5763.711-c; JACOBSON JT, 1983, INFECT CONT HOSP EP, V4, P100, DOI 10.1017/S0195941700057830; JAGGER J, 1987, INFECT CONT HOSP EP, V8, P51, DOI 10.1017/S0195941700067060; JAGGER J, 1986, LANCET, V1, P1274; JOFFE B, 1966, ANN INTERN MED, V65, P564, DOI 10.7326/0003-4819-65-3-564; KRASINSKI K, 1987, INFECT CONT HOSP EP, V8, P59, DOI 10.1017/S0195941700067084; MCCRAY E, 1986, NEW ENGL J MED, V314, P1127, DOI 10.1056/NEJM198604243141729; MEYERS JD, 1977, ANN INTERN MED, V87, P57, DOI 10.7326/0003-4819-87-1-57; OKSENHENDLER E, 1986, NEW ENGL J MED, V315, P582; RIBNER BS, 1987, INFECT CONT HOSP EP, V8, P63, DOI 10.1017/S0195941700067096; SAHN SA, 1974, AM J MED, V57, P676, DOI 10.1016/0002-9343(74)90023-0; Sanborn C, 1988, Nurs Adm Q, V12, P24; SARASIN G, 1963, AM J CLIN PATHOL, V40, P146; SEXTON DJ, 1975, NEW ENGL J MED, V292, P645; STRICOF RL, 1986, NEW ENGL J MED, V314, P1115; SU WPD, 1976, ARCH DERMATOL, V112, P1755, DOI 10.1001/archderm.112.12.1755; WILLIAMS WW, 1983, INFECT CONT HOSP EP, V4, P326; 1985, INJURY AM CONTINUING	32	283	294	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	1988	319	5					284	288		10.1056/NEJM198808043190506	http://dx.doi.org/10.1056/NEJM198808043190506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5161	3393183				2022-12-24	WOS:A1988P516100006
J	HADDAD, NG; HUSSEIN, IY; LIVINGSTONE, JRB; SMART, GE				HADDAD, NG; HUSSEIN, IY; LIVINGSTONE, JRB; SMART, GE			COLPOSCOPY IN TEENAGERS	BRITISH MEDICAL JOURNAL			English	Article											HADDAD, NG (corresponding author), ROYAL INFIRM,DEPT OBSTET & GYNAECOL,EDINBURGH EH3 9EW,SCOTLAND.							PATTERSON MEL, 1984, BRIT MED J, V289, P896; ROBERTS A., 1982, Health Trends, V14, P41; SADEGHI SB, 1984, AM J OBSTET GYNECOL, V148, P726, DOI 10.1016/0002-9378(84)90555-6; 1987, INTERCOLLEGIATE WORK, P8; 1984, HLTH SERVICES DEV SC	5	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					29	30		10.1136/bmj.297.6640.29	http://dx.doi.org/10.1136/bmj.297.6640.29			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408905	Green Published, Bronze			2022-12-24	WOS:A1988P100000024
J	OBRIEN, LA; GRISSO, JA; MAISLIN, G; LAPANN, K; KROTKI, KP; GRECO, PJ; SIEGERT, EA; EVANS, LK				OBRIEN, LA; GRISSO, JA; MAISLIN, G; LAPANN, K; KROTKI, KP; GRECO, PJ; SIEGERT, EA; EVANS, LK			NURSING-HOME RESIDENTS PREFERENCES FOR LIFE-SUSTAINING TREATMENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOPULMONARY-RESUSCITATION; DECISIONS; CARE	Objectives.-To determine life-sustaining treatment preferences among nursing home residents, whether information regarding cardiopulmonary resuscitation (CPR) affected these preferences, and with whom treatment preferences had been discussed, and to identify factors associated with CPR preferences. Design.-In-person survey. Setting.-Forty-nine randomly selected nursing homes. Subjects.-Four hundred twenty-one randomly selected nursing home residents capable of making decisions. Main Outcome Measures.-Preferences regarding CPR, hospitalization, and enteral tube feedings, and individual factors associated with CPR preferences. Results.-Of 1458 randomly selected nursing home residents assessed for the ability to participate in the study, 552 residents (38%) were eligible to participate and 421 agreed to be interviewed. Sixty percent of participants able to participate in the decision reported that they would elect CPR, 89% would choose hospitalization if seriously ill, and 33% would elect enteral tube feedings a no longer able to eat because of permanent brain damage. Individual factors associated with preferences for CPR included the following: African-American ethnicity, high self-reported physical mobility, belief that most important medical care decisions should be made by the doctor, moderate-to-severe impairment in daily decision-making skills, and not having a spouse. Fourteen percent changed their preference from preferring CPR to not preferring CPR after receiving additional information about CPR procedures. Twelve percent reported having discussed preferences with health care providers, and 31% discussed preferences with family members. Conclusions-More than half of nursing home residents capable of making decisions preferred the use of CPR. Few had discussed their preferences with health care providers. Individual preferences should be assessed when considering the use of life-sustaining treatments.	UNIV PENN,SCH NURSING,PHILADELPHIA,PA 19104; TEMPLE UNIV,INST SURVEY RES,PHILADELPHIA,PA 19122; CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,CAMDEN,NJ 08103	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center	OBRIEN, LA (corresponding author), UNIV PENN,SCH MED,CTR CLIN EPIDEMIOL & BIOSTAT,DIV GEN INTERNAL MED,PHILADELPHIA,PA 19104, USA.		Maislin, Greg/S-5322-2019		AHRQ HHS [1-R01-HS-06815] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; FILLENBAUM GG, 1980, J AM GERIATR SOC, V28, P381, DOI 10.1111/j.1532-5415.1980.tb01103.x; GERETY MB, 1993, J AM GERIATR SOC, V41, P953, DOI 10.1111/j.1532-5415.1993.tb06761.x; GRISSO JA, 1994, NEW ENGL J MED, V330, P1555, DOI 10.1056/NEJM199406023302202; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; JONSEN AR, 1986, CLIN ETHICS PRACTICA, P52; KISH L, 1965, SURVEY SAMPLING, P230; KOENIG HG, 1992, INT J PSYCHIAT MED, V22, P183, DOI 10.2190/M1F5-F40P-C4KD-YPA3; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; OUSLANDER JG, 1989, ARCH INTERN MED, V149, P1367, DOI 10.1001/archinte.149.6.1367; PFEIFFER E, 1975, J AM GERIATR SOC, V25, P433; SACHS GA, 1992, J AM GERIATR SOC, V42, P269; SCHONWETTER RS, 1991, J AM GERIATR SOC, V39, P372, DOI 10.1111/j.1532-5415.1991.tb02902.x; SHADLEN F, 1990, J AM GERIATR SOC, V38, pA55; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; SINGER PA, 1991, HASTINGS CTR REP S2, V21, P1; TENO J, 1991, CLIN RES, V39, pA632; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; 1993, SUDAAN VERSION 6 33; 1990, SAS P200 I INC TECHN, P194	23	134	135	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	1995	274	22					1775	1779		10.1001/jama.274.22.1775	http://dx.doi.org/10.1001/jama.274.22.1775			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TJ225	7500508				2022-12-24	WOS:A1995TJ22500027
J	MANNING, WJ; WEINTRAUB, RM; WAKSMONSKI, CA; HAERING, JM; ROONEY, PS; MASLOW, AD; JOHNSON, RG; DOUGLAS, PS				MANNING, WJ; WEINTRAUB, RM; WAKSMONSKI, CA; HAERING, JM; ROONEY, PS; MASLOW, AD; JOHNSON, RG; DOUGLAS, PS			ACCURACY OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY FOR IDENTIFYING LEFT ATRIAL THROMBI - A PROSPECTIVE, INTRAOPERATIVE STUDY	ANNALS OF INTERNAL MEDICINE			English	Article						ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART ATRIUM; THROMBOSIS, CORONARY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS	RHEUMATIC HEART-DISEASE; MITRAL-VALVE; DIMENSIONAL ECHOCARDIOGRAPHY; FIBRILLATION; CARDIOVERSION; DIAGNOSIS; CONTRAST	Objective: To determine the ability of transesophageal echocardiography to accurately identify or exclude left atrial thrombi. Design: Prospective cohort study. Setting: University hospital. Patients: 231 consecutive patients having transesophageal echocardiography before elective repair or replacement of the mitral valve or excision of a left atrial tumor. Fifty-six percent of patients had a history of atrial fibrillation, and 17% had a history of thromboembolism. Measurement: Identification of left atrial thrombi during transesophageal echocardiographic examination and comparison with direct near-simultaneous visualization during cardiac surgery. Results: Transesophageal echocardiography identified 14 left atrial thrombi in 14 patients (6%). Thrombus size ranged from 3 to 80 mm. Surgery confirmed 12 of 14 thrombi (86%), including 9 thrombi confined to the left appendage. No additional thrombi were found on direct inspection of the atria (sensitivity, 100% [95% CI, 74% to 100%]; specificity, 99% [CI, 97% to 99.9%]; positive predictive value, 86% [12/14]; negative predictive value, 100% [217/217]; for a population that had a 5.2% prevalence of thrombi). All 12 surgically confirmed thrombi were identified by two independent observers. Neither thrombus seen by only a single observer on transesophageal echocardiography was confirmed during direct inspection of the atria at surgery. Conclusion: Transesophageal echocardiography is highly accurate for identifying left atrial thrombi and can be used clinically to exclude left atrial thrombi.	HARVARD UNIV, SCH MED, BOSTON, MA USA	Harvard University; Harvard Medical School	MANNING, WJ (corresponding author), BETH ISRAEL HOSP, DIV CARDIOVASC, CHARLES A DANA & HARVARD THORNDIKE LAB, 330 BROOKLINE AVE, BOSTON, MA 02215 USA.			Douglas, Pamela/0000-0001-9876-4049				ABERG H, 1969, ACTA MED SCAND, V185, P373; ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163, DOI 10.1016/S0735-1097(86)80275-3; BLACK IW, 1991, J AM COLL CARDIOL, V18, P398, DOI 10.1016/0735-1097(91)90592-W; BLACKSHEAR JL, 1993, AM J CARDIOL, V72, P840, DOI 10.1016/0002-9149(93)91079-W; CASTELLO R, 1990, AM J CARDIOL, V65, P1149, DOI 10.1016/0002-9149(90)90330-4; DEPACE NL, 1981, AM J CARDIOL, V48, P954, DOI 10.1016/0002-9149(81)90364-7; GUIRAUDON GM, 1991, ANN THORAC SURG, V52, P1058, DOI 10.1016/0003-4975(91)91281-Y; HERZOG CA, 1984, J AM COLL CARDIOL, V3, P1340, DOI 10.1016/S0735-1097(84)80195-3; HWANG JJ, 1993, AM J CARDIOL, V72, P677; KRONZON I, 1990, J AM COLL CARDIOL, V16, P1320, DOI 10.1016/0735-1097(90)90572-7; MANNING WJ, 1993, NEW ENGL J MED, V328, P750, DOI 10.1056/NEJM199303183281102; MANNING WJ, 1992, BRIT HEART J, V67, P170; MUGGE A, 1990, American Journal of Cardiac Imaging, V4, P173; Olson J D, 1992, J Am Soc Echocardiogr, V5, P52; ORSINELLI DA, 1993, AM J CARDIOL, V72, P1337, DOI 10.1016/0002-9149(93)90315-4; Pearlman A S, 1992, J Am Soc Echocardiogr, V5, P187; PEARSON AC, 1991, J AM COLL CARDIOL, V17, P66, DOI 10.1016/0735-1097(91)90705-E; POP G, 1990, STROKE, V21, P560, DOI 10.1161/01.STR.21.4.560; SCHWEIZER P, 1981, BRIT HEART J, V45, P148; Seward J B, 1992, J Am Soc Echocardiogr, V5, P288; SHRESTHA NK, 1983, CIRCULATION, V67, P341, DOI 10.1161/01.CIR.67.2.341; STARLING MR, 1983, AM HEART J, V106, P1143, DOI 10.1016/0002-8703(83)90664-6; TARDIF JC, 1994, AM HEART J, V128, P156, DOI 10.1016/0002-8703(94)90022-1; VISSER CA, 1983, CHEST, V83, P228, DOI 10.1378/chest.83.2.228	24	301	312	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1995	123	11					817	+		10.7326/0003-4819-123-11-199512010-00001	http://dx.doi.org/10.7326/0003-4819-123-11-199512010-00001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG209	7486462				2022-12-24	WOS:A1995TG20900001
J	STEWART, T; STEWART, N				STEWART, T; STEWART, N			BREAST-CANCER IN FEMALE FLIGHT ATTENDANTS	LANCET			English	Editorial Material									UNIV OTTAWA,OTTAWA,ON,CANADA	University of Ottawa	STEWART, T (corresponding author), OTTAWA GEN HOSP,OTTAWA,ON K1H 8L6,CANADA.			Stewart, Nicolas/0000-0002-8969-4242				COHEN BL, 1994, INT ARCH OCC ENV HEA, V66, P71, DOI 10.1007/BF00383360; ENSOLI B, 1992, IMMUNOL REV, V127, P147, DOI 10.1111/j.1600-065X.1992.tb01412.x; LEVY JA, 1995, LANCET, V346, P786, DOI 10.1016/S0140-6736(95)91611-3; LIU SZ, 1985, CHINESE J RADIOL MED, V5, P124; LIU SZ, 1987, HLTH PHYS, V52, P579; Luckey TD, 1991, RAD HORMESIS; PUKKALA E, 1995, BRIT MED J, V311, P649, DOI 10.1136/bmj.311.7006.649; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; TUSCHL H, 1980, RADIAT RES, V81, P1, DOI 10.2307/3575358	9	5	5	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1379	1379		10.1016/S0140-6736(95)92400-0	http://dx.doi.org/10.1016/S0140-6736(95)92400-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475815				2022-12-24	WOS:A1995TG20700003
J	TROTTIER, Y; LUTZ, Y; STEVANIN, G; IMBERT, G; DEVYS, D; CANCEL, G; SAUDOU, F; WEBER, C; DAVID, G; TORA, L; AGID, Y; BRICE, A; MANDEL, JL				TROTTIER, Y; LUTZ, Y; STEVANIN, G; IMBERT, G; DEVYS, D; CANCEL, G; SAUDOU, F; WEBER, C; DAVID, G; TORA, L; AGID, Y; BRICE, A; MANDEL, JL			POLYGLUTAMINE EXPANSION AS A PATHOLOGICAL EPITOPE IN HUNTINGTONS-DISEASE AND 4 DOMINANT CEREBELLAR ATAXIAS	NATURE			English	Article							LOCUS	A POLYGLUTAMINE expansion (encoded by a CAG repeat) in specific proteins causes neurodegeneration in Huntington's disease (HD) and four other disorders(1-6), by an unknown mechanism thought to involve gain of function or toxicity of the mutated protein(7,8). The pathological threshold is 37-40 glutamines in three of these diseases, whereas the corresponding normal proteins contain polymorphic repeats of up to about 35 glutamines(1-3). The age of onset of clinical manifestations is inversely correlated to the length of the polyglutamine expansion. Here we report the characterization of a monoclonal antibody that selectively recognizes polyglutamine expansion in the proteins implicated in HD and in spinocerebellar ataxia (SCA) 1 and 3. The intensity of signal depends on the length of the polyglutamine expansion, and the antibody also detects specific pathological proteins expected to contain such expansion, in SCA2 and in autosomal dominant cerebellar ataxia with retinal degeneration, whose genes have not yet been identified(9-13).	ULP,CNRS,INSERM,INST GENET & BIOL MOLEC CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; HOP LA PITIE SALPETRIERE,INSERM,U289,F-75651 PARIS 13,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite			Stevanin, Giovanni/E-5038-2016; brice, alexis/AAE-8275-2019; Trottier, Yvon/H-8852-2016; Tora, Laszlo/E-9999-2018; Brice, Alexis/A-2170-2009; SAUDOU, Frédéric/L-3454-2014	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Tora, Laszlo/0000-0001-7398-2250; SAUDOU, Frédéric/0000-0001-6107-1046; Trottier, Yvon/0000-0001-7230-4810; Devys, Didier/0000-0001-9655-3512; Cancel-Tassin, Geraldine/0000-0002-9583-6382				ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; BELAL S, 1994, NEUROLOGY, V44, P1423, DOI 10.1212/WNL.44.8.1423; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; DURR A, IN PRESS BRAIN; GARDNER K, 1994, NEUROLOGY, V44, pA361; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GISPERT S, 1995, AM J HUM GENET, V56, P183; GOSTOUT B, 1995, AM J HUM GENET, V52, P1182; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; KAWAGUCHI Y, 1995, NAT GENET, V8, P221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; LEZIN A, IN PRESS HUM GENET; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SITTLER A, IN PRESS HUM MOL GEN; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; 1993, CELL, V72, P971	31	567	589	1	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					403	406		10.1038/378403a0	http://dx.doi.org/10.1038/378403a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477379				2022-12-24	WOS:A1995TF89300063
J	SCHOUTEN, EJ; BORGDORFF, MW				SCHOUTEN, EJ; BORGDORFF, MW			INCREASED MORTALITY AMONG DUTCH DEVELOPMENT WORKERS	BRITISH MEDICAL JOURNAL			English	Article									ROYAL TROP INST,1092 AD AMSTERDAM,NETHERLANDS		SCHOUTEN, EJ (corresponding author), HEALTHNET INT,1017 MB AMSTERDAM,NETHERLANDS.							FRAME JD, 1992, AM J TROP MED HYG, V46, P686, DOI 10.4269/ajtmh.1992.46.686; HARGARTEN SW, 1985, JAMA-J AM MED ASSOC, V10, P1326; Houweling H, 1991, Int J STD AIDS, V2, P252; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; 1975, INT CLASSIFICATION D	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1343	1344		10.1136/bmj.311.7016.1343	http://dx.doi.org/10.1136/bmj.311.7016.1343			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TF901	7496285	Green Published			2022-12-24	WOS:A1995TF90100023
J	BEHAN, DP; HEINRICHS, SC; TRONCOSO, JC; LIU, XJ; KAWAS, CH; LING, N; DESOUZA, EB				BEHAN, DP; HEINRICHS, SC; TRONCOSO, JC; LIU, XJ; KAWAS, CH; LING, N; DESOUZA, EB			DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE	NATURE			English	Article							FACTOR-LIKE IMMUNOREACTIVITY; CENTRAL NERVOUS-SYSTEM; FACTOR RECEPTORS; HUMAN-PLASMA; RAT; CRF; DIAGNOSIS; DISORDERS; DEMENTIA; BEHAVIOR	In Alzheimer's disease (AD) there are dramatic reductions in the content of corticotropin releasing factor (CRF)(1-4), reciprocal increases in CRF receptors(1,2), and morphological abnormalities in CRF neurons(5) in affected brain areas. Cognitive impairment in AD patients is associated with a lower cerebrospinal fluid concentration of CRF(6), which is known to induce increases in learning and memory in rodents(7-9). This suggests that CRF deficits contribute to cognitive impairment. The identification in post-mortem brain of CRF-binding protein (CRF-BP)(10,11), a high-affinity binding protein that inactivates CRF, and the differential distribution of CRF-BP12 and CRF receptors(13), provides the potential for improving learning and memory without stress effects of CRF receptor agonists(14). Here we show that ligands that dissociate CRF from CRF-BP increase brain levels of 'free CRF' in AD to control levels and show cognition-enhancing properties in models of learning and memory in animals without the characteristic stress effects of CRF receptor agonists.	JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	BEHAN, DP (corresponding author), NEUROCRINE BIOSCI INC, 3050 SCI PK RD, SAN DIEGO, CA 92121 USA.			Kawas, Claudia/0000-0001-9577-230X; Heinrichs, Stephen/0000-0002-8395-6096				BEHAN DP, 1993, ANN NY ACAD SCI, V697, P1, DOI 10.1111/j.1749-6632.1993.tb49918.x; BISSETTE G, 1985, JAMA-J AM MED ASSOC, V254, P3067, DOI 10.1001/jama.254.21.3067; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; DESOUZA EB, 1987, J NEUROSCI, V7, P88; DESOUZA EB, 1988, HOSP PRACT, V23, P59; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; DESOUZA EB, 1986, NATURE, V319, P591; DESOUZA EB, 1990, ANNU REP MED CHEM, V25, P215; DIAMANT M, 1993, NEUROENDOCRINOLOGY, V57, P1071, DOI 10.1159/000126473; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KOOB GF, 1985, FED PROC, V44, P259; KOOB GF, 1993, CIBA F SYMP, V172, P277; LIANG KC, 1988, PSYCHOPHARMACOLOGY, V96, P232; LINTON EA, 1988, CLIN ENDOCRINOL, V28, P315, DOI 10.1111/j.1365-2265.1988.tb01218.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; ORTH DN, 1987, BIOCHEM BIOPH RES CO, V143, P411, DOI 10.1016/0006-291X(87)91369-6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; POMARA N, 1989, BIOL PSYCHIAT, V26, P500, DOI 10.1016/0006-3223(89)90071-1; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; POWERS RE, 1987, SYNAPSE, V1, P405, DOI 10.1002/syn.890010504; STEWART CA, 1993, BEHAV NEUROSCIENCE P, P107; SUDA T, 1988, J CLIN ENDOCR METAB, V67, P1278, DOI 10.1210/jcem-67-6-1278; SUTTON SW, 1995, ENDOCRINOLOGY, V136, P1097, DOI 10.1210/en.136.3.1097; WHITEHOUSE PJ, 1987, NEUROLOGY, V37, P905, DOI 10.1212/WNL.37.6.905	26	203	215	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1995	378	6554					284	287		10.1038/378284a0	http://dx.doi.org/10.1038/378284a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477348	Green Published			2022-12-24	WOS:A1995TE85800050
J	YAO, B; ZHANG, YH; DELIKAT, S; MATHIAS, S; BASU, S; KOLESNICK, R				YAO, B; ZHANG, YH; DELIKAT, S; MATHIAS, S; BASU, S; KOLESNICK, R			PHOSPHORYLATION OF RAF BY CERAMIDE-ACTIVATED PROTEIN-KINASE	NATURE			English	Article							TYROSINE PHOSPHORYLATION; RECEPTOR; SERINE; C-RAF-1; INSULIN; CELLS	The sphingomyelin pathway, initiated by hydrolysis of sphingomyelin to ceramide and stimulation of a Ser/Thr ceramide-activated protein (CAP) kinase, mediates tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta action(1-4). CAP kinase is membrane-bound and proline-directed, recognizing the minimal substrate motif Thr-Leu-Pro (ref. 5). TNF may use the sphingomyelin pathway to signal Raf1 to activate the MAP kinase cascade(6-8). Evidence shows that cytoplasmic Raf1 binds to GTP-ras upon cellular stimulation, is recruited to the plasma membrane, and activated(9,11). How membrane-bound Raf1 is activated is uncertain, but regulation of its kinase activity may involve its phosphorylation(12,19). Specific Raf kinases, however, have not hitherto been identified. Here we report that CAP kinase phosphorylates Raf1 on Thr 269, increasing its activity towards MEK (MAP kinase or ERK kinase). Moreover, in intact HL-60 cells, CAP kinase complexes with Raf1 and, in response to TNF and ceramide analogues, phosphorylates and activates Raf1, implicating CAP kinase as a link between the TNF receptor and Raf1.	MEM SLOAN KETTERING CANC CTR,SIGNAL TRANSDUCT LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center								APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GUILBINS E, 1995, IMMUNITY, V2, P341; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; IZUMI T, 1991, J BIOL CHEM, V266, P7933; JOSEPH CK, 1993, J BIOL CHEM, V268, P2002; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LIU J, 1994, J BIOL CHEM, V269, P3047; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MOORE DJ, 1994, METHOD ENZYMOL, V226, P448; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; PANTAZIS P, 1991, P NATL ACAD SCI USA, V88, P2481, DOI 10.1073/pnas.88.6.2481; RAINES MA, 1993, J BIOL CHEM, V268, P14572; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; VIETOR I, 1993, J BIOL CHEM, V268, P18994; WANG HG, 1994, ONCOGENE, V9, P2751; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	30	306	315	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					307	310		10.1038/378307a0	http://dx.doi.org/10.1038/378307a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477354				2022-12-24	WOS:A1995TE85800056
J	GEKAKIS, N; SAEZ, L; DELAHAYEBROWN, AM; MYERS, MP; SEHGAL, A; YOUNG, MW; WEITZ, CJ				GEKAKIS, N; SAEZ, L; DELAHAYEBROWN, AM; MYERS, MP; SEHGAL, A; YOUNG, MW; WEITZ, CJ			ISOLATION OF TIMELESS BY PER PROTEIN-INTERACTION - DEFECTIVE INTERACTION BETWEEN TIMELESS PROTEIN AND LONG-PERIOD MUTANT PER(L)	SCIENCE			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; DROSOPHILA CLOCK; GENE-PRODUCT; MOSAIC ANALYSIS; TRANSFORMATION; MELANOGASTER; EXPRESSION; SYSTEM; DNA; ELEMENT	The period (per) gene likely encodes a component of the Drosophila circadian clock. Circadian oscillations in the abundance of per messenger RNA and per protein (PER) are thought to arise from negative feedback control of per gene transcription by PER. A recently identified second clock locus, timeless (tim), apparently regulates entry of PER into the nucleus. Reported here are the cloning of complementary DNAs derived from the tim gene in a two-hybrid screen for PER-interacting proteins and the demonstration of a physical interaction between the tim protein (TIM) and PER in vitro. A restricted segment of TIM binds directly to a part of the PER dimerization domain PAS. PER(L), a mutation that causes a temperature-sensitive lengthening of circadian period and a temperature-sensitive delay in PER nuclear entry, exhibits a temperature-sensitive defect in binding to TIM. These results suggest that the interaction between TIM and PER determines the timing of PER nuclear entry and therefore the duration of part of the circadian cycle.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; ROCKEFELLER UNIV,CTR BIOL TIMING,HOWARD HUGHES MED INST,NATL SCI FDN SCI & TECHNOL,NEW YORK,NY 10021; ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021; UNIV PENN,MED CTR,DEPT NEUROSCI,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,CTR SLEEP & RESP NEUROBIOL,PHILADELPHIA,PA 19104	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University; Rockefeller University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine			, 机智的马小跳和机智的羊不愁/ABC-5169-2020					ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; BRUCE VG, 1972, GENETICS, V70, P537; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; CHUA KL, UNPUB; COLOT HV, 1988, EMBO J, V7, P3929, DOI 10.1002/j.1460-2075.1988.tb03279.x; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Edmunds LN, 1988, CELLULAR MOL BASES B; EWER J, 1992, J NEUROSCI, V12, P3321; FELDMAN J F, 1973, Genetics, V75, P605; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRIESEN WO, 1993, ANNU REV PHYSIOL, V55, P661, DOI 10.1146/annurev.ph.55.030193.003305; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, UUNPUB; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HILL J, 1991, NUCLEIC ACIDS RES, V19, P57911; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOFFMANN K, 1976, P DAHLEM WORKSHOP, V20, P63; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LIU X, 1991, NEURON, V6, P753, DOI 10.1016/0896-6273(91)90172-V; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Moore-Ede MC., 1982, CLOCKS TIME US; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; ROTHENFLUHHILFI.A, UNPUB; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1; ZENG H, 1994, EMBO J, V3, P3590; ZWEIBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882	49	299	313	2	30	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					811	815		10.1126/science.270.5237.811	http://dx.doi.org/10.1126/science.270.5237.811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481773				2022-12-24	WOS:A1995TC71200045
J	LOPEZ, MJ; WONG, SKF; KISHIMOTO, I; DUBOIS, S; MACH, V; FRIESEN, J; GARBERS, DL; BEUVE, A				LOPEZ, MJ; WONG, SKF; KISHIMOTO, I; DUBOIS, S; MACH, V; FRIESEN, J; GARBERS, DL; BEUVE, A			SALT-RESISTANT HYPERTENSION IN MICE LACKING THE GUANYLYL CYCLASE-A RECEPTOR FOR ATRIAL-NATRIURETIC-PEPTIDE	NATURE			English	Article							BLOOD-PRESSURE; SODIUM SENSITIVITY; CLEARANCE RECEPTOR; BRAIN; GENES	AROUND half of all humans with essential hypertension are resistant to salt (blood pressure does not change by more than 5 mm Hg when salt intake is high)(1-5), and although various inbred strains of rats display salt-insensitive elevated blood pressure(6), a gene defect to account for the phenotype has not been described. Atrial natriuretic peptide (ANP) is released from the heart in response to atrial stretch and is thought to mediate its natriuretic and vasorelaxant effects through the guanylyl cyclase-A receptor (GC-A)(7). Here we report that disruption of the GC-A gene results in chronic elevations of blood pressure in mice on a normal salt diet. Unexpectedly, the blood pressure remains elevated and unchanged in response to either minimal or high salt diets. Aldosterone and ANP concentrations are not affected by the genotype. Therefore, mutations in the GC-A gene could explain some salt-resistant forms of essential hypertension and, coupled with previous works further suggest that the GC-A signalling pathway dominates at the level of peripheral resistance, where it can operate independently of ANP.	UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	LOPEZ, MJ (corresponding author), UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA.							ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; ATLAS SA, 1990, HYPERTENSION PATHOPH, P861; BALLERMANN BJ, 1991, KIDNEY, P510; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; DIETZ JR, 1994, CLIN EXP PHARMACOL P, V21, P599, DOI 10.1111/j.1440-1681.1994.tb02560.x; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; FULLER F, 1988, J BIOL CHEM, V263, P9395; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KAWASAKI T, 1978, AM J MED, V64, P193, DOI 10.1016/0002-9343(78)90045-1; Kimura G, 1994, Curr Opin Nephrol Hypertens, V3, P1; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; LEVIN ER, 1993, AM J PHYSIOL, V264, pE483, DOI 10.1152/ajpendo.1993.264.4.E483; NUSSENZVEIG DR, 1990, J BIOL CHEM, V265, P20952; OGAWA Y, 1994, J CLIN INVEST, V93, P1911, DOI 10.1172/JCI117182; OPARIL S, 1988, J CARDIOVASC PHARM, V12, pS56; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SULLIVAN JM, 1988, HYPERTENSION, V11, P717, DOI 10.1161/01.HYP.11.6.717; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; WEINBERGER MH, 1990, HYPERTENSION PATHOPH, P1999; YAMAGUCHI M, 1990, J BIOL CHEM, V265, P20414	28	387	400	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 2	1995	378	6552					65	68		10.1038/378065a0	http://dx.doi.org/10.1038/378065a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477288				2022-12-24	WOS:A1995TC46900050
J	VANDENBERG, C; WILLEMSEN, V; HAGE, W; WEISBEEK, P; SCHERES, B				VANDENBERG, C; WILLEMSEN, V; HAGE, W; WEISBEEK, P; SCHERES, B			CELL FATE IN THE ARABIDOPSIS ROOT-MERISTEM DETERMINED BY DIRECTIONAL SIGNALING	NATURE			English	Article							LINEAGE PATTERNS; CAENORHABDITIS-ELEGANS; SHOOT MERISTEM; ZEA-MAYS; REGENERATION; EMBRYO; PLANTS	POSTEMBRYONIC development in plants is achieved by apical meristems. Surgical studies and clonal analysis have revealed indirectly that cells in shoot meristems have no predictable destiny(1-3) and that position is likely to play a role in the acquisition of cell identity(4-7). In contrast to animal systems(8-10) there has been no direct evidence for inductive signalling in plants until now. Here we present evidence for such signalling using laser ablation of cells in the root meristem of Arabidopsis thaliana. Although these cells show rigid clonal relationships, we now demonstrate that it is positional control that is most important in the determination of cell fate. Positional signals can be perpetuated from more mature to initial cells to guide the pattern of meristem cell differentiation. This offers an alternative to the general opinion that meristems are the source of patterning information(12).	NETHERLANDS INST DEV BIOL,3584 CT UTRECHT,NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	VANDENBERG, C (corresponding author), UNIV UTRECHT,DEPT MOLEC CELL BIOL,PADUALAAN 8,3584 CH UTRECHT,NETHERLANDS.			Scheres, Ben/0000-0001-5400-9578				ALBERTS B, 1994, MOL BIOL CELL, P1108; BARLOW P, 1974, NEW PHYTOL, V73, P937, DOI 10.1111/j.1469-8137.1974.tb01323.x; BENFEY PN, 1993, DEVELOPMENT, V119, P57; BENFEY PN, 1990, EMBO J, V9, P1685, DOI 10.1002/j.1460-2075.1990.tb08292.x; BERGER F, 1994, SCIENCE, V263, P1421, DOI 10.1126/science.263.5152.1421; DAWE RK, 1991, PLANT J, V1, P3, DOI 10.1111/j.1365-313X.1991.00003.x; DOLAN L, 1993, DEVELOPMENT, V119, P71; DUCKETT CM, 1994, DEVELOPMENT, V120, P3247; FELDMAN LJ, 1976, AM J BOT, V63, P345, DOI 10.2307/2441580; GODDIJN OJM, 1993, PLANT J, V4, P863, DOI 10.1046/j.1365-313X.1993.04050863.x; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HAESMAN J, 1984, CELL, V37, P185; JEGLA DE, 1989, DEV BIOL, V131, P215, DOI 10.1016/S0012-1606(89)80053-3; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; MCDANIEL CN, 1988, PLANTA, V175, P13, DOI 10.1007/BF00402877; Pilkington M, 1929, NEW PHYTOL, V28, P37; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; SCHIAVONE FM, 1991, DEVELOPMENT, V113, P1305; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; STEEVES TA, 1989, PATTERNS PLANT DEV, P86; STEWART RN, 1975, AM J BOT, V57, P816; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SUSSEX IM, 1989, CELL, V56, P225, DOI 10.1016/0092-8674(89)90895-7; WARDLAW CW, 1950, PHILOS T ROY SOC B, V234, P583, DOI 10.1098/rstb.1950.0012	27	401	415	0	54	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					62	65		10.1038/378062a0	http://dx.doi.org/10.1038/378062a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477287	Green Submitted			2022-12-24	WOS:A1995TC46900049
J	SHARP, NC; CRONIN, N; FELDBERG, I; EVANS, M; HODGSON, D; ELLIS, S				SHARP, NC; CRONIN, N; FELDBERG, I; EVANS, M; HODGSON, D; ELLIS, S			MICROWAVES FOR MENORRHAGIA - A NEW FAST TECHNIQUE FOR ENDOMETRIAL ABLATION	LANCET			English	Note								Current ablative techniques for treating menorrhagia are unsatisfactory. We tried microwave energy, delivered by an 8 mm diameter probe in the uterine cavity, to treat 23 patients with functional menorrhagia. The mean treatment time was 2 min 12 s (range 50-310 s). 6 months after treatment the success rate is 83%, 13 patients (57%) are amenorrhoeic, and six (26%) are experiencing light menstruation. Three initial failures have been successfully retreated. The technique is safe, and is easier and quicker to perform than current alternatives.	UNIV BATH,SCH PHYS,BATH BA2 7AY,AVON,ENGLAND; ROYAL UNITED HOSP,DEPT MED PHYS,BATH,AVON,ENGLAND	University of Bath	SHARP, NC (corresponding author), ROYAL UNITED HOSP,DEPT OBSTET & GYNAECOL,PRINCESS ANNE WING,BATH BA1 3NG,AVON,ENGLAND.							ARIEFF AI, 1993, JAMA-J AM MED ASSOC, V270, P1230, DOI 10.1001/jama.270.10.1230; BAUMANN R, 1990, BRIT MED J, V300, P304, DOI 10.1136/bmj.300.6720.304; PHIPPS JH, 1990, LANCET, V335, P374, DOI 10.1016/0140-6736(90)90207-L; 1994, MISTLETOE SURGERY UP	4	85	94	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 14	1995	346	8981					1003	1004		10.1016/S0140-6736(95)91689-X	http://dx.doi.org/10.1016/S0140-6736(95)91689-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RZ599	7475547				2022-12-24	WOS:A1995RZ59900011
J	PENCE, GE				PENCE, GE			ON THE ROAD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Papadimitratos, Panagiotis/J-4928-2012	Papadimitratos, Panagiotis/0000-0002-3267-5374					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	1988	260	13					1946	1946						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2703	3418860				2022-12-24	WOS:A1988Q270300035
J	SCHNEIDER, C; KING, RM; PHILIPSON, L				SCHNEIDER, C; KING, RM; PHILIPSON, L			GENES SPECIFICALLY EXPRESSED AT GROWTH ARREST OF MAMMALIAN-CELLS	CELL			English	Article											SCHNEIDER, C (corresponding author), EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,D-6900 HEIDELBERG,FED REP GER.							ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BASERGA R, 1985, BIOL CELL REPRODUCTI; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CRAIG RW, 1985, P NATL ACAD SCI USA, V82, P2062, DOI 10.1073/pnas.82.7.2062; DAVIS MM, 1984, P NATL ACAD SCI-BIOL, V81, P2194, DOI 10.1073/pnas.81.7.2194; DELSAL G, 1987, NUCLEIC ACIDS RES, V15, P10047; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DORSSERS L, 1987, NUCLEIC ACIDS RES, V15, P3629, DOI 10.1093/nar/15.8.3629; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; GREEN M, 1987, CELL, V51, P795, DOI 10.1016/0092-8674(87)90102-4; GRIMALDI G, 1987, NUCLEIC ACIDS RES, V15, P9608, DOI 10.1093/nar/15.22.9608; GUBLER U, 1983, GENE, V25, P262; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Howard A, 1953, HEREDITY           S, V6, P261; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407; MISKA D, 1980, BIOCHEM BIOPH RES CO, V93, P1140, DOI 10.1016/0006-291X(80)90608-7; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; PEPPERKOK R, 1988, P NATL ACAD SCI US, V85; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; STANBRIDGE EJ, 1982, SCIENCE, V215, P252, DOI 10.1126/science.7053574; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; WANG E, 1987, J CELL PHYSIOL, V133, P151, DOI 10.1002/jcp.1041330119; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WILLIAMS JG, 1975, CELL, V6, P197, DOI 10.1016/0092-8674(75)90010-0	31	853	892	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 9	1988	54	6					787	793		10.1016/S0092-8674(88)91065-3	http://dx.doi.org/10.1016/S0092-8674(88)91065-3			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	Q1020	3409319				2022-12-24	WOS:A1988Q102000008
J	VANDYKE, MW; ROEDER, RG; SAWADOGO, M				VANDYKE, MW; ROEDER, RG; SAWADOGO, M			PHYSICAL ANALYSIS OF TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY ON A CLASS-II GENE PROMOTER	SCIENCE			English	Article											VANDYKE, MW (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.		Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002	NCI NIH HHS [CA 42567] Funding Source: Medline; NIGMS NIH HHS [GM 38212] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038212] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATEMAN E, 1986, CELL, V47, P445, DOI 10.1016/0092-8674(86)90601-X; BATEMAN E, 1985, P NATL ACAD SCI USA, V82, P8004, DOI 10.1073/pnas.82.23.8004; BITTER GA, 1983, ANAL BIOCHEM, V128, P294, DOI 10.1016/0003-2697(83)90378-0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CAI H, 1987, J BIOL CHEM, V262, P298; CAI H, 1987, MOL CELL BIOL, V7, P3371, DOI 10.1128/MCB.7.10.3371; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CONCINO M, 1983, J BIOL CHEM, V258, P8493; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FIRE A, 1984, J BIOL CHEM, V259, P2509; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HEN R, 1982, P NATL ACAD SCI-BIOL, V79, P7132, DOI 10.1073/pnas.79.23.7132; HERTZBERG RP, 1982, J AM CHEM SOC, V104, P313, DOI 10.1021/ja00365a069; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HU SL, 1981, P NATL ACAD SCI-BIOL, V78, P820, DOI 10.1073/pnas.78.2.820; IVERSON BL, 1987, NUCLEIC ACIDS RES, V15, P7823, DOI 10.1093/nar/15.19.7823; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MATSUI T, 1980, J BIOL CHEM, V255, P1992; Maxam A M, 1980, Methods Enzymol, V65, P499; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NAKAJIMA N, IN PRESS MOL CELL BI; REINBERG D, 1987, J BIOL CHEM, V262, P3322; SAMUELS M, 1982, J BIOL CHEM, V257, P4419; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; VANDYKE M, UNPUB; VANDYKE MW, 1987, MOL CELL BIOL, V7, P1021, DOI 10.1128/MCB.7.3.1021; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; YU YT, 1984, NUCLEIC ACIDS RES, V12, P9309, DOI 10.1093/nar/12.24.9309	36	289	289	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 9	1988	241	4871					1335	1338		10.1126/science.3413495	http://dx.doi.org/10.1126/science.3413495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9812	3413495				2022-12-24	WOS:A1988P981200026
J	NICHOLLS, MG; RICHARDS, AM; LEWIS, LK; YANDLE, TG				NICHOLLS, MG; RICHARDS, AM; LEWIS, LK; YANDLE, TG			OUABAIN - A NEW STEROID-HORMONE	LANCET			English	Editorial Material							DIGITALIS-LIKE-FACTOR; HUMAN PLASMA		CHRISTCHURCH HOSP,DEPT ENDOCRINOL,CHRISTCHURCH,NEW ZEALAND	Christchurch Hospital New Zealand	NICHOLLS, MG (corresponding author), CHRISTCHURCH HOSP,DEPT MED,CHRISTCHURCH,NEW ZEALAND.							BOULANGER BR, 1993, AM J PHYSIOL, V264, pE413, DOI 10.1152/ajpendo.1993.264.3.E413; CAPPUCCIO FP, 1986, POSTGRAD MED J, V62, P265, DOI 10.1136/pgmj.62.726.265; DORIS PA, 1994, HYPERTENSION, V23, P632, DOI 10.1161/01.HYP.23.5.632; GOMEZSANCHEZ EP, 1994, AM J HYPERTENS, V7, P647, DOI 10.1093/ajh/7.7.647; HAMLYN JM, 1992, J HYPERTENS S7, V10, P99; HINSON JP, 1995, J ENDOCRINOL, V146, P369, DOI 10.1677/joe.0.1460369; LAREDO J, 1994, ENDOCRINOLOGY, V135, P794, DOI 10.1210/en.135.2.794; LEWIS LK, 1994, HYPERTENSION, V24, P549, DOI 10.1161/01.HYP.24.5.549; LUDENS JH, 1992, HYPERTENSION, V19, P721, DOI 10.1161/01.HYP.19.6.721; LUDENS JH, 1991, HYPERTENSION, V17, P923, DOI 10.1161/01.HYP.17.6.923; MATHEWS WR, 1991, HYPERTENSION, V17, P930, DOI 10.1161/01.HYP.17.6.930; NARUSE K, 1994, HYPERTENSION S1, V23, P102; ROSSI GP, 1995, 7TH EUR M HYP MIL; TYMIAK AA, 1993, P NATL ACAD SCI USA, V90, P8189, DOI 10.1073/pnas.90.17.8189; WOOLFSON RG, 1994, KIDNEY INT, V46, P297, DOI 10.1038/ki.1994.275	15	16	17	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1381	1382		10.1016/S0140-6736(95)92402-7	http://dx.doi.org/10.1016/S0140-6736(95)92402-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475817				2022-12-24	WOS:A1995TG20700005
J	DOUHAL, A; KIM, SK; ZEWAIL, AH				DOUHAL, A; KIM, SK; ZEWAIL, AH			FEMTOSECOND MOLECULAR-DYNAMICS OF TAUTOMERIZATION IN MODEL BASE-PAIRS	NATURE			English	Article							DOUBLE-PROTON-TRANSFER; TEMPERATURE	Hydrogen bonds commonly lend robustness and directionality to molecular recognition processes and supramolecular structures(1,2). In particular, the two or three hydrogen bonds in Watson-Crick base pairs bind the double-stranded DNA helix and determine the complementarity of the pairing. Watson and Crick pointed out(3), however, that the possible tautomers of base pairs, in which hydrogen atoms become attached to the donor atom of the hydrogen bond, might disturb the genetic code, as the tautomer is capable of pairing with different partners. But the dynamics of hydrogen bonds in general, and of this tautomerization process in particular, are not well understood. Here we report observations of the femtosecond dynamics of tautomerization in model base pairs (7-azaindole dimers) containing two hydrogen bonds. Because of the femtosecond resolution of proton motions, we are able to examine the cooperativity of formation of the tautomer (in which the protons on each base are shifted sequentially to the other base), and to determine the characteristic timescales of the motions in a solvent-free environment. We find that the first step occurs on a timescale of a few hundred femtoseconds, whereas the second step, to form the full tautomer, is much slower, taking place within several picoseconds; the timescales are changed significantly by replacing hydrogen with deuterium. These results establish the molecular basis of the dynamics and the role of quantum tunnelling.			DOUHAL, A (corresponding author), CALTECH, ARTHUR AMOS NOYES LAB CHEM PHYS, PASADENA, CA 91125 USA.		Kim, Sang Kyu/C-1613-2011; Douhal, Abderrazzak/L-4940-2014	Douhal, Abderrazzak/0000-0003-2247-7566				Ball P., 1994, DESIGNING MOL WORLD; BENDERSKII VA, 1992, INT REV PHYS CHEM, V11, P1, DOI 10.1080/01442359209353265; CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; FUKE K, 1989, J PHYS CHEM-US, V93, P614, DOI 10.1021/j100339a023; HEREK JL, 1992, J CHEM PHYS, V97, P9046, DOI 10.1063/1.463331; HETHERINGTON WM, 1979, CHEM PHYS LETT, V66, P230, DOI 10.1016/0009-2614(79)85004-6; INGHAM KC, 1974, J AM CHEM SOC, V96, P1674, DOI 10.1021/ja00813a006; KIM SK, 1995, J PHYS CHEM-US, V99, P7421, DOI 10.1021/j100019a027; LOWDIN PO, 1965, ADV QUANTUM CHEM, V2, P213, DOI DOI 10.1016/S0065-3276(08)60076-3; REIN R, 1965, J CHEM PHYS, V42, P2177, DOI 10.1063/1.1696263; SHARE P, 1991, J LUMIN, V48-9, P204, DOI 10.1016/0022-2313(91)90105-5; Stryer L., 1988, BIOCHEMISTRY-US; TAYLOR CA, 1969, P NATL ACAD SCI USA, V63, P253, DOI 10.1073/pnas.63.2.253; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015; Zewail A., 1992, CHEM BOND STRUCTURE; Zewail A. H., 1994, FEMTOCHEMISTRY ULTRA	17	425	427	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					260	263		10.1038/378260a0	http://dx.doi.org/10.1038/378260a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477342				2022-12-24	WOS:A1995TE85800042
J	TURNER, M; MEE, PJ; COSTELLO, PS; WILLIAMS, O; PRICE, AA; DUDDY, LP; FURLONG, MT; GEAHLEN, RL; TYBULEWICZ, VLJ				TURNER, M; MEE, PJ; COSTELLO, PS; WILLIAMS, O; PRICE, AA; DUDDY, LP; FURLONG, MT; GEAHLEN, RL; TYBULEWICZ, VLJ			PERINATAL LETHALITY AND BLOCKED B-CELL DEVELOPMENT IN MICE LACKING THE TYROSINE KINASE SYK	NATURE			English	Article							PRECURSORS; DISRUPTION; CULTURE; PROTEIN	The tyrosine kinase Syk (relative molecular mass 72,000), which is widely expressed in haematopoietic cells, becomes associated with and activated by engagement of the B-cell antigen receptor(1,2). Furthermore, it has been implicated in signalling through the receptors for interleukin-2 (IL-2)(3), granulocyte colony-stimulating factor (G-CSF)(4) and Fc(5), the T cell receptor, as well as through receptors for several platelet agonists(7). A homologous kinase, ZAP-70, is crucial in signalling through the T-cell receptor and in T-cell development(8,9). Using homologous recombination in embryonic stem cells, we created mice null for the syk gene which showed petechiae in utero and died shortly after birth. Irradiated mice reconstituted with Syk-deficient fetal liver showed a block in B-cell development at the pro-B to pre-B cell transition, consistent with a key role for Syk in pre-B-cell receptor signalling. Despite the production of small numbers of immature B cells, Syk-deficient radiation chimaeras failed to accumulate mature B cells, indicating a possible role for this protein in the production or maintenance of mature B cells. In addition, whereas the development of alpha beta T cells proceeded normally, Syk-deficient mice showed impaired development of thymocytes using the V gamma 3 variable region gene (V gamma 3(+) thymocytes). Finally, we show that Syk is not required for signalling through the IL-2 and G-CSF receptors.	NATL INST MED RES,LONDON NW7 1AA,ENGLAND; PURDUE UNIV,DEPT MED CHEM & PHARMACOGNOSY,W LAFAYETTE,IN 47907	MRC National Institute for Medical Research; Purdue University System; Purdue University; Purdue University West Lafayette Campus			Turner, Martin/N-9976-2014; Williams, Owen/B-5003-2013	Turner, Martin/0000-0002-3801-9896; Williams, Owen/0000-0002-1760-6880; Geahlen, Robert/0000-0001-8400-2924; Tybulewicz, Victor/0000-0003-2439-0798				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HERBERTSON B M, 1964, J Med Genet, V1, P10, DOI 10.1136/jmg.1.1.10; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KONG GH, 1995, IMMUNITY, V2, P485, DOI 10.1016/1074-7613(95)90029-2; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; PAIGE CJ, 1984, EUR J IMMUNOL, V14, P979, DOI 10.1002/eji.1830141104; RAMSDEN DA, 1994, J IMMUNOL, V153, P1150; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VONFREEDENJEFFR.U, 1995, J EXP MED, V181, P1518	30	628	655	0	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					298	302		10.1038/378298a0	http://dx.doi.org/10.1038/378298a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477352				2022-12-24	WOS:A1995TE85800054
J	CROFT, NM; MARSHALL, TG; FERGUSON, A				CROFT, NM; MARSHALL, TG; FERGUSON, A			GUT INFLAMMATION IN CHILDREN WITH CYSTIC-FIBROSIS ON HIGH-DOSE ENZYME SUPPLEMENTS	LANCET			English	Note							LAVAGE FLUID; DISEASE	We used a whole-gut perfusion technique to study subclinical gut inflammation in children with cystic fibrosis (18 elective tests, three lavages to treat distal intestinal obstruction syndrome); and in 12 control children with constipation or pre-colonoscopy. We assayed for haemoglobin, IgG, albumin, alpha-1-antitrypsin, granulocyte elastase, interleukin-1 beta (IL-1 beta) and IL-8 concentrations in whole-gut ravage fluid. Results for two children with distal intestinal obstruction syndrome, the only children in the series taking Nutrizym 22, were strikingly abnormal. This new test has revealed subclinical gut mucosal inflammation in a minority of CF children, for which distal intestinal obstruction syndrome, Nutrizym 22 treatment, or both, may be risk factors.	ROYAL HOSP SICK CHILDREN,EDINBURGH EH9 1LF,MIDLOTHIAN,SCOTLAND		CROFT, NM (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT MED,GASTROINTESTINAL UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							BRYDON WG, 1993, EUR J GASTROEN HEPAT, V5, P269, DOI 10.1097/00042737-199304000-00013; BRYDON WG, 1992, LANCET, V340, P1381, DOI 10.1016/0140-6736(92)92562-T; FERGUSON A, 1994, SCAND J GASTROENTERO, V29, P15, DOI 10.3109/00365529409091390; FERGUSON A, IN PRESS ADV DRUG DE; HODGES M, 1994, J PEDIATR GASTR NUTR, V19, P65, DOI 10.1097/00005176-199407000-00010; OMAHONY S, 1991, GUT, V32, P29, DOI 10.1136/gut.32.1.29; SMYTH RL, 1995, LANCET, V346, P1247, DOI 10.1016/S0140-6736(95)91860-4; SMYTH RL, 1994, LANCET, V343, P85, DOI 10.1016/S0140-6736(94)90817-6	8	25	25	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1265	1267						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475719				2022-12-24	WOS:A1995TE14500012
J	HALL, TMT; PORTER, JA; BEACHY, PA; LEAHY, DJ				HALL, TMT; PORTER, JA; BEACHY, PA; LEAHY, DJ			A POTENTIAL CATALYTIC SITE REVEALED BY THE 1.7-ANGSTROM CRYSTAL-STRUCTURE OF THE AMINO-TERMINAL SIGNALING DOMAIN OF SONIC HEDGEHOG	NATURE			English	Article							ANOMALOUS DIFFRACTION; RESOLUTION	WITHIN the past few years, members of the hedgehog (hh) family of secreted signalling proteins have emerged as the primary signals generated by certain embryonic patterning centres. In vertebrate embryos, for example, sonic hedgehog expression in the notochord appears to be responsible for the local and long-range induction of ventral cell types within the neural tube and somites (reviewed in refs 1, 2). Protein products encoded by hh family members are synthesized as precursors that undergo autoprocessing to generate an amino-terminal domain that appears to be responsible for both local and long-range signalling activities, and a carboxy-terminal domain that contains the autoprocessing activity(3'4). As part of an effort to understand how hit family members participate in cell-to-cell signalling, we have determined and report here the crystal structure at 1.7 Angstrom of the amino-terminal domain of murine Sonic hedgehog (Shh-N)(5-9). The structure revealed a tetrahedrally coordinated zinc ion that appears to be structurally analogous to the zinc coordination sites of zinc hydrolases, such as thermolysin and carboxypeptidase A. This previously unsuspected catalytic site represents a distinct activity from the autoprocessing activity that resides in the carboxy-terminal domain.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOPHYS & BIOPHYS CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University			Hall, Traci/F-5849-2019	Hall, Traci/0000-0001-6166-3009				Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CHANG DT, 1994, DEVELOPMENT, V120, P3339; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CONCORDET JP, 1995, NATURE, V375, P279, DOI 10.1038/375279a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EKKER SC, 1995, DEVELOPMENT, V121, P2337; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P1; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; OTINOWSKI Z, 1993, P CCP4 STUDY WEEKEND, P56; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; REES DC, 1983, J MOL BIOL, V168, P367, DOI 10.1016/S0022-2836(83)80024-2; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; ZECCA M, 1995, DEVELOPMENT, V121, P2265; 1979, SERC4 DAR LAB COLL C	30	163	174	0	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					212	216		10.1038/378212a0	http://dx.doi.org/10.1038/378212a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477329				2022-12-24	WOS:A1995TD75900062
J	RIDDLE, DR; LO, DC; KATZ, LC				RIDDLE, DR; LO, DC; KATZ, LC			NT-4-MEDIATED RESCUE OF LATERAL GENICULATE NEURONS FROM EFFECTS OF MONOCULAR DEPRIVATION	NATURE			English	Article							NERVE GROWTH-FACTOR; RAT VISUAL-CORTEX; FACTOR NGF; GENE-EXPRESSION; STRIATE CORTEX; MESSENGER-RNA; NUCLEUS; ORGANIZATION; MICROSPHERES; PLASTICITY	ALTERING the balance of activity between the two eyes during the critical period for visual-system development profoundly affects competitive interactions among neurons in the lateral geniculate nucleus and primary visual cortex(1-6). Neurons in the lateral geniculate nucleus that are deprived of activity by closing or silencing one eye atrophy as a result of competition with non-deprived neurons for some critical factor(s) presumed to be present in the cortex. Based on their actions in the developing visual system(7-12) neurotrophins are attractive candidates for such factors. We tested whether neurotrophins mediate intracortical competition of afferents from the lateral geniculate nucleus by using monocular deprivation and a new method for highly localized, in vivo delivery of neurotrophins. This method allowed unambiguous identification of neurons that were exposed to neurotrophin. Here we report that only one neurotrophin, the TrkB ligand NT-4, rescued neurons in the lateral geniculate nucleus from the dystrophic effects of monocular deprivation.			RIDDLE, DR (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.							ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BERARDI N, 1993, P ROY SOC B-BIOL SCI, V251, P17, DOI 10.1098/rspb.1993.0003; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CARMIGNOTO G, 1993, J PHYSIOL-LONDON, V464, P343, DOI 10.1113/jphysiol.1993.sp019638; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; DOMENICI L, 1994, VISUAL NEUROSCI, V11, P1093, DOI 10.1017/S095252380000691X; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; DOMENICI L, 1993, P ROY SOC B-BIOL SCI, V251, P25, DOI 10.1098/rspb.1993.0004; GUILLERY RW, 1970, J COMP NEUROL, V139, P413, DOI 10.1002/cne.901390403; GUILLERY RW, 1973, J COMP NEUROL, V144, P117; HAYASHI M, 1990, NEUROSCIENCE, V36, P683, DOI 10.1016/0306-4522(90)90011-R; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; LIN CS, 1978, J COMP NEUROL, V181, P809, DOI 10.1002/cne.901810408; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Lo D. C., 1995, Society for Neuroscience Abstracts, V21, P537; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	29	191	193	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					189	191		10.1038/378189a0	http://dx.doi.org/10.1038/378189a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477322				2022-12-24	WOS:A1995TD75900055
J	SAKAI, H; MEDRANO, LJ; MEYEROWITZ, EM				SAKAI, H; MEDRANO, LJ; MEYEROWITZ, EM			ROLE OF SUPERMAN IN MAINTAINING ARABIDOPSIS FLORAL WHORL BOUNDARIES	NATURE			English	Article							TRANSCRIPTION FACTOR-IIIA; HOMEOTIC GENES; PROTEIN; THALIANA; PRODUCT; DOMAIN; PLANTS; PETALS	THE Arabidopsis gene SUPERMAN (SUP) is necessary for the proper spatial development of reproductive floral tissues(1-3) Recessive mutations cause extra stamens to form interior to the normal third whorl stamens, at the expense of fourth whorl carpel development(1-3). The mutant phenotype is associated with the ectopic expression of the B function genes, AP3 and PI, in the altered floral region, closer to the centre of the flower than in the wild type(3), and ap3 sup and pi sup double mutants exhibit a phenotype similar to ap3 and pi single mutants. These findings led to SUP being interpreted as an upstream negative regulator of the B function organ-identity genes, acting in the fourth whorl(2,3), to establish a boundary between stamen and carpel whorls. Here we show, using molecular cloning and analysis, that it is expressed in the third whorl and acts to maintain this boundary in developing flowers. The putative SUPERMAN protein contains one zinc-finger and a region resembling a basic leucine zipper motif, suggesting a function in transcriptional regulation.			SAKAI, H (corresponding author), CALTECH, DIV BIOL, 156-29, PASADENA, CA 91125 USA.		Meyerowitz, Elliot M/A-7118-2009					BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1992, DEVELOPMENT, V114, P599; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HO CY, 1994, EMBO J, V13, P1403, DOI 10.1002/j.1460-2075.1994.tb06394.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; KRIZEK BA, IN PRESS DEVELOPMENT; MEYEROWITZ EM, 1991, DEVELOPMENT S1, V112, P157; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; SCHULTZ EA, 1991, PLANT CELL, V3, P1221, DOI 10.1105/tpc.3.11.1221; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; TAGUE BW, 1995, PLANT MOL BIOL, V28, P267, DOI 10.1007/BF00020246; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	29	335	376	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	1995	378	6553					199	203		10.1038/378199a0	http://dx.doi.org/10.1038/378199a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477325				2022-12-24	WOS:A1995TD75900058
J	HE, GP; MUISE, A; LI, AW; RO, HS				HE, GP; MUISE, A; LI, AW; RO, HS			A EUKARYOTIC TRANSCRIPTIONAL REPRESSOR WITH CARBOXYPEPTIDASE ACTIVITY	NATURE			English	Article							ENHANCER BINDING-PROTEIN; GENE-EXPRESSION; MOLECULAR-CLONING; FACTOR-VIII; ADIPOCYTE DIFFERENTIATION; GLUCOCORTICOID RECEPTOR; MESSENGER-RNA; CDNA CLONING; C-JUN; DNA	ADIPOCYTE differentiation involves the transcriptional activation of several genes in triglyceride metabolism, including the adipose P2 (aP2 or 422) gene that encodes the adipocyte lipid-binding protein ALBP(1-3). Within the mouse aP2 promoter region, the AE1 sequence functions as either a positive or a negative element in the regulation of aP2 gene expression(4-8). The AE-1 sequence is the binding site for the positive murine (3T3) adipocyte factor C/EBP-alpha(5,6), several human preadipocyte factors(7), and a 3T3 preadipocyte factor(s) that has been implicated as a repressor of aP2 gene expression(4,5,7,8). Here we report the cloning of new complementary DNAs that encode the 3T3 preadipocyte factor (termed AEBP1), and demonstrate that AEBP1 expression is abolished during adipocyte differentiation. Furthermore, we show that an activity of a carboxypeptidase associated with AEBP1 is important in the transcriptional repression function of AEBP1. Thus AEBP1 might represent a new type of transcription factor that regulates transcription by cleavage of factors involved in transcription.	DALHOUSIE UNIV,FAC MED,DEPT BIOCHEM,HALIFAX,NS B3H 4H7,CANADA	Dalhousie University				Ro, Hyo-Sung/0000-0003-4411-0386				AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; CHAPMAN AB, 1984, J BIOL CHEM, V259, P5548; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FOLK JE, 1960, J BIOL CHEM, V235, P2272; GEBHARD W, 1989, EUR J BIOCHEM, V178, P603, DOI 10.1111/j.1432-1033.1989.tb14488.x; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; RO HS, 1991, MOL CELL BIOL, V11, P2303, DOI 10.1128/MCB.11.4.2303; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAN FL, 1989, J BIOL CHEM, V264, P13165; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; XU L, 1994, NUCLEIC ACIDS RES, V22, P646, DOI 10.1093/nar/22.4.646; YANG VW, 1989, P NATL ACAD SCI USA, V86, P3629, DOI 10.1073/pnas.86.10.3629; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	29	130	141	1	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					92	96		10.1038/378092a0	http://dx.doi.org/10.1038/378092a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477299				2022-12-24	WOS:A1995TC46900058
J	PRIMAKOFF, P; LATHROP, W; WOOLMAN, L; COWAN, A; MYLES, D				PRIMAKOFF, P; LATHROP, W; WOOLMAN, L; COWAN, A; MYLES, D			FULLY EFFECTIVE CONTRACEPTION IN MALE AND FEMALE GUINEA-PIGS IMMUNIZED WITH THE SPERM PROTEIN PH-20	NATURE			English	Article											PRIMAKOFF, P (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT PHYSIOL,FARMINGTON,CT 06032, USA.							ADA GL, 1985, NATURE, V317, P288, DOI 10.1038/317288b0; ANDERSON DJ, 1983, FERTIL STERIL, V40, P557; BRONSON R, 1984, FERTIL STERIL, V42, P171; CHEN C, 1986, ARCH ANDROLOGY, V16, P183, DOI 10.3109/01485018608986940; COWAN AE, 1986, J CELL BIOL, V103, P1289, DOI 10.1083/jcb.103.4.1289; CROSS NL, 1988, BIOL REPROD, V38, P235, DOI 10.1095/biolreprod38.1.235; GOLDBERG E, 1973, SCIENCE, V181, P458, DOI 10.1126/science.181.4098.458; GOLDBERG E, 1981, FERTIL STERIL, V35, P214; Goldberg E, 1983, Res Front Fertil Regul, V2, P1; HAAS GG, 1986, FERTIL STERIL, V46, P753; HALENDA RM, 1987, BIOL REPROD, V36, P491, DOI 10.1095/biolreprod36.2.491; JONES WR, 1982, IMMUNOLOGICAL FERTIL; KUMMERFELD HL, 1976, BIOL REPROD, V14, P300, DOI 10.1095/biolreprod14.3.300; LERUM JE, 1974, BIOL REPROD, V11, P108, DOI 10.1095/biolreprod11.1.108; MENGE AC, 1979, BIOL REPROD, V20, P931, DOI 10.1095/biolreprod20.4.931; MORALES P, 1988, J ANDROL, V9, P24; MORTON DB, 1979, J REPROD IMMUNOL, V1, P61, DOI 10.1016/0165-0378(79)90030-5; MUNOZ MG, 1978, BIOL REPROD, V18, P669, DOI 10.1095/biolreprod18.4.669; MYLES DG, 1984, J CELL BIOL, V99, P1634, DOI 10.1083/jcb.99.5.1634; MYLES DG, 1987, DEV BIOL, V121, P559, DOI 10.1016/0012-1606(87)90191-6; PRIMAKOFF P, 1985, J CELL BIOL, V101, P2239, DOI 10.1083/jcb.101.6.2239; PRIMAKOFF P, 1988, BIOL REPROD, V38, P921, DOI 10.1095/biolreprod38.4.921; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; SINGER SL, 1985, GAMETE RES, V12, P29, DOI 10.1002/mrd.1120120104; SYNER FN, 1979, FERTIL STERIL, V32, P468; TUNG KSK, 1979, J REPROD IMMUNOL, V1, P145, DOI 10.1016/0165-0378(79)90015-9; TUNG KSK, 1986, REPRODUCTIVE IMMUNOL, P143	27	244	259	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 6	1988	335	6190					543	546		10.1038/335543a0	http://dx.doi.org/10.1038/335543a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q3412	3419530				2022-12-24	WOS:A1988Q341200054
J	DEACONSON, TF; OHAIR, DP; LEVY, MF; LEE, MBF; SCHUENEMAN, AL; CONDON, RE				DEACONSON, TF; OHAIR, DP; LEVY, MF; LEE, MBF; SCHUENEMAN, AL; CONDON, RE			SLEEP-DEPRIVATION AND RESIDENT PERFORMANCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									MED COLL WISCONSIN, DEPT SURG, 8700 W WISCONSIN AVE, ROOM 1014, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, DEPT BIOSTAT, MILWAUKEE, WI 53226 USA; LOYOLA UNIV, MED CTR, DEPT SURG, MAYWOOD, IL 60153 USA	Medical College of Wisconsin; Medical College of Wisconsin; Loyola University Chicago					NCRR NIH HHS [RR-0058] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ASKEN MJ, 1983, J MED EDUC, V58, P382; BEATTY J, 1977, VIGILANCE THEORY OPE, P511; BUROS OK, 1974, TESTS PRINT, V2; COLQUHOUN WF, 1975, SMS375 LOND MED RES; Denisco R A, 1987, J Clin Monit, V3, P22, DOI 10.1007/BF00770879; FORD CV, 1986, SOUTHERN MED J, V79, P595, DOI 10.1097/00007611-198605000-00019; FRIEDMAN FC, 1973, J MED EDUC, V48, P436; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HALSAM DR, 1982, ERGONOMICS, V25, P163; HAWKINS MR, 1985, J MED EDUC, V60, P530; HORNE JA, 1985, ACTA PSYCHOL, V58, P123, DOI 10.1016/0001-6918(85)90003-4; KLOSE JK, 1985, ANESTHESIOLOGY, V63, pA485; KOLLAR EJ, 1966, PSYCHOSOM MED, V28, P101, DOI 10.1097/00006842-196603000-00002; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; LUBY ED, 1962, ANN NY ACAD SCI, V96, P71, DOI 10.1111/j.1749-6632.1962.tb50102.x; MORGAN BB, 1974, HUM FACTORS, V16, P406, DOI 10.1177/001872087401600408; OPSTAD PK, 1978, AVIAT SPACE ENVIR MD, V49, P1065; PICKLEMAN J, 1986, MED ED SURGICAL PERS, P55; POULTON EC, 1978, ERGONOMICS, V21, P279, DOI 10.1080/00140137808931725; Reitan RM, 1974, CLIN NEUROPSYCHOLOGY; REZNICK RK, 1987, AM J SURG, V154, P520, DOI 10.1016/0002-9610(87)90269-8; SCHUENEMAN AL, 1985, SURGERY, V98, P506; SCHUENEMAN AL, 1984, SURGERY, V96, P288; SCHUENEMAN AL, 1985, 5TH ANN M ASS SURG E; SOKAL RR, 1969, BIOMETRY, P264; Thompson HL, 1983, MILIT REV, P14; VALKO RJ, 1975, DIS NERV SYST, V36, P26; WEBB WB, 1987, PSYCHOPHYSIOLOGY, V24, P426, DOI 10.1111/j.1469-8986.1987.tb00312.x; WEBB WB, 1974, PSYCHOPHYSIOLOGY, V11, P265, DOI 10.1111/j.1469-8986.1974.tb00543.x; WILKINSON RT, 1964, ERGONOMICS, V7, P175, DOI 10.1080/00140136408930736; WILKINSON RT, 1975, J OCCUP PSYCHOL, V48, P219, DOI 10.1111/j.2044-8325.1975.tb00318.x	32	131	143	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	1988	260	12					1721	1727		10.1001/jama.260.12.1721	http://dx.doi.org/10.1001/jama.260.12.1721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q1001	3411755				2022-12-24	WOS:A1988Q100100022
J	TOWNSEND, RR; HARDY, M; OLECHNO, JD; CARTER, SR				TOWNSEND, RR; HARDY, M; OLECHNO, JD; CARTER, SR			CHROMATOGRAPHY OF CARBOHYDRATES	NATURE			English	Review									JOHNS HOPKINS UNIV,MCCOLLUM PRATT INST,BALTIMORE,MD 21218; DIONEX CORP,501 MERCURY DR,SUNNYVALE,CA 94088	Johns Hopkins University; Thermo Fisher Scientific; Dionex Corporation	TOWNSEND, RR (corresponding author), JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218, USA.							BLANKEN WM, 1985, ANAL BIOCHEM, V145, P322, DOI 10.1016/0003-2697(85)90369-0; HARDY MR, 1988, P NATL ACAD SCI USA, V85, P3289, DOI 10.1073/pnas.85.10.3289; HUGHES S, 1981, ANAL CHIM ACTA, V132, P11, DOI 10.1016/S0003-2670(01)93872-3; NEUBERGER A, 1971, CARBOHYD RES, V17, P89, DOI 10.1016/S0008-6215(00)81545-1; RENDLEMAN JA, 1971, ADV CHEM SER, V117, P51; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; TOWNSEND RR, UNPUB; TOWNSEND RR, IN PRESS ANAL BIOCH; WANG WT, 1984, ANAL BIOCHEM, V141, P366, DOI 10.1016/0003-2697(84)90057-5	10	24	24	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					379	380		10.1038/335379a0	http://dx.doi.org/10.1038/335379a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419506				2022-12-24	WOS:A1988Q137300068
J	CHAMEIDES, WL; LINDSAY, RW; RICHARDSON, J; KIANG, CS				CHAMEIDES, WL; LINDSAY, RW; RICHARDSON, J; KIANG, CS			THE ROLE OF BIOGENIC HYDROCARBONS IN URBAN PHOTOCHEMICAL SMOG - ATLANTA AS A CASE-STUDY	SCIENCE			English	Article											CHAMEIDES, WL (corresponding author), GEORGIA INST TECHNOL,SCH GEOPHYS SCI,ATLANTA,GA 30332, USA.							ALTSHULLER AP, 1983, ATMOS ENVIRON, V17, P2131, DOI 10.1016/0004-6981(83)90211-1; ARNTS RR, 1981, ATMOSPHERIC BIOGENIC, V2, P117; COLLUM R, COMMUNICATION; FRIEDMAN RM, 1988, URBAN OZONE CLEAN AI, P1; HAAGENSMIT AJ, 1952, IND ENG CHEM, V44, P1362; LAMB B, 1987, ATMOS ENVIRON, V21, P1695, DOI 10.1016/0004-6981(87)90108-9; LINDSAY RM, UNPUB; LURMANN FW, 1984, ATMOS ENVIRON, V18, P1133, DOI 10.1016/0004-6981(84)90145-8; LURMANN FW, 1986, J GEOPHYS RES-ATMOS, V91, P905, DOI 10.1029/JD091iD10p10905; RASMUSSEN RA, 1972, JAPCA J AIR WASTE MA, V22, P537, DOI 10.1080/00022470.1972.10469676; RICHARDSON JL, 1988, THESIS GEORGIA I TEC; SCHERE KL, 1988, ENVIRON SCI TECHNOL, V22, P488, DOI 10.1021/es00170a002; SEINFELD JH, 1988, JAPCA J AIR WASTE MA, V38, P616, DOI 10.1080/08940630.1988.10466404; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; WALKER HM, 1985, JAPCA J AIR WASTE MA, V35, P903, DOI 10.1080/00022470.1985.10465969; WENT FW, 1960, P NATL ACAD SCI USA, V46, P212, DOI 10.1073/pnas.46.2.212; WESTBERG H, 1985, EPA600S385013 REP, P1; WHITTEN GZ, 1980, ENVIRON SCI TECHNOL, V14, P690, DOI 10.1021/es60166a008; Zimmerman P. R, 1979, EPA450479004, P1; ZIMMERMAN PR, 1980, P SPECIALTY C OZONE, P299; 1987, GUIDELINE USE CITY S, P1	21	784	804	6	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 16	1988	241	4872					1473	1475		10.1126/science.3420404	http://dx.doi.org/10.1126/science.3420404			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0479	3420404				2022-12-24	WOS:A1988Q047900031
J	SCHELLENBERG, GD; BIRD, TD; WIJSMAN, EM; MOORE, DK; BOEHNKE, M; BRYANT, EM; LAMPE, TH; NOCHLIN, D; SUMI, SM; DEEB, SS; BEYREUTHER, K; MARTIN, GM				SCHELLENBERG, GD; BIRD, TD; WIJSMAN, EM; MOORE, DK; BOEHNKE, M; BRYANT, EM; LAMPE, TH; NOCHLIN, D; SUMI, SM; DEEB, SS; BEYREUTHER, K; MARTIN, GM			ABSENCE OF LINKAGE OF CHROMOSOME 21Q21 MARKERS TO FAMILIAL ALZHEIMERS-DISEASE	SCIENCE			English	Article									VET ADM MED CTR,DIV NEUROL,SEATTLE,WA 98108; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; AMER LAKE VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,TACOMA,WA 98493; UNIV HEIDELBERG,CTR MOLEC BIOL,D-6900 HEIDELBERG,FED REP GER	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; Ruprecht Karls University Heidelberg	SCHELLENBERG, GD (corresponding author), UNIV WASHINGTON,DIV NEUROL RG-27,SEATTLE,WA 98195, USA.				NIA NIH HHS [AG 00057, AG 05136] Funding Source: Medline; NIGMS NIH HHS [GM 15253] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BIRD TD, IN PRESS ANN NEUROL; BREITNER JCS, 1986, J PSYCHIAT RES, V20, P31, DOI 10.1016/0022-3956(86)90021-X; BREITNER JCS, 1986, J PSYCHIAT RES, V20, P45, DOI 10.1016/0022-3956(86)90022-1; CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; COOK RH, 1981, ARCH NEUROL-CHICAGO, V38, P300, DOI 10.1001/archneur.1981.00510050066011; COOK RH, 1979, NEUROLOGY, V29, P1402, DOI 10.1212/WNL.29.10.1402; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GOODFELLOW PJ, 1986, NUCLEIC ACIDS RES, V14, P4375, DOI 10.1093/nar/14.10.4375; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; HESTON LL, 1966, ARCH NEUROL-CHICAGO, V15, P225, DOI 10.1001/archneur.1966.00470150003001; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HEYMAN A, 1988, Neurology, V38, P231; Hodge SE, 1979, AM J HUM GENET, V31, P761; HUNTER R, 1972, J NEUROL NEUROSUR PS, V35, P707, DOI 10.1136/jnnp.35.5.707; KALLMAN FJ, 1956, MENTAL DISORDERS LAT; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KITTUR SD, 1985, EMBO J, V4, P2257, DOI 10.1002/j.1460-2075.1985.tb03923.x; KORENBERG J R, 1988, Neurology, V38, P265; LARRSON T, 1963, ACTA PSYCHIATR  S167, V39, P1; Maniatis T., 1982, MOL CLONING; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1956, AM J HUM GENET, V8, P80; NOCHLIN D, 1988, Neurology, V38, P266; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L, P109; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROBAKIS NK, 1987, LANCET, V1, P384; ROSES A D, 1988, Neurology, V38, P173; RUDD NL, 1988, HUM GENET, V78, P175, DOI 10.1007/BF00278191; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SHARMAN MG, 1979, PSYCHOL MED, V9, P771, DOI 10.1017/S0033291700034103; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; SULKAVA R, 1983, J NEUROL NEUROSUR PS, V46, P9, DOI 10.1136/jnnp.46.1.9; TANZI R, 1985, CYTOGENET CELL GENET, V40, P760; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; WHALLEY LJ, 1982, BRIT J PSYCHIAT, V140, P249, DOI 10.1192/bjp.140.3.249; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180	49	226	239	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 16	1988	241	4872					1507	1510		10.1126/science.3420406	http://dx.doi.org/10.1126/science.3420406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0479	3420406				2022-12-24	WOS:A1988Q047900042
J	SAUSVILLE, EA; EDDY, JL; MAKUCH, RW; FISCHMANN, AB; SCHECHTER, GP; MATTHEWS, M; GLATSTEIN, E; IHDE, DC; KAYE, F; VEACH, SR; PHELPS, R; OCONNOR, T; TREPEL, JB; COTELINGAM, JD; GAZDAR, AF; MINNA, JD; BUNN, PA				SAUSVILLE, EA; EDDY, JL; MAKUCH, RW; FISCHMANN, AB; SCHECHTER, GP; MATTHEWS, M; GLATSTEIN, E; IHDE, DC; KAYE, F; VEACH, SR; PHELPS, R; OCONNOR, T; TREPEL, JB; COTELINGAM, JD; GAZDAR, AF; MINNA, JD; BUNN, PA			HISTOPATHOLOGIC STAGING AT INITIAL DIAGNOSIS OF MYCOSIS-FUNGOIDES AND THE SEZARY SYNDROME - DEFINITION OF 3 DISTINCTIVE PROGNOSTIC GROUPS	ANNALS OF INTERNAL MEDICINE			English	Article									NCI, BETHESDA, MD 20205 USA; USN HOSP, BETHESDA, MD 20814 USA; UNIFORMED SERV UNIV HLTH SCI, BETHESDA, MD 20814 USA; VET ADM MED CTR, WASHINGTON, DC 20422 USA; GEORGE WASHINGTON UNIV, WASHINGTON, DC 20052 USA; YALE UNIV, SCH MED, NEW HAVEN, CT 06510 USA; UNIV COLORADO, HLTH SCI CTR, DENVER, CO 80262 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SAUSVILLE, EA (corresponding author), GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, 3800 RESERVOIR RD NW, WASHINGTON, DC 20007 USA.		kaye, frederic/E-2437-2011		NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NCI NIH HHS [5P30-CA-16359] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AISENBERG AC, 1985, NEW ENGL J MED, V313, P529, DOI 10.1056/NEJM198508293130901; BERTNESS V, 1985, NEW ENGL J MED, V313, P534, DOI 10.1056/NEJM198508293130902; BLASIK LG, 1982, CANCER-AM CANCER SOC, V49, P742, DOI 10.1002/1097-0142(19820215)49:4<742::AID-CNCR2820490424>3.0.CO;2-1; BLUEFARB SM, 1971, CUTIS, V7, P393; BOUMSELL L, 1981, BLOOD, V57, P526; BRAVERMAN IM, 1987, J AM ACAD DERMATOL, V16, P45, DOI 10.1016/S0190-9622(87)70004-8; BRODER S, 1976, J CLIN INVEST, V58, P1297, DOI 10.1172/JCI108585; BRODER S, 1984, ANN INTERN MED, V100, P543, DOI 10.7326/0003-4819-100-4-543; BRODER S, 1980, SEMIN ONCOL, V7, P310; BUNN PA, 1980, ANN INTERN MED, V93, P223, DOI 10.7326/0003-4819-93-2-223; BUNN PA, 1979, CANCER TREAT REP, V63, P725; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; CASTELLINO RA, 1979, CANCER TREAT REP, V63, P581; COHEN SR, 1980, CANCER, V46, P2654, DOI 10.1002/1097-0142(19801215)46:12<2654::AID-CNCR2820461220>3.0.CO;2-1; COX DR, 1968, J ROY STAT SOC B, V30, P248, DOI 10.1111/j.2517-6161.1968.tb00724.x; CYR DP, 1966, ARCH DERMATOL, V94, P558, DOI 10.1001/archderm.94.5.558; DMITROVSKY E, 1987, J CLIN ONCOL, V5, P208, DOI 10.1200/JCO.1987.5.2.208; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; EPSTEIN EH, 1972, MEDICINE, V51, P61, DOI 10.1097/00005792-197201000-00004; FISCHMANN AB, 1979, CANCER TREAT REP, V63, P591; FUKS ZY, 1973, CANCER, V32, P1385, DOI 10.1002/1097-0142(197312)32:6<1385::AID-CNCR2820320617>3.0.CO;2-#; GREEN SB, 1981, CANCER-AM CANCER SOC, V47, P2671, DOI 10.1002/1097-0142(19810601)47:11<2671::AID-CNCR2820471125>3.0.CO;2-X; HALLAHAN D, 1986, J CLIN ONCOL, V4, P1638, DOI 10.1200/JCO.1986.4.11.1638; HAYNES BF, 1981, NEW ENGL J MED, V304, P1319, DOI 10.1056/NEJM198105283042202; HAYNES BF, 1982, BLOOD, V60, P463; HOPPE RT, 1977, INT J RADIAT ONCOL, V2, P843, DOI 10.1016/0360-3016(77)90182-1; HOPPE RT, 1987, J CLIN ONCOL, V5, P1796, DOI 10.1200/JCO.1987.5.11.1796; HOPPE RT, 1979, CANCER TREAT REP, V63, P691; HUBERMAN MS, 1980, CANCER, V45, P1683, DOI 10.1002/1097-0142(19800401)45:7<1683::AID-CNCR2820450727>3.0.CO;2-C; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAYE F, 1986, P AN M AM SOC CLIN, V5, P765; KUNG PC, 1981, BLOOD, V57, P261; LAMBERG SI, 1984, ANN INTERN MED, V100, P187, DOI 10.7326/0003-4819-100-2-187; LEHMAN EL, 1975, NONPARAMETRICS STATI; LEVI JA, 1975, MEDICINE, V54, P73, DOI 10.1097/00005792-197501000-00004; LONG JC, 1974, CANCER, V34, P1745, DOI 10.1002/1097-0142(197411)34:5<1745::AID-CNCR2820340524>3.0.CO;2-W; LUTZNER M, 1975, ANN INTERN MED, V83, P534, DOI 10.7326/0003-4819-83-4-534; MANZARI V, 1987, SCIENCE, V238, P1581, DOI 10.1126/science.2825353; MICAILY B, 1985, INT J RADIAT ONCOL, V11, P1111, DOI 10.1016/0360-3016(85)90057-4; NASU K, 1985, AM J PATHOL, V119, P436; ORFANAKIS NG, 1970, AM J CLIN PATHOL, V53, P647; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; POSNER LE, 1981, AM J MED, V71, P210, DOI 10.1016/0002-9343(81)90107-8; RALFKIAER E, 1985, AM J CLIN PATHOL, V84, P610, DOI 10.1093/ajcp/84.5.610; RAMSAY DL, 1984, ARCH DERMATOL, V120, P1585, DOI 10.1001/archderm.120.12.1585; RAPPAPORT H, 1974, CANCER-AM CANCER SOC, V34, P1198, DOI 10.1002/1097-0142(197410)34:4<1198::AID-CNCR2820340431>3.0.CO;2-E; SAUSVILLE EA, 1985, HUM PATHOL, V16, P1098, DOI 10.1016/S0046-8177(85)80177-5; SLATER DN, 1985, HISTOPATHOLOGY, V9, P587, DOI 10.1111/j.1365-2559.1985.tb02842.x; TADROS AAM, 1983, INT J RADIAT ONCOL, V9, P1279, DOI 10.1016/0360-3016(83)90258-4; VANDERLOO EM, 1979, VIRCHOWS ARCH B, V31, P193; VONDERHEID EC, 1977, ARCH DERMATOL, V113, P454, DOI 10.1001/archderm.113.4.454; VONDERHEID EC, 1979, CANCER TREAT REP, V63, P681; WALDMANN TA, 1984, J CLIN INVEST, V73, P1711, DOI 10.1172/JCI111379; WEISS LM, 1985, NEW ENGL J MED, V313, P539, DOI 10.1056/NEJM198508293130903; WINKLER CF, 1986, J CLIN ONCOL, V4, P1094, DOI 10.1200/JCO.1986.4.7.1094; WINKLER CF, 1984, CRITICAL REV ONCOLOG, V1, P49; WOOD GS, 1986, SEMIN DERMATOL, V5, P334	58	214	218	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	1988	109	5					372	382		10.7326/0003-4819-109-5-372	http://dx.doi.org/10.7326/0003-4819-109-5-372			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q0198	3408055				2022-12-24	WOS:A1988Q019800006
J	KROENKE, K; WOOD, DR; MANGELSDORFF, AD; MEIER, NJ; POWELL, JB				KROENKE, K; WOOD, DR; MANGELSDORFF, AD; MEIER, NJ; POWELL, JB			CHRONIC FATIGUE IN PRIMARY CARE - PREVALENCE, PATIENT CHARACTERISTICS, AND OUTCOME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									BROOKE ARMY MED CTR,DEPT PSYCHOL,FT SAM HOUSTON,TX 78234; USA,HLTH SERV COMMAND,HLTH CARE STUDIES & CLIN INVEST ACT,FT SAM HOUSTON,TX 78234	San Antonio Military Medical Center; United States Department of Defense; United States Army	KROENKE, K (corresponding author), BROOKE ARMY MED CTR,DEPT MED,BOX 523,BEACH PAVILL,FT SAM HOUSTON,TX 78234, USA.		anand, amit/A-7222-2009	Kroenke, Kurt/0000-0002-0114-4669				Allan FN, 1944, NEW ENGL J MED, V231, P414, DOI 10.1056/NEJM194409212311203; BARSKY AJ, 1979, ANN INTERN MED, V91, P63, DOI 10.7326/0003-4819-91-1-63; Beck A. T., 1960, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004; BERGNER L, 1984, AM J PUBLIC HEALTH, V74, P508, DOI 10.2105/AJPH.74.5.508; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BUCHWALD D, 1987, JAMA-J AM MED ASSOC, V257, P2303, DOI 10.1001/jama.257.17.2303; CARDENAS DD, 1982, NEPHRON, V30, P336, DOI 10.1159/000182512; CHRISTENSEN T, 1984, BRIT J SURG, V71, P473, DOI 10.1002/bjs.1800710624; FRANKEL HM, 1986, JAMA-J AM MED ASSOC, V255, P1292, DOI 10.1001/jama.255.10.1292; HALES RE, 1987, MIL MED, V152, P299, DOI 10.1093/milmed/152.6.299; HANKIN JR, 1982, AM J PUBLIC HEALTH, V72, P1000, DOI 10.2105/AJPH.72.9.1000; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; JERRETT WA, 1981, PRACTITIONER, V225, P731; JOHNSON JE, 1988, MIL MED, V152, P21; JONES JF, 1985, ANN INTERN MED, V102, P1, DOI 10.7326/0003-4819-102-1; KATON W, 1982, AM J MED, V72, P241, DOI 10.1016/0002-9343(82)90816-6; KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X; KAYE P L, 1973, Behavioral Neuropsychiatry, V5, P24; LANE TJ, 1988, CLIN RES, V316, P714; LINN LS, 1984, PSYCHOSOMATICS, V25, P593, DOI 10.1016/S0033-3182(84)72994-X; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; MERLIN TL, 1986, HUM PATHOL, V17, P2, DOI 10.1016/S0046-8177(86)80149-6; MILLER A, 1983, BRIT MED J, V286, P266, DOI 10.1136/bmj.286.6361.266; MILLON T, 1982, MILLON BEHAVIORAL HL; MONTGOMERY GK, 1983, J CONSULT CLIN PSYCH, V51, P517, DOI 10.1037/0022-006X.51.4.517; MORRISON JD, 1980, J FAM PRACTICE, V10, P795; NIELSEN AC, 1980, ARCH GEN PSYCHIAT, V37, P999; OTT CR, 1983, HEART LUNG, V12, P162; PETRICH J, 1977, MED CLIN N AM, V61, P825, DOI 10.1016/S0025-7125(16)31300-1; PINHOLT EM, 1987, ARCH INTERN MED, V147, P484; POTELIAKHOFF A, 1981, J PSYCHOSOM RES, V25, P91, DOI 10.1016/0022-3999(81)90095-7; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; ROCKEY PH, 1980, ARCH INTERN MED, V140, P1194, DOI 10.1001/archinte.140.9.1194; ROCKWELL DA, 1977, J FAM PRACTICE, V5, P853; SCHOEN I, 1970, AM J CLIN PATHOL, V53, P190; SOLBERG LI, 1984, JAMA-J AM MED ASSOC, V251, P3272, DOI 10.1001/jama.251.24.3272; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; STRAUS SE, 1985, ANN INTERN MED, V102, P7, DOI 10.7326/0003-4819-102-1-7; SUGARMAN JR, 1984, J FAM PRACTICE, V19, P643; SUMAYA CV, 1985, J INFECT DIS, V151, P984, DOI 10.1093/infdis/151.6.984; SURRIDGE DHC, 1984, BRIT J PSYCHIAT, V145, P269, DOI 10.1192/bjp.145.3.269; TAYLOR CB, 1985, PUBLIC HEALTH REP, V100, P195; WARTMAN SA, 1983, PUBLIC HEALTH REP, V98, P141; 1978, PHS781784 US DEP HLT	46	399	401	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	1988	260	7					929	934		10.1001/jama.260.7.929	http://dx.doi.org/10.1001/jama.260.7.929			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6566	3398197				2022-12-24	WOS:A1988P656600020
J	WAGNER, HN				WAGNER, HN			SCIENCE, POLITICS, AND RADIATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											WAGNER, HN (corresponding author), JOHNS HOPKINS MED INST,BALTIMORE,MD 21205, USA.							ROBERTS L, 1987, SCIENCE, V238, P1649, DOI 10.1126/science.3686005	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	1988	260	5					697	698		10.1001/jama.260.5.697	http://dx.doi.org/10.1001/jama.260.5.697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P4773	3392799				2022-12-24	WOS:A1988P477300037
J	MINARDO, JD; HEGER, JJ; MILES, WM; ZIPES, DP; PRYSTOWSKY, EN				MINARDO, JD; HEGER, JJ; MILES, WM; ZIPES, DP; PRYSTOWSKY, EN			CLINICAL CHARACTERISTICS OF PATIENTS WITH VENTRICULAR-FIBRILLATION DURING ANTIARRHYTHMIC DRUG-THERAPY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									INDIANA UNIV,SCH MED,DEPT MED,KRANNERT INST CARDIOL,INDIANAPOLIS,IN 46202; RICHARD L ROUDEBUSH VET ADM MED CTR,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center				Zipes, Douglas/0000-0001-7141-6829	NHLBI NIH HHS [HL-06308, HL-07182] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007182] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASKEY JM, 1946, ANN INTERN MED, V24, P371, DOI 10.7326/0003-4819-24-3-371; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BINDER MJ, 1952, AM J MED, V12, P491, DOI 10.1016/0002-9343(52)90229-5; DAVIES P, 1965, BRIT MED J, V2, P517, DOI 10.1136/bmj.2.5460.517; Drury AN, 1922, HEART-J STUD CIRC, V9, P365; ENGLER RL, 1981, AM HEART J, V101, P494, DOI 10.1016/0002-8703(81)90141-1; HEGER JJ, 1983, AM HEART J, V106, P887, DOI 10.1016/0002-8703(83)90012-1; HERRE JM, 1985, AM J CARDIOL, V55, P227, DOI 10.1016/0002-9149(85)90337-6; KELLY HG, 1963, CAN MED ASSOC J, V89, P546; KEREN A, 1981, CIRCULATION, V64, P1167, DOI 10.1161/01.CIR.64.6.1167; Kerr WJ, 1922, HEART-J STUD CIRC, V9, P269; LEAHEY EB, 1978, JAMA-J AM MED ASSOC, V240, P533, DOI 10.1001/jama.240.6.533; LEPESCHKIN E, 1953, AM HEART J, V46, P9, DOI 10.1016/0002-8703(53)90237-3; LEVY RL, 1922, JAMA-J AM MED ASSOC, V78, P1919; Lewis T, 1922, HEART-J STUD CIRC, V9, P207; MORGANROTH J, 1984, AM J CARDIOL, V53, pB89, DOI 10.1016/0002-9149(84)90509-5; NICHOLSON WJ, 1979, AM J CARDIOL, V43, P1053, DOI 10.1016/0002-9149(79)90374-6; REYNOLDS EW, 1976, MOD CONC CARDIOV DIS, V45, P117; RINKENBERGER RL, 1982, AM HEART J, V103, P177, DOI 10.1016/0002-8703(82)90490-2; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; ROKSETH R, 1963, ARCH INTERN MED, V111, P184, DOI 10.1001/archinte.1963.03620260044008; RUSKIN JN, 1983, NEW ENGL J MED, V309, P1302, DOI 10.1056/NEJM198311243092107; SANO T, 1958, CIRC RES, V6, P41, DOI 10.1161/01.RES.6.1.41; SCLAROVKSY S, 1979, AM J CARDIOL, V44, P339, DOI 10.1016/0002-9149(79)90326-6; SCLAROVSKY S, 1983, AM HEART J, V105, P6, DOI 10.1016/0002-8703(83)90270-3; SELZER A, 1964, CIRCULATION, V30, P17, DOI 10.1161/01.CIR.30.1.17; SMITH WM, 1980, ANN INTERN MED, V93, P578, DOI 10.7326/0003-4819-93-4-578; STANTON MS, 1987, J AM COLL CARDIOL, V9, pA245; SURAWICZ B, 1971, AM J CARDIOL, V28, P268, DOI 10.1016/0002-9149(71)90115-9; SURAWICZ B, 1984, J AM COLL CARDIOL, V4, P398, DOI 10.1016/S0735-1097(84)80232-6; THOMSON GW, 1956, CIRCULATION, V14, P757, DOI 10.1161/01.CIR.14.5.757; VELEBIT V, 1982, CIRCULATION, V65, P886, DOI 10.1161/01.CIR.65.5.886; Viko LE, 1923, ARCH INTERN MED, V31, P345, DOI 10.1001/archinte.1923.00110150044003	33	126	126	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	1988	319	5					257	262		10.1056/NEJM198808043190501	http://dx.doi.org/10.1056/NEJM198808043190501			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5161	3393179				2022-12-24	WOS:A1988P516100001
J	WEN, SW; HERNANDEZ, R; NAYLOR, CD				WEN, SW; HERNANDEZ, R; NAYLOR, CD			PITFALLS IN NONRANDOMIZED OUTCOMES STUDIES - THE CASE OF INCIDENTAL APPENDECTOMY WITH OPEN CHOLECYSTECTOMY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; PROSTATECTOMY; COMORBIDITY; DATABASES; RESECTION; MORBIDITY	Objectives.-To assess the short-term outcomes of incidental appendectomy through analysis of hospital administrative data and determine the consistency and plausibility of the observed results. Design.-Population-based historical cohort study. Setting.-All general hospitals in Ontario between 1981 and 1990. Patients.-Patients undergoing open primary cholecystectomy with (7846 exposed) and without (191 599 unexposed) incidental appendectomy. Main Outcome Measures.-In-hospital fatality rates, complication rates, and lengths of hospital stay. Results.-Crude comparisons showed a striking and paradoxical reduction in mortality after cholecystectomy when incidental appendectomy was performed (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.23 to 0.57; P<.001); mean length of stay was also lower by -0.46 day (P<.001). After adjustment for confounding differences, such as comorbidity and nonelective surgery, mortality and lengths of stay were similar for exposed and unexposed patients; but exposed patients showed a significant increase in nonfatal complications (OR, 1.53; 95% CI, 1.39 to 1.68; P<.001). Adverse effects from incidental appendectomy emerged consistently for all three outcomes only after restricting the analysis to subgroups of patients at low surgical risk. The increased mortality for exposed patients was largest among low-risk groups; for example, among those younger than 70 years undergoing elective surgery, the OR was 2.65 (95% CI, 1.25 to 5.64; P<.001). Conclusion.-These findings suggest that incidental appendectomy is associated with a small but definite increase in adverse postoperative outcomes. However, plausible and consistent findings were only obtained after restricting the analysis to low-risk subgroups in which unmeasured differences in patients' baseline characteristics were less likely to confound adjusted outcome comparisons. This exercise highlights the potential pitfalls in nonrandomized outcomes comparisons using data sources with limited clinical detail, such as hospital discharge abstracts,	SUNNYBROOK HLTH SCI CTR,CLIN EPIDEMIOL UNIT,N YORK,ON M4N 3M5,CANADA; INST CLIN EVALUAT SCI,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PREVENT MED & BIOSTAT,TORONTO,ON M5S 1A1,CANADA; UNIV TORONTO,DEPT MED & SURG,TORONTO,ON M5S 1A1,CANADA	University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto								ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ANDERSEN TF, 1990, MED CARE, V28, P870, DOI 10.1097/00005650-199010000-00002; BOGART J N, 1969, American Surgeon, V35, P650; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CONCATO J, 1992, JAMA-J AM MED ASSOC, V267, P1077, DOI 10.1001/jama.267.8.1077; DALEY J, 1994, RISK ADJUSTMENT MEAS, P199; DANS PE, 1993, ANN INTERN MED, V119, P855, DOI 10.7326/0003-4819-119-8-199310150-00014; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DONALDSON DR, 1989, BRIT J CLIN PRACT, V43, P15; ELSEFI TAM, 1989, INT SURG, V74, P32; GREEN J, 1993, MED CARE, V31, P719, DOI 10.1097/00005650-199308000-00005; GREENFIELD S, 1989, NEW ENGL J MED, V320, P1142, DOI 10.1056/NEJM198904273201710; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; LOWERY CH, 1962, ARCH SURG-CHICAGO, V85, P476; MALENKA DJ, 1990, J UROLOGY, V144, P224, DOI 10.1016/S0022-5347(17)39416-8; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; PASS HI, 1988, HARDYS TXB SURG, P574; POLLOCK AV, 1977, BRIT MED J, V1, P20, DOI 10.1136/bmj.1.6052.20; RILEY G, 1993, MED CARE, V31, P921, DOI 10.1097/00005650-199310000-00005; ROOS NP, 1989, NEW ENGL J MED, V320, P1120, DOI 10.1056/NEJM198904273201705; ROOS NP, 1992, JAMA-J AM MED ASSOC, V268, P1269, DOI 10.1001/jama.1992.03490100063027; SHUMAKE L B, 1971, American Surgeon, V37, P310; STROM PR, 1983, AM J SURG, V145, P819, DOI 10.1016/0002-9610(83)90150-2; SUGIMOTO T, 1987, AM J PUBLIC HEALTH, V77, P471, DOI 10.2105/AJPH.77.4.471; TUNGPHAISAL S, 1989, Journal of the Medical Association of Thailand, V72, P633; WATERS EG, 1977, OBSTET GYNECOL, V50, P511; WEN SW, 1994, PATTERNS HLTH CARE O, V95, P98; WENNBERG JE, 1994, SCIENCE, V264, P758, DOI 10.1126/science.7513442; WILSON EA, 1973, AM J OBSTET GYNECOL, V116, P76, DOI 10.1016/0002-9378(73)90887-9; 1990, INT CLASSIFICATION D, V1; 1991, CANADIAN HOSPITAL DI; 1986, CANADIAN CLASSIFICAT	32	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1687	1691		10.1001/jama.274.21.1687	http://dx.doi.org/10.1001/jama.274.21.1687			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH151	7474273				2022-12-24	WOS:A1995TH15100025
J	FRIEDLANDER, M; BROOKS, PC; SHAFFER, RW; KINCAID, CM; VARNER, JA; CHERESH, DA				FRIEDLANDER, M; BROOKS, PC; SHAFFER, RW; KINCAID, CM; VARNER, JA; CHERESH, DA			DEFINITION OF 2 ANGIOGENIC PATHWAYS BY DISTINCT ALPHA(V) INTEGRINS	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; MECHANISMS; FIBRINOGEN	Angiogenesis depends on cytokines and vascular cell adhesion events, Two cytokine-dependent pathways of angiogenesis were shown to exist and were defined by their dependency on distinct vascular cell integrins. In vivo angiogenesis in corneal or chorioallantoic membrane models induced by basic fibroblast growth factor or by tumor necrosis factor-alpha depended on alpha(V) beta(3), whereas angiogenesis initiated by vascular endothelial growth factor, transforming growth factor-alpha, or phorbol ester depended on alpha(V) beta(5). Antibody to each integrin selectively blocked one of these pathways, and a cyclic peptide antagonist of both integrins blocked angiogenesis stimulated by each cytokine tested. These pathways are further distinguished by their sensitivity to calphostin C, an inhibitor of protein kinase C that blocked angiogenesis potentiated by alpha(V) beta(5) but not by alpha(V) beta(3).	Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego	FRIEDLANDER, M (corresponding author), Scripps Res Inst, DEPT CELL BIOL, ROBERT MEALEY LAB STUDY MASCULAR DEGENERAT, LA JOLLA, CA 92037 USA.			Varner, Judith/0000-0002-9251-0600				AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BROOKS PM, UNPUB; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453; DRAKE CJ, 1995, J CELL SCI, V108, P2655; ENENSTEIN J, 1994, J INVEST DERMATOL, V103, P381, DOI 10.1111/1523-1747.ep12395390; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FRIEDLANDER M, 1995, SEP RET SOC M SANT F; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MILLER JW, 1994, AM J PATHOL, V145, P574; PFAFF M, 1994, J BIOL CHEM, V269, P20233; SHAFFER R, IN PRESS NATO ASI MO; WEINSTATSASLOW D, 1994, FASEB J, V8, P401, DOI 10.1096/fasebj.8.6.7513289	22	1139	1256	1	35	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1500	1502		10.1126/science.270.5241.1500	http://dx.doi.org/10.1126/science.270.5241.1500			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491498				2022-12-24	WOS:A1995TH37500041
J	TRIEMSTRA, M; ROSENDAAL, FR; SMIT, C; VANDERPLOEG, HM; BRIET, E				TRIEMSTRA, M; ROSENDAAL, FR; SMIT, C; VANDERPLOEG, HM; BRIET, E			MORTALITY IN PATIENTS WITH HEMOPHILIA - CHANGES IN A DUTCH POPULATION FROM 1986 TO 1992 AND 1973 TO 1986	ANNALS OF INTERNAL MEDICINE			English	Article						HEMOPHILIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; LIFE EXPECTANCY; HEPATITIS; NETHERLANDS	UNITED-STATES; DEATH	Objective: To determine causes of death and mortality rates in patients with hemophilia over a period of 20 years, to assess changes in mortality, and to distinguish between hemophilia-related death and recent death induced by viral infections. Design: Cohort study of 919 patients followed from January 1986 to June 1992. Results were compared with outcomes of previous follow-up from 1973 to 1986. Setting: Consecutive national questionnaire surveys on hemophilia, using patient registries of the Netherlands Hemophilia Society and Dutch hemophilia centers. Patients: 919 males with hemophilia A or B who participated in a national questionnaire survey on hemophilia in 1985. Median duration of follow-up was 6.4 years, which yielded 5753 person-years of follow-up. The mean age at study entry was 30 years (range, 1 to 85 years). Measurements: Standardized mortality ratios, causes of death, median life expectancy, age-adjusted relative risks associated with the type or severity of hemophilia, presence of inhibitors, prophylaxis, and human immunodeficiency virus infection. Results: 45 patients (5%) died between January 1986 and June 1992; 22.6 patients had been expected to die. Thus, the overall standardized mortality ratio was 2.0. The overall median life expectancy was 66 years for the cohort studied from 1973 to 1986 and 68 years for the cohort studied from 1986 to 1992. When deaths related to viral infection were excluded, the life expectancy almost equaled that of the general male population. Between 1986 and 1992, 1 patient died of ischemic heart disease compared with the 5.2 who were expected to die of this disease. Infection with HIV was the strongest independent predictor of death (relative risk, 27.5 [95% CI, 5.7 to 132.8]). After adjustment for HIV infection, no other hemophilia-related risk factors were associated with the risk for death. Conclusions: The acquired immunodeficiency syndrome and hepatitis strongly influence mortality in patients with hemophilia. In the absence of viral infections, the life expectancy of patients with hemophilia would almost equal that of the general male population.	LEIDEN UNIV HOSP, DEPT CLIN EPIDEMIOL, 2300 RC LEIDEN, NETHERLANDS; VRIJE UNIV AMSTERDAM, DEPT MED PSYCHOL, 1081 BT AMSTERDAM, NETHERLANDS; NETHERLANDS HEMOPHILIA SOC, 1171 GN BADHOEVEDORP, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam				Triemstra, Mattanja/0000-0001-7133-6028				ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; ARONSON DL, 1988, AM J HEMATOL, V27, P7, DOI 10.1002/ajh.2830270103; CHORBA TL, 1994, AM J HEMATOL, V45, P112, DOI 10.1002/ajh.2830450204; Cox D. R., 1984, ANAL SURVIVAL DATA; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; IKKALA E, 1982, BRIT J HAEMATOL, V52, P7, DOI 10.1111/j.1365-2141.1982.tb03856.x; JOHNSON RE, 1985, AM J EPIDEMIOL, V121, P797, DOI 10.1093/oxfordjournals.aje.a114051; JONES PK, 1991, ANN INTERN MED, V114, P641, DOI 10.7326/0003-4819-114-8-641; LARSSON SA, 1983, ACTA MED SCAND, V214, P199; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; MANN JM, 1992, AIDS WORLD 1992; MEADE TW, 1994, BRIT MED BULL, V50, P755, DOI 10.1093/oxfordjournals.bmb.a072924; PHILLIPS AN, 1994, BRIT MED J, V309, P309, DOI 10.1136/bmj.309.6950.309; RAMGREN O, 1962, ACTA MED SCAND, V171, P37; ROSENDAAL FR, 1990, BRIT J HAEMATOL, V75, P525, DOI 10.1111/j.1365-2141.1990.tb07793.x; ROSENDAAL FR, 1989, BRIT J HAEMATOL, V71, P71, DOI 10.1111/j.1365-2141.1989.tb06277.x; SMIT C, 1989, BRIT MED J, V298, P235, DOI 10.1136/bmj.298.6668.235; TELFER P, 1994, BRIT J HAEMATOL, V87, P555, DOI 10.1111/j.1365-2141.1994.tb08312.x; 1994, ETHICAL ASPECTS BIOM, P17; [No title captured]	20	149	152	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1995	123	11					823	+		10.7326/0003-4819-123-11-199512010-00002	http://dx.doi.org/10.7326/0003-4819-123-11-199512010-00002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG209	7486463				2022-12-24	WOS:A1995TG20900002
J	NELSON, RJ; DEMAS, GE; HUANG, PL; FISHMAN, MC; DAWSON, VL; DAWSON, TM; SNYDER, SH				NELSON, RJ; DEMAS, GE; HUANG, PL; FISHMAN, MC; DAWSON, VL; DAWSON, TM; SNYDER, SH			BEHAVIORAL ABNORMALITIES IN MALE-MICE LACKING NEURONAL NITRIC-OXIDE SYNTHASE	NATURE			English	Article								Is addition to its role in blood vessel(1,2) and macrophage(3,4) function, nitric oxide (NO) is a neurotransmitter(5) found in high densities in emotion-regulating brain regions(6-8). Mice with targeted disruption of neuronal NO synthase (nNOS) display grossly normal appearance, locomotor activity, breeding(9), long-term potentiation and long-term depression(11). The nNOS(-) mice are resistant to neural stroke damage following middle cerebral artery ligation(12). Although CO2-induced cerebral vasodilatation in wild-type mice is NO-dependent, in nNOS(-) mice this vasodilation is unaffected by NOS inhibitors(13). Establishing a behavioural role for NO has, until now, not been feasible, as NOS inhibitor drugs can only be administered acutely and because their pronounced effects on blood pressure and other body functions obfuscate behavioural interpretations. We now report a large increase in aggressive behaviour and excess, inappropriate sexual behaviour in nNOS(-) mice.	JOHNS HOPKINS UNIV,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT PHYSIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT PSYCHOL,BEHAV NEUROENDOCRINOL GRP,BALTIMORE,MD 21218; MASSACHUSETTS GEN HOSP,CARDIOVASC RES CTR,BOSTON,MA 02129	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital			Dawson, Valina/Y-9757-2019; Demas, Gregory/Y-1783-2019	Demas, Gregory/0000-0003-3914-0900; Nelson, Randy/0000-0002-8194-4016; Dawson, Valina/0000-0002-2915-3970				ALBERT DJ, 1984, NEUROSCI BIOBEHAV R, V8, P5, DOI 10.1016/0149-7634(84)90017-4; BRAIN PF, 1992, PSYCHONEUROENDOCRINO, V17, P537, DOI 10.1016/0306-4530(92)90014-X; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; DAWSON TM, 1994, J NEUROSCI, V14, P5147; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; IRIKURA K, 1995, P NATL ACAD SCI USA, V92, P6823, DOI 10.1073/pnas.92.15.6823; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; OGAWA S, 1995, END SOC ABSTR; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; REZUANI AH, 1995, PHARM BIOCH BEHAV, V50, P265; RODRIGO J, 1994, PHILOS T R SOC B, V345, P175, DOI 10.1098/rstb.1994.0096; SALIS PJ, 1971, NATURE, V232, P400, DOI 10.1038/232400a0; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SQUADRITO F, 1994, EUR J PHARMACOL, V255, P51, DOI 10.1016/0014-2999(94)90081-7; VINCENT SR, 1992, NEUROSCIENCE, V4, P755	24	524	535	1	28	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					383	386		10.1038/378383a0	http://dx.doi.org/10.1038/378383a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477374				2022-12-24	WOS:A1995TF89300058
J	DESPOSITO, M; DETRE, JA; ALSOP, DC; SHIN, RK; ATLAS, S; GROSSMAN, M				DESPOSITO, M; DETRE, JA; ALSOP, DC; SHIN, RK; ATLAS, S; GROSSMAN, M			THE NEURAL BASIS OF THE CENTRAL EXECUTIVE SYSTEM OF WORKING-MEMORY	NATURE			English	Article							HUMAN BRAIN; CORTEX; ATTENTION; ANATOMY	Working memory refers to a system for temporary storage and manipulation of information in the brain, a function critical for a wide range of cognitive operations. It has been proposed that working memory includes a central executive system (CES) to control attention and information flow to and from verbal and spatial short-term memory buffers(1). Although the prefrontal cortex is activated during both verbal and spatial passive working memory tasks(2-8), the brain regions involved in the CES component of working memory have not been identified. We have used functional magnetic resonance imaging (fMRI) to examine brain activation during the concurrent performance of two tasks, which is expected to engage the CES. Activation of the prefrontal cortex was observed when both tasks are performed together, but not when they are performed separately. These results support the view that the prefrontal cortex is involved in human working memory.	UNIV PENN,MED CTR,DEPT RADIOL,PHILADELPHIA,PA 19104	University of Pennsylvania	DESPOSITO, M (corresponding author), UNIV PENN,MED CTR,DEPT NEUROL,PHILADELPHIA,PA 19104, USA.		Alsop, David C/J-5764-2013	Alsop, David C/0000-0002-8206-1995				BADDLEY AD, 1986, WORKING MEMORY; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DESPOSITO M, IN PRESS NEUROPSYCHO; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Goldman-Rakic P. S., 1987, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.ne.11.030188.001033; GOLDMANRAKIC PS, 1993, BRAIN MECHANISMS OF PERCEPTION AND MEMORY: FROM NEURON TO BEHAVIOR, P445; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; SWARTZ BE, 1995, CEREB CORTEX, V3, P205; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063	22	1098	1109	7	112	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					279	281		10.1038/378279a0	http://dx.doi.org/10.1038/378279a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477346				2022-12-24	WOS:A1995TE85800048
J	ALADJEM, MI; GROUDINE, M; BRODY, LL; DIEKEN, ES; FOURNIER, REK; WAHL, GM; EPNER, EM				ALADJEM, MI; GROUDINE, M; BRODY, LL; DIEKEN, ES; FOURNIER, REK; WAHL, GM; EPNER, EM			PARTICIPATION OF THE HUMAN BETA-GLOBIN LOCUS-CONTROL REGION IN INITIATION OF DNA-REPLICATION	SCIENCE			English	Article							ACTIVATION REGION; CHROMATIN STRUCTURE; GENE DOMAIN; ORIGIN; CELLS; CHROMOSOMES; TRANSCRIPTION; EXPRESSION; HYBRIDS	The human beta-globin locus control region (LCR) controls the transcription, chromatin structure, and replication timing of the entire locus. DNA replication was found to initiate in a transcription-independent manner within a region located 50 kilobases downstream of the LCR in human, mouse, and chicken cells containing the entire human beta-globin locus. However, DNA replication did not initiate within a deletion mutant locus lacking the sequences that encompass the LCR. This mutant locus replicated in the 3' to 5' direction. Thus, interactions between distantly separated sequences can be required for replication initiation, and factors mediating this interaction appear to be conserved in evolution.	SALK INST,GENE EXPRESS LAB,SAN DIEGO,CA 92037; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98195; UNIV WASHINGTON,SEATTLE,WA 98195	Salk Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle			Aladjem, Mirit/G-2169-2010	Aladjem, Mirit/0000-0002-1875-3110				ALADJEM MI, UNPUB; BABA T, 1989, VIROLOGY, V144, P139; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; BREAM GL, 1992, J VIROL, V66, P7319, DOI 10.1128/JVI.66.12.7319-7327.1992; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; CADDLE MS, 1992, NUCLEIC ACIDS RES, V20, P5971, DOI 10.1093/nar/20.22.5971; CARROLL SM, 1993, MOL CELL BIOL, V13, P2971, DOI 10.1128/MCB.13.5.2971; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; Depamphilis Melvin L., 1993, Trends in Cell Biology, V3, P161, DOI 10.1016/0962-8924(93)90137-P; DEPAMPHILIS ML, 1993, J BIOL CHEM, V268, P1; DHAR V, 1989, MOL CELL BIOL, V9, P3524, DOI 10.1128/MCB.9.8.3524; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DOBBS DL, 1994, NUCLEIC ACIDS RES, V22, P2479, DOI 10.1093/nar/22.13.2479; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; EPNER E, 1988, P NATL ACAD SCI USA, V85, P8081, DOI 10.1073/pnas.85.21.8081; EPNER E, 1992, TRENDS GENET, V2, P262; FORRESTER WC, 1989, P NATL ACAD SCI USA, V86, P5439, DOI 10.1073/pnas.86.14.5439; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GILBERT DM, 1993, COLD SPRING HARB SYM, V58, P475, DOI 10.1101/SQB.1993.058.01.054; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUO ZS, 1992, MOL CELL BIOL, V12, P2514, DOI 10.1128/MCB.12.6.2514; HAMLIN JL, 1995, CURR OPIN GENET DEV, V5, P153, DOI 10.1016/0959-437X(95)80002-6; HANDELI S, 1989, CELL, V57, P909, DOI 10.1016/0092-8674(89)90329-2; KELLY RE, 1995, MOL CELL BIOL, V15, P4136; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; LI R, 1994, P NATL ACAD SCI USA, V91, P7051, DOI 10.1073/pnas.91.15.7051; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; NONET GH, 1993, SOMAT CELL MOLEC GEN, V19, P171, DOI 10.1007/BF01233532; TRASK BJ, 1993, COLD SPRING HARB SYM, V58, P767, DOI 10.1101/SQB.1993.058.01.084; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; YOON Y, 1995, MOL CELL BIOL, V15, P2482	37	188	191	0	3	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					815	819		10.1126/science.270.5237.815	http://dx.doi.org/10.1126/science.270.5237.815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481774				2022-12-24	WOS:A1995TC71200046
J	BENNETT, MB; TAYLOR, GC				BENNETT, MB; TAYLOR, GC			SCALING OF ELASTIC STRAIN-ENERGY IN KANGAROOS AND THE BENEFITS OF BEING BIG	NATURE			English	Article							TERRESTRIAL LOCOMOTION; COST; MECHANICS; WALLABY; TENDONS	LARGE kangaroos are unique among mammals in their ability to uncouple aerobic metabolic energy costs from the speed of locomotion(1,2), making hopping an economical gait. During the first half of the ground-contact phase, kinetic energy lost from the body is stored as elastic strain energy, predominantly in the hind limbs(3-5). The subsequent recoil returns kinetic and potential energy to the body. Here we show that the allometry of structures in the legs and feet of Macropodoidea is different from that of quadrupedal eutherian mammals. The potential for elastic energy storage in hoppers is shown to stale with strong positive allometry. This is a function of the structural properties of muscle-tendon units in the distal hind limbs and the postures adopted by hopping kangaroos. Our findings demonstrate how the use of tissue elasticity is strongly mass dependent and help explain the observed energetic phenomena.			BENNETT, MB (corresponding author), UNIV QUEENSLAND,DEPT ANAT SCI,ST LUCIA,QLD 4072,AUSTRALIA.		Bennett, Michael/A-7218-2012; Bennett, Michael/L-4483-2019	Bennett, Michael/0000-0001-8051-0040				ALEXANDER RM, 1979, J ZOOL, V187, P169; ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; ALEXANDER RM, 1988, ELASTIC MECHANISMS A; BAUDINETTE RV, 1992, AM J PHYSIOL, V262, pR771, DOI 10.1152/ajpregu.1992.262.5.R771; BENNETT MB, 1987, J ZOOL, V212, P457, DOI 10.1111/j.1469-7998.1987.tb02916.x; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; BENNETT MB, 1995, J ZOOL, V235, P33, DOI 10.1111/j.1469-7998.1995.tb05125.x; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; FARLEY CT, 1993, J EXP BIOL, V185, P71; HERZOG W, 1993, J BIOMECH, V26, P945, DOI 10.1016/0021-9290(93)90056-K; KER RF, 1986, J ZOOL, V208, P417; Murray Peter, 1991, P1071; POLLOCK CM, 1994, AM J PHYSIOL, V266, pR1022, DOI 10.1152/ajpregu.1994.266.3.R1022; THOMPSON SD, 1980, NATURE, V287, P223, DOI 10.1038/287223a0; WINDSOR DE, 1971, J ZOOL LOND, V153, P165	17	76	77	0	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					56	59		10.1038/378056a0	http://dx.doi.org/10.1038/378056a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477284				2022-12-24	WOS:A1995TC46900047
J	SCHEIFFELE, P; PERANEN, J; SIMONS, K				SCHEIFFELE, P; PERANEN, J; SIMONS, K			N-GLYCANS AS APICAL SORTING SIGNALS IN EPITHELIAL-CELLS	NATURE			English	Article							CANINE KIDNEY-CELLS; POLYMERIC IMMUNOGLOBULIN RECEPTOR; MDCK CELLS; PLASMA-MEMBRANE; PROTEINS; SECRETION; SURFACE; EXPRESSION; GLYCOSYLATION; TRANSPORT	IN epithelial Madin-Darby canine kidney (MDCK) cells newly synthesized molecules are sorted in the trans-Golgi network and directly delivered to their apical and basolateral surface destinations(1). Sorting is mediated by signals in the cytoplasmic domains of basolateral transmembrane proteins whereas glycosylphosphatidylinositol-linked proteins have apical sorting information in their glycolipid tails(5,6). Signals for apical transmembrane proteins are thought to reside in their ectodomains, because truncated forms lacking the cytoplasmic tail and the membrane anchor are secreted apically(7,8). Here we demonstrate that carbohydrates act as an apical targeting signal for secretory proteins. Growth hormone, which is non-glycosylated and secreted from both sides of MDCK cell lagers(9), is secreted from the apical side when glycosylated. Thus glycans not only play a general role in protein folding(10) but also appear to function in protein sorting in biosynthetic traffic.	EUROPEAN MOLEC BIOL LAB,CELL BIOL PROGRAMME,D-69112 HEIDELBERG,GERMANY	European Molecular Biology Laboratory (EMBL)				Simons, Kai/0000-0002-9231-9996				BALCAROVASTANDE.J, 1984, EMBO J, V3, P2687; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CORBEIL D, 1992, J BIOL CHEM, V267, P2798; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; FIEDLER K, 1995, CELL, V81, P1; GONZALEZ A, 1993, J BIOL CHEM, V268, P6662; GOTTLIEB TA, 1986, P NATL ACAD SCI USA, V83, P2100, DOI 10.1073/pnas.83.7.2100; GREEN RF, 1981, J CELL BIOL, V89, P230, DOI 10.1083/jcb.89.2.230; GUAN JL, 1985, CELL, V42, P489, DOI 10.1016/0092-8674(85)90106-0; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HUNZIKER W, 1991, CELL, V66, P1; KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222; KONDORKOCH C, 1985, CELL, V43, P297, DOI 10.1016/0092-8674(85)90035-2; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MEISS HK, 1982, MOL CELL BIOL, V2, P1287, DOI 10.1128/MCB.2.10.1287; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MOSTOV KE, 1987, J CELL BIOL, V105, P2031, DOI 10.1083/jcb.105.5.2031; MUSTO NA, 1993, EXP CELL RES, V209, P271, DOI 10.1006/excr.1993.1311; RAGNO P, 1992, EXP CELL RES, V203, P236, DOI 10.1016/0014-4827(92)90060-L; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VOGEL LK, 1992, J BIOL CHEM, V267, P2794; VOGEL LK, 1993, FEBS LETT, V330, P293, DOI 10.1016/0014-5793(93)80891-W; WAGNER M, 1995, EUR J CELL BIOL, V67, P84; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987	30	408	411	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					96	98		10.1038/378096a0	http://dx.doi.org/10.1038/378096a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477300				2022-12-24	WOS:A1995TC46900059
J	CHOW, LC; DITTRICH, HC; SHABETAI, R				CHOW, LC; DITTRICH, HC; SHABETAI, R			ENDOMYOCARDIAL BIOPSY IN PATIENTS WITH UNEXPLAINED CONGESTIVE HEART-FAILURE	ANNALS OF INTERNAL MEDICINE			English	Article									VET ADM MED CTR, 3350 LA JOLLA VILLAGE DR, SAN DIEGO, CA 92161 USA; UNIV CALIF SAN DIEGO, MED CTR, SAN DIEGO, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego					NHLBI NIH HHS [HL 07444] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aretz T., 1986, AM J CARDIOVASC PATH, V1, P3; BAANDRUP U, 1981, BRIT HEART J, V45, P487; BILLINGHAM M, 1987, BRIT HEART J, V58, P6; CASSLING RS, 1985, AM HEART J, V110, P713, DOI 10.1016/0002-8703(85)90447-8; DALY K, 1984, BRIT HEART J, V51, P30, DOI 10.1136/hrt.51.1.30; Das J P, 1981, Indian Heart J, V33, P18; DEC GW, 1985, NEW ENGL J MED, V312, P885, DOI 10.1056/NEJM198504043121404; FENOGLIO JJ, 1983, NEW ENGL J MED, V308, P12, DOI 10.1056/NEJM198301063080103; FIGULLA HR, 1985, CIRCULATION, V71, P1095, DOI 10.1161/01.CIR.71.6.1095; FOWLES RE, 1982, ANN INTERN MED, V97, P885, DOI 10.7326/0003-4819-97-6-885; HOSENPUD JD, 1985, J AM COLL CARDIOL, V6, P797, DOI 10.1016/S0735-1097(85)80485-X; MALL G, 1982, VIRCHOWS ARCH A, V397, P67, DOI 10.1007/BF00430894; MASON JW, 1980, AM J CARDIOL, V45, P1037, DOI 10.1016/0002-9149(80)90174-5; MASON JW, 1985, CIRCULATION, V71, P185, DOI 10.1161/01.CIR.71.2.185; NIPPOLDT TB, 1982, MAYO CLIN PROC, V57, P407; NODA S, 1980, JPN CIRC J, V44, P95, DOI 10.1253/jcj.44.95; OCONNELL JB, 1984, CIRCULATION, V70, P58, DOI 10.1161/01.CIR.70.1.58; OCONNELL JB, 1985, POSTGRAD MED J, V61, P1127, DOI 10.1136/pgmj.61.722.1127; OCONNELL JB, 1986, CURR PROB CARDIOLOGY, V8, P445; PARRILLO JE, 1984, CIRCULATION, V69, P93, DOI 10.1161/01.CIR.69.1.93; SCHOENFELD MH, 1987, CIRCULATION, V75, P1012, DOI 10.1161/01.CIR.75.5.1012; SCHWARZ F, 1983, AM J CARDIOL, V51, P501, DOI 10.1016/S0002-9149(83)80088-5; SEKIGUCHI M, 1985, CIRCULATION, V72, P109; UNVERFERTH BJ, 1983, HUM PATHOL, V14, P974, DOI 10.1016/S0046-8177(83)80177-4; UNVERFERTH DV, 1983, CIRCULATION, V68, P1194, DOI 10.1161/01.CIR.68.6.1194; ZEECHENG CS, 1984, J AM COLL CARDIOL, V3, P63, DOI 10.1016/S0735-1097(84)80431-3	26	63	63	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	1988	109	7					535	539		10.7326/0003-4819-109-7-535	http://dx.doi.org/10.7326/0003-4819-109-7-535			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4157	3421562				2022-12-24	WOS:A1988Q415700005
J	DAVIS, KH; HAWKS, RL; BLANKE, RV				DAVIS, KH; HAWKS, RL; BLANKE, RV			ASSESSMENT OF LABORATORY QUALITY IN URINE DRUG-TESTING - A PROFICIENCY TESTING PILOT-STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,MCV STN,BOX 597,RICHMOND,VA 23298; RES TRIANGLE INST,RES TRIANGLE PK,NC 27709; NIDA,ROCKVILLE,MD	Virginia Commonwealth University; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)					PHS HHS [271-84-4134] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		EDINGER SE, 1984, J MED TECHNOL, V1, P776; FRINGS CS, 1987, CLIN CHEM, V33, P1683; GORDON AJ, 1972, CHEM COMPANION, P485; HANSEN HJ, 1985, JAMA-J AM MED ASSOC, V253, P2382, DOI 10.1001/jama.253.16.2382; Hawks R, 1986, NIDA RES MONOGRAPH; WALSH JM, 1986, ADM861477 US DEP HLT; WILLETTE RE, 1986, NIDA RES MONOGRAPH, V73, P6; 1986, URINE TOXICOLOGY 198	8	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	1988	260	12					1749	1754		10.1001/jama.260.12.1749	http://dx.doi.org/10.1001/jama.260.12.1749			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q1001	3411757				2022-12-24	WOS:A1988Q100100027
J	HAJEK, P; JACKSON, P; BELCHER, M				HAJEK, P; JACKSON, P; BELCHER, M			LONG-TERM USE OF NICOTINE CHEWING GUM - OCCURRENCE, DETERMINANTS, AND EFFECT ON WEIGHT-GAIN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note											HAJEK, P (corresponding author), UNIV LONDON,INST PSYCHIAT,ADDICT RES UNIT,101 DENMARK HILL,LONDON SE5 8AF,ENGLAND.							BLITZER PH, 1977, J CHRON DIS, V30, P415, DOI 10.1016/0021-9681(77)90035-2; EMONT SL, 1987, ADDICT BEHAV, V12, P151, DOI 10.1016/0306-4603(87)90021-9; FAGERSTROM KO, 1987, ADDICT BEHAV, V12, P91, DOI 10.1016/0306-4603(87)90015-3; FEYERABEND C, 1979, J PHARM PHARMACOL, V31, P73; GRUNBERG NE, 1985, BRIT J ADDICT, V80, P369; HAJEK P, 1985, BRIT J CLIN PSYCHOL, V24, P289, DOI 10.1111/j.2044-8260.1985.tb00661.x; HALL SM, 1986, J CONSULT CLIN PSYCH, V54, P342, DOI 10.1037/0022-006X.54.3.342; HJALMARSON AIM, 1984, JAMA-J AM MED ASSOC, V252, P2835, DOI 10.1001/jama.252.20.2835; HUGHES JR, 1986, JAMA-J AM MED ASSOC, V255, P3277, DOI 10.1001/jama.255.23.3277; JACKSON PH, 1986, PREV MED, V15, P244, DOI 10.1016/0091-7435(86)90044-7; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; JARVIS MJ, 1980, BRIT MED J, V281, P484, DOI 10.1136/bmj.281.6238.484; JARVIS MJ, 1982, BRIT MED J, V285, P537, DOI 10.1136/bmj.285.6341.537; LAM W, 1987, LANCET, V2, P27; MCNABB ME, 1982, JAMA-J AM MED ASSOC, V248, P865, DOI 10.1001/jama.248.7.865; RAW M, 1980, BRIT MED J, V281, P481, DOI 10.1136/bmj.281.6238.481; RUSSELL MAH, 1983, BRIT MED J, V287, P1782, DOI 10.1136/bmj.287.6407.1782; RUSSELL MAH, 1976, BRIT MED J, V1, P1043, DOI 10.1136/bmj.1.6017.1043; RUSSELL MAH, 1974, J ROY STAT SOC A STA, V137, P313, DOI 10.2307/2344953; STITZER ML, 1988, NICOTINE REPLACEMENT, P163; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; TONNESEN P, 1988, ADDICT BEHAV, V13, P17, DOI 10.1016/0306-4603(88)90021-4; WEST RJ, 1985, PSYCHOL MED, V15, P891, DOI 10.1017/S0033291700005134; WEST RJ, 1985, PSYCHOPHARMACOLOGY, V87, P334, DOI 10.1007/BF00432717; WEST RJ, 1986, PSYCHOPHARMACOLOGY, V89, P189, DOI 10.1007/BF00310627	25	85	85	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	1988	260	11					1593	1596		10.1001/jama.260.11.1593	http://dx.doi.org/10.1001/jama.260.11.1593			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9650	3411739				2022-12-24	WOS:A1988P965000029
J	HERZOG, DB; COPELAND, PM				HERZOG, DB; COPELAND, PM			BULIMIA NERVOSA - PSYCHE AND SATIETY	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											HERZOG, DB (corresponding author), MASSACHUSETTS GEN HOSP,BOSTON,MA 02114, USA.							GERACIOTI TD, 1988, NEW ENGL J MED, V319, P683, DOI 10.1056/NEJM198809153191105; HERZOG DB, 1985, NEW ENGL J MED, V313, P295, DOI 10.1056/NEJM198508013130505; HEUFELDER A, 1985, J CLIN ENDOCR METAB, V61, P1053, DOI 10.1210/jcem-61-6-1053; HEWSON G, 1988, BRIT J PHARMACOL, V93, P79, DOI 10.1111/j.1476-5381.1988.tb11407.x; JONAS JM, 1987, PSYCHOBIOLOGY BULIMI, P115; KAYE WH, 1984, AM J PSYCHIAT, V141, P1598; KAYE WH, 1988, PSYCHIAT RES, V23, P31, DOI 10.1016/0165-1781(88)90032-7; KELLER MB, IN PRESS ARCH GEN PS; KEYS A, 1950, BIOL HUMAN STARVATIO, P846; LEIBOWITZ SF, 1986, FASEB J, V45, P1396; MITCHELL JE, 1986, BIOL PSYCHIAT, V21, P1399, DOI 10.1016/0006-3223(86)90331-8; MORLEY JE, 1987, ENDOCR REV, V8, P256, DOI 10.1210/edrv-8-3-256; SHIH WJ, 1987, EUR J NUCL MED, V13, P192; WURTMAN JJ, 1979, LIFE SCI, V24, P895, DOI 10.1016/0024-3205(79)90339-4	14	7	7	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	1988	319	11					716	718		10.1056/NEJM198809153191110	http://dx.doi.org/10.1056/NEJM198809153191110			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q0375	3412390				2022-12-24	WOS:A1988Q037500010
J	LABBE, JC; LEE, MG; NURSE, P; PICARD, A; DOREE, M				LABBE, JC; LEE, MG; NURSE, P; PICARD, A; DOREE, M			ACTIVATION AT M-PHASE OF A PROTEIN-KINASE ENCODED BY A STARFISH HOMOLOG OF THE CELL-CYCLE CONTROL GENE CDC2+	NATURE			English	Article									INSERM,F-34033 MONTPELLIER,FRANCE; UNIV OXFORD,DEPT BIOCHEM,MICROBIOL UNIT,IMPERIAL CANC RES FUND,CELL CYCLE CONTROL LAB,OXFORD OX1 3QU,ENGLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Oxford	LABBE, JC (corresponding author), CNRS,BP 5051,F-34033 MONTPELLIER,FRANCE.		labbe, jean-claude/B-2277-2009					BEACH D, 1982, NATURE, V300, P706, DOI 10.1038/300706a0; BRADBURY EM, 1974, NATURE, V247, P257, DOI 10.1038/247257a0; CAPONY JP, 1986, DEV BIOL, V117, P1, DOI 10.1016/0012-1606(86)90342-8; DABAUVALLE MC, 1988, CELL, V52, P525, DOI 10.1016/0092-8674(88)90465-5; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GUERRIER P, 1977, MOL CELL ENDOCRINOL, V7, P137, DOI 10.1016/0303-7207(77)90063-6; KANATANI H, 1969, NATURE, V211, P273; LABBE JC, IN PRESS DEV BIOL; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; PELECH SL, 1987, BIOCHEMISTRY-US, V26, P7960, DOI 10.1021/bi00398a062; PICARD A, 1985, DEV BIOL, V109, P311, DOI 10.1016/0012-1606(85)90458-0; PICARD A, 1987, DEV GROWTH DIFFER, V29, P93; QUIRINSTRICKER C, 1984, EUR J BIOCHEM, V142, P317, DOI 10.1111/j.1432-1033.1984.tb08288.x; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; RUSSELL P, 1987, CELL, V49, P469; SANO K, 1985, DEV GROWTH DIFFER, V27, P262; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; TASHEVA B, 1983, ANAL BIOCHEM, V129, P98, DOI 10.1016/0003-2697(83)90057-X; WITT JJ, 1975, ANAL BIOCHEM, V66, P253, DOI 10.1016/0003-2697(75)90743-5	23	295	298	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 15	1988	335	6187					251	254		10.1038/335251a0	http://dx.doi.org/10.1038/335251a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0477	3412486				2022-12-24	WOS:A1988Q047700059
J	LAKEBAKAAR, G; TOM, W; LAKEBAKAAR, D; GUPTA, N; BEIDAS, S; ELSAKR, M; STRAUS, E				LAKEBAKAAR, G; TOM, W; LAKEBAKAAR, D; GUPTA, N; BEIDAS, S; ELSAKR, M; STRAUS, E			GASTROPATHY AND KETOCONAZOLE MALABSORPTION IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)	ANNALS OF INTERNAL MEDICINE			English	Article									ASTRA RES CTR,S-15185 SODERTALJE,SWEDEN		LAKEBAKAAR, G (corresponding author), SUNY HLTH SCI CTR,BOX 1196,450 CLARKSON AVE,BROOKLYN,NY 11203, USA.							BRASS C, 1979, ANTIMICROB AGENTS CH, V15, P763, DOI 10.1128/AAC.15.6.763; DANESHMEND TK, 1984, ANTIMICROB AGENTS CH, V25, P1, DOI 10.1128/AAC.25.1.1; DANESHMEND TK, 1981, J ANTIMICROB CHEMOTH, V8, P299, DOI 10.1093/jac/8.4.299; HOLBROOK WP, 1979, POSTGRAD MED J, V55, P692, DOI 10.1136/pgmj.55.647.692; KOTLER DP, 1984, ANN INTERN MED, V101, P421, DOI 10.7326/0003-4819-101-4-421; LAKEBAKAAR G, 1988, ANN INTERN MED, V109, P471, DOI 10.7326/0003-4819-109-6-471; LAKEBAKAAR G, 1987, GASTROENTEROLOGY, V92, P1488; LELAWONGS P, 1988, CLIN PHARMACY, V7, P228; MAKSYMIUK AW, 1982, ANTIMICROB AGENTS CH, V22, P43, DOI 10.1128/AAC.22.1.43; TAVITIAN A, 1986, GASTROENTEROLOGY, V90, P443, DOI 10.1016/0016-5085(86)90946-7; 1985, PHYSICIANS DESK REFE, P1038; 1985, MMWR, V34, P373	12	188	188	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572	0003-4819			ANN INTERN MED	Ann. Intern. Med.	SEP 15	1988	109	6					471	473		10.7326/0003-4819-109-6-471	http://dx.doi.org/10.7326/0003-4819-109-6-471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2568	3415107				2022-12-24	WOS:A1988Q256800007
J	KOTWAL, GJ; MOSS, B				KOTWAL, GJ; MOSS, B			VACCINIA VIRUS ENCODES A SECRETORY POLYPEPTIDE STRUCTURALLY RELATED TO COMPLEMENT CONTROL PROTEINS	NATURE			English	Article											KOTWAL, GJ (corresponding author), NIAID,VIRAL DIS LAB,BETHESDA,MD 20892, USA.			Moss, Bernard/0000-0002-2154-8564				BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363; BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113; CHUNG LP, 1985, BIOCHEM J, V230, P133, DOI 10.1042/bj2300133; DEFILIPPES FM, 1982, J VIROL, V43, P136, DOI 10.1128/JVI.43.1.136-149.1982; KING CS, 1986, MOL CELL BIOL, V6, P332, DOI 10.1128/MCB.6.1.332; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MCCRAE MA, 1978, J VIROL, V28, P828, DOI 10.1128/JVI.28.3.828-834.1978; MOSS B, 1981, J VIROL, V40, P387, DOI 10.1128/JVI.40.2.387-395.1981; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; REISNER AH, 1985, NATURE, V313, P801, DOI 10.1038/313801a0; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1; TWARDZIK DR, 1985, P NATL ACAD SCI USA, V82, P5300, DOI 10.1073/pnas.82.16.5300; VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	17	307	331	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 8	1988	335	6186					176	178		10.1038/335176a0	http://dx.doi.org/10.1038/335176a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9647	3412473	Green Published			2022-12-24	WOS:A1988P964700059
J	BALDINO, F; OKANE, TM; FITZPATRICKMCELLIGOTT, S; WOLFSON, B				BALDINO, F; OKANE, TM; FITZPATRICKMCELLIGOTT, S; WOLFSON, B			COORDINATE HORMONAL AND SYNAPTIC REGULATION OF VASOPRESSIN MESSENGER-RNA	SCIENCE			English	Article									DUPONT CO,DEPT MED PROD,EXPTL STN,WILMINGTON,DE 19898	DuPont								ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; DAVIS LG, 1986, P NATL ACAD SCI USA, V83, P1145, DOI 10.1073/pnas.83.4.1145; GILLIES GE, 1982, NATURE, V299, P355, DOI 10.1038/299355a0; HOUYU A, 1982, J HISTOCHEM CYTOCHEM, V30, P1249, DOI 10.1177/30.12.6185560; KISS JZ, 1984, P NATL ACAD SCI-BIOL, V81, P1854, DOI 10.1073/pnas.81.6.1854; LEWIS ME, 1986, J NEUROSCI RES, V16, P117, DOI 10.1002/jnr.490160112; OLDFIELD BJ, 1985, BRAIN RES BULL, V14, P143, DOI 10.1016/0361-9230(85)90074-7; PITTMAN QJ, 1981, BRAIN RES, V215, P5; POULAIN DA, 1980, NEUROSCIENCE, V5, P379, DOI 10.1016/0306-4522(80)90113-X; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; ROTH KA, 1982, LIFE SCI, V31, P1957; SALVIATI G, 1986, NATURE, V322, P637, DOI 10.1038/322637a0; SAPHIER D, 1987, NEUROSCIENCE, V20, P749, DOI 10.1016/0306-4522(87)90238-7; SAWCHENKO PE, 1984, P NATL ACAD SCI-BIOL, V81, P1883, DOI 10.1073/pnas.81.6.1883; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; SEGGIE J, 1974, NEUROENDOCRINOLOGY, V16, P225, DOI 10.1159/000122568; SILVERMAN AJ, 1984, PEPTIDES, V5, P139, DOI 10.1016/0196-9781(84)90272-9; SILVERMAN AJ, 1981, BRAIN RES BULL, V6, P47, DOI 10.1016/S0361-9230(81)80068-8; TRAMU G, 1983, NEUROENDOCRINOLOGY, V37, P467, DOI 10.1159/000123595; TRIBOLLET E, 1981, NEUROSCIENCE, V6, P1315, DOI 10.1016/0306-4522(81)90190-1; WALICKE PA, 1977, P NATL ACAD SCI US, V74, P5867; WOLFSON B, 1985, NATURE, V315, P59, DOI 10.1038/315059a0	22	64	64	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 19	1988	241	4868					978	981		10.1126/science.3406747	http://dx.doi.org/10.1126/science.3406747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7065	3406747				2022-12-24	WOS:A1988P706500039
J	DOHERTY, VR; MACKIE, RM				DOHERTY, VR; MACKIE, RM			EXPERIENCE OF A PUBLIC-EDUCATION PROGRAM ON EARLY DETECTION OF CUTANEOUS MALIGNANT-MELANOMA	BRITISH MEDICAL JOURNAL			English	Article									UNIV GLASGOW,DEPT DERMATOL,GLASGOW G12 8QQ,SCOTLAND	University of Glasgow								ARUNDELL FD, 1986, JAMA-J AM MED ASSOC, V255, P2443, DOI 10.1001/jama.1986.03370180069016; BRESLOW A, 1979, J CUTAN PATHOL, V6, P208, DOI 10.1111/j.1600-0560.1979.tb01125.x; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; CASSILETH BR, 1982, CANCER-AM CANCER SOC, V49, P198, DOI 10.1002/1097-0142(19820101)49:1<198::AID-CNCR2820490138>3.0.CO;2-9; DOHERTY VR, 1986, BRIT MED J, V292, P987, DOI 10.1136/bmj.292.6526.987; ELDH J, 1985, CUTANEOUS MELANOMA, P473; FIELD SI, 1987, J AM ACAD DERMATOL, V16, P578, DOI 10.1016/S0190-9622(87)70077-2; KOPF AW, 1987, CANCER, V59, P1236, DOI 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I; KOPF AW, 1984, J AM ACAD DERMATOL, V11, P674, DOI 10.1016/S0190-9622(84)70225-8; MACKIE RM, 1985, LANCET, V2, P859; MCLEOD GR, 1988, PIGMENT CELL, V9, P133; OLSEN TG, 1987, J AM ACAD DERMATOL, V16, P637; SCHREIBER MM, 1981, ARCH DERMATOL, V117, P6, DOI 10.1001/archderm.117.1.6; SWERDLOW AJ, 1984, CLINICAL ONCOLOGY MONOGRAPHS, V3, P407; TEMOSHOK L, 1984, CANCER, V54, P3048, DOI 10.1002/1097-0142(19841215)54:12<3048::AID-CNCR2820541239>3.0.CO;2-M; URIST MM, 1985, CANCER-AM CANCER SOC, V55, P1398, DOI 10.1002/1097-0142(19850315)55:6<1398::AID-CNCR2820550639>3.0.CO;2-A	16	109	109	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					388	391		10.1136/bmj.297.6645.388	http://dx.doi.org/10.1136/bmj.297.6645.388			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P5450	3408978	Bronze, Green Published			2022-12-24	WOS:A1988P545000019
J	VAIRA, D; HOLTON, J; CAIRNS, SR; FALZON, M; POLYDOROU, A; DOWSETT, JF; SALMON, PR				VAIRA, D; HOLTON, J; CAIRNS, SR; FALZON, M; POLYDOROU, A; DOWSETT, JF; SALMON, PR			ANTIBODY-TITERS TO CAMPYLOBACTER PYLORI AFTER TREATMENT FOR GASTRITIS	BMJ-BRITISH MEDICAL JOURNAL			English	Article									MIDDLESEX HOSP, MICROBIOL, LONDON W1N 8AA, ENGLAND; MIDDLESEX HOSP, HISTOPATHOL, LONDON W1N 8AA, ENGLAND	University of London; University College London; University of London; University College London	VAIRA, D (corresponding author), MIDDLESEX HOSP, GASTROENTEROL, LONDON W1N 8AA, ENGLAND.							LANGENBERG ML, 1985, CAMPYLOBACTER, V3, P162; MCNULTY CAM, 1986, BRIT MED J, V293, P645, DOI 10.1136/bmj.293.6548.645; RATHBONE BJ, 1986, GUT, V27, P642, DOI 10.1136/gut.27.6.642; VAIRA D, 1988, J CLIN PATHOL, V41, P812, DOI 10.1136/jcp.41.3.355-b	4	66	66	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	1988	297	6645					397	397		10.1136/bmj.297.6645.397	http://dx.doi.org/10.1136/bmj.297.6645.397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408982	Bronze, Green Published			2022-12-24	WOS:A1988P545000023
J	ROENNEBERG, T; NAKAMURA, H; HASTINGS, JW				ROENNEBERG, T; NAKAMURA, H; HASTINGS, JW			CREATINE ACCELERATES THE CIRCADIAN CLOCK IN A UNICELLULAR ALGA	NATURE			English	Article									HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138	Harvard University	ROENNEBERG, T (corresponding author), HARVARD UNIV,DEPT CELLULAR & DEV BIOL,16 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							ATKINSON DE, 1971, ADV ENZYME REGUL, V9, P207; BESSMAN SP, 1966, BIOCHEM BIOPH RES CO, V22, P597, DOI 10.1016/0006-291X(66)90317-2; BESSMAN SP, 1987, ANAL BIOCHEM, V161, P519, DOI 10.1016/0003-2697(87)90483-0; BRUCE VG, 1960, J CELL COMPAR PHYSL, V56, P25, DOI 10.1002/jcp.1030560105; CORRENT G, 1982, AM J PHYSIOL, V11, pR333; DELMER DP, 1975, J BACTERIOL, V121, P548, DOI 10.1128/JB.121.2.548-553.1975; ENRIGHT JT, 1971, Z VERGL PHYSIOL, V75, P332, DOI 10.1007/BF00340685; FELDMAN JF, 1967, P NATL ACAD SCI USA, V57, P1080, DOI 10.1073/pnas.57.4.1080; Hastings J.W., 1985, TEMPORAL ORDER, P213; Hastings J. Woodland, 1976, MOL BASIS CIRCADIAN; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; JOHNSON CH, 1986, AM SCI, V74, P29; KARAKASHIAN MW, 1963, J GEN PHYSIOL, V47, P1, DOI 10.1085/jgp.47.1.1; KONDO T, UNPUB J BIOL RHYTH; KONDO T, UNPUB PL PHYSL; LOIKE JD, 1986, AM J PHYSIOL, V251, pC128, DOI 10.1152/ajpcell.1986.251.1.C128; LOIKE JD, IN PRESS P NATN ACAD; MCDANIEL M, 1974, P NATL ACAD SCI USA, V71, P4389, DOI 10.1073/pnas.71.11.4389; MCMURRY L, 1972, SCIENCE, V175, P1137, DOI 10.1126/science.175.4026.1137; NJUS D, 1981, CELL BIOPHYS, V3, P223, DOI 10.1007/BF02782625; RALPH MR, 1985, BRAIN RES, V325, P362, DOI 10.1016/0006-8993(85)90341-5; ROTHMAN BS, 1976, J GEN PHYSIOL, V68, P359, DOI 10.1085/jgp.68.4.359; SCHMID HP, 1986, J INTERDISCIPL CYCLE, V16, P324; TAYLOR W, 1979, J COMP PHYSIOL, V130, P359, DOI 10.1007/BF00689855; TAYLOR W, 1982, J INTERDISCIPL CYCLE, V13, P71, DOI 10.1080/09291018209359765; TAYLOR W, 1979, J COMP PHYSIOL, V130, P355, DOI 10.1007/BF00689854; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; TUREK FW, 1986, NATURE, V321, P167, DOI 10.1038/321167a0; WAGNER E, 1974, BER DEUT BOT GES, V87, P291; WAGNER E, 1976, MOL BASIS CIRCADIAN, P215	30	39	39	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					432	434		10.1038/334432a0	http://dx.doi.org/10.1038/334432a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	3405289				2022-12-24	WOS:A1988P529200059
J	GLASS, CK; HOLLOWAY, JM; DEVARY, OV; ROSENFELD, MG				GLASS, CK; HOLLOWAY, JM; DEVARY, OV; ROSENFELD, MG			THE THYROID-HORMONE RECEPTOR BINDS WITH OPPOSITE TRANSCRIPTIONAL EFFECTS TO A COMMON SEQUENCE MOTIF IN THYROID-HORMONE AND ESTROGEN RESPONSE ELEMENTS	CELL			English	Article									UNIV CALIF SAN DIEGO,SCH MED,DEPT CHEM,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,SCH MED,HOWARD HUGHES MED INST,LA JOLLA,CA 92093	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	GLASS, CK (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,EUKARYOTIC REGULATORY BIOL PROGRAM,M-013,LA JOLLA,CA 92093, USA.		Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592				ADLER S, 1988, CELL, V52, P685, DOI 10.1016/0092-8674(88)90406-0; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NELSON C, 1986, NATURE, V322, P557, DOI 10.1038/322557a0; PEALE FV, 1988, P NATL ACAD SCI USA, V85, P1038, DOI 10.1073/pnas.85.4.1038; Ptashne M., 1986, A GENETIC SWITCH; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHEIDEREIT C, 1986, DNA-J MOLEC CELL BIO, V5, P383, DOI 10.1089/dna.1986.5.383; SHUPNIK MA, 1985, J BIOL CHEM, V260, P2900; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SILVA ES, 1977, J BIOL CHEM, V252, P6799; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14; WEATHERHILL PJ, 1988, IN PRESS J STEROID B; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	41	638	647	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 29	1988	54	3					313	323		10.1016/0092-8674(88)90194-8	http://dx.doi.org/10.1016/0092-8674(88)90194-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P5747	3396073				2022-12-24	WOS:A1988P574700004
J	MCCARTER, L; HILMEN, M; SILVERMAN, M				MCCARTER, L; HILMEN, M; SILVERMAN, M			FLAGELLAR DYNAMOMETER CONTROLS SWARMER CELL-DIFFERENTIATION OF V-PARAHAEMOLYTICUS	CELL			English	Article											MCCARTER, L (corresponding author), AGOURON INST,505 COAST BLVD S,LA JOLLA,CA 92037, USA.							ALLEN RD, 1971, J BACTERIOL, V107, P295, DOI 10.1128/JB.107.1.295-302.1971; AMES GFL, 1974, J BIOL CHEM, V249, P634; BELAS MR, 1982, J BACTERIOL, V151, P1568, DOI 10.1128/JB.151.3.1568-1580.1982; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; De Boer W. E., 1975, NETH J SEA RES, V9, P197; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GUTIERREZ C, 1987, J MOL BIOL, V195, P289, DOI 10.1016/0022-2836(87)90650-4; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; MENDELSON NH, 1982, MICROBIOL REV, V46, P341, DOI 10.1128/MMBR.46.3.341-375.1982; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; SHINODA S, 1974, J BACTERIOL, V120, P923, DOI 10.1128/JB.120.2.923-928.1974; SHINODA S, 1977, J BACTERIOL, V129, P1266, DOI 10.1128/JB.129.3.1266-1271.1977; SILVERMAN M, 1977, ANNU REV MICROBIOL, V31, P397, DOI 10.1146/annurev.mi.31.100177.002145; ULITZUR S, 1973, ARCH MIKROBIOL, V94, P331, DOI 10.1007/BF00769028	22	226	226	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 29	1988	54	3					345	351		10.1016/0092-8674(88)90197-3	http://dx.doi.org/10.1016/0092-8674(88)90197-3			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P5747	3396074				2022-12-24	WOS:A1988P574700007
J	Vakil, NB; Schwartz, SM; Buggy, BP; Brummitt, CF; Kherellah, M; Letzer, DM; Gilson, IH; Jones, PG				Vakil, NB; Schwartz, SM; Buggy, BP; Brummitt, CF; Kherellah, M; Letzer, DM; Gilson, IH; Jones, PG			Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; SCLEROSING CHOLANGITIS; CHOLANGIOPATHY; VIRUS; SPECTRUM; DISEASE	Background. In March 1993, the municipal water supply in Milwaukee became contaminated with cruptosporidium and a widespread outbreak of cryptosporidiosis occurred. Methods. We retrospectively studied the relations among the clinical presentation, CD4 count, and survival in a group of 82 patients infected with the human immunodeficiency virus (HIV) in whom cryptosporidiosis developed during the outbreak. Infection was documented by the finding of cryptosporidium in stool. Results. There was a sharp increase in the number of HIV-infected patients with cryptosporidiosis after the period of water contamination. Four of 24 patients with biliary symptoms (17 percent) and 30 of 58 without biliary symptoms (52 percent) were alive one year after the outbreak (P = 0.003). Twenty-one of the patients with biliary symptoms had CD4 counts less than or equal to 50 per cubic millimeter, as compared with 36 of 57 patients without biliary symptoms (88 percent vs. 63 percent, P = 0.03). The CD4 count was not available for one patient in the latter group, Within one year, 41 of the patients with CD4 counts less than or equal to 50 per cubic millimeter had died, as compared with 6 of those with higher counts (72 percent vs. 25 percent, P < 0.001). After adjustment for the CD4 count, independent predictors of death were older age and the presence of nausea and vomiting. Conclusions, When HIV-infected patients are exposed to cryptosporidium, those with CD4 counts less than or equal to 50 per cubic millimeter are at increased risk for biliary symptoms and for death within one year after the infection. (C) 1996, Massachusetts Medical Society.	MED COLL WISCONSIN,MILWAUKEE,WI 53226	Medical College of Wisconsin	Vakil, NB (corresponding author), UNIV WISCONSIN,SCH MED,SINAI SAMARITAN MED CTR,DEPT MED,MILWAUKEE CAMPUS,945 N 12TH ST,RM A 324,MILWAUKEE,WI 53233, USA.							ARMITAGE P, 1987, STATISTICAL METHODS; BENATOR DA, 1994, ANN INTERN MED, V121, P663, DOI 10.7326/0003-4819-121-9-199411010-00006; BENHAMOU Y, 1993, DIGEST DIS SCI, V38, P1113, DOI 10.1007/BF01295729; BERKELMAN RL, 1994, SCIENCE, V264, P368, DOI 10.1126/science.8153621; BOUCHE H, 1993, J HEPATOL, V17, P34, DOI 10.1016/S0168-8278(05)80518-5; CELLO JP, 1989, AM J MED, V86, P539, DOI 10.1016/0002-9343(89)90381-1; CHAN MF, 1992, HEPATOLOGY, V16, pA127; COX DR, 1972, J R STAT SOC B, V34, P187; FLANIGAN T, 1992, ANN INTERN MED, V116, P840, DOI 10.7326/0003-4819-116-10-840; FORBES A, 1993, GUT, V34, P116, DOI 10.1136/gut.34.1.116; GODWIN TA, 1991, HUM PATHOL, V22, P1215, DOI 10.1016/0046-8177(91)90103-V; HAYES EB, 1989, NEW ENGL J MED, V320, P1372, DOI 10.1056/NEJM198905253202103; KAVIN H, 1986, ANN INTERN MED, V104, P53, DOI 10.7326/0003-4819-104-1-53; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; MARGULIS SJ, 1986, ANN INTERN MED, V105, P207, DOI 10.7326/0003-4819-105-2-207; PETERSEN C, 1992, CLIN INFECT DIS, V15, P903, DOI 10.1093/clind/15.6.903; PITLIK SD, 1983, ARCH INTERN MED, V143, P2269, DOI 10.1001/archinte.143.12.2269; POL S, 1993, NEW ENGL J MED, V328, P95, DOI 10.1056/NEJM199301143280204; RICHARDSON AJ, 1991, EPIDEMIOL INFECT, V107, P485, DOI 10.1017/S0950268800049189; SCHNEIDERMAN DJ, 1987, ANN INTERN MED, V106, P546, DOI 10.7326/0003-4819-106-4-546; SOAVE R, 1984, ANN INTERN MED, V100, P504, DOI 10.7326/0003-4819-100-4-504; WHITE AC, 1994, J INFECT DIS, V170, P419, DOI 10.1093/infdis/170.2.419	22	109	117	1	10	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1996	334	1					19	23		10.1056/NEJM199601043340104	http://dx.doi.org/10.1056/NEJM199601043340104			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM482	7494565				2022-12-24	WOS:A1996TM48200004
J	BONE, RC				BONE, RC			ANOTHER TASTE OF LEMONADE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1656	1656		10.1001/jama.274.21.1656	http://dx.doi.org/10.1001/jama.274.21.1656			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH151	7474255				2022-12-24	WOS:A1995TH15100001
J	NISSEN, P; KJELDGAARD, M; THIRUP, S; POLEKHINA, G; RESHETNIKOVA, L; CLARK, BFC; NYBORG, J				NISSEN, P; KJELDGAARD, M; THIRUP, S; POLEKHINA, G; RESHETNIKOVA, L; CLARK, BFC; NYBORG, J			CRYSTAL-STRUCTURE OF THE TERNARY COMPLEX OF PHE-TRNA(PHE), EF-TU, AND A GTP ANALOG	SCIENCE			English	Article							ELONGATION-FACTOR-TU; AMINOACYL-TRANSFER-RNA; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTALLOGRAPHIC REFINEMENT; BINDING-SITE; PROTEIN; YEAST; RESOLUTION; RIBOSOME	The structure of the ternary complex consisting of yeast phenylalanyl-transfer RNA (Phe-tRNA(Phe)), Thermus aquaticus elongation factor Tu (EF-Tu), and the guanosine triphosphate (GTP) analog GDPNP was determined by x-ray crystallography at 2.7 angstrom resolution. The ternary complex participates in placing the amino acids in their correct order when messenger RNA is translated into a protein sequence on the ribosome. The EF-Tu-GDPNP component binds to one side of the acceptor helix of Phe-tRNA(Phe) involving all three domains of EF-Tu. Binding sites for the phenylalanylated CCA end and the phosphorylated 5' end are located at domain interfaces, whereas the T stem interacts with the surface of the beta-barrel domain 3. The binding involves many conserved residues in EF-Tu. The overall shape of the ternary complex is similar to that of the translocation factor, EF-G-GDP, and this suggests a novel mechanism involving ''molecular mimicry'' in the translational apparatus.	AARHUS UNIV, INST CHEM, DEPT BIOSTRUCT CHEM, DK-8000 AARHUS C, DENMARK; RUSSIAN ACAD SCI, VA ENGELHARDT MOLEC BIOL INST, MOSCOW 117984, RUSSIA	Aarhus University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS			Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628; Thirup, Soren/0000-0002-0061-7137				Abrahams Jan Pieter, 1992, Spectroscopy (Amsterdam), V10, P1; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; ANDERSEN C, 1994, EUR J BIOCHEM, V220, P739, DOI 10.1111/j.1432-1033.1994.tb18674.x; ANTONSSON B, 1984, EUR J BIOCHEM, V141, P483, DOI 10.1111/j.1432-1033.1984.tb08218.x; ANTONSSON B, 1986, BIOCHEMISTRY-US, V25, P3655, DOI 10.1021/bi00360a027; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3578; BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; CANTOR CR, 1979, TRANSFER RNA STRUCTU, P363; Clark Brian F. C., 1995, P423; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; COTTRELLE P, 1985, J BIOL CHEM, V260, P3090; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; DINCBAS V, 1995, FEBS LETT, V357, P19, DOI 10.1016/0014-5793(94)01318-U; DOUDNA JA, 1995, P NATL ACAD SCI USA, V92, P2355, DOI 10.1073/pnas.92.6.2355; EHRENBERG M, 1990, J MOL BIOL, V211, P739, DOI 10.1016/0022-2836(90)90074-V; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FAULHAMMER HG, 1987, FEBS LETT, V217, P203, DOI 10.1016/0014-5793(87)80664-6; FORSTER C, 1994, P NATL ACAD SCI USA, V91, P4254, DOI 10.1073/pnas.91.10.4254; FORSTER C, 1993, BIOCHIMIE, V75, P1159, DOI 10.1016/0300-9084(93)90015-K; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; GIRSHOVICH AS, 1986, FEBS LETT, V197, P192, DOI 10.1016/0014-5793(86)80325-8; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; JACK A, 1976, J MOL BIOL, V108, P619, DOI 10.1016/S0022-2836(76)80109-X; JONAK J, 1994, FEBS LETT, V343, P94, DOI 10.1016/0014-5793(94)80614-4; JONAK J, 1984, EUR J BIOCHEM, V144, P295, DOI 10.1111/j.1432-1033.1984.tb08463.x; JONES MD, 1980, EUR J BIOCHEM, V108, P507, DOI 10.1111/j.1432-1033.1980.tb04748.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIESEWETTER S, 1990, NUCLEIC ACIDS RES, V18, P4677, DOI 10.1093/nar/18.16.4677; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LANGER JA, 1986, J MOL BIOL, V187, P617, DOI 10.1016/0022-2836(86)90339-6; LEBERMAN R, 1995, FEBS LETT, V358, P71, DOI 10.1016/0014-5793(94)01398-K; LIM V, 1992, NUCLEIC ACIDS RES, V20, P2627, DOI 10.1093/nar/20.11.2627; LOUIE A, 1984, J BIOL CHEM, V259, P5010; METZBOUTIGUE MH, 1989, FEBS LETT, V245, P194, DOI 10.1016/0014-5793(89)80220-0; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MURZIN AG, 1995, NAT STRUCT BIOL, V2, P25, DOI 10.1038/nsb0195-25; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NIERHAUS KH, 1993, TRANSLATIONAL APPARATUS, P263; NISSEN P, 1994, FEBS LETT, V356, P165, DOI 10.1016/0014-5793(94)01254-7; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OSTERBERG R, 1981, EUR J BIOCHEM, V117, P155; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; OTWINOWSKI Z, 1993, CCP4 STUDY WEEKEND D; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PINGOUD A, 1982, J BIOL CHEM, V257, P1261; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SCOBLE J, 1994, BIOCHIMIE, V76, P59, DOI 10.1016/0300-9084(94)90063-9; SHULMAN RG, 1974, J MOL BIOL, V90, P601, DOI 10.1016/0022-2836(74)90237-X; SPURIO R, 1993, TRANSLATIONAL APPARATUS, P241; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; THIRUP S, 1990, PROTEINS, V7, P291, DOI 10.1002/prot.340070310; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; TRONRUD DE, 1992, ACTA CRYSTALLOGR A, V48, P912, DOI 10.1107/S0108767392005415; VANNOORT JM, 1985, P NATL ACAD SCI USA, V82, P3212, DOI 10.1073/pnas.82.10.3212; VANNOORT JM, 1984, P NATL ACAD SCI-BIOL, V81, P3969; VOSS RH, 1992, EUR J BIOCHEM, V207, P839, DOI 10.1111/j.1432-1033.1992.tb17115.x; WEIJLAND A, 1994, TRENDS BIOCHEM SCI, V19, P188, DOI 10.1016/0968-0004(94)90018-3; WIKMAN FP, 1982, EMBO J, V1, P1095, DOI 10.1002/j.1460-2075.1982.tb01302.x; Yarus Michael, 1995, P443; 1979, CCP4 DAR LAB	77	787	803	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	1995	270	5241					1464	1472		10.1126/science.270.5241.1464	http://dx.doi.org/10.1126/science.270.5241.1464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491491				2022-12-24	WOS:A1995TH37500030
J	TAYLOR, MFJ; SHEN, Y; KREITMAN, ME				TAYLOR, MFJ; SHEN, Y; KREITMAN, ME			A POPULATION GENETIC TEST OF SELECTION AT THE MOLECULAR-LEVEL	SCIENCE			English	Article							INSECTICIDE RESISTANCE; HELIOTHIS-VIRESCENS; DROSOPHILA-MELANOGASTER; TOBACCO BUDWORM; LEPIDOPTERA; NOCTUIDAE; POLYMORPHISMS; PATTERNS; LOCUS	The role of natural selection in molecular evolution has been inferred primarily by rejection of null hypotheses based on neutral theory, rather than by acceptance of specific predictions based on selection. In this report, a population genetic lest of a specific prediction for selection on DNA polymorphism is presented. Pyrethroid insecticide use constitutes an experiment for which form of selection and molecular target (voltage-gated sodium channels) are both known. As predicted, differential pyrethroid selection on tobacco budworm populations generated significant geographic heterogeneity in sodium channel marker allele frequencies, compared with arbitrary loci.	UNIV CHICAGO,DEPT ECOL & EVOLUT,CHICAGO,IL 60637	University of Chicago	TAYLOR, MFJ (corresponding author), UNIV ARIZONA,CTR INSECT SCI,DEPT ENTOMOL,TUCSON,AZ 85721, USA.							BERRY A, 1993, GENETICS, V134, P869; CHRISTIANSEN FB, 1974, GENETICS, V77, P765; FFRENCHCONSTANT RH, 1993, P NATL ACAD SCI USA, V90, P1957, DOI 10.1073/pnas.90.5.1957; HANZLIK TN, 1989, J BIOL CHEM, V264, P12419; HARSHMAN LG, 1994, INSECT BIOCHEM MOLEC, V24, P671, DOI 10.1016/0965-1748(94)90054-X; HEAD RB, 1990, P BELTWIDE COTTON PR, P157; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; KING EG, 1990, P BELTWIDE COTTON C, P140; KORMAN AK, 1993, ANN ENTOMOL SOC AM, V86, P182, DOI 10.1093/aesa/86.2.182; KREITMAN M, 1991, GENETICS, V127, P565; LESSA EP, 1993, MOL ECOL, V2, P119, DOI 10.1111/j.1365-294X.1993.tb00006.x; LEWONTIN RC, 1973, GENETICS, V74, P175; MCCAFFERY AR, 1991, SOUTHWEST ENTOMOL S, V15, P143; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NARAHASHI T, 1986, NEUROPHARMACOLOGY PE, P37; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; NEI M, 1975, GENETICS, V80, P395; NEUNZIG HH, 1963, J ECON ENTOMOL, V56, P135, DOI 10.1093/jee/56.2.135; PLAPP FW, 1990, J ECON ENTOMOL, V83, P335, DOI 10.1093/jee/83.2.335; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; ROBERTSON A, 1975, GENETICS, V80, P396; ROEHRDANZ RL, 1994, ANN ENTOMOL SOC AM, V87, P856, DOI 10.1093/aesa/87.6.856; ROSENHEIM JA, 1986, J ECON ENTOMOL, V79, P1161, DOI 10.1093/jee/79.5.1161; SATTELLE DB, 1988, ADV INSECT PHYSL, V20, P145; SOKAL R, 1981, BIOMETRY, pCH18; STADELBACHER E A, 1972, Environmental Entomology, V1, P318; STAETZ CA, 1985, J ECON ENTOMOL, V78, P505, DOI 10.1093/jee/78.3.505; TABASHNIK BE, 1987, J ECON ENTOMOL, V80, P1091, DOI 10.1093/jee/80.6.1091; TAYLOR MFJ, 1993, INSECT BIOCHEM MOLEC, V23, P763, DOI 10.1016/0965-1748(93)90064-Y	29	62	65	0	15	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1497	1499		10.1126/science.270.5241.1497	http://dx.doi.org/10.1126/science.270.5241.1497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491497				2022-12-24	WOS:A1995TH37500040
J	ITOH, K; STEVENS, B; SCHACHNER, M; FIELDS, RD				ITOH, K; STEVENS, B; SCHACHNER, M; FIELDS, RD			REGULATED EXPRESSION OF THE NEURAL CELL-ADHESION MOLECULE L1 BY SPECIFIC PATTERNS OF NEURAL IMPULSES	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; NERVOUS-SYSTEM; SCHWANN-CELLS; SURFACE; GROWTH; NEURONS; STEP; ACID	Development of the mammalian nervous system is regulated by neural impulse activity, but the molecular mechanisms are not well understood. If cell recognition molecules [for example, L1 and the neural cell adhesion molecule (NCAM)] were influenced by specific patterns of impulse activity, cell-cell interactions controlling nervous system structure could be regulated by nervous system function at critical stages of development. Low frequency electrical pulses delivered to mouse sensory neurons in culture (0.1 hertz for 5 days) down-regulated expression of L1 messenger RNA and protein (but not NCAM). Fasciculation of neurites, adhesion of neuroblastoma cells, and the number of Schwann cells on neurites was reduced after 0.1-hertz stimulation, but higher frequencies or stimulation after synaptogenesis were without effect.	NICHHD,NEUROCYTOL & PHYSIOL UNIT,BETHESDA,MD 20892; ETH HONGGERBERG,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Swiss Federal Institutes of Technology Domain; ETH Zurich								BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BOCK E, 1985, EMBO J, V4, P2765, DOI 10.1002/j.1460-2075.1985.tb04001.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fields R. Douglas, 1992, P67; FIELDS RD, 1991, J NEUROSCI, V11, P134; FIELDS RD, 1992, INT REV NEUROBIOL, V34, P133, DOI 10.1016/S0074-7742(08)60098-7; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; Fitzgerald M, 1992, SENSORY NEURONS DIVE, P287; ITOH K, 1995, J NEUROSCI, V15, P2504, DOI 10.1523/JNEUROSCI.15-03-02504.1995; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; MOOS M, 1989, NATURE, V334, P701; MOSCOSO LM, 1995, J COMP NEUROL, V352, P321, DOI 10.1002/cne.903520302; RATHJEN FG, 1984, EMBO J, V3, P1; RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G; SCHACHNER M, 1990, MORPHOREGULATORY MOL, P443; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SPRINKLE TJ, 1987, BRAIN RES, V426, P349, DOI 10.1016/0006-8993(87)90888-2; SWEADNER KJ, 1983, J NEUROSCI, V3, P2504; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; XIAONAN G, 1995, NATURE, V375, P784	22	152	153	0	3	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1369	1372		10.1126/science.270.5240.1369	http://dx.doi.org/10.1126/science.270.5240.1369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481827				2022-12-24	WOS:A1995TF89900042
J	BRANNIGAN, JA; DODSON, G; DUGGLEBY, HJ; MOODY, PCE; SMITH, JL; TOMCHICK, DR; MURZIN, AG				BRANNIGAN, JA; DODSON, G; DUGGLEBY, HJ; MOODY, PCE; SMITH, JL; TOMCHICK, DR; MURZIN, AG			A PROTEIN CATALYTIC FRAMEWORK WITH AN N-TERMINAL NUCLEOPHILE IS CAPABLE OF SELF-ACTIVATION	NATURE			English	Article							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; ESCHERICHIA-COLI K-12; PENICILLIN ACYLASE; TRANSPEPTIDASE; CYSTEINE; GENE	THE crystal structures of three amidohydrolases have been determined recently(1-3): glutamine PRPP amidotransferase (GAT), penicillin acylase, and the proteasome. These enzymes use the side chain of the amino-terminal residue, incorporated in a beta-sheet, as the nucleophile in the catalytic attack at the carbonyl carbon. The nucleophile is cysteine in GAT, serine in penicillin acylase, and threonine in the proteasome. Here we show that all three enzymes share an unusual fold in which the nucleophile and other catalytic groups occupy equivalent sites. This fold provides both the capacity for nucleophilic attack and the possibility of autocatalytic processing. We suggest the name Ntn (N-terminal nucleophile) hydrolases for this structural superfamily of enzymes which appear to be evolutionarily related but which have diverged beyond any recognizable sequence similarity.	NATL INST MED RES,LONDON NW7 1AA,ENGLAND; PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907; MRC,CTR PROT ENGN,CAMBRIDGE CB2 2QH,ENGLAND	MRC National Institute for Medical Research; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Cambridge	BRANNIGAN, JA (corresponding author), UNIV YORK,DEPT CHEM,YORK YO1 5DD,N YORKSHIRE,ENGLAND.		Tomchick, Diana/HGV-2018-2022; Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238; Tomchick, Diana/0000-0002-7529-4643	NIDDK NIH HHS [R37 DK042303] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGGRAWAL AK, 1995, CURR OPINION STRUCT, V5, P11; BRUNS W, 1985, J MOL APPL GENET, V3, P36; CHOTHIA C, 1981, P NATL ACAD SCI-BIOL, V78, P4146, DOI 10.1073/pnas.78.7.4146; COLSTON MJ, 1994, MOL MICROBIOL, V12, P359, DOI 10.1111/j.1365-2958.1994.tb01025.x; DODSON GG, 1992, FARADAY DISCUSS, V93, P95, DOI 10.1039/fd9929300095; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; GALLAGHER T, 1993, J MOL BIOL, V230, P516, DOI 10.1006/jmbi.1993.1168; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; KUMAGAI H, 1993, J MOL BIOL, V234, P1259, DOI 10.1006/jmbi.1993.1677; LOUGH TJ, 1992, PLANT MOL BIOL, V19, P391, DOI 10.1007/BF00023386; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MANTSALA P, 1984, J BIOL CHEM, V259, P4230; MATSUDA A, 1987, J BACTERIOL, V169, P5821, DOI 10.1128/jb.169.12.5821-5826.1987; MONONEN I, 1993, FASEB J, V7, P1247, DOI 10.1096/fasebj.7.13.8405810; OINONEN C, IN PRESS NATURE STRU; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; SEEMULLER E, 1995, FEBS LETT, V359, P173, DOI 10.1016/0014-5793(95)00036-9; SIZMANN D, 1990, EUR J BIOCHEM, V192, P143, DOI 10.1111/j.1432-1033.1990.tb19207.x; Smith JL, 1995, BIOCHEM SOC T, V23, P894, DOI 10.1042/bst0230894; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; SOUCIET JL, 1988, J BIOL CHEM, V263, P3323; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; TARENTINO AL, 1995, ARCH BIOCHEM BIOPHYS, V316, P399, DOI 10.1006/abbi.1995.1053; TATE SS, 1985, METHOD ENZYMOL, V113, P400; WALLACE CJA, 1993, PROTEIN SCI, V2, P697, DOI 10.1002/pro.5560020501; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; ZHOU G, 1992, J BIOL CHEM, V267, P7936; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	31	545	552	3	39	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					416	419		10.1038/378416a0	http://dx.doi.org/10.1038/378416a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477383				2022-12-24	WOS:A1995TF89300067
J	LI, XJ; LI, SH; SHARP, AH; NUCIFORA, FC; SCHILLING, G; LANAHAN, A; WORLEY, P; SNYDER, SH; ROSS, CA				LI, XJ; LI, SH; SHARP, AH; NUCIFORA, FC; SCHILLING, G; LANAHAN, A; WORLEY, P; SNYDER, SH; ROSS, CA			A HUNTINGTIN-ASSOCIATED PROTEIN ENRICHED IN BRAIN WITH IMPLICATIONS FOR PATHOLOGY	NATURE			English	Article							TRINUCLEOTIDE REPEAT; DISEASE GENE; LENGTH; EXPRESSION; TISSUES; CLONING; IT-15; ONSET; YEAST; AGE	HUNTINGTON'S disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanding polyglutamine repeat in the IT15 or huntingtin gene(1). Although this gene is widely expressed(2-9) and is required for normal development(10-12), the pathology of HD is restricted to the brain, for reasons that remain poorly understood. The huntingtin gene product is expressed at similar levels in patients and controls, and the genetics of the disorder(13,14) suggest that the expansion of the polyglutamine repeat induces a toxic gain of function, perhaps through interactions with other cellular proteins(15-18). Here we report the identification of a protein (huntingtin-associated protein (HAP)-1) that binds to huntingtin. This binding is enhanced by an expanded polyglutamine repeat, the length of which is also known to correlate with the age of disease onset(19-21). The HAP-1 protein is enriched in the brain, suggesting a possible basis for the selective brain pathology of HD.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	LI, XJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205, USA.		Ross, Christopher A/H-8395-2013; NUCIFORA, FREDERICK/X-2364-2019					ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; AMBROSE CM, 1995, SOMAT CELL MOLEC GEN, V20, P27; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GUSELLA JF, 1993, ARCH NEUROL-CHICAGO, V50, P1157, DOI 10.1001/archneur.1993.00540110037003; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; LI XJ, 1994, P NATL ACAD SCI USA, V91, P1814, DOI 10.1073/pnas.91.5.1814; MARGOLIS RL, IN PRESS MOL BRAIN R; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; 1993, CELL, V72, P971	31	522	549	0	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					398	402		10.1038/378398a0	http://dx.doi.org/10.1038/378398a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477378				2022-12-24	WOS:A1995TF89300062
J	BRUNET, M; BEAUVILAIN, A; COPPENS, Y; HEINTZ, E; MOUTAYE, AHE; PILBEAM, D				BRUNET, M; BEAUVILAIN, A; COPPENS, Y; HEINTZ, E; MOUTAYE, AHE; PILBEAM, D			THE FIRST AUSTRALOPITHECINE 2,500 KILOMETERS WEST OF THE RIFT-VALLEY (CHAD)	NATURE			English	Article								The first sites with Pliocene and Pleistocene mammals west of the Rift Valley in Central Africa in northern Chad mere reported in 1959 (ref. 1), and documented the presence of mixed savannah and woodland habitats. Further sites(2) and a probable Homo erectus cranio-facial fragment(3) mere subsequently discovered. In 1993 a survey of Pliocene and Pleistocene formations in the Borkou-Ennedi-Tibesti Province of Chad (B.E.T.) led to the discovery of 17 new sites in the region of Bahr el Ghazal (classical Arabic for River of the Gazelles) near Koro Toro. One site, KT 12 (15 degrees 58'10'' N, 18 degrees 52'46'' E) yielded an australopithecine mandible associated with a fauna biochronologically estimated to be 3.0-3.5 Myr old. Australopithecine species described since 1925 are known from southern Africa and from sites spread along the eastern Rift Valley from Tanzania to Ethiopia (Fig. 1). This new find from Chad, which is most similar in morphology to Australopithecus afarensis(4), documents the presence of an early hominid a considerable distance, 2,500 km, west of the Rift Valley.	CNAR, NDJAMENA, CHAD; COLL FRANCE, CHAIRE PALEOANTHROPOL & PREHIST, F-75005 PARIS, FRANCE; CNRS, F-75794 PARIS 16, FRANCE; DRGM, NDJAMENA, CHAD; HARVARD UNIV, DEPT ANTHROPOL, CAMBRIDGE, MA 02138 USA	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Harvard University	BRUNET, M (corresponding author), UNIV POITIERS, FAC SCI JE 273 MST, GEOBIOL BIOCHRONOL & PALEONTOL HUMAINE, 40 AVE RECTEUR PINEAU, F-86022 POITIERS, FRANCE.		Lund, Laura/H-7335-2012; Klein, Richard G/B-5910-2009					ABADLE J, 1959, CR HEBD ACAD SCI, V248, P3329; Beden M, 1985, ENV HOMINIDES PLIO P, P21; BRAGA JC, 1995, THESIS U BORDEAUX; COOKE HBS, 1985, ENV HOMINIDES PLIO P, P101; COPPENS Y, 1965, CR HEBD ACAD SCI, V260, P2869; COPPENS Y, 1983, SINGE AFRIQUE HOMME, P1; COPPENS YVES, 1967, P89; EISENMANN U, 1993, KOOBI FORA PROJECT, P156; EISENMANN V, 1976, Geobios (Villeurbanne), V9, P577, DOI 10.1016/S0016-6995(76)80025-3; GEZE R, 1980, THESIS U PARIS; Geze R., 1985, ENV HOMINIDES PLIO P, P81; Groves C.P., 1986, P187; GRUPP P, 1993, PIGS PECCARIES HIPPO, P66; Guerin C., 1979, Bulletin de la Societe Geologique de France, V21, P283; HARRIS JM, 1979, T AM PHILOS SOC, V69, P5; HARRIS JM, 1983, KOOBI FORA RES PROJE, V2, P215; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Jolly Clifford J., 1993, P67; KORTLANDT A, 1972, NEW PERSPECTIVES APE, P9; LEAKEY MD, 1976, NATURE, V262, P460, DOI 10.1038/262460a0; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Pickford M., 1990, Human Evolution, V5, P1, DOI 10.1007/BF02436472; RUVOLO M, 1994, P NATL ACAD SCI USA, V91, P8900, DOI 10.1073/pnas.91.19.8900; SCHNEIDER JL, 1989, THESIS U AVIGNON; SCHNEIDER JL, 1992, DOCUMENT BRGM, V209; UCHIDA A, 1993, AM J PHYS ANTHR S, V16, P198; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WOOD BA, 1992, CAMBRIDGE ENCY HUMAN, P231	28	178	185	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1995	378	6554					273	275		10.1038/378273a0	http://dx.doi.org/10.1038/378273a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477344				2022-12-24	WOS:A1995TE85800046
J	CHAMBERS, HF; MILLER, RT; NEWMAN, MD				CHAMBERS, HF; MILLER, RT; NEWMAN, MD			RIGHT-SIDED STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG-ABUSERS - 2-WEEK COMBINATION THERAPY	ANNALS OF INTERNAL MEDICINE			English	Article									UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	CHAMBERS, HF (corresponding author), SAN FRANCISCO GEN HOSP, 5H22 MED SERV, SAN FRANCISCO, CA 94110 USA.							ABRAMS B, 1979, ANN INTERN MED, V90, P789, DOI 10.7326/0003-4819-90-5-789; BAYER AS, 1988, CHEST, V93, P247, DOI 10.1378/chest.93.2.247; BAYER AS, 1982, ARCH INTERN MED, V142, P1169, DOI 10.1001/archinte.142.6.1169; CATES JE, 1951, Q J MED, V20, P93; CHAMBERS HF, 1983, MEDICINE, V62, P170, DOI 10.1097/00005792-198305000-00004; DRAKE TA, 1983, ANTIMICROB AGENTS CH, V24, P653, DOI 10.1128/AAC.24.5.653; GRINZTON LE, 1982, AM J CARDIOL, V49, P1853; IANNINI PB, 1976, ANN INTERN MED, V84, P558, DOI 10.7326/0003-4819-84-5-558; KARCHMER AW, 1985, AM J MED, V78, P116, DOI 10.1016/0002-9343(85)90374-2; KORZENIOWSKI O, 1982, ANN INTERN MED, V97, P496, DOI 10.7326/0003-4819-97-4-496; MENDA KB, 1973, ANN INTERN MED, V78, P25, DOI 10.7326/0003-4819-78-1-25; NOLAN CM, 1976, AM J MED, V60, P495, DOI 10.1016/0002-9343(76)90715-4; REISBERG BE, 1979, PROG CARDIOVASC DIS, V22, P193, DOI 10.1016/0033-0620(79)90023-9; ROBBINS MJ, 1986, AM J MED, V80, P165, DOI 10.1016/0002-9343(86)90004-5; SANDE MA, 1976, J LAB CLIN MED, V88, P118; SANDE MA, 1980, ANN INTERN MED, V92, P390, DOI 10.7326/0003-4819-92-3-390; SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1437, DOI 10.1056/NEJM198405313102206; SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1368, DOI 10.1056/NEJM198405243102107; WATANAKUNAKORN C, 1982, ANTIMICROB AGENTS CH, V22, P903, DOI 10.1128/AAC.22.5.903; WATANAKUNAKORN C, 1977, AM J MED SCI, V273, P133, DOI 10.1097/00000441-197703000-00002; WILSON R, 1957, AM J MED, V22, P437, DOI 10.1016/0002-9343(57)90099-2; WILSON WR, 1978, CIRCULATION, V57, P1158, DOI 10.1161/01.CIR.57.6.1158; ZAR JH, 1974, BIOSTAT ANAL, P295	23	166	169	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	1988	109	8					619	624		10.7326/0003-4819-109-8-619	http://dx.doi.org/10.7326/0003-4819-109-8-619			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q6974	3421575				2022-12-24	WOS:A1988Q697400007
J	GROSS, MD; SHAPIRO, B; BOUFFARD, JA; GLAZER, GM; FRANCIS, IR; WILTON, GP; KHAFAGI, F; SONDA, LP				GROSS, MD; SHAPIRO, B; BOUFFARD, JA; GLAZER, GM; FRANCIS, IR; WILTON, GP; KHAFAGI, F; SONDA, LP			DISTINGUISHING BENIGN FROM MALIGNANT EUADRENAL MASSES	ANNALS OF INTERNAL MEDICINE			English	Article									UNIV MICHIGAN, MED CTR, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan	GROSS, MD (corresponding author), VET ADM MED CTR, NUCL MED SERV 115, 2215 FULLER RD, ANN ARBOR, MI 48105 USA.				NCI NIH HHS [CA-09015, R01-CA-43300-01] Funding Source: Medline; NIADDK NIH HHS [R01-AM-2147702] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM021477] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043300] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABECASSIS M, 1985, AM J SURG, V149, P783, DOI 10.1016/S0002-9610(85)80186-0; ABRAMS HL, 1959, J UROLOGY, V81, P711; BAKER ME, 1987, RADIOLOGY, V163, P669, DOI 10.1148/radiology.163.3.3575711; BEIERWALTES WH, 1974, J NUCL MED, V15, P246; BELLDEGRUN A, 1986, SURG GYNECOL OBSTET, V163, P203; BERKMAN WA, 1984, CANCER, V53, P2098, DOI 10.1002/1097-0142(19840515)53:10<2098::AID-CNCR2820531018>3.0.CO;2-0; BERLINER L, 1982, J COMPUT ASSIST TOMO, V6, P281, DOI 10.1097/00004728-198204000-00009; BERNARDINO ME, 1985, AM J ROENTGENOL, V144, P67, DOI 10.2214/ajr.144.1.67; CHARBONNEL B, 1981, J NUCL MED, V22, P1059; COOK B, 1987, J ENDOCRINOL, V113, P331, DOI 10.1677/joe.0.1130331; COPELAND PM, 1983, ANN INTERN MED, V98, P940, DOI 10.7326/0003-4819-98-6-940; DELAMONTE SM, 1984, AM J PATHOL, V114, P131; DUNNICK NR, 1982, J COMPUT ASSIST TOMO, V6, P978, DOI 10.1097/00004728-198210000-00020; FRANCIS IR, 1988, RADIOLOGY, V166, P353, DOI 10.1148/radiology.166.2.3336710; FREITAS JE, 1978, J NUCL MED, V19, P149; GLAZER GM, 1986, RADIOLOGY, V158, P73, DOI 10.1148/radiology.158.1.3940402; GLAZER HS, 1982, AM J ROENTGENOL, V139, P81, DOI 10.2214/ajr.139.1.81; GROSS MD, 1987, J NUCL MED, V28, P1401; GROSS MD, 1981, J CLIN ENDOCR METAB, V52, P1062, DOI 10.1210/jcem-52-6-1062; GROSS MD, 1984, CLIN NUCL MED, V9, P264, DOI 10.1097/00003072-198405000-00005; GROSS MD, 1983, J CLIN ENDOCR METAB, V57, P477, DOI 10.1210/jcem-57-3-477; GUERIN CK, 1983, AM J MED, V75, P653, DOI 10.1016/0002-9343(83)90452-7; GUERRERO LA, 1985, UROLOGY, V26, P435, DOI 10.1016/0090-4295(85)90149-9; HEASTON DK, 1982, AM J ROENTGENOL, V138, P1143, DOI 10.2214/ajr.138.6.1143; HEDELAND H, 1968, ACTA MED SCAND, V184, P211; HUSSAIN S, 1986, EUR J RADIOL, V6, P127; HUSSAIN S, 1985, AM J ROENTGENOL, V144, P61, DOI 10.2214/ajr.144.1.61; KATZ RL, 1985, CANCER, V55, P1995, DOI 10.1002/1097-0142(19850501)55:9<1995::AID-CNCR2820550928>3.0.CO;2-0; MITNICK JS, 1983, RADIOLOGY, V148, P495, DOI 10.1148/radiology.148.2.6867348; MITTY HA, 1983, AM J ROENTGENOL, V141, P727, DOI 10.2214/ajr.141.4.727; NEVILLE AM, 1978, INVEST CELL PATHOL, V1, P99; OLIVER TW, 1984, RADIOLOGY, V153, P217, DOI 10.1148/radiology.153.1.6473783; PRINZ RA, 1982, JAMA-J AM MED ASSOC, V248, P701, DOI 10.1001/jama.248.6.701; QURAISHI MA, 1981, CANCER, V48, P714, DOI 10.1002/1097-0142(19810801)48:3<714::AID-CNCR2820480309>3.0.CO;2-#; REINIG JW, 1986, RADIOLOGY, V158, P81, DOI 10.1148/radiology.158.1.3940403; REMINGTON RD, 1970, STATISTICS APPLICATI, P183; RIZZA RA, 1978, J NUCL MED, V19, P458; SCHAMBELAN M, 1981, NEW ENGL J MED, V304, P1047; SCHWARTZ AN, 1986, AM J ROENTGENOL, V146, P553, DOI 10.2214/ajr.146.3.553; SHAMMA A H, 1958, J Chronic Dis, V8, P587, DOI 10.1016/0021-9681(58)90051-1; SHAPIRO B, 1983, J NUCL MED, V24, P732; SIEKAVIZZA JL, 1981, UROLOGY, V18, P625, DOI 10.1016/0090-4295(81)90476-3; THRALL JH, 1978, SEMIN NUCL MED, V8, P23, DOI 10.1016/S0001-2998(78)80005-1; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; YANKASKAS BC, 1986, INVEST RADIOL, V21, P325, DOI 10.1097/00004424-198604000-00006	45	99	99	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	1988	109	8					613	618		10.7326/0003-4819-109-8-613	http://dx.doi.org/10.7326/0003-4819-109-8-613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q6974	3421574				2022-12-24	WOS:A1988Q697400006
J	POLLAK, VE				POLLAK, VE			ADVERSE-EFFECTS AND PYROGENIC REACTIONS DURING HEMODIALYSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											POLLAK, VE (corresponding author), UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267, USA.							ALTER MJ, 1988, JAMA-J AM MED ASSOC, V260, P2073, DOI 10.1001/jama.260.14.2073; ALTER MJ, 1986, J INFECT DIS, V153, P1149, DOI 10.1093/infdis/153.6.1149; CHAROENPANICH R, 1987, ARTIF ORGANS, V11, P123, DOI 10.1111/j.1525-1594.1987.tb02642.x; DAUGIRDAS JT, 1985, ARCH INTERN MED, V145, P489, DOI 10.1001/archinte.145.3.489; GORDON SM, 1988, JAMA-J AM MED ASSOC, V260, P2077, DOI 10.1001/jama.260.14.2077; KANT KS, 1981, KIDNEY INT, V19, P728, DOI 10.1038/ki.1981.73; PETERSEN NJ, 1981, T AM SOC ART INT ORG, V27, P155; POLLAK VE, 1986, NEPHRON, V42, P217, DOI 10.1159/000183670; POLLAK VE, 1985, JAMA-J AM MED ASSOC, V253, P62; POLLAK VE, 1988, KIDNEY INT S24, V33, pS49; ROBSON MD, 1986, AM J NEPHROL, V6, P101, DOI 10.1159/000167063	11	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	1988	260	14					2106	2107						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q3421	3418877				2022-12-24	WOS:A1988Q342100031
J	LARSON, JS; SCHUETZ, TJ; KINGSTON, RE				LARSON, JS; SCHUETZ, TJ; KINGSTON, RE			ACTIVATION INVITRO OF SEQUENCE-SPECIFIC DNA-BINDING BY A HUMAN REGULATORY FACTOR	NATURE			English	Article									HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital								ANATHAN J, 1986, SCIENCE, V232, P522; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Beckwith J. R., 1970, LACTOSE OPERON; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HOLMGREN R, 1979, CELL, V18, P1359, DOI 10.1016/0092-8674(79)90246-0; KINGSTON RE, 1987, MOL CELL BIOL, V7, P1530, DOI 10.1128/MCB.7.4.1530; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MIRAULT ME, 1982, EMBO J, V1, P1279, DOI 10.1002/j.1460-2075.1982.tb00025.x; MUNRO S, 1985, NATURE, V317, P477, DOI 10.1038/317477a0; NOVER L, 1984, HEAT SHOCK RESPONSE; PELHAM H, 1985, TRENDS GENET, V1, P31, DOI 10.1016/0168-9525(85)90012-5; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SEGUIN C, 1987, SCIENCE, V235, P1383, DOI 10.1126/science.3103216; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; VERJEE ZHM, 1969, EUR J BIOCHEM, V9, P439, DOI 10.1111/j.1432-1033.1969.tb00628.x; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5415; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	29	226	228	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					372	375		10.1038/335372a0	http://dx.doi.org/10.1038/335372a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419505				2022-12-24	WOS:A1988Q137300066
J	OTWINOWSKI, Z; SCHEVITZ, RW; ZHANG, RG; LAWSON, CL; JOACHIMIAK, A; MARMORSTEIN, RQ; LUISI, BF; SIGLER, PB				OTWINOWSKI, Z; SCHEVITZ, RW; ZHANG, RG; LAWSON, CL; JOACHIMIAK, A; MARMORSTEIN, RQ; LUISI, BF; SIGLER, PB			CRYSTAL-STRUCTURE OF TRP REPRESSOR OPERATOR COMPLEX AT ATOMIC RESOLUTION	NATURE			English	Article									UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58 ST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT CHEM,CHICAGO,IL 60637	University of Chicago; University of Chicago			Otwinowski, Zbyszek/F-3665-2011	Lawson, Catherine/0000-0002-3261-7035; Otwinowski, Zbyszek/0000-0003-3640-8545				AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; BASS S, 1987, GENE DEV, V1, P565, DOI 10.1101/gad.1.6.565; BOSSI L, 1984, CELL, V39, P643, DOI 10.1016/0092-8674(84)90471-9; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; CARUTHERS MH, 1986, PROTEIN STRUCTURE FO, P221; CHOTHIA C, 1976, P NATL ACAD SCI USA, V73, P3793, DOI 10.1073/pnas.73.11.3793; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; DICKERSON RE, 1985, BIOL MACROMOL, V2, P38; DREW HR, 1987, J MOL BIOL, V195, P143, DOI 10.1016/0022-2836(87)90333-0; EBRIGHT RH, 1984, P NATL ACAD SCI-BIOL, V81, P7274, DOI 10.1073/pnas.81.23.7274; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; GOTOH O, 1981, BIOPOLYMERS, V20, P1033, DOI 10.1002/bip.1981.360200513; HARAN TE, 1984, J BIOMOL STRUCT DYN, V2, P397, DOI 10.1080/07391102.1984.10507575; HARRISON SC, 1988, B I PASTEUR, V86, P55; HENDRICKSON WA, 1981, STRUCTURE CONFORMATI, V1, P43; JANIN J, 1978, 12TH FEBS M DRESD, V52, P227; JOACHIMIAK A, 1987, J BIOL CHEM, V262, P4917; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; KELLEY RL, 1985, P NATL ACAD SCI USA, V82, P483, DOI 10.1073/pnas.82.2.483; KLUG A, 1979, J MOL BIOL, V131, P669, DOI 10.1016/0022-2836(79)90196-7; KUMAMOTO AA, 1987, GENE DEV, V1, P556, DOI 10.1101/gad.1.6.556; LAWSON CL, 1988, PROTEINS, V3, P18, DOI 10.1002/prot.340030103; LAWSON CL, 1988, NATURE, V233, P869; LEFEVRE JF, 1987, BIOCHEMISTRY-US, V26, P5076, DOI 10.1021/bi00390a029; LOMONOSSOFF GP, 1981, J MOL BIOL, V149, P745, DOI 10.1016/0022-2836(81)90356-9; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; MARMORSTEIN RQ, 1987, J BIOL CHEM, V262, P4922; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; OHLENDORF DH, 1983, J MOL EVOL, V19, P109, DOI 10.1007/BF02300748; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; PABO CO, 1982, NATURE, V298, P441, DOI 10.1038/298441a0; RECORD MT, 1988, UNUSUAL DNA STRUCTUR, P237; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; SNYDER M, 1986, NATURE, V324, P87, DOI 10.1038/324087a0; SOMERVILLE RL, 1983, AMINO ACIDS BIOSYNTH, P351; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZAHN K, 1987, SCIENCE, V236, P416, DOI 10.1126/science.2951850; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0	48	899	907	1	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					321	329		10.1038/335321a0	http://dx.doi.org/10.1038/335321a0			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419502				2022-12-24	WOS:A1988Q137300049
J	ROTH, D; ALARCON, FJ; FERNANDEZ, JA; PRESTON, RA; BOURGOIGNIE, JJ				ROTH, D; ALARCON, FJ; FERNANDEZ, JA; PRESTON, RA; BOURGOIGNIE, JJ			ACUTE RHABDOMYOLYSIS ASSOCIATED WITH COCAINE INTOXICATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											ROTH, D (corresponding author), UNIV MIAMI,SCH MED,DEPT MED,DIV NEPHROL R-126,POB 016960,MIAMI,FL 33101, USA.							Abelson H I, 1985, NIDA Res Monogr, V61, P35; BARRIDO DT, 1988, KIDNEY INT, V33, P181; Bywaters EGL., 1942, SURG GYNECOL OBS, V75, P612; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; FISHBURN PM, 1980, DHHS ADM80976 NAT I; FLANIGAN WJ, 1965, J CLIN INVEST, V44, P449, DOI 10.1172/JCI105158; GREENBLATT DJ, 1974, JAMA-J AM MED ASSOC, V229, P556; GROSSMAN RA, 1974, NEW ENGL J MED, V291, P807, DOI 10.1056/NEJM197410172911601; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; KENDRICK WC, 1977, ANN INTERN MED, V86, P381, DOI 10.7326/0003-4819-86-4-381; KLOSS MW, 1984, BIOCHEM PHARMACOL, V33, P169, DOI 10.1016/0006-2952(84)90471-4; KOFFLER A, 1976, ANN INTERN MED, V85, P23, DOI 10.7326/0003-4819-85-1-23; KROHN KD, 1988, ANN INTERN MED, V108, P639, DOI 10.7326/0003-4819-108-4-639_2; LICHTENFELD PJ, 1984, ARCH NEUROL-CHICAGO, V41, P223, DOI 10.1001/archneur.1984.04050140125041; MERIGIAN KS, 1987, J TOXICOL-CLIN TOXIC, V25, P135, DOI 10.3109/15563658708992619; MITTLEMAN RE, 1984, JAMA-J AM MED ASSOC, V252, P1889, DOI 10.1001/jama.252.14.1889; OLSON KR, 1987, PROB CRIT CARE, V1, P95; RICHTER RW, 1971, J AMER MED ASSOC, V216, P1172, DOI 10.1001/jama.216.7.1172; RITCHIE JM, 1985, GOODMAN GILMANS PHAR, P309; SHUSTER L, 1977, LIFE SCI, V20, P1035, DOI 10.1016/0024-3205(77)90291-0; SIMPSON RW, 1986, ARCH PATHOL LAB MED, V110, P479; THOMPSON ML, 1979, BIOCHEM PHARMACOL, V28, P2389, DOI 10.1016/0006-2952(79)90705-6	22	195	196	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	1988	319	11					673	677		10.1056/NEJM198809153191103	http://dx.doi.org/10.1056/NEJM198809153191103			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q0375	3412385				2022-12-24	WOS:A1988Q037500003
J	KEMP, BE; RYLATT, DB; BUNDESEN, PG; DOHERTY, RR; MCPHEE, DA; STAPLETON, D; COTTIS, LE; WILSON, K; JOHN, MA; KHAN, JM; DINH, DP; MILES, S; HILLYARD, CJ				KEMP, BE; RYLATT, DB; BUNDESEN, PG; DOHERTY, RR; MCPHEE, DA; STAPLETON, D; COTTIS, LE; WILSON, K; JOHN, MA; KHAN, JM; DINH, DP; MILES, S; HILLYARD, CJ			AUTOLOGOUS RED-CELL AGGLUTINATION ASSAY FOR HIV-1 ANTIBODIES - SIMPLIFIED TEST WITH WHOLE-BLOOD	SCIENCE			English	Article									AGEN BIOMED LTD,BRISBANE 4000,AUSTRALIA; FAIRFIELD HOSP,MCFARLANE BURNET CTR MED RES,NH & MRC SPECIAL UNIT AIDS VIROL,FAIRFIELD 3078,AUSTRALIA		KEMP, BE (corresponding author), UNIV MELBOURNE,REPATRIAT GEN HOSP,DEPT MED,HEIDELBERG,VIC 3081,AUSTRALIA.		Kemp, Bruce/G-9602-2019; McPhee, Dale A/D-1825-2011; Doherty, Richard/GVT-7356-2022; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Kemp, Bruce E/0000-0001-6735-5082; Doherty, Richard/0000-0002-3141-0083				BLOMBERG J, 1985, LEUKEMIA RES, V9, P1111, DOI 10.1016/0145-2126(85)90100-6; BURKE DS, 1987, J CLIN MICROBIOL, V25, P81, DOI 10.1128/JCM.25.1.81-84.1987; CHIODI F, 1987, AIDS RES HUM RETROV, V3, P165, DOI 10.1089/aid.1987.3.165; COOMBS RRA, 1987, J IMMUNOL METHODS, V101, P1, DOI 10.1016/0022-1759(87)90209-2; GAINES H, 1987, LANCET, V1, P1249; GNANN JW, 1987, J INFECT DIS, V156, P261, DOI 10.1093/infdis/156.2.261; GNANN JW, 1987, SCIENCE, V237, P1346, DOI 10.1126/science.2888192; GOEDERT JJ, 1984, LANCET, V2, P711; LITCHFIELD WJ, 1984, CLIN CHEM, V30, P1489; MASKILL W, 1986, J VIROL METHODS, V13, P273, DOI 10.1016/0166-0934(86)90051-0; RIGGIN CH, 1987, J CLIN MICROBIOL, V25, P1772, DOI 10.1128/JCM.25.9.1772-1773.1987; RYLATT, UNPUB; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; STEWART JM, 1966, SOLID PHASE PEPTIDE, P44; WANG JJG, 1986, P NATL ACAD SCI USA, V83, P6159, DOI 10.1073/pnas.83.16.6159; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WHICHER JT, 1984, CLIN BIOCH ANAL, V14; YOSHIDA T, 1986, JPN J CANCER RES, V77, P1211	20	64	77	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 9	1988	241	4871					1352	1354		10.1126/science.3413497	http://dx.doi.org/10.1126/science.3413497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9812	3413497				2022-12-24	WOS:A1988P981200031
J	CHETCUTI, P; MYERS, NA; PHELAN, PD; BEASLEY, SW				CHETCUTI, P; MYERS, NA; PHELAN, PD; BEASLEY, SW			ADULTS WHO SURVIVED REPAIR OF CONGENITAL ESOPHAGEAL ATRESIA AND TRACHEO-OESOPHAGEAL FISTULA	BRITISH MEDICAL JOURNAL			English	Article									ROYAL CHILDRENS HOSP,DEPT GEN SURG,PARKVILLE,VIC 3052,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT THORAC MED,PARKVILLE,VIC 3052,AUSTRALIA; UNIV MELBOURNE,DEPT PAEDIAT,PARKVILLE,VIC 3052,AUSTRALIA	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne								AYRES JG, 1986, THORAX, V41, P106, DOI 10.1136/thx.41.2.106; AYRES JG, 1986, THORAX, V41, P111, DOI 10.1136/thx.41.2.111; CRISPIN AR, 1966, THORAX, V81, P104; DUDLEY NE, 1976, ARCH DIS CHILD, V51, P279, DOI 10.1136/adc.51.4.279; EMERY JL, 1971, ARCH DIS CHILD, V46, P236, DOI 10.1136/adc.46.247.236; HOLDER TM, 1981, SURG CLIN N AM, V61, P1051; HOLDER TM, 1964, PEDIATRICS, V34, P542; HUKS LM, 1981, J THORAC CARDIOVASC, V81, P358; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P724; KOOP CE, 1975, Z KINDERCHIR, V17, P125; Ladd WE, 1944, NEW ENGL J MED, V230, P625, DOI 10.1056/NEJM194405252302101; LAKS H, 1972, J PEDIATR SURG, V7, P591, DOI 10.1016/0022-3468(72)90218-7; LESOUEF PN, 1987, J PEDIATR SURG, V22, P918, DOI 10.1016/S0022-3468(87)80589-4; LEVEN NL, 1936, J THORACIC SURG, V6, P30; LISTER J, 1964, ARCH DIS CHILD, V39, P131, DOI 10.1136/adc.39.204.131; MILLIGAN DWA, 1979, J PEDIATR-US, V95, P24, DOI 10.1016/S0022-3476(79)80076-1; Myers N A, 1977, Prog Pediatr Surg, V10, P5; MYERS NA, 1974, ANN ROY COLL SURG, V54, P277; MYERS NA, 1979, CAUSES POSTOPERATIVE, P141; NAKAZATO Y, 1986, J PEDIATR SURG, V21, P831, DOI 10.1016/S0022-3468(86)80002-1; NEBEL OT, 1976, AM J DIG DIS, V21, P953, DOI 10.1007/BF01071906; SPITZ L, 1987, J PEDIATR SURG, V22, P103, DOI 10.1016/S0022-3468(87)80420-7; WAILOO MP, 1979, HISTOPATHOLOGY, V3, P329, DOI 10.1111/j.1365-2559.1979.tb03014.x; WATERSON DJ, 1962, LANCET, V1, P819; 1983, AUSTR SMOKING RATES	26	57	57	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 30	1988	297	6644					344	346		10.1136/bmj.297.6644.344	http://dx.doi.org/10.1136/bmj.297.6644.344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4527	3416169	Bronze, Green Published			2022-12-24	WOS:A1988P452700029
J	WEST, MJ; KING, AP				WEST, MJ; KING, AP			FEMALE VISUAL-DISPLAYS AFFECT THE DEVELOPMENT OF MALE SONG IN THE COWBIRD	NATURE			English	Article									DUKE UNIV,DEPT PSYCHOL,DURHAM,NC 27706	Duke University	WEST, MJ (corresponding author), UNIV N CAROLINA,DEPT PSYCHOL,CHAPEL HILL,NC 27599, USA.							KING AP, 1983, NATURE, V305, P704, DOI 10.1038/305704a0; KING AP, IN PRESS ANIM BEHAV; KROODSMA DE, 1982, ACOUSTIC COMMUNICATI, V2, P1; MCGREGOR PK, 1982, BEHAVIOUR, V79, P127; Petrinovich L., 1988, P255; WEST MJ, 1985, Z TIERPSYCHOL, V70, P225; WEST MJ, 1986, J COMP PSYCHOL, V100, P296, DOI 10.1037/0735-7036.100.3.296	7	272	274	0	33	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 21	1988	334	6179					244	246		10.1038/334244a0	http://dx.doi.org/10.1038/334244a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3802	3398921				2022-12-24	WOS:A1988P380200053
J	GAETJE, R; KOTZIAN, S; HERRMANN, G; BAUMANN, R; STARZINSKIPOWITZ, A				GAETJE, R; KOTZIAN, S; HERRMANN, G; BAUMANN, R; STARZINSKIPOWITZ, A			INVASIVENESS OF ENDOMETRIOTIC CELLS IN-VITRO	LANCET			English	Note								The pathogenesis of endometriosis is not known. The currently favoured theory is that viable endometrial cells, shed from the endometrium into the pelvic cavity by retrograde menstruation, reattach and invade other tissues. We used a collagen gel invasion assay to assess invasive potential of endometriotic cells. The invasion indices of cells from peritoneal endometriotic lesions and a metastatic bladder carcinoma cell line (EJ28) were similar (2.2-15.6 vs 8.4-11.6) whereas cells from normal endometrium and non-metastatic carcinoma cells (RT112) were non-invasive (indices <1). Invasiveness of endometriotic cells might contribute to the pathogenesis of endometriosis.	UNIV FRANKFURT,D-60054 FRANKFURT,GERMANY; UNIV FRANKFURT KLINIKUM,ZENTRUM FRAUENHEILKUNDE & GEBURTSCHILFE,W-6000 FRANKFURT,GERMANY; UNIV FRANKFURT KLINIKUM,ZENTRUM SENCKENBERG PATHOL,W-6000 FRANKFURT,GERMANY	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital								BATTISTA G, 1991, OBSTET GYNECOL SURV, V46, P374; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GLDMANN MB, 1990, CURRENT CONCEPTS END, P15; HANEY AF, 1990, CURRENT CONCEPTS END, P1; HULSKEN J, 1994, CURR OPIN CELL BIOL, V6, P711, DOI 10.1016/0955-0674(94)90098-1; LANFRANCONE L, 1994, CURR OPIN GENET DEV, V4, P109, DOI 10.1016/0959-437X(94)90099-X; MACKINNON WB, 1992, INVAS METAST, V12, P241; OSTEEN KG, 1989, FERTIL STERIL, V52, P965; RAMEY JW, 1993, FERTIL STERIL, V60, P1	9	126	137	1	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 2	1995	346	8988					1463	1464		10.1016/S0140-6736(95)92474-4	http://dx.doi.org/10.1016/S0140-6736(95)92474-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490993				2022-12-24	WOS:A1995TH15600011
J	AUGENBRAUN, M; FELDMAN, J; CHIRGWIN, K; ZENILMAN, J; CLARKE, L; DEHOVITZ, J; LANDESMAN, S; MINKOFF, H				AUGENBRAUN, M; FELDMAN, J; CHIRGWIN, K; ZENILMAN, J; CLARKE, L; DEHOVITZ, J; LANDESMAN, S; MINKOFF, H			INCREASED GENITAL SHEDDING OF HERPES-SIMPLEX VIRUS TYPE-2 IN HIV-SEROPOSITIVE WOMEN	ANNALS OF INTERNAL MEDICINE			English	Note							ACQUIRED IMMUNODEFICIENCY; RISK-FACTORS; INFECTION; TRANSMISSION; ACQUISITION; FREQUENCY; PARTNER; HISTORY	Objective: To compare the prevalence of genital herpes simplex virus type 2 (HSV-2) shedding in human immunodeficiency virus (HIV)-seropositive women and HIV-seronegative women. Design: Cross-sectional study Setting: A major inner-city medical center. Patients: 106 women who were HIV-seropositive and HSV-2-seropositive and 70 women who were HIV-seronegative and HSV-2-seropositive were enrolled from various primary care settings. Measurements: Herpes simplex virus type 2 antibody determinations were done for all patients. Regardless of symptoms, vulvar and cervical HSV cultures were obtained from all HIV-seropositive women and from a randomly selected subgroup of HIV-seronegative women. Results: The prevalence of HSV-2 shedding was nearly four times greater in HIV-seropositive than in HIV-seronegative women (13.2% compared with 3.6%; P = 0.04; odds ratio, 4.1 [95% CI, 1.0 to 27.4]) when the serum antibody for HSV-2 was present. Seventy-nine percent of viral shedding among HIV-seropositive women was asymptomatic. Overall viral shedding increased significantly as the CD4 cell count decreased. Conclusions: Women with HIV infection, particularly those with low CD4 cell counts, shed HSV-2 from the vulva and cervix more commonly than women not infected with HIV. Most of this shedding is asymptomatic.	JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD 21205 USA	Johns Hopkins University	AUGENBRAUN, M (corresponding author), SUNY HLTH SCI CTR, 450 CLARKSON AVE, BOX 56, BROOKLYN, NY 11203 USA.			DeHovitz, Jack/0000-0001-7307-0614	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031834, N01AI095014, U01AI031834] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-95014, AI31834-03] Funding Source: Medline; BHP HRSA HHS [CSA-92-100] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BHP HRSA HHS		ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BROCK BV, 1990, JAMA-J AM MED ASSOC, V263, P418, DOI 10.1001/jama.263.3.418; BROWN ZA, 1985, AM J OBSTET GYNECOL, V153, P24, DOI 10.1016/0002-9378(85)90584-8; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; DEHOVITZ JA, 1994, AM J EPIDEMIOL, V140, P1125, DOI 10.1093/oxfordjournals.aje.a117212; ERLICH KS, 1989, NEW ENGL J MED, V320, P293, DOI 10.1056/NEJM198902023200506; MERTZ GJ, 1988, J INFECT DIS, V157, P1169, DOI 10.1093/infdis/157.6.1169; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; MERTZ GJ, 1985, SEX TRANSM DIS, V12, P33, DOI 10.1097/00007435-198501000-00007; RATTRAY MC, 1978, BRIT J VENER DIS, V54, P262; ROONEY JF, 1986, NEW ENGL J MED, V314, P1561, DOI 10.1056/NEJM198606123142407; SAFRIN S, 1991, AIDS, V5, P1107, DOI 10.1097/00002030-199109000-00008; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; STENZELPOORE MP, 1987, SEX TRANSM DIS, V14, P17, DOI 10.1097/00007435-198701000-00004; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; YEAGER AS, 1984, PEDIATRICS, V73, P188; 1987, MMWR-MORBID M      S, V36, P1	18	162	165	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1995	123	11					845	847		10.7326/0003-4819-123-11-199512010-00006	http://dx.doi.org/10.7326/0003-4819-123-11-199512010-00006			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG209	7486467				2022-12-24	WOS:A1995TG20900006
J	GORMAN, JM				GORMAN, JM			RESPIRATION DISORDERS IN PANIC ATTACKS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											GORMAN, JM (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,NEW YORK,NY 10032, USA.							Barlow D. H., 2004, ANXIETY ITS DISORDER; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; PAPP LA, 1993, AM J PSYCHIAT, V150, P1149	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	1995	274	19					1504	1504						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD571	7474206				2022-12-24	WOS:A1995TD57100010
J	ZHOU, JN; HOFMAN, MA; GOOREN, LJG; SWAAB, DF				ZHOU, JN; HOFMAN, MA; GOOREN, LJG; SWAAB, DF			A SEX DIFFERENCE IN THE HUMAN BRAIN AND ITS RELATION TO TRANSSEXUALITY	NATURE			English	Article							BED NUCLEUS; STRIA TERMINALIS; GONADAL-STEROIDS; RAT; ANDROGEN; IMMUNOREACTIVITY; FOREBRAIN; SEPTUM; AREA	TRANSSEXUALS have the strong feeling, often from childhood onwards, of having been born the wrong sex. The possible psychogenic or biological aetiology of transsexuality has been the subject of debate for many years(1,2). Here we show that the volume of the central subdivision of the bed nucleus of the stria terminalis (BSTc), a brain area that is essential for sexual behaviour(3,4), is larger in men than in women. A female-sized BSTc was found in male-to-female transsexuals. The size of the BSTc was not influenced by sex hormones in adulthood and was independent of sexual orientation. Our study is the first to show a female brain structure in genetically male transsexuals and supports the hypothesis that gender identity develops as a result of an interaction between the developing brain and sex hormones(5,6).	NETHERLANDS INST BRAIN RES,GRAD SCH NEUROSCI,1105 AZ AMSTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT ENDOCRINOL,1007 MB AMSTERDAM,NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER			Zhou, JiangNing/N-3374-2013; Hofman, Michel A./ABG-7621-2020; Oostenbruggen, Belle/D-7966-2012	Swaab, Dick/0000-0002-9665-7845				ALLEN LS, 1990, J COMP NEUROL, V302, P697, DOI 10.1002/cne.903020402; ARLUISON M, 1994, BRAIN RES BULL, V34, P319, DOI 10.1016/0361-9230(94)90026-4; BLEIER R, 1982, J COMP NEUROL, V212, P118, DOI 10.1002/cne.902120203; CLARO F, 1995, BRAIN RES BULL, V36, P1, DOI 10.1016/0361-9230(94)00118-K; COMMINS D, 1985, J COMP NEUROL, V231, P473, DOI 10.1002/cne.902310406; DELABRIL A, 1987, DEV BRAIN RES, V32, P295, DOI 10.1016/0165-3806(87)90110-6; DEOLMOS JS, 1990, HUMAN NERVOUS SYSTEM, P597; DEVRIES GJN, 1990, NEUROENDOCRINOLOGY, V20, P1; EIDEN LE, 1985, NEUROSCIENCE, V15, P999, DOI 10.1016/0306-4522(85)90249-0; EMERY DE, 1976, PHYSIOL BEHAV, V17, P803, DOI 10.1016/0031-9384(76)90044-5; GOOREN L, 1990, PSYCHONEUROENDOCRINO, V15, P3, DOI 10.1016/0306-4530(90)90041-7; GUILLAMON A, 1988, DEV BRAIN RES, V44, P281, DOI 10.1016/0165-3806(88)90226-X; JAKAB RL, 1993, J STEROID BIOCHEM, V44, P481, DOI 10.1016/0960-0760(93)90253-S; KAWAKAMI M, 1974, ENDOCRINOL JAPON, V21, P125; MONEY J, 1984, PSYCHONEUROENDOCRINO, V9, P405, DOI 10.1016/0306-4530(84)90048-9; Money J, 1970, Int J Psychiatry, V9, P249; PILGRIM C, 1992, HORM METAB RES, V24, P353, DOI 10.1055/s-2007-1003334; SHERIDAN PJ, 1979, ENDOCRINOLOGY, V104, P130, DOI 10.1210/endo-104-1-130; SIMERLY RB, 1990, TRENDS NEUROSCI, V13, P104, DOI 10.1016/0166-2236(90)90186-E; SIMERLY RB, 1987, P NATL ACAD SCI USA, V84, P2087, DOI 10.1073/pnas.84.7.2087; SWAAB DF, 1995, TRENDS NEUROSCI, V18, P264, DOI 10.1016/0166-2236(95)93913-I; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; SWAAB DF, 1994, BRAIN RES, V7, P249; WALTER A, 1991, J CHEM NEUROANAT, V4, P281, DOI 10.1016/0891-0618(91)90019-9; WOODHAMS PL, 1983, NEUROSCIENCE, V8, P677, DOI 10.1016/0306-4522(83)90003-9; ZHOU JN, 1995, BRAIN RES, V672, P285, DOI 10.1016/0006-8993(94)01430-P; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; 1991, LANCET, V338, P603	28	451	458	2	130	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					68	70		10.1038/378068a0	http://dx.doi.org/10.1038/378068a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477289	Green Submitted			2022-12-24	WOS:A1995TC46900051
J	MILLS, SL; MASSEY, SC				MILLS, SL; MASSEY, SC			DIFFERENTIAL PROPERTIES OF 2 GAP JUNCTIONAL PATHWAYS MADE BY AII AMACRINE CELLS	NATURE			English	Article							ROD BIPOLAR CELLS; RABBIT RETINA; NITRIC-OXIDE; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; MAMMALIAN RETINA; TARGET-CELLS; CAT RETINA; GLUTAMATE; PERMEABILITY; CHANNELS	THE retina is sensitive to light stimuli varying over more than 12 log units in intensity. It accomplishes this, in part, by switching between rod-dominated circuits designed for maximum utilization of scarce photons and cone circuits designed for greater acuity. Rod signals are integrated into the cone pathways through AII amacrine cells, which are connected by gap junctions both to other AII amacrine cells and to cone bipolar cells. To determine the relative permeabilities of the two junctional pathways, we have measured the distribution of biotinylated tracers across this heterologous cell assembly after injecting a single An amacrine cell. We found that neurobiotin (relative molecular mass, 286) passed easily through both types of gap junctions, but that biotin-X cadaverine (relative molecular mass, 442) passed through AII/bipolar cell gap junctions poorly compared to AII/AII gap junctions. Thus, the AII/bipolar cell channel has a lower permeability to large molecules than does the AII/AII amacrine cell channel. The two pathways are also regulated differently. Dopamine and cyclic AMP agonists, known to diminish AII-AII coupling(1), did not change the relative labelling intensity of AII to bipolar cells. However, nitric oxide and cGMP agonists selectively reduced labelling in bipolar cells relative to AII amacrine cells, perhaps by acting at the bipolar side of this gap junction. This suggests that increased cGMP controls the network switching between rod and cone pathways associated with light adaptation.			MILLS, SL (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT OPHTHALMOL & VISUAL SCI,HOUSTON,TX 77030, USA.		Massey, Stephen/A-7217-2009					BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; BRINK PR, 1980, NATURE, V285, P101, DOI 10.1038/285101a0; BRUZZONE R, 1994, J CELL SCI, V107, P955; FLAGGNEWTON J, 1979, SCIENCE, V205, P406; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; KOISTINAHO J, 1993, NEUROSCIENCE, V57, P587, DOI 10.1016/0306-4522(93)90008-4; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; MASSEY SC, 1993, INVEST OPHTH VIS SCI, V34, P1382; MILLS SL, 1991, J COMP NEUROL, V304, P491, DOI 10.1002/cne.903040312; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Rae J L, 1979, Curr Top Eye Res, V1, P37; SHIELLS R, 1992, NEUROREPORT, V3, P845, DOI 10.1097/00001756-199210000-00006; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; TIAN N, 1994, J NEUROPHYSIOL, V71, P2258, DOI 10.1152/jn.1994.71.6.2258; TORK I, 1979, BRAIN RES, V169, P261, DOI 10.1016/0006-8993(79)91029-1; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VEENSTRA RD, 1994, CIRC RES, V75, P483, DOI 10.1161/01.RES.75.3.483; VOIGT T, 1987, J NEUROSCI, V7, P4115; WERNER R, 1989, P NATL ACAD SCI USA, V86, P5380, DOI 10.1073/pnas.86.14.5380; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; YAMAMOTO R, 1993, NEUROSCIENCE, V54, P189, DOI 10.1016/0306-4522(93)90393-T; YAMASHITA M, 1991, J NEUROSCI, V11, P2372; ZIMMERMAN AL, 1985, J MEMBRANE BIOL, V84, P269, DOI 10.1007/BF01871390	29	299	305	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					734	737		10.1038/377734a0	http://dx.doi.org/10.1038/377734a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477263				2022-12-24	WOS:A1995TB46900057
J	BRUCCOLERI, RE; HABER, E; NOVOTNY, J				BRUCCOLERI, RE; HABER, E; NOVOTNY, J			STRUCTURE OF ANTIBODY HYPERVARIABLE LOOPS REPRODUCED BY A CONFORMATIONAL SEARCH ALGORITHM	NATURE			English	Article									MASSACHUSETTS GEN HOSP,CELLULAR & MOLEC RES LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUCCOLERI RE, 1987, BIOPOLYMERS, V26, P137, DOI 10.1002/bip.360260114; BRUCCOLERI RE, 1985, MACROMOLECULES, V18, P2767, DOI 10.1021/ma00154a069; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1986, SCIENCE, V233, P755, DOI 10.1126/science.3090684; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DELAPAZ P, 1986, EMBO J, V5, P415, DOI 10.1002/j.1460-2075.1986.tb04227.x; DYSON HJ, 1985, NATURE, V318, P480; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; FINE R M, 1986, Proteins Structure Function and Genetics, V1, P342, DOI 10.1002/prot.340010408; Go N., 1970, MACROMOLECULES, V3, P178, DOI DOI 10.1021/MA60014A012; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; KABAT EA, 1972, P NATL ACAD SCI USA, V69, P960, DOI 10.1073/pnas.69.4.960; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; MOULT J, 1986, Proteins Structure Function and Genetics, V1, P146, DOI 10.1002/prot.340010207; NOVOTNY J, 1985, P NATL ACAD SCI USA, V82, P4592, DOI 10.1073/pnas.82.14.4592; NOVOTNY J, 1984, J MOL BIOL, V177, P787, DOI 10.1016/0022-2836(84)90049-4; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; PINCUS MR, 1982, P NATL ACAD SCI USA, V79, P5107, DOI 10.1073/pnas.79.16.5107; RASHIN AA, 1984, BIOPOLYMERS, V23, P1605, DOI 10.1002/bip.360230813; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SHIH HHL, 1985, P NATL ACAD SCI USA, V82, P1697, DOI 10.1073/pnas.82.6.1697; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; SMITHGILL SJ, 1987, J MOL BIOL, V194, P713, DOI 10.1016/0022-2836(87)90249-X; SNOW ME, 1986, PROTEIN-STRUCT FUNCT, V1, P276; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211	30	176	184	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 6	1988	335	6190					564	568		10.1038/335564a0	http://dx.doi.org/10.1038/335564a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q3412	3419534				2022-12-24	WOS:A1988Q341200061
J	JANDA, KD; SCHLOEDER, D; BENKOVIC, SJ; LERNER, RA				JANDA, KD; SCHLOEDER, D; BENKOVIC, SJ; LERNER, RA			INDUCTION OF AN ANTIBODY THAT CATALYZES THE HYDROLYSIS OF AN AMIDE BOND	SCIENCE			English	Article									PENN STATE UNIV, DEPT CHEM, UNIVERSITY PK, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	JANDA, KD (corresponding author), SCRIPPS CLIN & RES FDN, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA.							BARTLETT PA, 1983, BIOCHEMISTRY-US, V22, P4618, DOI 10.1021/bi00289a002; BENDER ML, 1961, J AM CHEM SOC, V83, P4183, DOI 10.1021/ja01481a021; BENKOVIC SJ, 1988, P NATL ACAD SCI USA, V85, P5355, DOI 10.1073/pnas.85.15.5355; BLANCHARD JS, 1980, BIOCHEMISTRY-US, V19, P3543, DOI 10.1021/bi00556a020; BRUICE TC, 1966, BIOORG MECH, pCH1; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; EDMUNDSON AB, 1984, MOL IMMUNOL, V21, P561, DOI 10.1016/0161-5890(84)90041-5; EDMUNDSON AB, 1985, MOL IMMUNOL, V22, P463, DOI 10.1016/0161-5890(85)90131-2; EDMUNDSON AB, 1986, CIBA F SYMP, V119, P107; Engvall E, 1980, Methods Enzymol, V70, P419; Fersht A., 1985, ENZYME STRUCTURE MEC; FISHBEIN JC, 1987, J AM CHEM SOC, V109, P5790, DOI 10.1021/ja00253a034; GALARDY RE, 1983, BIOCHEMISTRY-US, V22, P1990, DOI 10.1021/bi00277a039; GIBSON AL, 1985, MOL IMMUNOL, V22, P499, DOI 10.1016/0161-5890(85)90135-X; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; HILVERT D, 1988, P NATL ACAD SCI USA, V85, P4953, DOI 10.1073/pnas.85.14.4953; HILVERT D, 1988, J AM CHEM SOC, V110, P5593, DOI 10.1021/ja00224a066; JACKSON DY, 1988, J AM CHEM SOC, V110, P4841, DOI 10.1021/ja00222a060; JACOBS J, 1987, J AM CHEM SOC, V109, P2174, DOI 10.1021/ja00241a042; JANDA KD, 1988, J AM CHEM SOC, V110, P4835, DOI 10.1021/ja00222a056; JENCKS WP, 1972, CHEM REV, V72, P705, DOI 10.1021/cr60280a004; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P354; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Landsteiner K, 1936, SPECIFICITY SEROLOGI; LERNER RA, 1987, TRENDS BIOCHEM SCI, V12, P427, DOI 10.1016/0968-0004(87)90208-8; LERNER RA, 1983, 18TH P SOLV C CHEM, P43; LERNER RA, IN PRESS BIOASSAYS; LIENHARD GE, 1973, SCIENCE, V180, P149, DOI 10.1126/science.180.4082.149; Modro TA, 1981, ACS SYM SER, V171, P619; NAPPER AD, 1987, SCIENCE, V237, P1041, DOI 10.1126/science.3616626; NISONOFF A, 1957, J AM CHEM SOC, V79, P1616, DOI 10.1021/ja01564a025; PAULING L, 1948, Am Sci, V36, P51; POLJAK RJ, 1974, P NATL ACAD SCI USA, V71, P3440, DOI 10.1073/pnas.71.9.3440; POLLACK RM, 1970, J AM CHEM SOC, V92, P7190; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; POTTER M, 1977, ADV IMMUNOL, V25, P141; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7018, DOI 10.1021/ja00829a034; SEGAL DM, 1974, P NATL ACAD SCI USA, V71, P4298, DOI 10.1073/pnas.71.11.4298; TRAMONTANO A, 1988, J AM CHEM SOC, V110, P2282, DOI 10.1021/ja00215a045; TRAMONTANO A, 1987, COLD SPRING HARB SYM, V52, P91, DOI 10.1101/SQB.1987.052.01.013; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; TRAMONTANO A, 1986, P NATL ACAD SCI USA, V83, P6736, DOI 10.1073/pnas.83.18.6736; Williams J W, 1979, Methods Enzymol, V63, P437; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002	44	224	246	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	1988	241	4870					1188	1191		10.1126/science.3413482	http://dx.doi.org/10.1126/science.3413482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9021	3413482				2022-12-24	WOS:A1988P902100028
J	OTTE, AP; KOSTER, CH; SNOEK, GT; DURSTON, AJ				OTTE, AP; KOSTER, CH; SNOEK, GT; DURSTON, AJ			PROTEIN KINASE-C MEDIATES NEURAL INDUCTION IN XENOPUS-LAEVIS	NATURE			English	Article											OTTE, AP (corresponding author), NETHERLANDS INST DEV BIOL,HUBRECHT LAB,UPPSALALAAN 8,3584 CT UTRECHT,NETHERLANDS.							AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; DAVIDS M, 1987, ROUX ARCH DEV BIOL, V196, P137, DOI 10.1007/BF00402036; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; FLICKINGER RA, 1949, J EXP ZOOL, V112, P165; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; NIEDEL J E, 1986, P47; Nieuwkoop P.D., 1977, Current Topics Dev Biol, V11, P115, DOI 10.1016/S0070-2153(08)60744-9; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PARKER PJ, 1984, EMBO J, V3, P953, DOI 10.1002/j.1460-2075.1984.tb01913.x; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SCHAKELFORD G, 1987, CELL, V50, P89; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SNOEK GT, 1986, DEV BIOL, V115, P282, DOI 10.1016/0012-1606(86)90249-6; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	23	108	108	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 18	1988	334	6183					618	620		10.1038/334618a0	http://dx.doi.org/10.1038/334618a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7090	3405309				2022-12-24	WOS:A1988P709000065
J	YEN, TJ; MACHLIN, PS; CLEVELAND, DW				YEN, TJ; MACHLIN, PS; CLEVELAND, DW			AUTOREGULATED INSTABILITY OF BETA-TUBULIN MESSENGER-RNAS BY RECOGNITION OF THE NASCENT AMINO TERMINUS OF BETA-TUBULIN	NATURE			English	Article											YEN, TJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Cleveland, Don/AAN-9783-2021	Yen, Tim/0000-0003-2159-0997; Cleveland, Don/0000-0002-1934-3682				BIRD RC, 1986, BIOCHEM CELL BIOL, V64, P99, DOI 10.1139/o86-017; CAPASSO O, 1987, EMBO J, V6, P1825, DOI 10.1002/j.1460-2075.1987.tb02437.x; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; CARON JM, 1985, NATURE, V317, P648, DOI 10.1038/317648a0; CLEVELAND DW, 1987, J CELL BIOL, V104, P381, DOI 10.1083/jcb.104.3.381; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GRAVES RA, 1987, CELL, V48, P795; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LAU JTY, 1985, MOL CELL BIOL, V5, P1611, DOI 10.1128/MCB.5.7.1611; LEE MG, 1983, CELL, V33, P477; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MILLER AD, 1984, CELL, V36, P51; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PITTENGER MF, 1985, J CELL BIOL, V101, P1941, DOI 10.1083/jcb.101.5.1941; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	22	321	333	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 18	1988	334	6183					580	585		10.1038/334580a0	http://dx.doi.org/10.1038/334580a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7090	3405308				2022-12-24	WOS:A1988P709000052
J	MCCORMICK, DA; PAPE, HC				MCCORMICK, DA; PAPE, HC			ACETYLCHOLINE INHIBITS IDENTIFIED INTERNEURONS IN THE CAT LATERAL GENICULATE-NUCLEUS	NATURE			English	Article											MCCORMICK, DA (corresponding author), YALE UNIV,SCH MED,NEUROANAT SECT,333 CEDAR ST,NEW HAVEN,CT 06510, USA.		McCormick, David A/J-2649-2015; Kobelt, Liza/F-5926-2011	McCormick, David A/0000-0002-9803-8335; 				AHLSEN G, 1984, J PHYSIOL-LONDON, V347, P593, DOI 10.1113/jphysiol.1984.sp015085; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; DELIMA AD, 1985, EXP BRAIN RES, V59, P206, DOI 10.1007/BF00237681; DELIMA AD, 1987, J COMP NEUROL, V259, P92, DOI 10.1002/cne.902590107; EGAN TM, 1986, NATURE, V319, P405, DOI 10.1038/319405a0; EYSEL UT, 1986, J PHYSIOL-LONDON, V370, P233, DOI 10.1113/jphysiol.1986.sp015932; EYSEL UT, 1987, J PHYSIOL-LONDON, V388, P199, DOI 10.1113/jphysiol.1987.sp016610; FRANCESCONI W, IN PRESS J NEUROPHYS; GODFRAIND JM, 1978, BRIT J PHARMACOL, V63, P295, DOI 10.1111/j.1476-5381.1978.tb09760.x; GUILLERY RW, 1966, J COMP NEUROL, V128, P21, DOI 10.1002/cne.901280104; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; MCCORMICK DA, 1986, NATURE, V319, P402, DOI 10.1038/319402a0; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; PAPE HC, 1988, BRAIN RES, V440, P79, DOI 10.1016/0006-8993(88)91160-2; PHILLIS JW, 1967, J PHYSIOL-LONDON, V192, P695, DOI 10.1113/jphysiol.1967.sp008326; RYE DB, 1987, J COMP NEUROL, V259, P483, DOI 10.1002/cne.902590403; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SINGER W, 1972, BRAIN RES, V41, P214, DOI 10.1016/0006-8993(72)90632-4; SINGER W, 1973, BRAIN RES, V61, P35, DOI 10.1016/0006-8993(73)90514-3; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1	26	213	214	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 21	1988	334	6179					246	248		10.1038/334246a0	http://dx.doi.org/10.1038/334246a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3802	3398922				2022-12-24	WOS:A1988P380200054
J	HALL, CL				HALL, CL			PENICILLAMINE NEPHROPATHY	BRITISH MEDICAL JOURNAL			English	Letter											HALL, CL (corresponding author), ROYAL UNITED HOSP,BATH BA1 3N6,ENGLAND.							DEQUEKER J, 1984, J RHEUMATOL, V11, P282; EMERY P, 1988, BRIT MED J, V296, P1538, DOI 10.1136/bmj.296.6635.1538-c; NUOTIO P, 1986, SCAND J RHEUMATOL, V15, P255, DOI 10.3109/03009748609092588	3	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1988	297	6641					137	137		10.1136/bmj.297.6641.137-e	http://dx.doi.org/10.1136/bmj.297.6641.137-e			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1954	3408946	Green Published, Green Submitted, Bronze			2022-12-24	WOS:A1988P195400055
J	ROBINSON, JC; CASALINO, LP				ROBINSON, JC; CASALINO, LP			THE GROWTH OF MEDICAL GROUPS PAID THROUGH CAPITATION IN CALIFORNIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNIVERSAL HEALTH-INSURANCE; MANAGED COMPETITION; PROMOTE QUALITY; ECONOMY; 1990S; PLAN	Background. In California, it is common for health maintenance organizations (HMOs) to contract with large medical groups that are paid through capitation and are responsible for managing a full spectrum of medical services. Methods. We studied six large medical groups in California - Bristol Park Medical, Friendly Hills HealthCare Network, HealthCare Partners Medical Group, Mullikin Medical Centers, Palo Alto Medical Foundation, and San Jose Medical Group - that are paid through capitation and that are growing as a result of contracts with managed-care organizations. We conducted interviews and obtained data on factors such as patient enrolment, capitation and other revenue, numbers of days spent by enrollees in the hospital, and numbers of visits to physicians per enrollee. Results Between 1990 and 1994, the number of HMO enrollees whose care was paid for through capitation in the six medical groups increased by 91 percent, from 398,359 to 759,474. In 1994, the mean number of hospital days per 1000 HMO enrollees ranged from 120 to 149 for non-Medicare patients and from 643 to 936 days for Medicare patients. By comparison, in 1993 the mean numbers of hospital days per 1000 HMO enrollees not covered by Medicare were 232 for California and 297 for the United States; for HMO enrollees covered by Medicare, the numbers were 1337 for California and 1698 for the United States. In 1994, the average annual number of visits to physicians for HMO patients in the six groups not covered by Medicare ranged from 3.1 to 3.9; for Medicare patients, it ranged from 6.8 to 9.3; these rates were slightly lower than statewide and national rates. Four of the groups have sold their assets (such as facilities, supplies, equipment, and patients' charts) to outside investors; the physicians remain employed by physician-owned professional corporations. Conclusions. Medical groups paid through capitation offer a model for the status of physicians in managed-care systems that differs from the employee status offered by staff-model HMOs and the subcontractor status offered by HMOs that negotiate directly with individual physicians. Despite their growth, such medical groups in California face substantial challenges, such as obtaining the financial assets necessary to sustain rapid growth.			ROBINSON, JC (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,418 WARREN HALL,BERKELEY,CA 94720, USA.		Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P24, DOI 10.1377/hlthaff.12.suppl_1.24; HODAPP TE, 1994, HMOS 1995 RIGHT PLAC; KRONICK R, 1993, NEW ENGL J MED, V328, P148, DOI 10.1056/NEJM199301143280225; MORRISON EM, 1995, CONSOLIDATION PROVID; 1994, MARION MERRELL DOW M; 1994, CAPITATION STRATEGY	8	131	132	0	10	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	1995	333	25					1684	1687		10.1056/NEJM199512213332506	http://dx.doi.org/10.1056/NEJM199512213332506			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TL401	7477222				2022-12-24	WOS:A1995TL40100006
J	OLSEN, JH; BOICE, JD; SEERSHOLM, N; BAUTZ, A; FRAUMENI, JF				OLSEN, JH; BOICE, JD; SEERSHOLM, N; BAUTZ, A; FRAUMENI, JF			CANCER IN THE PARENTS OF CHILDREN WITH CANCER	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOFT-TISSUE SARCOMA; CHILDHOOD-CANCER; BREAST-CANCER; RETINOBLASTOMA PATIENTS; RELATIVES; RISK; MORTALITY; SURVIVORS; FAMILIES; MOTHERS	Background. Certain types of cancer in children and young adults have been linked with an increased risk of cancer in close relatives. However, the relation between childhood cancer and familial risk remains to be fully assessed in population-based studies. Methods. We conducted a nationwide study in Denmark of 11,380 parents of children with cancer. The children were identified from records in the Danish Cancer Registry; their parents were identified from population registers. The occurrence and rate of cancer in the parents were determined with use of the Cancer Registry's files and compared with national incidence rates for various categories of tumor. Results. Overall, 1445 cancers were diagnosed in the parents, as compared with 1496 expected from national incidence rates, to yield standardized incidence ratios of 1.0 (95 percent confidence interval, 0.9 to 1.0) for all parents, 1.0 for mothers, and 0.9 for fathers. The lower rate of cancer among fathers reflected their lower standardized incidence ratio for lung cancer (0.8; 95 percent confidence interval, 0.6 to 0.9), as calculated from 114 observations. Conclusions. Genetic determinants are important in several types of childhood cancer, but the genetic susceptibility to tumors does not generally extend to the parents of children with cancer, nor do the patterns of incidence point to the influence of shared environmental factors. Thus, cancer in children should not be viewed as a general marker for an increased risk of cancer in the patients' parents.	NCI,EPIDEMIOL & BIOSTAT PROGRAM,BETHESDA,MD	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	OLSEN, JH (corresponding author), DANISH CANC SOC,DIV CANC EPIDEMIOL,STRANDBOULEVARDEN 49,DK-2100 COPENHAGEN,DENMARK.			Olsen, Jorgen Helge/0000-0001-9633-5662				[Anonymous], 1976, INT CLASSIFICATION D; BATAILLE V, 1995, BRIT J DERMATOL, V132, P134, DOI 10.1111/j.1365-2133.1995.tb08639.x; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BIRCH JM, 1984, BRIT J CANCER, V49, P325, DOI 10.1038/bjc.1984.51; BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; BROWN PD, 1989, INT J EPIDEMIOL, V18, P546, DOI 10.1093/ije/18.3.546; BURKE E, 1991, CANCER-AM CANCER SOC, V67, P1467, DOI 10.1002/1097-0142(19910301)67:5<1467::AID-CNCR2820670535>3.0.CO;2-4; DERKINDEREN DJ, 1988, INT J CANCER, V41, P499, DOI 10.1002/ijc.2910410405; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; EWERTZ M, 1990, INT J CANCER, V46, P597, DOI 10.1002/ijc.2910460408; FARWELL J, 1984, NEW ENGL J MED, V311, P749, DOI 10.1056/NEJM198409203111201; GARBER JE, 1991, CANCER RES, V51, P6094; GRUNDY GW, 1973, JNCI-J NATL CANCER I, V51, P767, DOI 10.1093/jnci/51.3.767; HARTLEY AL, 1993, CANCER, V72, P923, DOI 10.1002/1097-0142(19930801)72:3<923::AID-CNCR2820720343>3.0.CO;2-Y; HARTLEY AL, 1986, BRIT J CANCER, V54, P819, DOI 10.1038/bjc.1986.245; HAYASAKA S, 1986, BRIT J OPHTHALMOL, V70, P107, DOI 10.1136/bjo.70.2.107; Jensen O M, 1985, Natl Cancer Inst Monogr, V68, P245; KNUDSON AG, 1985, CANCER RES, V45, P1437; LI FP, 1982, JAMA-J AM MED ASSOC, V247, P2692, DOI 10.1001/jama.247.19.2692; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; MATTHIESSEN PC, 1984, GROWTH POPULATION CA; MOUTOU C, 1994, J MED GENET, V31, P429, DOI 10.1136/jmg.31.6.429; OLSEN JH, 1990, HUM GENET, V85, P283; PASTORE G, 1987, CANCER LETT, V37, P17, DOI 10.1016/0304-3835(87)90141-8; PERSHAGEN G, 1992, INT J EPIDEMIOL, V21, P1, DOI 10.1093/ije/21.1.1; ROTHMAN K, 1979, DHHS NIH791649 PUBL; SEVERSON RK, 1993, CANCER EPIDEM BIOMAR, V2, P433; STRONG LC, 1984, J NATL CANCER I, V73, P303, DOI 10.1093/jnci/73.2.303; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; THOMPSON EN, 1988, BRIT J CANCER, V57, P127, DOI 10.1038/bjc.1988.25; 1957, MANUAL INT STATISTIC	32	77	79	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	1995	333	24					1594	1599		10.1056/NEJM199512143332403	http://dx.doi.org/10.1056/NEJM199512143332403			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK065	7477194				2022-12-24	WOS:A1995TK06500003
J	NELLES, J; HARDING, T				NELLES, J; HARDING, T			PREVENTING HIV TRANSMISSION IN PRISON - A TALE OF MEDICAL DISOBEDIENCE AND SWISS PRAGMATISM	LANCET			English	Editorial Material									INST UNIV MED LEGALE,GENEVA,SWITZERLAND	University of Geneva	NELLES, J (corresponding author), UNIV BERN,PSYCHIAT KLIN,BERN,SWITZERLAND.							[Anonymous], 1991, Lancet, V337, P647; CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; MARTIN V, 1994, TUBERCLE LUNG DIS, V75, P49, DOI 10.1016/0962-8479(94)90102-3; NELLES J, 1995, DROGEN HIV PRAVENTIO; POWER KG, 1992, BRIT J ADDICT, V87, P35; SCHALLER S, 1995, MED SOC PREVEN, V40, P298; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Turnbull P. J., 1991, PRISON HIV AIDS RISK; VALWAY SE, 1994, AM J EPIDEMIOL, V140, P113, DOI 10.1093/oxfordjournals.aje.a117222; 1990, HIV DISEASE CORRECTI; 1993, WHO GUIDELINES HIV I	12	27	27	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 9	1995	346	8989					1507	1508		10.1016/S0140-6736(95)92047-1	http://dx.doi.org/10.1016/S0140-6736(95)92047-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ291	7491043				2022-12-24	WOS:A1995TJ29100006
J	DINCHUK, JE; CAR, BD; FOCHT, RJ; JOHNSTON, JJ; JAFFEE, BD; COVINGTON, MB; CONTEL, NR; ENG, VM; COLLINS, RJ; CZERNIAK, PM; GORRY, SA; TRZASKOS, JM				DINCHUK, JE; CAR, BD; FOCHT, RJ; JOHNSTON, JJ; JAFFEE, BD; COVINGTON, MB; CONTEL, NR; ENG, VM; COLLINS, RJ; CZERNIAK, PM; GORRY, SA; TRZASKOS, JM			RENAL ABNORMALITIES AND AN ALTERED INFLAMMATORY RESPONSE IN MICE LACKING CYCLOOXYGENASE-II	NATURE			English	Article							RAT PREOVULATORY FOLLICLES; PROSTAGLANDIN SYNTHASE; HORMONAL-REGULATION; ARACHIDONIC-ACID; MESSENGER-RNA; H SYNTHASE; CELLS; MOUSE; EXPRESSION; INDUCTION	PROSTAGLANDINS have wide-ranging effects in the body and are thought to be important mediators of inflammation. Cyclooxygenase (COX) plays a keg regulatory role in prostaglandin synthesis, and occurs in both constitutive (COX-1) and inducible (COX-2) isoforms(1,2). COX-1 is thought to provide cytoprotective effects(3), whereas COX-2 is both inducible and the major isoform of inflammatory cells(4), Reduction of prostaglandin production by inhibition of cyclooxygenases appears to be the main mechanism of action of most non-steroidal anti-inflammatory drugs (NSAIDS)(5), Here we present an animal model of COX-2 deficiency that was generated by gene targeting. Defects in null mice correlating with reduced viability included renal alterations, characteristic of renal dysplasia (100% penetrance), and cardiac fibrosis (50% penetrance). Female Cox-2 -/- mice were infertile, COX-2 deficiency failed to alter inflammatory responses in several standard models, but striking mitigation of endotoxin-induced hepatocellular cytotoxicity was observed.	UNIV PENN, ANIM RESOURCES LAB, PHILADELPHIA, PA 19104 USA; DUPONT MERCK PHARMACEUT CO, WILMINGTON, DE 19880 USA	University of Pennsylvania; DuPont	DINCHUK, JE (corresponding author), DUPONT MERCK PHARMACEUT CO, GLENOLDEN, PA 19036 USA.							ABRAMSON SB, 1989, ARTHRITIS RHEUM, V32, P1, DOI 10.1002/anr.1780320102; ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; CALHOUN W, 1987, AGENTS ACTIONS, V21, P306, DOI 10.1007/BF01966499; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; DEWITT DL, 1993, AM J MED S, V40, pS40; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; GANS KR, 1990, J PHARMACOL EXP THER, V254, P180; GIERSE JK, 1995, BIOCHEM J, V305, P479, DOI 10.1042/bj3050479; GOULET JL, 1994, P NATL ACAD SCI USA, V91, P12852, DOI 10.1073/pnas.91.26.12852; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; KINKAIDSMITH P, 1993, DISEASES KIDNEY, P1099; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN M, 1994, KIDNEY INT, V45, P150, DOI 10.1038/ki.1994.18; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PETERS T, 1990, EUR J BIOCHEM, V191, P583, DOI 10.1111/j.1432-1033.1990.tb19161.x; RAMIREZSOLIS R, 1993, GUIDE TECHNIQUES MOU, P855; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; SIROIS J, 1992, J BIOL CHEM, V267, P11586; SIROIS J, 1993, J BIOL CHEM, V268, P12199; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; TIEGS G, 1988, BIOCHEM PHARMACOL, V37, P2569, DOI 10.1016/0006-2952(88)90248-1; WONG WYL, 1992, ENDOCRINOLOGY, V130, P3512, DOI 10.1210/en.130.6.3512; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YOUNG JM, 1984, J INVEST DERMATOL, V82, P367, DOI 10.1111/1523-1747.ep12260709	30	845	859	0	24	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					406	409		10.1038/378406a0	http://dx.doi.org/10.1038/378406a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477380				2022-12-24	WOS:A1995TF89300064
J	CAO, WX; TYKODI, SS; ESSER, MT; BRACIALE, VL; BRACIALE, TJ				CAO, WX; TYKODI, SS; ESSER, MT; BRACIALE, VL; BRACIALE, TJ			PARTIAL ACTIVATION OF CD8(+) T-CELLS BY A SELF-DERIVED PEPTIDE	NATURE			English	Article							LIGAND	T cells are normally activated when the peptide for which they are specific is presented to them in the context of the appropriate major histocompatibility complex (MHC) (class I and Class II for CD8(+) and CD4(+) T cells, respectively). An increasing body of evidence indicates that structural homologues of the immunogenic peptide can partially activate or antagonize CD4(+) T cells(1-3). CD8(+) T cells may also be partially antagonized by such peptides(4,5), and self-derived peptides of this type may play a role in CD8(+) T cell selection in the thymus(6-8). Activated CD8(+) T cells lyse their targets by perforin-dependent granule exocytosis(9,10) and by inducing apoptosis mediated bs CD95 (also known as Fas or APO1) with its ligand (CD95L)(11-15). Here we show that a clone of K-d-restricted CD8(+) T cells specific for influenza haemagglutinin, which can also be activated in a crossreactive manner by a peptide derived from a myeloma tumour immunoglobulin heavy-chain variable region (IgVH) to kill by both routes(16), kills only by the CD95-CD95L pathway when stimulated by the corresponding germline IgVH peptide. As this germline IgVH peptide differs from the tumour peptide only at a single position buried in the MHC-binding be triggered independently of the perforin-mediated pathway, and can be selectively affected by changes in MHC conformation.	UNIV VIRGINIA,HLTH SCI CTR,BELRNE B CARTER CTR IMMUNOL RES,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT PATHOL,CHARLOTTESVILLE,VA 22908; WASHINGTON UNIV,SCH MED,DIV BIOL & BIOMED SCI,PROGRAM IMMUNOL,ST LOUIS,MO 63110	University of Virginia; University of Virginia; University of Virginia; Washington University (WUSTL)								BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BODMER HC, 1988, CELL, V52, P253, DOI 10.1016/0092-8674(88)90514-4; CAO WX, 1994, J EXP MED, V179, P195, DOI 10.1084/jem.179.1.195; CHATTOPADHYAY S, 1993, J EXP MED, V179, P213; CRISPE IN, 1994, IMMUNITY, V1, P347; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; ITO N, 1991, CELL, V66, P233; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OSTERGAARD HL, 1987, NATURE, V330, P71, DOI 10.1038/330071a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STAIDER T, 1994, J IMMUNOL, V152, P1127; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; WALSH CM, 1994, J IMMUNOL, V153, P2506	29	90	90	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					295	298		10.1038/378295a0	http://dx.doi.org/10.1038/378295a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE858	7477351				2022-12-24	WOS:A1995TE85800053
J	HYRIEN, O; MARIC, C; MECHALI, M				HYRIEN, O; MARIC, C; MECHALI, M			TRANSITION IN SPECIFICATION OF EMBRYONIC METAZOAN DNA-REPLICATION ORIGINS	SCIENCE			English	Article							RIBOSOMAL-RNA GENES; SACCHAROMYCES-CEREVISIAE; EGG EXTRACTS; 3' END; INITIATION; SITES; DOMAIN; SPACER	In early Xenopus embryos, in which ribosomal RNA genes (rDNA) are not transcribed, rDNA replication initiates and terminates at 9- to 12-kilobase pair intervals, with no detectable dependence on specific DNA sequences. Resumption of ribosomal RNA (rRNA) synthesis at late blastula and early gastrula is accompanied by a specific repression of replication initiation within transcription units; the frequency of initiation within intergenic spacers remains as high as in early blastula, These results demonstrate that for rRNA genes, circumscribed zones of replication initiation emerge in intergenic DNA during the time in metazoan development when the chromatin is remodeled to allow gene transcription.			HYRIEN, O (corresponding author), INST JACQUES MONOD, F-75251 PARIS 05, FRANCE.		Hyrien, Olivier/R-5108-2017	Hyrien, Olivier/0000-0001-8879-675X				BENARD M, 1995, NUCLEIC ACIDS RES, V23, P1447, DOI 10.1093/nar/23.9.1447; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1994, CURR OPIN GENET DEV, V4, P196, DOI 10.1016/S0959-437X(05)80045-0; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BURHANS WC, 1990, CELL, V62, P955, DOI 10.1016/0092-8674(90)90270-O; CALLAN HG, 1972, PROC R SOC SER B-BIO, V181, P19, DOI 10.1098/rspb.1972.0039; Depamphilis Melvin L., 1993, Trends in Cell Biology, V3, P161, DOI 10.1016/0962-8924(93)90137-P; DEWINTER RFJ, 1986, NUCLEIC ACIDS RES, V14, P6041, DOI 10.1093/nar/14.15.6041; DIJKWEL PA, 1994, NUCLEIC ACIDS RES, V22, P4989, DOI 10.1093/nar/22.23.4989; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; GILBERT DM, 1995, MOL CELL BIOL, V15, P2942; HAASE SB, 1994, MOL CELL BIOL, V14, P2516, DOI 10.1128/MCB.14.4.2516; HAMLIN JL, 1995, CURR OPIN GENET DEV, V5, P153, DOI 10.1016/0959-437X(95)80002-6; HERNANDEZ P, 1993, EMBO J, V12, P1475, DOI 10.1002/j.1460-2075.1993.tb05791.x; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; KELLY RE, 1995, MOL CELL BIOL, V15, P4136; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; LINSKENS MHK, 1990, NUCLEIC ACIDS RES, V18, P647, DOI 10.1093/nar/18.3.647; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600; LUCCHINI R, 1992, MOL CELL BIOL, V12, P4288, DOI 10.1128/MCB.12.10.4288; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; PAN WJ, 1995, MOL CELL BIOL, V15, P3372; REEDER RH, 1990, TRENDS GENET, V6, P390, DOI 10.1016/0168-9525(90)90298-K; SHIOKAWA K, 1981, DEV GROWTH DIFFER, V23, P579; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; TASHEVA ES, 1994, MOL CELL BIOL, V14, P5628, DOI 10.1128/MCB.14.9.5628; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; WIESENDANGER B, 1994, NUCLEIC ACIDS RES, V22, P5038, DOI 10.1093/nar/22.23.5038; WU CL, 1993, BIOCHIM BIOPHYS ACTA, V1174, P258, DOI 10.1016/0167-4781(93)90194-I; YOON Y, 1995, MOL CELL BIOL, V15, P2482	34	265	266	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	1995	270	5238					994	997		10.1126/science.270.5238.994	http://dx.doi.org/10.1126/science.270.5238.994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481806				2022-12-24	WOS:A1995TD87800051
J	RAETZ, CRH; RODERICK, SL				RAETZ, CRH; RODERICK, SL			A LEFT-HANDED PARALLEL BETA-HELIX IN THE STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE	SCIENCE			English	Article							LIPID-A BIOSYNTHESIS; ESCHERICHIA-COLI; ENDOTOXIN BIOSYNTHESIS; 1ST STEP; PROTEIN; GENE; CONFORMATION; REFINEMENT; SHEETS; LPXA	UDP-N-acetylglucosamine 3-O-acyltransferase (LpxA) catalyzes the transfer of (R)-3-hydroxymyristic acid from its acyl carrier protein thioester to UDP-N-acetylglucosamine. LpxA is the first enzyme in the lipid A biosynthetic pathway and is a target for the design of antibiotics. The x-ray crystal structure of LpxA has been determined to 2.6 angstrom resolution and reveals a domain motif composed of parallel beta strands, termed a left-handed parallel beta helix (L beta H). This unusual fold displays repeated violations of the protein folding constraint requiring right-handed crossover connections between strands of parallel beta sheets and may be present in other enzymes that share amino acid sequence homology to the repeated hexapeptide motif of LpxA.	ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,BRONX,NY 10461; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Yeshiva University; Albert Einstein College of Medicine; Duke University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38328] Funding Source: Medline; NIGMS NIH HHS [GM51310] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLIGNET J, 1995, ANTIMICROB AGENTS CH, V39, P2027, DOI 10.1128/AAC.39.9.2027; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; CHOTHIA C, 1973, J MOL BIOL, V75, P295, DOI 10.1016/0022-2836(73)90022-3; CHOU KC, 1987, J MOL BIOL, V205, P241; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; CROWELL DN, 1986, J BACTERIOL, V168, P152, DOI 10.1128/jb.168.1.152-159.1986; DICKER IB, 1992, MOL MICROBIOL, V6, P817, DOI 10.1111/j.1365-2958.1992.tb01532.x; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FUREY W, 1995, AM CRYSTALLOGRAPHIC, P73; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KELLY TM, 1993, J BIOL CHEM, V268, P19866; NAGANO K, 1977, J MOL BIOL, V109, P235, DOI 10.1016/S0022-2836(77)80032-6; PARENT R, 1992, J BACTERIOL, V174, P2891, DOI 10.1128/JB.174.9.2891-2897.1992; PFITZNER U, 1995, PROTEINS, V22, P191, DOI 10.1002/prot.340220212; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, UNPUB; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1976, P NATL ACAD SCI USA, V73, P2619, DOI 10.1073/pnas.73.8.2619; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; STERNBERG MJE, 1977, J MOL BIOL, V110, P269, DOI 10.1016/S0022-2836(77)80072-7; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; VUORIO R, 1991, FEBS LETT, V292, P90, DOI 10.1016/0014-5793(91)80841-P; VUORIO R, 1994, FEBS LETT, V337, P289, DOI 10.1016/0014-5793(94)80211-4; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; YOUNG K, 1991, J BACTERIOL, V173, P3609, DOI 10.1128/JB.173.12.3609-3614.1991; YOUNG K, 1993, FED PROC, V7, P1252	33	297	303	0	7	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					997	1000		10.1126/science.270.5238.997	http://dx.doi.org/10.1126/science.270.5238.997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481807				2022-12-24	WOS:A1995TD87800052
J	JORGENSEN, EM; HARTWIEG, E; SCHUSKE, K; NONET, ML; JIN, YS; HORVITZ, HR				JORGENSEN, EM; HARTWIEG, E; SCHUSKE, K; NONET, ML; JIN, YS; HORVITZ, HR			DEFECTIVE RECYCLING OF SYNAPTIC VESICLES IN SYNAPTOTAGMIN MUTANTS OF CAENORHABDITIS-ELEGANS	NATURE			English	Article							C-ELEGANS; MEMBRANE-PROTEIN; DOCKING; UNC-104; TISSUE	SYNAPTOTAGMIN, an integral membrane protein of the synaptic vesicle(1,2), binds calcium and interacts with proteins of the plasma membrane(4-6). These observations suggest several possible functions for synaptotagmin in synaptic vesicle dynamics: it could facilitate exocytosis by promoting calcium-dependent fusion(3), inhibit exocytosis by preventing fusion(7), or facilitate endocytosis of synaptic vesicles from the plasma membrane by acting as a receptor for the endocytotic proteins of the clathrin AP2 complex(8). Here we show that synaptic vesicles are depleted at synaptic terminals in synaptotagmin mutants of the nematode Caenorhabditis elegans. This depletion is not caused by a defect in transport or by increased synaptic vesicle release, but rather by a defect in retrieval of synaptic vesicles from the plasma membrane. Thus we propose that, as well as being involved in exocytosis, synaptotagmin functions in vesicular recycling.	MIT,HOWARD HUGHES MED INST,DEPT BIOL,CAMBRIDGE,MA 02139; WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	JORGENSEN, EM (corresponding author), UNIV UTAH,DEPT BIOL,SALT LAKE CITY,UT 84112, USA.			Jin, Yishi/0000-0002-9371-9860				AVERY L, 1993, GENETICS, V133, P897; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CLARK SG, 1994, GENETICS, V137, P987; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; LEVEQUE C, 1992, P NATL ACAD SCI USA, V89, P3625, DOI 10.1073/pnas.89.8.3625; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MUNDIGL O, 1994, CURR OPIN CELL BIOL, V6, P561, DOI 10.1016/0955-0674(94)90077-9; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; RAND JB, 1984, GENETICS, V106, P227; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	26	263	273	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					196	199		10.1038/378196a0	http://dx.doi.org/10.1038/378196a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477324				2022-12-24	WOS:A1995TD75900057
J	HIRSCHL, RB; PRANIKOFF, T; GAUGER, P; SCHREINER, RJ; DECHERT, R; BARTLETT, RH				HIRSCHL, RB; PRANIKOFF, T; GAUGER, P; SCHREINER, RJ; DECHERT, R; BARTLETT, RH			LIQUID VENTILATION IN ADULTS, CHILDREN, AND FULL-TERM NEONATES	LANCET			English	Note								We evaluated the safety and efficacy of partial liquid ventilation in a series of 19 adults, children, and neonates who were in respiratory failure and on extracorporeal life support. During partial liquid ventilation, the alveolar-arterial oxygen difference decreased from 590 (SE 25) to 471 (42) mm Hg (p=0 . 0002) and static pulmonary compliance increased from 0 . 18 (0 . 04) to 0 . 29 (0 . 04) mL cm H2O-1 kg(-1) (p=0 . 0002). 11 patients (58%) survived. These preliminary data suggest that partial liquid ventilation can be safely used in patients with severe respiratory failure and may improve lung function.	UNIV MICHIGAN, DEPT SURG, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan			Gauger, Paul/W-8176-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015434] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD15434] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTLETT RH, 1990, CURR PROB SURG, V27, P623; FUHRMAN BP, 1991, CRIT CARE MED, V19, P712, DOI 10.1097/00003246-199105000-00019; GATTINONI L, 1993, JAMA-J AM MED ASSOC, V269, P2122, DOI 10.1001/jama.269.16.2122; GREENSPAN JS, 1990, J PEDIATR-US, V117, P106, DOI 10.1016/S0022-3476(05)82457-6; HIRSCHL RB, 1994, SURGERY, V116, P159; HIRSCHL RB, 1995, CHEST, V108, P500, DOI 10.1378/chest.108.2.500; LOWE CA, 1986, J APPL PHYSIOL, V60, P154, DOI 10.1152/jappl.1986.60.1.154; SHAFFER TH, 1992, PEDIATR PULM, V14, P102, DOI 10.1002/ppul.1950140208	8	157	162	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	1995	346	8984					1201	1202		10.1016/S0140-6736(95)92903-7	http://dx.doi.org/10.1016/S0140-6736(95)92903-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC976	7475663				2022-12-24	WOS:A1995TC97600013
J	FILICE, G; CEREDA, PM; VARNIER, OE				FILICE, G; CEREDA, PM; VARNIER, OE			INFECTION OF RABBITS WITH HUMAN IMMUNODEFICIENCY VIRUS	NATURE			English	Article									SCH MED,INST MICROBIOL,I-27100 PAVIA,ITALY; SCH MED,INST MICROBIOL,HUMAN RETROVIROL LAB,I-16132 GENOVA,ITALY		FILICE, G (corresponding author), IST RICOVERO & CURA CARATTERE SCI SAN MATTEO,INST INFECT DIS,I-27100 PAVIA,ITALY.							ALTER HJ, 1984, SCIENCE, V226, P549, DOI 10.1126/science.6093251; ASJO B, 1987, VIROLOGY, V157, P359, DOI 10.1016/0042-6822(87)90278-9; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; CEREDA PM, 1984, MICROBIOLOGICA, V7, P107; CLAPHAM PR, 1987, VIROLOGY, V158, P44, DOI 10.1016/0042-6822(87)90236-4; DAVIS LG, 1986, BASIC METHODS MOL BI, P44; DESROSIERS RC, 1987, REV INFECT DIS, V9, P438; FULTZ PN, 1986, J INFECT DIS, V154, P896, DOI 10.1093/infdis/154.5.896; FULTZ PN, 1986, J VIROL, V58, P116, DOI 10.1128/JVI.58.1.116-124.1986; GAJDUSEK DC, 1985, LANCET, V1, P55; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; KOTANI S, 1986, INT J CANCER, V37, P843, DOI 10.1002/ijc.2910370608; KULAGA H, 1988, P NATL ACAD SCI USA, V85, P4455, DOI 10.1073/pnas.85.12.4455; MATTHEWS TJ, 1987, AIDS RES HUM RETROV, V3, P197, DOI 10.1089/aid.1987.3.197; MORROW WJW, 1987, J GEN VIROL, V68, P2253, DOI 10.1099/0022-1317-68-8-2253; MULLER N, 1986, J ORG CHEM, V51, P263, DOI 10.1021/jo00352a032; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935	19	99	103	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 22	1988	335	6188					366	369		10.1038/335366a0	http://dx.doi.org/10.1038/335366a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q1373	3419504				2022-12-24	WOS:A1988Q137300064
J	KAZAKOV, SA; ASTASHKINA, TG; MAMAEV, SV; VLASSOV, VV				KAZAKOV, SA; ASTASHKINA, TG; MAMAEV, SV; VLASSOV, VV			SITE-SPECIFIC CLEAVAGE OF SINGLE-STRANDED DNAS AT UNIQUE SITES BY A COPPER-DEPENDENT REDOX REACTION	NATURE			English	Article											KAZAKOV, SA (corresponding author), ACAD SCI USSR,INST BIOORGAN CHEM,LAVRENTIEV PROSPEKT 8,NOVOSIBIRSK 630090,USSR.		Vlassov, Valentin/F-4720-2013	Vlassov, Valentin/0000-0003-2845-2992				BASILE LA, 1987, J AM CHEM SOC, V109, P7550, DOI 10.1021/ja00258a061; BRAM S, 1980, NATURE, V284, P629, DOI 10.1038/284629a0; BROWN RS, 1983, NATURE, V303, P543, DOI 10.1038/303543a0; BROWN RS, 1985, BIOCHEMISTRY-US, V24, P4785, DOI 10.1021/bi00339a012; CHEN CHB, 1986, P NATL ACAD SCI USA, V83, P7147, DOI 10.1073/pnas.83.19.7147; CHIOU SH, 1985, J BIOCHEM-TOKYO, V98, P1723, DOI 10.1093/oxfordjournals.jbchem.a135445; CHIOU SH, 1983, J BIOCHEM, V94, P1259, DOI 10.1093/oxfordjournals.jbchem.a134471; CHIOU SH, 1984, J BIOCHEM-TOKYO, V96, P1307, DOI 10.1093/oxfordjournals.jbchem.a134951; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; GOLDSTEIN S, 1986, J AM CHEM SOC, V108, P2244, DOI 10.1021/ja00269a020; GUERRIERTAKADA C, 1986, BIOCHEMISTRY-US, V25, P1509, DOI 10.1021/bi00355a006; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HERTZBERG RP, 1984, BIOCHEMISTRY-US, V23, P3934, DOI 10.1021/bi00312a022; JAMES BR, 1961, J CHEM SOC, P2007, DOI 10.1039/jr9610002007; MARSHALL LE, 1981, BIOCHEMISTRY-US, V20, P244, DOI 10.1021/bi00505a003; MARX G, 1985, BIOCHEM J, V236, P397; Maxam A M, 1980, Methods Enzymol, V65, P499; MORITA J, 1985, NUCLEIC ACIDS RES, V13, P449, DOI 10.1093/nar/13.2.449; MURATA A, 1986, AGR BIOL CHEM TOKYO, V50, P1481, DOI 10.1080/00021369.1986.10867593; PATTON JR, 1982, ANAL BIOCHEM, V126, P231, DOI 10.1016/0003-2697(82)90134-8; RORDORF BF, 1976, BIOPOLYMERS, V15, P1491, DOI 10.1002/bip.1976.360150805; ROWLEY DA, 1983, ARCH BIOCHEM BIOPHYS, V225, P279, DOI 10.1016/0003-9861(83)90031-0; RUBIN JR, 1983, J BIOMOL STRUCT DYN, V1, P639, DOI 10.1080/07391102.1983.10507471; SAMUNI A, 1981, J BIOL CHEM, V256, P2632; SIGMAN DS, 1985, BIOPOLYMERS, V24, P183, DOI 10.1002/bip.360240115; SIGMAN DS, 1986, ACCOUNTS CHEM RES, V19, P180, DOI 10.1021/ar00126a004; Sissoeff I, 1976, Prog Biophys Mol Biol, V31, P165; VLASSOV VV, 1986, NUCLEIC ACIDS RES, V14, P4065, DOI 10.1093/nar/14.10.4065; WACKER WEC, 1959, J BIOL CHEM, V234, P3257; WEITBERG AB, 1987, MUTAT RES, V191, P53, DOI 10.1016/0165-7992(87)90170-9; WERNER C, 1976, BIOCHIM BIOPHYS ACTA, V432, P161, DOI 10.1016/0005-2787(76)90158-1	31	54	55	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 8	1988	335	6186					186	188		10.1038/335186a0	http://dx.doi.org/10.1038/335186a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9647	3412475				2022-12-24	WOS:A1988P964700063
J	MCNEISH, JD; SCOTT, WJ; POTTER, SS				MCNEISH, JD; SCOTT, WJ; POTTER, SS			LEGLESS, A NOVEL MUTATION FOUND IN PHT1-1 TRANSGENIC MICE	SCIENCE			English	Article									CHILDRENS HOSP RES FDN,DEPT PEDIAT,CINCINNATI,OH 45229; UNIV CINCINNATI,COLL MED,CINCINNATI,OH 45229	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	MCNEISH, JD (corresponding author), CHILDRENS HOSP RES FDN,DIV BASIC SCI RES,CINCINNATI,OH 45229, USA.							ABBOTT UK, 1983, LIMB DEV REGENERAT A, P13; COVARRUBIAS L, 1985, COLD SPRING HARB SYM, V50, P447, DOI 10.1101/SQB.1985.050.01.056; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRIDLEY T, 1987, TRENDS GENET, V3, P162, DOI 10.1016/0168-9525(87)90218-6; HINCHLIFFE JR, 1973, J EMBRYOL EXP MORPH, V30, P753; JAENISCH R, 1983, CELL, V32, P209, DOI 10.1016/0092-8674(83)90511-1; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; MARK WH, 1985, COLD SPRING HARB SYM, V50, P453, DOI 10.1101/SQB.1985.050.01.057; MCNEISH JD, UNPUB; OVERBEEK PA, 1986, SCIENCE, V231, P1574, DOI 10.1126/science.3006249; PALMITER RD, 1984, CELL, V36, P869, DOI 10.1016/0092-8674(84)90036-9; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; SHANI M, 1986, MOL CELL BIOL, V6, P2624, DOI 10.1128/MCB.6.7.2624; SORIANO P, 1987, GENE DEV, V1, P366, DOI 10.1101/gad.1.4.366; Wilson J.G., 1965, TERATOLOGY PRINCIPLE, P251; WOYCHIK RP, 1985, NATURE, V318, P36, DOI 10.1038/318036a0; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414	19	73	73	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 12	1988	241	4867					837	839		10.1126/science.3406741	http://dx.doi.org/10.1126/science.3406741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P6162	3406741				2022-12-24	WOS:A1988P616200030
J	COLQUHOUN, MC				COLQUHOUN, MC			USE OF DEFIBRILLATORS BY GENERAL-PRACTITIONERS	BRITISH MEDICAL JOURNAL			English	Article																		ARMSTRONG A, 1972, BRIT HEART J, V34, P67; COBB LA, 1975, CIRCULATION       S3, V51, P223; CUMMINS RO, 1985, BRIT MED J, V291, P1401, DOI 10.1136/bmj.291.6506.1401; PAI GR, 1987, BRIT MED J, V294, P352, DOI 10.1136/bmj.294.6568.352; RAWLINS DC, 1981, BRIT MED J, V282, P1677, DOI 10.1136/bmj.282.6277.1677	5	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 30	1988	297	6644					336	336		10.1136/bmj.297.6644.336	http://dx.doi.org/10.1136/bmj.297.6644.336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4527	3416166	Green Published, Bronze			2022-12-24	WOS:A1988P452700025
J	FOX, PL; DICORLETO, PE				FOX, PL; DICORLETO, PE			FISH OILS INHIBIT ENDOTHELIAL-CELL PRODUCTION OF PLATELET-DERIVED GROWTH-FACTOR LIKE PROTEIN	SCIENCE			English	Article											FOX, PL (corresponding author), CLEVELAND CLIN,RES INST,DEPT BRAIN & VASC RES,CLEVELAND,OH 44106, USA.		Abrams, William R/A-5782-2008		NHLBI NIH HHS [HL1561, HL40352, HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040352, P01HL029582, K04HL001561] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANG HO, 1972, ACTA MED SCAND, V192, P85; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BARRETT TB, 1984, P NATL ACAD SCI-BIOL, V81, P6772, DOI 10.1073/pnas.81.21.6772; CAHILL PD, 1988, J VASC SURG, V7, P108, DOI 10.1067/mva.1988.avs0070108; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; DANIEL TO, 1987, J BIOL CHEM, V262, P11893; DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919; FOX PL, 1984, J CELL PHYSIOL, V121, P298, DOI 10.1002/jcp.1041210206; FOX PL, 1986, P NATL ACAD SCI USA, V83, P4774, DOI 10.1073/pnas.83.13.4774; FOX PL, 1987, J BIOL CHEM, V262, P6046; GAJDUSEK C, 1986, J CELL BIOL, V103, P419, DOI 10.1083/jcb.103.2.419; GAJDUSEK C, 1980, J CELL BIOL, V85, P467, DOI 10.1083/jcb.85.2.467; HAJJAR KA, 1987, J EXP MED, V166, P235, DOI 10.1084/jem.166.1.235; HARLAN JM, 1986, J CELL BIOL, V103, P1129, DOI 10.1083/jcb.103.3.1129; HARRIS WS, 1983, METABOLISM, V32, P179, DOI 10.1016/0026-0495(83)90226-3; HEPBURN FN, 1986, J AM DIET ASSOC, V86, P788; HIRAI A, 1980, LANCET, V2, P1132; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LANDYMORE RW, 1985, J THORAC CARDIOV SUR, V89, P351; MOREL DW, 1984, ARTERIOSCLEROSIS, V4, P357, DOI 10.1161/01.ATV.4.4.357; MORTON RE, 1986, J LIPID RES, V27, P1124; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; REEVES JB, 1978, AGR HDB USDA, V84; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; WEINER BH, 1986, NEW ENGL J MED, V315, P841, DOI 10.1056/NEJM198610023151401	26	261	268	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 22	1988	241	4864					453	456		10.1126/science.3393911	http://dx.doi.org/10.1126/science.3393911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3354	3393911				2022-12-24	WOS:A1988P335400035
J	PENNEY, TM				PENNEY, TM			DELAYED COMMUNICATION BETWEEN HOSPITALS AND GENERAL-PRACTITIONERS - WHERE DOES THE PROBLEM LIE	BRITISH MEDICAL JOURNAL			English	Article									SUNDON MED CTR,LUTON,BEDS,ENGLAND									BADO W, 1984, BRIT MED J, V288, P1813, DOI 10.1136/bmj.288.6433.1813; Dover S B, 1984, Health Trends, V16, P48; MAGEEAN RJ, 1986, BRIT MED J, V293, P1283, DOI 10.1136/bmj.293.6557.1283; TULLOCH AJ, 1975, BRIT MED J, V4, P443, DOI 10.1136/bmj.4.5994.443	4	61	62	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					28	29		10.1136/bmj.297.6640.28-a	http://dx.doi.org/10.1136/bmj.297.6640.28-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408904	Bronze, Green Published			2022-12-24	WOS:A1988P100000023
J	[Anonymous]				[Anonymous]			ARE GERM-LINES SPECIAL	NATURE			English	Editorial Material																		WEATHERALL DJ, 1988, NATURE, V331, P13, DOI 10.1038/331013a0	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	1988	331	6152					100	100						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	L6688	3422342				2022-12-24	WOS:A1988L668800003
J	WILCOX, AJ; WEINBERG, CR; BAIRD, DD				WILCOX, AJ; WEINBERG, CR; BAIRD, DD			TIMING OF SEXUAL INTERCOURSE IN RELATION TO OVULATION - EFFECTS ON THE PROBABILITY OF CONCEPTION, SURVIVAL OF THE PREGNANCY, AND SEX OF THE BABY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY ESTROGEN; NORMAL MEN; TEMPERATURE; SPERMATOZOA; SPERM	Background. The timing of sexual intercourse in relation to ovulation strongly influences the chance of conception, although the actual number of fertile days in a woman's menstrual cycle is uncertain. The timing of intercourse may also be associated with the sex of the baby. Methods. We recruited 221 healthy women who were planning to become pregnant. At the same time the women stopped using birth-control methods, they began collecting daily urine specimens and keeping daily records of whether they had sexual intercourse. We measured estrogen and progesterone metabolites in urine to estimate the day of ovulation. Results. In a total of 625 menstrual cycles for which the dates of ovulation could be estimated, 192 pregnancies were initiated, as indicated by increases in the urinary concentration of human chorionic gonadotropin around the expected time of implantation. Two thirds (n=129) ended in live births. Conception occurred only when intercourse took place during a six-day period that ended on the estimated day of ovulation. The probability of conception ranged from 0.10 when intercourse occurred five days before ovulation to 0.33 when it occurred on the day of ovulation itself. There was no evident relation between the age of sperm and the viability of the conceptus, although only 6 percent of the pregnancies could be firmly attributed to sperm that were three or more days old. Cycles producing male and female babies had similar patterns of intercourse in relation to ovulation. Conclusions. Among healthy women trying to conceive, nearly all pregnancies can be attributed to intercourse during a six-day period ending on the day of ovulation. For practical purposes, the timing of sexual intercourse in relation to ovulation has no influence on the sex of the baby.	NIEHS,STAT & BIOMATH BRANCH,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	WILCOX, AJ (corresponding author), NIEHS,EPIDEMIOL BRANCH,RES TRIANGLE PK,NC 27709, USA.		Wilcox, Allen J/C-7723-2019; Baird, Donna D/D-5214-2017	Wilcox, Allen J/0000-0002-3376-1311; Baird, Donna D/0000-0002-5544-2653; Weinberg, Clarice/0000-0002-7713-8556				ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209; BAIRD DD, 1995, EPIDEMIOLOGY, V6, P547, DOI 10.1097/00001648-199509000-00015; BAKER RJ, 1978, GLIM SYSTEM; BARRETT JC, 1969, POP STUD-J DEMOG, V23, P455, DOI 10.1080/00324728.1969.10405297; Bongaarts J., 1983, DETERMINANTS FERTILI, V1, P103; Campbell K L, 1985, Res Front Fertil Regul, V3, P1; CHECK JH, 1989, AM J OBSTET GYNECOL, V160, P598, DOI 10.1016/S0002-9378(89)80036-5; COHEN J, 1985, FERTIL STERIL, V44, P254; COLLINS WP, 1983, CURRENT TOPICS REPRO, V3, P49; FRANCE JT, 1992, INT J FERTIL, V37, P244; FREUND M, 1962, J REPROD FERTIL, V4, P143; Glezerman M, 1993, INFERTILITY MALE FEM; GUERREROV R, 1975, NEW ENGL J MED, V293, P573; KESNER JS, 1994, STEROIDS, V59, P205, DOI 10.1016/0039-128X(94)90029-9; MACLEOD J, 1952, FERTIL STERIL, V3, P297; PERLOFF WH, 1964, AM J OBSTET GYNECOL, V88, P439; POLAND ML, 1985, FERTIL STERIL, V44, P396; POTTER RG, 1961, MILBANK FUND Q, V39, P132, DOI 10.2307/3348639; ROYSTON JP, 1982, BIOMETRICS, V38, P397, DOI 10.2307/2530453; SARNARAJEEWA P, 1979, J STEROID BIOCHEM, V11, P1165; SCHWARTZ D, 1980, POP STUD-J DEMOG, V34, P397, DOI 10.1080/00324728.1980.10410398; SHETTLES LB, 1984, CHOOSE SEX YOUR BABY; SIMPSON J L, 1988, Advances in Contraception, V4, P247, DOI 10.1007/BF01849266; WEINBERG CR, 1994, BIOMETRICS, V50, P358, DOI 10.2307/2533379; WEINBERG CR, 1995, HUM REPROD, V10, P304, DOI 10.1093/oxfordjournals.humrep.a135932; WEINBERG CR, IN PRESS PONTIFICAL; Wilcox A J, 1990, Epidemiology, V1, P382, DOI 10.1097/00001648-199009000-00008; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; WILCOX AJ, 1985, FERTIL STERIL, V44, P366; WRIGHT K, 1978, STEROIDS, V31, P407, DOI 10.1016/0039-128X(78)90053-3; ZARUTSKIE PW, 1989, FERTIL STERIL, V52, P891; 1983, FERTIL STERIL, V40, P773; 1984, FERTIL STERIL, V41, P593	34	720	738	3	65	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	1995	333	23					1517	1521		10.1056/NEJM199512073332301	http://dx.doi.org/10.1056/NEJM199512073332301			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH157	7477165				2022-12-24	WOS:A1995TH15700001
J	MEISSNER, RS; REBEK, J; DEMENDOZA, J				MEISSNER, RS; REBEK, J; DEMENDOZA, J			AUTOENCAPSULATION THROUGH INTERMOLECULAR FORCES - A SYNTHETIC SELF-ASSEMBLING SPHERICAL COMPLEX	SCIENCE			English	Article								The synthesis and characterization of a system for the study of molecular recognition phenomena are described. The system involves a tetraurea molecule that is capable of assembly into various associated states through hydrogen bonding. In organic solvents, the dynamic transition between a low-ordered (aggregate) state and a highly ordered dimeric assembly can be induced by the introduction of smaller molecules of appropriate size and shape. These smaller molecules, such as benzene, adamantanes, and ferrocenes, act as guests that occupy the pseudospherical capsule formed by the dimeric host, Among various guests, those that best fill the cavity and offer chemical complementarity to the host are preferentially encapsulated.	MIT,DEPT CHEM,CAMBRIDGE,MA 02139; UNIV AUTONOMA MADRID,DEPT QUIM,E-28049 MADRID,SPAIN	Massachusetts Institute of Technology (MIT); Autonomous University of Madrid								[Anonymous], 1992, INTERMOLECULAR SURFA; BAXTER P, 1993, ANGEW CHEM INT EDIT, V32, P69, DOI 10.1002/anie.199300691; BEERLI R, 1995, TETRAHEDRON LETT, V36, P1813, DOI 10.1016/0040-4039(95)00150-B; BONARLAW RP, 1993, TETRAHEDRON LETT, V34, P1677, DOI 10.1016/0040-4039(93)85039-Y; BRANDA N, 1994, SCIENCE, V263, P1267, DOI 10.1126/science.8122107; CARPINO LA, 1963, J AM CHEM SOC, V85, P2144, DOI 10.1021/ja00897a024; CRAM DJ, 1992, NATURE, V356, P29, DOI 10.1038/356029a0; CRAM DJ, 1993, J AM CHEM SOC, V115, P10111, DOI 10.1021/ja00075a029; DUGAS H, 1989, BIOORG CHEM, P20; FUJITA M, 1995, J AM CHEM SOC, V117, P1649, DOI 10.1021/ja00110a026; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1995, ANGEW CHEM INT EDIT, V34, P93, DOI 10.1002/anie.199500931; MATHIAS JP, 1994, J AM CHEM SOC, V116, P4326, DOI 10.1021/ja00089a022; MATTIAS JP, 1994, J AM CHEM SOC, V116, P1725; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; SETO CT, 1991, J AM CHEM SOC, V113, P712, DOI 10.1021/ja00002a071; SIMARD M, 1991, J AM CHEM SOC, P4696; WYLER R, 1993, ANGEW CHEM INT EDIT, V32, P1699, DOI 10.1002/anie.199316991; YANG J, 1993, J AM CHEM SOC, V115, P5314, DOI 10.1021/ja00065a061	19	201	201	1	40	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1485	1488		10.1126/science.270.5241.1485	http://dx.doi.org/10.1126/science.270.5241.1485			4	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491493				2022-12-24	WOS:A1995TH37500036
J	IMPALLOMENI, M; GALLETLY, NP; WORT, SJ; STARR, JM; ROGERS, TR				IMPALLOMENI, M; GALLETLY, NP; WORT, SJ; STARR, JM; ROGERS, TR			INCREASED RISK OF DIARRHEA CAUSED BY CLOSTRIDIUM-DIFFICILE IN ELDERLY PATIENTS RECEIVING CEFOTAXIME	BRITISH MEDICAL JOURNAL			English	Article									ROYAL POSTGRAD MED SCH,DEPT INFECT DIS & BACTERIOL,LONDON W12 0NN,ENGLAND	Imperial College London	IMPALLOMENI, M (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,DIV GERIATR MED,LONDON W12 0HS,ENGLAND.		Starr, John/C-8951-2011	Rogers, Thomas/0000-0003-4336-7729				GOLLEDGE CL, 1989, J ANTIMICROB CHEMOTH, V23, P929, DOI 10.1093/jac/23.6.929; GREEN ST, 1985, ULSTER MED J, V54, P80; PEAR SM, 1994, ANN INTERN MED, V120, P272, DOI 10.7326/0003-4819-120-4-199402150-00003; 1994, CLOSTRIDIUM DIFFICIL; 1993, BR J HOSP MED, V49, P346	5	86	88	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1345	1346		10.1136/bmj.311.7016.1345	http://dx.doi.org/10.1136/bmj.311.7016.1345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496287	Green Published			2022-12-24	WOS:A1995TF90100025
J	KLONOFFCOHEN, H; EDELSTEIN, SL				KLONOFFCOHEN, H; EDELSTEIN, SL			BED SHARING AND THE SUDDEN-INFANT-DEATH-SYNDROME	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HONG-KONG; SLEEP	Objective-To determine whether infants who died of the sudden infant death syndrome routinely shared their parents' bed more commonly than control infants. Design-Case-control study. Setting-Southern California. Subjects-200 white, African-American, Latin American, and Asian infants who died and 200 living controls, matched by birth hospital, date of birth, sex, and race. Main outcome measures-Routine bedding (for example, crib, cradle), day and night time sleeping arrangement (for example, alone or sharing a bed); for cases only, sleeping arrangement at death. Differences in bed sharing practices among races. Results-Of the infants who died of the syndrome, 45 (22.4%) were sharing a bed. Daytime bed sharing was more common in African-American (P<0.001) and Latin American families (P < 0.001) than in white families. The overall adjusted odds ratio for the syndrome and routine bed sharing in the daytime was 1 38 (95% confidence interval 0.59 to 3.22) and for night was 1.21 (0.59 to 2.48). These odds ratios were adjusted for routine sleep position, passive smoking, breast feeding, intercom use, infant birth weight, medical conditions at birth, and maternal age and education. There was no interaction between bed sharing and passive smoking or alcohol use by either parent. Conclusions-Although there was a significant difference between bed sharing among African-American and Latin American parents compared with white parents, there was no significant relation between routine bed sharing and the sudden infant death syndrome.	GEORGE WASHINGTON UNIV, CTR BIOSTAT, ROCKVILLE, MD 20852 USA	George Washington University	KLONOFFCOHEN, H (corresponding author), UNIV CALIF SAN DIEGO, DEPT FAMILY & PREVENT MED, DIV EPIDEMIOL, LA JOLLA, CA 92037 USA.							BOURNE AJ, 1994, BRIT MED J, V308, P537, DOI 10.1136/bmj.308.6927.537c; CARPENTER RG, 1972, SUDDEN UNEXPECTED DE, P7; DAVIES DP, 1985, LANCET, V2, P1346; FAROOQI I, 1994, BMJ-BRIT MED J, V308, P204, DOI 10.1136/bmj.308.6922.204b; GUNTHEROTH WG, 1989, CRIB DEATH SUDDEN IN; HOPPENBROUWERS T, 1982, SLEEP, V5, P131; KONNER M, 1987, ROLE CLTURE DEV DISO; LEE NNY, 1989, BRIT MED J, V298, P721, DOI 10.1136/bmj.298.6675.721; LUKE JL, 1978, J FORENSIC SCI, V23, P379; MCKENNA JJ, 1993, ACTA PAEDIATR, V82, P31, DOI 10.1111/j.1651-2227.1993.tb12871.x; MCKENNA JJ, 1990, AM J PHYS ANTHROPOL, V83, P331, DOI 10.1002/ajpa.1330830307; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; MITCHELL EA, 1993, SLEEP, V16, P387; MITCHELL EA, 1993, BMJ-BRIT MED J, V306, P13, DOI 10.1136/bmj.306.6869.13; Mitchell EA, 1992, J PAEDIAT CHILD HL S, V28, P3; MOSKO S, 1993, J BEHAV MED, V16, P589, DOI 10.1007/BF00844721; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; TASAKI H, 1992, J PAEDIATRIC ASS JAP, P364; 1989, MONTHLY VITAL STATIS; 1990, SAS USERS GUIDE STAT; 1993, EGRET EPIDEMIOLOGICA	21	56	56	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	1995	311	7015					1269	1272		10.1136/bmj.311.7015.1269	http://dx.doi.org/10.1136/bmj.311.7015.1269			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE859	7496236	Green Published			2022-12-24	WOS:A1995TE85900021
J	NAKASHIMA, K; IKEMATSU, H; HAYASHI, J; KISHIHARA, Y; MITSUTAKE, A; KASHIWAGI, S				NAKASHIMA, K; IKEMATSU, H; HAYASHI, J; KISHIHARA, Y; MITSUTAKE, A; KASHIWAGI, S			INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS AMONG THE POPULATION OF AN ENDEMIC AREA OF JAPAN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							POLYMERASE CHAIN-REACTION; NON-B-HEPATITIS; NON-A; GENOME; SEQUENCE; PRIMERS; RNA	Objectives.-To assess the role of intrafamilial transmission of hepatitis C virus (HCV) among general populations. Design and Setting.-Cross-sectional study in an HCV-endemic area of Japan. Participants.-A total of 1122 residents (mean age, 41.7 years; range, 0 to 80 years), including 359 mother-child pairs and 234 pairs of spouses. Main Outcome Measures.-Antibody to HCV (anti-HCV) was examined using second-generation anti-HCV testing by passive hemagglutination assay. Hepatitis C virus RNA was detected by polymerase chain reaction with primers deduced from the 5'-noncoding region and HCV genotypes by reaction with type-specific primers deduced from the HCV core gene. Results.-Prevalence of anti-HCV was 14.1% (158/1122), and HCV RNA was detected in 82.9% of those who tested positive for anti-HCV. Prevalence of anti-HCV increased with advancing age, but no anti-HCV was found among 312 persons younger than 20 years. Of the 53 children with anti-HCV-positive mothers, three were positive for anti-HCV, all were older than 20 years, and all had a history of surgical treatment. Hepatitis C virus RNA was found in one mother-child pair but with different HCV genotypes. Both spouses were positive for anti-HCV in 17 of 234 pairs. Of the 11 pairs of spouses in whom the HCV genotypes of both were determined, five had different HCV genotypes. Conclusions.-While HCV is highly endemic in this area, neither vertical nor horizontal transmission between spouses seems to play an important role in its spread. The incidence of intrafamilial transmission of HCV seems to be low.			NAKASHIMA, K (corresponding author), KYUSHU UNIV HOSP 71,DEPT GEN MED,HIGASHI KU,FUKUOKA 812,JAPAN.							CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; HAYASHI J, 1995, AM J GASTROENTEROL, V90, P794; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; NAKASHIMA K, 1992, AM J EPIDEMIOL, V136, P1132, DOI 10.1093/oxfordjournals.aje.a116579; NAKASHIMA K, 1994, J EPIDEMIOL, V4, P14; OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103; OKAMOTO H, 1990, JPN J EXP MED, V60, P215; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; TAJIMA K, 1991, LANCET, V337, P1410, DOI 10.1016/0140-6736(91)93089-R	12	62	65	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	1995	274	18					1459	1461		10.1001/jama.274.18.1459	http://dx.doi.org/10.1001/jama.274.18.1459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC477	7474193				2022-12-24	WOS:A1995TC47700029
J	JASS, JR; COTTIER, DS; JEEVARATNAM, P; POKOS, V; HOLDAWAY, KM; BOWDEN, ML; VANDEWATER, NS; BROWETT, PJ				JASS, JR; COTTIER, DS; JEEVARATNAM, P; POKOS, V; HOLDAWAY, KM; BOWDEN, ML; VANDEWATER, NS; BROWETT, PJ			DIAGNOSTIC USE OF MICROSATELLITE INSTABILITY IN HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER	LANCET			English	Note							DINUCLEOTIDE REPEAT POLYMORPHISMS	50 families with a history of colorectal cancer were divided according to whether criteria for hereditary non-polyposis colorectal cancer (HNPCC) were fulfilled totally (A, n=19) or partly (B, n=31) and stratified by the demonstration that at least half the cancers tested per family were positive for DNA replication errors (RER+). Accepted clinical and pathological characteristics of HNPCC were found to cluster within 12 A/RER+ families in which the mean number of affected individuals per family was 10 . 1. Reliance upon clinical data alone may result in over-diagnosis of HNPCC, in small families who just meet the minimum criteria, whereas underdiagnosis is rare. The criteria could be refined by inclusion of RER status.	UNIV AUCKLAND,SCH MED,DEPT MOLEC MED,AUCKLAND,NEW ZEALAND	University of Auckland	JASS, JR (corresponding author), UNIV AUCKLAND,SCH MED,DEPT PATHOL,PRIVATE BAG 92019,AUCKLAND,NEW ZEALAND.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015434] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD15434] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AALTONEN LA, 1994, CANCER RES, V54, P1645; EASTON DF, 1993, AM J HUM GENET, V52, P678; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KIM HG, 1994, AM J PATHOL, V145, P148; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; RISINGER JI, 1991, HUM MOL GENET, V1, P657; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	11	87	87	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 4	1995	346	8984					1200	1201		10.1016/S0140-6736(95)92902-9	http://dx.doi.org/10.1016/S0140-6736(95)92902-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC976	7475662				2022-12-24	WOS:A1995TC97600012
J	JAYME, DW; EPSTEIN, DA; CONRAD, DR				JAYME, DW; EPSTEIN, DA; CONRAD, DR			FETAL BOVINE SERUM ALTERNATIVES	NATURE			English	Editorial Material											JAYME, DW (corresponding author), LIFE TECHNOL INC,GIBCO LABS,DEPT CELL CULTURE RES & DEV,POB 68,GRAND ISL,NY 14072, USA.							BARNES D, 1987, BIOTECHNIQUES, V5, P534; BODZIAK ML, 1985, IN VITRO CELL DEV B, V21, pA47; BROWN BL, 1987, COMMERCIAL PRODUCTIO, P35; DANNER D, 1987, IN VITRO CELL DEV B, V23, pA19; EPSTEIN D A, 1987, Journal of Cell Biology, V105, p162A; EVEGE E K, 1985, Journal of Cell Biology, V101, p489A; Freshney RI., 1987, CULTURE ANIMAL CELLS; HU WS, 1988, ENG F C CELL CULTURE; Jayme D W, 1985, Adv Biotechnol Processes, V5, P1; Keay L, 1978, Methods Cell Biol, V20, P169, DOI 10.1016/S0091-679X(08)62019-1; Lambert KJ, 1985, ANIMAL CELL BIOTECHN, V1, P85; MARTINEZ EC, 1985, IN VITRO CELL DEV B, V21, pA30; MATHER JP, 1984, MAMMALIAN CELL CULTU, pR7; PETERSON WD, UNPUB; SATO GH, 1984, MOL MECHANISMS REGUL, P65; TAUB M, 1985, TISSUE CULTURE EPITH, P255; WILLIAMS J, 1988, BIO-TECHNOL, V6, P575, DOI 10.1038/nbt0588-575	17	33	33	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 11	1988	334	6182					547	548		10.1038/334547a0	http://dx.doi.org/10.1038/334547a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P6163	3405300				2022-12-24	WOS:A1988P616300068
J	VERBER, I				VERBER, I			IT IS NOT ONE OF THEM - IT IS ONE OF ALL OF US	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1988	297	6641					149	149		10.1136/bmj.297.6641.149	http://dx.doi.org/10.1136/bmj.297.6641.149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1954	3408947	Bronze, Green Published			2022-12-24	WOS:A1988P195400061
J	ROSA, F; ROBERTS, AB; DANIELPOUR, D; DART, LL; SPORN, MB; DAWID, IB				ROSA, F; ROBERTS, AB; DANIELPOUR, D; DART, LL; SPORN, MB; DAWID, IB			MESODERM INDUCTION IN AMPHIBIANS - THE ROLE OF TGF-BETA-2-LIKE FACTORS	SCIENCE			English	Article									NCI,DIV CANC ETIOL,CHEMOPREVENT LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	ROSA, F (corresponding author), NICHHD,MOLEC GENET LAB,BETHESDA,MD 20892, USA.		Rosa, Frederic/L-5990-2017					ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; FROLIK CA, 1984, J BIOL CHEM, V259, P995; GIMLICH RL, 1986, DEV BIOL, V115, P340, DOI 10.1016/0012-1606(86)90254-X; GURDON JB, 1984, CELL, V38, P691, DOI 10.1016/0092-8674(84)90264-2; IKEDA T, 1987, BIOCHEMISTRY-US, V26, P2406, DOI 10.1021/bi00383a002; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; MARQUARDT H, 1987, J BIOL CHEM, V262, P12127; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; NAKAMURA O, 1971, P JPN ACAD, V47, P407, DOI 10.2183/pjab1945.47.407; NAKAMURA O, 1970, P JPN ACAD, V46, P694, DOI 10.2183/pjab1945.46.694; Nieuwkoop P D, 1973, Adv Morphog, V10, P1; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; SARGENT TD, 1986, DEV BIOL, V114, P238, DOI 10.1016/0012-1606(86)90399-4; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1987, DEVELOPMENT, V99, P3; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; SUDARWAT.S, 1971, ROUX ARCH DEV BIOL, V166, P189, DOI 10.1007/BF00650029; TIEDEMANN H, 1982, BIOCH DIFFERENTIATIO, V33, P275; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; WAKEFIELD L, UNPUB; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	32	416	424	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 12	1988	239	4841					783	785		10.1126/science.3422517	http://dx.doi.org/10.1126/science.3422517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M0209	3422517				2022-12-24	WOS:A1988M020900034
J	FELBER, BK; PAVLAKIS, GN				FELBER, BK; PAVLAKIS, GN			A QUANTITATIVE BIOASSAY FOR HIV-1 BASED ON TRANS-ACTIVATION	SCIENCE			English	Article											FELBER, BK (corresponding author), NCI,FREDERICK CANC RES FACIL,BIONET RES INC,BASIC RES PROGRAM,POB B,FREDERICK,MD 21701, USA.				NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; ARYA SK, 1987, NATURE, V328, P548, DOI 10.1038/328548a0; BARIN F, 1985, LANCET, V2, P1387; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0; COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GENDELMAN HE, 1986, P NATL ACAD SCI USA, V83, P9759, DOI 10.1073/pnas.83.24.9759; GOH WC, 1986, J VIROL, V59, P181, DOI 10.1128/JVI.59.1.181-184.1986; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; HEN R, 1985, SCIENCE, V230, P1391, DOI 10.1126/science.2999984; HIRSCH V, 1987, CELL, V49, P307, DOI 10.1016/0092-8674(87)90283-2; JHAPPAN C, 1986, J VIROL, V60, P750, DOI 10.1128/JVI.60.2.750-753.1986; KANKI PJ, 1985, SCIENCE, V230, P951, DOI 10.1126/science.2997923; KANKI PJ, 1985, LANCET, V1, P1330; KANKI PJ, 1985, SCIENCE, V228, P1199, DOI 10.1126/science.3873705; KANKI PJ, 1986, SCIENCE, V232, P238, DOI 10.1126/science.3006256; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KLATZMANN D, 1984, SCIENCE, V225, P59, DOI 10.1126/science.6328660; KNIGHT DM, 1987, SCIENCE, V236, P837, DOI 10.1126/science.3033827; KORNFELD H, 1987, NATURE, V326, P610, DOI 10.1038/326610a0; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; MITSUYA H, 1987, NATURE, V325, P773, DOI 10.1038/325773a0; MITSUYA H, 1987, P NATL ACAD SCI USA, V84, P2033, DOI 10.1073/pnas.84.7.2033; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MITSUYA H, 1986, P NATL ACAD SCI US, V83, P1919; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NEWMANN JR, 1987, BIOTECHNIQUES, V5, P444; PAVLAKIS GN, 1988, P UCLA S HUMAN RETRO, V71; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PUTNEY SD, 1986, SCIENCE, V234, P1392, DOI 10.1126/science.2431482; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SHAW W, 1975, METHOD ENZYMOL, V53, P737; SIEGEL L, 1986, VIROLOGY, V148, P228; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; SODROSKI J, 1985, SCIENCE, V227, P171, DOI 10.1126/science.2981427; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; VELCICH A, 1985, CELL, V40, P705, DOI 10.1016/0092-8674(85)90219-3; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WRIGHT CM, 1986, SCIENCE, V234, P988, DOI 10.1126/science.3490693	58	179	200	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 8	1988	239	4836					184	187		10.1126/science.3422113	http://dx.doi.org/10.1126/science.3422113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	L5256	3422113				2022-12-24	WOS:A1988L525600036
J	WEISS, M; LOPRINZI, CL; CREAGAN, ET; DALTON, RJ; NOVOTNY, P; OFALLON, JR				WEISS, M; LOPRINZI, CL; CREAGAN, ET; DALTON, RJ; NOVOTNY, P; OFALLON, JR			UTILITY OF FOLLOW-UP TESTS FOR DETECTING RECURRENT DISEASE IN PATIENTS WITH MALIGNANT MELANOMAS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							BREAST-CANCER; GUIDELINES; POLICY	Objective.-To determine the effectiveness of follow-up tests for signaling recurrences in patients with intermediate- and high-risk malignant melanomas treated with curative intention. Design.-Retrospective analysis of prospectively collected data. Setting.-North Central Cancer Treatment Group. Patients.-A total of 261 patients with resected local (greater than or equal to 1.69 mm) and regional nodal malignant melanomas who were enrolled in a single prospective adjuvant trial were studied. All patients were scheduled to be followed up monthly for 2 months, then every 2 months for the first year, every 4 months the second year, every 6 months the next 3 years, and annually thereafter, with each visit consisting of a history, physical examination, complete blood cell count, blood chemistry panel, and a chest x-ray. Results.-Of the 145 evaluable patients who developed recurrent melanomas, 99 patients (68%) developed symptoms that signaled the diagnosis of recurrent disease. Physical examination of asymptomatic patients led to the diagnosis of recurrent disease in 37 patients (26%). The other nine patients (6%) with recurrent disease had abnormal chest x-rays. Laboratory results were never a sole indicator of recurrent disease. Conclusion.-The majority of recurrences following resection of primary melanomas are discovered by history and/or physical examination despite the frequent use of other follow-up tests. The present data indicate that routine blood analyses and chest x-rays have limited value in the postoperative follow-up of patients with resected intermediate- and high-risk melanomas.	MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; DULUTH COMMUNITY CLIN ONCOL PROGRAM, DULUTH, MN USA	Mayo Clinic					NATIONAL CANCER INSTITUTE [U10CA025224, P30CA015083, U10CA037404] Funding Source: NIH RePORTER; NCI NIH HHS [CA-37404, CA-15083, CA-25224] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baughan C A, 1993, Clin Oncol (R Coll Radiol), V5, P174, DOI 10.1016/S0936-6555(05)80321-8; BRANDT SE, 1990, J SURG ONCOL, V43, P157, DOI 10.1002/jso.2930430307; BROWMAN GP, 1995, J CLIN ONCOL, V13, P502, DOI 10.1200/JCO.1995.13.2.502; BROYN T, 1982, ACTA CHIR SCAND, V148, P401; COLLINS CD, 1993, BRIT J RADIOL, V66, P117, DOI 10.1259/0007-1285-66-782-117; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; DEMBROW VD, 1986, FUNDAMENTALS SURGICA, P141; DRAKE LA, 1993, J AM ACAD DERMATOL, V28, P638, DOI 10.1016/S0190-9622(08)81784-7; HALL WH, 1992, JAMA-J AM MED ASSOC, V268, P1314, DOI 10.1001/jama.1992.03490100112037; JILLELLA A, 1995, P AN M AM SOC CLIN, V14, P413; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; KAUFMANN P M, 1992, Aktuelle Radiologie, V2, P81; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P881, DOI 10.1200/JCO.1994.12.5.881; MARTINI L, 1994, TUMORI, V80, P188, DOI 10.1177/030089169408000305; MCCARTHY WH, 1988, SURG GYNECOL OBSTET, V166, P497; MCEWAN L, 1990, PLAST RECONSTR SURG, V86, P527, DOI 10.1097/00006534-199009000-00024; PANDYA KJ, 1985, CANCER, V55, P202, DOI 10.1002/1097-0142(19850101)55:1<202::AID-CNCR2820550132>3.0.CO;2-X; PEARLMAN NW, 1992, AM J SURG, V164, P458, DOI 10.1016/S0002-9610(05)81180-8; ROMERO JB, 1994, J DERMATOL SURG ONC, V20, P175, DOI 10.1111/j.1524-4725.1994.tb00462.x; SCANLON EF, 1980, CANCER, V46, P977, DOI 10.1002/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0; SCHAPIRA DV, 1991, JAMA-J AM MED ASSOC, V265, P380, DOI 10.1001/jama.265.3.380; SLINGLUFF CL, 1992, CANCER-AM CANCER SOC, V70, P1917, DOI 10.1002/1097-0142(19921001)70:7<1917::AID-CNCR2820700719>3.0.CO;2-5; TAHERY DP, 1992, INT J DERMATOL, V31, P629, DOI 10.1111/j.1365-4362.1992.tb03980.x; WINCHESTER DP, 1979, CANCER, V43, P956, DOI 10.1002/1097-0142(197903)43:3<956::AID-CNCR2820430326>3.0.CO;2-L; ZWAVELING A, 1987, J SURG ONCOL, V34, P194, DOI 10.1002/jso.2930340314; 1994, JAMA-J AM MED ASSOC, V271, P1587	27	119	119	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1703	1705		10.1001/jama.274.21.1703	http://dx.doi.org/10.1001/jama.274.21.1703			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH151	7474276				2022-12-24	WOS:A1995TH15100028
J	REES, JH; SOUDAIN, SE; GREGSON, NA; HUGHES, RAC				REES, JH; SOUDAIN, SE; GREGSON, NA; HUGHES, RAC			CAMPYLOBACTER-JEJUNI INFECTION AND GUILLAIN-BARRE-SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROPATHY	Background. Although infection with Campylobacter jejuni is recognized as a common antecedent of the Guillain-Barre syndrome, the clinical and epidemiologic features of this association are not well understood. Methods. We performed a prospective case-control study in a cohort of patients with Guillajn-Barre syndrome (96 patients) or Miller Fisher syndrome (7 patients) who were admitted to hospitals throughout England and Wales between November 1992 and April 1994. Bacteriologic and serologic techniques were used to diagnose preceding C. jejuni infection. Results. There was evidence of recent C. jejuni infection in 26 percent of the patients with Guillain-Barre or Miller Fisher syndrome, as compared with 2 percent of household controls and 1 percent of age-matched hospital controls (P<0.001). Of the 27 patients with C. jejuni infection, 19 (70 percent) reported having had a diarrheal illness within 12 weeks before the onset of the neurologic illness. No specific serotypes were associated with Guillain-Barre syndrome. C. jejuni infection was slightly more common in men (P=0.14) and was more likely to be associated with a pure motor syndrome and a slower recovery (P=0.03). The patients with preceding C. jejuni infection were more likely to have acute axonal neuropathy or axonal degeneration in association with acute inflammatory demyelinating polyradiculoneuropathy, and they had greater disability after one year (P=0.02). C. jejuni infection was significantly associated with a poor outcome even after correction for other factors associated with a poor prognosis. Conclusions. Infection with C. jejuni often precedes the Guillain-Barre syndrome and is associated with axonal degeneration, slow recovery, and severe residual disability.	UNITED MED & DENT SCH,GUYS HOSP,DEPT NEUROL,LONDON SE1 9RT,ENGLAND; UNITED MED & DENT SCH,GUYS HOSP,DIV ANAT & CELL BIOL,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London			Rees, Jeremy/AAH-4382-2019					ALBERS JW, 1985, MUSCLE NERVE, V8, P528, DOI 10.1002/mus.880080609; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; BLASER MJ, 1984, INFECT IMMUN, V44, P292, DOI 10.1128/IAI.44.2.292-298.1984; DYCK PJ, 1993, NEUROLOGY, V43, P1277, DOI 10.1212/WNL.43.7.1277; ENDERS U, 1993, ANN NEUROL, V34, P136, DOI 10.1002/ana.410340208; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; GREGSON NA, 1993, Q J MED, V86, P111; KALDOR J, 1984, BRIT MED J, V288, P1867, DOI 10.1136/bmj.288.6434.1867; KUROKI S, 1993, ANN NEUROL, V33, P243, DOI 10.1002/ana.410330304; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; MISHU B, 1993, ANN INTERN MED, V118, P947, DOI 10.7326/0003-4819-118-12-199306150-00006; Palace J A, 1994, Eur J Neurol, V1, P21, DOI 10.1111/j.1468-1331.1994.tb00046.x; REES JH, 1993, Q J MED, V86, P623, DOI 10.1093/qjmed/86.10.623; ROBERTS T, 1987, J NEUROL NEUROSUR PS, V50, P1557, DOI 10.1136/jnnp.50.11.1557; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; SKIRROW MB, 1987, EPIDEMIOL INFECT, V99, P647, DOI 10.1017/S0950268800066504; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P613, DOI 10.1136/jnnp.51.5.613; WROE SJ, 1985, J NEUROL NEUROSUR PS, V48, P593, DOI 10.1136/jnnp.48.6.593; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771	19	533	546	0	23	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	1995	333	21					1374	1379		10.1056/NEJM199511233332102	http://dx.doi.org/10.1056/NEJM199511233332102			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF521	7477117	Bronze			2022-12-24	WOS:A1995TF52100002
J	PARKES, C; WALD, NJ; MURPHY, P; GEORGE, L; WATT, HC; KIRBY, R; KNEKT, P; HELZLSOUER, KJ; TUOMILEHTO, J				PARKES, C; WALD, NJ; MURPHY, P; GEORGE, L; WATT, HC; KIRBY, R; KNEKT, P; HELZLSOUER, KJ; TUOMILEHTO, J			PROSPECTIVE OBSERVATIONAL STUDY TO ASSESS VALUE OF PROSTATE-SPECIFIC ANTIGEN AS SCREENING-TEST FOR PROSTATE-CANCER	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERUM VITAMIN-E; RISK; SELENIUM; MEN	Objective-To evaluate measurement of serum prostate specific antigen as a potential screening test for future clinical prostate cancer among healthy men. Design-Nested case-control study with stored serum samples collected from 49261 men with follow up using national death and cancer registration systems. Subjects-265 asymptomatic men who subsequently developed clinical prostate cancer and 1055 controls matched for age, study centre, and duration of storage of samples. Main outcome measures-Distribution of concentrations of the antigen in men who developed prostate cancer and in controls. Results-Prostate specific antigen concentrations were significantly higher in men who subsequently developed prostate cancer than in controls. In the first three years after blood collection the median concentration was 23 times greater in cases than in controls of the same age at the same centre (that is, 23 multiples of the median). A smaller difference persisted thereafter; 4.0 multiples of the median 3-6 years after blood collection, 3.6 6-10 years, and 1.8 after 10 years. In the first three years the proportion of men who developed prostate cancer and had raised levels of the antigen (greater than or equal to 12 multiples of the median) (detection rate or sensitivity) was 81% (95% confidence interval 54% to 96%). The proportion of men who did not develop prostate cancer but had levels this high (false positive rate) was only 0.5%. Conclusion-Prostate specific antigen measurement is a highly discriminatory screening test for prostate cancer among healthy men. In the general population, 60-74 year old men who had greater than or equal to 12 times the normal median level would have about a 50% chance of developing clinical prostate cancer in the next three years. Measurement of this antigen is a good enough screening test to justify a randomised controlled trial to determine any reduction in mortality from prostate cancer.	UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL, WOLFSON INST PREVENT MED, LONDON EC1M 6BQ, ENGLAND; UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL, DEPT UROL, LONDON EC1A 7BE, ENGLAND; NATL PUBL HLTH INST, DEPT HLTH & DISABIL, HELSINKI, FINLAND; SOCIAL INSURANCE INST, RES & DEV UNIT, HELSINKI, FINLAND; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, TRAINING CTR PUBL HLTH RES, BALTIMORE, MD 21742 USA; NATL PUBL HLTH INST, DEPT EPIDEMIOL & HLTH PROMOT, HELSINKI, FINLAND	University of London; Queen Mary University London; University of London; Queen Mary University London; Finland National Institute for Health & Welfare; Johns Hopkins University; Finland National Institute for Health & Welfare			Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					AXTELL LM, 1976, US DHEW5 REP; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; FRANKS LM, 1954, J PATHOL BACTERIOL, V68, P603, DOI 10.1002/path.1700680233; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; HELZLSOUER KJ, 1989, CANCER RES, V49, P6144; HELZLSOUER KJ, 1992, CANCER EPIDEM BIOMAR, V1, P537; JOHANSSON JE, 1992, JAMA-J AM MED ASSOC, V267, P2191, DOI 10.1001/jama.267.16.2191; KABALIN JN, 1989, J UROLOGY, V141, P1091, DOI 10.1016/S0022-5347(17)41178-5; KILLIAN CS, 1990, CANCER INVEST, V8, P27, DOI 10.3109/07357909009017544; KNEKT P, 1988, INT J CANCER, V42, P846, DOI 10.1002/ijc.2910420609; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; PALKEN M, 1990, J UROLOGY, V143, P1155, DOI 10.1016/S0022-5347(17)40213-8; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; STAMEY TA, 1989, J UROLOGY, V141, P1070; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; WALD NJ, 1987, BRIT J CANCER, V56, P69, DOI 10.1038/bjc.1987.156; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354; 1994, CANCER STATISTICS RE; 1990, 3813BE HYBR EUR CAT; 1993, MORTALITY STATIS DH2	23	54	54	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	1995	311	7016					1340	1343		10.1136/bmj.311.7016.1340	http://dx.doi.org/10.1136/bmj.311.7016.1340			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496284	Green Published			2022-12-24	WOS:A1995TF90100022
J	VANHERWERDEN, L; HARRAP, SB; WONG, ZYH; ABRAMSON, MJ; KUTIN, JJ; FORBES, AB; RAVEN, J; LANIGAN, A; WALTERS, EH				VANHERWERDEN, L; HARRAP, SB; WONG, ZYH; ABRAMSON, MJ; KUTIN, JJ; FORBES, AB; RAVEN, J; LANIGAN, A; WALTERS, EH			LINKAGE OF HIGH-AFFINITY IGE RECEPTOR GENE WITH BRONCHIAL HYPERREACTIVITY, EVEN IN ABSENCE OF ATOPY	LANCET			English	Article							CHROMOSOME-11Q; HYPERRESPONSIVENESS; ASTHMA	Asthma is a manifestation of bronchial hyperreactivity (BHR) and forms part of the spectrum of atopic diease. Some pedigree studies of atopy have suggested linkage with the high-affinity IgE receptor (Fc epsilon RI beta) gene on chromosome 11q13, but others find no linkage. The molecular genetics of asthma and BHR have not been studied in the general population. We examined the genetic linkage of the Fc epsilon RI beta gene with clinical asthma and the underlying phenotypes of BHR (to methacholine) and atopy (defined by skinprick testing) in 123 affected sibling-pairs recruited from the general population. We found evidence of significant linkage of a highly polymorphic microsatellite marker in the fifth intron of the Fc epsilon RI beta gene to a diagnosis of asthma (18.0% excess of shared alleles, p=0.002) and to SHR (21.7% excess of shared alleles, p=0.001). Significant linkage was also observed in siblings sharing BHR when those with atopy were excluded (32.8% excess of shared alleles, p=0.004). Atopy in the absence of BHR did not show significant linkage to the Fc epsilon RI beta gene (7.2% excess of shared alleles, p=0.124). These findings suggest that mutations in the Fc epsilon RI beta gene or a closely linked gene influence the BHR underlying asthma, even in the absence of atopy.	MONASH UNIV SCH MED,DEPT SOCIAL & PREVENT MED,PRAHRAN,VIC,AUSTRALIA; ALFRED HOSP,DEPT RESP MED,PRAHRAN,VIC,AUSTRALIA	Monash University; Florey Institute of Neuroscience & Mental Health			WALTERS, Eugene/AAL-2264-2021; Abramson, Michael/AAQ-2671-2020; van Herwerden, Lynne/I-1087-2012	Abramson, Michael/0000-0002-9954-0538; van Herwerden, Lynne/0000-0001-6717-8995; Harrap, Stephen/0000-0003-2907-6714; Kutin, Jozica Johanna/0000-0002-3812-0417; Forbes, Andrew/0000-0003-4269-914X				ABRAMSON MJ, 1991, J ASTHMA, V28, P129, DOI 10.3109/02770909109082737; AMELUNG PJ, 1992, CLIN EXP ALLERGY, V22, P1077, DOI 10.1111/j.1365-2222.1992.tb00133.x; BOOTH H, 1995, AM J RESP CRIT CARE, V152, P45, DOI 10.1164/ajrccm.152.1.7599861; BRERETON HM, 1994, CLIN EXP ALLERGY, V24, P868, DOI 10.1111/j.1365-2222.1994.tb01809.x; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; DANIELS SE, 1994, HUM MOL GENET, V3, P213, DOI 10.1093/hmg/3.1.213; HIZAWA N, 1992, CLIN EXP ALLERGY, V22, P1065, DOI 10.1111/j.1365-2222.1992.tb00131.x; HOLGATE ST, 1987, CLIN SCI, V73, P561, DOI 10.1042/cs0730561; HOLMANS P, 1993, AM J HUM GENET, V52, P362; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P961; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LYMPANY P, 1992, CLIN EXP ALLERGY, V22, P1085, DOI 10.1111/j.1365-2222.1992.tb00134.x; LYMPANY P, 1992, J ALLERGY CLIN IMMUN, V89, P619, DOI 10.1016/0091-6749(92)90330-5; MARSH DG, 1992, NAT GENET, V2, P252, DOI 10.1038/ng1292-252; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MOFFATT MF, 1992, CLIN EXP ALLERGY, V22, P1046, DOI 10.1111/j.1365-2222.1992.tb00128.x; MORTON NE, 1992, CLIN EXP ALLERGY, V22, P1041, DOI 10.1111/j.1365-2222.1992.tb00126.x; NEELY JD, 1994, J ALLERGY CLIN IMMUN, V93, P220; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339, DOI 10.1159/000235398; RAVETCH JV, 1994, NAT GENET, V7, P117, DOI 10.1038/ng0694-117; RICH SS, 1992, CLIN EXP ALLERGY, V22, P1070, DOI 10.1111/j.1365-2222.1992.tb00132.x; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SHIRAKAWA T, 1991, CYTOGENET CELL GENET, V58, P1070; SIBBALD B, 1980, THORAX, V35, P671, DOI 10.1136/thx.35.9.671	26	121	122	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1262	1265		10.1016/S0140-6736(95)91863-9	http://dx.doi.org/10.1016/S0140-6736(95)91863-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475718				2022-12-24	WOS:A1995TE14500011
J	DENOOIJ, JC; HARIHARAN, IK				DENOOIJ, JC; HARIHARAN, IK			UNCOUPLING CELL FATE DETERMINATION FROM PATTERNED CELL-DIVISION IN THE DROSOPHILA EYE	SCIENCE			English	Article							C-ELEGANS EMBRYOS; COMPOUND EYE; CYCLIN-A; EXPRESSION; PROTEIN; HOMOLOG; MELANOGASTER; INHIBITOR; MUTANTS; KINASES	Cell proliferation and cell fate specification are under strict spatiotemporal control in the developing Drosophila eye. Cells excluded from five-cell preclusters synchronously enter a single additional cell cycle, the second mitotic wave, after which the remaining cells are sequentially recruited. When the second mitotic wave was blocked with the human cyclin-dependent kinase inhibitor p21(CIP1/WAF1), each cell type was still specified. Hence, cell fate determination is regulated independently of the division pattern of precursor cells. However, the second mitotic wave is needed to generate appropriate numbers of each cell type. Moreover, p21 can arrest precursor cell proliferation and allow appropriate fate choice in vivo.	MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129; HARVARD UNIV,SCH MED,BOSTON,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								BOWERMAN B, 1993, CELL, V74, P443, DOI 10.1016/0092-8674(93)80046-H; Campos-Ortega J A, 1980, Curr Top Dev Biol, V15 Pt 1, P347; DENOOIJ JC, UNPUB; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELLIS MC, 1993, DEVELOPMENT, V119, P855; FOE VE, 1989, DEVELOPMENT, V107, P1; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; HARPER JW, 1993, CELL, V75, P805; HAY BA, 1994, DEVELOPMENT, V120, P2121; JIANG HP, 1994, ONCOGENE, V9, P3397; JIMENEZ J, 1990, EMBO J, V9, P3565, DOI 10.1002/j.1460-2075.1990.tb07567.x; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; TOMLINSON A, 1987, DEV BIOL, V120, P336; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOLFF T, 1991, DEVELOPMENT, V113, P825; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	28	117	118	0	3	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					983	985		10.1126/science.270.5238.983	http://dx.doi.org/10.1126/science.270.5238.983			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481802				2022-12-24	WOS:A1995TD87800047
J	THOMIS, DC; GURNIAK, CB; TIVOL, E; SHARPE, AH; BERG, LJ				THOMIS, DC; GURNIAK, CB; TIVOL, E; SHARPE, AH; BERG, LJ			DEFECTS IN B-LYMPHOCYTE MATURATION AND T-LYMPHOCYTE ACTIVATION IN MICE LACKING JAK3	SCIENCE			English	Article							RECEPTOR; IDENTIFICATION; MUTATION; MOUSE	Biochemical studies of signaling mediated by many cytokine and growth factor receptors have implicated members of the Jak family of tyrosine kinases in these pathways. Specifically, Jak3 has been shown to be associated with the interleukin-2 (IL-2) receptor gamma chain, a component of the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15. Mice lacking Jak3 showed a severe block in B cell development at the pre-B stage in the bone marrow. In contrast, although the thymuses of these mice were small, T cell maturation progressed relatively normally. In response to mitogenic signals, peripheral T cells in Jak3-deficient mice did not proliferate and secreted small amounts of IL-2. These data demonstrate that Jak3 is critical for the progression of B cell development in the bone marrow and for the functional competence of mature T cells.	HARVARD UNIV, DEPT MOLEC & CELLULAR BIOL, CAMBRIDGE, MA 02138 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HLO7627] Funding Source: Medline; NIAMS NIH HHS [1PO30AR42689] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BIERER BE, 1994, CHEM IMMUNOL, V59, P128; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; GROSS JA, 1992, J IMMUNOL, V149, P380; GURNIAK CB, UNPUB; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RANE SG, 1994, ONCOGENE, V9, P2415; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; THOMIS DC, UNPUB; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	25	450	469	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	1995	270	5237					794	797		10.1126/science.270.5237.794	http://dx.doi.org/10.1126/science.270.5237.794			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481767				2022-12-24	WOS:A1995TC71200039
J	YOCHEM, J; WESTON, K; GREENWALD, I				YOCHEM, J; WESTON, K; GREENWALD, I			THE CAENORHABDITIS-ELEGANS LIN-12 GENE ENCODES A TRANSMEMBRANE PROTEIN WITH OVERALL SIMILARITY TO DROSOPHILA-NOTCH	NATURE			English	Article									MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology	YOCHEM, J (corresponding author), PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544, USA.							AKAM M, 1986, NATURE, V319, P447, DOI 10.1038/319447a0; APPELLA E, 1987, J BIOL CHEM, V262, P4437; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; BENDER W, 1985, CELL, V43, P559, DOI 10.1016/0092-8674(85)90224-7; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; GREENWALD I, 1985, CELL, V43, P583, DOI 10.1016/0092-8674(85)90230-2; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MANIATIS T, 1982, MOL CLONING LABORATO; OKUDA A, 1987, J BIOL CHEM, V262, P3858; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STERNBERG P, 1988, NATURE, V335; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	28	264	277	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 6	1988	335	6190					547	550		10.1038/335547a0	http://dx.doi.org/10.1038/335547a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q3412	3419531				2022-12-24	WOS:A1988Q341200055
J	ANDREWS, G; NEILSON, M; CURLEE, R				ANDREWS, G; NEILSON, M; CURLEE, R			STUTTERING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											ANDREWS, G (corresponding author), UNIV NEW S WALES,CLIN RES UNIT ANXIETY DISORDERS,299 FORBES ST,DARLINGHURST,NSW,AUSTRALIA.		Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Neilson, Megan D./0000-0001-8396-956X; Neilson, Peter D./0000-0002-4136-3233				ANDREWS G, 1983, J SPEECH HEAR DISORD, V48, P226, DOI 10.1044/jshd.4803.226; ANDREWS G, 1980, J SPEECH HEAR DISORD, V45, P287, DOI 10.1044/jshd.4503.287; ANDREWS G, 1985, BEHAV MODIF, V9, P443, DOI 10.1177/01454455850094003; BOHR T, 1986, JAMA-J AM MED ASSOC, V255, P467, DOI 10.1001/jama.1986.03370040037017; COSTELLO J, 1984, SPEECH DISORDERS CHI; FEYER AM, 1987, THESIS U NEW S WALES; 1986, JAMA, V255, P464; 1985, JAMA, V254, P953	8	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	1988	260	10					1445	1445						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9020	3404603				2022-12-24	WOS:A1988P902000028
J	STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; SPEIZER, FE; HENNEKENS, CH				STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; SPEIZER, FE; HENNEKENS, CH			A PROSPECTIVE-STUDY OF MODERATE ALCOHOL-CONSUMPTION AND THE RISK OF CORONARY-DISEASE AND STROKE IN WOMEN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HARVARD UNIV,SCH MED,CHANNING LAB,DEPT PREVENT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	STAMPFER, MJ (corresponding author), HARVARD UNIV,SCH MED,CHANNING LAB,DEPT MED,180 LONGWOOD AVE,BOSTON,MA 02115, USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA040935] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALANKO T, 1984, RES ADV ALCOHOL DRUG, V8, P209; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; BALLANTYNE FC, 1982, METABOLISM, V31, P433, DOI 10.1016/0026-0495(82)90230-X; BELFRAGE P, 1977, EUR J CLIN INVEST, V7, P127, DOI 10.1111/j.1365-2362.1977.tb01584.x; BURSTEIN M, 1960, CLIN CHIM ACTA, V5, P609, DOI 10.1016/0009-8981(60)90075-9; CAMARGO C A JR, 1985, Journal of the American Medical Association, V253, P2854, DOI 10.1001/jama.253.19.2854; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; COLDITZ GA, 1985, AM HEART J, V109, P886, DOI 10.1016/0002-8703(85)90654-4; COLDITZ GA, 1988, NEW ENGL J MED, V318, P937, DOI 10.1056/NEJM198804143181501; COLDITZ GA, 1987, INT J EPIDEMIOL, V16, P392, DOI 10.1093/ije/16.3.392; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1987, AM J EPIDEMIOL, V126, P629, DOI 10.1093/oxfordjournals.aje.a114702; CULLEN K, 1982, INT J EPIDEMIOL, V11, P67, DOI 10.1093/ije/11.1.67; DEYKIN D, 1982, NEW ENGL J MED, V306, P852, DOI 10.1056/NEJM198204083061406; DONAHUE RP, 1986, JAMA-J AM MED ASSOC, V255, P2311, DOI 10.1001/jama.255.17.2311; FRASER GE, 1983, ATHEROSCLEROSIS, V46, P275, DOI 10.1016/0021-9150(83)90178-8; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; GOFMAN JW, 1966, CIRCULATION, V34, P679, DOI 10.1161/01.CIR.34.4.679; GORDON T, 1983, AM HEART J, V105, P667, DOI 10.1016/0002-8703(83)90492-1; GORELICK P B, 1987, Stroke, V18, P268; HASKELL WL, 1984, NEW ENGL J MED, V310, P805, DOI 10.1056/NEJM198403293101301; HENNEKENS CH, 1987, CIRCULATION, V76, P501; HILLBOM M, 1983, STROKE, V14, P694, DOI 10.1161/01.STR.14.5.694; KLATSKY AL, 1974, ANN INTERN MED, V81, P294, DOI 10.7326/0003-4819-81-3-294; KLATSKY AL, 1981, ANN INTERN MED, V95, P139, DOI 10.7326/0003-4819-95-2-139; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; LANDOLFI R, 1984, BLOOD, V64, P679; LAUG WE, 1983, JAMA-J AM MED ASSOC, V250, P772, DOI 10.1001/jama.250.6.772; LONGSTRETH WT, 1985, STROKE, V16, P377, DOI 10.1161/01.STR.16.3.377; MEADE TW, 1987, LANCET, V2, P986; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MOORE RD, 1986, MEDICINE, V65, P242, DOI 10.1097/00005792-198607000-00004; PETITTI DB, 1979, JAMA-J AM MED ASSOC, V242, P1150, DOI 10.1001/jama.242.11.1150; ROSENBERG L, 1981, AM J PUBLIC HEALTH, V71, P82, DOI 10.2105/AJPH.71.1.82; ROSS RK, 1981, LANCET, V1, P858; SILVERBERG E, 1987, CA-CANCER J CLIN, V37, P2; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002; STASON WB, 1976, AM J EPIDEMIOL, V104, P603, DOI 10.1093/oxfordjournals.aje.a112338; STRYKER WS, 1988, AM J EPIDEMIOL, V127, P283, DOI 10.1093/oxfordjournals.aje.a114804; TAYLOR KG, 1981, ATHEROSCLEROSIS, V38, P11, DOI 10.1016/0021-9150(81)90098-8; THORNTON J, 1983, LANCET, V2, P819; TOIVANEN J, 1984, THROMB RES, V33, P1, DOI 10.1016/0049-3848(84)90149-X; VALIMAKI M, 1986, ATHEROSCLEROSIS, V59, P147, DOI 10.1016/0021-9150(86)90043-2; Walker AE, 1981, STROKE S1, V12, P13; WAUTIER JL, 1981, NOUV PRESSE MED, V10, P2040; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WITTEMAN JCM, 1987, CIRCULATION, V76, P19; Wolf P A, 1983, Neurol Clin, V1, P317; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	61	708	715	0	23	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	1988	319	5					267	273		10.1056/NEJM198808043190503	http://dx.doi.org/10.1056/NEJM198808043190503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5161	3393181				2022-12-24	WOS:A1988P516100003
J	CLARK, SS; MCLAUGHLIN, J; TIMMONS, M; PENDERGAST, AM; BEN-NERIAH, Y; DOW, LW; CRIST, W; ROVERA, G; SMITH, SD; WITTE, ON				CLARK, SS; MCLAUGHLIN, J; TIMMONS, M; PENDERGAST, AM; BEN-NERIAH, Y; DOW, LW; CRIST, W; ROVERA, G; SMITH, SD; WITTE, ON			EXPRESSION OF A DISTINCTIVE BCR-ABL ONCOGENE IN PH1-POSITIVE ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)	SCIENCE			English	Article									UNIV CALIF LOS ANGELES, INST MOLEC BIOL, DEPT MICROBIOL, LOS ANGELES, CA 90024 USA; UNIV TENNESSEE, COLL MED, DEPT PEDIAT, MEMPHIS, TN 38101 USA; UNIV CALIF LOS ANGELES, HOWARD HUGHES MED INST, LOS ANGELES, CA 90024 USA; HEBREW UNIV JERUSALEM, HADASSAH MED SCH, LAUTENBERG CTR GEN & TUMOR IMMUNOL, IL-91010 JERUSALEM, ISRAEL; ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38101 USA; WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA; CHILDRENS HOSP STANFORD, DEPT PEDIAT, PALO ALTO, CA 94304 USA	University of California System; University of California Los Angeles; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Hebrew University of Jerusalem; St Jude Children's Research Hospital; The Wistar Institute			Ben-Neriah, Yinon/L-6285-2019	Pendergast, Ann Marie/0000-0002-1250-6880	NCI NIH HHS [CA-21765, CA-34233, CA-20180] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA020180, P01CA034233, P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; BERK AJ, 1978, P NATL ACAD SCI USA, V75, P1274, DOI 10.1073/pnas.75.3.1274; CANAANI E, 1984, LANCET, V1, P593; CATOVSKY D, 1979, BRIT J HAEMATOL, V42, P493, DOI 10.1111/j.1365-2141.1979.tb01161.x; CHAMBERL.M, 1973, J BIOL CHEM, V248, P2235; CHAN LC, 1987, NATURE, V325, P635, DOI 10.1038/325635a0; CLARK SJ, UNPUB; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; COLLINS SJ, 1984, SCIENCE, V225, P72, DOI 10.1126/science.6587568; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; ERIKSON J, 1986, P NATL ACAD SCI USA, V83, P1807, DOI 10.1073/pnas.83.6.1807; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; GALE RP, 1984, P NATL ACAD SCI-BIOL, V81, P5648, DOI 10.1073/pnas.81.18.5648; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; GROSVELD G, 1986, MOL CELL BIOL, V6, P607, DOI 10.1128/MCB.6.2.607; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HERMANS A, 1987, CELL, V51, P33, DOI 10.1016/0092-8674(87)90007-9; KLOETZER W, 1985, VIROLOGY, V140, P230, DOI 10.1016/0042-6822(85)90361-7; KONOPKA JB, 1984, J VIROL, V51, P223, DOI 10.1128/JVI.51.1.223-232.1984; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KURZROCK R, 1987, NATURE, V325, P631, DOI 10.1038/325631a0; LANGE B, 1987, BLOOD, V70, P192; LEIBOWITZ D, 1985, BLOOD, V65, P526; LEIBOWITZ D, 1985, BLOOD, V66, P243; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAXWELL S, 1985, CANCER RES, V47, P1731; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MESMASSON AM, 1986, P NATL ACAD SCI USA, V83, P9768, DOI 10.1073/pnas.83.24.9768; NAUMOVSKI L, UNPUB; NOWELL PC, 1960, SCIENCE, V132, P1497; PENDERGAST AM, UNPUB; RODENHUIS S, 1985, NEW ENGL J MED, V313, P51; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; WALKER LC, 1987, NATURE, V329, P851, DOI 10.1038/329851a0; WESTBROOK CG, 1987, J CELL BIOCH A S, V11, P200; 1981, CANCER GENET CYTOGEN, V4, P95	40	232	241	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	1988	239	4841					775	777		10.1126/science.3422516	http://dx.doi.org/10.1126/science.3422516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M0209	3422516				2022-12-24	WOS:A1988M020900031
J	DAVIDSON, EH; PETERSON, KJ; CAMERON, RA				DAVIDSON, EH; PETERSON, KJ; CAMERON, RA			ORIGIN OF BILATERIAN BODY PLANS - EVOLUTION OF DEVELOPMENTAL REGULATORY MECHANISMS	SCIENCE			English	Article							MARINE-INVERTEBRATES; LARVAL DEVELOPMENT; PATTERN-FORMATION; HOX CODE; DROSOPHILA; HINDBRAIN; PHYLOGENY; EMBRYOS; GENES; EXPRESSION	An argument is proposed to explain the origin of large metazoans, based on the regulatory processes that underlie the morphogenetic organization of pattern in modern animals. Genetic regulatory systems similar to those used in modern, indirectly developing marine invertebrates are considered to indicate the Precambrian regulatory platform on which were erected innovations that underlie the development of macroscopic body plans. Those systems are genetic regulatory programs that produce groups of unspecified ''set-aside cells'' and hierarchical regulatory programs that initially define regions of morphogenetic space in terms of domains of transcription factor expression, These ideas affect interpretation of the development of arthropods and chordates as well as interpretation of the role of the genes of the homeotic complex in embryogenesis.	UNIV CALIF LOS ANGELES,DEPT EARTH & SPACE SCI,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles	DAVIDSON, EH (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Peterson, Kevin J/A-2188-2009	Cameron, R. Andrew/0000-0003-3947-6041	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005753, R37HD005753] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006591] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-06591] Funding Source: Medline; NICHD NIH HHS [HD-05753] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; BALSER EJ, 1990, ACTA ZOOL-STOCKHOLM, V71, P235, DOI 10.1111/j.1463-6395.1990.tb01082.x; BENGTSON S., 1986, PROBLEMATIC FOSSIL T, P3; Berrill N.J., 1955, ORIGIN VERTEBRATES; BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRITTEN RJ, 1971, QUART REV BIOL, V46, P111; Brusca R.C., 1990, INVERTEBRATES; CAMERON R A, 1989, Molecular Reproduction and Development, V1, P149, DOI 10.1002/mrd.1080010302; CAMERON RA, 1987, GENE DEV, V1, P75, DOI 10.1101/gad.1.1.75; CAMERON RA, 1989, DEVELOPMENT, V113, P1085; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CARROLL SB, 1994, DEVELOPMENT, P217; Coffman JA, 1992, CURR OPIN GENET DEV, V2, P260, DOI 10.1016/S0959-437X(05)80283-7; COHEN B, 1993, DEVELOPMENT, V117, P597; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; CZIHAK G, 1965, ROUX ARCH ENTW MECH, V155, P709; DAMEN P, 1994, DEV BIOL, V162, P364, DOI 10.1006/dbio.1994.1094; Dan, 1968, INVERTEBRATE EMBRYOL; DAVIDSON EH, 1990, DEVELOPMENT, V108, P365; DAVIDSON EH, 1993, DEVELOPMENT, V118, P665; DAVIDSON EH, 1991, DEVELOPMENT, V113, P1; DAVIDSON EH, 1994, BIOESSAYS, V16, P603, DOI 10.1002/bies.950160903; DAVIDSON EH, 1986, GENE ACTIVITY EARLY, pCH3; EDGAR LG, 1994, DEVELOPMENT, V120, P443; EMLET RB, 1995, DEV BIOL, V167, P405, DOI 10.1006/dbio.1995.1037; FEDONKIN MA, 1994, NOBEL S, V84, P370; GARCIABELLIDO A, 1994, P NATL ACAD SCI USA, V91, P10222, DOI 10.1073/pnas.91.21.10222; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; GONZALEZGAITAN M, 1994, MECH DEVELOP, V40, P183; Gould S.J, 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1992, ORIGIN EARLY EVOLUTI; Hadfield M.G., 1975, P185; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HASZPRUNAR G, 1995, ACTA ZOOL-STOCKHOLM, V76, P141, DOI 10.1111/j.1463-6395.1995.tb00988.x; HOLLAND LZ, 1989, MAR BIOL, V101, P83, DOI 10.1007/BF00393481; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Hyman L. H., 1959, INVERTEBRATES SMALLE, VV; IZPISUABELMONTE JC, 1992, DEV BIOL, V152, P26, DOI 10.1016/0012-1606(92)90153-8; Jagersten G, 1972, EVOLUTION METAZOAN L; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEAHY PS, 1994, MECH DEVELOP, V45, P255, DOI 10.1016/0925-4773(94)90012-4; MacBride EW, 1903, PHILOS T R SOC LON B, V195, P285, DOI 10.1098/rstb.1903.0006; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; MOLVEN A, 1990, DEVELOPMENT, V109, P279; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; MORGAN BA, 1994, DEVELOPMENT, P181; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; MORRIS SC, 1994, DEVELOPMENT S, V1; NIELSEN C, 1985, BIOL J LINN SOC, V25, P243, DOI 10.1111/j.1095-8312.1985.tb00396.x; Pearse JS, 1991, REPRODUCTION MARINE, P514; PETERSON KJ, 1995, LETHAIA, V28, P25, DOI 10.1111/j.1502-3931.1995.tb01591.x; QUIRING R, 1994, SCIENCE, V265, P85; RAFF RA, 1987, DEV BIOL, V119, P6, DOI 10.1016/0012-1606(87)90201-6; RAFF RA, 1994, ANNU REV ECOL SYST, V25, P351, DOI 10.1146/annurev.es.25.110194.002031; RAFF RA, 1994, NOB S, V84, P489; REUTER R, 1990, DEVELOPMENT, V109, P289; REUTER R, 1994, DEVELOPMENT, V120, P1123; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; RUNNEGAR B, 1982, J GEOL SOC AUST, V29, P395, DOI 10.1080/00167618208729222; Runnegar Bruce, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V195, P303; SCHELTEMA AH, 1993, BIOL BULL, V171, P57; SCHNEIDERMAUNOU.S, 1993, CELL, V0075; Sepkoski J.J. Jr, 1992, P1171; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; STRATHMANN RR, 1978, EVOLUTION, V32, P894, DOI 10.1111/j.1558-5646.1978.tb04642.x; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; VALENTINE JW, 1994, NOBEL S, V84, P401; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; WEIGUO S, 1994, NOBLE S, V84, P358; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; WILLIAMS JA, 1993, BIOESSAYS, V15, P567, DOI 10.1002/bies.950150902; WRAY GA, 1994, DEVELOPMENT, P97; WRAY GA, 1994, AM ZOOL, V34, P353; [No title captured]	83	308	315	1	44	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1319	1325		10.1126/science.270.5240.1319	http://dx.doi.org/10.1126/science.270.5240.1319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481819				2022-12-24	WOS:A1995TF89900028
J	JAMPEL, HD				JAMPEL, HD			PATCHING FOR CORNEAL ABRASIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CONTACT				JAMPEL, HD (corresponding author), JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21218, USA.							ANDERSON C, 1991, CORNEA, V10, P478, DOI 10.1097/00003226-199111000-00003; ASWAD MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P1667, DOI 10.1001/archopht.1989.01070020745040; COHEN EJ, 1987, OPHTHALMOLOGY, V94, P109; SCHEIN OD, 1993, AM J EMERG MED, V11, P606, DOI 10.1016/0735-6757(93)90012-Z	4	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	1995	274	19					1504	1504						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD571	7474205				2022-12-24	WOS:A1995TD57100009
J	BARRETTCONNOR, E; GOODMANGRUEN, D				BARRETTCONNOR, E; GOODMANGRUEN, D			PROSPECTIVE-STUDY OF ENDOGENOUS SEX-HORMONES AND FATAL CARDIOVASCULAR-DISEASE IN POSTMENOPAUSAL WOMEN	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; STEROIDS; THERAPY; HEALTH; PLASMA	Objectives-To examine the association between androstenedione, total and bioavailable testosterone, oestrone, and total and bioavailable oestradiol concentrations and the risk of death from cardiovascular and ischaemic heart disease. Design-19 year old population based prospective study with 99.9% follow up. Setting-Rancho Bernardo, California. Subjects-651 postmenopausal women, none taking oestrogen. Main outcome measures-Concentrations of plasma sex hormones measured by radioimmunoassay in an endocrinology research laboratory. Cardiovascular and ischaemic heart disease deaths assessed by death certificate; 85% of 30% sample validated by record review. Results-Age adjusted concentrations of sex hormones did not differ significantly in women with and without a history of heart disease at baseline and did not predict cardiovascular death or death from ischaemic heart disease. Most 95% confidence intervals for the age adjusted relative risk of cardiovascular death or death from ischaemic heart disease were narrow, and all included one. Endogenous oestrogen concentrations were not associated with significantly more favourable risk factors for heart disease, and testosterone was not associated with less favourable risk factors. Conclusion-These prospective data do not support a causal or preventive role for endogenous oestrogens or androgens and cardiovascular mortality in older women.			BARRETTCONNOR, E (corresponding author), UNIV CALIF SAN DIEGO,DEPT FAMILY & PREVENT MED,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031801] Funding Source: NIH RePORTER; NIDDK NIH HHS [2RO1 DK31 801-0942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DC, 1976, STEROIDS, V28, P179, DOI 10.1016/0039-128X(76)90108-2; BUSH TL, 1990, P S MENOPAUSE, P211; CAULEY JA, 1994, ARTERIOSCLER THROMB, V14, P14, DOI 10.1161/01.ATV.14.1.14; CAULEY JA, 1989, AM J EPIDEMIOL, V129, P1120, DOI 10.1093/oxfordjournals.aje.a115234; CAULEY JA, 1991, AM J EPIDEMIOL, V133, P50, DOI 10.1093/oxfordjournals.aje.a115801; CAULEY JA, 1991, AM J EPIDEMIOL, V132, P884; COX DR, 1972, J R STAT SOC B, V34, P187; MELDRUM DR, 1981, OBSTET GYNECOL, V57, P624; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; TRACY R, 1976, J CHRON DIS, V19, P1245; TREMBLAY RR, 1974, CONTRACEPTION, V10, P599, DOI 10.1016/0010-7824(74)90099-7; TUNSTALLPEDOE H, 1991, BMJ-BRIT MED J, V303, P701, DOI 10.1136/bmj.303.6804.701; VERMEULEN A, 1979, CLIN ENDOCRINOL, V9, P59; WINGARD DL, 1984, ANNU REV PUBL HEALTH, V5, P433, DOI 10.1146/annurev.pu.05.050184.002245; ZUMOFF B, 1982, ARTERIOSCLEROSIS, V2, P58, DOI 10.1161/01.ATV.2.1.58; 1985, SAS USERS GUIDE	17	138	145	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1193	1196		10.1136/bmj.311.7014.1193	http://dx.doi.org/10.1136/bmj.311.7014.1193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488894	Green Published			2022-12-24	WOS:A1995TD76800017
J	SURENDER, R; BRADLOW, J; COULTER, A; DOLL, H; BROWN, SS				SURENDER, R; BRADLOW, J; COULTER, A; DOLL, H; BROWN, SS			PROSPECTIVE-STUDY OF TRENDS IN REFERRAL PATTERNS IN FUNDHOLDING AND NON-FUNDHOLDING PRACTICES IN THE OXFORD REGION, 1990-4	BRITISH MEDICAL JOURNAL			English	Article								Objective-To compare outpatient referral patterns in fundholding and non-fundholding practices before and after the NHS reforms in April 1991. Design-Prospective collection of data on general practitioners' referrals to specialist outpatient clinics between June 1990 and January 1994 and detailed comparisons of three phases-October 1990 to March 1991 (phase 1), October 1991 to March 1992 (phase 2), and October 1993 to January 1994 (phase 3). Setting-10 first wave fundholding practices and six non-fundholding practices in the Oxford region. Subjects-Patients referred to consultant outpatient clinics. Results-NHS referral rates increased in fundholding practices in phase 2 and phase 3 of the study by 8.1/1000 patients a year (95% confidence interval 5.7 to 10.5), an increase of 7.5% from phase 1 (107.3/1000) to phase 3 (115.4/1000). Non-fundholders' rates increased significantly, by 25.3/1000 patients (22.5-28.1), an increase of 26.6% from phase 1 (95.0/1000) to phase 3 (120.3/1000). The fundholders' referral rates to private clinics decreased by 8.8%, whereas those from non-fundholding practices increased by 12.2%. The proportion of referrals going outside district boundaries did not change significantly. Three of the four practices entering the third and fourth wave of fundholding increased their referral rates significantly in the year before becoming fundholders. Conclusions-No evidence existed that budgetary pressures caused first wave fundholders to reduce referral rates, although the method of budget allocation may have encouraged general practitioners to inflate their referral rates in the preparatory year. Despite investment in new practice based facilities, no evidence yet exists that fundholding encourages a shift away from specialist care.	KINGS FUND DEV CTR,LONDON W1M 0AN,ENGLAND; UNIV OXFORD,RADCLIFFE INFIRM,DEPT PUBL HLTH & PRIMARY CARE,HLTH SERV RES UNIT,OXFORD OX2 6HE,ENGLAND; UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,HLTH CARE EPIDEMIOL UNIT,OXFORD OX3 7LF,ENGLAND	Radcliffe Infirmary; University of Oxford; University of Oxford			Coulter, Angela/N-6998-2019	Coulter, Angela/0000-0002-6308-8375				BRADLOW J, 1992, PATTERNS REFERRAL; COULTER A, 1993, BRIT MED J, V306, P433, DOI 10.1136/bmj.306.6875.433; COULTER A, IN PRESS EUR J PUBLI; GARDINER M, 1990, BMJ; GLENNERSTER H, 1994, IMPLEMENTING GP FUND; Roland M, 1992, HOSPITAL REFERRALS; SHELDON TA, 1994, BRIT MED J, V309, P1059, DOI 10.1136/bmj.309.6961.1059	7	45	45	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1205	1208		10.1136/bmj.311.7014.1205	http://dx.doi.org/10.1136/bmj.311.7014.1205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488902	Green Published			2022-12-24	WOS:A1995TD76800026
J	MARICQ, AV; PECKOL, E; DRISCOLL, M; BARGMANN, CI				MARICQ, AV; PECKOL, E; DRISCOLL, M; BARGMANN, CI			MECHANOSENSORY SIGNALING IN C-ELEGANS MEDIATED BY THE GLR-1 GLUTAMATE-RECEPTOR	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; GENE; NEURODEGENERATION; ACETYLCHOLINE; EXPRESSION; SEQUENCE; CLONING; FAMILY; SET	NEURONAL signalling across synapses involves activation of many neurotransmitter receptors on postsynaptic cells. glr-1 encodes a potential glutamate receptor in the nematode Caenorhabditis elegans which is most similar to vertebrate AMPA-type ionotropic glutamate receptors(1). glr-1 is expressed in motor neurons and interneurons, including interneurons implicated in the control of locomotion(2). Here we investigate the contribution of glr-1 to the normal signalling of these neurons, by generating a deletion mutation in glr-1. We find that mutant worms are deficient in their ability to withdraw backwards when mechanically stimulated, but they withdraw normally in response to chemical repellents. The ASH sensory neurons mediate withdrawal responses both to mechanical stimuli and to chemical repellents(3,4), and ASH makes chemical synapses with glr-1-expressing interneurons. Our results suggest that postsynaptic interneurons use different neurotransmitter receptors to process two sensory stimuli detected by one sensory neuron.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT ANAT, GENET PROGRAM, SAN FRANCISCO, CA 94143 USA; RUTGERS STATE UNIV, CTR ADV BIOTECHNOL & MED, DEPT MOLEC BIOL & BIOCHEM, PISCATAWAY, NJ 08855 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Rutgers State University New Brunswick				Bargmann, Cornelia/0000-0002-8484-0618				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHURCH PJ, 1993, J NEUROSCI, V13, P2790; CULOTTI JG, 1978, GENETICS, V90, P243; Darlison Mark G., 1993, V63, P48; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; SCHOTLAND J, 1995, NATURE, V374, P266, DOI 10.1038/374266a0; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; ULTSCH A, 1992, P NATL ACAD SCI USA, V89, P10484, DOI 10.1073/pnas.89.21.10484; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	31	274	282	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	1995	378	6552					78	81		10.1038/378078a0	http://dx.doi.org/10.1038/378078a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477293				2022-12-24	WOS:A1995TC46900054
J	ANDERSON, HV				ANDERSON, HV			INTRAVENOUS THROMBOLYSIS IN REFRACTORY UNSTABLE ANGINA-PECTORIS	LANCET			English	Editorial Material							TRIAL; PLACEBO		HERMANN HOSP,HOUSTON,TX		ANDERSON, HV (corresponding author), UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225, USA.							ANDERSON HV, IN PRESS J AM COLL C; BAR FW, 1992, CIRCULATION, V86, P131, DOI 10.1161/01.CIR.86.1.131; DUVVURI S, 1994, J MYOCARD ISCHEMIA, V6, P11; FREEMAN MR, 1992, CIRCULATION, V85, P150, DOI 10.1161/01.CIR.85.1.150; GRAVES EJ, 1993, NATIONAL CTR HLTH 13, V114; GURKFINKEL E, 1995, J AM COLL CARDIOL, pA420; ROMEO F, 1995, J AM COLL CARDIOL, V25, P1295, DOI 10.1016/0735-1097(95)00002-L; SCHREIBER TL, 1992, CIRCULATION, V86, P1407, DOI 10.1161/01.CIR.86.5.1407; Theroux P, 1993, Curr Probl Cardiol, V18, P157	9	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1113	1114						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475596				2022-12-24	WOS:A1995TB54900003
J	BODY, JJ; DEMEESTERMIRKINE, N; CORVILAIN, J				BODY, JJ; DEMEESTERMIRKINE, N; CORVILAIN, J			CALCITONIN DEFICIENCY AFTER RADIOACTIVE IODINE TREATMENT	ANNALS OF INTERNAL MEDICINE			English	Note									HOP UNIV BRUGMANN, SERV MED, B-1020 BRUSSELS, BELGIUM		BODY, JJ (corresponding author), INST JULES BORDET, SERV MED, UNITE ENDOCRINOL, 1 RUE HEGER BORDET, B-1000 BRUSSELS, BELGIUM.		Body, Jean-Jacques/G-9785-2015					AUSTIN LA, 1981, NEW ENGL J MED, V304, P269, DOI 10.1056/NEJM198101293040505; BODY JJ, 1983, J CLIN ENDOCR METAB, V57, P897, DOI 10.1210/jcem-57-5-897; BODY JJ, 1986, J CLIN ENDOCR METAB, V62, P700; COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48; GRAHAM GD, 1986, ANN INTERN MED, V105, P900, DOI 10.7326/0003-4819-105-6-900; KENDALLTAYLOR P, 1984, BRIT MED J, V289, P361, DOI 10.1136/bmj.289.6441.361; NUSYNOWITZ ML, 1982, J NUCL MED, V23, P143; REFETOFF S, 1977, J NUCL MED ALLIED S, V21, P23; THURSTON V, 1982, ACTA ENDOCRINOL-COP, V99, P72, DOI 10.1530/acta.0.0990072; TIEGS RD, 1986, J BONE MINER RES, V1, P339	10	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	1988	109	7					590	591		10.7326/0003-4819-109-7-590	http://dx.doi.org/10.7326/0003-4819-109-7-590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4157	3421566				2022-12-24	WOS:A1988Q415700012
J	ROOMAN, MJ; WODAK, SJ				ROOMAN, MJ; WODAK, SJ			IDENTIFICATION OF PREDICTIVE SEQUENCE MOTIFS LIMITED BY PROTEIN-STRUCTURE DATA-BASE SIZE	NATURE			English	Article									UNIV LIBRE BRUXELLES,UNITE CONFORMAT MACROMOLEC BIOL,B-1050 BRUSSELS,BELGIUM	Universite Libre de Bruxelles	ROOMAN, MJ (corresponding author), UNIV LIBRE BRUXELLES,PLANT GENET SYST,CP 160 P2,AVE P HEGER,B-1050 BRUSSELS,BELGIUM.			wodak, shoshana/0000-0002-0701-6545				BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COHEN FE, 1986, BIOCHEMISTRY-US, V25, P266, DOI 10.1021/bi00349a037; COHEN FE, 1983, BIOCHEMISTRY-US, V22, P4894, DOI 10.1021/bi00290a005; CRAWFORD JL, 1973, P NATL ACAD SCI USA, V70, P538, DOI 10.1073/pnas.70.2.538; EDWARDS MS, 1987, PROTEIN ENG, V1, P173, DOI 10.1093/protein/1.3.173; FINKELSTEIN AV, 1971, J MOL BIOL, V62, P613, DOI 10.1016/0022-2836(71)90160-4; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1987, PROTEINS, V2, P188, DOI 10.1002/prot.340020304; LIM VI, 1974, J MOL BIOL, V88, P873, DOI 10.1016/0022-2836(74)90405-7; Rescher N., 2012, TEMPORAL LOGIC, V3; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; TAYLOR WR, 1984, J MOL BIOL, V173, P487, DOI 10.1016/0022-2836(84)90393-0; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012	21	136	136	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 1	1988	335	6185					45	49		10.1038/335045a0	http://dx.doi.org/10.1038/335045a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9022	3412459				2022-12-24	WOS:A1988P902200045
J	FUJIWARA, T; MIZUUCHI, K				FUJIWARA, T; MIZUUCHI, K			RETROVIRAL DNA INTEGRATION - STRUCTURE OF AN INTEGRATION INTERMEDIATE	CELL			English	Article											FUJIWARA, T (corresponding author), NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892, USA.							ARTHUR A, 1979, MOL GEN GENET, V175, P267, DOI 10.1007/BF00397226; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COBRINIK D, 1987, J VIROL, V61, P1999, DOI 10.1128/JVI.61.6.1999-2008.1987; COLICELLI J, 1985, CELL, V42, P573, DOI 10.1016/0092-8674(85)90114-X; CRAIGIE R, 1985, CELL, V41, P867, DOI 10.1016/S0092-8674(85)80067-2; CRAIGIE R, 1987, CELL, V51, P493, DOI 10.1016/0092-8674(87)90645-3; DONEHOWER LA, 1984, P NATL ACAD SCI-BIOL, V81, P6461, DOI 10.1073/pnas.81.20.6461; DUYK G, 1985, J VIROL, V56, P589, DOI 10.1128/JVI.56.2.589-599.1985; EGLITIS MA, 1985, SCIENCE, V230, P1395, DOI 10.1126/science.2999985; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; GRANDGENETT DP, 1986, J VIROL, V58, P970, DOI 10.1128/JVI.58.3.970-974.1986; JU G, 1980, CELL, V22, P379, DOI 10.1016/0092-8674(80)90348-7; KRIEGLER M, 1983, MOL CELL BIOL, V3, P325, DOI 10.1128/MCB.3.3.325; MAJORS JE, 1981, ICN UCLA S MOL CELL, V18, P241; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MAXWELL A, 1987, P NATL ACAD SCI USA, V84, P699, DOI 10.1073/pnas.84.3.699; MIZUUCHI K, 1986, ANNU REV GENET, V20, P385; PANGANIBAN AT, 1983, NATURE, V306, P155, DOI 10.1038/306155a0; PANGANIBAN AT, 1984, CELL, V36, P673, DOI 10.1016/0092-8674(84)90347-7; PANGANIBAN AT, 1984, P NATL ACAD SCI-BIOL, V81, P7885, DOI 10.1073/pnas.81.24.7885; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RICHET E, 1986, CELL, V46, P1011, DOI 10.1016/0092-8674(86)90700-2; SCHWARTZBERG P, 1984, CELL, V37, P1043, DOI 10.1016/0092-8674(84)90439-2; SHAPIRO JA, 1979, P NATL ACAD SCI USA, V76, P1933, DOI 10.1073/pnas.76.4.1933; SHIBA T, 1983, NATURE, V302, P119, DOI 10.1038/302119a0; SHIMOTOHNO K, 1980, P NATL ACAD SCI-BIOL, V77, P7357, DOI 10.1073/pnas.77.12.7357; SHOEMAKER C, 1981, J VIROL, V40, P164, DOI 10.1128/JVI.40.1.164-172.1981; SKALKA AM, 1988, IN PRESS GENETIC REC; VARMUS H, 1982, RNA TUMOR VIRUSES; VARMUS HE, 1985, RNA TUMOR VIRUSES; VARMUS HE, 1983, MOBILE GENETIC ELEME, P411	34	335	341	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 12	1988	54	4					497	504		10.1016/0092-8674(88)90071-2	http://dx.doi.org/10.1016/0092-8674(88)90071-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P7984	3401925				2022-12-24	WOS:A1988P798400009
J	MOISE, KJ; HUHTA, JC; SHARIF, DS; OU, CN; KIRSHON, B; WASSERSTRUM, N; CANO, L				MOISE, KJ; HUHTA, JC; SHARIF, DS; OU, CN; KIRSHON, B; WASSERSTRUM, N; CANO, L			INDOMETHACIN IN THE TREATMENT OF PREMATURE LABOR - EFFECTS ON THE FETAL DUCTUS-ARTERIOSUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BAYLOR COLL MED,DEPT PEDIAT,DIV PEDIAT CARDIOL,HOUSTON,TX 77030; BAYLOR COLL MED,PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	MOISE, KJ (corresponding author), BAYLOR COLL MED,DEPT OBSTET & GYNECOL,DIV MATERNAL FETAL MED,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							ALPERT BS, 1979, J PEDIATR-US, V95, P578, DOI 10.1016/S0022-3476(79)80774-X; BENEDETTI TJ, 1982, OBSTET GYNECOL, V59, pS33; BRANCH DW, 1985, NEW ENGL J MED, V313, P1322, DOI 10.1056/NEJM198511213132104; CABROL D, 1987, AM J OBSTET GYNECOL, V157, P422, DOI 10.1016/S0002-9378(87)80185-0; CSABA IF, 1978, J PEDIATR-US, V92, P484, DOI 10.1016/S0022-3476(78)80454-5; DUDLEY DKL, 1985, AM J OBSTET GYNECOL, V151, P181, DOI 10.1016/0002-9378(85)90008-0; FUCHS F, 1976, AM J OBSTET GYNECOL, V126, P809, DOI 10.1016/0002-9378(76)90670-0; GERSONY WM, 1983, J PEDIATR-US, V102, P895, DOI 10.1016/S0022-3476(83)80022-5; HADLOCK FP, 1983, J CLIN ULTRASOUND, V11, P313, DOI 10.1002/jcu.1870110605; HUHTA JC, 1987, CIRCULATION, V75, P406, DOI 10.1161/01.CIR.75.2.406; LEVIN DL, 1979, CIRCULATION, V60, P360, DOI 10.1161/01.CIR.60.2.360; MANCHESTER D, 1976, AM J OBSTET GYNECOL, V126, P467, DOI 10.1016/0002-9378(76)90640-2; MICHALAK D, 1983, AM J OBSTET GYNECOL, V146, P861, DOI 10.1016/0002-9378(83)91092-X; MITCHELL MD, 1977, BRIT J OBSTET GYNAEC, V84, P35, DOI 10.1111/j.1471-0528.1977.tb12463.x; MITCHELL MD, 1977, BRIT MED J, V2, P1183, DOI 10.1136/bmj.2.6096.1183; NIEBYL JR, 1986, AM J OBSTET GYNECOL, V155, P747, DOI 10.1016/S0002-9378(86)80012-6; NIEBYL JR, 1980, AM J OBSTET GYNECOL, V136, P1014, DOI 10.1016/0002-9378(80)90629-8; Niswander K.R., 1972, WOMEN THEIR PREGNANC; OU CN, 1984, CLIN CHEM, V30, P898; RICHARDS SR, 1987, J REPROD MED, V32, P798; Rudolph A M, 1978, Adv Prostaglandin Thromboxane Res, V4, P231; SHARPE GL, 1975, PROSTAGLANDINS, V9, P585, DOI 10.1016/0090-6980(75)90064-7; SIDERIS EB, 1983, ADV PROSTAG THROMB L, V12, P477; TRUDINGER B, 1988, 8TH ANN M SOC PER OB; TURNER GR, 1984, CLIN PERINATOL, V11, P581, DOI 10.1016/S0095-5108(18)30903-5; WALLENBURG HCS, 1986, LANCET, V1, P1; ZUCKERMAN H, 1974, OBSTET GYNECOL, V44, P787	27	290	294	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	1988	319	6					327	331		10.1056/NEJM198808113190602	http://dx.doi.org/10.1056/NEJM198808113190602			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6095	3393194				2022-12-24	WOS:A1988P609500002
J	BLAKE, GH; ABELL, TD; STANLEY, WG				BLAKE, GH; ABELL, TD; STANLEY, WG			CIGARETTE-SMOKING AND UPPER RESPIRATORY-INFECTION AMONG RECRUITS IN BASIC COMBAT TRAINING	ANNALS OF INTERNAL MEDICINE			English	Article									BAYNE JONES ARMY COMMUNITY HOSP, FT POLK, LA USA; MARTIN ARMY COMMUNITY HOSP, FT BENNING, GA USA		BLAKE, GH (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, COLL MED, DEPT FAMILY MED, POB 26901, OKLAHOMA CITY, OK 73190 USA.							BOAKE WC, 1958, NEW ENGL J MED, V259, P1245, DOI 10.1056/NEJM195812252592602; BUCK C, 1956, AM J HYG, V63, P1; GWALTNEY JM, 1967, J AMER MED ASSOC, V202, P494, DOI 10.1001/jama.202.6.494; HAYNES WF, 1966, AM REV RESPIR DIS, V93, P730; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; MONTO AS, 1977, BRIT J PREV SOC MED, V31, P101; PARNELL JL, 1966, NEW ENGL J MED, V274, P979, DOI 10.1056/NEJM196605052741801; PETERS JM, 1967, AM REV RESPIR DIS, V95, P774	9	61	62	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1988	109	3					198	202		10.7326/0003-4819-109-3-198	http://dx.doi.org/10.7326/0003-4819-109-3-198			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6065	3389603				2022-12-24	WOS:A1988P606500008
J	TRAYNORKAPLAN, AE; HARRIS, AL; THOMPSON, BL; TAYLOR, P; SKLAR, LA				TRAYNORKAPLAN, AE; HARRIS, AL; THOMPSON, BL; TAYLOR, P; SKLAR, LA			AN INOSITOL TETRAKISPHOSPHATE-CONTAINING PHOSPHOLIPID IN ACTIVATED NEUTROPHILS	NATURE			English	Article									UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093	University of California System; University of California San Diego	TRAYNORKAPLAN, AE (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037, USA.							AMBLER SK, 1987, MOL PHARMACOL, V32, P376; BALLA T, 1987, J BIOL CHEM, V262, P9952; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; GOLDSTEIN I, 1973, P NATL ACAD SCI USA, V70, P2916, DOI 10.1073/pnas.70.10.2916; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; HAWKINS PT, 1984, BIOCHEM J, V218, P785, DOI 10.1042/bj2180785; HESLOP JP, 1985, J EXP BIOL, V119, P395; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; LEW PD, 1984, J CELL BIOL, V99, P1212, DOI 10.1083/jcb.99.4.1212; MALMSTEN CL, 1980, ACTA PHYSIOL SCAND, V110, P449, DOI 10.1111/j.1748-1716.1980.tb06696.x; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; RIDER LG, 1987, J BIOL CHEM, V262, P5603; SANTIAGOCALVO E, 1964, BIOCHIM BIOPHYS ACTA, V84, P550, DOI 10.1016/0926-6542(64)90125-8; SANTIAGOCALVO E, 1963, BIOCHIM BIOPHYS ACTA, V70, P91, DOI 10.1016/0926-6542(63)90013-1; SCHACHT J, 1978, J LIPID RES, V19, P1063; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; STEPHENS L, 1988, BIOCHEM J, V249, P271, DOI 10.1042/bj2490271; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; TOLLEY JO, 1987, J LEUKOCYTE BIOL, V42, P43, DOI 10.1002/jlb.42.1.43; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WRIGHT CD, 1987, BIOCHEM BIOPH RES CO, V142, P53, DOI 10.1016/0006-291X(87)90450-5	23	267	274	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 28	1988	334	6180					353	356		10.1038/334353a0	http://dx.doi.org/10.1038/334353a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4349	3393226				2022-12-24	WOS:A1988P434900062
J	YU, BD; HESS, JL; HORNING, SE; BROWN, GAJ; KORSMEYER, SJ				YU, BD; HESS, JL; HORNING, SE; BROWN, GAJ; KORSMEYER, SJ			ALTERED HOX EXPRESSION AND SEGMENTAL IDENTITY IN MLL-MUTANT MICE	NATURE			English	Article							DROSOPHILA-TRITHORAX; ACUTE LEUKEMIAS; ALL-1 GENE; MOUSE; TRANSFORMATIONS; REGULATOR; MUTATION; DOMAINS; MOTIF	THE mixed-lineage leukaemia gene (MLL/HRX/ALL-1) is disrupted by chromosomal translocation in human acute leukaemias that often display mixed lymphoid-myeloid phenotypes and present in infancy(1-4). MLL possesses a highly conserved SET domain also found in Drosophila trithorax (trx) and Polycomb group (Pc-G) genes, which are known to regulate homeotic genes (HOM-C) in a positive or negative fashion, respectively(5). Mll was targeted in mice by homologous recombination in embryonic stem (ES) cells to assess its role in pattern development. MII heterozygous (+/-) mice had retarded growth, displayed haematopoietic abnormalities, and demonstrated bidirectional homeotic transformations of the axial skeleton as well as sternal malformations. Mll deficiency (-/-) was embryonic lethal. Anterior boundaries of Hoxa-7 and Noxc-9 expression were shifted posteriorly in Mll +/- embryos, but their expression was abolished in Mll -/- embryos. Thus Mll is required for proper segment identity in mammals, displays haplo-insufficiency, and positively regulates Hox gene expression.	WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED,DIV MOLEC ONCOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PATHOL,DIV MOLEC ONCOL,ST LOUIS,MO 63110	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)				Yu, Benjamin/0000-0001-6663-6616				ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; BREEN TR, 1991, MECH DEVELOP, V35, P113, DOI 10.1016/0925-4773(91)90062-B; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; DUBOULE D, 1994, DEVELOPMENT, P135; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hogan B, 1994, MANIPULATING MOUSE E; INGHAM P, 1980, MOL GEN GENET, V179, P607, DOI 10.1007/BF00271751; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Kaufman M.H., 1992, ATLAS MOUSE DEV; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KNITTEL T, 1995, DEVELOPMENT, V121, P1077; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAWRENCE HJ, 1992, BLOOD, V80, P2445; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MA Q, 1993, P NATL ACAD SCI USA, V90, P6350, DOI 10.1073/pnas.90.13.6350; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; PARO R, 1995, TRENDS GENET, V11, P295, DOI 10.1016/S0168-9525(00)89081-2; PoPeSKo P, 1992, COLOUR ATLAS ANATOMY, V2; REEVES R, 1990, J BIOL CHEM, V265, P8573; ROWLEY JD, 1993, SEMIN CANCER BIOL, V4, P377; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; SINGH PB, 1994, J CELL SCI, V107, P2653; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361	29	688	709	0	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					505	508		10.1038/378505a0	http://dx.doi.org/10.1038/378505a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477409				2022-12-24	WOS:A1995TH05400075
J	DALY, MJ; MINTON, KW				DALY, MJ; MINTON, KW			RESISTANCE TO RADIATION	SCIENCE			English	Editorial Material											DALY, MJ (corresponding author), UNIFORMED SERV UNIV HLTH SCI,DEPT PATHOL,BETHESDA,MD 20814, USA.							DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; DALY MJ, 1995, J BACTERIOL, V177, P7506; MATTIMORE V, IN PRESS J BACTERIOL; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514	5	29	32	0	4	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1318	1318		10.1126/science.270.5240.1318	http://dx.doi.org/10.1126/science.270.5240.1318			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481818				2022-12-24	WOS:A1995TF89900027
J	STEVENS, MCG; HOCKLEY, AD; SPOONER, D; WALSH, AR				STEVENS, MCG; HOCKLEY, AD; SPOONER, D; WALSH, AR			TREATMENT FOR CHILDREN WITH BRAIN-TUMORS	BRITISH MEDICAL JOURNAL			English	Article								The overall survival for children with malignant brain tumours has not greatly improved in recent years, so that apparently innovative treatments may seem attractive, especially in cases with a poor prognosis. Problems associated with treating such children include balancing the need to provide optimum treatment for individual patients with the need to properly evaluate advances in treatment in clinical trials and determining who should be responsible for decisions about funding such treatments. Treatment abroad is rarely justified when judged on the basis of whether the treatment is available in Britain (or European Community) and whether there is accepted evidence for its clinical benefit. However, referral to specialist paediatric centres is essential. The range of daily experience in such centres allows an educated choice between established and new treatments. Close collaboration these centres is essential for clinical trials.			STEVENS, MCG (corresponding author), BIRMINGHAM CHILDRENS HOSP NHS TRUST,LADYWOOD MIDDLEWAY,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND.			Stevens, Michael/0000-0001-6466-551X				LUKENS JN, 1994, CANCER-AM CANCER SOC, V74, P2710, DOI 10.1002/1097-0142(19941101)74:9+<2710::AID-CNCR2820741821>3.0.CO;2-G; MAGRATH I, 1995, LANCET, V345, P601, DOI 10.1016/S0140-6736(95)90516-2; SMYTH JF, 1994, BRIT MED J, V309, P457, DOI 10.1136/bmj.309.6952.457; STILLER CA, 1988, ARCH DIS CHILD, V63, P23, DOI 10.1136/adc.63.1.23; STILLER CA, 1994, BRIT MED J, V309, P1612, DOI 10.1136/bmj.309.6969.1612; 1993, SAFE NEUROSURGERY MA; 1992, ASSESSING EFFECTS HL; [No title captured]	8	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	1995	311	7014					1213	1214		10.1136/bmj.311.7014.1213	http://dx.doi.org/10.1136/bmj.311.7014.1213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD768	7488906	Green Published			2022-12-24	WOS:A1995TD76800030
J	HEATH, SL; TEW, JG; TEW, JG; SZAKAL, AK; BURTON, GF				HEATH, SL; TEW, JG; TEW, JG; SZAKAL, AK; BURTON, GF			FOLLICULAR DENDRITIC CELLS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIVITY	NATURE			English	Article							MONOCLONAL-ANTIBODY; HIV-INFECTION; EXPRESSION; RETENTION; TISSUE; CLONE; AIDS	LARGE amounts of human immunodeficiency virus (HIV) localize on follicular dendritic cells (FDC) in the follicles of secondary lymploid tissues following viral infection(1,2). During clinical latency, active viral infection occurs primarily at these sites(3,4). As HIV on FDC is in the form of immune complexes(5), some of which may be formed with neutralizing antibody, we investigated whether HIV on FDC is infectious. We report here that HIV on FDC is highly infectious. Furthermore, FDC can convert neutralized HIV into an infectious form even in the presence of a vast excess of neutralizing antibody. Thus FDC may provide a mechanism whereby HIV infection can continue in the presence of neutralizing antibody.	VIRGINIA COMMONWEALTH UNIV, DEPT MICROBIOL & IMMUNOL, DIV IMMUNOBIOL, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, DEPT ANAT, RICHMOND, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University								BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; BIBERFELD P, 1988, CANCER DETECT PREV, V12, P217; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON GF, 1993, J IMMUNOL, V150, P31; BUTCH AW, 1994, CELL IMMUNOL, V155, P27, DOI 10.1006/cimm.1994.1099; BUTCH AW, 1993, J IMMUNOL, V150, P39; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; CHESEBRO B, 1988, J VIROL, V62, P3779, DOI 10.1128/JVI.62.10.3779-3788.1988; CLOUSE KA, 1989, J IMMUNOL, V142, P431; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; FOX CH, 1992, IMMUNOL TODAY, V13, P353, DOI 10.1016/0167-5699(92)90171-3; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; GRAY D, 1991, INT IMMUNOL, V3, P141, DOI 10.1093/intimm/3.2.141; KOSCO MH, 1992, J IMMUNOL, V148, P2331; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PINCUS SH, 1989, J IMMUNOL, V142, P3070; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; POSNER MR, 1991, J IMMUNOL, V146, P4325; POSNER MR, 1995, J ACQU IMMUN DEFIC S, V6, P7; Racz P, 1989, APMIS Suppl, V8, P16; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; TENNERRACZ K, 1991, ACCESSORY CELLS IN HIV AND OTHER RETROVIRAL INFECTIONS, P83; TEW JG, 1976, CELL IMMUNOL, V26, P141, DOI 10.1016/0008-8749(76)90358-0; TEW JG, 1979, AUST J EXP BIOL MED, V57, P401, DOI 10.1038/icb.1979.40; TEW JG, IN PRESS HDB EXPT IM	29	252	259	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 26	1995	377	6551					740	744		10.1038/377740a0	http://dx.doi.org/10.1038/377740a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477265				2022-12-24	WOS:A1995TB46900059
J	MANU, P; LANE, TJ; MATTHEWS, DA				MANU, P; LANE, TJ; MATTHEWS, DA			THE FREQUENCY OF THE CHRONIC FATIGUE SYNDROME IN PATIENTS WITH SYMPTOMS OF PERSISTENT FATIGUE	ANNALS OF INTERNAL MEDICINE			English	Article									VET ADM MED CTR, NEWINGTON, CT 06111 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	MANU, P (corresponding author), UNIV CONNECTICUT, CTR HLTH, SCH MED, DIV GEN MED, AM-028, FARMINGTON, CT 06032 USA.							ACHESON ED, 1959, AM J MED, V26, P569, DOI 10.1016/0002-9343(59)90280-3; ANTHONY JC, 1985, ARCH GEN PSYCHIAT, V42, P667; BEHAN PO, 1985, J INFECTION, V10, P211, DOI 10.1016/S0163-4453(85)92488-0; BENDER CE, 1962, JAMA-J AM MED ASSOC, V182, P156; BUCHWALD D, 1987, JAMA-J AM MED ASSOC, V257, P2303, DOI 10.1001/jama.257.17.2303; DUBOIS RE, 1984, SOUTHERN MED J, V77, P1376, DOI 10.1097/00007611-198411000-00007; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; HELZER JE, 1985, ARCH GEN PSYCHIAT, V42, P657; HENDERSON DA, 1959, NEW ENGL J MED, V260, P757, DOI 10.1056/NEJM195904092601506; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; ISAACS R, 1948, BLOOD, V3, P858, DOI 10.1182/blood.V3.8.858.858; Robins L.N., 1985, DIAGNOSTIC INTERVIEW; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Robins LN, 1981, NIMH DIAGNOSTIC INTE; TOBI M, 1982, LANCET, V1, P61; 1978, DHEW PHS791787 PUBL	17	125	125	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	1988	109	7					554	556		10.7326/0003-4819-109-7-554	http://dx.doi.org/10.7326/0003-4819-109-7-554			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q4157	3421564				2022-12-24	WOS:A1988Q415700008
J	TAYLOR, DN; HOUSTON, R; SHLIM, DR; BHAIBULAYA, M; UNGAR, BLP; ECHEVERRIA, P				TAYLOR, DN; HOUSTON, R; SHLIM, DR; BHAIBULAYA, M; UNGAR, BLP; ECHEVERRIA, P			ETIOLOGY OF DIARRHEA AMONG TRAVELERS AND FOREIGN RESIDENTS IN NEPAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									US PEACE CORPS,KATHMANDU,NEPAL; CIWEC CLIN,KATHMANDU,NEPAL; SIRIRAJ HOSP,DEPT PARASITOL,BANGKOK 7,THAILAND; UNIFORMED SERV UNIV HLTH SCI,DIV TROP PUBL HLTH,BETHESDA,MD 20814	Mahidol University; Uniformed Services University of the Health Sciences - USA	TAYLOR, DN (corresponding author), ARMED FORCES RES INST MED SCI,DEPT BACTERIOL,BANGKOK 10400,THAILAND.							BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BLACK RE, 1986, REV INFECT DIS, V8, pS131; BRODSKY RE, 1974, J INFECT DIS, V130, P219; BRONSDON MA, 1984, J CLIN MICROBIOL, V19, P952, DOI 10.1128/JCM.19.6.952-953.1984; DEAN AG, 1972, J INFECT DIS, V125, P407, DOI 10.1093/infdis/125.4.407; DUPONT HL, 1973, JAMA-J AM MED ASSOC, V226, P1525, DOI 10.1001/jama.226.13.1525; ERICSSON CD, 1987, ANN INTERN MED, V106, P216, DOI 10.7326/0003-4819-106-2-216; Ewing W.H., 1986, EDWARDS EWINGS IDENT; JOHNSON PC, 1986, JAMA-J AM MED ASSOC, V255, P757, DOI 10.1001/jama.255.6.757; JOKIPII AMM, 1985, LANCET, V2, P487; KAIN KC, 1987, DIAGN MICR INFEC DIS, V8, P235, DOI 10.1016/0732-8893(87)90055-1; KROGSTAD DJ, 1978, ANN INTERN MED, V88, P89, DOI 10.7326/0003-4819-88-1-89; MARKELL EK, 1986, AM J TROP MED HYG, V35, P1023, DOI 10.4269/ajtmh.1986.35.1023; MATHEWSON JJ, 1985, J INFECT DIS, V151, P471, DOI 10.1093/infdis/151.3.471; MOORE GT, 1969, NEW ENGL J MED, V281, P402, DOI 10.1056/NEJM196908212810802; NATARO JP, 1985, INFECT IMMUN, V48, P378, DOI 10.1128/IAI.48.2.378-383.1985; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; SACK DA, 1975, INFECT IMMUN, V11, P334, DOI 10.1128/IAI.11.2.334-336.1975; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; SERENY B, 1955, ACTA MICROBIOL ACAD, V2, P193; SPEELMAN P, 1983, SCAND J GASTROENTERO, V18, P19; STEELE TW, 1984, PATHOLOGY, V16, P263, DOI 10.3109/00313028409068535; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; TAYLOR DN, 1986, REV INFECT DIS, V8, pS136; TAYLOR DN, 1985, LANCET, V1, P381; TAYLOR DN, 1986, J INFECT DIS, V153, P1132, DOI 10.1093/infdis/153.6.1132; UNGAR BLP, 1985, AM J TROP MED HYG, V34, P465, DOI 10.4269/ajtmh.1985.34.465; WANG WLL, 1983, J CLIN MICROBIOL, V18, P803, DOI 10.1128/JCM.18.4.803-807.1983; 1987, NEPAL TOURISM STATIS	30	115	115	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	1988	260	9					1245	1248		10.1001/jama.260.9.1245	http://dx.doi.org/10.1001/jama.260.9.1245			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P7929	3404637				2022-12-24	WOS:A1988P792900024
J	LEAVY, JA; WEIL, MH; RACKOW, EC				LEAVY, JA; WEIL, MH; RACKOW, EC			LACTATE WASHOUT FOLLOWING CIRCULATORY ARREST	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV HLTH SCI CHICAGO MED SCH,DEPT MED,3333 GREEN BAY RD,N CHICAGO,IL 60064	Chicago Medical School								APSTEIN CS, 1983, CIRC RES, V52, P512; BARNER HB, 1977, J THORAC CARDIOVASC, V73, P858; BAXBY K, 1974, LANCET, V2, P977; BECKER H, 1981, J THORAC CARDIOV SUR, V81, P507; BOYCKS E, 1975, CLIN CHEM, V21, P113; BRAZIER JR, 1977, J THORAC CARDIOV SUR, V73, P102; BRODER G, 1964, SCIENCE, V143, P1457, DOI 10.1126/science.143.3613.1457; BUHL MR, 1976, TRANSPLANTATION, V21, P460, DOI 10.1097/00007890-197606000-00004; Cady L D Jr, 1973, Crit Care Med, V1, P75, DOI 10.1097/00003246-197303000-00003; COHEN RD, 1976, CLIN BIOCH ASPECTS L, P10; ENGER EA, 1978, EUR SURG RES, V10, P230, DOI 10.1159/000128012; HALJAMAE H, 1975, ANN SURG, V182, P9, DOI 10.1097/00000658-197507000-00002; HENNING RJ, 1982, CIRC SHOCK, V9, P307; JALONEN J, 1981, SCAND J THORAC CARD, V15, P67, DOI 10.3109/14017438109101026; JOHNSON RWG, 1973, BRIT MED J, V1, P391, DOI 10.1136/bmj.1.5850.391; KREISBERG RA, 1984, ANNU REV MED, V35, P181, DOI 10.1146/annurev.me.35.020184.001145; LEAVY JA, 1985, CLIN RES, V33, P931; MANSBERGER AR, 1966, ANN SURG, V163, P778, DOI 10.1097/00000658-196605000-00015; MEERBAUM S, 1975, P423; Park R, 1980, Adv Intern Med, V25, P33; PERETZ DI, 1964, CAN MED ASSOC J, V90, P673; PERETZ DI, 1965, ANN NY ACAD SCI, V119, P1133, DOI 10.1111/j.1749-6632.1965.tb47467.x; PURI VK, 1980, CIRC SHOCK, V7, P447; RACKOW EC, 1987, FED PROC, V46, P1401; ROSENBERG JC, 1968, SURG GYNECOL OBSTETR, V126, P1247; VINCENT JL, 1983, CRIT CARE MED, V11, P449, DOI 10.1097/00003246-198306000-00012; VINCENT JL, 1981, CIRCULATION, V64, P18, DOI 10.1161/01.CIR.64.1.18; VITEK V, 1971, ANN SURG, V173, P308, DOI 10.1097/00000658-197102000-00021; VONPLANTA M, 1987, CLIN RES, V3, P879; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; WEIL MH, 1981, CRIT CARE MED, V9, P236; YAMAGUCHI M, 1984, CLIN RES, V32, P14	32	30	31	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	1988	260	5					662	664		10.1001/jama.260.5.662	http://dx.doi.org/10.1001/jama.260.5.662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4773	3392792				2022-12-24	WOS:A1988P477300028
J	CNATTINGIUS, S; HAGLUND, B; MEIRIK, O				CNATTINGIUS, S; HAGLUND, B; MEIRIK, O			CIGARETTE-SMOKING AS RISK FACTOR FOR LATE FETAL AND EARLY NEONATAL DEATH	BMJ-BRITISH MEDICAL JOURNAL			English	Article									WHO, HUMAN REPROD PROGRAMME, CH-1211 GENEVA 27, SWITZERLAND	World Health Organization	CNATTINGIUS, S (corresponding author), UNIV HOSP UPPSALA, CTR PRIMARY CARE RES, S-75185 UPPSALA, SWEDEN.							Bakketeig L. S., 1984, PERINATAL EPIDEMIOLO, P99; BUTLER NR, 1963, 1ST REPORT BRIT PERI, P14; CNATTINGIUS S, 1985, OBSTET GYNECOL, V66, P449; ERICSON A, 1984, ACTA PAEDIATR SCAND, V73, P69, DOI 10.1111/j.1651-2227.1984.tb09900.x; FREDRICK J, 1978, BRIT J OBSTET GYNAEC, V85, P1; KARLBERG P, 1980, PERINATAL AUDIT SURV, P221; KLEINMAN JC, 1988, AM J EPIDEMIOL, V127, P274, DOI 10.1093/oxfordjournals.aje.a114803; KRUSE J, 1986, OBSTET GYNECOL, V67, P627, DOI 10.1097/00006250-198605000-00005; KULLANDER S, 1971, ACTA OBSTET GYN SCAN, V50, P83, DOI 10.3109/00016347109157292; MCCORMICK MC, 1984, AM J PUBLIC HEALTH, V74, P18, DOI 10.2105/AJPH.74.1.18; MCILWAINE GM, 1979, BMJ-BRIT MED J, V2, P1103, DOI 10.1136/bmj.2.6198.1103; McIntosh I D, 1984, Public Health Rev, V12, P29; MEYER MB, 1974, AM J EPIDEMIOL, V100, P443, DOI 10.1093/oxfordjournals.aje.a112056; MEYER MB, 1976, AM J EPIDEMIOL, V103, P464, DOI 10.1093/oxfordjournals.aje.a112248; ROOTH G, 1979, LANCET, V2, P1170; Schlesselman J., 1982, CASE CONTROL STUDIES, P354; SEXTON M, 1984, JAMA-J AM MED ASSOC, V251, P911, DOI 10.1001/jama.251.7.911; WERLER MM, 1985, TERATOLOGY, V32, P473, DOI 10.1002/tera.1420320316; 1985, SAS USERS GUIDE BASI, P1290	19	157	159	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	1988	297	6643					258	261		10.1136/bmj.297.6643.258	http://dx.doi.org/10.1136/bmj.297.6643.258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4266	3416144	Green Published, Bronze			2022-12-24	WOS:A1988P426600018
J	HIDDINGA, HJ; CRUM, CJ; HU, J; ROTH, DA				HIDDINGA, HJ; CRUM, CJ; HU, J; ROTH, DA			VIROID-INDUCED PHOSPHORYLATION OF A HOST PROTEIN RELATED TO A DSRNA-DEPENDENT PROTEIN-KINASE	SCIENCE			English	Article									UNIV WYOMING,DEPT PLANT SOIL & INSECT SCI,LARAMIE,WY 82071	University of Wyoming								BERRY MJ, 1985, J BIOL CHEM, V260, P1240; BERRY MJ, 1985, BIOCHEM BIOPH RES CO, V133, P168, DOI 10.1016/0006-291X(85)91856-X; BRANCH AD, 1984, SCIENCE, V223, P450, DOI 10.1126/science.6197756; DIENER TO, 1982, ANNU REV MICROBIOL, V36, P239, DOI 10.1146/annurev.mi.36.100182.001323; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ERICKSON RL, 1979, P NATL ACAD SCI USA, V76, P6260; EVANS RK, 1985, J BIOL CHEM, V260, P7800; GALABRU J, 1987, J BIOL CHEM, V262, P15538; GROSFELD H, 1980, P NATL ACAD SCI-BIOL, V77, P6526, DOI 10.1073/pnas.77.11.6526; HALEY BE, 1983, FED P, V42, P283; HIDDINGA HJ, UNPUB; HOPPE J, 1979, EUR J BIOCHEM, V93, P141, DOI 10.1111/j.1432-1033.1979.tb12804.x; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1975, J BIOL CHEM, V250, P409; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; ISHIKAWA M, 1984, MOL GEN GENET, V196, P421, DOI 10.1007/BF00436189; JACQUES R, 1981, PROG NUCLEIC ACID RE, V25, P127; KEESE P, 1987, VIROIDS VIROID LIKE, P2; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; MORROW CD, 1985, CELL, V40, P913, DOI 10.1016/0092-8674(85)90351-4; OCHOA S, 1983, ARCH BIOCHEM BIOPHYS, V223, P325, DOI 10.1016/0003-9861(83)90598-2; PETRYSHYN R, 1983, METHOD ENZYMOL, V99, P346; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; ROBERTSON HD, 1987, VIROIDS VIROID LIKE, P49; SAMUEL CE, 1977, VIROLOGY, V83, P56, DOI 10.1016/0042-6822(77)90210-0; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1984, J BIOL CHEM, V259, P3451; [No title captured]	29	69	70	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 22	1988	241	4864					451	453		10.1126/science.3393910	http://dx.doi.org/10.1126/science.3393910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P3354	3393910				2022-12-24	WOS:A1988P335400034
J	PANDYA, SK				PANDYA, SK			AN UNMITIGATED TRAGEDY	BRITISH MEDICAL JOURNAL			English	Article									KING EDWARD MEM HOSP,BOMBAY 400012,INDIA	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	PANDYA, SK (corresponding author), SETH GS MED COLL,DEPT NEUROSURG,BOMBAY 400012,INDIA.							[Anonymous], 1988, REPORT COMMISSION IN; CHINAI R, 1987, INDIAN EXPRESS  0621; CHINAI R, 1987, INDIAN EXPRESS  0823; CHINAI R, 1987, INDIAN EXPRESS  0216; CHINAI R, 1987, INDIAN EXPRESS  0215; 1987, INDIAN EXPRESS  1121; 1988, INDIAN EXPRESS  0218; 1987, TIMES INDIA     0616; 1987, TIMES INDIA     1130	9	41	41	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1988	297	6641					117	119		10.1136/bmj.297.6641.117	http://dx.doi.org/10.1136/bmj.297.6641.117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1954	3408933	Green Published, Bronze			2022-12-24	WOS:A1988P195400025
J	COHEN, SI				COHEN, SI			OVERDIAGNOSIS OF SCHIZOPHRENIA - ROLE OF ALCOHOL AND DRUG MISUSE	LANCET			English	Editorial Material							PRECEDING 1ST ADMISSIONS; PSYCHOSIS											AZUONYE IO, 1992, PSYCHIATR B, V16, P311; COHEN SI, 1988, BRIT MED J, V297, P1270, DOI 10.1136/bmj.297.6658.1270-c; COHEN SI, 1994, BRIT J PSYCHIAT, V165, P410, DOI 10.1192/bjp.165.3.410; COHEN SI, 1995, J ROY SOC MED, V88, P73; COHEN SI, 1993, BRIT J PSYCHIAT, V163, P547; COHEN SI, 1992, PSYCHIATR B, V16, P513; COHEN SI, 1992, PSYCHIATRIC B, V16, P664; COOPER JE, 1972, MAUDSLEY MONOGRAPHS, V20; DUKE PJ, 1994, BRIT J PSYCHIAT, V164, P630, DOI 10.1192/bjp.164.5.630; EVA J, 1992, PSYCHIAT B, V16, P310; EVANS M, 1992, PSYCHIATR B, V16, P327; HUMPHREYS MS, 1992, BRIT J PSYCHIAT, V161, P501, DOI 10.1192/bjp.161.4.501; MARTINEZAREVALO MJ, 1994, BRIT J PSYCHIAT, V164, P679, DOI 10.1192/bjp.164.5.679; ROTTANBURG D, 1982, LANCET, V2, P1364; Sandford T, 1995, Nurs Stand, V9, P16; SCADDING G, 1993, BRIT J PSYCHIAT, V162, P237, DOI 10.1192/S0007125000180109; SMITH J, 1994, BRIT J PSYCHIAT, V165, P13, DOI 10.1192/bjp.165.1.13; VANPRAAG HM, 1992, BRIT J PSYCHIAT, V160, P266, DOI 10.1192/bjp.160.2.266; WILSON GT, 1988, BEHAV RES THER, V26, P369, DOI 10.1016/0005-7967(88)90070-8	19	12	11	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 9	1995	346	8989					1541	1542		10.1016/S0140-6736(95)92058-7	http://dx.doi.org/10.1016/S0140-6736(95)92058-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TJ291	7491053				2022-12-24	WOS:A1995TJ29100017
J	TOGNONI, G; RONCAGLIONI, MC				TOGNONI, G; RONCAGLIONI, MC			DISSENT - AN ALTERNATIVE INTERPRETATION OF MAST-I	LANCET			English	Note											TOGNONI, G (corresponding author), MARIO NEGRI INST PHARMACOL RES,DEPT CARDIOVASC RES,VIA ERITREA 62,I-20157 MILAN,ITALY.		roncaglioni, maria carla/AAB-1875-2020	roncaglioni, maria carla/0000-0002-2029-7847				DONNAN GA, 1995, LANCET, V345, P578; HACKE W, 1995, JAMA-J AM MED ASSOC, V284, P1017; HOMMEL M, 1995, LANCET, V345, P57, DOI 10.1016/S0140-6736(95)91179-0	3	18	18	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 9	1995	346	8989					1515	1515		10.1016/S0140-6736(95)92050-1	http://dx.doi.org/10.1016/S0140-6736(95)92050-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ291	7491045				2022-12-24	WOS:A1995TJ29100009
J	OPPENHEIMER, BR; KULKARNI, SR; MATTHEWS, K; NAKAJIMA, T				OPPENHEIMER, BR; KULKARNI, SR; MATTHEWS, K; NAKAJIMA, T			INFRARED SPECTRUM OF THE COOL BROWN DWARF-GL-229B	SCIENCE			English	Article								Spectroscopic measurements of a cool brown dwarf, Gl 229B, reveal absorption features attributable to methane in the near infrared much like those of Jupiter, These features are not seen in any star. The presence of methane indicates that the surface temperature of Gl 229B is below 1000 kelvin. Features attributed to water vapor also indicate that Gl 229B is much cooler than any known star.	CALTECH,PALOMAR OBSERV 10524,PASADENA,CA 91125	California Institute of Technology				Oppenheimer, Rebecca/0000-0001-7130-7681				Allard F., 1995, Bottom of the Main Sequence - and Beyond. Proceedings of the ESO Workshop, P32; BURROWS A, 1993, REV MOD PHYS, V65, P301, DOI 10.1103/RevModPhys.65.301; DANIELSON RE, 1966, ASTROPHYS J, V143, P949, DOI 10.1086/148570; JONES HRA, 1994, MON NOT R ASTRON SOC, V267, P413, DOI 10.1093/mnras/267.2.413; KUMAR SS, 1963, ASTROPHYS J, V137, P1121, DOI 10.1086/147589; NAKAJIMA T, IN PRESS NATURE; Stevenson D.J., 1986, ASTROPHYSICS BROWN D, P218; STEVENSON DJ, 1991, ANNU REV ASTRON ASTR, V29, P163; Tsuji T., 1995, Bottom of the Main Sequence - and Beyond. Proceedings of the ESO Workshop, P45; Tsuji T., 1964, ANN TOKYO ASTRON OBS, V9, P1; ZUCKERMAN B, 1992, ASTROPHYS J, V386, P260, DOI 10.1086/171012	11	260	260	0	5	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1478	1479		10.1126/science.270.5241.1478	http://dx.doi.org/10.1126/science.270.5241.1478			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491492				2022-12-24	WOS:A1995TH37500033
J	BARONE, MV; COURTNEIDGE, S				BARONE, MV; COURTNEIDGE, S			MYC BUT NOT FOS RESCUE OF PDGF SIGNALING BLOCK CAUSED BY KINASE INACTIVE SRC	NATURE			English	Article							C-MYC; GROWTH-FACTOR; CELL-PROLIFERATION; PROTO-ONCOGENE; 3T3 CELLS; TYROSINE KINASES; ANTISENSE RNA; MESSENGER-RNA; GENE; EXPRESSION	GROWTH factors such as platelet-derived growth factor (PDGF) elicit the transcriptional activation of a large number of immediate early genes (many of which encode transcription factors), and ultimately DNA synthesis(1). Both AP1 and Myc are activated in fibroblasts in response to growth factor stimulation(2-5), and various experiments suggest their importance in proliferation(6-10). Src family kinases are required for PDGF (and other growth factors) to induce DNA synthesis(11,12). We have examined which transcription factors, when constitutively expressed, 'rescue' the block elicited by dominant negative Src. We report here that Myc, but not Fos and/or Jun, was able to rescue the block. In contrast, Fos and Jun, but not Myc, rescued the block induced by dominant negative Ras. Our data suggest that Src kinases control the transcriptional activation of Myc.	EUROPEAN MOLEC BIOL LAB,DIFFERENTIAT PROGRAMME,D-69012 HEIDELBERG,GERMANY; SUGEN INC,REDWOOD CITY,CA 94063	European Molecular Biology Laboratory (EMBL)				BARONE, Maria Vittoria/0000-0001-6190-4917				ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; BARONE MV, 1989, EMBO J, V8, P1079, DOI 10.1002/j.1460-2075.1989.tb03476.x; BIRO S, 1993, P NATL ACAD SCI USA, V90, P654, DOI 10.1073/pnas.90.2.654; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COURTNEIDGE SA, 1993, EMBO J, V12, P943, DOI 10.1002/j.1460-2075.1993.tb05735.x; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUCHINO Y, 1985, JPN J CANCER RES, V76, P75; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SOVOVA V, 1993, INT J CANCER, V53, P983; STACEY DW, 1987, MOL CELL BIOL, V7, P523, DOI 10.1128/MCB.7.1.523; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; WELHAM MJ, 1990, ONCOGENE, V5, P161; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581	30	290	292	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					509	512		10.1038/378509a0	http://dx.doi.org/10.1038/378509a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477410				2022-12-24	WOS:A1995TH05400076
J	ZISCHLER, H; GEISERT, H; VONHAESELER, A; PAABO, S				ZISCHLER, H; GEISERT, H; VONHAESELER, A; PAABO, S			A NUCLEAR FOSSIL OF THE MITOCHONDRIAL D-LOOP AND THE ORIGIN OF MODERN HUMANS	NATURE			English	Article							DNA SEQUENCES; EVOLUTION	MAMMALIAN mitochondrial DNA sequences evolve more rapidly than nuclear sequences(1). Although the rapid rate of evolution is an advantage for the study of closely related species and populations, it presents a problem in situations where related species, used as outgroups in phylogenetic analyses, have accumulated so much change that multiple substitutions obliterate the phylogenetic information(2). However, mitochondrial DNA sequences are frequently inserted into the nuclear genome(3), where they presumably evolve as nuclear pseudogene sequences and therefore more slowly than their mitochondrial counterparts. Such sequences thus represent molecular 'fossils' that could shed light on the evolution of the mitochondrial genome and could be used as outgroups in situations where no appropriate outgroup species exist. Here we show that human chromosome 11 carries a recent integration of the mitochondrial control region that can be used to gain further insight into the origin of the human mitochondrial gene pool.			ZISCHLER, H (corresponding author), UNIV MUNICH,INST ZOOL,POB 202136,LUISENSTR 14,D-80021 MUNICH,GERMANY.		von Haeseler, Arndt/HCI-9958-2022	von Haeseler, Arndt/0000-0002-3366-4458; Zischler, Hans/0000-0002-3440-8376				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; FELSENSTEIN J, 1994, PHYLIP VERSION 3 5P; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nei M, 1987, MOL EVOLUTIONARY GEN; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; PULT I, 1994, BIOL CHEM H-S, V375, P837; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Sambrook J., 1989, MOL CLONING LAB MANU; TAPPER DP, 1981, J BIOL CHEM, V256, P5106; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; ZULLO S, 1991, J MOL BIOL, V221, P1123	21	176	181	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					489	492		10.1038/378489a0	http://dx.doi.org/10.1038/378489a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477404				2022-12-24	WOS:A1995TH05400070
J	VONKONIG, CHW; POSTELSMULTANI, S; BOCK, HL; SCHMITT, HJ				VONKONIG, CHW; POSTELSMULTANI, S; BOCK, HL; SCHMITT, HJ			PERTUSSIS IN ADULTS - FREQUENCY OF TRANSMISSION AFTER HOUSEHOLD EXPOSURE	LANCET			English	Article							WHOOPING-COUGH; INFECTION; ERYTHROMYCIN; PREVENTION; EFFICACY	Although pertussis in adults is well documented, opinions differ about incidence of adult disease and about the role of adults as reservoirs of infection. We made use of a prospective household contact study of an acellular pertussis vaccine to collect data about pertussis in adults. All members of families with an index case of pertussis were monitored for respiratory symptoms, and pertussis was confirmed by laboratory tests. In 122 households, 104 children (85%) and 18 adults (15%) were the source of pertussis. These households consisted of 265 adults (aged 19-83 years), in 84 of whom (31%) pertussis was confirmed. Of these 84, 81% had respiratory symptoms for 21 days or more. The spread of pertussis was independent of whether a child (74/104) or an adult (14/18) was the index case. Most adult index cases had no pertussis recall (odds ratio 11.8). The overall attack rate in adult contacts was 0.267 and was independent of the social status and the size of the family and of a pertussis recall, although it differed significantly between women and men (p<0.05). Erythromycin treatment of the index case reduced the attack rate significantly (p<0.05). Patients whose first pertussis episode dated back more than 20 years had similar symptoms and attack rates to patients without a recall. We conclude that adults are often involved in the spread of pertussis, and that they can be susceptible to reinfection 20 years after a first pertussis episode.	UNIV MAINZ,KINDERKLIN,W-6500 MAINZ,GERMANY; SMITHKLINE BEECHAM PHARMA,CLIN RES,MUNICH,GERMANY	Johannes Gutenberg University of Mainz; GlaxoSmithKline	VONKONIG, CHW (corresponding author), STADT KRANKENANSTALTEN,INST HYG & LAB MED,LUTHERPL 40,D-47805 KREFELD,GERMANY.							AOYAMA T, 1992, AM J DIS CHILD, V146, P163, DOI 10.1001/archpedi.1992.02160140029015; BASS JW, 1986, PEDIATR INFECT DIS J, V5, P154, DOI 10.1097/00006454-198601000-00051; CROMER BA, 1993, AM J DIS CHILD, V147, P575, DOI 10.1001/archpedi.1993.02160290081031; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FEER E, 1914, MED KLIN, V10, P837; GIAMMANCO A, 1991, REV INFECT DIS, V13, P1216; GORDON JE, 1951, AM J MED SCI, V222, P333, DOI 10.1097/00000441-195109000-00011; GROB PR, 1981, LANCET, V1, P772; HE QS, 1994, J INFECT DIS, V170, P705, DOI 10.1093/infdis/170.3.705; ISACSON J, 1993, PEDIATR INFECT DIS J, V12, P284, DOI 10.1097/00006454-199304000-00005; MacLean D W, 1982, J R Coll Gen Pract, V32, P298; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; MINK CM, 1994, ARCH PEDIAT ADOL MED, V148, P153, DOI 10.1001/archpedi.1994.02170020039006; MORSE SI, 1968, ANN INTERN MED, V68, P953, DOI 10.7326/0003-4819-68-4-953; MORTIMER EA, 1990, J INFECT DIS, V161, P473, DOI 10.1093/infdis/161.3.473; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; SCHMITT HJ, IN PRESS JAMA; SCHMITZ M, 1994, MONATSSCHR KINDERH, V142, P41; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; STORSAETER J, 1992, AM J DIS CHILD, V146, P167, DOI 10.1001/archpedi.1992.02160140033016; TROLLFORS B, 1981, BRIT MED J, V283, P696, DOI 10.1136/bmj.283.6293.696; VONKONIG CHW, 1991, DEUT MED WOCHENSCHR, V116, P649, DOI 10.1055/s-2008-1063661; VONKONIG CHW, 1992, METHODEN MIKROBIOLOG; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; Ziegler R, 1988, Offentl Gesundheitswes, V50, P25; 1992, LANCET, V339, P526	26	151	156	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 18	1995	346	8986					1326	1329						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE916	7475771				2022-12-24	WOS:A1995TE91600009
J	KATAN, MB				KATAN, MB			EXIT TRANS-FATTY-ACIDS	LANCET			English	Editorial Material											KATAN, MB (corresponding author), AGR UNIV WAGENINGEN,DEPT HUMAN NUTR,WAGENINGEN,NETHERLANDS.							ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; ARO A, 1995, LANCET, V345, P273, DOI 10.1016/S0140-6736(95)90273-2; GILLMAN MW, 1995, CIRCULATION, V91, P925; KATAN MB, 1995, ANNU REV NUTR, V15, P473, DOI 10.1146/annurev.nutr.15.1.473; Kris-Etherton P. M., 1995, American Journal of Clinical Nutrition, V62, p655S; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; ROBERTS TL, 1995, LANCET, V345, P278, DOI 10.1016/S0140-6736(95)90274-0; SENTI FRE, 1988, HLTH ASPECTS DIETARY; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; ZOCK PL, 1995, AM J CLIN NUTR, V61, P617, DOI 10.1093/ajcn/61.3.617; 1995, TRANS FATTY ACIDS	11	32	34	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 11	1995	346	8985					1245	1246		10.1016/S0140-6736(95)91858-2	http://dx.doi.org/10.1016/S0140-6736(95)91858-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE145	7475713	Green Accepted			2022-12-24	WOS:A1995TE14500006
J	GREENFIELD, S; ROGERS, W; MANGOTICH, M; CARNEY, MF; TARLOV, AR				GREENFIELD, S; ROGERS, W; MANGOTICH, M; CARNEY, MF; TARLOV, AR			OUTCOMES OF PATIENTS WITH HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS TREATED BY DIFFERENT SYSTEMS AND SPECIALTIES - RESULTS FROM THE MEDICAL OUTCOMES STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL STATUS; CARE; QUALITY; THERAPY; LIFE; MEN	Objective.-To compare the outcomes of patients with hypertension and non-insulin-dependent diabetes mellitus (NIDDM) who were cared for in three different systems of care and by generalist and subspecialist physicians. Design.-An observational study with follow-up at three periods: (1) a 2-year study of 532 patients with hypertension and 170 patients with NIDDM who had entrance and exit histories, physical examinations, and laboratory tests; (2) a 4-year follow-up of 1044 patients with hypertension and 317 patients with NIDDM based on patient-reported functional status; and (3) 7-year mortality for 1296 patients with hypertension and 424 patients with NIDDM. Setting and Participants.-Patients sampled from health maintenance organizations, large multispecialty groups, and solo or single-specialty group practices in Boston, Mass, Los Angeles, Calif, and Chicago, III. Patients were designated as belonging to one of three systems of care: fee for service; prepaid patients in solo or small single-specialty groups or in large multispecialty group practices, referred to as independent practice associations; and staff-model health maintenance organizations. The principal providers were family practitioners, general internists, cardiologists, or endocrinologists. Main Outcome Measures.-Physiological, functional, and mortality. For hypertension, we measured blood pressure and stroke incidence. For NIDDM, we measured blood pressure, glycosylated hemoglobin level, visual function, vibration sense, ulcers and infections in the feet, and albumin excretion rate. Functional outcomes were assessed using the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). Mortality was assessed for the 7 years following the entrance examination. Results.-We found no evidence that any one system of care or physician specialty achieved consistently better e-year or 4-year outcomes than others for patients with NIDDM or hypertension, Endocrinologists appeared to achieve better foot-ulcer and infection outcomes for patients with NIDDM, particularly when compared with family practitioners, However, no other specialist differences were found in any individual measures for either condition. Moreover, no adjusted mortality differences among systems or among physician specialties were observed in the 7-year follow-up period. Conclusion.-No meaningful differences were found in the mean health outcomes for patients with hypertension or NIDDM, whether they were treated by different care systems or by different physician specialists. Although prepaid medicine relies more heavily on generalist physicians than does fee for service, there is no evidence from these analyses that the quality of care of moderately ill patients with these two common diseases was adversely affected, These findings must be viewed in light of the historically higher costs of fee-for-service medicine and of subspecialty physician practice.	TUFTS UNIV, SCH MED, DEPT MED, BOSTON, MA 02111 USA; HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA; VALUE HLTH SCI, SANTA MONICA, CA USA; RAND CORP, SANTA MONICA, CA USA	Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation	GREENFIELD, S (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR, INST HLTH, 750 WASHINGTON ST, BOX 345, BOSTON, MA 02111 USA.			Greenfield, Sheldon/0000-0003-4628-1998				[Anonymous], 1992, Am J Hypertens, V5, P207; BLOOM S, 1984, BRIT MED J, V288, P1793, DOI 10.1136/bmj.288.6433.1793; CAPUTO GM, 1994, NEW ENGL J MED, V331, P854, DOI 10.1056/NEJM199409293311307; CARLISLE DM, 1992, AM J PUBLIC HEALTH, V82, P1626, DOI 10.2105/AJPH.82.12.1626; GEFFNER DL, 1992, DIABETES CARE, V15, P44, DOI 10.2337/diacare.15.1.S44; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KRAVITZ RL, 1992, JAMA-J AM MED ASSOC, V267, P1617, DOI 10.1001/jama.267.12.1617; LOGERFO JP, 1978, MED CARE, V16, P488, DOI 10.1097/00005650-197806000-00005; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANNING WG, 1984, NEW ENGL J MED, V310, P1505, DOI 10.1056/NEJM198406073102305; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; MOLITCH ME, 1994, DIABETES CARE, V17, P756, DOI 10.2337/diacare.17.7.756; MURRAY JP, 1992, MED CARE, V30, P252, DOI 10.1097/00005650-199203000-00007; NEWHOUSE JP, 1993, HLTH INSURANCE MED C; RETCHIN SM, 1992, HEALTH SERV RES, V27, P651; ROGERS W, 1992, MEASURING FUNCTIONAL, P27; ROST KM, 1991, DIABETES CARE, V14, P881, DOI 10.2337/diacare.14.10.881; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; SAFRAN DG, 1994, JAMA-J AM MED ASSOC, V271, P1579, DOI 10.1001/jama.271.20.1579; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHERWIN RS, 1988, JAMA-J AM MED ASSOC, V260, P37; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Stewart AL, 1992, MEASURING FUNCTIONIN, P67; TARLOV AR, 1989, JAMA-J AM MED ASSOC, V262, P925, DOI 10.1001/jama.262.7.925; TESTA MA, 1993, NEW ENGL J MED, V328, P907, DOI 10.1056/NEJM199304013281302; TIU SC, 1993, DIABETES CARE, V16, P616, DOI 10.2337/diacare.16.4.616; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MEASURING FUNCTIONIN, P3; YELIN EH, 1985, NEW ENGL J MED, V312, P962, DOI 10.1056/NEJM198504113121506; YELIN EH, 1986, MED CARE, V24, P236, DOI 10.1097/00005650-198603000-00006	35	308	310	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	1995	274	18					1436	1444						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TC477	7474189				2022-12-24	WOS:A1995TC47700025
J	NOSAKA, T; VANDEURSEN, JMA; TRIPP, RA; THIERFELDER, WE; WITTHUHN, BA; MCMICKLE, AP; DOHERTY, PC; GROSVELD, GC; IHLE, JN				NOSAKA, T; VANDEURSEN, JMA; TRIPP, RA; THIERFELDER, WE; WITTHUHN, BA; MCMICKLE, AP; DOHERTY, PC; GROSVELD, GC; IHLE, JN			DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING JAK3	SCIENCE			English	Article							RECEPTOR	The Janus tyrosine kinases (Jaks) play a central role in signaling through cytokine receptors. Although Jak1, Jak2, and Tyk2 are widely expressed, Jak3 is predominantly expressed in hematopoietic cells and is known to associate only with the common gamma (gamma(c)) chain of the interleukin (IL)-2, IL-4, IL-7, IL-9, and IL-15 receptors. Homozygous mutant mice in which the Jak3 gene had been disrupted were generated by gene targeting. Jak3-deficient mice had profound reductions in thymocytes and severe B cell and T cell lymphopenia similar to severe combined immunodeficiency disease (SCID), and the residual T cells and B cells were functionally deficient. Thus, Jak3 plays a critical role in gamma(c) signaling and lymphoid development.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT GENET, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT IMMUNOL, MEMPHIS, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital			witthuhn, bruce/GSE-3193-2022; Tripp, Ralph/F-5218-2011; Doherty, Peter Charles/C-4185-2013	Tripp, Ralph/0000-0002-2924-9956; Doherty, Peter Charles/0000-0002-5028-3489	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749] Funding Source: Medline; NIDDK NIH HHS [R01 DK/HL42932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOSAKA T, UNPUB; OUELLE FW, 1995, MOL CELL BIOL, V15, P3336; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SECKINGER P, 1994, J IMMUNOL, V153, P97; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	23	549	574	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					800	802		10.1126/science.270.5237.800	http://dx.doi.org/10.1126/science.270.5237.800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481769				2022-12-24	WOS:A1995TC71200041
J	YOSHIBA, M; OKAMOTO, H; MISHIRO, S				YOSHIBA, M; OKAMOTO, H; MISHIRO, S			DETECTION OF THE GBV-C HEPATITIS-VIRUS GENOME IN SERUM FROM PATIENTS WITH FULMINANT-HEPATITIS OF UNKNOWN ETIOLOGY	LANCET			English	Note								Hepatitis viruses A, B, C, D, and E have not accounted for all cases of hepatitis, hence ''non A-E'' agent(s) might be implicated. A set of new viruses (GBV-A, -B, and -C) whose genomes have been sequenced, are being investigated as possible causes of non A-E hepatitis. We investigated six cases of fulminant hepatitis of unknown aetiology for the presence of GBV-C genome in their serum, and three showed positive signals by semi-nested PCR using primers derived from the NS3/helicase region. Nucleotide sequence analyses confirmed these signals to be derived from a GBV-C sequence. The results suggest the importance of GBV-C in the aetiology of fulminant hepatitis.	TOSHIBA GEN HOSP, DEPT MED SCI, SHINAGAWA KU, TOKYO 140, JAPAN; SHOWA UNIV, FUJIGAOKA HOSP, SCH MED, DEPT GASTROENTEROL, YOKOHAMA, KANAGAWA 227, JAPAN; JICHI MED SCH, DIV IMMUNOL, MINAMI KAWACHI, TOCHIGI 32904, JAPAN	Toshiba Corporation; Showa University; Jichi Medical University			Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964; Mishiro, Shunji/0000-0001-9618-6468				DEINHARDT F, 1967, J EXP MED, V125, P673, DOI 10.1084/jem.125.4.673; FAGAN EA, 1992, J MED VIROL, V38, P71, DOI 10.1002/jmv.1890380115; OKAMOTO H, 1994, HEPATOLOGY, V20, P1131, DOI 10.1016/0270-9139(94)90747-1; SIMONS JN, 1995, P NATL ACAD SCI USA, V92, P3401, DOI 10.1073/pnas.92.8.3401; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; SUZUKI H, 1994, VIRAL HEPATITIS LIVE, P426; YOSHIBA M, 1994, HEPATOLOGY, V19, P829	7	474	484	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	1995	346	8983					1131	1132		10.1016/S0140-6736(95)91802-7	http://dx.doi.org/10.1016/S0140-6736(95)91802-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475605				2022-12-24	WOS:A1995TB54900012
J	MOORMAN, JR; ACKERMAN, SJ; KOWDLEY, GC; GRIFFIN, MP; MOUNSEY, JP; CHEN, ZH; CALA, SE; OBRIAN, JJ; SZABO, G; JONES, LR				MOORMAN, JR; ACKERMAN, SJ; KOWDLEY, GC; GRIFFIN, MP; MOUNSEY, JP; CHEN, ZH; CALA, SE; OBRIAN, JJ; SZABO, G; JONES, LR			UNITARY ANION CURRENTS THROUGH PHOSPHOLEMMAN CHANNEL MOLECULES	NATURE			English	Article							PROTEIN; TAURINE; MYOCARDIUM; EXPRESSION; TRANSPORT; CLONING; HEART; ISK; K+	PHOSPHOLEMMAN (PLM) is a 72-amino-acid peptide with a single transmembrane domain(1-3), the expression of which induces chloride currents in Xenopus oocytes(4-6). It has remained unknown whether PLM is an ion channel or acts as a channel regulator. Here we show, by measuring unitary anion currents across planar phospholipid bilayers to which immunoaffinity-purified recombinant PLM was added, that it does indeed form ion channels. Excised patches of oocytes expressing PLM had similar currents. Of the ions tested, the sulphonic amino acid taurine was the most permeant, and expression of PLM increased fluxes of radiolabelled taurine in oocytes. Phospholemman is the smallest protein in cell membranes known to form an ion channel and the taurine selectivity suggests that it is involved in cell volume regulation.	UNIV VIRGINIA, HLTH SCI CTR, DEPT MOLEC PHYSIOL & BIOL PHYS, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT PEDIAT, DIV NEONATOL, CHARLOTTESVILLE, VA 22908 USA; INDIANA UNIV, SCH MED, KRANNERT INST CARDIOL, DEPT INTERNAL MED, INDIANAPOLIS, IN 46202 USA; DUPONT MERCK PHARMACEUT CO, WILMINGTON, DE 19898 USA	University of Virginia; University of Virginia; Indiana University System; Indiana University-Purdue University Indianapolis; DuPont	MOORMAN, JR (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, DEPT INTERNAL MED, DIV CARDIOVASC, CHARLOTTESVILLE, VA 22908 USA.		Moorman, J Randall/ABG-9946-2020					ATLAS M, 1984, J MOL CELL CARDIOL, V16, P311, DOI 10.1016/S0022-2828(84)80602-1; ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; BANDERALI U, 1992, AM J PHYSIOL, V263, pC1200, DOI 10.1152/ajpcell.1992.263.6.C1200; CALA SE, 1994, BIOPHYS J, V66, pA226; DIAMOND JM, 1969, PHYSIOL REV, V49, P581; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; GOLDSTEIN L, 1994, AM J PHYSIOL, V267, pR426, DOI 10.1152/ajpregu.1994.267.2.R426; HARLOW E, 1988, ANTIBODIES LABORATOR; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; Hille B., 1992, IONIC CHANNELS EXCIT; HUXTABLE R, 1977, SCIENCE, V198, P409, DOI 10.1126/science.198879; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; KIRK K, 1992, J BIOL CHEM, V267, P23475; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; LINDEMANN JP, 1986, J BIOL CHEM, V261, P4860; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; MORRISON BW, 1994, ONCOGENE, V9, P3417; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; MOUNSEY JP, 1995, J CLIN INVEST, V95, P2379, DOI 10.1172/JCI117931; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; PANG IH, 1989, P NATL ACAD SCI USA, V86, P7814, DOI 10.1073/pnas.86.20.7814; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754	25	128	131	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	1995	377	6551					737	740		10.1038/377737a0	http://dx.doi.org/10.1038/377737a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477264				2022-12-24	WOS:A1995TB46900058
J	CUMMINGS, SR; HANSEN, B; RICHARD, RJ; STEIN, MJ; COATES, TJ				CUMMINGS, SR; HANSEN, B; RICHARD, RJ; STEIN, MJ; COATES, TJ			INTERNISTS AND NICOTINE GUM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & INT HLTH,SAN FRANCISCO,CA 94143; KAISER PERMANENTE MED GRP,DEPT CLIN PSYCHOL,OAKLAND,CA; KAISER PERMANENTE MED GRP,DEPT MED,SAN FRANCISCO,CA	University of California System; University of California San Francisco; Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Permanente Medical Groups	CUMMINGS, SR (corresponding author), UNIV CALIF SAN FRANCISCO,MED CTR,DEPT MED,DIV GEN INTERNAL MED,A-405,400 PARNASSUS,SAN FRANCISCO,CA 94143, USA.				NCI NIH HHS [CA388374A] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENOWITZ NL, 1986, ANNU REV MED, V37, P21; BENOWITZ NL, 1988, NICOTINE REPLACEMENT, P187; CAMPBELL IA, 1987, PRACTITIONER, V231, P114; COCHRAN WG, 1977, SAMPLING TECHNIQUES, P91; FAGERSTROM KO, 1984, PREV MED, V13, P517, DOI 10.1016/0091-7435(84)90020-3; FAGERSTROM KO, 1985, RES MONOGRAPH NATION, V53, P103; GLASSMAN AH, 1988, JAMA-J AM MED ASSOC, V259, P2863; GLASSMAN AH, 1984, SCIENCE, V226, P864, DOI 10.1126/science.6387913; HUGHES JR, 1984, JAMA-J AM MED ASSOC, V252, P2855, DOI 10.1001/jama.252.20.2855; HUGHES JR, 1986, PHARM TREATMENT TOBA, P141; JAMROZIK K, 1984, BRIT MED J, V289, P794, DOI 10.1136/bmj.289.6448.794; KLETKE PR, 1987, ANN INTERN MED, V107, P93, DOI 10.7326/0003-4819-107-1-93; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; LAM W, 1987, LANCET, V2, P27; MELIN B, 1984, EFFECTER AV TVA OLIK; OCKENE JK, 1987, PREV MED, V16, P723, DOI 10.1016/0091-7435(87)90054-5; OSTER G, 1986, JAMA-J AM MED ASSOC, V256, P1315, DOI 10.1001/jama.256.10.1315; RUSSELL MAH, 1983, BRIT MED J, V287, P1782, DOI 10.1136/bmj.287.6407.1782; RUSSELL MAH, 1976, BMJ-BRIT MED J, V2, P391, DOI 10.1136/bmj.2.6032.391; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P1599, DOI 10.1136/bmj.280.6231.1599; RUSSELL MAH, 1985, RES MONOGRAPH NATION, V53, P110; Sachs D P, 1986, Clin Geriatr Med, V2, P337; SCHNEIDER N G, 1987, Comprehensive Therapy, V13, P32; Schneider N G, 1985, NIDA Res Monogr, V53, P83; STITZER ML, 1988, NICOTINE REPLACEMENT, P163; SUTTON S, 1987, AM J PUBLIC HEALTH, V77, P1210, DOI 10.2105/AJPH.77.9.1210; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; 1985, SAS USERS GUIDE STAT, P470; 1987, PHYSICIANS DESK REFE, P1070; 1983, BR MED J, V286, P595	30	23	23	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	1988	260	11					1565	1569		10.1001/jama.260.11.1565	http://dx.doi.org/10.1001/jama.260.11.1565			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9650	3411736				2022-12-24	WOS:A1988P965000024
J	KIZER, KW; WARRINER, TE; BOOK, SA				KIZER, KW; WARRINER, TE; BOOK, SA			SOUND SCIENCE IN THE IMPLEMENTATION OF PUBLIC-POLICY - A CASE-REPORT ON CALIFORNIAS PROPOSITION-65	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									CALIF HLTH & WELF AGCY,SACRAMENTO,CA; PROPOSIT 65 SCI ADVISORY PANEL,SACRAMENTO,CA		KIZER, KW (corresponding author), CALIF DEPT HLTH SERV,714 P ST,ROOM 1253,SACRAMENTO,CA 95814, USA.							TRAVIS CC, 1987, ENVIRON SCI TECHNOL, V21, P415, DOI 10.1021/es00159a001; 1985, NTP85002 US DEP HLTH; 1982, CHEM IND PROCESSE S4, V1; 1975, ICRP23 INT COMM RAD	4	24	24	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	1988	260	7					951	955		10.1001/jama.260.7.951	http://dx.doi.org/10.1001/jama.260.7.951			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6566	3398200				2022-12-24	WOS:A1988P656600024
J	MAVLIGIT, GM; CHARNSANGAVEJ, C; CARRASCO, CH; PATT, YZ; BENJAMIN, RS; WALLACE, S				MAVLIGIT, GM; CHARNSANGAVEJ, C; CARRASCO, CH; PATT, YZ; BENJAMIN, RS; WALLACE, S			REGRESSION OF OCULAR MELANOMA METASTATIC TO THE LIVER AFTER HEPATIC ARTERIAL CHEMOEMBOLIZATION WITH CISPLATIN AND POLYVINYL SPONGE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DIV DIAGNOST IMAGING,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center	MAVLIGIT, GM (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DIV MED,BOX 41,1515 HOLCOMBE,HOUSTON,TX 77030, USA.							BEDIKIAN AY, 1981, SOUTHERN MED J, V74, P574, DOI 10.1097/00007611-198105000-00017; CARRASCO CH, 1986, JAMA-J AM MED ASSOC, V255, P3152, DOI 10.1001/jama.255.22.3152; DANIELS JR, 1986, P AM ASSOC CANC RES, V27, P404; EINHORN LH, 1974, CANCER, V34, P1001, DOI 10.1002/1097-0142(197410)34:4<1001::AID-CNCR2820340406>3.0.CO;2-Z; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; PATT YZ, 1983, CANCER, V51, P1359, DOI 10.1002/1097-0142(19830415)51:8<1359::AID-CNCR2820510807>3.0.CO;2-V; RAJPAL S, 1983, CANCER, V52, P334, DOI 10.1002/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E; RUIZ RS, 1985, CANCER B, V37, P6; WALLACE S, 1984, CURRENT PROBLEMS CAN, P4	9	117	120	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	1988	260	7					974	976		10.1001/jama.260.7.974	http://dx.doi.org/10.1001/jama.260.7.974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P6566	3398202				2022-12-24	WOS:A1988P656600029
J	LANGLEY, JM; MARRIE, TJ; COVERT, A; WAAG, DM; WILLIAMS, JC				LANGLEY, JM; MARRIE, TJ; COVERT, A; WAAG, DM; WILLIAMS, JC			POKER PLAYERS PNEUMONIA - AN URBAN OUTBREAK OF Q-FEVER FOLLOWING EXPOSURE TO A PARTURIENT CAT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									VICTORIA GEN HOSP,RM 4090 ACC,1278 TOWER RD,HALIFAX B3H 2Y9,NS,CANADA; DALHOUSIE UNIV,DEPT MED,HALIFAX B3H 4H2,NS,CANADA; DALHOUSIE UNIV,DEPT PATHOL,HALIFAX B3H 4H2,NS,CANADA; USA,MED RES INST INFECT DIS,FREDERICK,MD 21701; NIAID,OFF DIRECTOR INTRAMURAL RES PROGRAMS,BETHESDA,MD 20205	Dalhousie University; University of Victoria; Dalhousie University; Dalhousie University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								GILLESPIE JH, 1952, AM J VET RES, V13, P91; KOSATSKY T, 1984, LANCET, V2, P1447; MARRIE TJ, 1985, AM J PUBLIC HEALTH, V75, P763, DOI 10.2105/AJPH.75.7.763; MARRIE TJ, 1985, CAN J PUBLIC HEALTH, V76, P233; MARRIE TJ, 1986, LANCET, V1, P427; MARRIE TJ, IN PRESS J INFECT DI; SAWYER LA, 1987, REV INFECT DIS, V9, P935; WELSH HH, 1958, ANN NY ACAD SCI, V70, P528, DOI 10.1111/j.1749-6632.1958.tb35409.x; WILLIAMS JC, 1981, INFECT IMMUN, V32, P840, DOI 10.1128/IAI.32.2.840-851.1981; WILLIAMS JC, 1986, J CLIN MICROBIOL, V24, P929, DOI 10.1128/JCM.24.6.929-934.1986	10	106	111	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	1988	319	6					354	356		10.1056/NEJM198808113190607	http://dx.doi.org/10.1056/NEJM198808113190607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P6095	3393197				2022-12-24	WOS:A1988P609500007
J	SEN, D; GILBERT, W				SEN, D; GILBERT, W			FORMATION OF PARALLEL 4-STRANDED COMPLEXES BY GUANINE-RICH MOTIFS IN DNA AND ITS IMPLICATIONS FOR MEIOSIS	NATURE			English	Article											SEN, D (corresponding author), HARVARD UNIV,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138, USA.							ARNOTT S, 1974, BIOCHEM J, V141, P537, DOI 10.1042/bj1410537; ASHLEY T, 1974, CAN J GENET CYTOL, V16, P61, DOI 10.1139/g74-006; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; EVANS T, 1984, NUCLEIC ACIDS RES, V12, P8043, DOI 10.1093/nar/12.21.8043; GILLIES CB, 1975, CR TRAV LAB CARLSB, V40, P135; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HOLM PB, 1977, CARLSBERG RES COMMUN, V42, P103, DOI 10.1007/BF02906489; HOOGSTEEN K, 1959, ACTA CRYSTALLOGR, V12, P822, DOI 10.1107/S0365110X59002389; HOTTA Y, 1971, J MOL BIOL, V55, P337, DOI 10.1016/0022-2836(71)90322-6; JOHN B, 1976, CHROMOSOMA, V54, P295, DOI 10.1007/BF00292812; KILPATRICK MW, 1986, J BIOL CHEM, V261, P1350; MAGUIRE MP, 1984, J THEOR BIOL, V106, P605, DOI 10.1016/0022-5193(84)90010-9; Maxam A M, 1980, Methods Enzymol, V65, P499; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; MOENS PB, 1984, COLD SPRING HARB QUA, V49, P699; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; OKA Y, 1987, NUCLEIC ACIDS RES, V15, P8877, DOI 10.1093/nar/15.21.8877; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; WEINER AM, 1988, CELL, V52, P155, DOI 10.1016/0092-8674(88)90501-6; ZIMMERMAN SB, 1975, J MOL BIOL, V92, P181, DOI 10.1016/0022-2836(75)90222-3	20	1506	1544	4	168	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 28	1988	334	6180					364	366		10.1038/334364a0	http://dx.doi.org/10.1038/334364a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4349	3393228				2022-12-24	WOS:A1988P434900066
J	WILCOX, AJ; WEINBERG, CR; OCONNOR, JF; BAIRD, DD; SCHLATTERER, JP; CANFIELD, RE; ARMSTRONG, EG; NISULA, BC				WILCOX, AJ; WEINBERG, CR; OCONNOR, JF; BAIRD, DD; SCHLATTERER, JP; CANFIELD, RE; ARMSTRONG, EG; NISULA, BC			INCIDENCE OF EARLY LOSS OF PREGNANCY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NIEHS,DIV BIOMETRY & RISK ASSESSMENT,STAT & BIOMATH BRANCH,RES TRIANGLE PK,NC 27709; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	WILCOX, AJ (corresponding author), NIEHS,EPIDEMIOL BRANCH,BOX 12233,RES TRIANGLE PK,NC 27709, USA.		Wilcox, Allen J/C-7723-2019; Baird, Donna D/D-5214-2017	Wilcox, Allen J/0000-0002-3376-1311; Baird, Donna D/0000-0002-5544-2653; Weinberg, Clarice/0000-0002-7713-8556	NCRR NIH HHS [RR-00645] Funding Source: Medline; NICHD NIH HHS [HD-15455] Funding Source: Medline; NIEHS NIH HHS [N01-ES-4-4054] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; BAKER H W G, 1987, Clinical Reproduction and Fertility, V5, P15; BIRKEN S, IN PRESS ENDOCRINOLO; BLOCH SK, 1978, J REPROD MED, V21, P251; BORKOWSKI A, 1979, NEW ENGL J MED, V301, P298, DOI 10.1056/NEJM197908093010603; CANFIELD RE, 1976, B WORLD HEALTH ORGAN, V54, P463; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; FISHEL SB, 1984, SCIENCE, V223, P816, DOI 10.1126/science.6546453; GRUDZINSKAS JG, 1985, ANN NY ACAD SCI, V442, P38, DOI 10.1111/j.1749-6632.1985.tb37503.x; HERTIG AT, 1959, PEDIATRICS, V23, P202; Leridon H., 1977, HUMAN FERTILITY BASI; MILLER JF, 1980, LANCET, V2, P554; MORRIS NM, 1967, AM J OBSTET GYNECOL, V98, P1148, DOI 10.1016/0002-9378(67)90043-9; NORMAN RJ, 1987, OBSTET GYNECOL, V69, P590; OCONNOR JF, 1988, CANCER RES, V48, P1361; ODELL WD, 1987, NEW ENGL J MED, V317, P1688, DOI 10.1056/NEJM198712313172702; Searle S.R., 1987, LINEAR MODELS UNBALA; SHARP NC, 1986, BRIT J OBSTET GYNAEC, V93, P1072, DOI 10.1111/j.1471-0528.1986.tb07833.x; STEIN ZA, 1985, AM J EPIDEMIOL, V121, P327, DOI 10.1093/oxfordjournals.aje.a114004; TIETZE C, 1968, INT J FERTIL, V13, P385; VANHELL H, 1966, NATURE, V212, P261, DOI 10.1038/212261a0; WEHMANN RE, 1981, CLIN CHEM, V27, P1997; WHITTAKER PG, 1983, LANCET, V1, P1126; WILCOX AJ, 1985, FERTIL STERIL, V44, P366; WILCOX AJ, 1987, ENVIRON HEALTH PERSP, V75, P29, DOI 10.2307/3430573; YOUNG DS, 1975, NEW ENGL J MED, V292, P795	26	1697	1731	1	75	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	1988	319	4					189	194		10.1056/NEJM198807283190401	http://dx.doi.org/10.1056/NEJM198807283190401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4105	3393170				2022-12-24	WOS:A1988P410500001
J	BECKMANN, H; CHEN, JL; OBRIEN, T; TJIAN, R				BECKMANN, H; CHEN, JL; OBRIEN, T; TJIAN, R			COACTIVATOR AND PROMOTER-SELECTIVE PROPERTIES OF RNA-POLYMERASE-I TAFS	SCIENCE			English	Article							TRANSCRIPTION FACTOR; BINDING	Human ribosomal RNA synthesis by RNA polymerase I requires the activator UBF and the promoter selectivity factor SL1, which consists of the TATA binding protein (TBP) and three associated subunits, TAF(I) 110, TAF(I)63, and TAF(I)48. Here it is shown that both TAF(I)110 and TAF(I)63 contact the promoter, whereas TAF(l)48 serves as a target for interaction with UBF and is required to form a transcriptionally active SL1 complex responsive to UBF in vitro. TAF(I)48 also alters the ability of TBP to interact with TATA box elements, and the resulting complex fails to support transcription by RNA polymerase II. Thus, TAF(I)48 may function both as a target to mediate UBF activation and as a class-specific promoter selectivity factor.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				O'Brien, Thomas/0000-0002-9161-8070				BECKMANN H, UNPUB; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; GOODRICH LA, 1994, CURR OPIN CELL BIOL, V6, P403, DOI 10.1016/0955-0674(94)90033-7; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; KWON H, 1994, J BIOL CHEM, V269, P30140; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; RADEBAUGH CA, 1994, MOL CELL BIOL, V14, P597, DOI 10.1128/MCB.14.1.597; RUDLOFF U, 1994, EMBO J, V13, P2611, DOI 10.1002/j.1460-2075.1994.tb06551.x; RUPPERT S, IN PRESS GENES DEV; SMALE S.T., 1994, TRANSCRIPTION MECHAN, P63; TANSEY WP, 1994, GENE DEV, V8, P2756, DOI 10.1101/gad.8.22.2756; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	30	82	85	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	1995	270	5241					1506	1509		10.1126/science.270.5241.1506	http://dx.doi.org/10.1126/science.270.5241.1506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491500				2022-12-24	WOS:A1995TH37500043
J	HAMMER, MF				HAMMER, MF			A RECENT COMMON ANCESTRY FOR HUMAN-Y-CHROMOSOMES	NATURE			English	Article							EVOLUTION; POLYMORPHISM; POPULATIONS; SEQUENCES	THE male-specific portion of the Y chromosome is especially useful for studies of human origins. Patterns of nucleotide variation that are neutral with respect to fitness should permit estimates of when and where ancestral Y chromosomes existed(1). However, variation on the human Y chromosome has been observed to be greatly reduced relative to the autosomes and the X chromosome(2-5). One explanation is that selection for a favourable mutation on the nonrecombining portion of the Y chromosome has resulted in the recent fixation of a single Y haplotype(5,6). A 2.6-kilobase fragment encompassing a polymorphic Alu insertion was sequenced from 16 human and four chimpanzee Y chromosomes. Patterns of nucleotide sequence diversity and divergence provide no evidence for a recent, strong selective sweep on the human Y chromosome. The time back to a common ancestral human Y chromosome is estimated to be 188,000 years, with a 95% confidence interval from 51,000 to 411,000 years. These results are consistent with autosomal and mitochondrial DNA studies that suggest a long-term human effective population size of 10,000 and a sex ratio of 1 (ref. 7). These inferences contradict predictions of the multiregional hypothesis(8) positing a widespread transformation of Homo erectus populations into Homo sapiens.			HAMMER, MF (corresponding author), UNIV ARIZONA,MOLEC SYSTEMAT & EVOLUT LAB,BIOSCI W,TUCSON,AZ 85721, USA.		Klein, Richard G/B-5910-2009					DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; ELLIS N, 1990, CELL, V63, P977, DOI 10.1016/0092-8674(90)90501-5; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; GOLDMAN N, 1992, NATURE, V367, P440; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HUDSON RR, 1987, GENETICS, V116, P153; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; KREITMAN M, 1991, GENETICS, V127, P565; LI WH, 1991, GENETICS, V129, P513; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; MAYNARDSMITH J, 1990, NATURE, V344, P591; Nei M, 1987, MOL EVOLUTIONARY GEN; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; STRINGER CB, 1988, SCIENCE, V158, P1263; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WOLPOFF MH, 1989, HUMAN REVOLUTIONS BE, P123	26	297	304	1	34	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					376	378		10.1038/378376a0	http://dx.doi.org/10.1038/378376a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477371				2022-12-24	WOS:A1995TF89300055
J	SCHOENENBERGER, RA; TANASIJEVIC, MJ; JHA, A; BATES, DW				SCHOENENBERGER, RA; TANASIJEVIC, MJ; JHA, A; BATES, DW			APPROPRIATENESS OF ANTIEPILEPTIC DRUG LEVEL MONITORING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHENYTOIN; EPILEPSY; MANAGEMENT; PHYSICIAN; IMPACT	Objectives.-To develop explicit, reliable appropriateness criteria for antiepileptic drug level monitoring and to assess the appropriateness of monitoring in one tertiary care institution. Design.-Appropriateness criteria derived from the literature and through expert opinion were used to evaluate a stratified random sample of antiepileptic drug level determinations obtained from chart review. Setting.-Tertiary care center performing more than 10 000 antiepileptic drug level determinations per year. Patients.-A total of 330 inpatients in whom antiepileptic drug levels were measured a total of 855 times. Methods.-Drug levels were assessed at least 200 times for each of four antiepileptic drugs (phenytoin, carbamazepine, phenobarbital, and valproic acid). Main Outcome Measures.-The proportion of antiepileptic drug levels with an appropriate indication and, of those, the proportion sampled appropriately. Results.-Overall, 27% (95% confidence interval, 24% to 30%) of levels had an appropriate indication. Interrater agreement for appropriateness was substantial (kappa=0.61). There was no significant difference in the appropriateness rate among the four drugs (range, 25% to 29%), Of the 624 antiepileptic drug level determinations considered inappropriate (73%), only four (0.6%) were more than 20% higher than the upper limit of normal, and none of the four patients had clinical signs of drug toxicity, A median of six levels (range, one through 69) was determined per patient, and the median interval between level determinations was 24 hours. Of the 27% of level determinations with an appropriate indication, 51% were sampled correctly, resulting in an overall appropriateness rate of 14%. Conclusions.-Only 27% of antiepileptic drug level determinations had an appropriate indication, and half of these were not sampled correctly. Routine daily monitoring without pharmacological justification accounted for most of the inappropriate drug level determinations. Efforts to decrease inappropriate monitoring may result in substantial cost reductions without missing important clinical results.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV GEN MED & PRIMARY CARE,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV CLIN EPIDEMIOL,BOSTON,MA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital					AHRQ HHS [R01-HS07107-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bates D W, 1994, Qual Manag Health Care, V2, P18; BEARDSLEY RS, 1983, EPILEPSIA, V24, P330, DOI 10.1111/j.1528-1157.1983.tb04896.x; BRODIE MJ, 1988, BRIT MED J, V296, P1110, DOI 10.1136/bmj.296.6629.1110; BUSSEY HI, 1983, THER DRUG MONIT, V5, P245, DOI 10.1097/00007691-198309000-00002; CHADWICK DW, 1987, BRIT MED J, V294, P723, DOI 10.1136/bmj.294.6574.723; CHOONARA IA, 1990, CLIN PHARMACOKINET, V18, P318, DOI 10.2165/00003088-199018040-00004; Feinstein A.R., 1985, CLIN EPIDEMIOLOGY; FINEBERG HV, 1979, DHEW PHS793216 PUBL, P144; Fleiss JL, 1981, STAT METHODS RATES P; FROESCHER W, 1981, J NEUROL, V224, P193; FROESCHER W, 1992, WIEN KLIN WOCHEN S15, V19, P15; GARDNER MJ, 1989, BRIT MED J; HOLFORD NHG, 1987, AVERYS DRUG TREATMEN, P195; JOHANNESSEN SI, 1991, COMPREHENSIVE EPILEP, P505; KNOTT C, 1990, CLIN PHARMACOKINET, V19, P425, DOI 10.2165/00003088-199019060-00002; KUTT H, 1985, RECENT ADV EPILEPSY, P183; LEVIN B, 1981, AM J HOSP PHARM, V38, P845, DOI 10.1093/ajhp/38.6.845; LEVINE M, 1988, THER DRUG MONIT, V10, P50, DOI 10.1097/00007691-198801000-00009; LOTT R, 1988, APPL THER, P1371; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P639, DOI 10.1001/jama.249.5.639; MALONEY TW, 1979, NEW ENGL J MED, V301, P1413; MCDONALD CJ, 1994, JAMA-J AM MED ASSOC, V271, P872, DOI 10.1001/jama.271.11.872; MCINNES GT, 1989, BRIT J CLIN PHARMACO, V27, P281, DOI 10.1111/j.1365-2125.1989.tb05365.x; MCKEE PJW, 1993, THER DRUG MONIT, V15, P83, DOI 10.1097/00007691-199304000-00003; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; PANZER RJ, 1987, J GEN INTERN MED, V2, P365, DOI 10.1007/BF02596179; PATSALOS PN, 1987, LANCET, V2, P39; PEARCE GA, 1990, THER DRUG MONIT, V12, P250, DOI 10.1097/00007691-199005000-00007; PITTERLE ME, 1985, AM J HOSP PHARM, V42, P1547, DOI 10.1093/ajhp/42.7.1547; PORTER RJ, 1989, ANTIEPILEPTIC DRUGS, P117; RICHENS A, 1992, TXB EPILEPSY, P535; RIED LD, 1989, AM J HOSP PHARM, V46, P945, DOI 10.1093/ajhp/46.5.945; RUBENSTEIN KE, 1972, BIOCHEM BIOPH RES CO, V47, P846, DOI 10.1016/0006-291X(72)90570-0; SPECTOR R, 1988, CLIN PHARMACOL THER, V43, P345, DOI 10.1038/clpt.1988.42; THEODORE WH, 1992, PHARMACOL THERAPEUT, V54, P297, DOI 10.1016/0163-7258(92)90004-J; TOMSON T, 1994, EPILEPSIA, V35, P122, DOI 10.1111/j.1528-1157.1994.tb02921.x; TRISOLINI MG, 1987, MED CARE, V25, P286, DOI 10.1097/00005650-198704000-00003; TROUPIN AS, 1984, ANN INTERN MED, V100, P854, DOI 10.7326/0003-4819-100-6-854; VOZEH S, 1980, EUR J CLIN PHARMACOL, V17, P33, DOI 10.1007/BF00561674; VOZEH S, 1987, CLIN PHARMACOKINET, V13, P131; WING DS, 1989, THER DRUG MONIT, V11, P32, DOI 10.1097/00007691-198901000-00007; 1993, EPILEPSIA, V34, P585; 1989, LANCET, V2, P1190	43	76	77	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	1995	274	20					1622	1626		10.1001/jama.274.20.1622	http://dx.doi.org/10.1001/jama.274.20.1622			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE738	7474249				2022-12-24	WOS:A1995TE73800029
J	MYERS, MP; WAGERSMITH, K; WESLEY, CS; YOUNG, MW; SEHGAL, A				MYERS, MP; WAGERSMITH, K; WESLEY, CS; YOUNG, MW; SEHGAL, A			POSITIONAL CLONING AND SEQUENCE-ANALYSIS OF THE DROSOPHILA CLOCK GENE, TIMELESS	SCIENCE			English	Article							MESSENGER-RNA LEVELS; PERIOD GENE; AH-RECEPTOR; NUCLEAR-PROTEIN; VISUAL-SYSTEM; NOTCH LOCUS; MELANOGASTER; PRODUCT; MUTATIONS; MUTANTS	The Drosophila genes timeless (tim) and period (per) interact, and both are required for production of circadian rhythms. Here the positional cloning and sequencing of tim are reported. The tim gene encodes a previously uncharacterized protein of 1389 amino acids, and possibly another protein of 1122 amino acids. The arrhythmic mutation tim(01) is a 64-base pair deletion that truncates TIM to 749 amino acids. Absence of sequence similarity to the PER dimerization motif (PAS) indicates that direct interaction between PER and TIM would require a heterotypic protein association.	ROCKEFELLER UNIV,CTR BIOL TIMING,HOWARD HUGHES MED INST,NATL SCI FDN SCI & TECHNOL,NEW YORK,NY 10021; ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021; UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,CTR SLEEP & RESP NEUROBIOL,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University; Rockefeller University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine			, 机智的马小跳和机智的羊不愁/ABC-5169-2020					BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COHEN SA, COMMUNICATION; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HAMILTON BA, 1991, NUCLEIC ACIDS RES, V19, P1951, DOI 10.1093/nar/19.8.1951; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; JACKSON FR, 1986, NATURE, V320, P185, DOI 10.1038/320185a0; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KIDD S, 1983, CELL, V34, P421, DOI 10.1016/0092-8674(83)90376-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LIU X, 1992, J NEUROSCI, V12, P2735; MATSUSHITA N, 1993, J BIOL CHEM, V268, P21002; MYERS M, UNPUB; Pirrotta V., 1986, DROSOPHILA PRACTICAL, P83; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; ROTHENFLUHHILFI.A, UNPUB; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SEKELSKY JJ, 1995, GENETICS, V139, P1347; SHUBO Z, 1995, EMBO J, V14, P2884; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; WESLEY CS, 1994, NUCLEIC ACIDS RES, V22, P538, DOI 10.1093/nar/22.3.538; WHITELAW ML, 1994, MOL CELL BIOL, V14, P8343, DOI 10.1128/MCB.14.12.8343; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; ZERR DM, 1990, J NEUROSCI, V10, P2749	40	211	220	1	18	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					805	808		10.1126/science.270.5237.805	http://dx.doi.org/10.1126/science.270.5237.805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481771				2022-12-24	WOS:A1995TC71200043
J	WANG, XQ; MERZENICH, MM; SAMESHIMA, K; JENKINS, WM				WANG, XQ; MERZENICH, MM; SAMESHIMA, K; JENKINS, WM			REMODELING OF HAND REPRESENTATION IN ADULT CORTEX DETERMINED BY TIMING OF TACTILE STIMULATION	NATURE			English	Article							SOMATOSENSORY CORTEX; OWL MONKEYS; TOPOGRAPHIC REORGANIZATION; FUNCTIONAL REORGANIZATION; SQUIRREL-MONKEYS; DIGIT AMPUTATION; AREA-3B; PLASTICITY; DEAFFERENTATION; DENERVATION	THE primate somatosensory cortex, which processes tactile stimuli, contains a topographic representation of the signals it receives, but the way in which such maps are maintained is poorly understood. Previous studies of cortical plasticity(1-20) indicated that changes in cortical representation during learning arise largely as a result of hebbian synaptic change mechanisms. Here we show, using adult owl monkeys trained to respond to specific stimulus sequence events, that serial application of stimuli to the fingers results in changes to the neuronal response specificity and maps of the hand surfaces in the true primary somatosensory cortical field (S1 area 3b). In this representational remodelling stimuli applied sychronously to the fingers resulted in these fingers being integrated in their representation, whereas fingers to which stimuli were applied asynchronously were segregated in their representation. Ventroposterior thalamus response maps derived in these monkeys were not equivalently reorganized. This representational plasticity appears to be cortical in origin.	UNIV CALIF SAN FRANCISCO,COLEMAN LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,KECK CTR INTEGRAT NEUROSCI,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco			Sameshima, Koichi/C-2857-2012; Sameshima, Koichi/AHA-5593-2022	Sameshima, Koichi/0000-0002-0290-2927; Sameshima, Koichi/0000-0002-0290-2927				ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; CODE RA, 1992, EXP BRAIN RES, V88, P341, DOI 10.1007/BF02259109; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; GARRAGHTY PE, 1991, P NATL ACAD SCI USA, V88, P6976, DOI 10.1073/pnas.88.16.6976; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; KALASKA J, 1979, J NEUROPHYSIOL, V42, P618, DOI 10.1152/jn.1979.42.2.618; MERZENICH MM, 1987, J COMP NEUROL, V258, P281, DOI 10.1002/cne.902580208; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MERZENICH MM, 1991, COLD SPRING HARB SYM, V55, P873; MOGILNER A, 1993, P NATL ACAD SCI USA, V90, P3593, DOI 10.1073/pnas.90.8.3593; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RASMUSSON DD, 1982, J COMP NEUROL, V205, P313, DOI 10.1002/cne.902050402; RECANZONE GH, 1991, BEHAV RES METH INS C, V23, P357, DOI 10.3758/BF03203397; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; STRYKER MP, 1987, J COMP NEUROL, V258, P297, DOI 10.1002/cne.902580209; SUR M, 1980, J NEUROPHYSIOL, V44, P295, DOI 10.1152/jn.1980.44.2.295; WALL JT, 1983, SCIENCE, V221, P771, DOI 10.1126/science.6879175; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994; YANG TT, 1994, NEUROREPORT, V5, P701, DOI 10.1097/00001756-199402000-00010	27	349	352	0	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 2	1995	378	6552					71	75		10.1038/378071a0	http://dx.doi.org/10.1038/378071a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC469	7477291				2022-12-24	WOS:A1995TC46900052
J	HEIN, L; BARSH, GS; PRATT, RE; DZAU, VJ; KOBILKA, BK				HEIN, L; BARSH, GS; PRATT, RE; DZAU, VJ; KOBILKA, BK			BEHAVIORAL AND CARDIOVASCULAR EFFECTS OF DISRUPTING THE ANGIOTENSIN-II TYPE-2 RECEPTOR GENE IN MICE	NATURE			English	Article							RAT-BRAIN; WATER-INTAKE; EXPRESSION; INJECTION; MECHANISMS; SUBTYPES; APPETITE; DRINKING; CLONING; FETUS	ANGIOTENSIN II, a potent regulator of blood pressure and of water and electrolyte balance, binds to two different G-protein-coupled receptors. The type-1 receptor (AT(1)) mediates the vasopressive and aldosterone-secreting effects of angiotensin II, but the function of the type-2 receptor (AT(2); refs 1, 2) is unknown, although it is expressed in both adult(3) and embryonic(4) life. To address this question, we have generated mice lacking the gene encoding the AT(2) receptor. Mutant mice develop normally, but have an impaired drinking response to water deprivatian as well as a reduction in spontaneous movements. Their baseline blood pressure is normal, but they show an increased vasopressor response to injection of angiotensin II. Thus, although the AT(2) receptor is not required for embryonic development, it plays a role in the central nervous system and cardiovascular functions that are mediated by the renin-angiotensin system.	STANFORD UNIV, FALK CARDIOVASC RES CTR, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT MED, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT PEDIAT, STANFORD, CA 94305 USA; STANFORD UNIV, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University				Kobilka, Brian/0000-0001-5958-3990				CHAASSAGNE C, 1995, GENOMICS, V25, P601, DOI 10.1016/0888-7543(95)80072-T; COONEY AS, 1993, EXP PHYSIOL, V78, P767, DOI 10.1113/expphysiol.1993.sp003724; DOURISH CT, 1992, EUR J PHARMACOL, V211, P113, DOI 10.1016/0014-2999(92)90271-5; FEUILLAN PP, 1993, REGUL PEPTIDES, V44, P159, DOI 10.1016/0167-0115(93)90239-5; GEORGIEV V, 1991, METHOD FIND EXP CLIN, V13, P5; GEORGIEV V, 1990, POL J PHARMACOL PHAR, V42, P553; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; GRADY EF, 1993, REGUL PEPTIDES, V44, P171, DOI 10.1016/0167-0115(93)90240-9; HOGARTY DC, 1992, BRAIN RES, V586, P289, DOI 10.1016/0006-8993(92)91638-U; HUANG Y, 1987, J NEUROCHEM, V49, P1541, DOI 10.1111/j.1471-4159.1987.tb01025.x; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KOIKE G, 1994, BIOCHEM BIOPH RES CO, V203, P1842, DOI 10.1006/bbrc.1994.2402; LOPEZ JJ, 1994, AM J PHYSIOL, V267, pH844, DOI 10.1152/ajpheart.1994.267.2.H844; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKAJIMA M, 1993, BIOCHEM BIOPH RES CO, V197, P393, DOI 10.1006/bbrc.1993.2492; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; PETKOVA B, 1991, Acta Physiologica et Pharmacologica Bulgarica, V17, P84; ROWE BP, 1992, NEUROENDOCRINOLOGY, V55, P563, DOI 10.1159/000126177; ROWLAND NE, 1992, BRAIN RES BULL, V29, P389, DOI 10.1016/0361-9230(92)90073-7; ROWLAND NE, 1993, BRAIN RES BULL, V32, P391, DOI 10.1016/0361-9230(93)90205-P; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SUMNERS C, 1983, AM J PHYSIOL, V244, pR257, DOI 10.1152/ajpregu.1983.244.2.R257; TSUTSUMI K, 1992, MOL PHARMACOL, V41, P290; VISWANATHAN M, 1992, J CLIN INVEST, V90, P1707, DOI 10.1172/JCI116043; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; WRIGHT JW, 1994, NEUROSCI BIOBEHAV R, V18, P21, DOI 10.1016/0149-7634(94)90034-5; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; ZHUO, 1995, HYPERTENSION PATHOPH, P1739	30	646	657	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 26	1995	377	6551					744	747		10.1038/377744a0	http://dx.doi.org/10.1038/377744a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477266				2022-12-24	WOS:A1995TB46900060
J	HEGARTY, JD; ABRAMS, EJ; HUTCHINSON, VE; NICHOLAS, SW; SUAREZ, MS; HEAGARTY, MC				HEGARTY, JD; ABRAMS, EJ; HUTCHINSON, VE; NICHOLAS, SW; SUAREZ, MS; HEAGARTY, MC			THE MEDICAL-CARE COSTS OF HUMAN IMMUNODEFICIENCY VIRUS - INFECTED CHILDREN IN HARLEM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											HEGARTY, JD (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,HARLEM HOSP CTR,DEPT PEDIAT,506 LENOX AVE,NEW YORK,NY 10037, USA.							Berger R, 1985, Md Med J, V34, P1173; BERNSTEIN LJ, 1985, J PEDIATR-US, V107, P352, DOI 10.1016/S0022-3476(85)80505-9; BERNSTEIN LJ, 1985, PEDIATR INFECT DIS J, V4, P472, DOI 10.1097/00006454-198509000-00005; EPSTEIN LG, 1986, PEDIATRICS, V78, P678; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; HARDY AM, 1986, JAMA-J AM MED ASSOC, V255, P209, DOI 10.1001/jama.255.2.209; Kaufman S L, 1982, Inquiry, V19, P167; LAMBERTSEN EC, 1984, PROJECTING REQUIREME; OBERG CN, 1987, PEDIATRICS, V79, P567; OSTERHOLM MT, 1987, JAMA-J AM MED ASSOC, V258, P2736; RUBINSTEIN A, 1983, JAMA-J AM MED ASSOC, V249, P2350, DOI 10.1001/jama.249.17.2350; RUBINSTEIN A, 1986, CURR PROBL PEDIATR, V16, P363; SCITOVSKY AA, 1987, PUBLIC HEALTH REP, V102, P5; SCITOVSKY AA, 1986, JAMA-J AM MED ASSOC, V256, P3103, DOI 10.1001/jama.256.22.3103; SCOTT GB, 1987, AIDS MODERN CONCEPTS, P245; SEAGE GR, 1986, JAMA-J AM MED ASSOC, V256, P3107, DOI 10.1001/jama.256.22.3107; SISK JE, 1987, HLTH AFF         SUM, P7; ULTMANN MH, 1985, DEV MED CHILD NEUROL, V27, P563, DOI 10.1111/j.1469-8749.1985.tb14127.x; 1987, HRSDMC871 US DEP HLT; 1987, MMWR S, V36, P801; 1988, AIDS SURVEILLANCE UP; 1987, MMWR, V36, P225; 1988, AIDS WEEKLY SURVEILL	23	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	1988	260	13					1901	1905						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2703	3418851				2022-12-24	WOS:A1988Q270300024
J	NICOLL, A; JENKINSON, D				NICOLL, A; JENKINSON, D			DECISION-MAKING FOR ROUTINE MEASLES MMR AND WHOOPING-COUGH IMMUNIZATION	BRITISH MEDICAL JOURNAL			English	Article									QUEENS MED CTR,DEPT CHILD HLTH,NOTTINGHAM NG7 2UH,ENGLAND	University of Nottingham								ADAJE N, 1983, BR MED J, V286, P1478; ALBERMAN E, 1986, ARCH DIS CHILD, V61, P251, DOI 10.1136/adc.61.3.251; BEGG NT, 1985, BRIT MED J, V291, P1370, DOI 10.1136/bmj.291.6506.1370; CAMPBELL AGM, 1983, ARCH DIS CHILD, V58, P3, DOI 10.1136/adc.58.1.3; HULL D, 1981, BRIT MED J, V283, P1231, DOI 10.1136/bmj.283.6301.1231; JAMES J, 1986, ARCH DIS CHILD, V61, P630; JELLEY DM, 1984, BRIT MED J, V288, P1582, DOI 10.1136/bmj.288.6430.1582; NICOLL A, 1985, LANCET, V1, P679; NICOLL A, 1987, HLTH TRENDS, V19, P19; STETLER HC, 1985, J PEDIATR-US, V107, P175, DOI 10.1016/S0022-3476(85)80120-7; TAYLOR DJ, 1985, LANCET, V1, P713; WALKER D, 1986, BRIT MED J, V292, P1501, DOI 10.1136/bmj.292.6534.1501; 1988, STATE WORLDS CHILDRE; 1988, IMMUNISATION INFECTI	14	10	10	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					405	407		10.1136/bmj.297.6645.405	http://dx.doi.org/10.1136/bmj.297.6645.405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	P5450	3408985	Green Published, Bronze			2022-12-24	WOS:A1988P545000027
J	SIMONSEN, JN; CAMERON, DW; GAKINYA, MN; NDINYAACHOLA, JO; DCOSTA, LJ; KARASIRA, P; CHEANG, M; RONALD, AR; PIOT, P; PLUMMER, FA				SIMONSEN, JN; CAMERON, DW; GAKINYA, MN; NDINYAACHOLA, JO; DCOSTA, LJ; KARASIRA, P; CHEANG, M; RONALD, AR; PIOT, P; PLUMMER, FA			HUMAN IMMUNODEFICIENCY VIRUS-INFECTION AMONG MEN WITH SEXUALLY-TRANSMITTED DISEASES - EXPERIENCE FROM A CENTER IN AFRICA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV NAIROBI,DEPT MED MICROBIOL,NAIROBI,KENYA; KENYA MED RES INST,CTR MICROBIOL RES,NAIROBI,KENYA; NAIROBI SPECIAL TREATMENT CLIN,NAIROBI,KENYA; UNIV MANITOBA,DEPT MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED MICROBIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; INST TROP MED PRINCE LEOPOLD,DEPT MICROBIOL,B-2000 ANTWERP,BELGIUM	University of Nairobi; Kenya Medical Research Institute; University of Manitoba; University of Manitoba; Institute of Tropical Medicine (ITM)				Cameron, Bill/0000-0002-0090-3539; Ronald, Allan/0000-0002-5746-3490				BIGGAR RJ, 1986, LANCET, V1, P79; BLACKMORE CA, 1985, J INFECT DIS, V151, P840, DOI 10.1093/infdis/151.5.840; CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217; DCOSTA LJ, 1985, SEX TRANSM DIS, V12, P64, DOI 10.1097/00007435-198504000-00002; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; HAMMOND GW, 1980, REV INFECT DIS, V2, P867; HOLMBERG SD, 1987, AUG INT SOC SEX TRAN; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; NSANZE H, 1981, BRIT J VENER DIS, V57, P378; PADIAN NS, 1987, REV INFECT DIS, V9, P947; PIOT P, 1984, LANCET, V2, P65; PIOT P, 1987, J INFECT DIS, V155, P1108, DOI 10.1093/infdis/155.6.1108; PLUMMER FA, 1983, LANCET, V2, P1293; QUINN TC, 1988, NEW ENGL J MED, V318, P197, DOI 10.1056/NEJM198801283180401; VANDEPERRE P, 1984, LANCET, V2, P62; WHITTINGTON WL, 1986, JAMA-J AM MED ASSOC, V255, P1702, DOI 10.1001/jama.1986.03370130058008	16	379	384	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	1988	319	5					274	278		10.1056/NEJM198808043190504	http://dx.doi.org/10.1056/NEJM198808043190504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5161	3393182				2022-12-24	WOS:A1988P516100004
J	MAITY, SN; GOLUMBEK, PT; KARSENTY, G; DECROMBRUGGHE, B				MAITY, SN; GOLUMBEK, PT; KARSENTY, G; DECROMBRUGGHE, B			SELECTIVE ACTIVATION OF TRANSCRIPTION BY A NOVEL CCAAT BINDING-FACTOR	SCIENCE			English	Article											MAITY, SN (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC GENET,HOUSTON,TX 77030, USA.			Maity, Sankar/0000-0002-2387-6545				BAGCHI MK, 1987, MOL CELL BIOL, V7, P4151, DOI 10.1128/MCB.7.12.4151; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; COHEN RB, 1986, MOL CELL BIOL, V6, P821, DOI 10.1128/MCB.6.3.821; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GORMAN C, 1982, EUKARYOTIC GENE EXPR, P129; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HARBERS K, 1984, P NATL ACAD SCI-BIOL, V81, P1504, DOI 10.1073/pnas.81.5.1504; HATAMOCHI A, 1986, J BIOL CHEM, V261, P1310; HATAMOCHI A, 1988, J BIOL CHEM, V263, P5940; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; HU SL, 1981, P NATL ACAD SCI-BIOL, V78, P820, DOI 10.1073/pnas.78.2.820; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KARSENTY G, IN PRESS J BIOL CHEM; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MUDRYJ M, 1988, THESIS G WASHINGTON; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; OIKARINEN J, 1987, J BIOL CHEM, V262, P11064; Ptashne M, 1986, GENETIC SWITCH; ROSSI P, 1987, P NATL ACAD SCI USA, V84, P5590, DOI 10.1073/pnas.84.16.5590; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; TSAI SY, 1987, CELL, V50, P701, DOI 10.1016/0092-8674(87)90328-X; WEEKENS MP, 1978, J BIOL CHEM, V253, P2483	31	193	195	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1988	241	4865					582	585		10.1126/science.3399893	http://dx.doi.org/10.1126/science.3399893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4350	3399893				2022-12-24	WOS:A1988P435000036
J	BETHELL, HJN				BETHELL, HJN			SET UP A CORONARY REHABILITATION PROGRAM	BRITISH MEDICAL JOURNAL			English	Article											BETHELL, HJN (corresponding author), HLTH CTR,ALTON GU34 2QX,HANTS,ENGLAND.							ANDERSEN EL, 1971, FUNDAMENTALS EXERCIS; ASTRAND PO, 1976, TXB WORK PHYSL; CLAUSEN JP, 1977, PHYSIOL REV, V57, P779, DOI 10.1152/physrev.1977.57.4.779; SHEPHARD RJ, 1981, ISCHAEMIC HEART DISE; WENGER NK, 1978, REHABILITATION CORON; 1975, J R COLL PHYSICIANS, V9, P281; 1983, MYOCARDIAL INFARCTIO	7	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 9	1988	297	6641					120	121		10.1136/bmj.297.6641.120	http://dx.doi.org/10.1136/bmj.297.6641.120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1954	3408934	Bronze, Green Published			2022-12-24	WOS:A1988P195400026
J	ALEXIEWICZ, JM; KUMAR, D; SMOGORZEWSKI, M; KLIN, M; MASSRY, SG				ALEXIEWICZ, JM; KUMAR, D; SMOGORZEWSKI, M; KLIN, M; MASSRY, SG			POLYMORPHONUCLEAR LEUKOCYTES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - ABNORMALITIES IN METABOLISM AND FUNCTION	ANNALS OF INTERNAL MEDICINE			English	Article						DIABETES MELLITUS, NON-INSULIN-DEPENDENT; NEUTROPHILS; PHAGOCYTOSIS; CALCIUM CHANNELS; GLYBURIDE	INCREASES CYTOSOLIC CALCIUM; PROTEIN KINASE-C; PHOSPHATE-DEPLETION; IMPAIRED PHAGOCYTOSIS; PARATHYROID-HORMONE; PANCREATIC-ISLETS; CA-2+ TRANSPORT; RAT ADIPOCYTES; MECHANISM; SODIUM	Objective: To determine basal levels of cytosolic calcium ([Ca2+]i) and phagocytic activity in polymorphonuclear leukocytes (PMNLs) from patients with non-insulin-dependent diabetes (NIDDM). Design: Prospective cohort study. Setting: A university-county hospital. Measurements: Cytosolic calcium levels, adenosine triphosphate (ATP) content, and phagocytosis of PMNLs from patients with NIDDM and from controls. Intervention: In patients with NIDDM, we evaluated the effect of treatment with an oral hypoglycemic agent (glyburide) on [Ca2+]i levels, ATP content, and the phagocytosis of PMNLs. Patients: 22 controls and 34 patients with NIDDM were examined. Fifteen patients were studied before and after 3 months of treatment with glyburide. Results: Polymorphonuclear leukocytes from patients with NIDDM showed significantly elevated basal levels of [Ca2+]i (68 +/- 9.6 compared with 43 +/- 4.9 nmol/L; P < 0.01); reduced ATP content (1.30 +/- 0.58 compared with 2.35 +/- 0.45 nmol/10(6) PMNLs; P < 0.01); and impaired phagocytosis (117 +/- 21.0 compared with 145 +/- 17.4 mu g oil/10(7) PMNLs per minute; P < 0.01) compared with controls. There was a direct and significant correlation (P < 0.01, r = 0.80) between [Ca2+]i levels in PMNLs and serum glucose levels and an inverse correlation between phagocytic ability and [Ca2+]i levels (P < 0.01; r = 0.62) as well as between phagocytic activity and fasting serum glucose levels (P < 0.01, r = 0.54) in patients with NIDDM. Glyburide therapy resulted in significant reduction in fasting serum glucose levels; in PMNLs, this treatment resulted in a significant reduction in [Ca2+]i levels, a significant increase in ATP content, and a significant improvement of phagocytosis. Conclusions: Patients with NIDDM have elevated [Ca2+]i levels in PMNLs. This abnormality is probably induced by hyperglycemia and is primarily responsible for the impaired phagocytosis seen in these patients.	UNIV SO CALIF, SCH MED, DIV NEPHROL, LOS ANGELES, CA 90033 USA; UNIV SO CALIF, SCH MED, DIV ENDOCRINOL DIABET & HYPERTENS, LOS ANGELES, CA 90033 USA	University of Southern California; University of Southern California			Kalra, D/H-6661-2019	Kalra, D/0000-0001-5254-4067	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029955, R55DK029955] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 29955] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXIEWICZ JM, 1991, AM J NEPHROL, V11, P102, DOI 10.1159/000168284; ALEXIEWICZ JM, 1995, AM J KIDNEY DIS, V25, P440, DOI 10.1016/0272-6386(95)90106-X; ALEXIEWICZ JM, 1992, AM J HYPERTENS, V5, P536, DOI 10.1093/ajh/5.8.536; ALLO SN, 1991, AM J PHYSIOL, V260, pC1165, DOI 10.1152/ajpcell.1991.260.6.C1165; BACZYNSKI R, 1985, KIDNEY INT, V27, P718, DOI 10.1038/ki.1985.71; BAGDADE JD, 1974, DIABETES, V23, P9, DOI 10.2337/diab.23.1.9; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHERVU I, 1992, KIDNEY INT, V41, P1501, DOI 10.1038/ki.1992.219; CRADDOCK PR, 1974, NEW ENGL J MED, V290, P1403, DOI 10.1056/NEJM197406202902504; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; DOWD TL, 1993, J BIOL CHEM, V268, P991; DRAZNIN B, 1989, ENDOCRINOLOGY, V125, P2341, DOI 10.1210/endo-125-5-2341; DRAZNIN B, 1988, BIOCHEM BIOPH RES CO, V156, P570, DOI 10.1016/S0006-291X(88)80880-5; ERNE P, 1984, NEW ENGL J MED, V310, P1084, DOI 10.1056/NEJM198404263101705; FADDA GZ, 1990, AM J PHYSIOL, V258, pE975, DOI 10.1152/ajpendo.1990.258.6.E975; FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8; GREENE DA, 1983, J CLIN INVEST, V72, P1058, DOI 10.1172/JCI111030; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS M, 1979, DIABETES, V28, P1039; KIERSZTEJN M, 1992, J AM SOC NEPHROL, V2, P1484; KLIN M, 1994, AM J PHYSIOL-GASTR L, V267, pG754, DOI 10.1152/ajpgi.1994.267.5.G754; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; LUNDIN A, 1986, METHOD ENZYMOL, V133, P27; MAKINO N, 1987, AM J PHYSIOL, V253, pE202, DOI 10.1152/ajpendo.1987.253.2.E202; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; MASSRY SG, 1994, SEMIN NEPHROL, V14, P219; MASSRY SG, 1992, MINER ELECTROL METAB, V18, P133; MASSRY SG, 1991, AM J PHYSIOL, V260, pF12, DOI 10.1152/ajprenal.1991.260.1.F12; MAZZANTI L, 1990, DIABETES, V39, P850, DOI 10.2337/diabetes.39.7.850; OHARA T, 1991, DIABETES, V40, P1560, DOI 10.2337/diabetes.40.11.1560; OSHIMA T, 1987, JPN CIRC J, V51, P1184, DOI 10.1253/jcj.51.1184; RESNICK LM, 1991, HYPERTENSION, V17, P951, DOI 10.1161/01.HYP.17.6.951; SOUTHWICK FS, 1986, MANUAL CLIN LABORATO, P326; STOJCEVATANEVA O, 1993, NEPHRON, V64, P592, DOI 10.1159/000187406; STUDER RK, 1989, ENDOCRINOLOGY, V125, P2421, DOI 10.1210/endo-125-5-2421; TRIVELLI LA, 1971, NEW ENGL J MED, V284, P353, DOI 10.1056/NEJM197102182840703; TRUMP BE, 1987, ADV MOD ENV TOXICOL, V14, P27; TSCHOPE D, 1994, AM J MED, V96, P260; ZERNEL MB, 1990, METABOLISM, V39, P704; ZHANG YB, 1994, KIDNEY INT, V45, P1113, DOI 10.1038/ki.1994.148; ZHOU XJ, 1991, KIDNEY INT, V39, P120, DOI 10.1038/ki.1991.15	41	155	161	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1995	123	12					919	+		10.7326/0003-4819-123-12-199512150-00004	http://dx.doi.org/10.7326/0003-4819-123-12-199512150-00004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK120	7486486				2022-12-24	WOS:A1995TK12000004
J	RIMELL, FL; THOME, A; STOOL, S; REILLY, JS; RIDER, G; STOOL, D; WILSON, CL				RIMELL, FL; THOME, A; STOOL, S; REILLY, JS; RIDER, G; STOOL, D; WILSON, CL			CHARACTERISTICS OF OBJECTS THAT CAUSE CHOKING IN CHILDREN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOREIGN-BODIES; CHILDHOOD ASPHYXIATION; AIRWAY; BODY; INHALATION	Objective.-To characterize the types, shapes, and sizes of objects causing choking or asphyxiation in children and to compare these characteristics to current standards. Design.-To evaluate morbidity, retrospective 5-year medical record survey; to evaluate mortality, data reanalysis. Settings.-Pediatric hospital and consumer product testing laboratory. Patients.-All children (n=165) who underwent endoscopy for foreign body aspiration or ingestion at Children's Hospital of Pittsburgh (Pa) between 1989 and 1993 and children (n=449) whose deaths due to choking on man-made objects were recorded by the Consumer Product Safety Commission (CPSC) between 1972 and 1992. Main Outcome Measures.-Objects removed from children's aerodigestive tracts were characterized by location, procedure for removal, and type. Objects causing death were characterized by type, shape, and consistency. Three-dimensional objects that had caused asphyxiation were analyzed by computer-simulated models. Results.-Of the 165 children treated by endoscopy, 69% were 3 years of age or younger. Foreign bodies most often ingested or aspirated were food (in 36 children) and coins (in 60 children). Of 449 children whose deaths after aspirating foreign bodies were reported to the CPSC, 65% were younger than 3 years. Balloons caused 29% of deaths overall. Conforming objects such as balloons caused a significantly (P<.001) higher proportion of deaths in those aged 3 years or older (60%) vs those younger than 3 years (33%). Of the 101 objects causing deaths that we could analyze, 14 met current standards for use by children younger than 3 years. Conclusions.-Balloons pose a high risk of asphyxiation to children of any age. Changes in regulations regarding products intended for children's use might have prevented up to 14 (14%) of 101 deaths in this study.	CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT OTOLARYNGOL,PITTSBURGH,PA 15213; ALFRED I DUPONT INST,DIV PEDIAT OTOLARYNGOL,WILMINGTON,DE; INCHCAPE TESTING SERV RISK ANAL & MANAGEMENT,MOONACHIE,NJ	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nemours Alfred I. duPont Hospital for Children								AYTAC A, 1977, J THORAC CARDIOV SUR, V74, P145; BAKER SP, 1980, JAMA-J AM MED ASSOC, V244, P1343; Baker SP, 1992, THE INJURY FACT BOOK, V2nd; BINDER L, 1984, ANN EMERG MED, V13, P112, DOI 10.1016/S0196-0644(84)80573-9; BLAZER S, 1980, AM J DIS CHILD, V134, P68, DOI 10.1001/archpedi.1980.02130130050015; HARRIS CS, 1984, JAMA-J AM MED ASSOC, V251, P2231, DOI 10.1001/jama.251.17.2231; HAWKINS DB, 1990, ANN OTO RHINOL LARYN, V99, P935, DOI 10.1177/000348949009901201; Kenna M A, 1988, Pediatr Rev, V10, P25, DOI 10.1542/pir.10-1-25; KIM IG, 1973, LARYNGOSCOPE, V83, P347, DOI 10.1288/00005537-197303000-00004; MITTLEMAN RE, 1984, AM J FOREN MED PATH, V5, P201, DOI 10.1097/00000433-198409000-00003; MU LC, 1991, LARYNGOSCOPE, V101, P657; ODELOWO EOO, 1990, INT SURG, V75, P148; RIMELL FL, 1994, DEC SOC RISK AN ANN; WOLACH B, 1994, INT J PEDIATR OTORHI, V30, P1, DOI 10.1016/0165-5876(94)90045-0; 1995, MONTHLY VITAL STAT S, V40; 1979, METHOD IDENTIFYING T; 1994, VITAL HLTH STATISTIC	17	108	110	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	1995	274	22					1763	1766		10.1001/jama.274.22.1763	http://dx.doi.org/10.1001/jama.274.22.1763			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ225	7500505				2022-12-24	WOS:A1995TJ22500024
J	DALY, LE; KIRKE, PN; MOLLOY, A; WEIR, DG; SCOTT, JM				DALY, LE; KIRKE, PN; MOLLOY, A; WEIR, DG; SCOTT, JM			FOLATE LEVELS AND NEURAL-TUBE DEFECTS - IMPLICATIONS FOR PREVENTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID; VITAMIN SUPPLEMENTATION; TRIAL	Using data from a recent case-control study, a woman's risk of having a child with a neural tube defect (NTD) was found to be associated with early pregnancy red cell folate levels in a continuous dose-response relationship. These findings were used to calculate the reduction in NTD cases that would be expected under two different strategies to raise folate levels. Targeting high-risk individuals has a small effect on the population prevalence but can substantially change an individual's risk. Targeting the population produces a small change in individual risk but has a large effect on the population prevalence. Supplementation of high-risk women would be the most efficient method to implement the high-risk strategy, while food fortification would be preferable for the population approach. The current guidelines for the prevention of NTD are for an increased folio acid intake of 0.4 mg per day. This would result in a 48% reduction in NTDs, which may be near optimal. The two intervention strategies should be considered complementary in prevention of NTDs.	HLTH RES BOARD,DUBLIN,IRELAND; TRINITY COLL DUBLIN,DEPT CLIN MED,DUBLIN,IRELAND; TRINITY COLL DUBLIN,DEPT BIOCHEM,DUBLIN,IRELAND	Health Research Board - Ireland; Trinity College Dublin; Trinity College Dublin	DALY, LE (corresponding author), UNIV DUBLIN TRINITY COLL,DEPT EPIDEMIOL & PUBL HLTH MED,EARLSFORT TERRACE,DUBLIN 2,IRELAND.			Molloy, Anne/0000-0002-1688-9049				BERESFORD SAA, 1994, AM J PUBLIC HEALTH, V84, P348, DOI 10.2105/AJPH.84.3.348; CLARK NAC, 1994, BRIT J OBSTET GYNAEC, V101, P709, DOI 10.1111/j.1471-0528.1994.tb13190.x; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; HESEKER H, 1987, J NUTR SCI VITAMINOL, V33, P163, DOI 10.3177/jnsv.33.163; HUBER AM, 1988, J AM DIET ASSOC, V88, P791; KIRKE PN, 1992, ARCH DIS CHILD, V67, P1442, DOI 10.1136/adc.67.12.1442; LAURENCE KM, 1981, BRIT MED J, V282, P1509, DOI 10.1136/bmj.282.6275.1509; OAKLEY GP, 1993, JAMA-J AM MED ASSOC, V269, P1292, DOI 10.1001/jama.269.10.1292; SCOTT J, 1994, Q J MED, V87, P705, DOI 10.1093/oxfordjournals.qjmed.a068887; SMITHELLS RW, 1983, LANCET, V1, P1027; TSUI JC, 1990, J AM DIET ASSOC, V90, P1551; WALD N, 1991, LANCET, V338, P131; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; WOTEKI CE, 1988, AM J CLIN NUTR, V47, P320, DOI 10.1093/ajcn/47.2.320; 1993, POSITION PAPER FOLIC; 1992, FOLIC ACID PREVENTIO	16	564	583	0	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1698	1702		10.1001/jama.274.21.1698	http://dx.doi.org/10.1001/jama.274.21.1698			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH151	7474275				2022-12-24	WOS:A1995TH15100027
J	GHOSH, P; AMAYA, M; MELLINS, E; WILEY, DC				GHOSH, P; AMAYA, M; MELLINS, E; WILEY, DC			THE STRUCTURE OF AN INTERMEDIATE IN CLASS-II MHC MATURATION - CLIP BOUND TO HLA-DR3	NATURE			English	Article							ANTIGEN-PROCESSING MUTANT; INVARIANT CHAIN PEPTIDES; HLA-DR MOLECULES; CELL LINE; ASSOCIATION; BINDING	A complex between HLA-DR3 and a fragment of invariant chain called CLIP was isolated from a human cell line defective in antigen presentation and its X-ray crystal structure determined. Previous data indicate that this complex is an intermediate in class II histocompatibility maturation, occurring between invariant chain-DR3 and antigenic peptide-DR3 complexes. The structure shows that the CLIP fragment binds to DR3 in a way almost identical to that in which antigenic peptides bind class II histocompatibility glycoproteins. The structure is the substrate for the loading of antigenic peptides by an exchange process catalysed by DM.	HARVARD UNIV,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138; HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138; UNIV PENN,CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; CHILDRENS SEASHORE HOUSE,PHILADELPHIA,PA 19104	Harvard University; Harvard University; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia								[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BROWN JH, 1993, NATURE, V368, P33; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GAUTAM AM, 1995, P NATL ACAD SCI USA, V92, P335, DOI 10.1073/pnas.92.1.335; GELUK A, 1995, MOL IMMUNOL, V32, P975, DOI 10.1016/0161-5890(95)00058-M; GELUK A, 1994, J IMMUNOL, V152, P5742; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GORGA JC, 1991, RES IMMUNOL, V142, P401, DOI 10.1016/0923-2494(91)90038-K; GORGA JC, 1987, J BIOL CHEM, V262, P16087; HUANG CC, 1991, J MOL GRAPHICS, V9, P230, DOI 10.1016/0263-7855(91)80016-S; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JASANOFF A, 1995, P NATL ACAD SCI USA, V92, P9900, DOI 10.1073/pnas.92.21.9900; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; KROPSHOFER H, 1995, P NATL ACAD SCI USA, V92, P8313, DOI 10.1073/pnas.92.18.8313; LEE C, 1995, P NATL ACAD SCI USA, V92, P8269, DOI 10.1073/pnas.92.18.8269; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; MALCHEREK G, 1993, INT IMMUNOL, V5, P1229, DOI 10.1093/intimm/5.10.1229; MAURER D, 1991, J IMMUNOL, V146, P621; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MONJI T, 1994, J IMMUNOL, V153, P4468; MORKOWSKI S, 1995, J EXP MED, V182, P1403, DOI 10.1084/jem.182.5.1403; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751; XU MZ, 1994, MOL IMMUNOL, V31, P723, DOI 10.1016/0161-5890(94)90146-5	50	523	537	0	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					457	462		10.1038/378457a0	http://dx.doi.org/10.1038/378457a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477400				2022-12-24	WOS:A1995TH05400059
J	OLIVER, MF				OLIVER, MF			STATINS PREVENT CORONARY HEART-DISEASE	LANCET			English	Editorial Material											OLIVER, MF (corresponding author), UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED, NATL HEART & LUNG INST, LONDON, ENGLAND.							BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419; DAYTON S, 1969, CIRCULATION S2, V39, P63; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LORD I, 1992, J CLIN EPIDEMIOL, V45, P849, DOI 10.1016/0895-4356(92)90068-X; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; OLIVER MF, 1994, LANCET, V344, P633; PEDERSEN TR, 1995, LANCET, V345, P1274; PEDERSEN TR, 1994, LANCET, V344, P1383; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STROES ESG, 1995, LANCET, V346, P467, DOI 10.1016/S0140-6736(95)91322-X; WATERS D, 1994, CIRCULATION, V89, P959, DOI 10.1161/01.CIR.89.3.959; 1993, MORTALITY STATIS DH2	16	26	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	1995	346	8987					1378	1379		10.1016/S0140-6736(95)92399-3	http://dx.doi.org/10.1016/S0140-6736(95)92399-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475814	Bronze			2022-12-24	WOS:A1995TG20700002
J	PERRY, IJ; REFSUM, H; MORRIS, RW; EBRAHIM, SB; UELAND, PM; SHAPER, AG				PERRY, IJ; REFSUM, H; MORRIS, RW; EBRAHIM, SB; UELAND, PM; SHAPER, AG			PROSPECTIVE-STUDY OF SERUM TOTAL HOMOCYSTEINE CONCENTRATION AND RISK OF STROKE IN MIDDLE-AGED BRITISH MEN	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; PLASMA HOMOCYST(E)INE	Moderate hyperhomocysteinaemia is common in the general population and has been linked with cardiovascular disease. However, there are no data from prospective, population-based studies. We examined the association between serum total homocysteine (tHcy) concentration and stroke in a nested case-control study within the British Regional Heart Study cohort. Between 1978 and 1980 serum was saved from 5661 men, aged 40-59 years, randomly selected from the population of one general practice in each of 18 towns in the UK. During follow-up to December, 1991, there were 141 incident cases of stroke among men with no history of stroke at screening. Serum tHcy was measured in 107 cases and 118 control men (matched for age-group and town, without a history of stroke at screening, who did not develop a stroke or myocardial infarction during follow-up). tHcy concentrations were significantly higher in cases than controls (geometric mean 13.7 [95% CI 12.7-14.8] vs 11.9 [11.3-12.6] mu mol/L; p=0004). There was a graded increase in the relative risk of stroke in the second, third, and fourth quarters of the tHcy distribution (odds ratios 1.3, 1.9, 2.8; trend p=0.005) relative to the first. Adjustment for age-group, town, social class, body-mass index, hypertensive status, cigarette smoking, expiratory volume, packed-cell volume, alcohol diabetes, high-density-lipoprotein cholesterol, and serum creatinine did not attenuate the association. These findings suggest that tHcy is a strong and independent risk factor for stroke.	UNIV BERGEN,DEPT BIOL CLIN,DIV PHARMACOL,BERGEN,NORWAY	University of Bergen	PERRY, IJ (corresponding author), ROYAL FREE HOSP,SCH MED,DEPT PUBL HLTH,LONDON NW3 2PF,ENGLAND.		Refsum, Helga/A-4073-2010; Ueland, Per M/C-7340-2013	Ueland, Per Magne/0000-0002-1903-0571; Morris, Richard/0000-0001-7240-4563; Perry, Ivan/0000-0002-4965-9792				ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; BRATTSTROM L, 1994, J INTERN MED, V236, P633, DOI 10.1111/j.1365-2796.1994.tb00856.x; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; FISKERSTRAND T, 1993, CLIN CHEM, V39, P263; GUTTORMSEN AB, 1994, J NUTR, V124, P1934, DOI 10.1093/jn/124.10.1934; ISRAELSSON B, 1993, SCAND J CLIN LAB INV, V39, P263; LANDGREN F, 1995, J INTERN MED, V237, P381, DOI 10.1111/j.1365-2796.1995.tb01190.x; MALINOW MR, 1993, CIRCULATION, V87, P1107, DOI 10.1161/01.CIR.87.4.1107; MALINOW MR, 1994, J INTERN MED, V236, P603, DOI 10.1111/j.1365-2796.1994.tb00854.x; MASSER PE, 1995, J IR COLL PHYS SURG, V24, P25; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; POCOCK SJ, 1989, J CLIN PATHOL, V42, P172, DOI 10.1136/jcp.42.2.172; REFSUM H, 1989, CLIN CHEM, V35, P1921; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; SHAPER AG, 1985, J EPIDEMIOL COMMUN H, V39, P197, DOI 10.1136/jech.39.3.197; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; SHAPER AG, 1991, BRIT MED J, V302, P1111, DOI 10.1136/bmj.302.6785.1111; SHAPER AG, 1984, BRIT HEART J, V51, P595, DOI 10.1136/hrt.51.6.595; SHAPER AG, 1988, LANCET, V2, P1268; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; STAMPFER MJ, 1995, NEW ENGL J MED, V332, P328, DOI 10.1056/NEJM199502023320511; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; THELLE DS, 1984, BRIT HEART J, V49, P205; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924; WALKER M, 1984, J R COLL GEN PRACT, V34, P197; WANNAMETHEE G, 1994, J INTERN MED, V235, P163, DOI 10.1111/j.1365-2796.1994.tb01050.x	30	714	744	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 25	1995	346	8987					1395	1398		10.1016/S0140-6736(95)92407-8	http://dx.doi.org/10.1016/S0140-6736(95)92407-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG207	7475822	Bronze			2022-12-24	WOS:A1995TG20700010
J	WILSON, RPH; BUCHAN, I; WALLEY, T				WILSON, RPH; BUCHAN, I; WALLEY, T			ALTERATIONS IN PRESCRIBING BY GENERAL-PRACTITIONER FUNDHOLDERS - AN OBSERVATIONAL STUDY	BRITISH MEDICAL JOURNAL			English	Article							COSTS	Objectives-To compare prescribing in general practices before and after they become fundholders to assess whether this affected prescribing patterns. Design-Analysis of prescribing data (PACT) for one year before and one year after practices become first, second, or third wave fundholders and comparison with practices that were not fundholders during any part of the study. Main outcome measures-Prescribing costs (net ingredient cost per prescribing unit), prescribing volume (items per 1000 prescribing units), net ingredient cost per item, and percentage of generic prescribing. Setting-Former Mersey Regional Health Authority. Subjects-100 fundholders (20 first wave, 31 second wave, 49 third wave) and 312 non-fundholders. Results-Prescribing costs and volume rose throughout the study in all groups. In all three fundholding waves the rate of increase of prescribing costs was significantly lower than for non-fundholders. Both cost per item and prescribing volume tended to decrease, the former probably because of a significant increase in generic prescribing: Fundholding and non-fundholding practices differed in several respects. Conclusion-Fundholding has altered practice prescribing patterns compared with those of non-fundholders, increasing generic prescribing and reducing the rate of increase of prescribing costs.	UNIV LIVERPOOL,DEPT THERAPEUT & PHARMACOL,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND; UNIV LIVERPOOL,DEPT MED,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND	University of Liverpool; University of Liverpool			Buchan, Iain E/H-5767-2013	Buchan, Iain E/0000-0003-3392-1650				BOGLE SM, 1994, BRIT MED J, V308, P637, DOI 10.1136/bmj.308.6929.637; BRADLOW J, 1993, BRIT MED J, V307, P1186, DOI 10.1136/bmj.307.6913.1186; BRITTEN N, 1995, BRIT MED J, V310, P1067, DOI 10.1136/bmj.310.6986.1067c; CHEW R, 1995, OHE COMPENDIUM HLTH; DOWELL JS, 1995, BRIT MED J, V310, P505, DOI 10.1136/bmj.310.6978.505; GILLIGAN JD, 1991, 54 ROYAL COLL GEN PR; GLENNERSTER H, 1994, EVALUATING NHS REFOR; KEELEY D, 1994, BRIT MED J, V308, P206, DOI 10.1136/bmj.308.6922.206c; LLOYD DCEF, 1995, BRIT MED J, V310, P165, DOI 10.1136/bmj.310.6973.165; MAXWELL M, 1993, BRIT MED J, V307, P1190, DOI 10.1136/bmj.307.6913.1190; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; SHINE C, 1995, BRIT MED J, V310, P1070, DOI 10.1136/bmj.310.6986.1070a; WALLEY T, 1995, PHARMACOECONOMICS, V7, P320, DOI 10.2165/00019053-199507040-00006; 1994, PRESCRIPTION IMPROVE; 1994, PRIORITY SETTING NHS; 1995, BRIEFING GP FUNDHOLD; [No title captured]	17	48	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1347	1350		10.1136/bmj.311.7016.1347	http://dx.doi.org/10.1136/bmj.311.7016.1347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496289	Green Published			2022-12-24	WOS:A1995TF90100027
J	HUANG, WP; CIOCHON, R; GU, YM; LARICK, R; FANG, QR; SCHWARCZ, H; YONGE, C; DEVOS, J; RINK, W				HUANG, WP; CIOCHON, R; GU, YM; LARICK, R; FANG, QR; SCHWARCZ, H; YONGE, C; DEVOS, J; RINK, W			EARLY HOMO AND ASSOCIATED ARTIFACTS FROM ASIA	NATURE			English	Article							ORIGIN	The site of Longgupo Cave was discovered in 1984 and excavated in 1985-1988 by the Institute of Vertebrate Paleontology and Paleoanthropology (Beijing) and the Chongqing National Museum (Sichuan Province). Important finds include very archaic hominid dental fragments, Gigantopithecus teeth and primitive stone tools. Palaeomagnetic analysis and the presence of Ailuropoda microta (pygmy giant panda) suggested that the hominid-bearing levels dated to the earliest Pleistocene(1). In 1992, joint Chinese-American-Canadian geochronological research corroborated the age using electron spin resonance (ESR) analysis. We report here that the hominid dentition and stone tools from Longgupo Cave are comparable in age and morphology with early representives of the genus Homo (H. habilis and H. ergaster) and the Oldowan technology in East Africa. The Longgupo dentition is demonstrably more primitive than that seen in Asian Homo erectus. Longgupo's diverse and well preserved Plio-Pleistocene fauna of 116 species provide a sensitive contextual base for interpreting the early arrival of the genus Homo in Asia.	UNIV MASSACHUSETTS,DEPT ANTHROPOL,AMHERST,MA 01003; CHONGOING MUSEUM NAT HIST,CHONGQING 630013,PEOPLES R CHINA; UNIV CALGARY,DEPT PHYS & ASTRON,HAMILTON,ON L85 4M1,CANADA; NATL MUSEUM NAT HIST,2300 RA LEIDEN,NETHERLANDS; UNIV IOWA,DEPT PEDIAT DENT,IOWA CITY,IA 52242; ACAD SINICA,INST VERTEBRATE PALEONTOL & PALEOANTHROPOL,BEIJING 100044,PEOPLES R CHINA	University of Massachusetts System; University of Massachusetts Amherst; University of Calgary; University of Iowa; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	HUANG, WP (corresponding author), UNIV IOWA,DEPT ANTHROPOL,IOWA CITY,IA 52242, USA.							Brown Barbara, 1993, P161; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; CIOCHON R, IN PRESS P NATN ACAD; CLARKE RJ, 1990, J HUM EVOL, V19, P699, DOI 10.1016/0047-2484(90)90004-U; CLARKE RJ, 1988, WORLD ARCHAEOL, V21, P1; COLBERT EH, 1953, B AM MUS NAT HIST, V102, P1; Gao Jian, 1975, Vertebrata Palasiatica, V13, P81; GRUN R, 1987, CAN J EARTH SCI, V24, P1022, DOI 10.1139/e87-099; Harris J.W.K., 1983, AFR ARCHAEOL REV, V1, P3, DOI DOI 10.1007/BF01116770; HOWELL FC, 1994, ORIGINS ANATOMICALLY, P253; Huang W., 1991, WUSHAN HOMINID SITE; Huang Wanpo, 1993, Vertebrata Palasiatica, V31, P191; Leakey M.D., 1971, OLDUVAI GORGE, V3, P1960; Luo H., 1989, ACTA ANTHROPOL SIN, V8, P172; MATTHEW WD, 1923, B AM MUS NAT HIST, V46, P563; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; SCHWARCZ HP, 1994, J HUM EVOL, V26, P175, DOI 10.1006/jhev.1994.1010; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; TOBIAS PV, 1991, OLDUVAL GORGE, V4; WANG L, 1982, VERTEBRAT PALASIATIC, V20, P255; WELDENREICH F, 1937, PALEONTOL SINICA D, V1, P1; Woo J. K., 1962, Palaeontologia Sinica New Ser D, V11, P1; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood Bernard, 1993, P485; ZHANG YY, 1982, AM J PHYS ANTHROPOL, V59, P21; ZHENG SH, 1986, VERTEBRAT PALASIATIC, V24, P81; Zheng SH, 1993, QUATERNARY RODENTS S, P3	29	178	214	2	43	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 16	1995	378	6554					275	278						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TE858	7477345				2022-12-24	WOS:A1995TE85800047
J	DOWSE, GK; GAREEBOO, H; ALBERTI, KGMM; ZIMMET, P; TUOMILEHTO, J; PURRAN, A; FAREED, D; CHITSON, P; COLLINS, VR; HEMRAJ, F				DOWSE, GK; GAREEBOO, H; ALBERTI, KGMM; ZIMMET, P; TUOMILEHTO, J; PURRAN, A; FAREED, D; CHITSON, P; COLLINS, VR; HEMRAJ, F			CHANGES IN POPULATION CHOLESTEROL CONCENTRATIONS AND OTHER CARDIOVASCULAR RISK FACTOR LEVELS AFTER 5 YEARS OF THE NONCOMMUNICABLE DISEASE INTERVENTION PROGRAM IN MAURITIUS	BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; STANFORD 5-CITY PROJECT; CORONARY HEART-DISEASE; HYPERTENSION-CONTROL; CHINESE MAURITIANS; PLASMA-CHOLESTEROL; HEALTH EDUCATION; BLOOD-PRESSURE; PREVALENCE; NIDDM	Objective-To study changes in the prevalence of risk factors for cardiovascular disease after a five year population-wide intervention programme promoting a healthy lifestyle in a developing country. Design-Cross sectional cluster surveys in 1987 and 1992. Methodology included a two hour 75 g oral glucose tolerance test, measurement of body mass index, waist:hip ratio, basal Lipid concentrations, and blood pressure; and a lifestyle questionnaire. Setting-Mauritius, in the Indian Ocean. Subjects-All adults aged 25-74 years residing in geographically defined clusters. Main outcome measures-Age standardised prevalence of categorical disease and risk factor conditions and mean levels and frequency distributions of continuous variables. Results-Response rates were 86.2% (5080/5892) in 1987 and 89.5% (5162/5770) in 1992. Significant decreases were found in the prevalence of hypertension (15.0% to 12.1% in men and 12.4% to 10.9% in women); cigarette smoking (58.2% to 47.2% and 6.9% to 3.7% respectively); and heavy alcohol consumption (38.2% to 14.4% and 2 6% to 0.6% respectively). Moderate leisure physical activity increased from 16.9% to 22.1% in men and from 1.3% to 2.7% in women. Mean population serum total cholesterol concentration fell appreciably from 5.5 mmol/l to 4.7 mmol/l (P < 0.001). The prevalence of overweight or obesity increased, and the rates of glucose intolerance changed little. The population frequency distributions of blood pressure, serum lipid concentration, and a composite risk factor score shifted advantageously. Conclusions-Lifestyle intervention projects can be implemented and have positive effects in developing countries. A pronounced improvement in the population lipid profile in Mauritius was probably related to a change in the saturated fat content of a widely used cooking oil.	INT DIABET INST,MELBOURNE,VIC,AUSTRALIA; MINIST HLTH,PORT LOUIS,MAURITIUS; UNIV NEWCASTLE UPON TYNE,CTR HUMAN DIABET & METAB RES,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND; NATL PUBL HLTH INST,DEPT EPIDEMIOL & HLTH PROMOT,HELSINKI,FINLAND; WHO,PORT LOUIS,MAURITIUS	Newcastle University - UK; Finland National Institute for Health & Welfare; World Health Organization			Zimmet, Paul/O-8486-2019	Zimmet, Paul/0000-0003-0627-0776	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025446] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-25446] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALROOMI KA, 1989, AM J EPIDEMIOL, V129, P503, DOI 10.1093/oxfordjournals.aje.a115161; ARMITAGE P, 1987, STATISTICAL METHODS; BENNETT SA, 1994, MED J AUSTRALIA, V161, P519, DOI 10.5694/j.1326-5377.1994.tb127594.x; BONANOME A, 1988, NEW ENGL J MED, V318, P1244, DOI 10.1056/NEJM198805123181905; COLLINS VR, 1994, DIABETES CARE, V17, P288, DOI 10.2337/diacare.17.4.288; DOWSE GK, 1990, DIABETES, V39, P390, DOI 10.2337/diabetes.39.3.390; DOWSE GK, 1991, DIABETES CARE, V14, P271, DOI 10.2337/diacare.14.4.271; DOWSE GK, 1991, DIABETES CARE, V14, P968, DOI 10.2337/diacare.14.11.968; DOWSE GK, 1994, MED J AUSTRALIA, V160, P767, DOI 10.5694/j.1326-5377.1994.tb125945.x; EPSTEIN FH, 1989, INT J EPIDEMIOL, V18, pS203; FORTMANN SP, 1993, AM J EPIDEMIOL, V137, P1039, DOI 10.1093/oxfordjournals.aje.a116608; FORTMANN SP, 1990, AM J EPIDEMIOL, V132, P629, DOI 10.1093/oxfordjournals.aje.a115705; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; HIGGINS M, 1989, INT J EPIDEMIOL, V18, pS58; HODGE AM, 1994, INT J OBESITY, V18, P419; LI N, 1991, J HYPERTENS, V9, P859; MATTSON FH, 1985, J LIPID RES, V26, P194; NISSINEN A, 1988, AM J EPIDEMIOL, V127, P488, DOI 10.1093/oxfordjournals.aje.a114825; PUSKA P, 1985, ANNU REV PUBL HEALTH, V6, P147, DOI 10.1146/annurev.pu.06.050185.001051; ROSSOUW JE, 1993, INT J EPIDEMIOL, V22, P428, DOI 10.1093/ije/22.3.428; SHIGAN E N, 1988, World Health Statistics Quarterly, V41, P267; TUOMILEHTO J, 1986, ADDICT BEHAV, V11, P1, DOI 10.1016/0306-4603(86)90002-X; TUOMILEHTO J, 1993, J INTERN MED, V233, P187, DOI 10.1111/j.1365-2796.1993.tb00672.x; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; WILHELMSEN L, 1989, INT J EPIDEMIOL, V18, pS101; ZIMMET PZ, 1991, AM J EPIDEMIOL, V134, P862, DOI 10.1093/oxfordjournals.aje.a116161; 1993, 1993 WORLD BANK DEV; 1988, WORLD HLTH STATISTIC; 1978, WHO TECHNICAL REPORT, V628; 1990, STATISTICAL PACKAGE	31	161	169	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 11	1995	311	7015					1255	1259		10.1136/bmj.311.7015.1255	http://dx.doi.org/10.1136/bmj.311.7015.1255			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TE859	7496233	Green Published			2022-12-24	WOS:A1995TE85900018
J	JACOBSEN, SJ; KATUSIC, SK; BERGSTRALH, EJ; OESTERLING, JE; OHRT, D; KLEE, GG; CHUTE, CG; LIEBER, MM				JACOBSEN, SJ; KATUSIC, SK; BERGSTRALH, EJ; OESTERLING, JE; OHRT, D; KLEE, GG; CHUTE, CG; LIEBER, MM			INCIDENCE OF PROSTATE-CANCER DIAGNOSIS IN THE ERAS BEFORE AND AFTER SERUM PROSTATE-SPECIFIC ANTIGEN TESTING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Objective.-To estimate the incidence of prostate cancer in Olmsted County, Minnesota, from 1983 through 1999 to describe the secular changes that have occurred since the introduction of serum prostate-specific antigen (PSA) testing to the community medical practice in 1987. Design.-Population-based, descriptive epidemiological study with ecologic and individual level comparisons over time. Study Setting.-Olmsted County, Minnesota, where the Rochester Epidemiology Project provides passive surveillance of the population for health outcomes. Subjects.-All 511 biopsy-proven incident cases of adenocarcinoma of the prostate diagnosed from 1983 through 1992. The community inpatient and outpatient medical records of all incident cases were reviewed to evaluate the presenting characteristics of men at the time of diagnosis. Results.-The age-adjusted incidence of biopsy-proven prostate cancer increased from 64 per 100 000 person-years in 1983 to 215 per 100 000 person-years in 1992. The increase occurred primarily between 1987 and 1988 and was predominately for organ-confined tumors. The age-specific incidence increased dramatically in this same period among men aged 50 years and older. Among men aged 70 years and older, however, prostate carcinoma incidence rates declined after 1990 following the initial increase. This decline among older men contrasted with community-based estimates of PSA utilization rates, which demonstrated consistent increases since 1987 to nearly 50% of the older population in 1992. Conclusion.-These results support the premise that the recent increase in prostate cancer is due in part to the increased utilization of serum PSA testing. Further, the increased incidence appears to be a transient phenomenon due to the depletion of previously undiagnosed cases from the prevalence pool. Finally, these data suggest that, in terms of stage at diagnosis, early detection efforts may be effective in identifying more early stage (smaller) cancers.	MAYO CLIN & MAYO FDN, BIOSTAT SECT, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DEPT HLTH SCI RES, DIV METAB & HEMATOL BIOCHEM, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DEPT UROL, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DEPT LAB MED & PATHOL, ROCHESTER, MN 55905 USA; BLUE CROSS BLUE SHIELD MINNESOTA, ST PAUL, MN USA; MAYO CLIN & MAYO FDN, HLTH SERV EVALUAT SECT, ROCHESTER, MN USA; MAYO CLIN & MAYO FDN, MED INFORMAT RESOURCES SECT, ROCHESTER, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	JACOBSEN, SJ (corresponding author), MAYO CLIN & MAYO FDN, CLIN EPIDEMIOL SECT, 200 1ST ST SW, ROCHESTER, MN 55905 USA.			Jacobsen, Steven/0000-0002-8174-8533	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENDER AP, 1993, MINN CANCER SURVEILL, V6, P1; BENOIT RM, 1994, UROLOGY, V44, P795, DOI 10.1016/S0090-4295(94)80160-6; BERGSTRALH EJ, 1992, MAYO CLIN TECHNICAL, V49; BETSILL WL, 1975, CANCER, V36, P305, DOI 10.1002/1097-0142(197508)36:2<305::AID-CNCR2820360202>3.0.CO;2-D; BOSTWICK DG, 1994, SEMIN SURG ONCOL, V10, P60, DOI 10.1002/ssu.2980100110; BRAWLEY OW, 1994, UROLOGY, V43, P594, DOI 10.1016/0090-4295(94)90169-4; Breslow N. E., 1987, STATISTICAL METHODS, VII; Burks D A, 1992, Henry Ford Hosp Med J, V40, P89; CATALONA WJ, 1993, UROLOGY, V42, P113, DOI 10.1016/0090-4295(93)90632-K; CHISHOLM GD, 1993, BRIT J UROL, V71, P375, DOI 10.1111/j.1464-410X.1993.tb15975.x; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; CHODAK GW, 1993, UROLOGY, V42, P116, DOI 10.1016/0090-4295(93)90633-L; CORDER EH, 1994, CANCER CAUSE CONTROL, V5, P207, DOI 10.1007/BF01830238; DEMERS RY, 1994, ARCH INTERN MED, V154, P1211, DOI 10.1001/archinte.154.11.1211; DENIS LJ, 1992, PROSTATE, P63; FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E; GERBER GS, 1991, J NATL CANCER I, V83, P329, DOI 10.1093/jnci/83.5.329; GILLILAND F, 1994, CANCER EPIDEM BIOMAR, V3, P105; GILLILAND FD, 1994, CANCER, V73, P2192, DOI 10.1002/1097-0142(19940415)73:8<2192::AID-CNCR2820730826>3.0.CO;2-Y; GOHAGAN JK, 1994, AM J PREV MED, V10, P245, DOI 10.1016/S0749-3797(18)30600-7; GREENWALD P, 1995, CA-CANCER J CLIN, V45, P31, DOI 10.3322/canjclin.45.1.31; JONLER M, 1994, UROLOGY, V44, P876, DOI 10.1016/S0090-4295(94)80174-6; KURLAND LT, 1981, SCI AM, V245, P54, DOI 10.1038/scientificamerican1081-54; Kurland LT, 1970, COMMUNITY EPIDEMIOLO, P47; LANGE PH, 1995, JAMA-J AM MED ASSOC, V273, P336, DOI 10.1001/jama.273.4.336; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; LUYAO GL, 1994, LANCET, V343, P251, DOI 10.1016/S0140-6736(94)91109-6; LYON JL, 1977, AM J EPIDEMIOL, V105, P439, DOI 10.1093/oxfordjournals.aje.a112402; METTLIN C, 1994, J UROLOGY, V152, P1737, DOI 10.1016/S0022-5347(17)32373-X; METTLIN C, 1993, CA-CANCER J CLIN, V43, P42, DOI 10.3322/canjclin.43.1.42; MILLER BA, 1993, NIH932789 PUBL; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; MORRISON AS, 1982, INT J EPIDEMIOL, V11, P261, DOI 10.1093/ije/11.3.261; MORTON RA, 1994, UROLOGY, V44, P637, DOI 10.1016/S0090-4295(94)80196-7; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; SOX HC, 1994, AM J PREV MED, V10, P187, DOI 10.1016/S0749-3797(18)30589-0; TAYLOR JD, 1994, CANCER-AM CANCER SOC, V73, P1704, DOI 10.1002/1097-0142(19940315)73:6<1704::AID-CNCR2820730625>3.0.CO;2-Y; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; 1992, 1992 AM UR ASS POL S, V4, P20	39	185	193	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	1995	274	18					1445	1449		10.1001/jama.274.18.1445	http://dx.doi.org/10.1001/jama.274.18.1445			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC477	7474190				2022-12-24	WOS:A1995TC47700026
J	KOGAN, MD; ALEXANDER, GR; TEITELBAUM, MA; JACK, BW; KOTELCHUCK, M; PAPPAS, G				KOGAN, MD; ALEXANDER, GR; TEITELBAUM, MA; JACK, BW; KOTELCHUCK, M; PAPPAS, G			THE EFFECT OF GAPS IN HEALTH-INSURANCE ON CONTINUITY OF A REGULAR SOURCE OF CARE AMONG PRESCHOOL-AGED CHILDREN IN THE UNITED-STATES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-CARE; AMERICAN CHILDREN; ACCESS; TERMINATION; SERVICES; POOR	Objective.-To estimate the prevalence and length of gaps in health insurance coverage and their effect on having a regular source of care in a national sample of preschool-aged children. Design.-Follow-up survey of a nationally representative sample of 3-year-old children in the US population by phone or personal interview. Participants.-A total of 8129 children whose mothers were interviewed for the 1991 Longitudinal Follow-up to the National Maternal and Infant Health Survey. Main Outcome Measures.-Report of any gap in health insurance for the children, the length of the gap, and the number of different sites where the children were taken for medical care as a measure of continuity of a regular source of care. Results.-About one quarter of US children were without health insurance for at least 1 month during their first 3 years of life, Over half of these children had a health insurance gap of more than 6 months. Less than half of US children had only one site of care during their first 3 years. Children with health insurance gaps of longer than 6 months were at increased risk of having more than one care site (odds ratio = 1.52; 95% confidence interval, 1.19 to 1.96). This risk further increased when an emergency treatment was discounted as a multiple site of care. Conclusions.-Having a gap in health insurance coverage is an important determinant for not having a regular source of care for preschool-aged children. This finding is of concern, given the sizable percentage of children in the United States who lacked continuous health care coverage during a critical period of development.	CHILDRENS DEF FUND,WASHINGTON,DC; BROWN UNIV,SCH MED,DEPT FAMILY MED,PROVIDENCE,RI 02912; UNIV N CAROLINA,DEPT MATERNAL & CHILD HLTH,CHAPEL HILL,NC; UNIV ALABAMA,DEPT MATERNAL & CHILD HLTH,BIRMINGHAM,AL	Brown University; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham	KOGAN, MD (corresponding author), CTR DIS CONTROL & PREVENT,NATL CTR HLTH STAT,6525 BELCREST RD,ROOM 840,HYATTSVILLE,MD 20782, USA.			Jack, Brian/0000-0002-6497-2437				ADAY LA, 1984, AM J PUBLIC HEALTH, V74, P1331, DOI 10.2105/AJPH.74.12.1331; ALPERT JJ, 1976, PEDIATRICS, V57, P917; [Anonymous], 1994, CURRENT POPULATION S; ATKINSON WL, 1992, ANNU REV MED, V43, P451, DOI 10.1146/annurev.med.43.1.451; BENNIFIELD RL, 1994, DYNAMICS EC WELL BEI, P70; BRAVEMAN P, 1989, NEW ENGL J MED, V321, P508, DOI 10.1056/NEJM198908243210805; BUTLER JA, 1985, PEDIATRICS, V76, P495; CORNELIUS LJ, 1993, J NATL MED ASSOC, V85, P281; Cunningham P J, 1994, Future Child, V4, P24, DOI 10.2307/1602433; CUNNINGHAM PJ, 1990, HLTH AFF MILLWOOD, V90, P76; DAVIS K, 1981, ANNU REV PUBL HEALTH, V2, P159, DOI 10.1146/annurev.pu.02.050181.001111; HAYWARD RA, 1988, NEW ENGL J MED, V318, P1507, DOI 10.1056/NEJM198806093182305; HUBBELL FA, 1989, AM J MED, V87, P127; Johansen A. S, 1994, ANAL CONCEPT PRIMARY; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V272, P1025, DOI 10.1001/jama.272.13.1025; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; MARQUIS MS, 1992, JAMA-J AM MED ASSOC, V268, P3473; MAURER HM, 1993, AM J DIS CHILD, V147, P529, DOI 10.1001/archpedi.1993.02160290035015; MCDANIEL DB, 1975, PEDIATRICS, V56, P504; MONHEIT AC, 1984, FUTURE CHILD, V74, P1331; MOSCOVICE I, 1987, MED CARE, V25, P413, DOI 10.1097/00005650-198705000-00005; NEWACHECK PW, 1994, MATERNAL CHILD HLTH; ORR ST, 1991, MED CARE, V29, P283, DOI 10.1097/00005650-199103000-00009; PETER G, 1994, 1994 REDBOOK; RASK KJ, 1994, JAMA-J AM MED ASSOC, V271, P1931, DOI 10.1001/jama.271.24.1931; REICHEL W, 1981, JAMA-J AM MED ASSOC, V246, P2065, DOI 10.1001/jama.246.18.2065; SANDERSON M, 1991, BIRTH-ISS PERINAT C, V18, P26, DOI 10.1111/j.1523-536X.1991.tb00050.x; SPILLMAN BC, 1992, INQUIRY-J HEALTH CAR, V29, P457; Starfield B., 1992, PRIMARY CARE CONCEPT; SWARTZ K, 1990, INQUIRY-J HEALTH CAR, V27, P281; SWARTZ K, 1993, INQUIRY, V80, P64; SZILAGYI PG, 1993, PEDIATRICS, V91, P1; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; 1993, 1991 LONGITUDINAL FO; 1993, SURVEY DATA ANAL VER; 1994, MMWR MORB MORTAL WKL, V43; 1991, JAMA-J AM MED ASSOC, V266, P1547	38	129	129	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	1995	274	18					1429	1435		10.1001/jama.274.18.1429	http://dx.doi.org/10.1001/jama.274.18.1429			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TC477	7474188				2022-12-24	WOS:A1995TC47700024
J	YOUNGER, SJ				YOUNGER, SJ			WHO DEFINES FUTILITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									CASE WESTERN RESERVE UNIV,UNIV HOSP CLEVELAND,SCH MED,CTR BIOMED ETHICS,DEPT MED,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	YOUNGER, SJ (corresponding author), CASE WESTERN RESERVE UNIV,UNIV HOSP CLEVELAND,SCH MED,CTR BIOMED ETHICS,DEPT PSYCHIAT,CLEVELAND,OH 44106, USA.							ANGELL M, 1985, JAMA-J AM MED ASSOC, V254, P1203, DOI 10.1001/jama.254.9.1203; BLENDON RJ, 1984, NEW ENGL J MED, V311, P613, DOI 10.1056/NEJM198408303110938; BLENDON RJ, 1988, JAMA-J AM MED ASSOC, V259, P3587, DOI 10.1001/jama.259.24.3587; CALLAHAN D, 1988, HASTINGS CENT REP, V18, P14, DOI 10.2307/3562403; Callahan D., 1987, MED GOALS AGEING SOC; Childress JF., 1970, SOUNDINGS, V53, P339; EVANS RW, 1983, JAMA-J AM MED ASSOC, V249, P2208, DOI 10.1001/jama.249.16.2208; EVANS RW, 1983, JAMA-J AM MED ASSOC, V249, P2047; MCQUILLEN MP, 1988, NEW ENGL J MED, V318, P1756; MURPHY DJ, 1988, JAMA-J AM MED ASSOC, V260, P2098, DOI 10.1001/jama.260.14.2098; NOLAN K, 1987, HASTINGS CENT REP, V17, P9, DOI 10.2307/3562663; RESCHER N, 1969, ETHICS, V79, P173, DOI 10.1086/291723; TOMLINSON T, 1988, NEW ENGL J MED, V318, P43, DOI 10.1056/NEJM198801073180109	13	227	228	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	1988	260	14					2094	2095		10.1001/jama.260.14.2094	http://dx.doi.org/10.1001/jama.260.14.2094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q3421	3418875				2022-12-24	WOS:A1988Q342100025
J	HARNETT, JD; GREEN, JS; CRAMER, BC; JOHNSON, G; CHAFE, L; MCMANAMON, P; FARID, NR; PRYSEPHILLIPS, W; PARFREY, PS				HARNETT, JD; GREEN, JS; CRAMER, BC; JOHNSON, G; CHAFE, L; MCMANAMON, P; FARID, NR; PRYSEPHILLIPS, W; PARFREY, PS			THE SPECTRUM OF RENAL-DISEASE IN LAURENCE-MOON-BIEDL SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									MEM UNIV NEWFOUNDLAND,HLTH SCI CTR,DEPT RADIOL,ST JOHNS A1B 3V6,NEWFOUNDLAND,CANADA; MEM UNIV NEWFOUNDLAND,HLTH SCI CTR,DEPT OPHTHALMOL,ST JOHNS A1B 3V6,NEWFOUNDLAND,CANADA	Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	HARNETT, JD (corresponding author), MEM UNIV NEWFOUNDLAND,HLTH SCI CTR,DEPT MED,DIV NEPHROL,ST JOHNS A1B 3V6,NEWFOUNDLAND,CANADA.							ALTON DJ, 1973, RADIOLOGY, V109, P659, DOI 10.1148/109.3.659; AMMANN F, 1970, J GENET HUM, V18, P1; BARDET G, 1920, THESIS U PARIS PARIS; BAUMAN ML, 1973, AM J DIS CHILD, V126, P119, DOI 10.1001/archpedi.1973.02110190107024; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; BLUETT NH, 1977, ARCH DIS CHILD, V52, P968, DOI 10.1136/adc.52.12.968; CHURCHILL DN, 1981, CLIN NEPHROL, V16, P151; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; HURLEY RM, 1975, J PEDIATR-US, V87, P206, DOI 10.1016/S0022-3476(75)80580-4; Laurence J.Z., 1866, OPHTHALMIC REV, V2, P32; LINNE T, 1986, ACTA PAEDIATR SCAND, V75, P240, DOI 10.1111/j.1651-2227.1986.tb10192.x; MCKUSICK VA, 1971, MENDELIAN INHERITANC, P328; MCLOUGHLIN TG, 1967, J PATHOL BACTERIOL, V93, P65, DOI 10.1002/path.1700930106; OKUYAMA A, 1983, BRIT J UROL, V55, P243, DOI 10.1111/j.1464-410X.1983.tb06571.x; PRICE D, 1981, CLIN NEPHROL, V16, P283; SCHACHAT AP, 1982, ARCH OPHTHALMOL-CHIC, V100, P285	16	123	123	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 8	1988	319	10					615	618		10.1056/NEJM198809083191005	http://dx.doi.org/10.1056/NEJM198809083191005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9226	3412378				2022-12-24	WOS:A1988P922600005
J	FOX, KM; SHAPIRO, LM				FOX, KM; SHAPIRO, LM			HEART-DISEASE IN ASIANS IN BRITAIN	BRITISH MEDICAL JOURNAL			English	Editorial Material									PAPWORTH HOSP,CAMBRIDGE CB3 8RE,ENGLAND	Papworth Hospital	FOX, KM (corresponding author), NATL HEART HOSP,LONDON W1M 8BA,ENGLAND.							BALARAJAN R, 1984, BRIT MED J, V289, P1185, DOI 10.1136/bmj.289.6453.1185; BECKLES GLA, 1986, LANCET, V1, P1298; BEEVERS DG, 1981, POSTGRAD MED J, V57, P763, DOI 10.1136/pgmj.57.674.763; CRUICKSHANK JK, 1980, BRIT MED J, V281, P1108, DOI 10.1136/bmj.281.6248.1108; DANARAJ TJ, 1959, AM HEART J, V58, P516, DOI 10.1016/0002-8703(59)90085-7; JACOBSON MS, 1987, LANCET, V2, P656, DOI 10.1016/S0140-6736(87)92443-3; LAWRENCE RE, 1985, BRIT MED J, V290, P1472, DOI 10.1136/bmj.290.6480.1472; LOWER PJ, 1982, BR HEART J; MARMOT MG, 1981, POSTGRAD MED J, V57, P760, DOI 10.1136/pgmj.57.674.760; MARMOT MG, 1984, LANCET, V1, P1455, DOI 10.1016/S0140-6736(84)91943-3; MCKEIGUE PM, 1985, LANCET, V2, P1086; PADHANI A, 1986, LANCET, V1, P213; SHAPER AG, 1959, LANCET, V2, P534; 1986, CORONARY HEART DISEA	14	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 30	1988	297	6644					311	312		10.1136/bmj.297.6644.311	http://dx.doi.org/10.1136/bmj.297.6644.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4527	3416160	Bronze, Green Published			2022-12-24	WOS:A1988P452700005
J	SCHULZE, E; KIRSCHNER, M				SCHULZE, E; KIRSCHNER, M			NEW FEATURES OF MICROTUBULE BEHAVIOR OBSERVED INVIVO	NATURE			English	Article											SCHULZE, E (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.							Goldman R., 1976, CELL MOTILITY; GOTLIEB AI, 1981, J CELL BIOL, V91, P539; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; INOUE S, 1976, 40TH S SOC DEV BIOL, P35; KELLOG DR, IN PRESS DEVELOPMENT; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KIRSCHNER M, 1986, J CELL SCI S, V5, P293; KRISTOFFERSON D, 1986, J CELL BIOL, V102, P1007, DOI 10.1083/jcb.102.3.1007; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; SALMON ED, 1987, 45TH P ANN M EL MICR, P636; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; THOMPSON WC, 1984, J CELL BIOL, V98, P1017, DOI 10.1083/jcb.98.3.1017	17	184	184	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 28	1988	334	6180					356	359		10.1038/334356a0	http://dx.doi.org/10.1038/334356a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P4349	3393227				2022-12-24	WOS:A1988P434900063
J	KING, MB				KING, MB			AIDS AND THE GENERAL-PRACTITIONER - VIEWS OF PATIENTS WITH HIV INFECTION AND AIDS	BRITISH MEDICAL JOURNAL			English	Article											KING, MB (corresponding author), INST PSYCHIAT,DENMARK HILL,LONDON SE5 8AF,ENGLAND.		King, Michael B/D-7477-2011	King, Michael B/0000-0003-4715-7171				ADLER MW, 1987, BRIT MED J, V295, P27, DOI 10.1136/bmj.295.6589.27; BUCKNALL A, 1986, J ROY COLL GEN PRACT, V36, P491; CASSENS BJ, 1985, ANN INTERN MED, V103, P768, DOI 10.7326/0003-4819-103-5-768; DARDICK L, 1980, ANN INTERN MED, V93, P115, DOI 10.7326/0003-4819-93-1-115; DILLEY JW, 1985, AM J PSYCHIAT, V142, P82; Goldthorpe J. H., 1974, SOCIAL GRADING OCCUP; King M B, 1987, Health Trends, V19, P1; KLEIN M, 1985, NEW PHYSICIAN    SEP, P43; LEACH G, 1985, BRIT MED J, V290, P583, DOI 10.1136/bmj.290.6468.583; MORTON AD, 1986, BRIT MED J, V293, P1212, DOI 10.1136/bmj.293.6556.1212; NORELL JS, 1986, BRIT MED J, V293, P1213, DOI 10.1136/bmj.293.6556.1213; OWEN WF, 1980, ANN INTERN MED, V93, P90, DOI 10.7326/0003-4819-93-1-90; WACHTER RM, 1986, NEW ENGL J MED, V314, P177, DOI 10.1056/NEJM198601163140310; 1987, J R COLL GEN PRACT, V37, P289	14	48	48	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 16	1988	297	6642					182	184		10.1136/bmj.297.6642.182	http://dx.doi.org/10.1136/bmj.297.6642.182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P2951	3408958	Green Published, Bronze			2022-12-24	WOS:A1988P295100024
J	AVORN, J; GURWITZ, JH; BOHN, RL; MOGUN, H; MONANE, M; WALKER, A				AVORN, J; GURWITZ, JH; BOHN, RL; MOGUN, H; MONANE, M; WALKER, A			INCREASED INCIDENCE OF LEVODOPA THERAPY FOLLOWING METOCLOPRAMIDE USE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							DRUG	Objective.-To determine whether there is an increase in use of antiparkinsonian therapy in older persons taking metoclopramide hydrochloride. Design.-Case-control study. Setting.-New Jersey Medicaid program. Patients.-Medicaid enrollees aged 65 years and older. Cases were patients newly prescribed a levodopa-containing medication (n=1253); a secondary case group were patients newly prescribed an anticholinergic antiparkinsonian drug (n=2377). The control group consisted of 16 435 Medicaid enrollees older than 65 years who were not users of any antiparkinsonian therapy. Main Outcome Measures.-We used logistic regression to determine the odds ratio (OR) for the initiation of antiparkinsonian therapy in patients using metoclopramide relative to nonusers, after adjusting for age, sex, race, nursing home residence, exposure to antipsychotic medication, and days hospitalized. Results.-Metoclopramide users were three times more likely to begin use of a levodopa-containing medication compared with nonusers (OR=3.09; 95% confidence interval [CI], 2.25 to 4.26). Risk increased with increasing daily metoclopramide dose: the OR was 1.19 (95% CI, 0.50 to 2.81) for more than 0 to 10 mg per day, 3.33 (95% CI, 1.98 to 5.58) for more than 10 to 20 mg per day, and 5.25 (95% CI, 1.16 to 8.50) for more than 20 mg per day. The effect persisted after adjustment for demographic, health service utilization, and medication use variables. The OR for initiation of anticholinergic antiparkinsonian drugs was also elevated in metoclopramide users. Conclusion.-Metoclopramide use confers an increased risk for the initiation of treatment generally reserved for the management of idiopathic Parkinson's disease. Such polypharmacy may represent the misdiagnosis of Parkinson's disease in patients with drug-induced parkinsonian symptoms, which should be ruled out before starting dopaminergic therapy for this condition.	HARVARD UNIV,SCH MED,BOSTON,MA; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	AVORN, J (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV GERONTOL,PROGRAM ANAL CLIN STRATEGIES,221 LONGWOOD AVE,BOSTON,MA 02115, USA.				NIA NIH HHS [AG09634] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009634] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avorn J, 1993, J Glaucoma, V2, P158; AVORN J, 1990, JAMA-J AM MED ASSOC, V263, P1823, DOI 10.1001/jama.263.13.1823; AVORN J, 1995, AM J MED, V99, P48, DOI 10.1016/S0002-9343(99)80104-1; AVORN J, 1990, GERIATRIC MED; BERKOW R, 1992, MERCK MANUAL DIAGNOS, P1283; BRIGHT RA, 1989, J CLIN EPIDEMIOL, V42, P937, DOI 10.1016/0895-4356(89)90158-3; DURAZO FA, 1993, AM J GASTROENTEROL, V88, P1657; Gilman AG., 1990, J MED CHEM, V8th, DOI DOI 10.1021/acs.jmedchem.8b01308; GURWITZ JH, 1991, ANN INTERN MED, V114, P956, DOI 10.7326/0003-4819-114-11-956; GURWITZ JH, 1994, ARCH INTERN MED, V154, P97, DOI 10.1001/archinte.154.1.97; KALISH SC, 1995, J AM GERIATR SOC, V43, P967, DOI 10.1111/j.1532-5415.1995.tb05559.x; Koller W, 1987, Adv Neurol, V45, P317; MARTTILA RJ, 1976, ACTA NEUROL SCAND, V53, P81; MCEVOY GK, 1995, AHFS 95 DRUG INFORMA, P2042; SNAPE WJ, 1982, ANN INTERN MED, V96, P444, DOI 10.7326/0003-4819-96-4-444; 1993, MED LETT DRUGS THER, V35, P124	16	45	46	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	1995	274	22					1780	1782		10.1001/jama.274.22.1780	http://dx.doi.org/10.1001/jama.274.22.1780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ225	7500509				2022-12-24	WOS:A1995TJ22500028
J	WARNOCK, DW; DELVES, HT; CAMPELL, CK; CROUDACE, IW; DAVEY, KG; JOHNSON, EM; SIENIAWSKA, C				WARNOCK, DW; DELVES, HT; CAMPELL, CK; CROUDACE, IW; DAVEY, KG; JOHNSON, EM; SIENIAWSKA, C			TOXIC GAS GENERATION FROM PLASTIC MATTRESSES AND SUDDEN-INFANT-DEATH-SYNDROME	LANCET			English	Article								Microbial generation of toxic gases from antimony, arsenic, or phosphorus in compounds used as fire retardants in cot mattresses has been proposed as a cause of sudden infant death. To test this hypothesis, 23 polyvinyl chloride mattress samples from cot death cases were incubated on malt agar plates until good microbial growth was obtained. Silver nitrate and mercuric chloride test papers were then inserted and the colour reactions recorded. The predominant organism, recovered from all mattresses tested, was not, as claimed in earlier work, the fungus Scopulariopsis brevicaulis, but a mix of common environmental Bacillus spp. Test paper colour changes occurred whenever bacterial growth was present, but these reactions also occurred in control tests in which no mattress material was present on the plates. Chemical and instrumental analyses of exposed test papers showed that the colour reactions were not due to deposits of antimony, arsenic, or phosphorus. Our findings do not support the hypothesis that toxic gases derived from antimony, arsenic, or phosphorus are a cause of sudden infant death. More sulphur was found in test papers exposed in plates containing bacterial growth than in those without such growth. This result suggests that the test paper reactions were due to the generation of sulphur-containing compounds during bacterial growth on the agar medium.	SOUTHAMPTON GEN HOSP,DEPT CLIN BIOCHEM,TRACE ELEMENT UNIT,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND; UNIV SOUTHAMPTON,SOUTHAMPTON OCEANOG CTR,DEPT GEOL,SOUTHAMPTON,HANTS,ENGLAND	University of Southampton; NERC National Oceanography Centre; University of Southampton	WARNOCK, DW (corresponding author), PUBL HLTH LAB,PHLS MYCOL REFERENCE LAB,BRISTOL BS2 8EL,AVON,ENGLAND.		Croudace, Ian W/N-7018-2013	Croudace, Ian W/0000-0003-1547-5650				CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; GATES PN, 1995, LANCET, V345, P386, DOI 10.1016/S0140-6736(95)90372-0; KELLEY J, 1992, HUM EXP TOXICOL, V11, P247; MORTON FJ, 1963, 86 COMM MYC I MYC PA; ONIONS AHS, 1966, SCOPULARIOPSIS BREVI; RICHARDSON BA, 1994, J FORENSIC SCI SOC, V34, P199, DOI 10.1016/S0015-7368(94)72915-7; RICHARDSON BA, 1990, LANCET, V335, P670, DOI 10.1016/0140-6736(90)90463-F; TURNBULL PCB, 1990, TOPLEY WILSONS PRINC, V2, P187; 1991, SUDDEN INFANT DEATH	9	33	33	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 9	1995	346	8989					1516	1520		10.1016/S0140-6736(95)92051-X	http://dx.doi.org/10.1016/S0140-6736(95)92051-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TJ291	7491046				2022-12-24	WOS:A1995TJ29100010
J	FINKELHOR, D; WOLAK, J				FINKELHOR, D; WOLAK, J			NONSEXUAL ASSAULTS TO THE GENITALS IN THE YOUTH POPULATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACE-TO-FACE; CHILD SEXUAL ABUSE; TELEPHONE; RELIABILITY; TRAUMA; BOYS	Objective.-To assess the frequency with which youth suffer nonsexual assaults to the genitals and their context and consequences. Design.-Telephone survey with follow-up interview 1 year later. Setting.-General population of the United States living in households with telephones. Participants.-Random sample of 1042 boys and 958 girls aged 10 through 16 years. Results.-A nonsexual assault to the genitals was experienced by 9.2% of the boys and 1.0% of the girls in the year prior to the initial interview and 9.1% of the boys and 2.2% of the girls in the year prior to the follow-up interview. Among the boys, about a quarter of the assaults involved some injury, but only one in 50 needed medical attention. The most common assailants were same-aged peers. The assaults occurred in a variety of contexts including gang attacks, peer fighting, bullying, and some situations in which girls retaliated against the genitals of harassing boys. Boy victims of nonsexual genital assault had significantly higher levels of posttraumatic and depression symptomatology than boys without such assaults. Conclusions.-Nonsexual genital violence needs additional clinical and research attention. Youth should be educated about its possible consequences. Clinicians should ask about nonsexual genital violence when taking a history, particularly with youth who have experienced other kinds of assaults.			FINKELHOR, D (corresponding author), UNIV NEW HAMPSHIRE,FAMILY RES LAB,126 HORTON SOCIAL SCI CTR,DURHAM,NH 03824, USA.							BAJOS N, 1992, AIDS, V6, P315; BAYS J, 1990, AM J DIS CHILD, V144, P1319, DOI 10.1001/archpedi.1990.02150360043017; BAYS J, 1993, CHILD ABUSE NEGLECT, V17, P91, DOI 10.1016/0145-2134(93)90011-S; BERMACK E, 1989, PSYCHOL REP, V65, P259, DOI 10.2466/pr0.1989.65.1.259; BONEYMCCOY S, 1995, J CONSULT CLIN PSYCH, V63, P726, DOI 10.1037/0022-006X.63.5.726; Czaja R, 1987, Int Q Community Health Educ, V8, P23, DOI 10.2190/XT6W-31CX-TD87-E643; EVANS C, 1993, J CONTEMP ETHNOGR, V22, P139, DOI 10.1177/089124193022002001; FINE GA, 1987, LITTLE LEAGUE BASEBA; FINKEL MA, 1989, PEDIATRICS, V84, P317; FINKELHOR D, 1994, PEDIATRICS, V94, P413; Finkelhor D, 1994, Future Child, V4, P31, DOI 10.2307/1602522; FINKELHOR D, 1995, CHILD ABUSE NEGL, V19, P137; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; GROTH N, 1979, MEN RAPE; HARLEY J, 1995, JAN SAN DIEG C RESP; HAUSMAN AJ, 1992, J ADOLESCENT HEALTH, V13, P668, DOI 10.1016/1054-139X(92)90061-F; HERMANGIDDENS ME, 1987, PEDIATRICS, V80, P203; HERMANGIDDENS ME, 1989, JAMA-J AM MED ASSOC, V261, P577; HOBBS CJ, 1989, CHILD ABUSE NEGLECT, V13, P195, DOI 10.1016/0145-2134(89)90006-9; JOHNSON CF, 1985, CHILD ABUSE NEGLECT, V9, P207, DOI 10.1016/0145-2134(85)90013-4; KERNS DL, 1992, AM J DIS CHILD, V146, P494; MARIN G, 1989, HISPANIC J BEHAV SCI, V11, P330, DOI 10.1177/07399863890114003; MCCANN J, 1992, PEDIATRICS, V89, P307; MERRITT KA, 1994, PEDIATRICS, V94, P17; MORRISON L J, 1988, Journal of Emergency Medicine, V6, P521, DOI 10.1016/0736-4679(88)90412-X; MURAM D, 1989, CHILD ABUSE NEGLECT, V13, P211, DOI 10.1016/0145-2134(89)90007-0; POTTS MK, 1990, J PSYCHIATR RES, V24, P335, DOI 10.1016/0022-3956(90)90005-B; RIMZA ME, 1982, PEDIATRICS, V69, P8; SHAFFER D, 1992, NATIONAL I MENTAL HL; SLOSBERG EJ, 1978, AM J DIS CHILD, V132, P719, DOI 10.1001/archpedi.1978.02120320079019; SPENCER MJ, 1986, PEDIATRICS, V78, P133; STEWART WF, 1989, PSYCHOSOM MED, V51, P559, DOI 10.1097/00006842-198909000-00007; WEEKS MF, 1983, AM J PUBLIC HEALTH, V73, P1389, DOI 10.2105/AJPH.73.12.1389; WELLS KB, 1988, J PSYCHIAT RES, V22, P207, DOI 10.1016/0022-3956(88)90006-4; 1994, CRIMINAL VICTIMIZATI	35	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	1995	274	21					1692	1697		10.1001/jama.274.21.1692	http://dx.doi.org/10.1001/jama.274.21.1692			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TH151	7474274				2022-12-24	WOS:A1995TH15100026
J	KAULA, WM				KAULA, WM			VENUS RECONSIDERED	SCIENCE			English	Article							THERMAL EVOLUTION; PHASE-TRANSITION; MAGELLAN DATA; TECTONICS; MODEL; CONSTRAINTS; MANTLE; EARTH; WATER	The Magellan imagery shows that Venus has a crater abundance equivalent to a surface age of 300 million to 500 million years and a crater distribution close to random. Hence, the tectonics of Venus must be quiescent compared to those of Earth in the last few 100 million years. The main debate is whether the decline in tectonic activity on Venus is closer to monotonic or episodic, with enhanced tectonism and volcanism yet to come. The former hypothesis implies that most radioactive heat sources have been differentiated upward; the latter, that they have remained at depth. The low level of activity in the last few 100 million years inferred from imagery favors the monotonic hypothesis; some chemical evidence, particularly the low abundance of radiogenic argon, favors the episodic. A problem for both hypotheses is the rapid decline of thermal and tectonic activity some 300 million to 500 million years ago. The nature of the convective instabilities that caused the decline, and their propagation, are unclear.			KAULA, WM (corresponding author), UNIV CALIF LOS ANGELES, DEPT EARTH & SPACE SCI, LOS ANGELES, CA 90095 USA.							ARKANIHAMED J, 1994, J GEOPHYS RES-PLANET, V99, P2019, DOI 10.1029/93JE03172; ARKANIHAMED J, 1993, J GEOPHYS RES-PLANET, V98, P5309, DOI 10.1029/93JE00052; ARKANIHAMED J, 1993, PHYS EARTH PLANET IN, V76, P75, DOI 10.1016/0031-9201(93)90056-F; BAKER VR, 1992, J GEOPHYS RES-PLANET, V97, P13421, DOI 10.1029/92JE00927; BIRD GP, 1995, REV GEOPHYS S, V33, P379; BRACKETT RA, 1995, J GEOPHYS RES-PLANET, V100, P1553, DOI 10.1029/94JE02708; Burnham C. W., 1979, EVOLUTION IGNEOUS RO, P439, DOI DOI 10.2307/J.CTT13X1DKM.19; CARLSON RW, 1994, REV GEOPHYS, V32, P337, DOI 10.1029/94RG01874; FORSYTH DW, 1985, J GEOPHYS RES-SOLID, V90, P2623, DOI 10.1029/JB090iB14p12623; FREED AM, 1995, LUNAR PLANET SCI C, V26, P421; GREEN DH, 1973, EARTH PLANET SC LETT, V19, P37, DOI 10.1016/0012-821X(73)90176-3; GRIMM RE, 1988, J GEOPHYS RES-SOLID, V93, P11911, DOI 10.1029/JB093iB10p11911; GRIMM RE, 1994, J GEOPHYS RES-PLANET, V99, P23163, DOI 10.1029/94JE02196; HERRICK RR, 1994, GEOLOGY, V22, P703, DOI 10.1130/0091-7613(1994)022<0703:RHOV>2.3.CO;2; Herzog S. G., 1995, LUNAR PLANET SCI C, P591; IVANOV MA, 1993, GEOPHYS RES LETT, V20, P2579, DOI 10.1029/93GL02692; JULL MG, 1995, PHYS EARTH PLANET IN, V89, P163, DOI 10.1016/0031-9201(95)03015-O; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; KARGEL JS, 1993, ICARUS, V103, P253, DOI 10.1006/icar.1993.1069; KAULA WM, 1993, GEOPHYS RES LETT, V20, P2583, DOI 10.1029/93GL03086; KAULA WM, 1981, GEOPHYS RES LETT, V8, P1187, DOI 10.1029/GL008i012p01187; KAULA WM, 1992, J GEOPHYS RES-PLANET, V97, P16085, DOI 10.1029/92JE01643; KAULA WM, 1990, SCIENCE, V247, P1191, DOI 10.1126/science.247.4947.1191; KAULA WM, UNPUB; KAULA WM, 1993, LUNAR PLANET SCI C, V24, P767; KIEFER WS, 1986, GEOPHYS RES LETT, V13, P14, DOI 10.1029/GL013i001p00014; KLOSE KB, 1992, J GEOPHYS RES-PLANET, V97, P16353, DOI 10.1029/92JE01865; KONOPLIV AS, UNPUB; LACHENBRUCH AH, 1970, J GEOPHYS RES, V75, P3291, DOI 10.1029/JB075i017p03291; LITHGOWBERTELLONI C, 1993, GEOPHYS RES LETT, V20, P375, DOI 10.1029/93GL00168; MACKWELL SJ, 1995, ROCK MECHANICS - PROCEEDINGS OF THE 35TH U.S. SYMPOSIUM, P207; NAMIKI N, 1994, SCIENCE, V265, P929, DOI 10.1126/science.265.5174.929; NAMIKI N, 1993, J GEOPHYS RES-PLANET, V98, P15025, DOI 10.1029/93JE01626; NAMIKI N, 1995, LUNAR PLANET SCI, V26, P1029; NIKOLAYEVA OV, 1995, LUNAR PLANET SCI C, V26, P1049; PARMENTIER EM, 1992, GEOPHYS RES LETT, V19, P2015, DOI 10.1029/92GL01862; PHILLIPS RJ, 1995, GEOPHYS RES LETT, V22, P1517, DOI 10.1029/95GL01412; PHILLIPS RJ, 1992, J GEOPHYS RES-PLANET, V97, P15923, DOI 10.1029/92JE01696; PHILLIPS RJ, 1994, ANNU REV EARTH PL SC, V22, P597, DOI 10.1146/annurev.ea.22.050194.003121; PHILLIPS RJ, 1991, SCIENCE, V252, P651, DOI 10.1126/science.252.5006.651; PHILLIPS RJ, 1990, J GEOPHYS RES-SOLID, V95, P1301, DOI 10.1029/JB095iB02p01301; PHILLIPS RJ, 1990, LUNAR PLANET SCI, V21, P1065; POLLACK JB, 1992, ICARUS, V51, P169; PRICE M, 1994, NATURE, V372, P756, DOI 10.1038/372756a0; SANDWELL DT, 1992, SCIENCE, V257, P766, DOI 10.1126/science.257.5071.766; SCHABER GG, 1992, J GEOPHYS RES-PLANET, V97, P13257, DOI 10.1029/92JE01246; SCHATZ JF, 1972, J GEOPHYS RES, V77, P6966, DOI 10.1029/JB077i035p06966; SOLOMON SC, 1993, LUNAR PLANET SCI, V24, P1331; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; STROM RG, 1994, J GEOPHYS RES-PLANET, V99, P10899, DOI 10.1029/94JE00388; SURKOV YA, 1987, J GEOPHYS RES-SOLID, V92, pE537, DOI 10.1029/JB092iB04p0E537; SURKOV YA, 1984, J GEOPHYS RES S, V89, pB383; TACKLEY PJ, 1993, NATURE, V361, P699, DOI 10.1038/361699a0; TURCOTTE DL, 1993, J GEOPHYS RES-PLANET, V98, P17061, DOI 10.1029/93JE01775; ZUBER MT, 1987, J GEOPHYS RES-SOLID, V92, pE541, DOI 10.1029/JB092iB04p0E541	55	28	28	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1460	1464		10.1126/science.270.5241.1460	http://dx.doi.org/10.1126/science.270.5241.1460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491490				2022-12-24	WOS:A1995TH37500029
J	REINISCH, JM; SANDERS, SA; MORTENSEN, EL; RUBIN, DB				REINISCH, JM; SANDERS, SA; MORTENSEN, EL; RUBIN, DB			IN-UTERO EXPOSURE TO PHENOBARBITAL AND INTELLIGENCE DEFICITS IN ADULT MEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; CENTRAL-NERVOUS-SYSTEM; MATERNAL ALCOHOL-USE; EDUCATIONAL-LEVEL; FEBRILE SEIZURES; BEHAVIOR; CHILDREN; PREGNANCY; INFANTS; DRUGS	Objective.-To test whether exposure to phenobarbital in utero is associated with deficits in intelligence scores in adult men and whether the magnitude of the postnatal effect is mediated by exposure parameters and/or postnatal environmental factors. Design.-Two double-blind studies were conducted on independent samples of adult men prenatally exposed to phenobarbital and matched control samples using different measures of general intelligence, Based on data from control subjects, regression models were built relating intelligence scores to relevant pre-exposure matching variables and age at testing, Models generated predicted scores for each exposed subject, Group mean differences between the individually predicted and observed scores estimated exposure effects. Setting.-Copenhagen, Denmark. Participants.-Exposed subjects were adult men born at the largest hospital in Copenhagen between 1959 and 1961 who were exposed to phenobarbital during gestation via maternal medical treatment and whose mothers had no history of a central nervous system disorder and no treatment during pregnancy with any other psychopharmacological drug. Study 1 included 33 men and study 2, 81 men. Controls were unexposed members of the same birth cohort matched on a wide spectrum of maternal variables recorded prenatally and perinatally. Controls for studies 1 and 2 included 52 and 101 men, respectively. Main Outcome Measures.-In study 1: Wechsler Adult intelligence Scale (Danish version); in study 2: Danish Military Draft Board Intelligence Test (Borge Priens Prove). Result.-Men exposed prenatally to phenobarbital had significantly lower verbal intelligence scores (approximately 0.5 SD) than predicted, Lower socioeconomic status and being the offspring of an ''unwanted'' pregnancy increased the magnitude of the negative effects; Exposure that included the last trimester was the most detrimental. Conclusion.-Phenobarbital exposure during early development can have long-term deleterious effects on cognitive performance. Detrimental environmental conditions can interact with prenatal biological insult to magnify negative outcomes, Physicians are urged to use increased caution in prescribing such medications during pregnancy.	INST PREVENT MED, HOSP CORP, COPENHAGEN, DENMARK; HARVARD UNIV, DEPT STAT, CAMBRIDGE, MA USA	Harvard University	REINISCH, JM (corresponding author), INDIANA UNIV, KINSEY INST RES SEX GENDER & REPROD, MORRISON HALL, 3RD FLOOR, BLOOMINGTON, IN 47405 USA.				NICHD NIH HHS [HD 20263, HD 17655] Funding Source: Medline; NIDA NIH HHS [DA 05056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017655, R01HD020263] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARAI Y, 1968, ENDOCRINOLOGY, V82, P1005, DOI 10.1210/endo-82-5-1005; ARAI Y, 1968, ENDOCRINOLOGY, V82, P1010, DOI 10.1210/endo-82-5-1010; ARMITAGE SG, 1952, J COMP PHYSIOL PSYCH, V45, P146, DOI 10.1037/h0062268; BRENT DA, 1990, PEDIATRICS, V85, P1086; CAMFIELD CS, 1979, J PEDIATR-US, V95, P361, DOI 10.1016/S0022-3476(79)80507-7; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; DEVASCONCELOS AP, 1990, EXP NEUROL, V108, P176, DOI 10.1016/0014-4886(90)90025-N; DODSON WE, 1989, CLIN PERINATOL, V16, P339, DOI 10.1016/S0095-5108(18)30636-5; FARWELL JR, 1990, NEW ENGL J MED, V323, P485; FARWELL JR, 1990, NEW ENGL J MED, V322, P364, DOI 10.1056/NEJM199002083220604; Feingold C, 1994, J Pediatr Nurs, V9, P91; FISHMAN RHB, 1983, NEUROSCI BIOBEHAV R, V7, P19, DOI 10.1016/0149-7634(83)90004-0; FRIIS B, 1977, ARCH DIS CHILD, V52, P239, DOI 10.1136/adc.52.3.239; GAILY E, 1990, DEV MED CHILD NEUROL, V32, P403; Graffar M., 1960, MOD PROBL PADIAT, V5, P30; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; HESS G, 1974, WAIS ANVENDT PA 698; HILL TD, 1985, CLIN PSYCHOL REV, V5, P287, DOI 10.1016/0272-7358(85)90009-1; HIRTZ DG, 1986, AM J DIS CHILD, V140, P909, DOI 10.1001/archpedi.1986.02140230079037; JONES DC, 1992, IND LABOR RELAT REV, V45, P452, DOI 10.2307/2524272; KALTENBACH K, 1986, NEUROTOXICOL TERATOL, V8, P353; KILBEY MM, 1991, DHHSNIDA114 NAT I DR; KLIPSTEIN FA, 1964, BLOOD, V23, P68, DOI 10.1182/blood.V23.1.68.68; LIEWENDAHL K, 1978, CLIN ENDOCRINOL, V8, P185, DOI 10.1111/j.1365-2265.1978.tb01493.x; LITTLE R, 1987, STATISTICAL ANAL MIS; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Martin J C, 1979, Neurobehav Toxicol, V1, P49; MARTIN JC, 1986, NEUROTOXICOL TERATOL, V8, P335; MIDDAUGH LD, 1986, NEUROTOXICOLOGY, V7, P287; MORALES WJ, 1986, OBSTET GYNECOL, V68, P295, DOI 10.1097/00006250-198609000-00001; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; PFEIFFER SI, 1990, PERCEPT MOTOR SKILL, V70, P1367, DOI 10.2466/PMS.70.3.1367-1378; Rayburn W, 1989, J Perinatol, V9, P268; RAYBURN W, 1988, AM J OBSTET GYNECOL, V159, P1491, DOI 10.1016/0002-9378(88)90580-7; REINISCH JM, 1982, NEUROSCI BIOBEHAV R, V6, P311, DOI 10.1016/0149-7634(82)90043-4; REINISCH JM, 1993, ACTA PSYCHIAT SCAND, V87, P54, DOI 10.1111/j.1600-0447.1993.tb05361.x; RODGERS B, 1978, DEV MED CHILD NEUROL, V20, P421, DOI 10.1111/j.1469-8749.1978.tb15242.x; ROSENBAUM PR, 1985, BIOMETRICS, V41, P103, DOI 10.2307/2530647; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; ROSENTHAL R, 1982, J EDUC PSYCHOL, V74, P708, DOI 10.1037/0022-0663.74.5.708; ROSENTHAL R, 1982, J EDUC PSYCHOL, V74, P166, DOI 10.1037/0022-0663.74.2.166; Rubin DB, 1984, WG COCHRANS IMPACT S, P37; RUSSELL M, 1991, ALCOHOL CLIN EXP RES, V15, P991, DOI 10.1111/j.1530-0277.1991.tb05200.x; Scarr S., 1981, RACE SOCIAL CLASS IN; SCHAIE KW, 1983, DEV PSYCHOL, V19, P531, DOI 10.1037/0012-1649.19.4.531; SCHRAEDER BD, 1986, NURS RES, V35, P237; SMITH I, 1991, ARCH DIS CHILD, V66, P311, DOI 10.1136/adc.66.3.311; Sobczyk W, 1977, Neurol Neurochir Pol, V11, P59; STREISSGUTH AP, 1989, DEV PSYCHOL, V25, P3, DOI 10.1037/0012-1649.25.1.3; TEASDALE TW, 1987, NATURE, V325, P119, DOI 10.1038/325119a0; TEASDALE TW, 1988, BRIT J EDUC PSYCHOL, V58, P307, DOI 10.1111/j.2044-8279.1988.tb00906.x; TEASDALE TW, 1991, HUM BIOL, V63, P19; VALAES T, 1980, PEDIATR RES, V14, P947, DOI 10.1203/00006450-198008000-00011; VANDERPOL MC, 1991, AM J OBSTET GYNECOL, V164, P121, DOI 10.1016/0002-9378(91)90640-D; VILLUMSEN AL, 1970, ENV FACTORS CONGENIT, P124; VINING EPG, 1987, PEDIATRICS, V80, P165; WALLIN A, 1984, ACTA PAEDIATR SCAND, V73, P488, DOI 10.1111/j.1651-2227.1984.tb09960.x; Wechsler D., 2008, WECHSLER ADULT INTEL; Wesson D. R, 1977, BARBITURATES THEIR U; WILSON JT, 1971, CLIN PEDIATR, V10, P684, DOI 10.1177/000992287101001202; WITKIN HA, 1976, SCIENCE, V193, P547, DOI 10.1126/science.959813; Yaffe S J, 1980, Prog Clin Biol Res, V36, P157; YAFFE SJ, 1990, DEV PHARMACOL THERAP, V15, P215, DOI 10.1159/000457649; YANAI J, 1989, NEUROTOXICOLOGY, V10, P543; YANAI J, 1981, EXP NEUROL, V73, P199, DOI 10.1016/0014-4886(81)90055-8; ZACHAUCHRISTIAN.B, 1975, BABIES HUMAN DEV 1ST; ZEMP JW, 1975, ADDICT DIS, V2, P307; 1951, CLASSIFICATION OCCUP, P3	68	214	217	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	1995	274	19					1518	1525		10.1001/jama.274.19.1518	http://dx.doi.org/10.1001/jama.274.19.1518			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TD571	7474220				2022-12-24	WOS:A1995TD57100028
J	JONES, SN; ROE, AE; DONEHOWER, LA; BRADLEY, A				JONES, SN; ROE, AE; DONEHOWER, LA; BRADLEY, A			RESCUE OF EMBRYONIC LETHALITY IN MDM2-DEFICIENT MICE BY ABSENCE OF P53	NATURE			English	Article							WILD-TYPE P53; MDM-2 ONCOGENE; PROTEIN; MOUSE; GROWTH; GENE; TRANSACTIVATION; LINE	THE Mdm2 proto-oncogene was originally identified as one of several genes contained on a mouse double minute chromosome present in a transformed derivative of 3T3 cells(1). Overexpression of Mdm2 can immortalize primary cultures of rodent fibroblasts(2). Human MDM2 is amplified in 30-40% of sarcomas, and is overexpressed in leukaemic cells(3,4). The Mdm2 oncoprotein forms a complex with the p53 tumour-suppressor protein and inhibits p53-mediated transregulation of gene expression(5,6) Because Mdm2 expression increases in response to p53, Mdm2-p53 binding may autoregulate Mdm2 expression and modulate the activity of p53 in the cell(7,8). We have created Mdm2-null and Mdm2/p53-null mice to determine whether Mdm2 possesses developmental functions in addition to the ability to complex with p53, and to investigate the biological role of Mdm2-p53 complex formation in development. Mice deficient for Mdm2 die early in development. In contrast, mice deficient for both Mdm2 and p53 develop normally and are viable. These results suggest that a critical role of Mdm2 in development is the regulation of p53 function.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC VIROL,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	JONES, SN (corresponding author), BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.			Bradley, Allan/0000-0002-2349-8839				BAKER SJ, 1990, SCIENCE, V253, P49; BUESORAMOS CE, 1993, BLOOD, V82, P2617; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; CHEN J, 1995, J MOL MED, V1, P142; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; JUVEN T, 1993, ONCOGENE, V8, P3411; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P2; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OLSON DC, 1993, ONCOGENE, V8, P2353; RAMIREZSOLIS R, 1993, GUIDE TECHNIQUES MOU, P855; SCHMID P, 1991, DEVELOPMENT, V113, P857; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	23	1040	1060	1	36	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					206	208		10.1038/378206a0	http://dx.doi.org/10.1038/378206a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477327				2022-12-24	WOS:A1995TD75900060
J	LUNA, RMD; WAGNER, DS; LOZANO, G				LUNA, RMD; WAGNER, DS; LOZANO, G			RESCUE OF EARLY EMBRYONIC LETHALITY IN MDM2-DEFICIENT MICE BY DELETION OF P53	NATURE			English	Article							WILD-TYPE P53; MDM-2 ONCOGENE; PROTEIN; APOPTOSIS; PROTOONCOGENE; IRRADIATION; ACTIVATION; DISRUPTION; RADIATION; CELLS	THE gene p53 encodes a transcriptional activator(1,2) of genes involved in growth arrest(3,4), DNA repair(5) and apoptosis(6-8). Loss p53 function contributes to tumor development in vivo(9-11). The transcriptional activation function of p53 is inactivated by interaction with the mdm2 gene product(11-14). Amplification of mdm2 has been observed in 36% of human sarcomas, indicating that it may represent an alternative mechanism of preventing p53 function in tumor development(15). To study mdm2 function in vivo, we generated an mdm2 null allele by homologous recombination. Mdm2 null mice are not viable, and further analysis revealed embryonic lethality around implantation. To examine the importance of the interaction of MDM2 with p53 in vivo, we crossed mice heterozygous for mdm2 null alleles. Rescue of the mdm2(-/-) lethality in a p53 null background suggests that a critical in vivo function of MDM2 is the negative regulation of p53 activity.	UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MOLEC GENET, HOUSTON, TX 77030 USA; UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center			Wagner, Daniel S/C-9379-2009	Wagner, Daniel S/0000-0002-0595-2436				CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HARPER JW, 1993, CELL, V75, P805; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	27	1099	1116	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 9	1995	378	6553					203	206						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477326				2022-12-24	WOS:A1995TD75900059
J	HIETALA, J; SYVALAHTI, E; VUORIO, K; RAKKOLAINEN, V; BERGMAN, J; HAAPARANTA, M; SOLIN, O; KUOPPAMAKI, M; KIRVELA, O; RUOTSALAINEN, U; SALOKANGAS, RKR				HIETALA, J; SYVALAHTI, E; VUORIO, K; RAKKOLAINEN, V; BERGMAN, J; HAAPARANTA, M; SOLIN, O; KUOPPAMAKI, M; KIRVELA, O; RUOTSALAINEN, U; SALOKANGAS, RKR			PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS	LANCET			English	Note							POSITRON EMISSION TOMOGRAPHY; ABNORMALITIES; RECEPTORS	Presynaptic dopamine function (6-[F-18]-fluorodopa uptake) in the brains of seven neuroleptic-naive first-admission schizophrenic patients and eight healthy controls was studied with positron emission tomography. The fluorodopa influx constant (K-i) in putamen was higher in the patients than in controls (average mean: 0.0149 vs 0.0129, p=0.034). The changes in caudate were smaller but significantly lateralised to the left caudate. There was one catatonic schizophrenic patient in our sample. This patient had lower striatal K-i than any control. Alterations in striatal presynaptic dopamine function may constitute a part of disrupted neural circuits that predispose to schizophrenic psychosis.	TURKU MED CYCLOTRON PET PROJECT,TURKU,FINLAND; TURKU CITY PSYCHIAT HOSP,TURKU,FINLAND; ABO AKAD UNIV,ACCELERATOR LAB,TURKU,FINLAND; TURKU UNIV HOSP,DEPT ANAESTHESIOL,SF-20520 TURKU,FINLAND; TURKU UNIV HOSP,DEPT PSYCHIAT,SF-20520 TURKU,FINLAND	Abo Akademi University; University of Turku; University of Turku	HIETALA, J (corresponding author), UNIV TURKU,DEPT PHARMACOL,KIINAMYLLYNKATU 10,SF-20520 TURKU,FINLAND.		Ruotsalainen, Ulla/J-5678-2014	Ruotsalainen, Ulla/0000-0001-7775-3412				Bergman J., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P476; BILDER RM, 1994, AM J PSYCHIAT, V151, P1437; FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213; HIETALA J, 1994, ARCH GEN PSYCHIAT, V51, P116; PELLIZARI A, 1989, J COMPUT ASSIST TOMO, V13, P20; PILOWSKY LS, 1994, BRIT J PSYCHIAT, V164, P16, DOI 10.1192/bjp.164.1.16; REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495	10	262	266	0	19	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1130	1131		10.1016/S0140-6736(95)91801-9	http://dx.doi.org/10.1016/S0140-6736(95)91801-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TB549	7475604				2022-12-24	WOS:A1995TB54900011
J	MONTAGUE, PR; DAYAN, P; PERSON, C; SEJNOWSKI, TJ				MONTAGUE, PR; DAYAN, P; PERSON, C; SEJNOWSKI, TJ			BEE FORAGING IN UNCERTAIN ENVIRONMENTS USING PREDICTIVE HEBBIAN LEARNING	NATURE			English	Article							BUMBLE BEES; HONEYBEES; CHOICE; BEHAVIOR; DOPAMINE; REWARD	RECENT work has identified a neuron with widespread projections to odour processing regions of the honeybee brain whose activity represents the reward value of gustatory stimuli(1,2). We have constructed a model of bee foraging in uncertain environments based on this type of neuron and a predictive form of hebbian synaptic plasticity. The model uses visual input from a simulated three-dimensional world and accounts for a wide range of experiments on bee learning during foraging, including risk aversion. The predictive model shows how neuromodulatory influences can be used to bias actions and control synaptic plasticity in a way that goes beyond standard correlational mechanisms. Although several behavioural models of conditioning in bees have been proposed(3-7), this model is based on the neural substrate and was tested in a simulation of bee flight.	MIT,DEPT BRAIN & COGNIT SCI,CBCL,CAMBRIDGE,MA 02139; SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,LA JOLLA,CA 92037; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	MONTAGUE, PR (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.		Sejnowski, Terrence/AAV-5558-2021	Dayan, Peter/0000-0003-3476-1839				BARTO AG, 1989, 8995 U MASS COMP INF; Berry D A, 1985, BANDIT PROBLEMS SEQU; COUVILLON PA, 1991, ANIM LEARN BEHAV, V19, P381, DOI 10.3758/BF03197899; COUVILLON PA, 1986, ANIM LEARN BEHAV, V14, P225, DOI 10.3758/BF03200062; COUVILLON PA, 1985, ANIM LEARN BEHAV, V13, P246, DOI 10.3758/BF03200017; GOLDSTEIN RS, 1991, J COMP PHYSIOL A, V168, P103, DOI 10.1007/BF00217108; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; Hammer M., 1994, Society for Neuroscience Abstracts, V20, P582; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAMMER M, 1995, NEUROSCIENCE, V15, P1617; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HEBB DO, 1949, ORG BEHAVIOR; Konorski J., 1948, CONDITIONED REFLEXES; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; LOCKERY SR, 1991, J COMP PHYSIOL A, V168, P165, DOI 10.1007/BF00218409; Menzel Randolf, 1993, P79; Montague P. R., 1993, ADV NEURAL INFORMATI, V5, P969; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; REAL L, 1990, ECOLOGY, V71, P1625, DOI 10.2307/1938299; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; REAL LA, 1981, ECOLOGY, V62, P20, DOI 10.2307/1936663; Rescorla R., 1972, CLASSICAL CONDITION, P64; SAMUEL AL, 1956, IBM J RES DEV, V3, P211; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SPUDICH JL, 1975, P NATL ACAD SCI USA, V72, P710, DOI 10.1073/pnas.72.2.710; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; SUTTON RS, 1987, LEARNING COMPUTATION, P497; Widrow B., 1985, ADAPTIVE SIGNAL PROC	30	200	205	4	37	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					725	728		10.1038/377725a0	http://dx.doi.org/10.1038/377725a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TB469	7477260				2022-12-24	WOS:A1995TB46900054
J	NOSE, A; NAGAFUCHI, A; TAKEICHI, M				NOSE, A; NAGAFUCHI, A; TAKEICHI, M			EXPRESSED RECOMBINANT CADHERINS MEDIATE CELL SORTING IN MODEL SYSTEMS	CELL			English	Article											NOSE, A (corresponding author), KYOTO UNIV,FAC SCI,DEPT BIOPHYS,SAKYO KU,KYOTO 606,JAPAN.		Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; CURTIS ASG, 1967, CELL SURFACE ITS MOL; EDELMAN GM, 1984, P NATL ACAD SCI-BIOL, V81, P1460, DOI 10.1073/pnas.81.5.1460; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2808, DOI 10.1073/pnas.84.9.2808; GIBRALTER D, 1985, DEV BIOL, V112, P292, DOI 10.1016/0012-1606(85)90400-2; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; MOSCONA A, 1952, J ANAT, V86, P287; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1987, TRENDS GENET, V3, P213, DOI 10.1016/0168-9525(87)90238-1; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; TAKEICHI M, 1985, MOL DETERMINANTS ANI, P223; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; Xie H, 1984, CELL STRUCT FUNCT, V8, P315	28	604	611	1	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 23	1988	54	7					993	1001		10.1016/0092-8674(88)90114-6	http://dx.doi.org/10.1016/0092-8674(88)90114-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	Q3063	3416359				2022-12-24	WOS:A1988Q306300012
J	KLINGLER, M; ERDELYI, M; SZABAD, J; NUSSLEINVOLHARD, C				KLINGLER, M; ERDELYI, M; SZABAD, J; NUSSLEINVOLHARD, C			FUNCTION OF TORSO IN DETERMINING THE TERMINAL ANLAGEN OF THE DROSOPHILA EMBRYO	NATURE			English	Article									BIOL RES CTR,INST GENET,H-6701 SZEGED,HUNGARY	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	KLINGLER, M (corresponding author), MAX PLANCK INST ENTWICKLUNGSBIOL,SPEMANNSTR 35-III,D-7400 TUBINGEN,FED REP GER.		Klingler, Martin/J-8383-2013	Klingler, Martin/0000-0001-8859-1965				ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; CARROLL SB, 1985, CELL, V43, P47, DOI 10.1016/0092-8674(85)90011-X; DEGELMANN A, 1986, DEV BIOL, V115, P479, DOI 10.1016/0012-1606(86)90268-X; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FROHNHOFER HG, 1986, J EMBRYOL EXP MORPH, V97, P169; GAUL U, 1987, CELL, V51, P549, DOI 10.1016/0092-8674(87)90124-3; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; JURGENS G, 1986, W ROUXS ARCH DEV BIO, V195, P359; JURGENS G, 1987, W ROUX ARCH DEV BIOL, V196, P141; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MEINHARDT H, 1986, J CELL SCI S, V4, P357; MLODZIK M, 1987, GENE DEV, V1, P603, DOI 10.1101/gad.1.6.603; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; PERRIMON N, 1986, GENETICS, V113, P695; SCHUEPBACH T, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P302; STRECKER TR, 1986, DEV BIOL, V113, P64, DOI 10.1016/0012-1606(86)90108-9; STRECKER TR, 1988, DEVELOPMENT, V102, P721	20	212	212	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 15	1988	335	6187					275	277		10.1038/335275a0	http://dx.doi.org/10.1038/335275a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q0477	3412488				2022-12-24	WOS:A1988Q047700067
J	BELL, SP; LEARNED, RM; JANTZEN, HM; TJIAN, R				BELL, SP; LEARNED, RM; JANTZEN, HM; TJIAN, R			FUNCTIONAL COOPERATIVITY BETWEEN TRANSCRIPTION FACTOR-UBF1 AND FACTOR-SL1 MEDIATES HUMAN RIBOSOMAL-RNA SYNTHESIS	SCIENCE			English	Article											BELL, SP (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT BIOCHEM, BERKELEY, CA 94720 USA.			Bell, Stephen/0000-0002-2876-610X	NIGMS NIH HHS [GM 32856] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032856] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER S, 1988, CELL, V52, P685, DOI 10.1016/0092-8674(88)90406-0; BATEMAN E, 1985, P NATL ACAD SCI USA, V82, P8004, DOI 10.1073/pnas.82.23.8004; BELL SG, UNPUB; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CLOS J, 1986, P NATL ACAD SCI USA, V83, P604, DOI 10.1073/pnas.83.3.604; DAVISON BL, 1979, J BIOL CHEM, V254, P9220; DEWINTER RFJ, 1986, CELL, V44, P313, DOI 10.1016/0092-8674(86)90765-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; GRUMMT I, 1982, NATURE, V296, P173, DOI 10.1038/296173a0; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; JANTZEN HM, UNPUB; JONES MH, 1988, P NATL ACAD SCI USA, V85, P669, DOI 10.1073/pnas.85.3.669; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KATO H, 1986, MOL CELL BIOL, V6, P3418, DOI 10.1128/MCB.6.10.3418; KOWNIN P, 1987, CELL, V50, P693, DOI 10.1016/0092-8674(87)90327-8; LABHART P, 1984, CELL, V37, P285, DOI 10.1016/0092-8674(84)90324-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; LEARNED RM, 1983, P NATL ACAD SCI-BIOL, V80, P3558, DOI 10.1073/pnas.80.12.3558; LEARNED RM, UNPUB; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MILLER KG, 1985, MOL CELL BIOL, V5, P554, DOI 10.1128/MCB.5.3.554; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REINBERG D, 1987, J BIOL CHEM, V262, P3310; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; TOWER J, 1986, MOL CELL BIOL, V6, P3451, DOI 10.1128/MCB.6.10.3451; TSAI SY, 1987, CELL, V50, P701, DOI 10.1016/0092-8674(87)90328-X; WINDLE JJ, 1986, MOL CELL BIOL, V6, P4585, DOI 10.1128/MCB.6.12.4585; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	40	310	314	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	1988	241	4870					1192	1197		10.1126/science.3413483	http://dx.doi.org/10.1126/science.3413483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P9021	3413483				2022-12-24	WOS:A1988P902100029
J	THOMAS, JD; CONRAD, RC; BLUMENTHAL, T				THOMAS, JD; CONRAD, RC; BLUMENTHAL, T			THE C-ELEGANS TRANS-SPLICED LEADER RNA IS BOUND TO SM AND HAS A TRIMETHYLGUANOSINE CAP	CELL			English	Article									INDIANA UNIV,DEPT BIOL,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	THOMAS, JD (corresponding author), INDIANA UNIV,PROGRAM MOLEC CELLULAR & DEV BIOL,BLOOMINGTON,IN 47405, USA.				NIGMS NIH HHS [GM30870, GM7227] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030870] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEKTESH SL, 1988, NUCLEIC ACIDS RES, V16, P5692, DOI 10.1093/nar/16.12.5692; BRENNER S, 1974, GENETICS, V77, P71; BRINGMANN P, 1983, EMBO J, V2, P1129, DOI 10.1002/j.1460-2075.1983.tb01557.x; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; BROW DA, 1988, IN PRESS NATURE; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; CHABOT B, 1985, SCIENCE, V230, P1344, DOI 10.1126/science.2933810; EMMONS SW, 1988, NEMATODE CAENORHABDI; FRITZ A, 1984, J MOL BIOL, V178, P273, DOI 10.1016/0022-2836(84)90144-X; GERKE V, 1986, CELL, V47, P973, DOI 10.1016/0092-8674(86)90812-3; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; MANIATIS T, 1982, MOL CLONING LABORATO; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PATTERSON B, 1987, CELL, V49, P613, DOI 10.1016/0092-8674(87)90537-X; REDDY R, 1988, NUCL ACIDS RES SEQ S, V16, pR70; RIEDEL N, 1987, SCIENCE, V235, P328, DOI 10.1126/science.2948278; RIEDEL N, 1986, P NATL ACAD SCI USA, V83, P8097, DOI 10.1073/pnas.83.21.8097; RINKE J, 1985, J MOL BIOL, V185, P721, DOI 10.1016/0022-2836(85)90057-9; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; SHARP PA, 1987, CELL, V50, P147, DOI 10.1016/0092-8674(87)90207-8; SILICIANO PG, 1987, SCIENCE, V237, P1484, DOI 10.1126/science.3306922; SPIETH J, 1985, NUCLEIC ACIDS RES, V13, P5283, DOI 10.1093/nar/13.14.5283; STEITZ JA, 1983, COLD SPRING HARB SYM, V47, P893; SULSTON JE, 1974, GENETICS, V77, P95; SUTTON RE, 1988, MOL CELL BIOL, V8, P494, DOI 10.1128/MCB.8.1.494; TAZI J, 1986, CELL, V47, P755, DOI 10.1016/0092-8674(86)90518-0; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; TSCHUDI C, 1986, NUCLEIC ACIDS RES, V14, P8893, DOI 10.1093/nar/14.22.8893; VILLENEUVE AM, 1987, CELL, V48, P25, DOI 10.1016/0092-8674(87)90352-7; WISE JA, 1981, J BIOL CHEM, V256, P956; WISE JA, 1983, CELL, V35, P743, DOI 10.1016/0092-8674(83)90107-1; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZUCKERAPRISON E, 1988, IN PRESS NUCL ACIDS	40	124	124	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 12	1988	54	4					533	539		10.1016/0092-8674(88)90075-X	http://dx.doi.org/10.1016/0092-8674(88)90075-X			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	P7984	3401926				2022-12-24	WOS:A1988P798400013
J	GEELHOED, GC; LANDAU, LI; LESOUEF, PN				GEELHOED, GC; LANDAU, LI; LESOUEF, PN			PREDICTIVE VALUE OF OXYGEN-SATURATION IN EMERGENCY EVALUATION OF ASTHMATIC-CHILDREN	BRITISH MEDICAL JOURNAL			English	Article									PRINCESS MARGARET HOSP CHILDREN,PAEDIAT,PERTH,WA 6008,AUSTRALIA	University of Western Australia	GEELHOED, GC (corresponding author), PRINCESS MARGARET HOSP CHILDREN,DEPT RESP MED,BOX D184,PERTH,WA 6008,AUSTRALIA.		Le Souef, Peter N/H-5256-2014	Le Souef, Peter/0000-0003-0930-1654				BURKI NK, 1983, CHEST, V83, P666, DOI 10.1378/chest.83.4.666; LEE DA, 1983, BRIT MED J, V286, P1258; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; REBUCK AS, 1983, CHEST, V83, P860, DOI 10.1378/chest.83.6.860	4	43	43	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					395	396		10.1136/bmj.297.6645.395	http://dx.doi.org/10.1136/bmj.297.6645.395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	3408980	Bronze, Green Published			2022-12-24	WOS:A1988P545000021
J	SAAG, MS; HAHN, BH; GIBBONS, J; LI, YX; PARKS, ES; PARKS, WP; SHAW, GM				SAAG, MS; HAHN, BH; GIBBONS, J; LI, YX; PARKS, ES; PARKS, WP; SHAW, GM			EXTENSIVE VARIATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INVIVO	NATURE			English	Article									UNIV ALABAMA,DEPT INTERNAL MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOCHEM,BIRMINGHAM,AL 35294; UNIV MIAMI,SCH MED,DEPT PEDIAT,MIAMI,FL 33101	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Miami				Hahn, Beatrice/0000-0002-9400-9887				ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; BENN S, 1985, SCIENCE, V230, P949, DOI 10.1126/science.2997922; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CLEMENTS JE, 1980, P NATL ACAD SCI-BIOL, V77, P4454, DOI 10.1073/pnas.77.8.4454; COFFIN JM, 1986, CELL, V46, P1, DOI 10.1016/0092-8674(86)90851-2; DESAI SM, 1986, P NATL ACAD SCI USA, V83, P8380, DOI 10.1073/pnas.83.21.8380; DESROSIERS RC, 1985, J VIROL, V54, P552, DOI 10.1128/JVI.54.2.552-560.1985; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; KESTLER HW, 1988, NATURE, V331, P619, DOI 10.1038/331619a0; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; MONTELARO RC, 1984, J BIOL CHEM, V259, P539; Narayan O, 1987, Contrib Microbiol Immunol, V8, P60; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; PAYNE SL, 1987, VIROLOGY, V161, P321, DOI 10.1016/0042-6822(87)90124-3; PAYNE SL, 1987, J VIROL, V61, P1266, DOI 10.1128/JVI.61.4.1266-1270.1987; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; SRINIVASAN A, 1987, BLOOD, V69, P1766; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; WILLEY RL, 1986, P NATL ACAD SCI USA, V83, P5038, DOI 10.1073/pnas.83.14.5038; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; WONGSTAAL F, 1985, SCIENCE, V229, P759, DOI 10.1126/science.2992084	22	393	404	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					440	444		10.1038/334440a0	http://dx.doi.org/10.1038/334440a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	3405290				2022-12-24	WOS:A1988P529200062
J	GARROW, JS; HASTINGS, EJ; COX, AG; NORTH, WRS; GIBSON, M; THOMAS, TM; MEADE, TW				GARROW, JS; HASTINGS, EJ; COX, AG; NORTH, WRS; GIBSON, M; THOMAS, TM; MEADE, TW			OBESITY AND POSTOPERATIVE COMPLICATIONS OF ABDOMINAL OPERATION	BRITISH MEDICAL JOURNAL			English	Article									NORTHWICK PK HOSP,MRC,EPIDEMIOL & MED CARE UNIT,HARROW HA1 3UJ,MIDDX,ENGLAND; MRC,CLIN RES CTR,DIV CLIN SCI,HARROW HA1 3UJ,MIDDX,ENGLAND; NORTHWICK PK HOSP,DIV SURG,HARROW HA1 3UJ,MIDDX,ENGLAND	Imperial College London; Medical Research Council Clinical Trials Unit; Imperial College London								HARMAN EM, 1986, CHEST, V90, P153, DOI 10.1378/chest.90.2.153; KOZOL RA, 1986, SURG GYNECOL OBSTET, V162, P442	2	36	36	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 16	1988	297	6642					181	181		10.1136/bmj.297.6642.181	http://dx.doi.org/10.1136/bmj.297.6642.181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P2951	3408957	Bronze, Green Published			2022-12-24	WOS:A1988P295100023
J	ROBERTSON, JH; WOODEND, BE; CROZIER, EH; HUTCHINSON, J				ROBERTSON, JH; WOODEND, BE; CROZIER, EH; HUTCHINSON, J			RISK OF CERVICAL-CANCER ASSOCIATED WITH MILD DYSKARYOSIS	BRITISH MEDICAL JOURNAL			English	Article											ROBERTSON, JH (corresponding author), BELFAST CITY HOSP LABS,BELFAST BT9 7AD,NORTH IRELAND.							BELLINA JH, 1982, SOUTHERN MED J, V75, P6, DOI 10.1097/00007611-198201000-00003; BROWN MS, 1985, GYNECOL ONCOL, V22, P149, DOI 10.1016/0090-8258(85)90020-4; BUNNEY MH, 1986, BRIT MED J, V293, P1045, DOI 10.1136/bmj.293.6554.1045; CAMPION MJ, 1987, BRIT MED J, V294, P1337, DOI 10.1136/bmj.294.6583.1337; FOX H, 1987, BRIT MED J, V294, P1307, DOI 10.1136/bmj.294.6583.1307; HULKA BS, 1968, AM J OBSTET GYNECOL, V101, P190, DOI 10.1016/0002-9378(68)90187-7; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; RICHART RM, 1980, AM J OBSTET GYNECOL, V137, P823, DOI 10.1016/0002-9378(80)90892-3; ROBERTSON JH, 1987, ULSTER MED J, V56, P90	9	129	129	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					18	21		10.1136/bmj.297.6640.18	http://dx.doi.org/10.1136/bmj.297.6640.18			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408902	Green Published, Bronze			2022-12-24	WOS:A1988P100000019
J	SWARTZ, R; HOLMES, C				SWARTZ, R; HOLMES, C			MACROPHAGES	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									BAXTER HLTHCARE CORP,MCGAW PK,IL 60085	Baxter International Inc	SWARTZ, R (corresponding author), UNIV MICHIGAN HOSP,ANN ARBOR,MI 48109, USA.								0	1	1	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	1995	333	23					1546	1546		10.1056/NEJM199512073332306	http://dx.doi.org/10.1056/NEJM199512073332306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH157	7477170				2022-12-24	WOS:A1995TH15700006
J	CHAPMAN, LE; FOLKS, TM; SALOMON, DR; PATTERSON, AP; EGGERMAN, TE; NOGUCHI, PD				CHAPMAN, LE; FOLKS, TM; SALOMON, DR; PATTERSON, AP; EGGERMAN, TE; NOGUCHI, PD			XENOTRANSPLANTATION AND XENOGENEIC INFECTIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SIMIAN IMMUNODEFICIENCY VIRUS; CRIMEAN HEMORRHAGIC-FEVER; OUTBREAK; RETROVIRUSES; EVOLUTION; PHYLOGENY; DISEASE; AFRICA; HIV-2		SCRIPPS RES INST, LA JOLLA, CA 92037 USA; US FDA, BETHESDA, MD 20892 USA	Scripps Research Institute; US Food & Drug Administration (FDA)	CHAPMAN, LE (corresponding author), CTR DIS CONTROL, NATL CTR INFECT DIS, DIV AIDS STD & TB LAB RES, RETROVIRUS DIS BRANCH, ATLANTA, GA 30333 USA.		Salomon, Daniel/E-9380-2012					ALDHOUS P, 1990, NATURE, V347, P321, DOI 10.1038/347321c0; Allan Jonathan S., 1995, ILAR J, V37, P37; Beran GW, 1994, HDB ZOONOSES; BROWN P, 1992, LANCET, V340, P24, DOI 10.1016/0140-6736(92)92431-E; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; CHAPMAN LE, 1994, INFECT AGENT DIS, V3, P234; CHARI RS, 1994, NEW ENGL J MED, V331, P234, DOI 10.1056/NEJM199407283310404; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; COURGNAUD V, 1992, J VIROL, V66, P414, DOI 10.1128/JVI.66.1.414-419.1992; DEINHARDT F, 1980, VIRAL ONCOLOGY, P357; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; DOOLITTLE RF, 1990, CURR TOP MICROBIOL, V157, P1; DOOLITTLE RF, 1989, NATURE, V339, P338, DOI 10.1038/339338a0; DUNNING JJ, 1994, PATHOL BIOL, V42, P231; EASTLUND T, 1995, CELL TRANSPLANT, V4, P455, DOI 10.1016/0963-6897(95)00035-V; Fishman Jay A., 1994, Xenotransplantation, V1, P47, DOI 10.1111/j.1399-3089.1994.tb00049.x; FLUGEL RM, 1991, J ACQ IMMUN DEF SYND, V4, P739; FRANCHINI G, 1989, ANN NY ACAD SCI, V554, P81, DOI 10.1111/j.1749-6632.1989.tb22412.x; FRANCHINI G, 1994, AIDS RES HUM RETROV, V10, P1047, DOI 10.1089/aid.1994.10.1047; FRAZIER ME, 1985, ARCH VIROL, V83, P83, DOI 10.1007/BF01310966; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; HOLMES GP, 1995, CLIN INFECT DIS, V20, P421, DOI 10.1093/clinids/20.2.421; JIN MJ, 1994, J VIROL, V68, P8454, DOI 10.1128/JVI.68.12.8454-8460.1994; KALTER SS, 1976, HDB LABORATORY ANIMA, V3, P655; KANKI PJ, 1988, VET MICROBIOL, V17, P309, DOI 10.1016/0378-1135(88)90072-7; KHABBAZ RF, 1994, NEW ENGL J MED, V330, P172, DOI 10.1056/NEJM199401203300304; MARTINI GA, 1969, T ROY SOC TROP MED H, V63, P295, DOI 10.1016/0035-9203(69)90001-7; MCCLURE MA, 1988, P NATL ACAD SCI USA, V85, P2469, DOI 10.1073/pnas.85.8.2469; MICHAELS MG, 1994, TRANSPLANTATION, V57, P1, DOI 10.1097/00007890-199401000-00001; MOORE C, 1992, VET CLIN N AM-FOOD A, V8, P461, DOI 10.1016/S0749-0720(15)30698-8; MYERS G, 1992, RETROVIRIDAE, V1, P57; Nalesnik M A, 1994, Transplant Sci, V4, P61; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; NOWAK R, 1994, SCIENCE, V266, P1148, DOI 10.1126/science.7973690; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; PRUSINER SB, 1995, SCI AM, V272, P48, DOI 10.1038/scientificamerican0195-48; SHIIGI S, 1989, J MED PRIMATOL, V18, P185; Shortridge K F, 1992, Semin Respir Infect, V7, P11; SIMONDS RJ, 1993, AIDS, V7, pS35, DOI 10.1097/00002030-199311002-00008; SMITH DM, 1993, NEW ENGL J MED, V328, P142, DOI 10.1056/NEJM199301143280218; SULEIMAN MNEH, 1980, LANCET, V2, P939; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; VANIN EF, 1994, J VIROL, V68, P4241, DOI 10.1128/JVI.68.7.4241-4250.1994; WILSON ME, 1994, ANN NY ACAD SCI, V740, P1, DOI 10.1111/j.1749-6632.1994.tb19849.x; 1978, WHO ORG 1978, V56, P271; 1992, MMWR-MORBID MORTAL W, V41, P814	46	140	145	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	1995	333	22					1498	1501		10.1056/NEJM199511303332211	http://dx.doi.org/10.1056/NEJM199511303332211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG445	7477153				2022-12-24	WOS:A1995TG44500011
J	KROPSHOFER, H; VOGT, AB; STERN, LJ; HAMMERLING, GJ				KROPSHOFER, H; VOGT, AB; STERN, LJ; HAMMERLING, GJ			SELF-RELEASE OF CLIP IN PEPTIDE LOADING OF HLA-DR MOLECULES	SCIENCE			English	Article							ANTIGEN-PROCESSING MUTANT; INVARIANT CHAIN PEPTIDES; CELL LINE; ASSOCIATION; CONTAINS; BINDING	The assembly and transport of major histocompatibility complex (MHC) class II molecules require interaction with the invariant chain. A fragment of the invariant chain, CLIP, occupies the peptide-binding groove of the class II molecule. At endosomal pH, the binding of CLIP to human MHC class II HLA-DR molecules was counteracted by its amino-terminal segment (residues 81 to 89), which facilitated rapid release. The CLIP(81-89) fragment also catalyzed the release of CLIP(90-105) and a subset of other self-peptides, probably by transient interaction with an effector site outside the groove. Thus, CLIP may facilitate peptide loading through an allosteric release mechanism.	MIT,DEPT CHEM,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	KROPSHOFER, H (corresponding author), GERMAN CANC RES CTR,DEPT MOLEC IMMUNOL,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.							ADAMS S, 1995, EUR J IMMUNOL, V25, P1693, DOI 10.1002/eji.1830250632; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BARNES KA, 1995, J EXP MED, V181, P1715, DOI 10.1084/jem.181.5.1715; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BROOKS AG, 1994, J IMMUNOL, V153, P5382; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GELUK A, 1992, J IMMUNOL, V149, P2864; Ghosh P., COMMUNICATION; GORGA JC, 1987, J BIOL CHEM, V262, P16087; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KROPSHOFER H, 1993, P NATL ACAD SCI USA, V90, P403, DOI 10.1073/pnas.90.2.403; KROPSHOFER H, 1995, P NATL ACAD SCI USA, V92, P8313, DOI 10.1073/pnas.92.18.8313; KROPSHOFER H, 1991, BIOCHEMISTRY-US, V30, P9177, DOI 10.1021/bi00102a008; LEE C, 1995, P NATL ACAD SCI USA, V92, P8269, DOI 10.1073/pnas.92.18.8269; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751	40	93	98	0	0	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 24	1995	270	5240					1357	1359		10.1126/science.270.5240.1357	http://dx.doi.org/10.1126/science.270.5240.1357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF899	7481823				2022-12-24	WOS:A1995TF89900038
J	MACARTHUR, A; MACARTHUR, C; WEEKS, S				MACARTHUR, A; MACARTHUR, C; WEEKS, S			EPIDURAL-ANESTHESIA AND LOW-BACK-PAIN AFTER DELIVERY - A PROSPECTIVE COHORT STUDY	BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM BACKACHE; CHILDBIRTH	Objective-To determine whether epidural anaesthesia during labour and delivery is a risk factor for postpartum back pain. Design-Prospective cohort study with follow up at one day, seven days, and six weeks after delivery. Setting-Teaching hospital in Montreal. Subjects-329 women who delivered a live infant(s) during the study period, Exclusion criteria were back pain before pregnancy and delivery by elective caesarean section. Intervention-Epidural anaesthesia during labour and delivery. Main outcome measures and results-The primary outcome variable was development of postpartum low back pain, Back pain was quantified with self reports (yes/no), a pain score (numeric rating scale), and degree of interference with daily activities. Of the 329 women, 164 received epidural anaesthesia during labour and 165 did not. The incidence of low back pain in epidural v non-epidural group was 53% v 43% on day one; 21% v 23% on day seven; and 14% v 7% at six weeks, The relative risk for low back pain (epidural v non-epidural) adjusted for parity, delivery, ethnicity, and weight was 1.76 (95% confidence interval 1.06 to 2.92) on day one; 1.00 (0.54 to 1.86) on day seven; and 2.22 (0.89 to 5.53) at six weeks. There were no differences between the two groups in pain scores or the frequency of interference with daily activities. Similar results were obtained in the subgroup of women with low back pain of new onset-that is, those women with no back pain during their pregnancy, Conclusions-Postpartum low back pain was common but decreased considerably over the short term, The association between epidural anaesthesia and postpartum low back pain was inconsistent over time with a significantly increased risk of low back pain (epidural v non-epidural) noted only on the first day after delivery.	ROYAL VICTORIA HOSP,DEPT ANAESTHESIA,MONTREAL,PQ H3A 1A1,CANADA; MCGILL UNIV,DEPT EPIDEMIOL & BIOSTAT,MONTREAL,PQ,CANADA	McGill University; Royal Victoria Hospital; McGill University			MacArthur, Christine/ABA-8601-2021	MacArthur, Christine/0000-0003-0434-2158				Alexander J T, 1993, Neurosurg Clin N Am, V4, P153; BREEN TW, 1994, ANESTHESIOLOGY, V81, P29, DOI 10.1097/00000542-199407000-00006; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; GREEN LW, 1970, PUBLIC HEALTH REP, V85, P815, DOI 10.2307/4593972; Hosmer D.W., 1989, APPL LOGISTIC REGRES, P1; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; KITZINGER S, 1987, SOME WOMENS EXPERIEN; KRAMER MS, 1988, CLIN EPIDEMIOLOGY BI, P165; MACARTHUR C, 1990, BRIT MED J, V301, P9, DOI 10.1136/bmj.301.6742.9; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; RUSSELL R, 1993, BRIT MED J, V306, P1299, DOI 10.1136/bmj.306.6888.1299	11	52	54	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1336	1339		10.1136/bmj.311.7016.1336	http://dx.doi.org/10.1136/bmj.311.7016.1336			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496283	Green Published			2022-12-24	WOS:A1995TF90100020
J	SEHGAL, A; ROTHENFLUHHILFIKER, A; HUNTERENSOR, M; CHEN, YF; MYERS, MP; YOUNG, MW				SEHGAL, A; ROTHENFLUHHILFIKER, A; HUNTERENSOR, M; CHEN, YF; MYERS, MP; YOUNG, MW			RHYTHMIC EXPRESSION OF TIMELESS - A BASIS FOR PROMOTING CIRCADIAN CYCLES IN PERIOD GENE AUTOREGULATION	SCIENCE			English	Article							MESSENGER-RNA LEVELS; DROSOPHILA-MELANOGASTER; MOSAIC ANALYSIS; MUTANTS	The clock gene timeless (tim) is required for circadian rhythmicity in Drosophila. The accumulation of tim RNA followed a circadian rhythm, and the phase and period of the tim RNA rhythm were indistinguishable from those that have been reported for per. The tim RNA oscillations were found to be dependent on the presence of PER and TIM proteins, which demonstrates feedback control of tim by a mechanism previously shown to regulate per expression. The cyclic expression of tim appears to dictate the timing of PER protein accumulation and nuclear localization, suggesting that tim promotes circadian rhythms of per and tim transcription by restricting per RNA and PER protein accumulation to separate times of day.	UNIV PENN,MED CTR,CTR SLEEP & RESP NEUROBIOL,PHILADELPHIA,PA 19104; ROCKEFELLER UNIV,CTR BIOL TIMING,HOWARD HUGHES MED INST,NATL SCI FDN SCI & TECHNOL,NEW YORK,NY 10021; ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University; Rockefeller University	SEHGAL, A (corresponding author), UNIV PENN,MED CTR,DEPT NEUROSCI,PHILADELPHIA,PA 19104, USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Rothenfluh, Adrian/0000-0002-3813-5723				ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAYLIES MK, 1993, MOL GENETICS BIOL RH, P123; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EWER J, 1992, J NEUROSCI, V12, P3321; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; ROTHENFLUHHILFI.A, UNPUB; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SEHGAL A, UNPUB; THERKAUF WE, 1986, P NATL ACAD SCI USA, V83, P8477; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZATZ M, 1992, DISCUSS NEUROSCI, V8, P67; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	24	294	306	5	35	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					808	810		10.1126/science.270.5237.808	http://dx.doi.org/10.1126/science.270.5237.808			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481772				2022-12-24	WOS:A1995TC71200044
J	EWY, GA				EWY, GA			THE ABDOMINOJUGULAR TEST - TECHNIQUE AND HEMODYNAMIC CORRELATES	ANNALS OF INTERNAL MEDICINE			English	Article											EWY, GA (corresponding author), UNIV ARIZONA, COLL MED, CARDIOL SECT, TUCSON, AZ 85724 USA.							BARRATTBOYES BG, 1958, J LAB CLIN MED, V51, P72; BRAUNWALD E, 1984, HEART DISEASE TXB CA, P496; BURCH GE, 1954, AM HEART J, V48, P373, DOI 10.1016/0002-8703(54)90025-3; COHN JN, 1982, PERICARDIAL DISEASE, P249; CONSTANT J, 1964, AM HEART J, V67, P701, DOI 10.1016/0002-8703(64)90343-6; DUCAS J, 1983, AM J CARDIOL, V52, P1299, DOI 10.1016/0002-9149(83)90592-1; EWY GA, 1985, SIGNS SYMPTOMS CARDI, P132; HULTGREN HN, 1950, AM HEART J, V39, P592, DOI 10.1016/0002-8703(50)90256-0; HURST JW, 1978, HEART ARTERIES VEINS, P200; MATTHEWS MB, 1958, LANCET, V1, P873; OROURKE RA, 1987, HARRISONS PRINCIPLES, P867; OROURKE RA, 1986, HEART ARTERIES VEINS, P147; PASTEUR W, 1885, LANCET, V2, P524; SINGH SP, 1973, POSTGRAD MED J, V49, P10, DOI 10.1136/pgmj.49.567.10	14	70	72	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	1988	109	6					456	460		10.7326/0003-4819-109-6-456	http://dx.doi.org/10.7326/0003-4819-109-6-456			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2568	3415106				2022-12-24	WOS:A1988Q256800004
J	GERACIOTI, TD; LIDDLE, RA				GERACIOTI, TD; LIDDLE, RA			IMPAIRED CHOLECYSTOKININ SECRETION IN BULIMIA NERVOSA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NIH,CLIN NEUROENDOCRINOL BRANCH,BETHESDA,MD 20205; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; MT ZION HOSP & MED CTR,CELL BIOL LAB,SAN FRANCISCO,CA 94120; MT ZION HOSP & MED CTR,DEPT MED,SAN FRANCISCO,CA 94120; MET CTR,SAN FRANCISCO,CA	National Institutes of Health (NIH) - USA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion					NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK001291, R37DK038626, R01DK038626] Funding Source: NIH RePORTER; NCRR NIH HHS [S07-RR05755] Funding Source: Medline; NIDDK NIH HHS [DK 38626, DK 01291] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM SF, 1982, PSYCHOL MED, V12, P625, DOI 10.1017/S0033291700055732; AGRAS WS, 1987, INT J EAT DISORDER, V6, P29, DOI 10.1002/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2; BAILE CA, 1986, PHYSIOL REV, V66, P172, DOI 10.1152/physrev.1986.66.1.172; BAILE CA, 1985, ANN NY ACAD SCI, V448, P424, DOI 10.1111/j.1749-6632.1985.tb29937.x; BONDAR RJL, 1974, CLIN CHEM, V20, P586; CALAM J, 1982, J CLIN INVEST, V69, P218, DOI 10.1172/JCI110433; COOPER PJ, 1983, BRIT J PSYCHIAT, V142, P139, DOI 10.1192/bjp.142.2.139; CRAWLEY JN, 1985, PEPTIDES, V6, P927, DOI 10.1016/0196-9781(85)90324-9; DOCKRAY GJ, 1976, NATURE, V264, P568, DOI 10.1038/264568a0; HALMI KA, 1981, PSYCHOL MED, V11, P697, DOI 10.1017/S0033291700041192; Harper AA, 1943, J PHYSIOL-LONDON, V102, P115, DOI 10.1113/jphysiol.1943.sp004021; IVY A. C, 1928, AMER JOUR PHYSIOL, V85, P381; KATZMAN MA, 1984, INT J EAT DISORDER, V3, P53; KISSILEFF HR, 1981, AM J CLIN NUTR, V34, P154, DOI 10.1093/ajcn/34.2.154; KISSILEFF HR, 1986, PHYSIOL BEHAV, V38, P563, DOI 10.1016/0031-9384(86)90426-9; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; LIDDLE RA, 1984, GASTROENTEROLOGY, V87, P542; MITCHELL JE, 1986, BIOL PSYCHIAT, V21, P1399, DOI 10.1016/0006-3223(86)90331-8; MITCHELL JE, 1985, AM PSYCHIATRIC ASS A, V4, P464; MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115; MULLER JE, 1977, P NATL ACAD SCI USA, V74, P3035, DOI 10.1073/pnas.74.7.3035; MUTT V, 1976, CLIN ENDOCRINOL, V5, pS175, DOI 10.1111/j.1365-2265.1976.tb03825.x; MYERS RD, 1986, BRAIN RES BULL, V17, P583, DOI 10.1016/0361-9230(86)90229-7; PAGE L, 1978, BIOSCIENCE, V28, P192, DOI 10.2307/1307348; POPE HG, 1986, J CLIN PSYCHIAT, V47, P339; POPE HG, 1985, J CLIN PSYCHOPHARM, V5, P320, DOI 10.1097/00004714-198505060-00003; PYLE RL, 1981, J CLIN PSYCHIAT, V42, P60; REHFELD JF, 1978, J BIOL CHEM, V253, P4022; ROLLS ET, 1983, PHYSIOL BEHAV, V30, P185, DOI 10.1016/0031-9384(83)90003-3; SILVER AJ, 1988, PEPTIDES, V9, P221, DOI 10.1016/0196-9781(88)90254-9; SMITH GP, 1985, ANN NY ACAD SCI, V448, P417, DOI 10.1111/j.1749-6632.1985.tb29936.x; STACHER G, 1985, ANN NY ACAD SCI, V448, P431, DOI 10.1111/j.1749-6632.1985.tb29938.x; VANDERKOOY D, 1984, BRAIN RES, V295, P345, DOI 10.1016/0006-8993(84)90982-X; WALSH BT, 1988, ARCH GEN PSYCHIAT, V45, P471; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed; ZUCKERMAN DM, 1986, AM J PUBLIC HEALTH, V76, P1135, DOI 10.2105/AJPH.76.9.1135; [No title captured]; 1987, DIAGNOSTIC STATISTIC	38	198	201	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	1988	319	11					683	688		10.1056/NEJM198809153191105	http://dx.doi.org/10.1056/NEJM198809153191105			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q0375	3412386				2022-12-24	WOS:A1988Q037500005
J	LUNDEGARDH, G; ADAMI, HO; HELMICK, C; ZACK, M; MEIRIK, O				LUNDEGARDH, G; ADAMI, HO; HELMICK, C; ZACK, M; MEIRIK, O			STOMACH-CANCER AFTER PARTIAL GASTRECTOMY FOR BENIGN ULCER DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CTR DIS CONTROL,ATLANTA,GA 30333; WHO,CH-1211 GENEVA 27,SWITZERLAND	Centers for Disease Control & Prevention - USA; World Health Organization	ADAMI, HO (corresponding author), UNIV HOSP UPPSALA,DEPT SURG,S-75185 UPPSALA,SWEDEN.				NCI NIH HHS [5 R01 CA 40264-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040264] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMI HO, 1987, SCAND J GASTROENTERO, V22, P889, DOI 10.3109/00365528708991931; ARCHER MC, 1982, NUTRITIONAL TOXICOLO, V1, P327; Balfour DC, 1922, ANN SURG, V76, P405, DOI 10.1097/00000658-192209000-00014; BROLLO A, 1981, MINERVA MED, V72, P1921; CAYGILL CPJ, 1986, LANCET, V1, P929; CORREA P, 1975, LANCET, V2, P58; DEWAR P, 1984, J SURG RES, V37, P277, DOI 10.1016/0022-4804(84)90189-6; DOMELLOF L, 1977, AM J SURG, V134, P581, DOI 10.1016/0002-9610(77)90439-1; ERIKSSON SBS, 1984, THESIS U LUND LUND; FISCHER AB, 1983, BRIT J SURG, V70, P552, DOI 10.1002/bjs.1800700915; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; HELSINGEN N, 1956, ANN SURG, V143, P173; JOOSSENS J V, 1981, Nutrition and Cancer, V2, P250; KOBORI O, 1984, J NATL CANCER I, V73, P853; KRAUSE U, 1958, Acta Chir Scand, V114, P341; LIAVAAG K, 1962, ANN SURG, V155, P103, DOI 10.1097/00000658-196201000-00012; MATTSSON B, 1977, 15 SWED BOARD HLTH W; MELLSTROM D, 1982, SCAND J GASTROENTERO, V17, P433, DOI 10.3109/00365528209182082; MIRVISH SS, 1983, JNCI-J NATL CANCER I, V71, P629; MUNOZ N, 1968, INT J CANCER, V3, P809, DOI 10.1002/ijc.2910030614; Nicholls J C, 1979, World J Surg, V3, P731; PEARCE NE, 1986, INT J EPIDEMIOL, V15, P456, DOI 10.1093/ije/15.4.456; POP P, 1983, THESIS U MAASTRICHT; REED PI, 1981, LANCET, V2, P550; ROSS AHM, 1982, NEW ENGL J MED, V307, P519; RUDDELL WSJ, 1976, LANCET, V2, P1037; SCHAFER LW, 1983, NEW ENGL J MED, V309, P1210, DOI 10.1056/NEJM198311173092003; SCHRAGER J, 1967, GUT, V8, P497, DOI 10.1136/gut.8.5.497; SCHRUMPF E, 1977, LANCET, V2, P467; SHUKER DEG, 1981, J ORG CHEM, V46, P2092, DOI 10.1021/jo00323a023; TAKSDAL S, 1973, CANCER-AM CANCER SOC, V32, P162, DOI 10.1002/1097-0142(197307)32:1<162::AID-CNCR2820320123>3.0.CO;2-D; TATSUTA M, 1982, J NATL CANCER I, V69, P59; TOKUDOME S, 1984, CANCER RES, V44, P2208; VISTE A, 1986, LANCET, V2, P502; WATT PCH, 1984, GUT, V25, P246, DOI 10.1136/gut.25.3.246; 1960, CANCER INCIDENCE SWE; 1964, BIOMETRICS, V20, P639	37	176	181	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	1988	319	4					195	200		10.1056/NEJM198807283190402	http://dx.doi.org/10.1056/NEJM198807283190402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P4105	3393171				2022-12-24	WOS:A1988P410500002
J	HENRY, EW; SIDMAN, RL				HENRY, EW; SIDMAN, RL			LONG LIVES FOR HOMOZYGOUS TREMBLER MUTANT MICE DESPITE VIRTUAL ABSENCE OF PERIPHERAL-NERVE MYELIN	SCIENCE			English	Article									HARVARD UNIV,SCH MED,DEPT NEUROPATHOL,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DIV NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	HENRY, EW (corresponding author), PFIZER CENT RES,DEPT CLIN RES,EASTERN POINT RD,GROTON,CT 06340, USA.				NINDS NIH HHS [NS20820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020820] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNASON BGW, 1984, PERIPHERAL NEUROPATH, P2050; AYERS MM, 1973, ACTA NEUROPATHOL, V25, P54, DOI 10.1007/BF00686858; BUNGE RP, 1968, PHYSIOL REV, V48, P197, DOI 10.1152/physrev.1968.48.1.197; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; FRIEDE RL, 1968, J NEUROPATH EXP NEUR, V27, P546; HALLPIKE JF, 1983, MULTIPLE SCLEROSIS P; Henry EW, 1983, J NEUROGENET, V1, P39, DOI 10.3109/01677068309107071; HENRY EW, 1983, J NEUROPATH EXP NEUR, V42, P688, DOI 10.1097/00005072-198311000-00008; HESTON WE, 1951, J HERED, V42, P71, DOI 10.1093/oxfordjournals.jhered.a106167; HODES R, 1953, J NEUROPHYSIOL, V16, P145, DOI 10.1152/jn.1953.16.2.145; HUXLEY AF, 1949, J PHYSIOL-LONDON, V108, P315, DOI 10.1113/jphysiol.1949.sp004335; Lillie RS, 1925, J GEN PHYSIOL, V7, P473, DOI 10.1085/jgp.7.4.473; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4; MEIRI H, 1985, BRAIN RES, V359, P326, DOI 10.1016/0006-8993(85)91444-1; RASMINSKY M, 1984, ANN NY ACAD SCI, V436, P68, DOI 10.1111/j.1749-6632.1984.tb14776.x; Roderick T. H., 1981, Genetic variants and strains of the laboratory mouse., P279; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309	19	59	59	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 15	1988	241	4863					344	346		10.1126/science.3388045	http://dx.doi.org/10.1126/science.3388045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P2272	3388045				2022-12-24	WOS:A1988P227200031
J	WEETMAN, AP; BHANDAL, SK; BURRIN, JM; ROBINSON, K; MCKENNA, W				WEETMAN, AP; BHANDAL, SK; BURRIN, JM; ROBINSON, K; MCKENNA, W			AMIODARONE AND THYROID AUTOIMMUNITY IN THE UNITED-KINGDOM	BRITISH MEDICAL JOURNAL			English	Article									ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND; ROYAL POSTGRAD MED SCH,DEPT CARDIOVASC DIS,LONDON W12 0HS,ENGLAND; HAMMERSMITH HOSP,DEPT PHARM,LONDON W12 0HS,ENGLAND	Imperial College London; Imperial College London; Imperial College London			McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		MCGREGOR AM, 1985, THYROID DISORDERS AS, V22, P209; MONTEIRO E, 1986, BRIT MED J, V292, P227, DOI 10.1136/bmj.292.6515.227; SMYRK TC, 1987, AM J SURG PATHOL, V11, P197, DOI 10.1097/00000478-198703000-00004; WEETMAN AP, 1984, CLIN CHIM ACTA, V138, P237, DOI 10.1016/0009-8981(84)90130-X; WEIRSINGA WM, 1986, POSTGRAD MED J, V62, P909	5	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 2	1988	297	6640					33	33		10.1136/bmj.297.6640.33	http://dx.doi.org/10.1136/bmj.297.6640.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P1000	3408908	Green Published, Bronze			2022-12-24	WOS:A1988P100000028
J	ANNAS, GJ				ANNAS, GJ			WOMEN AND CHILDREN FIRST	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				KIPLING R, 1940, COMPLETE VERSE DEFIN, P432; KRAUTHAMMER C, 1995, WASHINGTON POST 0203, pA19; MAIER T, 1995, NEWSDAY         0622, P6; NORDHEIMER J, 1995, NY TIMES        0606, pB1; PARISI VM, 1995, NEW ENGL J MED, V333, P1635, DOI 10.1056/NEJM199512143332412; ROVNER J, 1995, LANCET, V346, P171, DOI 10.1016/S0140-6736(95)91219-3; SIMPSON AWB, 1984, CANNIBALISM COMMON L, P97; WERTZ RW, 1977, LYING IN HIST CHILDB; 1995, HOSPITAL LENGTH STAY; 1995, AM MED NEWS     0807, P13; 1995, MMWR-MORBID MORTAL W, V44, P335	11	44	45	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	1995	333	24					1647	1651		10.1056/NEJM199512143332420	http://dx.doi.org/10.1056/NEJM199512143332420			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK065	7477216				2022-12-24	WOS:A1995TK06500032
J	CAIRNCROSS, S				CAIRNCROSS, S			VICTORY OVER GUINEAWORM DISEASE - PARTIAL OR PYRRHIC	LANCET			English	Editorial Material							ERADICATION				CAIRNCROSS, S (corresponding author), LONDON SCH HYG & TROP MED,TROP HLTH EPIDEMIOL UNIT,LONDON WC1,ENGLAND.							EDUNGBOLA LD, 1992, AM J TROP MED HYG, V47, P529, DOI 10.4269/ajtmh.1992.47.529; GARETT L, 1995, COMING PLAGUE NEWLY, P47; GREER G, 1994, AM J TROP MED HYG, V50, P393, DOI 10.4269/ajtmh.1994.50.393; HOPKINS DR, 1990, AM J TROP MED HYG, V43, P296, DOI 10.4269/ajtmh.1990.43.296; HOURS M, 1994, T ROY SOC TROP MED H, V88, P559, DOI 10.1016/0035-9203(94)90163-5; RUIZTIBEN E, 1995, EMERG INFECT DIS, V1, P58, DOI 10.3201/eid0102.950205; 1995, GUINEA WORM WRAP UP, V48, P1; 1995, WKLY EPIDEMIOL REC, V70, P29; 1994, WKLY EPIDEMIOL REC, V69, P121; 1995, WKLY EPIDEMIOL REC, V70, P77	10	2	2	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 2	1995	346	8988					1440	1440		10.1016/S0140-6736(95)92465-5	http://dx.doi.org/10.1016/S0140-6736(95)92465-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490984				2022-12-24	WOS:A1995TH15600002
J	KATO, S; ENDOH, H; MASUHIRO, Y; KITAMOTO, T; UCHIYAMA, S; SASAKI, H; MASUSHIGE, S; GOTOH, Y; NISHIDA, E; KAWASHIMA, H; METZGER, D; CHAMBON, P				KATO, S; ENDOH, H; MASUHIRO, Y; KITAMOTO, T; UCHIYAMA, S; SASAKI, H; MASUSHIGE, S; GOTOH, Y; NISHIDA, E; KAWASHIMA, H; METZGER, D; CHAMBON, P			ACTIVATION OF THE ESTROGEN-RECEPTOR THROUGH PHOSPHORYLATION BY MITOGEN-ACTIVATED PROTEIN-KINASE	SCIENCE			English	Article							DEPENDENT TRANSCRIPTIONAL ACTIVATION; HUMAN-BREAST-CANCER; DOMAINS; IDENTIFICATION; BINDING; GROWTH; 4-HYDROXYTAMOXIFEN; TAMOXIFEN; ONCOGENE; ELEMENT	The phosphorylation of the human estrogen receptor (ER) serine residue at position 118 is required for full activity of the ER activation function 1 (AF-1). This Ser(118) is phosphorylated by mitogen-activated protein kinase (MAPK) in vitro and in cells treated with epidermal growth factor (EGF) and insulin-like growth factor (IGF) in vivo. Overexpression of MAPK kinase (MAPKK) or of the guanine nucleotide binding protein Ras, both of which activate MAPK, enhanced estrogen-induced and antiestrogen (tamoxifen);induced transcriptional activity of wild-type ER, but not that of a mutant ER with an alanine in place of Ser(118). Thus, the activity of the amino-terminal AF-1 of the ER is modulated by the phosphorylation of Ser(118) through the Ras-MAPK cascade of the growth factor signaling pathways.	UNIV STRASBOURG 1, INSERM, CNRS, INST GENET BIOL MOLEC & CELLULAIRE, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; TOKYO UNIV AGR, DEPT AGR CHEM, SETAGAYA KU, TOKYO 156, JAPAN; YAMANOUCHI INST DRUG DISCOVERY RES CO LTD, MOLEC MED RES LAB 2, TSUKUBA, IBARAKI 305, JAPAN; KYOTO UNIV, INST VIRUS RES, SAKYO KU, KYOTO 606, JAPAN	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tokyo University of Agriculture; Kyoto University				Kitamoto, Takuya/0000-0002-4008-5497; Metzger, Daniel/0000-0002-5555-046X				ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; ARNOLD SF, 1995, J STEROID BIOCHEM, V52, P159, DOI 10.1016/0960-0760(94)00166-J; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BRUNNER N, 1993, CANCER RES, V53, P3229; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DENTON RR, 1992, J BIOL CHEM, V267, P7263; Efremidis AP, 1989, CANCER J, V2, P288; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FUJIOKA H, 1992, J BIOL CHEM, V267, P926; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1994, ONCOGENE, V9, P1891; GOTTARDIS MM, 1988, CANCER RES, V48, P5183; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; GULLICK W J, 1990, Progress in Growth Factor Research, V2, P1, DOI 10.1016/0955-2235(90)90006-6; HARRIS AL, 1988, BREAST CANCER CELLUL, P93; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; JANES PW, 1994, ONCOGENE, V9, P3601; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; JORDAN VC, 1987, BREAST CANCER RES TR, V10, P31, DOI 10.1007/BF01806132; Kastner P., 1994, Vitamin A in health and disease., P189; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; KATO S, UNPUB; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LEES JA, 1989, J STEROID BIOCHEM, V34, P33, DOI 10.1016/0022-4731(89)90063-0; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; LOVE RR, 1988, BREAST CANCER RES TR, V12, P297, DOI 10.1007/BF01811242; MANGELSDORF DJ, 1994, RETINOIDS, pCH8; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASON S, 1995, BREAST, V4, P11, DOI 10.1016/0960-9776(95)90022-5; MCGUIRE WL, 1991, MOL ENDOCRINOL, V5, P157; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; METZGER D, 1995, MOL ENDOCRINOL, V9, P579, DOI 10.1210/me.9.5.579; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Murphy L C, 1990, Semin Cancer Biol, V1, P305; PETECH SL, 1992, SCIENCE, V257, P1355; ROCHLITZ CF, 1989, CANCER RES, V49, P357; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; WASBURN T, 1991, MOL ENDOCRINOL, V5, P235; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1	47	1605	1669	0	92	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 1	1995	270	5241					1491	1494		10.1126/science.270.5241.1491	http://dx.doi.org/10.1126/science.270.5241.1491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH375	7491495				2022-12-24	WOS:A1995TH37500038
J	KOSSLYN, SM; THOMPSON, WL; KIM, IJ; ALPERT, NM				KOSSLYN, SM; THOMPSON, WL; KIM, IJ; ALPERT, NM			TOPOGRAPHICAL REPRESENTATIONS OF MENTAL IMAGES IN PRIMARY VISUAL-CORTEX	NATURE			English	Article								WE report here the use of positron emission tomography (PET) to reveal that the primary visual cortex is activated when subjects close their eyes and visualize objects. The size of the image is systematically related to the location of maximal activity, which is as expected because the earliest visual areas are spatially organized(1-5). These results were only evident, however, when imagery conditions were compared to a non-imagery baseline in which the same auditory cues were presented (and hence the stimuli were controlled); when a resting baseline was used (and hence brain activation was uncontrolled), imagery activation was obscured because of activation in visual cortex during the baseline condition. These findings resolve a debate in the literature about whether imagery activates early visual cortex(6-11) and indicate that visual mental imagery involves 'depictive' representations, not solely language-like descriptions(12-14). Moreover, the fact that stored visual information can affect processing in even the earliest visual areas suggests that knowledge can fundamentally bias what one sees.	MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT RADIOL,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	KOSSLYN, SM (corresponding author), HARVARD UNIV,DEPT PSYCHOL,33 KIRKLAND ST,CAMBRIDGE,MA 02138, USA.		Park, Irene J. K./D-1798-2010					[Anonymous], 1993, BRAIN ACTIVATION; CHARLOT V, 1992, NEUROPSYCHOLOGIA, V30, P565, DOI 10.1016/0028-3932(92)90059-U; Damasio H., 1993, Society for Neuroscience Abstracts, V19, P1603; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Douglas K. L., 1992, Society for Neuroscience Abstracts, V18, P390; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; KOPS ER, 1990, J COMPUT ASSIST TOMO, V14, P437, DOI 10.1097/00004728-199005000-00022; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; KOSSLYN SM, 1977, COGNITIVE PSYCHOL, V9, P52, DOI 10.1016/0010-0285(77)90004-4; LEBIHAN D, 1993, P NATL ACAD SCI USA, V5, P11802; MENON R, 1993, FUNCTIONAL MRI BRAIN; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; ROLAND PE, 1985, J NEUROPHYSIOL, V53, P1219, DOI 10.1152/jn.1985.53.5.1219; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; TALAIRACH J, 1988, COOPLANAR STREOTAXIC; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981	20	480	494	0	29	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					496	498		10.1038/378496a0	http://dx.doi.org/10.1038/378496a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477406				2022-12-24	WOS:A1995TH05400072
J	STAYTON, PS; SHIMOBOJI, T; LONG, C; CHILKOTI, A; CHEN, GH; HARRIS, JM; HOFFMAN, AS				STAYTON, PS; SHIMOBOJI, T; LONG, C; CHILKOTI, A; CHEN, GH; HARRIS, JM; HOFFMAN, AS			CONTROL OF PROTEIN-LIGAND RECOGNITION USING A STIMULI-RESPONSIVE POLYMER	NATURE			English	Article							POLY(N-ISOPROPYLACRYLAMIDE); IMMUNOASSAY; MEMBRANE; RELEASE; GELS	STIMULI-responsive polymers exhibit reversible phase changes in response to changes in environmental factors such as pH or temperature(1-14). Conjugating such polymers to antibodies and proteins provides molecular systems for applications such as affinity separations, immunoassays and enzyme recovery and recycling(15-25). Here we show that conjugating a temperature-sensitive polymer to a genetically engineered site on a protein allows the protein's ligand binding affinity to be controlled. We synthesized a mutant of the protein streptavidin to enable site-specific conjugation of the responsive polymer near the protein's binding site. Normal binding of biotin to the modified protein occurs below 32 degrees C, whereas above this temperature the polymer collapses and blocks binding. The collapse of the polymer and thus the enabling and disabling of binding, is reversible. Such environmentally triggered control of binding may find many applications in biotechnology and biomedicine, such as the control of enzyme reaction rates and of biosensor activity, and the controlled release of drugs.	UNIV ALABAMA,DEPT CHEM,HUNTSVILLE,AL 35899	University of Alabama System; University of Alabama Huntsville	STAYTON, PS (corresponding author), UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195, USA.		Stayton, Patrick/C-1975-2018	Stayton, Patrick/0000-0001-6939-6371				BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5; BURNS JA, 1991, J ORG CHEM, V56, P2648, DOI 10.1021/jo00008a014; Chen G.H., 1992, POLYM PREPR-ACS, V33, P468; CHEN GH, 1994, J BIOMAT SCI-POLYM E, V5, P371; CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; CHEN GH, 1995, MACROMOL CHEM PHYS, V196, P1251, DOI 10.1002/macp.1995.021960424; CHEN JP, 1990, BIOMATERIALS, V11, P625, DOI 10.1016/0142-9612(90)90019-M; CHIIKOTI A, 1994, BIOCONJ CHEM, V5, P504; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; CUSSLER EL, 1984, AICHE J, V30, P578, DOI 10.1002/aic.690300408; Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6; HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x; IRIE M, 1990, ADV POLYM SCI, V94, P28; ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625; KABRA BG, 1991, POLYM COMMUN, V32, P322; KOKUFUTA E, 1994, J BIOMAT SCI-POLYM E, V6, P35, DOI 10.1163/156856295X00733; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0; MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429; MONJI N, 1994, J BIOMAT SCI-POLYM E, V5, P407, DOI 10.1163/156856294X00112; MONJI N, 1990, BIOCHEM BIOPH RES CO, V172, P652, DOI 10.1016/0006-291X(90)90724-2; OKUZAKI H, 1994, J BIOMAT SCI-POLYM E, V5, P485, DOI 10.1163/156856294X00167; STAYTON PS, 1988, J BIOL CHEM, V267, P13544; TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006; TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; YANG HJ, 1990, J POLYM SCI POL CHEM, V28, P219, DOI 10.1002/pola.1990.080280116; YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0	30	582	601	2	222	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					472	474		10.1038/378472a0	http://dx.doi.org/10.1038/378472a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477401				2022-12-24	WOS:A1995TH05400064
J	BEZRUKOV, SM; VODYANOY, I				BEZRUKOV, SM; VODYANOY, I			NOISE-INDUCED ENHANCEMENT OF SIGNAL-TRANSDUCTION ACROSS VOLTAGE-DEPENDENT ION CHANNELS	NATURE			English	Article							ALAMETHICIN; CONDUCTANCE	THE presence of noise in a signal transduction system usually interferes with its ability to transfer information reliably. But many nonlinear systems can use noise to enhance performance(1), and this phenomenon, called stochastic resonance, may underlie the extraordinary ability of some biological systems to detect and amplify small signals in noisy environments(2-5). Previous work has demonstrated the occurrence of stochastic resonance in a complex system of biological transducers and neural signal pathways(6), but the possibility that it could occur at the sub-cellular level has remained open. Here we report the observation of stochastic resonance in a system of voltage-dependent ion channels formed by the peptide alamethicin. A hundred-fold increase in signal transduction induced by external noise is accompanied by a growth in the output signal-to-noise ratio. The system of ion channels considered here represents the simplest biological system yet known to exhibit stochastic resonance.	OFF NAVAL RES, LONDON NW1 5TH, ENGLAND; ST PETERSBURG NUCL PHYS INST, GATCHINA 188350, RUSSIA; UCL, LONDON, ENGLAND	National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; University of London; University College London	BEZRUKOV, SM (corresponding author), NIH, DIV COMP RES & TECHNOL, BETHESDA, MD 20892 USA.			Vodyanoy, Vitaly/0000-0003-3092-6245				BEZRUKOV SM, 1993, BIOPHYS J, V64, P16, DOI 10.1016/S0006-3495(93)81336-5; BLOCK SM, 1992, SOC GEN PHY, V47, P1; BULSARA AR, 1994, PHYS REV E, V49, P4989, DOI 10.1103/PhysRevE.49.4989; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; HALL JE, 1984, BIOPHYS J, V45, P233, DOI 10.1016/S0006-3495(84)84151-X; Hille B., 1992, IONIC CHANNELS EXCIT; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; Makeyev V. M., 1993, Biophysics (English Translation of Biofizika), V38, P189; PANTAZELOU E, 1995, INT J BIFURCAT CHAOS, V5, P101, DOI 10.1142/S0218127495000089; PETRACCHI D, 1994, BIOPHYS J, V66, P1844, DOI 10.1016/S0006-3495(94)80978-6; POLK C, 13TH P A M NAT COUNC; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	14	338	341	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					362	364		10.1038/378362a0	http://dx.doi.org/10.1038/378362a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	7477370				2022-12-24	WOS:A1995TF89300049
J	DILLNER, J; KNEKT, P; SCHILLER, JT; HAKULINEN, T				DILLNER, J; KNEKT, P; SCHILLER, JT; HAKULINEN, T			PROSPECTIVE SEROEPIDEMIOLOGICAL EVIDENCE THAT HUMAN PAPILLOMAVIRUS TYPE-16 INFECTION IS A RISK FACTOR FOR ESOPHAGEAL SQUAMOUS-CELL CARCINOMA	BRITISH MEDICAL JOURNAL			English	Article							CANCER		NATL PUBL HLTH INST,HELSINKI,FINLAND; FINNISH SOCIAL INSURANCE INST,HELSINKI,FINLAND; NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892; KAROLINSKA INST,DEPT CANC EPIDEMIOL,STOCKHOLM,SWEDEN; FINNISH CANC REGISTRY,SF-00170 HELSINKI,FINLAND	Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Finnish Cancer Registry	DILLNER, J (corresponding author), KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN.		Schiller, John/ABK-8287-2022					CHANG FJ, 1992, GASTROENTEROLOGY, V103, P1336, DOI 10.1016/0016-5085(92)91526-A; HEINO P, 1995, J NATL CANCER I, V87, P437, DOI 10.1093/jnci/87.6.437; KIRNBAUER R, 1994, JNCI-J NATL CANCER I, V86, P494, DOI 10.1093/jnci/86.7.494; KNEKT P, 1988, AM J EPIDEMIOL, V127, P28, DOI 10.1093/oxfordjournals.aje.a114788; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958	5	70	72	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 18	1995	311	7016					1346	1346		10.1136/bmj.311.7016.1346	http://dx.doi.org/10.1136/bmj.311.7016.1346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF901	7496288	Green Published			2022-12-24	WOS:A1995TF90100026
J	REINSCHEID, RK; NOTHACKER, HP; BOURSON, A; ARDATI, A; HENNINGSEN, RA; BUNZOW, JR; GRANDY, DK; LANGEN, H; MONSMA, FJ; CIVELLI, O				REINSCHEID, RK; NOTHACKER, HP; BOURSON, A; ARDATI, A; HENNINGSEN, RA; BUNZOW, JR; GRANDY, DK; LANGEN, H; MONSMA, FJ; CIVELLI, O			ORPHANIN-FQ - A NEUROPEPTIDE THAT ACTIVATES AN OPIOID-LIKE G-PROTEIN-COUPLED RECEPTOR	SCIENCE			English	Article							FUNCTIONAL EXPRESSION; CLONING; BRAIN; CDNA	A heptadecapeptide was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP- binding protein (G protein)- coupled receptor (LC132) that is similar in sequence to opioid receptors. This peptide, orphanin FQ, has a primary structure reminiscent of that of opioid peptides. Nanomolar concentrations of orphanin FQ inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132. This inhibitory activity was not affected by the addition of opioid ligands, nor did the peptide activate opioid receptors. Orphanin FQ bound to its receptor in a saturable manner and with high affinity. When injected intracerebroventricularly into mice, orphanin FQ caused a decrease in locomotor activity but did not induce analgesia in the hot-plate test. However, the peptide produced hyperalgesia in the tail-flick assay. Thus, orphanin FQ may act as a transmitter in the brain by modulating nociceptive and locomotor behavior.	HOFFMANN LA ROCHE AG,CNS RES,DIV PHARMA,CH-4002 BASEL,SWITZERLAND; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; HOFFMANN LA ROCHE AG,DIV PHARMA,GENE TECHNOL RES,CH-4002 BASEL,SWITZERLAND	Roche Holding; Oregon Health & Science University; Roche Holding			Civelli, Olivier/A-8392-2012		NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008562, R21DA009620] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 09620, DA 08562] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; BOURSON A, UNPUB; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; CIVELLI O, 1987, MOL NEUROBIOL, V1, P373, DOI 10.1007/BF02935742; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; HALL ZW, 1987, TRENDS NEUROSCI, V10, P99, DOI 10.1016/0166-2236(87)90049-X; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; LACHOWICZ JE, 1995, J NEUROCHEM, V64, P34; LI CH, 1983, BIOCH CLIN ASPECTS N, P17; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LYNCH DR, 1986, ANNU REV BIOCHEM, V55, P773, DOI 10.1146/annurev.bi.55.070186.004013; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NELSON N, 1987, ANAL BIOCHEM, V165, P287, DOI 10.1016/0003-2697(87)90271-5; REINSCHEID RK, UNPUB; STEVENS CF, 1987, NATURE, V328, P198, DOI 10.1038/328198b0; WANG JB, 1994, FEBS LETT, V348, P75, DOI 10.1016/0014-5793(94)00557-5; WICK MJ, 1994, MOL BRAIN RES, V27, P37, DOI 10.1016/0169-328X(94)90181-3; WOOD PL, 1984, ANALGESICS NEUROCHEM, P175; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736	26	1693	1778	1	47	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 3	1995	270	5237					792	794		10.1126/science.270.5237.792	http://dx.doi.org/10.1126/science.270.5237.792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481766				2022-12-24	WOS:A1995TC71200038
J	REES, DC; COX, M; CLEGG, JB				REES, DC; COX, M; CLEGG, JB			WORLD DISTRIBUTION OF FACTOR-V LEIDEN	LANCET			English	Note							POOR ANTICOAGULANT RESPONSE; ACTIVATED PROTEIN-C; THROMBOPHILIA; EPIDEMIOLOGY; THROMBOSIS	We have analysed 3380 chromosomes (1690 unrelated individuals) from twenty-four populations for the presence of factor V Leiden, an important risk factor in venous thromboembolism, The allele frequency in 618 Europeans was 4.4%, with the highest prevalence among Greeks (7%). It was 0.6% in Asia Minor. Factor V Leiden was not found in any of 1600 chromosomes from Africa, Southeast Asia, Australasia, and the Americas. This distribution may partly explain the rarity of thromboembolic disease in these populations, The high prevalence in Europeans suggests that screening for this mutation should be considered in some circumstances.			REES, DC (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.		Rees, David/B-6789-2011	Rees, David/0000-0003-3647-1050				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BURKITT DP, 1972, BMJ-BRIT MED J, V2, P556, DOI 10.1136/bmj.2.5813.556; COOPER DN, 1994, BAILLIERE CLIN HAEM, V7, P637, DOI 10.1016/S0950-3536(05)80102-7; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; FLINT J, 1993, HUM GENET, V91, P91; KOELEMAN BPC, 1994, BLOOD, V84, P1031; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; NATHWANI AC, 1992, BAILLIERE CLIN HAEM, V5, P383, DOI 10.1016/S0950-3536(11)80025-9; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504	10	1065	1089	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1133	1134		10.1016/S0140-6736(95)91803-5	http://dx.doi.org/10.1016/S0140-6736(95)91803-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475606				2022-12-24	WOS:A1995TB54900013
J	AGASHE, VR; SHASTRY, MCR; UDGAONKAR, JB				AGASHE, VR; SHASTRY, MCR; UDGAONKAR, JB			INITIAL HYDROPHOBIC COLLAPSE IN THE FOLDING OF BARSTAR	NATURE			English	Article							FLOW CIRCULAR-DICHROISM; GLOBULAR-PROTEINS; SECONDARY STRUCTURE; INTERMEDIATE; MECHANISM; STABILITY; FRAMEWORK; PATHWAYS; STATE	Two models are commonly used to describe the poorly understood earliest steps of protein folding. The framework model(1-3) stresses very early formation of nascent secondary structures, which coalesce into a compact, molten, globule-like form(4,5) from which structure slowly develops(6,7). The hydrophobic collapse model(8-10) gives overriding precedence to a nonspecific collapse of the polypeptide chain which facilitates subsequent formation of specific secondary and tertiary structure(11,12). Here we report our analysis of the earliest observable events of the major folding pathway of barstar, a small protein. We compare the kinetics of folding using circular dichroism at 222 nm and 270 nm, intrinsic tryptophan fluorescence, fluorescence of the hydrophobic dye 8-anilino-1-naphthalene-sulphonic acid on binding, and restoration of tryptophan-dansyl fluorescence energy transfer as structure-monitoring probes. We show that the polypeptide chain rapidly collapses (within 4 ms) to a compact globule with a solvent-accessible hydrophobic core(6), but with no optically active secondary or tertiary structure. Thus the earliest event of the major folding pathway of barstar is a nonspecific hydrophobic collapse that does not involve concomitant secondary structure formation.	NATL CTR BIOL SCI,CTR TIFR,BANGALORE 560012,KARNATAKA,INDIA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)								CHAN HS, 1989, J CHEM PHYS, V90, P492, DOI 10.1063/1.456500; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; ELOVE GA, 1992, BIOCHEMISTRY-US, V31, P6876, DOI 10.1021/bi00145a003; FENG HP, 1994, BIOCHEMISTRY-US, V33, P13382, DOI 10.1021/bi00249a026; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; GUIJARRO JI, 1995, BIOCHEMISTRY-US, V34, P2998, DOI 10.1021/bi00009a031; GUTIN AM, 1995, BIOCHEMISTRY-US, V34, P3066, DOI 10.1021/bi00009a038; ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; KAWATA Y, 1991, BIOCHEMISTRY-US, V30, P4367, DOI 10.1021/bi00232a001; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; KHURANA R, 1994, BIOCHEMISTRY-US, V33, P106, DOI 10.1021/bi00167a014; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KUWAJIMA K, 1993, FEBS LETT, V334, P265, DOI 10.1016/0014-5793(93)80691-M; KUWAJIMA K, 1987, FEBS LETT, V221, P115, DOI 10.1016/0014-5793(87)80363-0; MANN CJ, 1993, BIOCHEMISTRY-US, V32, P5282, DOI 10.1021/bi00071a002; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; PTITSYN OB, 1994, PROTEIN ENG, V7, P593, DOI 10.1093/protein/7.5.593; PTITSYN OB, 1973, DOKL AKAD NAUK SSSR+, V210, P1213; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Ptitsyn Oleg B., 1992, P243; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; ROBSON B, 1971, J MOL BIOL, V58, P237, DOI 10.1016/0022-2836(71)90243-9; RODER H, 1994, MECHANISMS PROTEIN F, P26; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P11195, DOI 10.1021/bi00092a032; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; SHASTRY MCR, 1994, PROTEIN SCI, V3, P1409, DOI 10.1002/pro.5560030907; SUGAWARA T, 1991, BIOCHEMISTRY-US, V30, P2698, DOI 10.1021/bi00224a018; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553	31	193	196	1	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 26	1995	377	6551					754	757		10.1038/377754a0	http://dx.doi.org/10.1038/377754a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TB469	7477269				2022-12-24	WOS:A1995TB46900063
J	KAPLAN, KM; MARDER, DC; COCHI, SL; PREBLUD, SR				KAPLAN, KM; MARDER, DC; COCHI, SL; PREBLUD, SR			MUMPS IN THE WORKPLACE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									CTR DIS CONTROL,CTR PREVENT SERV,DIV IMMUNIZAT,ATLANTA,GA 30333; CHICAGO DEPT HLTH,CHICAGO,IL	Centers for Disease Control & Prevention - USA								BART KJ, 1986, DEV BIOL STAND, V55, P45; BEARD CM, 1977, MAYO CLIN PROC, V52, P3; BRUNELL PA, 1968, NEW ENGL J MED, V279, P1357, DOI 10.1056/NEJM196812192792502; CHAIKEN BP, 1987, JAMA-J AM MED ASSOC, V257, P2455; CHEN RT, IN PRESS AM J EPIDEM; COCHI SL, 1988, AM J DIS CHILD, V142, P499, DOI 10.1001/archpedi.1988.02150050037025; FELDMAN HA, 1982, VIRAL INFECTIONS HUM, P419; FRANK JA, 1985, AM J DIS CHILD, V139, P881, DOI 10.1001/archpedi.1985.02140110035024; GOODMAN AK, 1987, AM J PUBLIC HEALTH, V77, P725, DOI 10.2105/AJPH.77.6.725; GUSTAFSON TL, 1982, PEDIATRICS, V70, P550; HAYDEN GF, 1978, PEDIATRICS, V62, P965; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; JONES JF, 1980, J PEDIATR-US, V96, P912, DOI 10.1016/S0022-3476(80)80577-4; KOPLAN JP, 1982, AM J DIS CHILD, V136, P362, DOI 10.1001/archpedi.1982.03970400080021; KURTZ JB, 1982, BR MED J CLIN RES, V284, P47; McGuinness Aims C, 1944, WAR MED, V5, P95; Mumps-United States, 1987, MMWR, V36; PHILIP RN, 1959, AM J HYG, V69, P91; REMAN O, 1986, ARCH DIS CHILD, V61, P80, DOI 10.1136/adc.61.1.80; SIEGEL M, 1966, NEW ENGL J MED, V274, P768, DOI 10.1056/NEJM196604072741404; SOSIN DM, 1987, OCT AM PUBL HLTH ASS; SULLIVAN KM, 1985, PEDIATRICS, V76, P533; WHARTON M, IN PRESS J INFECT DI; WHITE CC, 1985, AM J PUBLIC HEALTH, V75, P739, DOI 10.2105/AJPH.75.7.739; 1987, MMWR, V36, P423; 1987, EC IMPACT CHICAGO EX; 1984, US DEP HLTH HUMAN SE; 1987, MMWR, V36, P496; 1987, MMWR, V36, P409	29	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	1988	260	10					1434	1438		10.1001/jama.260.10.1434	http://dx.doi.org/10.1001/jama.260.10.1434			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P9020	3404601				2022-12-24	WOS:A1988P902000026
J	PEARSON, RB; WETTENHALL, REH; MEANS, AR; HARTSHORNE, DJ; KEMP, BE				PEARSON, RB; WETTENHALL, REH; MEANS, AR; HARTSHORNE, DJ; KEMP, BE			AUTO-REGULATION OF ENZYMES BY PSEUDOSUBSTRATE PROTOTOPES - MYOSIN LIGHT CHAIN KINASE	SCIENCE			English	Article									UNIV MELBOURNE,REPATRIAT GEN HOSP,DEPT MED,HEIDELBERG,VIC 3081,AUSTRALIA; LA TROBE UNIV,DEPT BIOCHEM,BUNDOORA,VIC 3083,AUSTRALIA; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV ARIZONA,DEPT NUTR & FOOD SCI,TUCSON,AZ 85721	Florey Institute of Neuroscience & Mental Health; University of Melbourne; La Trobe University; Baylor College of Medicine; University of Arizona			Pearson, Richard Bruce/I-1451-2013; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019	Pearson, Richard Bruce/0000-0001-5919-5090; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082				BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; CHENG HC, 1985, BIOCHEM J, V231, P655, DOI 10.1042/bj2310655; CHENG HC, 1986, J BIOL CHEM, V261, P989; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; FOSTER C, 1986, ARCH BIOCHEM BIOPHYS, V251, P616, DOI 10.1016/0003-9861(86)90371-1; GUERRIERO V, 1986, BIOCHEMISTRY-US, V25, P8372, DOI 10.1021/bi00374a007; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; IKEBE M, 1987, J BIOL CHEM, V260, P13828; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KENNELLY PJ, 1987, J BIOL CHEM, V262, P11958; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; PAYNE ME, 1986, J BIOL CHEM, V261, P6346; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSON RB, 1986, J BIOL CHEM, V261, P25; PEARSON RW, UNPUB; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P4379, DOI 10.1073/pnas.82.13.4379; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4200, DOI 10.1021/bi00313a029; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; TITANI K, 1984, BIOCHEMISTRY-US, V23, P4193, DOI 10.1021/bi00313a028; WETTENHALL REH, 1986, J BIOL CHEM, V261, P2444	23	140	141	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 19	1988	241	4868					970	973		10.1126/science.3406746	http://dx.doi.org/10.1126/science.3406746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7065	3406746				2022-12-24	WOS:A1988P706500036
J	Lackritz, EM; Satten, GA; AberleGrasse, J; Dodd, RY; Raimondi, VP; Janssen, RS; Lewis, WF; Notari, EP; Petersen, LR				Lackritz, EM; Satten, GA; AberleGrasse, J; Dodd, RY; Raimondi, VP; Janssen, RS; Lewis, WF; Notari, EP; Petersen, LR			Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-HIV; TRANSFUSION; INFECTION; DONORS; PREVALENCE; TYPE-1; SAFETY; TESTS	Background. In the United States, transmission of the human immunodeficiency virus (HIV) by blood transfusion occurs almost exclusively when a recently infected blood donor is infectious but before antibodies to HIV become detectable (during the ''window period''). We estimated the risk of HIV transmission caused by transfusion on the basis of the window period associated with the use of current, sensitive enzyme immunosorbent assays and recent data on HIV incidence among blood donors. Methods. We analyzed demographic and laboratory data on more than 4.1 million blood donations obtained in 1992 and 1993 in 19 regions served by the American National Red Cross, as well as the results of HIV-antibody tests of 4.9 million donations obtained in an additional 23 regions. Results. We estimated that, in the 19 study regions, 1 donation in every 360,000 (95 percent confidence interval, 210,000 to 1,140,000) was made during the window period. In addition, it is estimated that 1 in 2,600,000 donations was HIV-seropositive but was not identified as such because of an error in the laboratory. We estimated that 15 to 42 percent of window-period donations were discarded because they were seropositive on laboratory tests other than the HIV-antibody test. When these results were extrapolated to include the additional 23 Red Cross service regions, there was a risk of 1 case of HIV transmission for every 450,000 to 660,000 donations of screened blood. If the Red Cross centers are assumed to be representative of all U.S. blood centers, among the 12 million donations collected nationally each year an estimated 18 to 27 infectious donations are available for transfusion. Conclusions The estimated risk of transmitting HIV by the transfusion of screened blood is very small and nearly half that estimated previously, primarily because the sensitivity of enzyme immunosorbent assays has been improved.	CTR DIS CONTROL & PREVENT,DIV HIV AIDS PREVENT,STAT & DATA MANAGEMENT BRANCH,ATLANTA,GA 30333; AMER NATL RED CROSS,JEROME H HOLLAND LAB,ROCKVILLE,MD; ORKAND CORP,ATLANTA,GA	Centers for Disease Control & Prevention - USA; American Red Cross	Lackritz, EM (corresponding author), CTR DIS CONTROL & PREVENT,DIV HIV AIDS PREVENT,HIV SEROEPIDEMIOL BRANCH,MAILSTOP E-46,ATLANTA,GA 30333, USA.			Lackritz, Eve/0000-0002-5397-7291; Satten, Glen/0000-0001-7275-5371				BUSCH MP, 1991, NEW ENGL J MED, V325, P1, DOI 10.1056/NEJM199107043250101; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; BUSCH MP, 1995, 1995 NAT I HLTH CONS, P29; CARSON JL, 1992, AM J MED, V92, P45, DOI 10.1016/0002-9343(92)90014-3; COHEN ND, 1989, NEW ENGL J MED, V320, P1172, DOI 10.1056/NEJM198905043201803; COUROUCE AM, 1993, REV FR TRANSFUS HEM, V36, P327, DOI 10.1016/S1140-4639(05)80238-2; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; DOCK NL, 1991, ARCH INTERN MED, V151, P525, DOI 10.1001/archinte.151.3.525; DODD RY, 1994, BLOOD SUPPLY RISKS P, P1; DONAHUE JG, 1990, NEW ENGL J MED, V323, P1709; JACKSON JB, 1990, NEW ENGL J MED, V322, P217, DOI 10.1056/NEJM199001253220402; JOHNSON ES, 1994, TRANSFUSION, V34, P769, DOI 10.1046/j.1537-2995.1994.34994378277.x; KALBFLEISCH JD, 1989, TRANSFUSION, V29, P672, DOI 10.1046/j.1537-2995.1989.29890020437.x; KLEINMAN S, 1988, TRANSFUSION, V28, P499, DOI 10.1046/j.1537-2995.1988.28588337347.x; KLEINMAN S, 1990, ARCH PATHOL LAB MED, V114, P298; KLEINMAN SH, 1989, TRANSFUSION, V29, P572, DOI 10.1046/j.1537-2995.1989.29789369672.x; LINDEN JV, 1994, TRANSFUS MED REV, V8, P169, DOI 10.1016/S0887-7963(94)70109-7; LINDEN JV, 1994, TRANSFUSION, V34, P1016, DOI 10.1046/j.1537-2995.1994.341195065028.x; PETERSEN L, 1992, 8TH INT C AIDS 3RD S, V1; PETERSEN LR, 1994, TRANSFUSION, V34, P283, DOI 10.1046/j.1537-2995.1994.34494233574.x; ROBERTS CR, 1994, ARCH PATHOL LAB MED, V118, P1188; SCHALLA WO, 1995, 2ND NAT C HUM RETR R, P120; SELIK RM, 1994, AM J EPIDEMIOL, V140, P105, DOI 10.1093/oxfordjournals.aje.a117221; SURGENOR DM, 1990, NEW ENGL J MED, V322, P1646, DOI 10.1056/NEJM199006073222306; VAMVAKAS EC, 1994, TRANSFUSION, V34, P471, DOI 10.1046/j.1537-2995.1994.34694295060.x; WARD JW, 1988, NEW ENGL J MED, V318, P473, DOI 10.1056/NEJM198802253180803; YOUNG FE, 1990, TRANSFUSION, V30, P4, DOI 10.1046/j.1537-2995.1990.30190117628.x; 1994, NATIONAL HIV SEROSUR, V3	28	270	281	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	1995	333	26					1721	1725		10.1056/NEJM199512283332601	http://dx.doi.org/10.1056/NEJM199512283332601			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM169	7491134				2022-12-24	WOS:A1995TM16900001
J	SELIK, RM; CHU, SY; WARD, JW				SELIK, RM; CHU, SY; WARD, JW			TRENDS IN INFECTIOUS-DISEASES AND CANCERS AMONG PERSONS DYING OF HIV-INFECTION IN THE UNITED-STATES FROM 1987 TO 1992	ANNALS OF INTERNAL MEDICINE			English	Note							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCYSTIS PROPHYLAXIS; AIDS PATIENTS; SURVIVAL	Objective: To determine trends in the relative frequency of infectious diseases and cancers among U.S. residents dying of human immunodeficiency virus (HIV) infection. Data Source: National multiple-cause mortality data for 1987 to 1992 compiled from death certificates. Subjects: Deaths reported with HIV infection as the underlying cause and with nonunderlying causes that could be secondary to HIV infection. Data Analysis: Trends in the annual percentage of deaths associated with each infectious disease or cancer that accounted for at least 1.0% of all HIV-related deaths. Results: From 1987 to 1992, the percentage of HIV-related deaths associated with the following diseases decreased: pneumocystosis, from 32.5% to 13.8%; cryptococcosis, from 7.7% to 5.0%; and candidiasis, from 2.3% to 1.7%. The percentage of deaths associated with the following diseases increased: nontuberculous mycobacteriosis, from 6.7% to 12.2%; cytomegalovirus disease, from 5.2% to 9.9%; bacterial septicemia, from 9.0% to 11.5%; non-Hodgkin lymphoma, from 3.9% to 5.7%; tuberculosis, from 2.9% to 4.1%; progressive multifocal leukoencephalopathy, from 0.8% to 1.9%; bacterial pneumonia, from 1.2% to 2.1%; and cryptosporidiosis or isosporiasis, from 0.7% to 1.2%, The percentages of deaths associated with toxoplasmosis, Kaposi sarcoma, and pneumonia caused by unspecified organisms had no significant linear trends (ranges from 4.9% to 5.5%, 10.4% to 12.1%, and 17.6% to 18.6%, respectively). Conclusions: The percentage of HIV-related deaths associated with pneumocystosis has decreased dramatically, probably because of chemoprophylaxis and improved treatment. Pneumonia caused by unspecified organisms has now become the leading secondary cause of death among persons dying of HIV infection. Decreases in the percentages of HIV-related deaths associated with cryptococcosis and candidiasis may reflect the use of new antifungal agents such as fluconazole.			SELIK, RM (corresponding author), CTR DIS CONTROL & PREVENT, MAIL STOP E47, 1600 CLIFTON RD, ATLANTA, GA 30333 USA.							BEAMAN MH, 1992, ANN INTERN MED, V117, P163, DOI 10.7326/0003-4819-117-2-163; BUEHLER JW, 1990, AM J PUBLIC HEALTH, V80, P1080, DOI 10.2105/AJPH.80.9.1080; BUEHLER JW, 1992, AM J PUBLIC HEALTH, V82, P1500, DOI 10.2105/AJPH.82.11.1500; CHAISSON RE, 1992, ARCH INTERN MED, V152, P2009, DOI 10.1001/archinte.152.10.2009; HARRIS JE, 1990, JAMA-J AM MED ASSOC, V263, P397, DOI 10.1001/jama.263.3.397; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; KATZ MH, 1994, J INFECT DIS, V170, P198, DOI 10.1093/infdis/170.1.198; KOCHANEK KD, 1995, MONTHLY VITAL STATIS, V43, P70; MASUR H, 1993, NEW ENGL J MED, V329, P898, DOI 10.1056/NEJM199309163291228; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; MUNOZ A, 1993, AM J EPIDEMIOL, V137, P423, DOI 10.1093/oxfordjournals.aje.a116691; NELSON MR, 1994, AIDS, V8, P651, DOI 10.1097/00002030-199405000-00011; PARENTE F, 1994, AM J GASTROENTEROL, V89, P416; SAAH AJ, 1995, JAMA-J AM MED ASSOC, V273, P1197, DOI 10.1001/jama.273.15.1197; SAMET JH, 1994, AM J MED, V97, P347, DOI 10.1016/0002-9343(94)90301-8; SELIK RM, 1987, AIDS, V1, P175; 1989, SAS P243 SAS I INC T, P1351; [No title captured]; 1994, MMWR-MORBID MORTAL W, V43, P826	20	105	105	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1995	123	12					933	936		10.7326/0003-4819-123-12-199512150-00006	http://dx.doi.org/10.7326/0003-4819-123-12-199512150-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK120	7486488				2022-12-24	WOS:A1995TK12000006
J	SAINSBURY, R				SAINSBURY, R			UPPER-LIMB DISEASE IN WOMEN TREATED FOR BREAST-CANCER	LANCET			English	Editorial Material											SAINSBURY, R (corresponding author), ROYAL INFIRM,HUDDERSFIELD,W YORKSHIRE,ENGLAND.							ADAM A, 1995, BRIT MED J, V311, P341, DOI 10.1136/bmj.311.7001.341; Janse A J, 1995, Eur J Surg Oncol, V21, P155, DOI 10.1016/S0748-7983(95)90270-8; TAYLOR PJ, 1995, BRIT J SURG, V82, P1089, DOI 10.1002/bjs.1800820827; 1995, MANAGEMENT ADVERSE E	4	4	4	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	DEC 2	1995	346	8988					1444	1444		10.1016/S0140-6736(95)92469-8	http://dx.doi.org/10.1016/S0140-6736(95)92469-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH156	7490988				2022-12-24	WOS:A1995TH15600006
J	SILLITO, AM; GRIEVE, KL; JONES, HE; CUDEIRO, J; DAVIS, J				SILLITO, AM; GRIEVE, KL; JONES, HE; CUDEIRO, J; DAVIS, J			VISUAL CORTICAL MECHANISMS DETECTING FOCAL ORIENTATION DISCONTINUITIES	NATURE			English	Article							DEPENDENT NEURONAL OSCILLATIONS; CROSS-CORRELATION ANALYSIS; CAT STRIATE CORTEX; RECEPTIVE-FIELDS; HYPERCOMPLEX CELLS; PATTERNS; RESPONSES; DISCRIMINATION; INHIBITION	NEURONS in the primary visual cortex (V1) respond in well defined ways to stimuli within their classical receptive field, but these responses can be modified by stimuli overlying the surrounding area(1-7). For example patch-suppressed cells respond to gratings of a specific orientation within their classical receptive field, but the response diminishes if the grating is expanded to cover the surrounding area(1-7). We report here more complex effects in many such cells. When stimulated at their optimal orientation, introducing a surrounding field at a significantly different (for example, orthogonal) orientation enhanced their output by both a disinhibitory mechanism and an active facilitatory mechanism producing 'supra-optimal' responses. Importantly, some cells responded well if the orientations of centre and surround stimuli were swapped. The output reflected the discontinuity because neither stimulus component alone was effective. Under these stimulus conditions simultaneously recorded cells with orthogonally oriented receptive fields showed correlated firing consistent with neuronal binding to the configuration. We propose a mechanism integrating orientation-dependent information over adjacent areas of visual space to represent focal orientation discontinuities such as junctions or corners.	UNIV LA CORUNA,HOSP JUAN CANALEJO,UNIDAD CIRUGAI,DEPT CIENCAS SALUD 1,EL FERROL,SPAIN	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	SILLITO, AM (corresponding author), INST OPHTHALMOL,DEPT VISUAL SCI,BATH ST,LONDON EC1V 9EL,ENGLAND.			Cudeiro, Javier/0000-0002-6597-6077				ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BERGEN JR, 1983, IEEE T SYST MAN CYB, V13, P857, DOI 10.1109/TSMC.1983.6313080; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7071, DOI 10.1073/pnas.88.16.7071; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; FRIES W, 1977, VISION RES, V17, P1001, DOI 10.1016/0042-6989(77)90002-5; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GRINVALD A, 1994, J NEUROSCI, V14, P2545; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; KEEBLE DRT, 1995, VISION RES, V35, P1991, DOI 10.1016/0042-6989(94)00284-S; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P833, DOI 10.1152/jn.1979.42.3.833; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; SILLITO AM, 1993, EXP BRAIN RES, V93, P6; SILLITO AM, 1977, J PHYSIOL-LONDON, V273, P791, DOI 10.1113/jphysiol.1977.sp012124; TSO DY, 1986, J NEUROSCI, V6, P1160	24	474	486	0	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 30	1995	378	6556					492	496		10.1038/378492a0	http://dx.doi.org/10.1038/378492a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TH054	7477405				2022-12-24	WOS:A1995TH05400071
J	HAN, S; ELTIS, LD; TIMMIS, KN; MUCHMORE, SW; BOLIN, JT				HAN, S; ELTIS, LD; TIMMIS, KN; MUCHMORE, SW; BOLIN, JT			CRYSTAL-STRUCTURE OF THE BIPHENYL-CLEAVING EXTRADIOL DIOXYGENASE FROM A PCB-DEGRADING PSEUDOMONAD	SCIENCE			English	Article							PROTEIN; DEGRADATION; MECHANISM; PATHWAY	Polychlorinated biphenyls (PCBs) typify a class of stable aromatic pollutants that are targeted by bioremediation strategies. In the aerobic degradation of biphenyl by bacteria, the key step of ring cleavage is catalyzed by an Fe(II)-dependent extradiol dioxygenase. The crystal structure of 2,3-dihydroxybiphenyl 1,2-dioxygenase from a PCB-degrading strain of Pseudomonas cepacia has been determined at 1.9 angstrom resolution, The monomer comprises amino- and carboxyl-terminal domains, Structural homology between and within the domains reveals evolutionary relationships within the extradiol dioxygenase family. The iron atom has five ligands in square pyramidal geometry: one glutamate and two histidine side chains, and two water molecules.	PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907; UNIV LAVAL,DEPT BIOCHEM,ST FOY,PQ G1K 7P4,CANADA; GESELL BIOTECHNOL FORSCH MBH,BEREICH MIKROBIOL,D-38124 BRAUNSCHWEIG,GERMANY	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Laval University; Gesellschaft fur Biotechnologische Forschung mbH			Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	NIGMS NIH HHS [GM 52831] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOWICZ DA, 1990, CRIT REV BIOTECHNOL, V10, P241, DOI 10.3109/07388559009038210; ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARCIERO DM, 1985, J BIOL CHEM, V260, P2170; ASTURIAS JA, 1994, J BIOL CHEM, V269, P7807; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERTINI I, 1994, BIOCHEMISTRY-US, V33, P10777, DOI 10.1021/bi00201a027; BOLDT YR, 1995, J BACTERIOL, V177, P1225, DOI 10.1128/jb.177.5.1225-1232.1995; BOLIN JT, UNPUB; BOLIN JT, 1993, MAY ANN M AM CRYST A; BOPP LH, 1986, J IND MICROBIOL, V1, P23, DOI 10.1007/BF01569413; BRUNGER AT, 1992, X PLOR; CCP4, 1979, CCP4 SUITE PROGRAMS; CERDAN P, 1994, J BACTERIOL, V176, P6074, DOI 10.1128/jb.176.19.6074-6081.1994; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; ELTIS LD, 1993, J BIOL CHEM, V268, P2727; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.micro.46.1.565; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HOFER B, 1993, GENE, V130, P47, DOI 10.1016/0378-1119(93)90345-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; HORI K, 1973, J BIOCHEM, V74, P375; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MABROUK PA, 1991, J AM CHEM SOC, V113, P4053, DOI 10.1021/ja00011a001; MINOR W, 1993, XDIS PLAYF; OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0; OHLENDORF DH, 1994, J MOL BIOL, V244, P586, DOI 10.1006/jmbi.1994.1754; OTWINOWSKI Z, 1991, P CCP4 STUDY WEEKEND, P56; RAMOS JL, 1987, SCIENCE, V235, P593, DOI 10.1126/science.3468623; SCARROW RC, 1994, BIOCHEMISTRY-US, V33, P15023, DOI 10.1021/bi00254a011; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; SINGH J, 1992, ATLAS PROTEIN SIDECH; SUGIYAMA K, 1995, P JPN ACAD B-PHYS, V71, P32, DOI 10.2183/pjab.71.32; TIMMIS KN, 1994, ANNU REV MICROBIOL, V48, P525, DOI 10.1146/annurev.mi.48.100194.002521; WASSERFALLEN A, 1991, BIO-TECHNOL, V9, P296, DOI 10.1038/nbt0391-296	39	309	313	2	44	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					976	980		10.1126/science.270.5238.976	http://dx.doi.org/10.1126/science.270.5238.976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481800				2022-12-24	WOS:A1995TD87800045
J	SMITH, CK; REGAN, L				SMITH, CK; REGAN, L			GUIDELINES FOR PROTEIN DESIGN - THE ENERGETICS OF BETA-SHEET SIDE-CHAIN INTERACTIONS	SCIENCE			English	Article							HELIX-FORMING TENDENCIES; TERTIARY STRUCTURE; AMINO-ACIDS; STABILITY; PEPTIDES	To determine the interaction energy between cross-strand pairs of side chains on an antiparallel beta sheet, pairwise amino acid substitutions were made on the solvent-exposed face of the B1 domain of streptococcal protein G, The measured interaction energies were substantial (1.8 kilocalories per mole) and comparable to the magnitude of the beta sheet propensities. The experimental results paralleled the statistical frequency with which the residue pairs are found in beta sheets of known structure.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06520	Yale University								BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11337; CHOU PY, 1973, BIOCHEMISTRY-US, V13, P211; GARRATT RC, 1991, FEBS LETT, V280, P141, DOI 10.1016/0014-5793(91)80223-P; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; LIFSON S, 1980, J MOL BIOL, V139, P627, DOI 10.1016/0022-2836(80)90052-2; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PADMANABHAN S, 1994, J MOL BIOL, V241, P706, DOI 10.1006/jmbi.1994.1545; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; PADMANABHAN S, 1995, PROTEIN SCI, V3, P1992; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SALEMME FR, 1983, PROG BIOPHYS MOL BIO, V42, P95, DOI 10.1016/0079-6107(83)90005-6; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; von Heijne G, 1977, J Mol Biol, V117, P821, DOI 10.1016/0022-2836(77)90073-0; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205	23	235	254	0	23	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					980	982		10.1126/science.270.5238.980	http://dx.doi.org/10.1126/science.270.5238.980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	7481801				2022-12-24	WOS:A1995TD87800046
J	SAUCIER, D; CAIN, DP				SAUCIER, D; CAIN, DP			SPATIAL-LEARNING WITHOUT NMDA RECEPTOR-DEPENDENT LONG-TERM POTENTIATION	NATURE			English	Article							WATER-MAZE; SELECTIVE IMPAIRMENT; SYNAPTIC PLASTICITY; ANTAGONIST; MEMORY; RAT; BLOCKADE; ACQUISITION; MECHANISMS; NPC-17742	HIPPOCAMPAL lesions impair spatial learning in the watermaze(1). Drugs that antagonize N-methyl-D-aspartate (NMDA)-receptor activity, which is required for long-term potentiation (LTP) at various hippocampal synapses(2-4), block LTP and impair watermaze learning(4-6). This has led to the hypothesis that NMDA receptors, through their involvement in LTP, may be necessary for spatial(4-11) and other forms of learning(12,13). We examined this hypothesis using NPC17742 (2R,4R,5S-2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptano acid), a potent and specific antagonist of NMDA receptors(14-17). Here we report that NPC17742 completely blocked dentate gyrus LTP but did not prevent normal spatial learning in rats that had been made familiar with the general task requirements by non-spatial pretraining. Although these results do not rule out a contribution of NMDA-mediated dentate LTP to spatial learning, they indicate that this form of LTP is not required for normal spatial learning in the watermaze.	UNIV WESTERN ONTARIO,GRAD PROGRAM NEUROSCI,LONDON,ON N6A 5C2,CANADA	Western University (University of Western Ontario)	SAUCIER, D (corresponding author), UNIV WESTERN ONTARIO,DEPT PSYCHOL,LONDON,ON N6A 5C2,CANADA.							BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; BAUDRY M, 1988, LONG TERM POTENTIATI; BOBELIS DJ, 1993, J PHARMACOL EXP THER, V264, P845; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; CAIN DP, IN PRESS BEHAV NEURO; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.ne.11.030188.000425; DAVIS S, 1992, J NEUROSCI, V12, P21; FERKANY JW, 1993, J PHARMACOL EXP THER, V264, P256; HARGREAVES EL, 1990, J NEUROSCI, V10, P1472; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; KEITH JR, 1990, PSYCHOBIOLOGY, V18, P251; KOROL DL, 1993, HIPPOCAMPUS, V3, P127, DOI 10.1002/hipo.450030204; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; OLNEY J, 1993, NEUROBIOLOGY CINGULA; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; SAUCIER D, IN PRESS BEHAV NEURO; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; STAUBLI U, 1989, BEHAV NEUROSCI, V103, P54, DOI 10.1037/0735-7044.103.1.54; SUTHERLAND RJ, 1993, HIPPOCAMPUS, V3, P141, DOI 10.1002/hipo.450030206; WILEY JL, 1994, PSYCHOPHARMACOLOGY, V116, P266, DOI 10.1007/BF02245327; WILLETTS J, 1993, J PHARMACOL EXP THER, V265, P1055	28	280	289	1	18	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 9	1995	378	6553					186	189		10.1038/378186a0	http://dx.doi.org/10.1038/378186a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477321				2022-12-24	WOS:A1995TD75900054
J	SILBERSWEIG, DA; STERN, E; FRITH, C; CAHILL, C; HOLMES, A; GROOTOONK, S; SEAWARD, J; MCKENNA, P; CHUA, SE; SCHNORR, L; JONES, T; FRACKOWIAK, RSJ				SILBERSWEIG, DA; STERN, E; FRITH, C; CAHILL, C; HOLMES, A; GROOTOONK, S; SEAWARD, J; MCKENNA, P; CHUA, SE; SCHNORR, L; JONES, T; FRACKOWIAK, RSJ			A FUNCTIONAL NEUROANATOMY OF HALLUCINATIONS IN SCHIZOPHRENIA	NATURE			English	Article							CEREBRAL BLOOD-FLOW; AUDITORY HALLUCINATIONS; AREA; PET	HALLUCINATIONS, perceptions in the absence of external stimuli, are prominent among the core symptoms of schizophrenia. The neural correlates of these brief, involuntary experiences are not well understood, and have not been imaged selectively. We have used new positron emission tomography (PET) methods(1,2) to study the brain state associated with the occurrence of hallucinations in six schizophrenic patients. Here we present a group study of five patients with classic auditory verbal hallucinations despite medication, demonstrating activations in subcortical nuclei (thalamic, striatal), limbic structures (especially hippocampus), and paralimbic regions (parahippocampal and cingulate gyri, as well as orbito-frontal cortex). We also present a case study of a unique, drug-naive patient with visual as well as auditory verbal hallucinations, demonstrating activations in visual and auditory/linguistic association cortices as part of a distributed cortical-subcortical network. Activity in deep brain structures, identified with group analysis, may generate or modulate hallucinations, and the particular neocortical regions entrained in individual patients may affect their specific perceptual content. The interaction of these distributed neural systems provides a biological basis for the bizarre reports of schizophrenic patients.	HAMMERSMITH HOSP, INST NEUROL, WELLCOME DEPT COGNIT NEUROL, LONDON W12 0NN, ENGLAND; NEW YORK HOSP, CORNELL MED CTR, FUNCT NEUROIMAGING LAB, NEW YORK, NY 10021 USA; FULBOURNE HOSP, FULBOURN CB1 5EF, ENGLAND	Imperial College London; University of London; University College London; Cornell University; NewYork-Presbyterian Hospital	SILBERSWEIG, DA (corresponding author), HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, DUCANE RD, LONDON W12 0NN, ENGLAND.		Stern, Emily/E-6035-2011; Frackowiak, Richard/H-4383-2011; Frith, Chris D/A-2171-2009; Frackowiak, Richard S/I-1809-2013	Frackowiak, Richard/0000-0002-3151-822X; Frith, Chris D/0000-0002-8665-0690; McKenna, Peter/0000-0001-5474-1144				ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BOGERTS B, 1993, SCHIZOPHRENIA BULL, V19, P431, DOI 10.1093/schbul/19.2.431; CLEGHORN JM, 1992, AM J PSYCHIAT, V149, P1062; CLEGHORN JM, 1990, BRIT J PSYCHIAT, V157, P562, DOI 10.1192/bjp.157.4.562; CSERNANSKY JG, 1991, BIOL PSYCHIAT, V30, P383, DOI 10.1016/0006-3223(91)90295-W; DELISI LE, 1989, BIOL PSYCHIAT, V25, P835, DOI 10.1016/0006-3223(89)90263-1; DOLAN RJ, 1995, HUMAN BRAIN MAPPIN S, V1, P417; FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; Friston K.J., 1994, HUMAN BRAIN MAPPING, V2, P211, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1992, BRAIN, V115, P367, DOI 10.1093/brain/115.2.367; FRISTON KJ, IN PRESS BIOL SCHIZO; KURACHI M, 1985, EUR NEUROL, V24, P176, DOI 10.1159/000115791; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; MARSH L, 1994, SCHIZOPHR RES, V11, P225, DOI 10.1016/0920-9964(94)90016-7; MATSUDA H, 1988, CLIN NUCL MED, V13, P53, DOI 10.1097/00003072-198801000-00015; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; MCGUIRE PK, IN PRESS PSYCHOL MED; Mesulam M. M., 1985, PRINCIPLES BEHAVIORA, P1; MUSALEK M, 1989, COMPR PSYCHIAT, V30, P99, DOI 10.1016/0010-440X(89)90123-5; NOTARDONATO H, 1989, CLIN NUCL MED, V14, P319, DOI 10.1097/00003072-198905000-00001; OLNEY JW, 1995, BIOL PSYCHIAT, V37, P667, DOI 10.1016/0006-3223(95)94677-O; SILBERSWEIG DA, 1994, J CEREBR BLOOD F MET, V14, P771, DOI 10.1038/jcbfm.1994.98; SILBERSWEIG DA, 1993, J CEREBR BLOOD F MET, V13, P617, DOI 10.1038/jcbfm.1993.80; TALAIRACH J, 1989, CO PLANAR STEREOTAXI; Trimble MR, 1991, PSYCHOSES EPILEPSY; VOLKOW ND, 1987, AM J PSYCHIAT, V144, P151; WEINBERGER DR, 1994, J NEUROPSYCH CLIN N, V6, P419; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; ZEKI S, 1991, J NEUROSCI, V11, P641	30	717	729	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	1995	378	6553					176	179		10.1038/378176a0	http://dx.doi.org/10.1038/378176a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD759	7477318				2022-12-24	WOS:A1995TD75900051
J	ARTENSTEIN, AW; COPPOLA, J; BROWN, AE; CARR, JK; SANDERSBUELL, E; GALBARINI, E; MASCOLA, JR; VANCOTT, TC; SCHONBROOD, P; MCCUTCHAN, FE; BURKE, DS				ARTENSTEIN, AW; COPPOLA, J; BROWN, AE; CARR, JK; SANDERSBUELL, E; GALBARINI, E; MASCOLA, JR; VANCOTT, TC; SCHONBROOD, P; MCCUTCHAN, FE; BURKE, DS			MULTIPLE INTRODUCTIONS OF HIV-1 SUBTYPE-E INTO THE WESTERN-HEMISPHERE	LANCET			English	Note								There are nine recognised genetic subtypes of HIV-1, and the epidemic in Southeast Asia is largely due to subtype E. We have investigated HIV-1 viral subtypes in 11 Uruguayan military personnel, six with infection acquired during a United Nations deployment to Cambodia and five with infection acquired in South America. We found subtype E in five of the six infections acquired in Southeast Asia, and subtype B in all five of the domestically acquired cases. These findings document multiple introductions of HIV-1 subtype E into the western hemisphere and mean that the genetic diversity of the global HIV-1 pandemic must be considered in strategies for epidemic control.	NATL HLTH DIRECTORATE ARMED FORCES,MONTEVIDEO,URUGUAY; HENRY M JACKSON FDN,ROCKVILLE,MD	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	ARTENSTEIN, AW (corresponding author), WALTER REED ARMY INST RES,DIV RETROVIROL,ROCKVILLE,MD 20850, USA.		Mascola, John/AAI-7193-2021	/0000-0002-5704-8094				ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; BERRIOLO R, 1992, AIDS, V6, P884; GAO F, 1994, AIDS RES HUM RETROV, V10, P625, DOI 10.1089/aid.1994.10.625; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; MCCUTCHAN FE, 1992, AIDS RES HUM RETROV, V8, P1887, DOI 10.1089/aid.1992.8.1887; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; MYERS G, 1994, HUMAN RETROVIRUSES A; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407	10	76	76	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	NOV 4	1995	346	8984					1197	1198		10.1016/S0140-6736(95)92900-2	http://dx.doi.org/10.1016/S0140-6736(95)92900-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC976	7475660	Bronze			2022-12-24	WOS:A1995TC97600010
J	NOGUCHI, S; MCNALLY, EM; BENOTHMANE, K; HAGIWARA, Y; MIZUNO, Y; YOSHIDA, M; YAMAMOTO, H; BONNEMANN, CG; GUSSONI, E; DENTON, PH; KYRIAKIDES, T; MIDDLETON, L; HENTATI, F; BENHAMIDA, M; NONAKA, I; VANCE, JM; KUNKEL, LM; OZAWA, E				NOGUCHI, S; MCNALLY, EM; BENOTHMANE, K; HAGIWARA, Y; MIZUNO, Y; YOSHIDA, M; YAMAMOTO, H; BONNEMANN, CG; GUSSONI, E; DENTON, PH; KYRIAKIDES, T; MIDDLETON, L; HENTATI, F; BENHAMIDA, M; NONAKA, I; VANCE, JM; KUNKEL, LM; OZAWA, E			MUTATIONS IN THE DYSTROPHIN-ASSOCIATED PROTEIN GAMMA-SARCOGLYCAN IN CHROMOSOME-13 MUSCULAR-DYSTROPHY	SCIENCE			English	Article							GLYCOPROTEIN COMPLEX; GENE; ORGANIZATION; DOMAIN; ACTIN; CDNA	Severe childhood autosomal recessive muscular dystrophy (SCARMD) is a progressive muscle-wasting disorder common in North Africa that segregates with microsatellite markers at chromosome 13q12. Here, it is shown that a mutation in the gene encoding the 35-kilodalton dystrophin-associated glycoprotein, gamma-sarcoglycan, is likely to be the primary genetic defect in this disorder. The human gamma-sarcoglycan gene was mapped to chromosome 13q12, and deletions that alter its reading frame were identified in three families and one of four sporadic cases of SCARMD. These mutations not only affect gamma-sarcoglycan but also disrupt the integrity of the entire sarcoglycan complex.	CHILDRENS HOSP, DIV GENET, BOSTON, MA 02155 USA; CHILDRENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02155 USA; DUKE UNIV, MED CTR, DEPT MED, DIV NEUROL, DURHAM, NC 27710 USA; CYPRUS INST NEUROL & GENET, NICOSIA, CYPRUS; INST NEUROL, TUNIS, TUNISIA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Duke University; Universite de Tunis-El-Manar; Institut National de Neurologie	NOGUCHI, S (corresponding author), NATL CTR NEUROL & PSYCHIAT, NATL INST NEUROSCI, 4-1-1 OGAWA HIGASHI CHO, KODAIRA, TOKYO 187, JAPAN.		Gussoni, Emanuela/AAL-6150-2021; McNally, Elizabeth/W-4909-2019	Gussoni, Emanuela/0000-0002-9915-3677; Vance, Jeffery/0000-0003-3815-8199; McNally, Elizabeth/0000-0002-1221-719X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740, P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [P01-NS26630, NS23740] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AZIBI K, 1993, HUM MOL GENET, V2, P1423; AZIBI K, 1991, CYTOGENET CELL GENET, V58, P1907; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BENOTHMANE K, 1995, AM J HUM GENET, V57, P732; BENOTHMANE K, UNPUB; BONNEMANN CG, IN PRESS NATURE GENE; BUENO MRP, 1994, AMJ HUM GENET, V55, pA199; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; ELKERCH F, 1994, J MED GENET, V31, P342, DOI 10.1136/jmg.31.4.342; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FARAG TI, 1990, AM J MED GENET, V37, P290, DOI 10.1002/ajmg.1320370229; HAMIDA MB, 1983, MUSCLE NERVE, V6, P469, DOI 10.1002/mus.880060702; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEVINE BA, 1990, FEBS LETT, V263, P159, DOI 10.1016/0014-5793(90)80728-2; LIM LE, IN PRESS NATURE GENE; LJUNGGREN A, 1995, ANN NEUROL, V38, P367, DOI 10.1002/ana.410380305; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; MCNALLY EM, UNPUB; MIZUNO Y, 1994, BIOCHEM BIOPH RES CO, V203, P979, DOI 10.1006/bbrc.1994.2278; MIZUNO Y, UNPUB; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NOGUCHI S, UNPUB; OZAWA E, IN PRESS HUM MOL GEN; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; YAMAMOTO H, 1994, J BIOCHEM-TOKYO, V115, P162, DOI 10.1093/oxfordjournals.jbchem.a124294; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401; ZATZ M, 1989, AM J MED GENET, V32, P407, DOI 10.1002/ajmg.1320320328	35	465	475	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	1995	270	5237					819	822		10.1126/science.270.5237.819	http://dx.doi.org/10.1126/science.270.5237.819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC712	7481775				2022-12-24	WOS:A1995TC71200047
J	EASTWOOD, M				EASTWOOD, M			THE DILEMMA OF LAXATIVE ABUSE	LANCET			English	Editorial Material											EASTWOOD, M (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT MED,GASTROINTESTINAL UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							MORTON J, 1987, ANN CLIN BIOCHEM, V24, P107, DOI 10.1177/000456328702400116; NEIMS DM, 1995, INT J EAT DISORDER, V17, P211, DOI 10.1002/1098-108X(199504)17:3<211::AID-EAT2260170302>3.0.CO;2-I; PHILLIPS S, 1995, ANN INTERN MED, V123, P97, DOI 10.7326/0003-4819-123-2-199507150-00003; READ NW, 1980, GASTROENTEROLOGY, V78, P264; WELTZIN TE, 1995, INT J EAT DISORDER, V17, P141, DOI 10.1002/1098-108X(199503)17:2<141::AID-EAT2260170206>3.0.CO;2-5	5	1	1	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1115	1115		10.1016/S0140-6736(95)91795-0	http://dx.doi.org/10.1016/S0140-6736(95)91795-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TB549	7475598				2022-12-24	WOS:A1995TB54900005
J	JUNGERS, P; HOUILLIER, P; FORGET, D; LABRUNIE, M; SKHIRI, H; GIATRAS, I; DESCAMPSLATSCHA, B				JUNGERS, P; HOUILLIER, P; FORGET, D; LABRUNIE, M; SKHIRI, H; GIATRAS, I; DESCAMPSLATSCHA, B			INFLUENCE OF PREGNANCY ON THE COURSE OF PRIMARY CHRONIC GLOMERULONEPHRITIS	LANCET			English	Article							GLOMERULAR-DISEASE; RENAL-DISEASE; WOMEN	According to some nephrologists, pregnancy has damaging effects on renal function in primary glomerulonephritis, but the evidence is conflicting. We evaluated the effect of pregnancy on the occurrence of end-stage renal failure (ESRF) in 360 patients with various histological forms of primary glomerulonephritis but with normal renal function (serum creatinine less than or equal to 0.11 mmol/L) at presentation. In actuarial analyses, overall ESRF-free survival did not significantly differ between women who became pregnant after clinical onset of renal disease (n=171) and those who did not conceive (n=189). Furthermore, in a case-control study pregnancy did not emerge as a risk factor for progression to ESRF (odds ratio 1.15 [95% CI 0.61-2.18]), whereas the type of glomerulonephritis and hypertension were major determinants. We conclude that pregnancy does not affect the course of renal disease in patients who have normal renal function al conception.	HOP NECKER ENFANTS MALAD,INSERM,U25,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	JUNGERS, P (corresponding author), HOP NECKER ENFANTS MALAD,DEPT NEPHROL,149 RUE SEVRES,F-75015 PARIS,FRANCE.		Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917				ABE S, 1985, AM J OBSTET GYNECOL, V153, P508, DOI 10.1016/0002-9378(85)90463-6; ABE S, 1994, CLIN NEPHROL, V41, P61; BARCELO P, 1986, KIDNEY INT, V30, P914, DOI 10.1038/ki.1986.272; HOU SH, 1985, AM J MED, V78, P185, DOI 10.1016/0002-9343(85)90425-5; IMBASCIATI E, 1986, AM J NEPHROL, V6, P193, DOI 10.1159/000167114; Jungers P, 1986, Adv Nephrol Necker Hosp, V15, P103; KATZ AI, 1980, KIDNEY INT, V18, P192, DOI 10.1038/ki.1980.128; PACKHAM DK, 1989, Q J MED, V266, P537; SURIAN M, 1984, NEPHRON, V36, P101, DOI 10.1159/000183126; 1989, LANCET, V2, P253	10	64	69	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0099-5355			LANCET	Lancet	OCT 28	1995	346	8983					1122	1124		10.1016/S0140-6736(95)91798-5	http://dx.doi.org/10.1016/S0140-6736(95)91798-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475601				2022-12-24	WOS:A1995TB54900008
J	VANITERSON, M; VANDERWAART, FJM; ERDMANN, W; TROUWBORST, A				VANITERSON, M; VANDERWAART, FJM; ERDMANN, W; TROUWBORST, A			SYSTEMIC HEMODYNAMICS AND OXYGENATION DURING HEMODILUTION IN CHILDREN	LANCET			English	Article							HEMODILUTION ANESTHESIA; BLOOD-TRANSFUSION; JEHOVAH WITNESSES; SURGERY; RESECTION	Transfusion of homologous blood should be avoided when possible, and one technique that diminishes perioperative requirement for donor blood is haemodilution. In children its effects on systemic haemodynamics and systemic oxygenation have not been reported. Six children aged 4-12 yr were anaesthetised for major surgery and blood was withdrawn to reduce packed cell volume to 25%. Cardiac index increased from 3.1 (SD 0.5) L min(-1) m(-2) at baseline to 4.4 (0.5) L min(-1) m(-2) at the end of surgery, when packed cell volume was 16 (1)%; this change, compensating for the decline in oxygen carrying capacity, was associated with a fall in systemic vascular resistance and a rise in stroke volume. Oxygen extraction from haemoglobin rose from 0.22 (0.05) to 0.33 (0.06). Perioperative blood loss was 40% of circulating blood volume; however, owing to reinfusion of autologous blood (and use of a cell saver in three patients), the haemoglobin one day after operation was only 19% lower than preoperatively (9.9 [1.5] vs 12.5 [2.5] g/dL). In this study, children seemed at least as able as adults to compensate for the effects of haemodilution, which allowed major surgery without transfusion of homologous blood.	UNIV AMSTERDAM, ACAD MED CTR, DEPT ANAESTHESIOL, 1105 AZ AMSTERDAM, NETHERLANDS; ERASMUS UNIV ROTTERDAM, DEPT ANAESTHESIOL, ROTTERDAM, NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam								ADZICK NS, 1985, J PEDIATR SURG, V20, P372, DOI 10.1016/S0022-3468(85)80222-0; BERKMAN SA, 1988, BLOOD REV, V2, P206, DOI 10.1016/0268-960X(88)90026-4; BLUMBERG N, 1989, TRANSFUSION, V29, P236, DOI 10.1046/j.1537-2995.1989.29389162731.x; CUTLER BS, 1984, SURGERY, V95, P717; DESA VP, 1991, ANESTH ANALG, V72, P645; HENDERSON AM, 1986, ANAESTHESIA, V41, P748, DOI 10.1111/j.1365-2044.1986.tb12846.x; HENLING CE, 1985, J THORAC CARDIOV SUR, V89, P914; KRAFT M, 1981, ANAESTHESIA, V36, P402, DOI 10.1111/j.1365-2044.1981.tb10247.x; LICHTIGER B, 1982, ANESTH ANALG, V61, P618; MESSMER K, 1986, EUR SURG RES, V18, P254, DOI 10.1159/000128533; NADLER SB, 1962, SURGERY, V51, P224; SCHALLER RT, 1983, AM J SURG, V146, P79, DOI 10.1016/0002-9610(83)90263-5; SCHALLER RT, 1984, J PEDIATR SURG, V19, P705, DOI 10.1016/S0022-3468(84)80356-5; SPAHN DR, 1994, ANESTH ANALG, V78, P1000; TOY PTCY, 1987, NEW ENGL J MED, V316, P517, DOI 10.1056/NEJM198702263160906; TROUWBORST A, 1990, LANCET, V336, P1295, DOI 10.1016/0140-6736(90)92973-L; TROUWBORST A, 1990, ANESTH ANALG, V70, P523; ZETTERSTROM H, 1986, ACTA ANAESTH SCAND, V30, P300, DOI 10.1111/j.1399-6576.1986.tb02418.x	18	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	1995	346	8983					1127	1129		10.1016/S0140-6736(95)91800-0	http://dx.doi.org/10.1016/S0140-6736(95)91800-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB549	7475603				2022-12-24	WOS:A1995TB54900010
J	LOELIGER, EA				LOELIGER, EA			DIPYRIDAMOLE AS AN ANTITHROMBOTIC DRUG	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											LOELIGER, EA (corresponding author), UNIV HOSP LEIDEN,2300 RC LEIDEN,NETHERLANDS.							FITZGERALD GA, 1987, NEW ENGL J MED, V316, P1247; LOELIGER EA, 1985, THROMB HAEMOSTASIS, V53, P437; RANHOSKY A, 1987, NEW ENGL J MED, V317, P1734; SULLIVAN JM, 1971, NEW ENGL J MED, V284, P1391, DOI 10.1056/NEJM197106242842501	4	1	1	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	1988	319	14					951	952						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	Q2854	3419462				2022-12-24	WOS:A1988Q285400021
J	STERNBERG, PW				STERNBERG, PW			LATERAL INHIBITION DURING VULVAL INDUCTION IN CAENORHABDITIS-ELEGANS	NATURE			English	Article											STERNBERG, PW (corresponding author), CALTECH,DIV BIOL 156-29,PASADENA,CA 91125, USA.			Sternberg, Paul/0000-0002-7699-0173				AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; BRENNER S, 1974, GENETICS, V77, P71; CAMPOSORTEGA JA, 1985, TRENDS NEUROSCI, V8, P245, DOI 10.1016/0166-2236(85)90097-9; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; GREENWALD I, 1985, CELL, V43, P583, DOI 10.1016/0092-8674(85)90230-2; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; TECHNAU G M, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P445; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wigglesworth VB, 1940, J EXP BIOL, V17, P180; WILCOX M, 1973, J CELL SCI, V12, P707; YOCHEM J, 1988, NATURE, V335	19	197	206	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 6	1988	335	6190					551	554		10.1038/335551a0	http://dx.doi.org/10.1038/335551a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	Q3412	3419532				2022-12-24	WOS:A1988Q341200056
J	BATEMAN, E; PAULE, MR				BATEMAN, E; PAULE, MR			PROMOTER OCCLUSION DURING RIBOSOMAL-RNA TRANSCRIPTION	CELL			English	Article											BATEMAN, E (corresponding author), COLORADO STATE UNIV,DEPT BIOCHEM,FT COLLINS,CO 80523, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022580] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22580] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; BAKER SM, 1986, CELL, V47, P839, DOI 10.1016/0092-8674(86)90795-6; BATEMAN E, 1986, CELL, V47, P445, DOI 10.1016/0092-8674(86)90601-X; BATEMAN E, 1988, MOL CELL BIOL, V8, P1940, DOI 10.1128/MCB.8.5.1940; BATEMAN E, 1985, P NATL ACAD SCI USA, V82, P8004, DOI 10.1073/pnas.82.23.8004; BROWN DD, 1984, CELL, V37, P359, DOI 10.1016/0092-8674(84)90366-0; DEWINTER RFJ, 1986, NUCLEIC ACIDS RES, V14, P6041, DOI 10.1093/nar/14.15.6041; GAY NJ, 1986, BIOCHEM J, V234, P111, DOI 10.1042/bj2340111; GRUMMT I, 1985, CELL, V43, P801, DOI 10.1016/0092-8674(85)90253-3; GRUMMT I, 1986, CELL, V47, P901, DOI 10.1016/0092-8674(86)90805-6; HENDERSON S, 1986, CELL, V47, P891, DOI 10.1016/0092-8674(86)90804-4; HOROWITZ H, 1982, NUCLEIC ACIDS RES, V10, P5447, DOI 10.1093/nar/10.18.5447; IIDA CT, 1985, P NATL ACAD SCI USA, V82, P1668, DOI 10.1073/pnas.82.6.1668; KOWNIN P, 1985, NUCLEIC ACIDS RES, V13, P6237, DOI 10.1093/nar/13.17.6237; KOWNIN P, 1988, MOL CELL BIOL, V8, P747, DOI 10.1128/MCB.8.2.747; KOWNIN P, 1987, CELL, V50, P693, DOI 10.1016/0092-8674(87)90327-8; LABHART P, 1987, CELL, V50, P51, DOI 10.1016/0092-8674(87)90661-1; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; MANIATIS T, 1982, MOL CLONING LABORATO; MCSTAY B, 1986, CELL, V47, P913, DOI 10.1016/0092-8674(86)90806-8; MITCHELSON K, 1987, NUCLEIC ACIDS RES, V15, P9577, DOI 10.1093/nar/15.22.9577; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; MURTIF VL, 1985, NUCLEIC ACIDS RES, V13, P3221, DOI 10.1093/nar/13.9.3221; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; SPINDLER SR, 1978, J BIOL CHEM, V253, P4669; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	33	104	104	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 23	1988	54	7					985	992		10.1016/0092-8674(88)90113-4	http://dx.doi.org/10.1016/0092-8674(88)90113-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	Q3063	3416358				2022-12-24	WOS:A1988Q306300011
J	BRIDGE, JHB; SPITZER, KW; ERSHLER, PR				BRIDGE, JHB; SPITZER, KW; ERSHLER, PR			RELAXATION OF ISOLATED VENTRICULAR CARDIOMYOCYTES BY A VOLTAGE-DEPENDENT PROCESS	SCIENCE			English	Article									UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah	BRIDGE, JHB (corresponding author), UNIV UTAH,NORA ECCLES HARRISON CARDIOVASC RES & TRAINING INST,SALT LAKE CITY,UT 84112, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL131140, R23HL031140, R01HL034288] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34288, HL31140] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARCENASRUIZ L, 1987, SCIENCE, V238, P1720, DOI 10.1126/science.3686010; BLANEY L, 1978, CIRC RES, V43, P520; CHAPMAN RA, 1985, Q J EXP PHYSIOL CMS, V70, P447, DOI 10.1113/expphysiol.1985.sp002928; EISNER DA, 1985, J PHYSIOL-LONDON, V364, P313, DOI 10.1113/jphysiol.1985.sp015747; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P469, DOI 10.1113/jphysiol.1975.sp011026; JUNDT H, 1975, J PHYSIOL-LONDON, V246, P229, DOI 10.1113/jphysiol.1975.sp010888; MEISSNER G, 1987, BIOPHYS J, V51, pA350; ROULET M, 1979, PFLUEGERS ARCH, V379, P359; STEADMAN BW, 1988, IEEE T BIO-MED ENG, V35, P264, DOI 10.1109/10.1375; WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750	11	80	80	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 12	1988	241	4867					823	825		10.1126/science.3406740	http://dx.doi.org/10.1126/science.3406740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P6162	3406740				2022-12-24	WOS:A1988P616200025
J	KATZ, SM; KRUEGER, LJ; FALKNER, B				KATZ, SM; KRUEGER, LJ; FALKNER, B			MICROSCOPIC NEPHROCALCINOSIS IN CYSTIC-FIBROSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HAHNEMANN UNIV, DIV GENET, PHILADELPHIA, PA 19102 USA; HAHNEMANN UNIV, DIV PEDIAT NEPHROL & HYPERTENS, PHILADELPHIA, PA 19102 USA	Drexel University; Drexel University	KATZ, SM (corresponding author), HAHNEMANN UNIV, DIV RENAL PATHOL & ELECTRON MICROSCOPY, BROAD & VINE ST, MS 435, PHILADELPHIA, PA 19102 USA.		Falkner, Bonita/Y-8451-2019					BODIAN M, 1953, FIBROCYSTIC DISEASE; FEIGAL RJ, 1986, ANN NY ACAD SCI, V488, P82; FEIGAL RJ, 1979, PEDIATR RES, V13, P764, DOI 10.1203/00006450-197906000-00009; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GRUSKIN AB, 1973, J PEDIATR-US, V82, P344, DOI 10.1016/S0022-3476(73)80190-8; KATZ S, 1978, PEDIATR RES, V12, P1033, DOI 10.1203/00006450-197811000-00001; KATZ S, 1980, CLIN CHIM ACTA, V100, P245, DOI 10.1016/0009-8981(80)90273-9; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Luna LG, 1968, MANUAL HISTOLOGIC ST; MANGOS JA, 1981, J DENT RES, V60, P19, DOI 10.1177/00220345810600010301; MANGOS JA, 1983, 12TH P ANN M EUR WOR, P21; MCPHERSON MA, 1988, TRENDS BIOCHEM SCI, V13, P10, DOI 10.1016/0968-0004(88)90010-2; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; SCHONI MH, 1987, CELL CALCIUM, V8, P53, DOI 10.1016/0143-4160(87)90036-4; SHAPIRO BL, 1987, LIFE SCI, V40, P2361, DOI 10.1016/0024-3205(87)90510-8; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0	17	73	73	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	1988	319	5					263	266		10.1056/NEJM198808043190502	http://dx.doi.org/10.1056/NEJM198808043190502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5161	3393180				2022-12-24	WOS:A1988P516100002
J	MATSUMURA, M; BECKTEL, WJ; MATTHEWS, BW				MATSUMURA, M; BECKTEL, WJ; MATTHEWS, BW			HYDROPHOBIC STABILIZATION IN T4 LYSOZYME DETERMINED DIRECTLY BY MULTIPLE SUBSTITUTIONS OF ILE-3	NATURE			English	Article									UNIV OREGON,DEPT PHYS,EUGENE,OR 97403; UNIV OREGON,DEPT CHEM,EUGENE,OR 97403	University of Oregon; University of Oregon	MATSUMURA, M (corresponding author), UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97403, USA.							ALBER T, 1988, SCIENCE, V239, P631, DOI 10.1126/science.3277275; ALBER T, 1987, METHOD ENZYMOL, V154, P511; ALBER T, 1987, NATURE, V330, P41, DOI 10.1038/330041a0; ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; ALBER T, 1986, UCLA S MOL CELL BIOL, V39, P307; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P619, DOI 10.1002/bip.360260505; BRYAN P N, 1986, Proteins Structure Function and Genetics, V1, P326; BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P655; Cantor C.R., 1980, BIOPHYS CHEM; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CREIGHTON TE, 1983, BIOPOLYMERS, V22, P49, DOI 10.1002/bip.360220110; DAMODARAN S, 1986, J BIOL CHEM, V261, P7220; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; ELWELL M, 1975, BIOCHIM BIOPHYS ACTA, V386, P309, DOI 10.1016/0005-2795(75)90273-1; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; FERMI G, 1981, HAEMOGLOBIN MYOGLOBI, P97; FEUDLER JH, 1975, J MOL EVOL, V6, P215; GRUTTER MG, 1979, NATURE, V277, P667, DOI 10.1038/277667a0; GRUTTER MG, 1983, BACTERIOPHAGE T4, P356; HAWKES R, 1984, J MOL BIOL, V175, P195, DOI 10.1016/0022-2836(84)90474-1; HECHT MH, 1984, P NATL ACAD SCI-BIOL, V81, P5685, DOI 10.1073/pnas.81.18.5685; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; KATZ BA, 1986, J BIOL CHEM, V261, P5480; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; MATSUMURA M, 1986, NATURE, V323, P356, DOI 10.1038/323356a0; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; MUCHMORE DC, IN PRESS METH ENZYM; MULLER S, 1987, J MOL BIOL, V196, P641; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; REMINGTON SJ, 1978, J MOL BIOL, V118, P81, DOI 10.1016/0022-2836(78)90245-0; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VILLAFRANCA JE, 1987, BIOCHEMISTRY-US, V26, P2182, DOI 10.1021/bi00382a017; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; WELLS JA, 1986, J BIOL CHEM, V261, P6564; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; YATANI K, 1987, P NATL ACAD SCI USA, V84, P4441; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	52	380	384	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					406	410		10.1038/334406a0	http://dx.doi.org/10.1038/334406a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	3405287				2022-12-24	WOS:A1988P529200048
